data_2e34_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e34 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.77 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.308 0.575 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.436 HG13 ' H ' ' A' ' 61' ' ' ALA . 27.9 m -116.5 -24.49 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.259 -0.9 . . . . 0.0 109.008 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.33 108.95 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.41 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -96.93 73.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.695 ' O ' ' O ' ' A' ' 55' ' ' VAL . 39.0 t -48.53 87.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 120.756 -1.215 . . . . 0.0 110.276 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 7' ' ' VAL . 1.6 tmmt? -82.77 36.65 0.5 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.803 0.811 . . . . 0.0 109.18 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.832 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.41 -173.94 3.54 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.775 0.798 . . . . 0.0 111.494 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -121.74 173.61 7.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -161.62 146.96 10.46 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 109.368 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.688 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 91.1 Cg_endo -87.33 126.91 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.343 2.029 . . . . 0.0 113.47 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -74.94 143.17 43.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.38 58.64 9.54 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 9.6 tttp 174.31 -1.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.807 -0.82 . . . . 0.0 108.831 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.5 153.93 24.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.902 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.68 165.95 4.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.668 -179.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 3.1 Cg_exo -49.19 34.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.57 1.513 . . . . 0.0 111.581 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.902 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.67 54.46 0.71 Allowed Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.614 -0.679 . . . . 0.0 109.245 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.717 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 13.3 Cg_endo -80.8 169.89 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.694 1.596 . . . . 0.0 111.729 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.27 -4.43 2.31 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 121.009 1.139 . . . . 0.0 111.039 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.747 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.0 t -110.68 -70.51 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.562 0.696 . . . . 0.0 110.253 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.01 -98.24 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.747 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.12 -55.57 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 CA-C-N 118.007 0.903 . . . . 0.0 109.951 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.434 ' C ' HG13 ' A' ' 23' ' ' VAL . . . -44.44 -12.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.173 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.627 HD13 ' CD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.65 -41.64 3.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.778 -1.201 . . . . 0.0 108.28 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.42 92.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 27' ' ' LEU . 43.1 mt-30 -158.5 -26.87 0.08 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.754 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.7 p80 -78.24 60.35 2.48 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.485 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 85.03 -9.87 64.91 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 84.96 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 112.163 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -157.83 122.61 4.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 108.801 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.691 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.4 mm -97.36 -63.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.609 -0.682 . . . . 0.0 109.732 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.74 -55.59 2.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.693 -1.254 . . . . 0.0 109.537 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 35' ' ' MET . 12.0 mt-10 -46.25 -45.73 17.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.498 -1.376 . . . . 0.0 107.468 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.691 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -54.18 -68.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.244 1.021 . . . . 0.0 109.636 178.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 42' ' ' ASN . 25.9 t -67.03 -38.29 81.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.681 -0.637 . . . . 0.0 110.018 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.1 tptm -45.29 -58.79 3.04 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.98 74.79 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.265 -0.897 . . . . 0.0 109.094 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 2.3 t80 -71.39 -77.26 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 120.368 -1.457 . . . . 0.0 107.124 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.2 t-20 -41.08 -33.95 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.879 -1.138 . . . . 0.0 110.739 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.33 -32.33 72.37 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.918 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.39 -48.54 7.06 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.652 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.541 ' O ' ' O ' ' A' ' 49' ' ' GLY . 1.5 p -58.92 -30.45 67.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.15 -44.78 21.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -57.81 -21.96 44.94 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.585 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.85 -72.46 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.585 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.21 -131.31 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.016 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -121.19 148.0 44.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.254 -1.145 . . . . 0.0 108.779 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.725 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 174.94 -153.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.752 -1.218 . . . . 0.0 110.929 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 2.6 mm -146.12 138.42 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 71' ' ' THR . 2.4 t -138.76 134.44 17.16 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.116 -0.99 . . . . 0.0 110.791 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -71.86 107.24 2.16 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.69 1.594 . . . . 0.0 111.012 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.832 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.1 m -81.1 136.92 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.722 -1.236 . . . . 0.0 111.464 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -130.74 68.04 1.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.551 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.1 mt -68.19 90.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.79 0.805 . . . . 0.0 110.231 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.09 96.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 64' ' ' SER . 50.2 mt -101.07 145.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.515 0.674 . . . . 0.0 110.728 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.77 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.4 m-85 -116.51 139.89 49.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.836 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.42 -32.78 5.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.147 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -50.94 -1.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.836 ' H ' ' C ' ' A' ' 61' ' ' ALA . 11.2 ttm180 75.33 68.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.952 0.882 . . . . 0.0 109.85 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 1.3 t -148.49 147.93 29.66 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.65 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 36.2 p90 -125.29 103.82 8.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.902 -1.124 . . . . 0.0 110.247 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.4 p -101.44 120.75 40.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 110.052 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.65 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.1 148.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.089 -1.007 . . . . 0.0 110.99 177.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.65 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 28.9 t -169.18 91.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.187 0.994 . . . . 0.0 108.491 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.5 147.05 24.65 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.768 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -132.25 125.15 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.397 -1.44 . . . . 0.0 110.604 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.768 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 14.8 p 76.18 150.64 0.13 Allowed Pre-proline 0 N--CA 1.493 1.68 0 CA-C-O 121.244 0.545 . . . . 0.0 109.975 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 73' ' ' PRO . 12.6 Cg_exo -40.8 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.653 2.235 . . . . 0.0 112.993 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.756 ' O ' ' N ' ' A' ' 75' ' ' SER . 25.0 Cg_exo -39.89 168.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.543 1.495 . . . . 0.0 111.905 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 54.05 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.756 ' N ' ' O ' ' A' ' 73' ' ' PRO . 11.2 t -43.05 -21.72 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.654 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 23.6 p90 -43.6 -38.76 3.17 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.77 -16.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 1.9 mt -58.27 -34.33 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.805 ' NH1' ' SD ' ' A' ' 134' ' ' MET . 0.0 OUTLIER -54.12 -49.74 68.47 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 82' ' ' ALA . 4.5 tmtt? -58.27 -64.81 0.79 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.58 -6.28 0.69 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.205 -0.934 . . . . 0.0 109.842 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.665 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -78.86 -82.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 112.216 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 178.88 32.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.957 -1.592 . . . . 0.0 110.464 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.559 ' N ' HD22 ' A' ' 84' ' ' LEU . 2.8 mt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 120.997 -1.296 . . . . 0.0 109.392 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 97' ' ' GLY . 85.6 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.217 0.532 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.441 ' N ' HG13 ' A' ' 96' ' ' VAL . . . 75.86 58.81 3.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.665 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.8 mtt180 -133.71 115.47 14.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.128 -1.219 . . . . 0.0 110.353 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.721 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.43 175.11 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.511 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -120.85 156.58 31.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.983 -1.073 . . . . 0.0 109.055 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.549 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 11.3 t-105 -45.18 -70.37 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 111.229 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.405 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 6.4 tp10 -50.45 -51.71 44.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.575 -1.328 . . . . 0.0 111.242 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -48.72 -44.38 38.24 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.5 m -70.88 -25.9 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.822 -1.551 . . . . 0.0 107.663 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.699 ' O ' ' N ' ' A' ' 109' ' ' LYS . 18.8 mt -65.36 -70.66 0.22 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 105' ' ' LEU . 3.1 tp10 -44.1 -45.7 8.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.935 -1.103 . . . . 0.0 108.566 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 107' ' ' ILE . 35.3 mt -61.26 -31.75 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.111 -0.993 . . . . 0.0 108.698 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.53 -25.98 16.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.347 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -58.08 -73.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 108.286 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.552 ' N ' ' CD ' ' A' ' 110' ' ' GLN . 2.4 mp0 -44.95 -26.1 0.38 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.078 -1.014 . . . . 0.0 108.794 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' LYS . 40.1 tttm -74.91 -8.29 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.803 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.59 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 7.7 ptm -132.87 62.4 61.98 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.056 -1.028 . . . . 0.0 109.861 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.473 ' HD3' ' N ' ' A' ' 112' ' ' MET . 3.0 Cg_endo -67.21 -35.06 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.565 1.51 . . . . 0.0 112.123 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 2.3 t70 174.96 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.359 -0.838 . . . . 0.0 109.107 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -47.96 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 0.0 109.575 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -151.81 -21.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.803 ' CG2' ' H ' ' A' ' 118' ' ' THR . 26.2 m -64.13 -164.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.101 -0.999 . . . . 0.0 109.616 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.803 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.48 -64.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.427 ' H ' HG21 ' A' ' 118' ' ' THR . 0.9 OUTLIER -74.93 141.27 44.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.084 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -59.93 -24.56 64.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.211 1.005 . . . . 0.0 109.12 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.5 -34.65 78.71 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -71.71 -75.18 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.045 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.59 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.0 -40.82 6.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.539 -1.351 . . . . 0.0 109.095 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -51.97 -69.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 108.647 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.658 ' O ' ' N ' ' A' ' 129' ' ' GLY . 23.1 ttt180 -43.35 -35.68 1.61 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.666 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.0 tpp -57.56 -78.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 108.778 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.652 ' O ' ' OG ' ' A' ' 130' ' ' SER . 26.9 mm -48.49 -56.99 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.0 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -67.39 -70.93 0.22 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -42.48 5.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.666 ' N ' ' O ' ' A' ' 126' ' ' MET . 54.3 p -54.72 -47.66 73.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.575 -1.544 . . . . 0.0 107.499 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -51.12 -48.53 61.73 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.785 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.01 -53.4 10.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.657 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.0 t -44.79 -67.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.805 ' SD ' ' NH1' ' A' ' 79' ' ' ARG . 11.6 ttm -49.94 -3.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 89.21 -26.05 9.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.566 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 30.4 t -49.22 165.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.736 -0.861 . . . . 0.0 109.405 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.534 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 87.8 mt-10 -142.8 162.66 34.88 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.755 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.32 165.1 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.721 ' N ' ' O ' ' A' ' 99' ' ' ILE . 6.4 p . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.767 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.338 0.589 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG13 ' H ' ' A' ' 61' ' ' ALA . 27.8 m -115.11 -24.45 3.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.34 100.39 3.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.041 -1.037 . . . . 0.0 110.252 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -87.86 74.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.664 ' O ' ' O ' ' A' ' 55' ' ' VAL . 11.3 t -48.22 87.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.558 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.662 ' HZ1' ' CB ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -81.83 36.29 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.897 0.856 . . . . 0.0 108.817 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.81 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -77.22 -174.46 3.24 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.725 0.774 . . . . 0.0 110.882 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.495 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.42 177.21 6.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.534 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -166.66 146.6 4.96 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 109.213 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HB2' ' CB ' ' A' ' 16' ' ' LYS . 65.8 Cg_endo -84.01 130.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.277 1.984 . . . . 0.0 113.587 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.731 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -76.16 142.77 41.48 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.684 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 51.61 55.35 20.57 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 5.5 mttp 174.53 14.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.695 -0.885 . . . . 0.0 109.212 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.13 154.74 17.08 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.862 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.86 165.74 4.07 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.005 . . . . 0.0 109.487 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 5.3 Cg_exo -51.05 32.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.457 1.438 . . . . 0.0 111.562 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.862 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -154.56 54.31 1.03 Allowed Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.64 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.732 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.84 169.06 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.725 1.617 . . . . 0.0 111.735 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.37 -4.56 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.077 1.185 . . . . 0.0 110.95 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.754 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.0 -72.62 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.796 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.49 -98.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.754 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.3 Cg_exo -59.03 -55.54 1.88 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 118.096 0.948 . . . . 0.0 110.003 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.7 -6.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.412 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.679 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -111.12 -44.07 3.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 179.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.34 88.67 0.01 OUTLIER Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.6 tt0 -150.97 -12.85 0.22 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.538 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 7.8 p-80 -87.73 -36.5 17.32 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.538 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -173.1 -1.49 0.03 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.5 ' O ' ' ND2' ' A' ' 33' ' ' ASN . . . 75.11 83.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 112.058 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 32' ' ' ALA . 31.8 m120 -157.71 120.09 3.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.982 -1.073 . . . . 0.0 108.614 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.8 mm -97.44 -65.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.689 -0.632 . . . . 0.0 109.853 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.492 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -41.42 -56.35 2.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 109.548 -177.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.3 mt-10 -44.69 -48.15 10.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.755 -1.215 . . . . 0.0 107.768 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 1.1 t80 -51.17 -68.17 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.884 1.326 . . . . 0.0 110.034 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 33.9 t -59.21 -37.2 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.805 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 7.1 ttpt -49.56 -65.7 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.08 -32.79 62.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.23 -0.918 . . . . 0.0 109.04 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.0 t80 -73.19 -78.45 0.09 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 7.4 m-20 -41.07 -32.76 0.27 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.856 -1.152 . . . . 0.0 110.745 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -70.04 -32.77 71.07 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.139 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.09 -47.17 7.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.476 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.684 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 8.7 p -59.5 -29.71 68.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.94 -45.27 20.79 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.555 ' OD1' ' O ' ' A' ' 43' ' ' ALA . 12.2 m120 -57.8 -22.14 45.69 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.601 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.32 -73.88 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.601 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -179.64 -127.82 1.15 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.05 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 14' ' ' ALA . 23.1 t70 -123.84 147.26 47.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.216 -1.167 . . . . 0.0 108.817 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.731 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 174.88 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 0.0 110.99 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 2.1 mm -146.82 139.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.403 HG11 ' OG1' ' A' ' 69' ' ' THR . 2.0 t -138.58 133.74 17.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 110.611 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -72.86 97.1 0.88 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.8 1.667 . . . . 0.0 111.03 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.81 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -70.95 134.46 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.675 1.226 . . . . 0.0 111.652 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 28.3 mt-10 -127.16 70.32 1.3 Allowed 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.568 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.2 mt -71.43 89.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.677 0.751 . . . . 0.0 110.5 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.16 95.46 0.09 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 64' ' ' SER . 95.7 mt -98.05 141.0 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.656 -0.653 . . . . 0.0 110.505 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.767 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 4.8 m-85 -115.99 139.82 49.87 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.826 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.81 -30.7 4.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.277 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 6.0 m-20 -53.47 3.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.826 ' H ' ' C ' ' A' ' 61' ' ' ALA . 49.8 mtp180 70.34 68.89 0.21 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.968 0.89 . . . . 0.0 109.793 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 9.5 p -148.97 150.98 33.78 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.2 p90 -128.18 103.76 7.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.992 -1.067 . . . . 0.0 110.105 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.609 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p -101.38 120.79 40.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.15 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.658 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 169.96 149.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.081 -1.012 . . . . 0.0 110.991 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.649 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 29.5 t -168.82 98.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.272 1.034 . . . . 0.0 108.35 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.403 ' OG1' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -107.39 148.2 29.4 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.784 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.2 mptt -133.21 125.09 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.523 -1.361 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.784 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.3 150.34 0.13 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 121.272 0.558 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' O ' ' O ' ' A' ' 73' ' ' PRO . 8.7 Cg_exo -42.88 175.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.548 2.166 . . . . 0.0 112.803 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.61 176.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.502 1.468 . . . . 0.0 111.788 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 47.87 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.774 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -43.71 -22.4 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.99 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.7 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 15.6 p90 -43.84 -37.68 2.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 0.0 108.961 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.644 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.35 -15.79 1.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.653 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 3.9 mt -60.13 -31.85 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.586 ' CD ' ' OG ' ' A' ' 75' ' ' SER . 2.2 mmp_? -56.08 -44.01 78.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.2 tmtm? -65.27 -66.76 0.5 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.407 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.5 -5.26 0.51 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.657 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.01 -80.31 0.19 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.547 -0.721 . . . . 0.0 111.582 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.46 53.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.285 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.446 HD12 ' NE ' ' A' ' 79' ' ' ARG . 2.0 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.236 . . . . 0.0 109.358 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 97' ' ' GLY . 88.5 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.258 0.551 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' N ' ' CG1' ' A' ' 96' ' ' VAL . . . 57.0 65.97 3.19 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.657 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.2 ttt180 -134.32 114.59 13.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 110.007 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -107.42 -169.23 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 108.976 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.436 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.4 OUTLIER -131.58 159.36 38.45 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 0.0 109.219 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.527 ' O ' HG23 ' A' ' 104' ' ' VAL . 18.2 t-105 -50.9 -68.72 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.504 -0.747 . . . . 0.0 110.87 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -51.27 -45.91 62.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.69 -1.256 . . . . 0.0 110.369 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.407 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -50.66 -47.65 58.6 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.234 -0.917 . . . . 0.0 109.777 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -70.78 -24.06 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.951 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.1 mt -66.88 -71.32 0.2 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.491 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 6.1 tm-20 -43.66 -43.12 5.66 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.891 -1.131 . . . . 0.0 108.374 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.4 mt -62.96 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.021 -1.049 . . . . 0.0 108.358 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.41 -27.36 16.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.651 ' N ' ' O ' ' A' ' 105' ' ' LEU . 17.3 mmtt -57.18 -73.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.837 -1.164 . . . . 0.0 108.124 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 109' ' ' LYS . 78.9 mt-30 -44.89 -25.01 0.26 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.006 -1.058 . . . . 0.0 108.769 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 109' ' ' LYS . 23.5 tptt -76.89 -8.25 57.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.919 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.599 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 7.5 ptm -132.27 60.87 53.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.8 Cg_endo -65.88 -40.34 16.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.559 1.506 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 6.9 t70 -178.75 8.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -46.76 -81.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -151.13 -18.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.129 -0.982 . . . . 0.0 109.699 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.817 ' CG2' ' H ' ' A' ' 118' ' ' THR . 26.4 m -65.88 -164.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.629 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.817 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.96 -62.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.266 -0.897 . . . . 0.0 109.865 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.411 ' H ' HG21 ' A' ' 118' ' ' THR . 0.8 OUTLIER -75.31 140.64 43.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -60.3 -23.8 64.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.126 0.965 . . . . 0.0 109.107 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.64 -34.29 77.94 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.78 -75.83 0.13 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.111 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.599 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.09 -31.37 1.35 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.468 -1.395 . . . . 0.0 109.268 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -60.75 -69.76 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 108.496 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.694 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.2 ttp180 -43.67 -44.1 6.22 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.631 ' O ' ' N ' ' A' ' 130' ' ' SER . 2.8 mtt -49.72 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.1 -1.0 . . . . 0.0 108.742 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.584 ' O ' ' OG ' ' A' ' 130' ' ' SER . 18.2 mm -47.28 -67.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.678 0.752 . . . . 0.0 110.076 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -55.23 -69.55 0.13 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.43 -37.29 2.49 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.631 ' N ' ' O ' ' A' ' 126' ' ' MET . 10.5 p -57.08 -54.21 49.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.445 -1.621 . . . . 0.0 107.336 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.625 ' N ' ' HG ' ' A' ' 130' ' ' SER . . . -44.98 -50.36 10.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -44.91 -55.73 5.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.169 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.698 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.8 t -44.91 -67.2 0.31 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.679 ' SD ' ' OG ' ' A' ' 75' ' ' SER . 6.8 ttp -47.79 -3.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.698 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 88.73 -24.72 11.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 31.1 t -52.74 165.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.989 -0.712 . . . . 0.0 109.347 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.553 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 41.7 mt-10 -142.99 163.28 33.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.44 143.84 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 99' ' ' ILE . 5.6 p . . . . . 0 N--CA 1.487 1.386 0 O-C-N 121.56 -0.713 . . . . 0.0 109.292 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.504 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG21 ' N ' ' A' ' 61' ' ' ALA . 27.8 m -123.66 -24.9 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.903 -1.123 . . . . 0.0 110.573 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -154.98 111.66 3.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.731 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -103.78 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.657 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.6 t -49.51 88.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.73 -1.231 . . . . 0.0 110.743 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.7 tmtp? -82.4 38.28 0.54 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.746 0.784 . . . . 0.0 109.358 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.892 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.24 -173.89 3.45 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.843 0.83 . . . . 0.0 111.437 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.98 174.83 7.33 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -167.73 159.66 9.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.85 -1.156 . . . . 0.0 110.159 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 15' ' ' GLY . 11.9 Cg_endo -68.95 109.83 2.24 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.034 1.823 . . . . 0.0 111.37 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.776 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -68.68 38.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.857 -1.152 . . . . 0.0 110.411 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -172.82 -19.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.372 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -144.37 80.39 1.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.642 -1.505 . . . . 0.0 110.408 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.53 166.05 11.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.747 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.0 164.4 4.26 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.874 -1.141 . . . . 0.0 110.086 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' C ' ' HD3' ' A' ' 21' ' ' PRO . 3.5 Cg_exo -54.11 32.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.663 1.575 . . . . 0.0 111.677 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.747 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.0 54.01 5.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.061 -1.024 . . . . 0.0 110.231 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.69 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.8 Cg_endo -84.67 155.11 11.88 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.73 1.62 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.91 -4.62 0.37 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.032 1.155 . . . . 0.0 111.136 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.77 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.9 t -111.85 -69.88 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 0.0 110.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.83 -97.73 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.77 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.8 Cg_exo -57.83 -55.66 2.2 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 CA-C-N 118.017 0.908 . . . . 0.0 110.28 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' C ' HG12 ' A' ' 23' ' ' VAL . . . -52.72 -11.83 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.628 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.634 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -96.51 -53.69 3.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.71 -1.244 . . . . 0.0 108.386 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.88 92.3 0.01 OUTLIER Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.9 tp60 -147.39 -15.05 0.39 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.557 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 4.9 p-80 -84.13 -37.37 22.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.557 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -171.57 -0.92 0.03 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 73.18 84.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.494 -1.003 . . . . 0.0 112.046 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -159.55 120.81 3.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 108.806 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.663 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 50.7 mm -94.4 -64.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.723 -0.61 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.624 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -41.0 -54.38 2.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.791 -1.193 . . . . 0.0 109.774 -176.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 35' ' ' MET . 5.5 mt-10 -48.41 -46.78 37.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.593 -1.317 . . . . 0.0 107.708 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.663 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -53.03 -68.91 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.572 1.177 . . . . 0.0 109.244 178.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 18' ' ' THR . 38.3 t -63.46 -36.84 77.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.706 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.0 mmmt -49.32 -55.55 12.44 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.11 75.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.484 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.439 ' CD2' HG23 ' A' ' 45' ' ' THR . 1.0 OUTLIER -70.13 -77.05 0.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.431 -1.418 . . . . 0.0 107.305 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 7.2 t-20 -41.52 -33.79 0.48 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -67.74 -33.88 75.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.417 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.538 ' CB ' ' NZ ' ' A' ' 70' ' ' LYS . . . -90.72 -53.18 4.52 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.714 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.776 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.8 p -53.35 -31.34 44.03 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.43 -44.71 17.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -54.69 -23.27 16.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.18 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.647 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.78 -85.3 0.53 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.182 -0.949 . . . . 0.0 109.693 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.647 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.82 -141.8 3.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.062 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -118.07 121.15 39.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -1.122 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -156.51 -153.04 0.4 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.483 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 4.6 mm -146.85 142.2 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 t -145.34 137.61 13.38 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 110.238 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -73.52 95.01 0.85 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.872 1.715 . . . . 0.0 111.52 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.892 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -61.44 138.06 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 111.354 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 26.8 tt0 -130.44 70.14 1.45 Allowed 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.614 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.6 mt -70.68 89.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.389 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 100.89 0.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 59' ' ' ILE . 21.1 mt -101.76 137.45 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.589 -0.695 . . . . 0.0 110.615 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.504 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -113.27 137.85 50.88 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.835 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -49.03 -30.76 6.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.583 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.6 m-20 -53.56 1.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.835 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 mtm180 71.05 69.91 0.18 Allowed 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.028 0.918 . . . . 0.0 109.953 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -151.27 126.11 9.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 18.2 p90 -102.53 103.84 14.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.093 -1.005 . . . . 0.0 110.035 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.2 121.31 41.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.1 -1.0 . . . . 0.0 110.227 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.666 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 170.38 148.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.052 . . . . 0.0 111.274 177.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.645 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 30.7 t -168.74 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.263 1.03 . . . . 0.0 108.232 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -98.07 132.4 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.602 ' O ' ' OG1' ' A' ' 71' ' ' THR . 24.5 mmtp -115.82 143.19 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.655 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 1.8 p 55.58 159.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.956 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.7 Cg_exo -38.18 175.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.887 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 75' ' ' SER . 22.8 Cg_exo -42.2 169.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.575 1.516 . . . . 0.0 112.161 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.516 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 58.73 -73.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 73' ' ' PRO . 5.6 p -43.65 -21.65 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 25.4 p90 -43.38 -42.95 4.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.366 -0.834 . . . . 0.0 109.087 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.54 -13.9 3.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.554 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 2.0 mt -61.02 -31.34 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.704 ' NH1' ' CD1' ' A' ' 84' ' ' LEU . 9.6 mmm180 -54.16 -45.81 72.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.2 tmmm? -65.21 -65.75 0.63 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.602 ' CB ' ' OE1' ' A' ' 103' ' ' GLN . . . -57.51 -5.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.671 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.643 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.81 -79.66 0.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 111.686 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 153.49 57.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.085 -1.531 . . . . 0.0 110.674 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.704 ' CD1' ' NH1' ' A' ' 79' ' ' ARG . 9.0 mt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.143 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 97' ' ' GLY . 87.4 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.273 0.559 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 96' ' ' VAL . . . 65.53 65.64 2.8 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.2 mtt180 -132.53 115.31 15.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.269 -1.136 . . . . 0.0 109.93 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 173.31 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.549 -0.719 . . . . 0.0 109.539 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.471 HG21 ' NE2' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -113.99 150.46 33.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.042 . . . . 0.0 109.092 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.535 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.0 t-105 -46.3 -67.6 0.27 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.347 -0.846 . . . . 0.0 110.897 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.505 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.68 -49.29 57.65 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.557 -1.34 . . . . 0.0 110.68 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.602 ' OE1' ' CB ' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -48.97 -45.93 42.84 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.884 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.4 -24.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 117.979 -1.489 . . . . 0.0 107.797 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.795 ' O ' ' N ' ' A' ' 109' ' ' LYS . 19.3 mt -66.22 -71.71 0.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 105' ' ' LEU . 86.7 tt0 -43.99 -44.95 7.6 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.892 -1.13 . . . . 0.0 108.472 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 67.2 mt -61.58 -32.47 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 108.493 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -95.8 -24.71 16.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.169 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.795 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.6 tptp -63.16 -74.55 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 109' ' ' LYS . 26.1 mt-30 -44.5 -27.85 0.51 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.984 -1.073 . . . . 0.0 108.772 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 109' ' ' LYS . 33.7 tttp -66.57 -13.66 61.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.578 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 5.5 ptm -131.02 69.25 82.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.638 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -68.82 -46.63 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.68 1.587 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.534 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 40.1 p30 -171.1 6.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 108.952 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -45.02 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.798 . . . . 0.0 109.577 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.765 HD21 ' N ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -150.89 -12.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.186 -0.946 . . . . 0.0 109.649 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.848 ' CG2' ' H ' ' A' ' 118' ' ' THR . 31.8 m -77.99 -164.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.848 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER 178.56 -57.2 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.264 -0.898 . . . . 0.0 109.576 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 1.1 p30 -63.27 132.25 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.513 -0.742 . . . . 0.0 109.998 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.602 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -67.22 -28.7 68.29 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.488 1.137 . . . . 0.0 108.469 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -64.45 -34.52 78.4 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.637 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.52 -76.27 0.1 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.68 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.578 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.58 -42.1 10.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.478 -1.389 . . . . 0.0 109.339 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.602 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -50.4 -69.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 108.806 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.49 -38.57 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.612 ' O ' ' N ' ' A' ' 130' ' ' SER . 13.4 tpp -53.79 -79.22 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.603 ' O ' ' OG ' ' A' ' 130' ' ' SER . 22.9 mm -47.29 -65.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.666 0.746 . . . . 0.0 110.289 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -57.5 -69.71 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.38 -37.8 2.62 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.645 ' HG ' ' N ' ' A' ' 131' ' ' ALA . 15.9 p -57.18 -53.79 54.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.506 -1.585 . . . . 0.0 107.451 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.645 ' N ' ' HG ' ' A' ' 130' ' ' SER . . . -45.0 -50.28 10.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.785 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.65 -55.01 6.88 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.696 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.6 t -44.74 -67.29 0.3 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 7.1 ttp -47.77 -3.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.696 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 87.62 -13.9 59.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 131' ' ' ALA . 35.7 t -69.36 135.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.997 -0.707 . . . . 0.0 109.444 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.87 167.25 10.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.97 125.95 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.666 ' N ' ' O ' ' A' ' 99' ' ' ILE . 11.2 p . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.563 -0.71 . . . . 0.0 109.736 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.761 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.464 HG13 ' H ' ' A' ' 61' ' ' ALA . 27.7 m -113.48 -24.53 3.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.214 -0.929 . . . . 0.0 108.52 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.66 112.27 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.05 -1.032 . . . . 0.0 110.273 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.9 p -100.47 73.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.15 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 55' ' ' VAL . 13.6 t -50.08 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.444 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.8 tmtp? -82.96 37.87 0.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.885 0.85 . . . . 0.0 109.168 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.815 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -77.28 -174.13 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.01 0.91 . . . . 0.0 111.395 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.6 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.73 174.94 7.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -164.42 147.06 7.29 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 0.0 109.361 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.637 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 80.0 Cg_endo -86.17 126.17 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.331 2.021 . . . . 0.0 113.213 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -72.28 143.06 48.87 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.714 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 53.01 61.86 6.5 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 8.7 tttp 174.08 -25.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.573 -0.957 . . . . 0.0 108.823 -177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 152.67 19.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.913 -1.117 . . . . 0.0 108.373 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.869 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.36 165.8 8.57 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.038 -1.039 . . . . 0.0 110.009 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 4.8 Cg_exo -50.25 36.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.721 1.614 . . . . 0.0 111.733 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.869 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.5 54.47 0.73 Allowed Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.68 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.698 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.2 Cg_endo -79.18 169.68 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.66 1.573 . . . . 0.0 111.849 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.59 -4.68 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.256 1.304 . . . . 0.0 111.29 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.779 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 5.2 t -113.23 -70.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.623 -0.673 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.07 -97.83 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.2 Cg_exo -58.72 -55.54 1.99 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 CA-C-N 117.97 0.885 . . . . 0.0 110.384 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' HG12 ' A' ' 23' ' ' VAL . . . -48.77 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.643 . . . . 0.0 110.779 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.615 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -103.24 -48.44 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.261 . . . . 0.0 107.956 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.27 86.74 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.4 mt-30 -146.33 -20.12 0.44 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.673 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 6.9 p80 -79.49 -38.24 34.92 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.595 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -170.89 -4.42 0.03 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 84.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.966 . . . . 0.0 112.346 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -158.92 120.11 3.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.076 -1.015 . . . . 0.0 108.711 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.71 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 26.4 mm -93.42 -66.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.728 -0.608 . . . . 0.0 110.076 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.709 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.8 tpt -41.14 -57.71 1.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.664 -1.273 . . . . 0.0 109.728 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.5 mm-40 -44.95 -47.06 11.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.56 -1.337 . . . . 0.0 107.793 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.71 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -53.05 -68.84 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.466 1.127 . . . . 0.0 109.899 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.655 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 21.9 t -66.38 -37.7 80.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.775 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.709 ' N ' ' O ' ' A' ' 35' ' ' MET . 44.1 tptt -45.67 -61.81 1.55 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.55 69.25 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 108.85 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 3.3 t80 -70.91 -77.07 0.09 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.655 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 1.9 m-80 -41.35 -32.23 0.29 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.953 -1.092 . . . . 0.0 110.751 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -69.52 -33.22 72.5 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.93 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -90.52 -47.07 7.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.612 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.714 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 2.2 p -58.6 -31.34 67.97 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.2 -46.04 21.47 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.97 -22.46 38.36 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 0.0 108.922 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.751 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.63 -73.98 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.406 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.751 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 175.17 -154.66 18.66 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 1.8 t0 -96.28 146.49 24.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.291 . . . . 0.0 108.934 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.74 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 175.01 -153.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.816 -1.178 . . . . 0.0 110.869 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 2.2 mm -146.09 137.36 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' CG1' ' HG1' ' A' ' 69' ' ' THR . 2.6 t -137.94 136.15 19.49 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.807 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.8 Cg_endo -72.78 104.66 1.78 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.803 1.669 . . . . 0.0 111.07 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.815 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.5 m -78.34 135.98 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 111.362 -178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.5 tt0 -129.07 69.98 1.4 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.555 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.2 mt -70.24 90.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.855 0.836 . . . . 0.0 109.967 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.59 95.88 1.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 64' ' ' SER . 60.1 mt -100.11 143.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.58 -0.7 . . . . 0.0 110.672 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.761 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.6 m-85 -114.46 138.0 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.823 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -46.43 -31.45 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.227 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.29 2.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.823 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 71.87 66.92 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.137 0.97 . . . . 0.0 109.631 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.4 OUTLIER -149.17 125.15 10.63 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.1 p90 -103.75 104.16 14.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.124 -0.985 . . . . 0.0 110.139 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.87 120.92 41.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.035 . . . . 0.0 110.249 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.652 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.7 OUTLIER 170.38 148.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.962 -1.086 . . . . 0.0 111.214 177.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.652 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 29.6 t -169.39 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.254 1.026 . . . . 0.0 108.639 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.489 ' HG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -106.59 149.2 27.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.758 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -133.63 122.98 24.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.343 -1.473 . . . . 0.0 110.525 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.758 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.8 p 76.02 148.8 0.12 Allowed Pre-proline 0 N--CA 1.492 1.661 0 CA-C-O 121.272 0.558 . . . . 0.0 110.235 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.2 Cg_exo -42.32 175.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.573 2.182 . . . . 0.0 112.803 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.0 Cg_exo -38.87 174.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.498 1.466 . . . . 0.0 111.855 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.507 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 53.03 -84.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 73' ' ' PRO . 71.8 p -44.67 -23.15 0.11 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 111.36 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.684 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 14.1 p90 -43.81 -39.59 3.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.174 -0.954 . . . . 0.0 109.199 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 76' ' ' TYR . 3.5 pp -135.05 -14.6 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.509 ' N ' HD11 ' A' ' 77' ' ' LEU . 6.6 mt -61.15 -31.22 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.753 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 10.8 mmt180 -55.38 -44.78 76.4 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -64.22 -66.89 0.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -58.51 -4.94 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.083 -1.011 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.638 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.21 -80.36 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 111.725 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 175.76 28.47 0.03 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.437 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.497 HD11 HH11 ' A' ' 79' ' ' ARG . 3.1 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.973 -1.31 . . . . 0.0 109.135 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 20.8 t . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.305 0.574 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 136' ' ' VAL . . . 72.37 50.46 16.11 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.777 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.58 114.46 14.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.133 -1.216 . . . . 0.0 109.966 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.37 -174.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -127.51 159.8 33.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.4 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.534 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 19.3 t-105 -50.61 -69.61 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.5 -0.75 . . . . 0.0 110.84 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.49 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.24 -46.76 55.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.686 -1.259 . . . . 0.0 110.352 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.19 -47.61 45.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.689 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.3 m -72.11 -23.43 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.097 -1.441 . . . . 0.0 107.99 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' A' ' 109' ' ' LYS . 17.8 mt -68.09 -73.47 0.14 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 79.5 tt0 -44.03 -41.26 5.32 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.969 -1.082 . . . . 0.0 108.436 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.421 ' CD1' HD12 ' A' ' 77' ' ' LEU . 48.4 mt -64.6 -30.71 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.128 -0.983 . . . . 0.0 108.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -95.73 -26.86 15.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.3 mtpm? -58.54 -73.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.992 -1.067 . . . . 0.0 108.402 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 109' ' ' LYS . 64.7 mt-30 -45.99 -27.38 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 108.911 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -70.99 -17.68 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.772 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.687 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.04 67.22 79.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.143 -0.973 . . . . 0.0 109.761 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.91 -33.5 32.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.574 1.516 . . . . 0.0 112.088 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 8.0 p30 174.96 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 109.207 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.25 -77.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.552 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -150.51 -25.02 0.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.792 ' CG2' ' H ' ' A' ' 118' ' ' THR . 23.8 m -65.65 -164.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.973 . . . . 0.0 109.59 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.792 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.42 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 0.0 109.921 -179.144 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.98 141.0 57.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 110.113 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -61.37 -22.04 64.59 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.24 1.019 . . . . 0.0 108.919 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.76 -37.81 87.35 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.504 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -69.22 -75.33 0.11 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.232 -1.387 . . . . 0.0 107.83 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.43 -42.09 6.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.462 -1.399 . . . . 0.0 109.32 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -50.29 -68.76 0.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.106 -0.996 . . . . 0.0 108.609 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.696 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.71 -41.95 5.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.653 ' O ' ' N ' ' A' ' 130' ' ' SER . 4.9 tpp -52.84 -80.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.077 -1.014 . . . . 0.0 109.082 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.625 ' O ' ' OG ' ' A' ' 130' ' ' SER . 19.4 mm -46.57 -62.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.478 -0.764 . . . . 0.0 110.019 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -59.65 -69.6 0.2 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -39.07 3.38 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.669 ' HG ' ' N ' ' A' ' 131' ' ' ALA . 27.5 p -56.48 -52.0 66.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.516 -1.579 . . . . 0.0 107.592 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.669 ' N ' ' HG ' ' A' ' 130' ' ' SER . . . -46.94 -49.05 21.23 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.17 -53.98 9.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.688 ' C ' ' H ' ' A' ' 135' ' ' GLY . 9.9 t -44.83 -67.17 0.31 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.753 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 10.1 ttm -49.23 -2.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.688 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 88.07 -26.27 7.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.231 -1.947 . . . . 0.0 108.231 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.576 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 30.1 t -49.49 165.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.864 . . . . 0.0 109.47 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 39.2 mp0 -141.99 162.48 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.627 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.4 164.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.699 ' N ' ' O ' ' A' ' 99' ' ' ILE . 3.7 p . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.74 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.292 0.568 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 61' ' ' ALA . 27.8 m -115.13 -24.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.19 -0.944 . . . . 0.0 108.478 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.75 107.59 5.39 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.258 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -95.59 73.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.714 ' O ' ' O ' ' A' ' 55' ' ' VAL . 18.1 t -46.78 89.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.662 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 7' ' ' VAL . 6.0 tmtt? -82.62 34.81 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.792 0.806 . . . . 0.0 108.909 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.845 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.36 -174.57 3.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.678 0.751 . . . . 0.0 111.17 -178.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.6 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -122.19 172.83 7.98 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -166.58 156.99 10.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 110.059 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 15' ' ' GLY . 11.3 Cg_endo -68.56 111.24 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.979 1.786 . . . . 0.0 111.668 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.742 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -69.85 39.22 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.982 -1.073 . . . . 0.0 110.499 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -175.0 -20.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.509 -1.805 . . . . 0.0 111.487 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -142.61 88.4 2.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.609 -1.524 . . . . 0.0 110.291 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.459 ' HB1' ' ND2' ' A' ' 42' ' ' ASN . . . -105.14 164.53 11.75 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.16 164.54 4.11 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 109.367 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.56 30.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.309 1.339 . . . . 0.0 111.781 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.74 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -151.62 54.07 1.27 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 110.02 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.74 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 19.8 Cg_endo -86.47 168.74 8.52 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.904 1.736 . . . . 0.0 111.614 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.1 -4.63 1.06 Allowed 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 120.935 1.09 . . . . 0.0 110.765 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.739 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.98 -71.25 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.477 0.656 . . . . 0.0 109.911 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.41 -98.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.739 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -59.39 -55.83 1.62 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-N 118.11 0.955 . . . . 0.0 109.961 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.67 -6.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.358 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.688 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -111.09 -44.58 3.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.77 -1.206 . . . . 0.0 108.803 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.34 84.32 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 27' ' ' LEU . 66.3 tp60 -149.07 -12.44 0.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.386 -1.067 . . . . 0.0 108.214 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.599 ' ND1' ' C ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -85.46 -37.13 20.1 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.543 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -170.21 2.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.75 78.6 0.18 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.84 -0.8 . . . . 0.0 111.969 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -156.54 120.57 4.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.004 -1.06 . . . . 0.0 108.688 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.593 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 30.1 mm -98.55 -63.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.724 -0.61 . . . . 0.0 109.746 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.47 ' C ' ' O ' ' A' ' 34' ' ' ILE . 4.9 tpt -41.39 -55.31 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.733 -1.229 . . . . 0.0 109.653 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' MET . 15.8 mt-10 -46.76 -48.3 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 107.741 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.613 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.8 OUTLIER -50.67 -68.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.945 1.355 . . . . 0.0 109.177 177.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG12 HD21 ' A' ' 42' ' ' ASN . 45.6 t -54.17 -34.68 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.608 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 1.5 mmmp? -56.55 -65.8 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.76 64.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.71 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.446 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -71.31 -76.74 0.1 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.5 m-80 -41.65 -34.54 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.512 1.148 . . . . 0.0 110.583 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' O ' ' CG ' ' A' ' 47' ' ' ASN . . . -66.45 -35.67 80.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.77 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.77 -52.0 5.09 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.683 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.742 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.1 p -54.32 -29.45 47.84 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.52 -47.2 12.44 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.553 ' CG ' ' O ' ' A' ' 43' ' ' ALA . 7.6 m120 -52.38 -23.24 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.318 -0.864 . . . . 0.0 108.983 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.641 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.65 -85.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.678 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.641 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.23 -135.77 1.89 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.855 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.29 125.87 44.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -1.106 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.643 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -159.4 -153.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.459 ' N ' ' HB1' ' A' ' 14' ' ' ALA . 4.5 mm -147.44 143.85 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.498 ' CG1' ' HG1' ' A' ' 69' ' ' THR . 5.9 t -145.16 136.94 12.93 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.2 Cg_endo -74.12 90.0 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.823 1.682 . . . . 0.0 110.763 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.845 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.9 m -61.98 137.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 122.783 1.278 . . . . 0.0 112.365 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.4 mt-10 -128.81 64.34 1.45 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mt -64.98 89.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.697 0.76 . . . . 0.0 110.501 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.22 96.89 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.1 mt -99.31 144.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.63 -0.669 . . . . 0.0 110.368 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.74 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 5.0 m-85 -115.81 140.3 49.36 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.85 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.75 -29.61 4.7 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.235 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 55.4 p30 -53.67 4.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.85 ' H ' ' C ' ' A' ' 61' ' ' ALA . 79.1 mtm180 69.05 68.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.985 0.898 . . . . 0.0 109.655 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 p -147.76 128.85 14.58 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -105.51 103.96 13.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.978 -1.076 . . . . 0.0 110.422 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 58' ' ' THR . 8.3 p -98.72 124.64 43.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.71 172.02 7.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.569 -1.332 . . . . 0.0 109.417 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.686 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 89.8 t -162.83 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 112.622 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.515 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.53 117.28 4.38 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.67 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.813 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.15 120.96 41.51 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.784 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.93 150.53 0.13 Allowed Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.434 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.631 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.7 Cg_exo -38.62 175.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.817 2.345 . . . . 0.0 113.35 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.763 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.72 166.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.574 1.516 . . . . 0.0 111.788 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 55.01 -76.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.763 ' N ' ' O ' ' A' ' 73' ' ' PRO . 55.3 p -43.17 -24.29 0.08 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 110.128 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.675 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 20.0 p90 -43.59 -43.16 5.5 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 0.0 109.227 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.584 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.88 -13.86 2.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.076 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 1.5 mt -62.33 -33.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.783 ' CG ' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.81 -40.81 73.27 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 82' ' ' ALA . 1.8 tmtp? -68.91 -66.33 0.59 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.76 -4.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.695 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.79 -80.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 111.958 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.01 52.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.049 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.559 HD11 ' HE ' ' A' ' 79' ' ' ARG . 18.3 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 120.844 -1.386 . . . . 0.0 109.045 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 97' ' ' GLY . 83.5 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.313 0.578 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.446 ' N ' ' CG1' ' A' ' 96' ' ' VAL . . . 72.75 63.66 2.8 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.695 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.4 mtt180 -134.72 112.48 10.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -1.205 . . . . 0.0 110.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -102.79 177.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.646 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -119.33 151.89 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 108.979 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.527 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 23.4 t-105 -45.93 -69.96 0.12 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 110.91 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.492 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 5.8 tp10 -49.23 -50.36 38.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.718 -1.239 . . . . 0.0 111.018 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.403 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 3.6 mt-30 -51.72 -42.09 62.01 Favored 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.509 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 105' ' ' LEU . 2.4 m -71.56 -26.1 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 117.46 -1.696 . . . . 0.0 107.184 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 109' ' ' LYS . 21.6 mt -65.97 -71.27 0.2 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 17.5 mm-40 -43.98 -43.15 6.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.921 -1.112 . . . . 0.0 108.534 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.8 mt -63.5 -31.87 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.592 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.63 -32.43 13.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.621 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 105' ' ' LEU . 4.7 mtpt -52.39 -71.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.835 -1.166 . . . . 0.0 108.275 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 109' ' ' LYS . 16.3 tt0 -44.76 -28.74 0.67 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 108.736 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -72.68 -6.95 47.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.75 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.577 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 7.3 ptm -134.13 63.97 63.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 109.828 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 112' ' ' MET . 4.0 Cg_endo -68.72 -41.13 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.607 1.538 . . . . 0.0 112.059 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.558 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 66.2 t0 -177.37 6.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.444 -0.785 . . . . 0.0 109.089 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.4 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.0 mm? -46.42 -83.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 109.583 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -148.66 -19.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.813 ' CG2' ' H ' ' A' ' 118' ' ' THR . 26.9 m -65.87 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.813 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.69 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.422 ' H ' HG22 ' A' ' 118' ' ' THR . 1.1 m-20 -73.01 140.41 47.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.431 -0.793 . . . . 0.0 110.121 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.583 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -59.65 -23.65 63.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.376 1.084 . . . . 0.0 108.883 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -64.15 -35.58 81.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.574 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -71.35 -75.99 0.12 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.272 -1.371 . . . . 0.0 108.072 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.577 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.01 -35.87 3.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.539 -1.351 . . . . 0.0 109.191 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -55.77 -70.4 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.022 -1.049 . . . . 0.0 108.668 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.665 ' O ' ' N ' ' A' ' 129' ' ' GLY . 20.1 ttp180 -43.51 -39.57 3.44 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.5 ttp -53.27 -78.71 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.134 -0.979 . . . . 0.0 108.53 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.502 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 22.1 mm -47.94 -63.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.481 -0.762 . . . . 0.0 109.978 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -60.74 -71.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.87 -41.91 4.72 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.22 -49.35 69.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.583 -1.539 . . . . 0.0 107.578 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -49.18 -47.83 45.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.08 -54.69 8.08 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.717 ' C ' ' H ' ' A' ' 135' ' ' GLY . 7.6 t -44.87 -68.83 0.16 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 3.4 ttp -46.0 -4.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.04 -31.77 5.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 27.1 t -45.28 165.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 3.5 tp10 -144.33 163.61 33.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.332 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.442 ' H ' ' HG3' ' A' ' 137' ' ' GLU . 1.8 t -79.04 123.93 36.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.622 ' N ' ' O ' ' A' ' 99' ' ' ILE . 9.0 p . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.574 -0.704 . . . . 0.0 110.345 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.451 HG21 ' N ' ' A' ' 61' ' ' ALA . 28.3 m -122.31 -24.85 2.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.057 -1.027 . . . . 0.0 110.12 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.42 104.91 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.605 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -97.26 74.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.665 ' O ' ' O ' ' A' ' 55' ' ' VAL . 16.5 t -48.82 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.503 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.615 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.3 tmtp? -82.94 37.31 0.53 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.861 0.839 . . . . 0.0 109.217 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.9 tp -78.09 -174.09 3.47 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.901 0.858 . . . . 0.0 111.235 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.792 HE21 ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.26 176.56 6.35 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -164.43 146.36 6.99 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.847 -1.158 . . . . 0.0 109.299 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.665 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 74.1 Cg_endo -84.9 125.78 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.324 2.016 . . . . 0.0 113.576 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.748 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -74.41 143.77 44.61 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.478 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 51.21 56.08 16.31 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.665 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 22.1 tttp 174.35 3.93 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.733 -0.863 . . . . 0.0 109.191 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.73 153.32 21.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.892 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.5 165.78 6.15 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.976 -1.078 . . . . 0.0 110.005 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 2.7 Cg_exo -49.04 33.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.684 1.589 . . . . 0.0 111.868 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.892 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -150.85 54.34 1.41 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.536 -0.728 . . . . 0.0 109.61 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 14.5 Cg_endo -80.23 167.0 20.06 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.72 1.613 . . . . 0.0 111.898 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.61 -4.66 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.24 1.294 . . . . 0.0 111.341 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.775 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.4 t -113.34 -69.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.193 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.41 -97.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.775 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_endo -58.71 -55.29 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 CA-C-N 117.892 0.846 . . . . 0.0 110.408 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' C ' HG11 ' A' ' 23' ' ' VAL . . . -49.56 -9.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.742 -0.599 . . . . 0.0 110.782 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.63 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -106.27 -49.04 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.682 -1.261 . . . . 0.0 108.237 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.62 94.13 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 27' ' ' LEU . 51.3 tt0 -154.54 -24.41 0.12 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.724 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -77.77 -44.78 26.54 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.891 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.724 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -165.98 -11.53 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.14 82.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -1.09 . . . . 0.0 112.397 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.613 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 28.2 p30 -153.01 69.63 0.85 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.83 -1.169 . . . . 0.0 109.14 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.711 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 24.0 mm -44.32 -69.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.702 ' O ' ' N ' ' A' ' 39' ' ' LYS . 7.8 tpt -41.71 -57.38 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.582 -1.324 . . . . 0.0 108.869 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.613 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 69.9 tt0 -44.86 -49.7 10.74 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.711 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -49.58 -65.57 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.723 1.249 . . . . 0.0 109.627 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 42' ' ' ASN . 23.8 t -67.21 -35.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -46.7 -62.2 1.49 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.73 70.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 108.922 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.533 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 2.8 t80 -71.05 -77.55 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.4 t-20 -41.33 -36.91 0.89 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.825 -1.172 . . . . 0.0 110.585 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -64.72 -33.83 76.89 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.11 -59.59 2.15 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.451 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.481 HG23 ' CE2' ' A' ' 41' ' ' PHE . 1.7 p -44.53 -31.7 1.19 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.75 23.89 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -56.34 -25.17 48.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.436 -0.79 . . . . 0.0 109.405 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -111.5 -73.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.04 -1.037 . . . . 0.0 109.864 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.51 -165.81 34.73 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.944 -1.598 . . . . 0.0 111.392 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -87.22 147.15 25.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.056 -1.261 . . . . 0.0 109.082 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.748 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 174.93 -153.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.122 . . . . 0.0 110.81 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 1.9 mm -146.26 138.18 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.63 ' CG1' ' HG1' ' A' ' 69' ' ' THR . 2.4 t -137.25 135.41 19.53 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.045 -1.034 . . . . 0.0 110.776 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -73.02 102.95 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.685 1.59 . . . . 0.0 111.161 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.825 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.7 m -76.51 136.53 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.658 -1.276 . . . . 0.0 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.1 tt0 -129.88 69.76 1.43 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.587 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.3 mt -70.31 88.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.721 0.772 . . . . 0.0 110.063 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.18 95.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 59' ' ' ILE . 53.9 mt -95.27 131.15 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.575 0.703 . . . . 0.0 110.479 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.554 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -108.29 133.09 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.834 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -45.79 -30.89 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.567 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.53 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 27.4 p30 -53.94 2.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.834 ' H ' ' C ' ' A' ' 61' ' ' ALA . 7.5 ttp180 70.83 67.08 0.18 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.2 1.0 . . . . 0.0 110.08 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.447 ' OG ' ' OD1' ' A' ' 62' ' ' ASP . 58.7 p -150.39 124.92 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.4 p90 -102.24 103.86 14.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.041 -1.037 . . . . 0.0 109.89 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.04 120.98 40.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.189 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.655 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.34 148.78 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 0.0 111.179 177.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.709 ' CG1' ' NZ ' ' A' ' 70' ' ' LYS . 29.0 t -169.98 96.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.63 ' HG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -103.08 145.11 30.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.752 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -129.41 123.69 32.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.509 -1.369 . . . . 0.0 110.545 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.752 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.21 150.66 0.13 Allowed Pre-proline 0 N--CA 1.493 1.685 0 CA-C-O 121.175 0.512 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.4 Cg_exo -41.86 175.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.731 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.1 Cg_exo -38.9 171.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.379 1.386 . . . . 0.0 112.035 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.474 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 52.67 -80.62 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 73' ' ' PRO . 86.6 p -43.61 -23.14 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 110.019 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.64 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 16.9 p90 -44.02 -38.91 3.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.704 ' CD1' ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -136.95 -14.29 1.59 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.704 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 1.7 mt -63.39 -33.25 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.51 ' HE ' ' HB2' ' A' ' 75' ' ' SER . 14.2 mmt180 -55.1 -42.69 73.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 82' ' ' ALA . 6.2 tmtt? -64.2 -65.99 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.558 ' CB ' ' OE1' ' A' ' 103' ' ' GLN . . . -58.29 -5.3 0.47 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.71 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.65 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.93 -80.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 111.778 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.98 47.52 0.03 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.071 -1.538 . . . . 0.0 110.671 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.442 HD11 HH11 ' A' ' 79' ' ' ARG . 4.0 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 0.0 109.132 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 97' ' ' GLY . 95.5 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.269 0.557 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.456 ' H ' HG12 ' A' ' 96' ' ' VAL . . . 78.72 56.92 3.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.65 ' O ' ' O ' ' A' ' 82' ' ' ALA . 3.6 ttt180 -130.57 116.65 18.43 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.287 -1.125 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.645 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.6 168.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.527 -0.733 . . . . 0.0 109.647 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.486 HG23 ' NE2' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -109.11 151.04 26.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 108.985 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.53 ' O ' HG23 ' A' ' 104' ' ' VAL . 25.8 t-105 -45.82 -68.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.471 -0.768 . . . . 0.0 110.872 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.414 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 5.9 tp10 -51.32 -47.2 62.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.528 -1.357 . . . . 0.0 110.892 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.558 ' OE1' ' CB ' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -51.49 -43.58 62.24 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.017 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.01 -24.8 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 117.89 -1.524 . . . . 0.0 107.617 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.65 ' O ' ' N ' ' A' ' 109' ' ' LYS . 20.8 mt -66.14 -71.55 0.19 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -44.19 -44.78 8.02 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.964 -1.085 . . . . 0.0 108.515 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 55.8 mt -61.02 -31.4 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.689 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -96.03 -24.28 16.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.65 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.1 mtpt -59.57 -73.65 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 108.158 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.472 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 37.5 mt-30 -51.27 -17.94 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.815 . . . . 0.0 109.292 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.56 -8.14 58.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.5 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -133.37 57.87 29.93 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.024 -1.047 . . . . 0.0 109.748 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.99 -41.91 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.521 1.481 . . . . 0.0 112.283 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' LEU . 24.9 t70 -160.68 8.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.438 ' H ' HD13 ' A' ' 115' ' ' LEU . 4.6 mp -44.93 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 109.293 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -165.18 -4.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.237 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.812 ' CG2' ' H ' ' A' ' 118' ' ' THR . 29.8 m -74.23 -164.66 0.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.584 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.812 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.97 -57.71 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.426 ' H ' HG22 ' A' ' 118' ' ' THR . 0.7 OUTLIER -80.01 135.02 36.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.577 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -54.24 -24.78 19.96 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.183 0.992 . . . . 0.0 109.172 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.14 -36.74 85.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.535 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.65 -74.71 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.499 -1.376 . . . . 0.0 108.039 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.89 -37.65 4.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.496 -1.378 . . . . 0.0 109.136 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -55.34 -70.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 108.925 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -43.49 -38.8 3.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.698 ' O ' ' N ' ' A' ' 130' ' ' SER . 14.0 ttm -53.77 -78.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.507 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 22.3 mm -48.04 -63.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 109.97 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -59.39 -71.84 0.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.9 -42.7 5.08 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 126' ' ' MET . 58.7 m -54.74 -46.18 74.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.616 -1.52 . . . . 0.0 107.462 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -50.43 -47.55 56.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.0 tmt_? -46.83 -52.32 14.54 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -48.62 -70.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.52 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 5.6 ttm -44.51 -4.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.15 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.75 22.91 54.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.52 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 29.8 t -109.23 138.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -115.03 166.67 11.55 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.837 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -82.79 124.82 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.645 ' N ' ' O ' ' A' ' 99' ' ' ILE . 12.2 p . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.768 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 61' ' ' ALA . 28.5 m -116.92 -24.49 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.18 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.53 114.18 9.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.118 . . . . 0.0 110.529 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -102.55 73.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.704 ' O ' ' O ' ' A' ' 55' ' ' VAL . 7.9 t -48.56 88.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.764 -1.21 . . . . 0.0 110.606 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.9 tmtt? -82.0 36.74 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.168 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.3 mp -77.21 -174.0 3.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.59 0.709 . . . . 0.0 110.977 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.995 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.07 177.76 6.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.471 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -170.27 157.91 5.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.943 -1.098 . . . . 0.0 109.839 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 15' ' ' GLY . 10.4 Cg_endo -66.69 104.92 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.373 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.776 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -60.9 38.65 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.338 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.652 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.57 -19.42 0.02 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.488 -1.815 . . . . 0.0 111.357 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -148.39 79.7 1.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.578 -1.542 . . . . 0.0 110.705 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.471 ' HB3' ' ND2' ' A' ' 42' ' ' ASN . . . -94.96 170.16 9.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.78 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.74 164.25 4.51 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.768 -1.207 . . . . 0.0 110.494 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.431 ' C ' ' HD3' ' A' ' 21' ' ' PRO . 5.4 Cg_exo -51.75 32.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.029 1.819 . . . . 0.0 112.11 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -137.92 53.98 6.91 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.077 -1.015 . . . . 0.0 110.384 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.7 Cg_endo -85.97 163.13 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.8 1.667 . . . . 0.0 111.809 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.1 -4.81 4.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.016 1.144 . . . . 0.0 111.405 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.82 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 22.0 t -118.59 -66.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.588 -0.695 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.53 -97.23 0.05 OUTLIER Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.82 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.2 Cg_exo -54.3 -55.05 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 CA-C-N 117.876 0.838 . . . . 0.0 110.538 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . -64.22 4.7 0.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.665 . . . . 0.0 111.211 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.706 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -109.62 -64.18 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.66 -1.275 . . . . 0.0 109.797 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.58 -16.75 0.07 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 28' ' ' GLY . 22.3 tp60 -42.08 -16.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.472 -1.605 . . . . 0.0 109.528 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.71 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -65.52 -46.29 80.2 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.71 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.67 -5.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.624 ' C ' ' ND2' ' A' ' 33' ' ' ASN . . . 70.86 76.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.077 -0.661 . . . . 0.0 111.892 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.624 ' ND2' ' C ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -152.06 64.86 0.84 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.307 1.051 . . . . 0.0 108.334 177.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.571 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.5 mm -43.22 -66.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.696 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.0 tpt -41.56 -42.52 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.619 -1.3 . . . . 0.0 108.759 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.21 -49.39 76.16 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -50.91 -67.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.66 1.219 . . . . 0.0 109.093 178.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.506 HG12 HD21 ' A' ' 42' ' ' ASN . 24.8 t -63.36 -36.46 76.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.3 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.5 ttpt -48.99 -60.17 3.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.33 71.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.354 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 1.9 t80 -68.79 -76.5 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.575 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.9 m-80 -41.8 -32.9 0.44 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.399 1.095 . . . . 0.0 110.893 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.75 77.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.611 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.82 -51.55 5.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.775 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.776 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 22.7 p -54.36 -31.48 54.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.33 -45.3 16.37 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -54.17 -22.99 12.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.394 -0.816 . . . . 0.0 109.145 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.625 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.1 -85.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.625 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.94 -144.17 3.99 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.015 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.17 119.8 37.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -1.11 . . . . 0.0 109.806 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -155.8 -152.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.855 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.476 ' N ' ' HB1' ' A' ' 14' ' ' ALA . 3.6 mm -146.26 141.83 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.46 HG21 ' N ' ' A' ' 71' ' ' THR . 6.9 t -144.32 137.5 13.98 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.911 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.55 ' C ' ' O ' ' A' ' 10' ' ' LEU . 9.6 Cg_endo -73.51 91.72 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.779 1.653 . . . . 0.0 111.482 178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.2 m -57.92 137.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.3 mt-10 -130.19 70.65 1.44 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.588 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.6 mt -70.67 90.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.856 0.836 . . . . 0.0 110.226 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 m -69.98 104.94 2.67 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 64' ' ' SER . 21.1 mt -110.33 148.23 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.494 -0.754 . . . . 0.0 110.927 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.768 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.9 m-85 -116.63 140.94 48.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.828 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.56 -32.46 5.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.267 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -51.44 -1.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.828 ' H ' ' C ' ' A' ' 61' ' ' ALA . 13.1 mtp180 75.02 70.03 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.992 0.901 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -149.44 138.08 20.96 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 42.9 p90 -115.13 103.93 11.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.963 -1.086 . . . . 0.0 110.312 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.47 121.07 41.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.089 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.634 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.37 148.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.955 -1.09 . . . . 0.0 111.211 177.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.634 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 30.8 t -168.49 79.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.16 138.15 31.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.656 ' O ' ' OG1' ' A' ' 71' ' ' THR . 8.1 mttm -122.94 140.15 53.3 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.198 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.679 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 2.2 p 57.73 158.07 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.603 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.569 ' O ' ' OG ' ' A' ' 75' ' ' SER . 12.7 Cg_exo -39.5 175.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.309 2.006 . . . . 0.0 112.691 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.715 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.9 Cg_exo -40.02 170.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.69 1.593 . . . . 0.0 112.253 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.458 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 58.07 -73.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.715 ' N ' ' O ' ' A' ' 73' ' ' PRO . 7.5 p -43.98 -25.34 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.945 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 17.4 p90 -43.61 -43.21 5.58 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.688 ' CD1' ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.85 -13.79 3.2 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.688 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 1.4 mt -63.31 -29.78 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.63 ' CG ' ' HG1' ' A' ' 71' ' ' THR . 3.6 mmt180 -54.07 -48.68 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.7 tmtt? -63.81 -66.14 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 99' ' ' ILE . . . -54.61 -6.54 0.12 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.56 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.623 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.57 -77.9 0.35 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 111.949 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 146.9 62.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.038 -1.553 . . . . 0.0 111.189 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.531 HD13 HH11 ' A' ' 79' ' ' ARG . 16.8 mt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.951 -1.323 . . . . 0.0 108.901 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 97' ' ' GLY . 86.2 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.271 0.557 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 96' ' ' VAL . . . 70.89 67.81 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.776 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.57 109.82 9.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -1.212 . . . . 0.0 110.403 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.687 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.42 175.59 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.518 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -123.34 158.38 31.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.524 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.4 t-105 -45.19 -70.86 0.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.351 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.511 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.72 -50.8 54.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.562 -1.336 . . . . 0.0 111.108 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -49.27 -43.66 43.24 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.288 -0.883 . . . . 0.0 110.35 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.35 -24.79 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.616 -1.634 . . . . 0.0 107.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.646 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.5 mt -66.32 -71.45 0.19 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.497 ' CD ' ' OE2' ' A' ' 102' ' ' GLU . 35.1 mt-10 -43.77 -43.72 6.26 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.93 -1.106 . . . . 0.0 108.461 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.65 -31.5 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 108.396 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.97 -26.77 15.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 109.62 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.646 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.8 mtpt -59.26 -73.56 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 0.0 108.211 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 3.1 tt0 -49.35 -18.27 0.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.253 -0.904 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.511 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.8 tmtt? -80.82 -10.2 59.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.581 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -132.38 55.46 17.82 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.9 Cg_endo -60.2 -40.89 55.87 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.567 1.512 . . . . 0.0 112.3 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.529 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -164.91 9.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.54 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.46 ' H ' HD11 ' A' ' 115' ' ' LEU . 4.2 mp -45.0 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.356 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -160.24 -10.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.816 ' CG2' ' H ' ' A' ' 118' ' ' THR . 29.0 m -68.65 -164.63 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.816 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.65 -57.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.422 ' H ' HG22 ' A' ' 118' ' ' THR . 1.0 OUTLIER -80.2 135.22 36.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -54.86 -23.74 19.89 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.16 0.981 . . . . 0.0 109.103 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.11 -35.8 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.47 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -71.63 -74.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.964 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.63 -39.05 4.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.342 -1.474 . . . . 0.0 109.152 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -53.5 -69.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.087 -1.008 . . . . 0.0 108.728 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.778 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -42.81 5.36 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.705 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.5 ttm -51.29 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.115 -0.991 . . . . 0.0 108.454 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.497 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 21.5 mm -48.37 -66.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.678 0.751 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -57.89 -71.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.86 -40.82 4.23 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 126' ' ' MET . 44.0 m -56.26 -51.25 68.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.518 -1.577 . . . . 0.0 107.723 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -47.14 -47.63 23.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.759 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -47.06 -54.26 10.75 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.717 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.1 t -44.77 -68.59 0.18 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.509 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 3.8 ttp -46.46 -4.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 88.73 -31.49 4.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.796 -2.122 . . . . 0.0 107.796 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 31.3 t -45.09 165.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.937 -0.743 . . . . 0.0 109.173 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.9 tm-20 -142.43 162.26 35.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.598 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.634 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -78.08 164.35 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.687 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.748 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.466 HG22 ' N ' ' A' ' 61' ' ' ALA . 28.0 m -121.12 -24.59 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.19 110.88 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.605 -1.309 . . . . 0.0 110.716 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.612 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -100.92 73.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.737 ' O ' ' O ' ' A' ' 55' ' ' VAL . 21.5 t -46.36 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 110.49 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.9 tmmm? -83.26 34.99 0.48 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.849 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -78.78 -174.15 3.81 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.917 0.865 . . . . 0.0 111.596 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.556 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -121.55 172.12 8.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.453 ' CD2' ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.51 160.93 4.11 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.854 -1.154 . . . . 0.0 109.857 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 12' ' ' LEU . 8.8 Cg_endo -61.53 129.41 27.91 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.042 1.828 . . . . 0.0 111.81 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.765 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -90.62 42.16 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 111.28 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.596 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 172.43 -12.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.59 70.96 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.419 . . . . 0.0 109.557 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.8 165.21 13.77 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.431 -0.793 . . . . 0.0 109.319 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.69 161.73 5.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.667 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -54.04 31.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.509 1.473 . . . . 0.0 111.466 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -144.94 54.3 2.44 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 0.0 110.265 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.698 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.3 Cg_endo -83.09 154.87 14.72 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.584 1.523 . . . . 0.0 111.544 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.58 -4.46 0.32 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.048 1.165 . . . . 0.0 111.018 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.745 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.9 t -103.77 -71.82 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.524 0.678 . . . . 0.0 110.592 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.29 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.745 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.11 -55.5 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 CA-C-N 118.048 0.924 . . . . 0.0 110.188 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.0 -7.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.815 -0.553 . . . . 0.0 110.657 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.745 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -108.37 -45.57 3.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.686 -1.259 . . . . 0.0 108.798 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.81 88.95 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' LEU . 2.7 tt0 -149.73 -15.19 0.27 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.617 ' ND1' ' C ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -89.46 -36.85 15.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.591 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -172.36 -1.82 0.03 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.09 82.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.96 . . . . 0.0 112.188 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.583 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 26.7 p-10 -156.74 119.22 3.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.867 -1.145 . . . . 0.0 109.08 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.2 mm -93.96 -65.26 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.4 tpt -42.72 -55.08 3.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.948 -1.095 . . . . 0.0 109.417 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' CB ' ' ND2' ' A' ' 33' ' ' ASN . 4.8 mp0 -51.01 -53.41 33.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 108.458 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.745 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -46.17 -59.11 3.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.936 1.35 . . . . 0.0 108.796 177.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 18' ' ' THR . 87.2 t -70.87 -26.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 35' ' ' MET . 23.1 tptt -56.26 -55.25 35.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.79 78.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.729 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.463 ' CZ ' ' CG1' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -67.37 -75.73 0.09 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.637 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 8.9 t-20 -41.78 -35.84 0.89 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.26 1.029 . . . . 0.0 110.715 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -62.95 -34.28 77.15 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.52 -60.33 1.91 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.502 1.144 . . . . 0.0 108.76 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.765 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 52.7 p -47.53 -28.06 2.07 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.764 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.29 -46.71 9.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -49.54 -19.92 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.239 -0.913 . . . . 0.0 108.883 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.682 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.83 -85.29 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.255 -0.903 . . . . 0.0 109.679 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.682 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -166.21 -150.8 6.48 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.912 -1.613 . . . . 0.0 110.962 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -106.39 107.81 19.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.565 -0.962 . . . . 0.0 110.037 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.612 ' CB ' ' HB2' ' A' ' 14' ' ' ALA . . . -143.48 -152.87 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 109.616 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.518 ' N ' ' HB3' ' A' ' 14' ' ' ALA . 7.1 mm -146.6 142.88 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.91 139.25 15.04 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.7 Cg_endo -75.75 91.48 1.08 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.766 1.644 . . . . 0.0 111.025 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.849 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.9 m -59.56 138.06 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 9.9 mt-10 -131.14 66.55 1.53 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.584 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.3 mt -66.53 92.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.665 0.745 . . . . 0.0 110.397 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.11 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 64' ' ' SER . 89.4 mt -103.05 142.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.509 -0.744 . . . . 0.0 110.683 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.748 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 5.6 m-85 -115.91 138.36 51.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.824 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.9 -30.75 4.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.437 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.23 1.5 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.824 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.7 OUTLIER 71.38 68.07 0.16 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.04 0.924 . . . . 0.0 109.893 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -149.47 131.24 15.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.3 p90 -108.63 104.11 13.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.049 -1.032 . . . . 0.0 110.098 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.5 121.02 41.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.978 -1.076 . . . . 0.0 110.201 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.666 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 170.21 149.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.953 -1.092 . . . . 0.0 111.283 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.662 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 30.1 t -169.69 84.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 138.7 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.817 ' O ' ' OG1' ' A' ' 71' ' ' THR . 14.8 mtmt -124.37 141.67 51.89 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.071 -1.451 . . . . 0.0 110.766 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.817 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 41.4 p 62.5 155.13 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.818 -0.552 . . . . 0.0 109.874 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.665 ' O ' ' OG ' ' A' ' 75' ' ' SER . 7.8 Cg_exo -42.09 175.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.406 2.071 . . . . 0.0 112.737 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 75' ' ' SER . 29.1 Cg_exo -38.43 170.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.494 1.462 . . . . 0.0 112.088 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.771 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 54.49 -73.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.782 ' N ' ' O ' ' A' ' 73' ' ' PRO . 21.3 p -43.42 -19.43 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.557 -0.714 . . . . 0.0 111.08 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.771 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -43.66 -41.14 4.54 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.779 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.488 ' N ' ' HD1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -133.2 -14.39 2.64 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 2.0 mt -59.19 -33.14 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.518 HH11 HD13 ' A' ' 84' ' ' LEU . 15.0 mmt180 -54.7 -42.56 71.64 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 82' ' ' ALA . 13.8 tmtt? -66.47 -66.1 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.577 ' CB ' ' OE1' ' A' ' 103' ' ' GLN . . . -57.83 -4.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.485 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.642 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.33 -79.7 0.23 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.437 -0.79 . . . . 0.0 111.694 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.602 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 167.08 45.09 0.02 OUTLIER Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.574 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.518 HD13 HH11 ' A' ' 79' ' ' ARG . 4.4 mt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.346 . . . . 0.0 109.248 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.252 0.549 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.431 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 93.94 66.38 1.04 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.79 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.93 114.87 14.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -103.97 177.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.778 . . . . 0.0 109.356 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.467 HG23 ' NE2' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -117.76 153.94 32.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.012 -1.055 . . . . 0.0 109.292 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.518 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 24.7 t-105 -48.12 -69.36 0.12 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.93 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.501 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.2 -46.47 54.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.696 -1.252 . . . . 0.0 110.646 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.577 ' OE1' ' CB ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -51.65 -45.07 63.22 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.041 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.3 m -72.24 -24.45 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.732 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.636 ' O ' ' N ' ' A' ' 109' ' ' LYS . 17.2 mt -66.91 -72.11 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 74.4 tt0 -43.93 -43.17 6.33 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.932 -1.105 . . . . 0.0 108.572 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.426 HG22 HD12 ' A' ' 107' ' ' ILE . 56.6 mt -62.66 -31.29 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 108.651 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -95.39 -26.94 15.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.451 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.3 mtpt -58.76 -73.36 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 108.346 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 109' ' ' LYS . 70.0 mt-30 -46.86 -25.68 0.82 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.815 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -72.8 -18.43 61.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.697 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -128.69 66.53 75.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 109.856 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.6 -41.25 26.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.501 1.468 . . . . 0.0 112.284 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.535 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 66.1 t0 -176.84 9.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.376 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.818 ' CD1' ' N ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.87 -85.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.792 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.521 ' H ' HD11 ' A' ' 115' ' ' LEU . 2.4 t30 -145.45 -21.97 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.398 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.802 ' CG2' ' H ' ' A' ' 118' ' ' THR . 25.5 m -65.84 -164.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.526 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.802 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.6 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.134 -0.979 . . . . 0.0 109.945 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.47 140.3 58.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.59 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -61.14 -22.15 64.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.255 1.026 . . . . 0.0 108.928 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.39 -38.07 88.87 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -69.42 -75.27 0.11 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.907 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.5 -43.05 7.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.405 -1.435 . . . . 0.0 109.402 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.59 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -49.69 -68.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.783 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -43.02 5.48 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.688 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.9 ttm -51.61 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -0.963 . . . . 0.0 108.74 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.492 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 21.4 mm -48.41 -64.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.674 0.749 . . . . 0.0 109.973 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -59.4 -71.47 0.12 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -39.39 3.67 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 126' ' ' MET . 36.6 m -56.33 -51.21 69.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.592 -1.534 . . . . 0.0 107.699 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.455 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -47.79 -47.66 30.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -46.62 -54.24 9.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.715 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.4 t -44.56 -67.82 0.25 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 2.9 ttp -46.64 -3.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.715 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 88.53 -24.02 13.77 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -57.47 135.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.975 -0.72 . . . . 0.0 109.387 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -112.09 164.74 12.82 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.35 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 139' ' ' VAL . 12.2 p . . . . . 0 C--N 1.303 -1.455 0 O-C-N 121.641 -0.662 . . . . 0.0 109.622 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.78 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.282 0.563 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.434 HG11 ' H ' ' A' ' 61' ' ' ALA . 27.9 m -114.79 -24.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.79 113.6 9.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.328 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -101.61 73.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 109.128 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.666 ' O ' ' O ' ' A' ' 55' ' ' VAL . 6.0 t -49.11 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 O-C-N 120.646 -1.284 . . . . 0.0 110.472 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.26 36.74 0.48 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.927 0.87 . . . . 0.0 109.017 179.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.1 mp -76.23 -174.1 2.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.874 0.845 . . . . 0.0 111.045 -178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.643 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.94 176.11 7.21 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.515 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -165.81 145.96 5.5 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.968 -1.082 . . . . 0.0 109.292 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.657 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 72.1 Cg_endo -84.94 126.71 3.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.232 1.955 . . . . 0.0 113.437 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -72.61 143.47 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.721 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 51.2 54.17 24.53 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 34.1 tttt 174.48 4.01 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.729 -0.865 . . . . 0.0 109.521 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.4 156.17 21.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.895 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.95 165.64 4.03 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.915 -1.115 . . . . 0.0 110.26 -178.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 6.9 Cg_exo -47.79 33.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.925 1.75 . . . . 0.0 111.943 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.895 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -142.06 54.2 3.68 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.998 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.7 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -83.35 169.01 12.82 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.832 1.688 . . . . 0.0 112.019 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.31 -4.83 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 121.244 1.296 . . . . 0.0 111.377 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.81 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 19.5 t -119.34 -64.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.582 -0.698 . . . . 0.0 109.505 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.29 -97.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.81 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -55.57 -55.24 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 CA-C-N 117.817 0.808 . . . . 0.0 110.642 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.551 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . -60.58 1.94 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.663 -0.648 . . . . 0.0 111.213 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.721 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.41 -58.0 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.697 -1.252 . . . . 0.0 109.411 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.751 ' O ' ' N ' ' A' ' 32' ' ' ALA . . . -43.12 -17.29 0.04 OUTLIER Glycine 0 N--CA 1.485 1.948 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.531 ' C ' ' O ' ' A' ' 28' ' ' GLY . 13.0 mm100 -42.63 -27.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.176 -1.779 . . . . 0.0 107.885 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.768 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 14.2 p-80 -66.33 54.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 89.55 -18.77 44.32 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.751 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 75.19 83.06 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -1.118 . . . . 0.0 112.09 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.599 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -153.22 67.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.952 -1.092 . . . . 0.0 109.251 177.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.742 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 29.5 mm -43.85 -67.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.728 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.0 tpt -41.1 -56.93 2.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.473 -1.392 . . . . 0.0 109.218 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.599 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 18.9 tt0 -44.71 -47.64 10.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.452 -1.405 . . . . 0.0 107.631 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.742 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -51.97 -69.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.583 1.182 . . . . 0.0 109.705 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 42' ' ' ASN . 27.8 t -65.32 -36.26 77.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.484 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 35' ' ' MET . 16.0 tttt -46.08 -62.06 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.81 -33.76 68.93 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.528 ' CD2' HG21 ' A' ' 45' ' ' THR . 2.8 t80 -71.45 -78.36 0.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.1 t-20 -41.23 -30.91 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.896 -1.127 . . . . 0.0 110.679 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -70.55 -32.86 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.089 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.621 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -90.33 -45.88 8.74 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.552 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.721 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 9.4 p -60.24 -31.16 69.93 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.85 23.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.75 -22.45 46.94 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.71 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.55 -71.82 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.71 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.47 -130.04 1.5 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.123 -1.513 . . . . 0.0 111.067 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -122.64 145.81 48.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -1.187 . . . . 0.0 108.85 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.746 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 176.93 -154.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.736 -1.228 . . . . 0.0 111.192 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 51' ' ' ALA . 1.9 mp -144.25 135.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 71' ' ' THR . 2.7 t -135.36 132.66 20.05 Favored Pre-proline 0 C--N 1.296 -1.75 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.92 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 8.9 Cg_endo -71.9 103.47 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.654 1.57 . . . . 0.0 111.192 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -75.96 136.39 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.652 -1.28 . . . . 0.0 111.493 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.1 mt-10 -129.08 70.39 1.41 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.538 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.4 mt -70.55 90.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.882 0.848 . . . . 0.0 110.07 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.453 ' HB ' ' HG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -70.82 95.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.578 ' CG2' ' O ' ' A' ' 64' ' ' SER . 46.4 mt -101.57 147.67 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.659 -0.651 . . . . 0.0 110.583 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.78 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.0 m-85 -115.62 142.2 47.05 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.841 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.28 -33.15 8.32 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.238 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 56.4 p30 -50.8 -1.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.841 ' H ' ' C ' ' A' ' 61' ' ' ALA . 16.2 ttm180 75.25 70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.048 0.928 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.578 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -149.49 147.04 27.73 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.9 p90 -123.32 103.91 8.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.974 -1.079 . . . . 0.0 110.188 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.624 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.5 p -101.48 120.77 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 110.002 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.648 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.9 OUTLIER 170.3 147.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.952 -1.092 . . . . 0.0 111.295 177.415 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.648 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 29.6 t -168.52 97.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.301 1.048 . . . . 0.0 108.519 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.432 ' HG1' ' HB2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -106.01 144.02 33.32 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.746 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -128.14 131.54 48.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.461 -1.399 . . . . 0.0 111.157 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER 67.75 160.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.954 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.624 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.5 Cg_exo -38.9 175.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.686 2.257 . . . . 0.0 113.193 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.732 ' O ' ' N ' ' A' ' 75' ' ' SER . 19.9 Cg_exo -44.27 171.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.566 1.511 . . . . 0.0 112.183 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.588 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 55.2 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.835 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 60.2 p -43.02 -19.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.446 -0.784 . . . . 0.0 110.367 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 27.5 p90 -43.47 -34.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.599 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.38 -16.73 1.82 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.835 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 6.8 mt -56.71 -31.73 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 75' ' ' SER . 9.1 mmm180 -54.43 -49.0 71.01 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.4 tmtt? -62.59 -65.74 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.608 ' CB ' ' OE1' ' A' ' 103' ' ' GLN . . . -56.62 -7.92 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 109.668 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -87.96 -78.11 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 111.519 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.19 68.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.333 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.194 -1.18 . . . . 0.0 109.313 179.48 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 97' ' ' GLY . 86.0 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.495 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 72.03 76.45 0.61 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 82' ' ' ALA . 14.9 ttm180 -135.36 106.23 6.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.3 -177.49 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 109.884 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.484 HG21 ' NE2' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -120.95 151.68 39.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.261 -0.899 . . . . 0.0 108.94 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.543 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 31.9 t-105 -48.28 -67.45 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 110.561 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 7.4 tp10 -50.5 -48.29 56.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.728 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.608 ' OE1' ' CB ' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -50.61 -44.01 56.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.02 -25.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 117.719 -1.593 . . . . 0.0 107.462 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.643 ' O ' ' N ' ' A' ' 109' ' ' LYS . 21.9 mt -66.26 -72.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.563 ' OE1' ' OE2' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -44.31 -43.29 7.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.089 -1.007 . . . . 0.0 108.802 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.51 -31.29 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.054 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -95.75 -30.62 13.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.292 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 105' ' ' LEU . 17.4 mtpt -54.73 -72.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 108.646 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 109' ' ' LYS . 6.8 tt0 -45.59 -31.12 1.72 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.16 -0.963 . . . . 0.0 109.032 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.513 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.1 tmtt? -63.99 -15.67 59.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.752 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.496 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -128.63 70.78 80.54 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.939 -1.101 . . . . 0.0 109.71 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.66 -39.29 21.38 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.565 1.51 . . . . 0.0 112.15 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.56 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -178.21 10.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.237 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -48.24 -82.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -151.37 -22.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.813 ' CG2' ' H ' ' A' ' 118' ' ' THR . 27.0 m -59.95 -164.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.989 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.813 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -176.0 -70.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.862 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.402 ' H ' HG22 ' A' ' 118' ' ' THR . 1.0 OUTLIER -65.28 137.5 57.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.611 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -59.21 -21.41 59.45 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.277 1.037 . . . . 0.0 108.746 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -65.69 -34.29 77.85 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.589 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.56 -76.23 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.464 -1.398 . . . . 0.0 107.935 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.64 -39.08 4.75 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.439 -1.413 . . . . 0.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.611 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -53.94 -67.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.06 -1.025 . . . . 0.0 108.535 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 12.9 ttt180 -43.36 -36.74 2.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' SER . 7.3 ttm -57.24 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 108.886 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.732 ' O ' ' OG ' ' A' ' 130' ' ' SER . 30.0 mm -48.63 -57.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 110.199 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.62 -70.28 0.26 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -42.42 5.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.732 ' OG ' ' O ' ' A' ' 127' ' ' ILE . 54.7 p -52.86 -50.0 64.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.512 -1.581 . . . . 0.0 107.152 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.64 ' H ' ' HG ' ' A' ' 130' ' ' SER . . . -49.2 -48.62 45.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.546 ' CD ' ' C ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -44.77 -51.67 9.17 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.1 t -50.57 -68.81 0.14 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.51 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 5.5 ttp -44.95 -4.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.713 -0.617 . . . . 0.0 110.407 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.4 25.47 47.3 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 28.9 t -107.71 165.52 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.858 -0.79 . . . . 0.0 109.233 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.536 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 5.1 tt0 -139.53 162.64 34.58 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.989 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.07 117.73 25.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.673 ' N ' ' O ' ' A' ' 99' ' ' ILE . 7.0 p . . . . . 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.823 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.481 HG21 ' N ' ' A' ' 61' ' ' ALA . 28.3 m -122.59 -24.91 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 110.093 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.41 107.38 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.758 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -98.62 74.31 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.689 ' O ' ' O ' ' A' ' 55' ' ' VAL . 25.1 t -48.73 88.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.956 -1.09 . . . . 0.0 110.876 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 tmtm? -82.38 37.05 0.49 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.715 0.769 . . . . 0.0 109.315 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.881 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -80.09 -174.07 4.29 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.721 0.772 . . . . 0.0 111.461 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.785 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.93 174.77 7.35 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.462 ' CD2' ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.78 161.75 3.84 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.704 -1.247 . . . . 0.0 110.098 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD2' ' CD2' ' A' ' 12' ' ' LEU . 9.5 Cg_endo -62.2 126.6 18.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.904 1.736 . . . . 0.0 111.668 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.778 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -88.1 42.21 1.05 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.035 -1.041 . . . . 0.0 111.332 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.555 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 174.81 -12.12 0.03 OUTLIER Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.906 -1.616 . . . . 0.0 110.832 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -143.26 73.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 109.622 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.549 ' O ' ' ND2' ' A' ' 42' ' ' ASN . . . -93.2 169.66 10.23 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.193 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -175.31 162.45 2.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.021 -1.049 . . . . 0.0 109.693 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -53.97 31.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.581 1.521 . . . . 0.0 111.33 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -147.38 54.03 1.8 Allowed Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.102 -0.999 . . . . 0.0 110.083 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.735 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.3 Cg_endo -85.06 157.83 11.42 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.746 1.631 . . . . 0.0 111.522 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HG2' HE22 ' A' ' 11' ' ' GLN . 3.5 Cg_exo -52.75 -4.52 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 120.939 1.093 . . . . 0.0 110.846 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.737 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.0 t -105.08 -72.08 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 121.623 0.725 . . . . 0.0 110.296 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 23' ' ' VAL . . . 54.65 -98.33 0.05 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.737 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -59.89 -55.39 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 CA-C-N 118.004 0.902 . . . . 0.0 109.959 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -43.8 -11.98 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.266 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -113.25 -38.73 4.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.686 -1.259 . . . . 0.0 108.114 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.38 96.13 0.01 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 27' ' ' LEU . 41.2 tt0 -162.94 -22.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.688 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -83.84 65.55 8.65 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 80.54 -5.99 62.64 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.37 83.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 112.021 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 33.2 m120 -159.32 124.85 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.903 -1.123 . . . . 0.0 108.905 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 20.8 mm -101.22 -62.1 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 0.0 109.858 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.663 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.49 -47.52 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 109.749 -176.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -55.75 -48.74 74.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 0.0 107.845 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.656 ' C ' ' CD1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -49.79 -63.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.612 1.196 . . . . 0.0 108.818 178.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG11 ' N ' ' A' ' 18' ' ' THR . 98.0 t -68.55 -30.15 46.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.194 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 35' ' ' MET . 36.0 tptt -54.83 -54.57 40.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.06 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 109.634 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -67.76 -75.5 0.1 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.231 -1.543 . . . . 0.0 106.896 176.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.645 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.7 m-20 -41.5 -38.26 1.26 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.117 -0.99 . . . . 0.0 110.735 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -61.53 -33.71 74.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . . . -91.13 -57.77 2.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.591 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.778 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 40.0 p -50.75 -26.82 6.07 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.766 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.645 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.12 -45.86 10.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -52.7 -18.94 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 0.0 108.886 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.528 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.41 -85.31 0.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . -168.15 -150.47 6.6 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.89 -1.624 . . . . 0.0 110.794 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -105.62 107.43 18.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -1.005 . . . . 0.0 109.976 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.608 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . . . -144.15 -152.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.854 . . . . 0.0 109.611 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 7.8 mm -146.04 143.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 71' ' ' THR . 2.2 t -143.6 137.18 14.24 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.128 -0.983 . . . . 0.0 110.497 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -74.53 91.61 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.841 1.694 . . . . 0.0 110.628 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.881 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -60.09 136.53 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 122.706 1.241 . . . . 0.0 111.662 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 30.4 tt0 -130.6 69.51 1.46 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.585 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.3 mt -71.08 90.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.719 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.73 96.02 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.1 mt -97.15 135.81 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.446 -0.784 . . . . 0.0 110.865 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -111.7 136.01 51.52 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.806 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -46.63 -32.94 3.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.742 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 56.0 m-20 -51.3 -2.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.806 ' H ' ' C ' ' A' ' 61' ' ' ALA . 9.7 ttm180 75.11 68.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.072 0.939 . . . . 0.0 109.74 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 10.4 m -149.72 124.97 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.717 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -102.9 103.98 14.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.157 -0.964 . . . . 0.0 110.009 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -100.55 120.51 40.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.969 -1.082 . . . . 0.0 109.911 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.662 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 169.94 150.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.956 177.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.659 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 30.6 t -169.45 78.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.404 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -84.14 148.97 26.48 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.772 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.1 mttm -136.46 134.1 37.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.906 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.772 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.3 p 75.34 150.75 0.13 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 73' ' ' PRO . 7.1 Cg_exo -43.4 175.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.46 2.106 . . . . 0.0 113.149 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.805 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.0 Cg_exo -41.98 177.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.74 1.627 . . . . 0.0 112.007 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 44.91 -84.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.805 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -43.96 -15.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 109.614 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 21.1 p90 -44.15 -35.67 2.3 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.69 ' CD1' ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -139.71 -14.86 1.06 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.69 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 2.0 mt -63.1 -33.25 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.5 ' HG2' ' CB ' ' A' ' 75' ' ' SER . 1.6 mmt180 -55.44 -44.88 76.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.457 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.1 tmtp? -61.54 -65.48 0.68 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.61 -6.13 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.475 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.641 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -82.24 -81.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.45 -0.781 . . . . 0.0 111.555 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.17 34.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.549 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 84' ' ' LEU . 3.5 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.884 -1.363 . . . . 0.0 109.031 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 97' ' ' GLY . 94.8 t . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.31 0.576 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.457 ' N ' ' CG1' ' A' ' 96' ' ' VAL . . . 72.16 60.26 4.23 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 82' ' ' ALA . 1.4 ttt180 -132.03 117.03 17.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -1.182 . . . . 0.0 110.117 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.47 -169.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.033 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.459 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.12 163.26 28.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.097 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.505 ' O ' HG21 ' A' ' 104' ' ' VAL . 23.8 t-105 -53.45 -69.5 0.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 110.643 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.454 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 7.4 tp10 -51.03 -45.31 61.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.527 -1.358 . . . . 0.0 110.427 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.3 -45.89 62.35 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.782 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.5 -22.78 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.774 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 109' ' ' LYS . 17.7 mt -68.01 -72.49 0.17 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 105' ' ' LEU . 76.3 tt0 -43.83 -43.95 6.55 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.889 -1.132 . . . . 0.0 108.508 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.77 -31.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 108.46 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.622 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -96.69 -20.85 17.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.462 -0.774 . . . . 0.0 109.481 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 105' ' ' LEU . 26.0 mttm -62.49 -74.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.852 -1.155 . . . . 0.0 108.167 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.478 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 56.7 mt-30 -50.48 -20.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -69.4 -4.97 20.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.042 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.586 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -135.69 63.09 51.71 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.903 -1.123 . . . . 0.0 109.715 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 112' ' ' MET . 5.1 Cg_endo -71.3 -30.79 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.572 1.515 . . . . 0.0 111.883 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -166.84 4.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mp -44.84 -85.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -171.96 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.206 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.822 ' CG2' ' H ' ' A' ' 118' ' ' THR . 29.6 m -75.43 -164.39 0.33 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.822 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.81 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.691 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -94.82 130.56 41.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -58.9 -35.02 72.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.418 1.104 . . . . 0.0 108.648 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 -62.75 -33.5 75.28 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.467 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -73.3 -74.25 0.18 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.586 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.23 -37.45 4.64 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.489 -1.382 . . . . 0.0 109.019 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -56.65 -69.48 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 108.847 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.646 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.6 OUTLIER -43.38 -35.95 1.74 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.669 ' O ' ' CB ' ' A' ' 130' ' ' SER . 6.0 ttm -56.13 -76.64 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.507 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 23.9 mm -48.82 -63.48 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.689 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -60.12 -72.26 0.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.49 -41.16 4.02 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.669 ' CB ' ' O ' ' A' ' 126' ' ' MET . 60.2 m -57.91 -47.87 81.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.547 -1.561 . . . . 0.0 107.443 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -49.25 -49.72 42.05 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.785 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.71 -55.09 6.89 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.702 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.5 t -44.67 -67.45 0.28 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.478 ' CE ' ' HB2' ' A' ' 75' ' ' SER . 0.6 OUTLIER -47.4 -4.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.702 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.55 -31.11 5.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 137' ' ' GLU . 41.3 t -45.02 165.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.909 -0.759 . . . . 0.0 108.972 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.582 ' H ' HG12 ' A' ' 136' ' ' VAL . 81.0 tt0 -142.25 162.73 34.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.456 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.8 t -83.26 137.68 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.677 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.2 p . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.455 -0.778 . . . . 0.0 109.533 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.738 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.441 HG12 ' H ' ' A' ' 61' ' ' ALA . 27.6 m -115.67 -24.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.44 110.18 6.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.344 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -98.16 73.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' ' O ' ' A' ' 55' ' ' VAL . 35.4 t -48.52 88.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.542 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.93 36.47 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.819 0.819 . . . . 0.0 109.324 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.866 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -77.91 -174.12 3.41 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.432 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -121.35 172.49 7.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.46 ' CD2' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -169.04 161.05 8.0 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.086 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.46 ' HD2' ' CD2' ' A' ' 12' ' ' LEU . 13.8 Cg_endo -66.95 109.61 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.065 1.844 . . . . 0.0 111.316 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.756 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -67.64 41.08 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.856 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.468 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 176.6 -14.15 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.515 -1.802 . . . . 0.0 111.522 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -138.25 56.83 1.72 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.6 . . . . 0.0 110.557 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.32 160.03 30.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.669 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.41 162.37 23.72 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.681 -1.262 . . . . 0.0 110.981 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.05 38.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.087 1.858 . . . . 0.0 111.847 178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.669 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -173.06 56.77 0.21 Allowed Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.53 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.8 Cg_endo -79.76 169.02 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 121.467 1.444 . . . . 0.0 111.382 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.08 -4.68 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.071 1.181 . . . . 0.0 110.922 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.752 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.0 t -106.85 -72.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.582 0.706 . . . . 0.0 110.256 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.35 -98.01 0.05 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.752 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.59 -55.65 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 CA-C-N 118.088 0.944 . . . . 0.0 110.055 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' C ' HG12 ' A' ' 23' ' ' VAL . . . -44.79 -10.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.83 -0.544 . . . . 0.0 110.243 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.617 HD11 ' CD2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.75 -44.11 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.859 -1.151 . . . . 0.0 108.815 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.62 96.38 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 27' ' ' LEU . 10.6 tt0 -159.49 -26.68 0.07 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.717 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.4 p80 -78.74 64.17 3.67 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.7 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 81.82 -7.84 61.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 83.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -1.126 . . . . 0.0 112.097 177.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -157.97 123.69 4.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.676 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.606 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 19.8 mm -97.55 -63.71 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.049 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.614 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.0 tpt -41.29 -51.64 3.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.768 -1.208 . . . . 0.0 109.989 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.57 -48.39 57.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.667 -1.271 . . . . 0.0 108.007 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.655 ' C ' ' CD1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -51.81 -65.83 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.535 1.16 . . . . 0.0 109.353 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 18' ' ' THR . 67.8 t -65.49 -30.03 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.915 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.4 OUTLIER -55.67 -56.1 24.38 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.14 77.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.608 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.445 ' CE2' HG21 ' A' ' 45' ' ' THR . 1.9 t80 -69.49 -76.77 0.09 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.341 -1.474 . . . . 0.0 107.155 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 9.8 t-20 -41.66 -32.36 0.37 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.971 -1.081 . . . . 0.0 110.734 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -67.84 -34.08 76.02 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.445 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -90.45 -53.39 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.603 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.756 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 27.9 p -53.51 -30.38 41.06 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.6 -45.2 16.16 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -54.15 -21.77 9.56 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.154 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.728 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.79 -85.0 0.54 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.728 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.91 -149.8 6.05 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.896 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 2.2 t0 -110.15 120.2 41.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -1.142 . . . . 0.0 109.902 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.593 ' CB ' ' HB2' ' A' ' 14' ' ' ALA . . . -153.72 -152.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.552 ' N ' ' HB3' ' A' ' 14' ' ' ALA . 6.0 mm -146.53 142.7 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 t -146.44 138.53 13.59 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 110.302 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.5 Cg_endo -73.93 93.06 0.87 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.75 1.633 . . . . 0.0 111.258 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.866 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.3 m -60.35 137.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.722 -1.236 . . . . 0.0 111.689 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.7 mt-10 -129.68 68.55 1.43 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.565 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.0 mt -68.93 93.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.859 0.838 . . . . 0.0 110.585 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.0 99.88 0.91 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 64' ' ' SER . 47.9 mt -104.46 145.08 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.537 -0.727 . . . . 0.0 110.756 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.738 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.2 m-85 -116.46 140.67 49.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.812 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.61 -33.08 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.304 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -1.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.812 ' H ' ' C ' ' A' ' 61' ' ' ALA . 36.2 mtm180 75.28 69.05 0.08 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.019 0.914 . . . . 0.0 109.727 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -148.73 148.06 29.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.669 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 39.3 p90 -125.23 103.97 8.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.277 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.2 p -101.6 120.92 41.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.655 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 170.17 146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.074 177.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.63 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 31.7 t -167.57 79.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.284 1.04 . . . . 0.0 108.348 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.426 ' HG1' ' HB3' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -87.03 136.79 32.79 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.598 ' O ' ' OG1' ' A' ' 71' ' ' THR . 5.1 mtmp? -121.0 140.62 51.66 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.227 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER 60.38 163.95 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.838 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 71' ' ' THR . 11.7 Cg_exo -41.08 175.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.099 1.866 . . . . 0.0 112.463 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.17 173.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.629 1.553 . . . . 0.0 112.499 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.751 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 56.79 -73.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 108.711 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -45.48 -17.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.716 . . . . 0.0 110.937 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.751 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 1.2 p90 -43.37 -38.63 2.8 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.889 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 76' ' ' TYR . 3.1 pp -133.65 -22.2 1.91 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 6.5 mt -54.95 -30.84 23.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.589 ' HG3' ' OG1' ' A' ' 71' ' ' THR . 6.0 mmt180 -52.65 -57.21 10.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 82' ' ' ALA . 5.3 tmtm? -52.06 -64.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -58.67 -6.53 0.75 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.813 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.582 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.34 -80.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 111.837 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.89 48.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.99 -1.576 . . . . 0.0 110.817 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.482 HD11 HH11 ' A' ' 79' ' ' ARG . 6.7 mt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.316 . . . . 0.0 109.003 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 97' ' ' GLY . 48.6 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.268 0.556 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 70.08 58.0 6.51 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.582 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.2 tmm_? -131.5 110.08 10.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.172 -1.193 . . . . 0.0 110.916 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.15 -175.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.483 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -127.33 164.3 22.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.889 -1.132 . . . . 0.0 109.656 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.526 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 21.1 t-105 -51.46 -71.04 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.579 -0.7 . . . . 0.0 111.152 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -48.79 -51.12 30.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.693 -1.255 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.4 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.1 mt-30 -49.18 -44.48 42.98 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.48 -25.09 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.518 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.652 ' O ' ' N ' ' A' ' 109' ' ' LYS . 18.2 mt -66.87 -71.8 0.19 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.478 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 46.7 mt-10 -43.81 -43.08 6.0 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.922 -1.111 . . . . 0.0 108.465 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 107' ' ' ILE . 57.9 mt -62.76 -30.71 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.433 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -95.63 -25.78 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.497 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 105' ' ' LEU . 8.4 mtpt -59.28 -73.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.919 -1.113 . . . . 0.0 108.362 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -45.35 -28.41 0.85 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.092 -1.005 . . . . 0.0 108.922 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.488 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 12.0 tttm -69.09 -19.28 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.863 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.694 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -129.65 68.9 81.13 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.092 -1.005 . . . . 0.0 109.884 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 -34.18 27.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.495 1.463 . . . . 0.0 112.072 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.532 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 3.5 t70 175.02 12.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -50.43 -77.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.631 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -149.83 -24.97 0.27 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.796 ' CG2' ' H ' ' A' ' 118' ' ' THR . 23.6 m -64.57 -164.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 0.0 109.579 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.796 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.61 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.251 -0.905 . . . . 0.0 109.935 -179.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.09 141.09 57.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.583 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -61.95 -22.72 65.87 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.243 1.021 . . . . 0.0 109.011 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.93 -38.41 90.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.526 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.92 -74.92 0.12 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.944 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.56 -43.08 7.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.46 -1.4 . . . . 0.0 109.28 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -49.12 -69.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 108.608 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.775 ' HG3' HH11 ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.58 -41.81 4.76 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.709 ' O ' ' N ' ' A' ' 130' ' ' SER . 12.0 ttm -52.32 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.187 -0.946 . . . . 0.0 108.643 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.504 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 20.5 mm -48.03 -64.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.424 -0.798 . . . . 0.0 109.848 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -59.23 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -41.75 4.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.6 m -54.91 -48.6 72.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.536 -1.567 . . . . 0.0 107.699 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -50.01 -47.71 52.92 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.672 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -45.68 -53.5 9.25 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.681 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.4 t -44.89 -67.59 0.27 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.589 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 10.7 ttm -49.42 -3.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.64 -27.26 8.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.597 HG13 ' H ' ' A' ' 137' ' ' GLU . 52.7 t -48.17 165.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.847 -0.796 . . . . 0.0 109.208 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.597 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -142.52 162.62 35.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.711 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.2 164.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.707 ' CG1' ' O ' ' A' ' 139' ' ' VAL . 1.3 p . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.741 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.444 HG13 ' H ' ' A' ' 61' ' ' ALA . 28.3 m -117.79 -24.59 3.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.261 -0.9 . . . . 0.0 109.224 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.24 111.22 6.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.385 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -100.37 73.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.679 ' O ' ' O ' ' A' ' 55' ' ' VAL . 6.1 t -49.12 88.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.611 -1.305 . . . . 0.0 110.715 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? -82.04 37.24 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.843 0.83 . . . . 0.0 109.054 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.855 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.4 mp -76.8 -174.2 2.95 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.817 0.818 . . . . 0.0 111.137 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.609 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.87 175.34 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -169.81 158.46 6.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.886 -1.134 . . . . 0.0 109.993 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 15' ' ' GLY . 11.5 Cg_endo -68.01 104.95 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.935 1.757 . . . . 0.0 111.417 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.765 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -60.94 38.72 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.144 -1.023 . . . . 0.0 110.34 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.5 -18.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.526 -1.797 . . . . 0.0 111.3 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -148.38 78.99 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.507 -1.584 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.24 170.25 9.64 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.36 164.52 3.94 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.773 -1.204 . . . . 0.0 110.487 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' C ' ' HD3' ' A' ' 21' ' ' PRO . 5.4 Cg_exo -51.97 32.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.048 1.832 . . . . 0.0 112.066 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.778 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -138.2 53.93 6.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 0.0 110.415 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.702 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.5 Cg_endo -86.36 162.39 9.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.83 1.687 . . . . 0.0 111.712 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.56 -4.89 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 121.079 1.186 . . . . 0.0 111.34 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.822 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 21.5 t -118.71 -66.51 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.44 -97.16 0.05 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 4.7 Cg_exo -53.96 -55.1 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 CA-C-N 117.816 0.808 . . . . 0.0 110.585 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.616 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . -64.96 5.5 0.33 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.544 -0.723 . . . . 0.0 111.182 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.711 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -109.64 -65.17 1.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.668 -1.27 . . . . 0.0 109.855 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.69 -16.33 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' LEU . 83.5 mt-30 -41.98 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.45 -1.618 . . . . 0.0 109.571 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -64.67 -45.37 87.0 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.678 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.92 -3.53 0.04 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 69.76 76.64 0.21 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 122.187 -0.596 . . . . 0.0 111.756 177.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 34' ' ' ILE . 1.1 m120 -152.41 63.61 0.82 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.291 1.043 . . . . 0.0 108.416 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 37' ' ' PHE . 26.7 mm -43.01 -66.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.651 ' O ' ' CG ' ' A' ' 39' ' ' LYS . 4.3 tpt -41.43 -37.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.695 -1.253 . . . . 0.0 108.67 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.13 -49.13 75.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.711 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -50.38 -66.37 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.842 1.306 . . . . 0.0 109.252 177.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 42' ' ' ASN . 24.4 t -64.11 -37.65 80.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.604 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CG ' ' O ' ' A' ' 35' ' ' MET . 5.8 mmmt -47.95 -59.93 2.98 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.82 72.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.364 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.469 ' CE2' HG23 ' A' ' 45' ' ' THR . 2.6 t80 -69.6 -77.42 0.08 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 5.0 m-20 -41.6 -34.86 0.64 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.398 1.094 . . . . 0.0 110.872 -177.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -65.82 -34.15 77.49 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.497 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.599 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.29 -53.72 4.33 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.393 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.765 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 21.4 p -52.47 -27.54 16.63 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.65 -46.06 13.73 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.677 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -54.67 -21.22 10.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.744 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.03 -85.2 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.744 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.32 -137.67 2.29 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.977 -1.583 . . . . 0.0 110.909 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.512 ' O ' ' CG ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -119.95 118.35 30.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.13 . . . . 0.0 109.971 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -153.74 -153.13 0.45 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.482 ' N ' ' HB1' ' A' ' 14' ' ' ALA . 3.8 mm -146.67 141.8 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' CG1' ' OG1' ' A' ' 69' ' ' THR . 2.2 t -145.66 138.62 14.07 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.552 ' C ' ' O ' ' A' ' 10' ' ' LEU . 10.1 Cg_endo -73.93 91.0 0.93 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.85 1.7 . . . . 0.0 111.519 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.855 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.3 m -56.46 137.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.751 -1.218 . . . . 0.0 111.229 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.6 tt0 -129.24 70.81 1.41 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.587 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.7 mt -71.33 89.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 0.0 110.307 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.39 104.02 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 64' ' ' SER . 41.2 mt -107.64 144.44 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.509 -0.745 . . . . 0.0 110.867 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.741 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.5 m-85 -115.03 139.47 49.84 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.816 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.51 -32.89 5.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.24 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -51.07 -2.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.816 ' H ' ' C ' ' A' ' 61' ' ' ALA . 4.6 mtt180 75.24 70.1 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.913 0.863 . . . . 0.0 109.843 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 2.5 t -150.7 125.13 9.53 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.631 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 33.2 p90 -102.14 103.87 14.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -100.74 121.05 41.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.985 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.648 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.45 148.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 111.231 177.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.648 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 28.0 t -169.3 88.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.489 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -94.74 145.07 25.12 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.811 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -129.53 118.56 22.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 0.0 110.213 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.811 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 23.0 p 75.96 150.02 0.13 Allowed Pre-proline 0 N--CA 1.493 1.689 0 CA-C-O 121.231 0.539 . . . . 0.0 110.025 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -40.16 175.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.682 2.255 . . . . 0.0 113.113 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.4 Cg_exo -39.55 171.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.52 1.48 . . . . 0.0 111.913 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 75' ' ' SER . . . 51.49 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.778 ' N ' ' O ' ' A' ' 73' ' ' PRO . 17.7 p -43.64 -27.75 0.33 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.654 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 8.0 p90 -43.55 -38.11 2.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.652 ' CD1' ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -135.27 -11.39 2.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.652 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 2.0 mt -66.32 -29.85 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.707 ' CZ ' ' CD1' ' A' ' 84' ' ' LEU . 7.3 mmm180 -55.73 -40.12 72.06 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.612 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.6 tmtt? -70.78 -67.95 0.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 99' ' ' ILE . . . -53.82 -4.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.277 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.713 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.61 -78.21 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.712 . . . . 0.0 112.155 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.22 55.71 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.873 -1.632 . . . . 0.0 110.811 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.707 ' CD1' ' CZ ' ' A' ' 79' ' ' ARG . 9.0 mt . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.05 -1.265 . . . . 0.0 109.097 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.362 0.601 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' HG11 ' A' ' 136' ' ' VAL . . . 65.15 73.44 0.59 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.814 ' HG3' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.34 105.31 6.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.128 -1.219 . . . . 0.0 110.979 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.46 ' CD1' HG11 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -105.72 -167.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.027 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.515 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -137.7 159.61 41.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 108.88 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.525 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 17.8 t-105 -47.6 -71.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 110.801 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.6 tp10 -50.77 -49.21 58.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.526 -1.359 . . . . 0.0 110.895 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.603 ' O ' ' CG1' ' A' ' 107' ' ' ILE . 4.2 mt-30 -51.11 -43.7 61.16 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 110.23 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 100' ' ' THR . 2.4 m -70.9 -25.3 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.521 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.673 ' O ' ' N ' ' A' ' 109' ' ' LYS . 18.1 mt -65.7 -71.54 0.19 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -44.41 -42.36 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.854 -1.154 . . . . 0.0 108.185 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 103' ' ' GLN . 1.8 mm -60.85 -33.28 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -98.88 -23.14 15.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.439 -0.788 . . . . 0.0 109.335 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.673 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.6 mttt -57.03 -72.34 0.08 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -48.75 -34.06 11.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.592 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 112' ' ' MET . 1.2 mptp? -80.06 64.43 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.222 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.536 ' H ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER 175.02 55.54 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 0.0 109.217 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.536 ' HD3' ' H ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.38 -55.05 1.05 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.545 1.497 . . . . 0.0 112.346 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 115' ' ' LEU . 1.5 m-20 -163.53 11.46 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.83 ' CD1' ' N ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.79 -85.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.613 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.52 ' H ' HD12 ' A' ' 115' ' ' LEU . 16.9 t30 -155.43 10.68 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.398 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.852 ' CG2' ' H ' ' A' ' 118' ' ' THR . 41.6 m -104.34 -164.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.852 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER 179.25 -55.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.199 -0.938 . . . . 0.0 110.007 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 118' ' ' THR . 3.7 m-20 -74.76 142.92 44.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.342 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -58.77 -33.15 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.221 1.01 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -60.46 -37.63 81.61 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.045 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.06 -72.72 0.2 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.872 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -46.16 -37.93 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.523 -1.361 . . . . 0.0 109.089 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -56.0 -71.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.042 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 129' ' ' GLY . 47.6 ttt180 -43.32 -34.83 1.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' SER . 15.1 ttm -56.2 -76.88 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.501 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 17.4 mm -48.37 -63.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.772 . . . . 0.0 109.785 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -59.57 -71.73 0.12 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.78 -42.66 4.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 126' ' ' MET . 57.9 m -55.49 -50.27 70.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.591 -1.535 . . . . 0.0 107.5 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -47.66 -48.72 28.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.2 tmt_? -44.82 -54.9 5.87 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.661 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -46.71 -69.26 0.14 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.505 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 7.6 ttp -45.07 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.622 -0.674 . . . . 0.0 110.639 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.06 8.62 75.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 28.2 t -88.5 165.31 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 1.3 tp10 -142.78 163.02 33.95 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.137 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.67 153.42 4.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG2' ' HG3' ' A' ' 98' ' ' ARG . 1.3 p . . . . . 0 C--N 1.3 -1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.252 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.484 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 61' ' ' ALA . 27.8 m -119.97 -24.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.063 -1.023 . . . . 0.0 109.621 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.401 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -154.32 101.31 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.316 -1.353 . . . . 0.0 110.635 178.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.657 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -92.36 73.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.746 ' O ' ' O ' ' A' ' 55' ' ' VAL . 24.4 t -45.53 88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.215 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.726 ' CB ' ' HZ2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -84.29 34.44 0.52 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.923 0.868 . . . . 0.0 109.019 179.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.763 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.52 -174.72 3.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.948 0.88 . . . . 0.0 111.381 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -117.19 169.41 9.48 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -163.0 144.59 7.75 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 120.544 -1.347 . . . . 0.0 110.16 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.498 ' HB2' ' CB ' ' A' ' 16' ' ' LYS . 36.5 Cg_endo -80.5 127.91 6.73 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.426 2.084 . . . . 0.0 113.97 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.735 ' O ' ' N ' ' A' ' 16' ' ' LYS . . . -72.83 141.34 47.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.737 ' C ' ' H ' ' A' ' 17' ' ' ALA . . . 61.41 -60.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 mtpp -60.46 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.801 -0.823 . . . . 0.0 108.884 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.737 ' H ' ' C ' ' A' ' 15' ' ' GLY . . . -114.4 151.42 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.73 165.93 6.87 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 -178.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 3.9 Cg_exo -49.38 36.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.723 1.615 . . . . 0.0 111.749 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.896 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -164.34 55.03 0.42 Allowed Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.631 -0.668 . . . . 0.0 109.819 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.0 Cg_endo -77.36 169.95 20.3 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.529 1.486 . . . . 0.0 111.801 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.02 -4.59 3.89 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 121.134 1.223 . . . . 0.0 110.971 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.738 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 t -105.08 -71.54 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.598 0.713 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.92 -98.41 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.738 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.5 Cg_endo -59.98 -55.41 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.972 0.886 . . . . 0.0 109.97 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.31 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.471 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -112.39 -42.49 3.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.608 -1.307 . . . . 0.0 108.703 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.5 85.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 27' ' ' LEU . 8.0 mm-40 -150.64 -13.82 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -1.102 . . . . 0.0 108.06 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.613 ' CD2' ' CE1' ' A' ' 65' ' ' PHE . 2.6 p-80 -86.21 -37.21 18.89 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.549 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -171.87 -1.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.0 80.62 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 111.971 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -156.7 121.7 4.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.505 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.638 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.5 mm -97.9 -64.83 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.646 . . . . 0.0 110.0 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.689 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.97 -57.05 2.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.59 -1.319 . . . . 0.0 109.424 -177.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' MET . 3.7 mp0 -46.54 -51.08 16.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.99 -1.069 . . . . 0.0 108.195 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.638 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -48.15 -59.94 3.02 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.46 1.124 . . . . 0.0 109.623 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 42' ' ' ASN . 50.6 t -73.72 -30.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.95 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.1 tttp -50.09 -62.01 1.82 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.62 -33.89 73.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.469 -0.769 . . . . 0.0 108.94 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 44' ' ' ALA . 2.1 t80 -70.73 -77.03 0.09 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -41.29 -34.21 0.47 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.42 1.105 . . . . 0.0 110.692 -177.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.1 -34.01 75.58 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.963 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.75 -45.55 8.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.69 ' CB ' ' H ' ' A' ' 15' ' ' GLY . 19.0 p -58.67 -29.31 66.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -80.0 -46.5 16.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.587 ' OD1' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -55.96 -23.18 30.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.784 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.83 -74.93 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.394 -0.816 . . . . 0.0 109.407 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.784 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 168.31 150.75 6.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.289 -1.434 . . . . 0.0 111.088 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 49' ' ' GLY . 1.1 m-20 -44.8 148.76 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.015 -1.285 . . . . 0.0 109.497 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.632 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 175.8 -154.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.986 -1.071 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.5 mm -146.98 141.07 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 71' ' ' THR . 2.7 t -144.32 135.59 12.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.744 -1.223 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 8.4 Cg_endo -70.96 99.82 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.624 1.55 . . . . 0.0 110.465 177.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.763 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.0 m -79.16 137.01 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 122.782 1.277 . . . . 0.0 112.262 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -128.25 61.32 1.46 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.417 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -61.57 86.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.646 0.736 . . . . 0.0 109.735 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -60.59 95.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' SER . 46.2 mt -95.75 136.53 26.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.566 -0.708 . . . . 0.0 110.237 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -110.45 138.66 46.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.83 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.68 -29.43 4.4 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.573 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 19.7 t0 -53.93 3.03 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.83 ' H ' ' C ' ' A' ' 61' ' ' ALA . 50.4 mtp180 69.69 70.11 0.24 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.045 0.926 . . . . 0.0 109.624 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 18.2 m -148.25 124.9 11.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.7 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -101.5 104.13 15.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 0.0 110.204 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 p -98.3 124.58 43.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.573 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -109.4 174.02 6.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.526 -1.359 . . . . 0.0 109.349 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.701 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 97.1 t -163.11 44.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.674 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.482 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 t -155.19 126.79 7.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 115.594 -2.442 . . . . 0.0 110.276 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.85 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -124.92 128.13 48.15 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.791 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.81 151.59 0.13 Allowed Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.522 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.0 Cg_exo -40.37 175.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.504 2.136 . . . . 0.0 113.063 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.818 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.63 170.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.651 1.567 . . . . 0.0 112.125 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 49.94 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.882 ' HG ' ' NE ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -43.55 -20.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.242 179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.719 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 11.6 p90 -43.83 -42.22 5.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.65 -0.656 . . . . 0.0 109.322 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.675 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -131.66 -19.52 2.66 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 1.6 mt -59.27 -32.03 47.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.882 ' NE ' ' HG ' ' A' ' 75' ' ' SER . 12.7 mmt180 -55.42 -44.12 75.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 82' ' ' ALA . 9.5 tmtt? -66.37 -66.4 0.56 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.515 ' CB ' ' OE1' ' A' ' 103' ' ' GLN . . . -57.93 -4.84 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.667 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.66 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.16 -80.38 0.19 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 111.987 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.2 53.46 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.036 -1.554 . . . . 0.0 110.466 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.482 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 5.7 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.039 -1.271 . . . . 0.0 109.558 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.482 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 2.4 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.34 0.59 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 50.87 61.2 6.29 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.784 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.87 111.84 10.19 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.997 -1.296 . . . . 0.0 110.327 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.25 -177.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.48 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -125.05 159.02 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.925 -1.109 . . . . 0.0 109.351 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.51 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 22.8 t-105 -49.81 -69.54 0.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.597 -0.69 . . . . 0.0 111.042 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.639 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 9.5 tp10 -50.2 -44.74 53.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.515 ' OE1' ' CB ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -55.31 -43.76 75.17 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.162 -0.961 . . . . 0.0 110.054 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.23 -24.32 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 117.649 -1.62 . . . . 0.0 107.656 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.653 ' O ' ' N ' ' A' ' 109' ' ' LYS . 17.1 mt -66.31 -71.72 0.19 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.639 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 20.5 mm-40 -44.08 -44.5 7.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.909 -1.119 . . . . 0.0 108.44 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 107' ' ' ILE . 65.4 mt -60.84 -32.55 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 108.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.98 -26.79 15.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.575 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.5 mttm -58.82 -73.27 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.935 -1.103 . . . . 0.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 109' ' ' LYS . 6.2 tt0 -45.24 -28.46 0.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.441 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 11.6 tttm -69.8 -18.44 63.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.58 68.13 81.15 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.031 -1.043 . . . . 0.0 109.821 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.8 -33.96 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.533 1.488 . . . . 0.0 112.088 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 174.97 15.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.77 . . . . 0.0 109.087 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.21 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.597 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -150.65 -25.03 0.23 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.793 ' CG2' ' H ' ' A' ' 118' ' ' THR . 23.5 m -64.94 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.793 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.45 -74.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.943 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.68 140.96 57.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 110.051 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.579 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -61.88 -22.65 65.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.214 1.007 . . . . 0.0 108.952 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.12 -38.42 90.6 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.57 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.69 -75.2 0.11 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.231 -1.387 . . . . 0.0 107.921 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.56 -43.02 7.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.475 -1.39 . . . . 0.0 109.292 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -49.63 -68.71 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 108.571 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.779 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.57 -42.95 5.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.682 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.21 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 108.562 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.491 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 19.9 mm -48.57 -65.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -58.81 -71.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.72 -39.04 3.36 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.9 m -57.8 -47.51 82.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.467 -1.608 . . . . 0.0 107.564 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -49.97 -48.47 52.16 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.649 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.2 tmm_? -46.62 -53.71 10.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.702 ' C ' ' H ' ' A' ' 135' ' ' GLY . 7.1 t -44.83 -68.5 0.19 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' A' ' 75' ' ' SER . 0.0 OUTLIER -47.27 -3.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.702 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 87.91 -23.67 13.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 47.4 t -53.44 165.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.849 -0.795 . . . . 0.0 109.17 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.498 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -142.66 162.58 35.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.025 -1.047 . . . . 0.0 109.723 179.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.44 ' H ' ' HG3' ' A' ' 137' ' ' GLU . 1.9 t -77.76 162.25 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.677 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.599 -0.688 . . . . 0.0 109.184 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.744 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 61' ' ' ALA . 27.8 m -112.82 -24.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.19 107.28 5.73 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.168 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.642 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.9 p -94.71 73.62 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 108.94 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.729 ' O ' ' O ' ' A' ' 55' ' ' VAL . 31.7 t -45.96 88.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.192 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.54 34.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.89 0.853 . . . . 0.0 109.076 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.816 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -78.23 -174.42 3.69 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.787 0.803 . . . . 0.0 111.31 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -119.78 171.84 8.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -168.3 160.11 9.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.689 -1.257 . . . . 0.0 110.288 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HD2' ' CD2' ' A' ' 12' ' ' LEU . 13.4 Cg_endo -67.74 109.19 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.251 1.967 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.763 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -69.45 40.21 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.963 -1.086 . . . . 0.0 110.733 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.496 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 179.31 -18.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 118.277 -1.915 . . . . 0.0 111.792 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' CE ' ' OD1' ' A' ' 50' ' ' ASP . 2.1 mptt -135.82 60.74 1.67 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.405 -1.644 . . . . 0.0 110.452 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.64 158.74 26.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.68 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -161.92 163.31 19.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.688 -1.258 . . . . 0.0 110.494 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.47 35.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.936 1.758 . . . . 0.0 111.852 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.68 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -171.17 57.18 0.25 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.41 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.0 Cg_endo -80.5 168.45 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.453 1.435 . . . . 0.0 111.432 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 -4.61 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.126 1.218 . . . . 0.0 111.044 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.728 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 1.9 t -105.48 -72.62 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.604 0.716 . . . . 0.0 110.277 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 23' ' ' VAL . . . 54.55 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -177.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.728 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.1 Cg_endo -60.49 -55.51 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 CA-C-N 118.047 0.923 . . . . 0.0 109.854 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.37 -8.6 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.39 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.652 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -111.62 -43.21 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.686 -1.259 . . . . 0.0 108.805 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.26 84.7 0.01 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tp-100 -148.9 -8.4 0.36 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.696 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 6.0 p-80 -92.78 -36.55 12.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.639 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -171.55 2.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 71.86 75.95 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.661 -0.905 . . . . 0.0 112.058 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -154.05 121.32 5.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 108.797 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.577 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.7 mm -97.94 -63.8 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.683 -0.636 . . . . 0.0 109.952 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -42.08 -54.22 3.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.787 -1.195 . . . . 0.0 109.79 -176.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -50.08 -51.25 44.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.948 -1.095 . . . . 0.0 108.601 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -47.19 -58.89 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.773 1.273 . . . . 0.0 109.566 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 82.0 t -71.78 -30.25 37.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.212 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 35' ' ' MET . 14.2 mmtt -53.48 -55.04 28.7 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.22 -34.14 76.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.575 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.454 ' CE2' HG21 ' A' ' 45' ' ' THR . 1.4 t80 -68.32 -76.19 0.09 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 19.0 m-20 -41.81 -37.5 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.45 1.119 . . . . 0.0 110.764 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -62.73 -34.56 77.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.327 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.57 -61.59 1.64 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.888 -1.125 . . . . 0.0 108.654 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.763 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 24.6 p -44.85 -29.74 0.85 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.29 -43.39 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 44' ' ' ALA . 4.8 t-20 -54.49 -24.39 20.28 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.44 -85.22 0.54 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -159.94 -148.98 5.42 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 118.996 -1.573 . . . . 0.0 111.051 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.521 ' OD1' ' CE ' ' A' ' 16' ' ' LYS . 3.5 t70 -113.55 126.02 54.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -1.095 . . . . 0.0 109.687 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -158.92 -152.85 0.34 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.5 ' N ' ' HB1' ' A' ' 14' ' ' ALA . 5.8 mm -147.0 143.37 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 71' ' ' THR . 5.2 t -145.72 137.58 13.17 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.2 Cg_endo -73.3 86.06 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.745 1.63 . . . . 0.0 110.601 177.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.816 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.7 m -58.01 137.71 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.762 1.267 . . . . 0.0 112.321 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.3 mt-10 -128.78 63.98 1.45 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 8' ' ' VAL . 3.7 mt -64.36 90.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.812 0.815 . . . . 0.0 110.316 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -64.25 98.48 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.403 ' O ' HG21 ' A' ' 4' ' ' VAL . 9.8 mt -100.72 142.68 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.561 -0.712 . . . . 0.0 110.375 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.744 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.7 m-85 -114.34 139.93 49.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.811 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.61 -30.0 4.9 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.349 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 8.1 t70 -53.53 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.811 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 70.46 69.04 0.2 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.122 0.963 . . . . 0.0 109.627 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -148.06 125.07 11.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.678 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -101.43 104.02 14.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 110.232 -179.311 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.5 p -99.16 124.67 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.558 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 1.8 p90 -108.52 171.32 7.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.569 -1.332 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.705 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 88.8 t -162.38 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 112.691 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.482 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.2 t -154.93 118.02 4.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.048 -2.282 . . . . 0.0 110.398 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.818 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.51 120.06 38.26 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.141 0.972 . . . . 0.0 108.599 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.789 ' HG1' ' CB ' ' A' ' 75' ' ' SER . 16.2 p 76.99 151.45 0.13 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.5 Cg_exo -39.12 175.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.762 2.308 . . . . 0.0 113.351 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.5 Cg_exo -40.99 167.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.652 1.568 . . . . 0.0 111.915 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 54.67 -77.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.789 ' CB ' ' HG1' ' A' ' 71' ' ' THR . 8.0 t -43.04 -25.05 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.981 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.659 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 17.9 p90 -43.27 -41.72 4.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.485 -0.76 . . . . 0.0 109.111 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -133.07 -15.48 2.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.51 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 1.6 mt -60.21 -33.21 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.665 ' CG ' ' OG ' ' A' ' 75' ' ' SER . 1.5 mtm180 -55.46 -43.37 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -67.15 -66.23 0.58 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.433 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -58.36 -4.8 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 109.684 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.669 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.42 -79.76 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 111.554 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 154.57 56.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.408 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.431 HD23 ' CG1' ' A' ' 96' ' ' VAL . 10.8 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.252 . . . . 0.0 109.23 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.431 ' CG1' HD23 ' A' ' 84' ' ' LEU . 41.1 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.315 0.578 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.471 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 58.45 66.51 2.75 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.777 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.16 113.11 11.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -1.166 . . . . 0.0 110.008 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.704 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.81 -173.37 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.444 HG23 ' NE2' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -127.5 158.04 38.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.401 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.537 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 22.7 t-105 -49.95 -69.47 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.498 -0.751 . . . . 0.0 110.753 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 4.4 tp10 -49.78 -45.04 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.706 -1.246 . . . . 0.0 110.539 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.444 ' NE2' HG23 ' A' ' 100' ' ' THR . 0.2 OUTLIER -52.71 -46.3 67.28 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.911 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 105' ' ' LEU . 2.4 m -71.46 -24.55 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.996 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.655 ' O ' ' N ' ' A' ' 109' ' ' LYS . 18.3 mt -65.91 -71.37 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.587 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 mm-40 -43.92 -43.31 6.4 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.959 -1.088 . . . . 0.0 108.66 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 57.6 mt -63.22 -32.3 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 108.817 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.21 -27.1 16.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.332 -0.855 . . . . 0.0 109.376 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 105' ' ' LEU . 15.3 mtpt -59.78 -74.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.594 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . 71.5 mt-30 -45.04 -27.32 0.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.229 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -74.59 -10.41 59.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.927 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.649 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.38 64.03 67.54 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.65 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.5 Cg_endo -66.13 -30.67 46.51 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.647 1.565 . . . . 0.0 112.084 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.539 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 1.7 t70 175.16 10.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.188 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -48.42 -79.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.19 -21.5 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.621 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.815 ' CG2' ' H ' ' A' ' 118' ' ' THR . 27.4 m -64.69 -164.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.948 . . . . 0.0 109.585 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.815 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.75 -67.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.807 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.422 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -69.57 138.39 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.583 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -58.29 -22.66 53.68 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.204 1.002 . . . . 0.0 108.85 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.16 -35.9 82.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.539 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.48 -75.84 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.212 -1.395 . . . . 0.0 107.985 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.84 -39.29 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.47 -1.394 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -53.27 -70.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.784 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.54 -38.96 3.18 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.568 ' O ' ' HB3' ' A' ' 130' ' ' SER . 10.4 ttm -54.54 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 108.872 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.478 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 24.4 mm -46.07 -63.95 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.642 0.734 . . . . 0.0 110.46 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -58.31 -69.05 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.29 -38.29 2.72 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 126' ' ' MET . 6.0 p -55.31 -53.75 52.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.602 -1.528 . . . . 0.0 107.282 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.506 ' H ' ' HG ' ' A' ' 130' ' ' SER . . . -44.84 -50.2 10.43 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.4 tmt_? -44.77 -56.6 4.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 135' ' ' GLY . 11.2 t -46.04 -69.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.496 ' SD ' ' HB2' ' A' ' 75' ' ' SER . 4.9 ttp -44.89 -5.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.648 -0.657 . . . . 0.0 110.255 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.84 20.06 60.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 30.9 t -102.8 165.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.911 -0.758 . . . . 0.0 108.969 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.509 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 82.8 mt-10 -141.31 162.53 35.26 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.07 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -77.86 160.98 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.704 ' N ' ' O ' ' A' ' 99' ' ' ILE . 5.4 p . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.714 ' N ' ' CZ ' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 59' ' ' ILE . 27.7 m -120.89 -24.71 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.124 -0.985 . . . . 0.0 110.107 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 59' ' ' ILE . . . -156.51 118.6 3.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.434 -1.416 . . . . 0.0 110.503 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.9 p -110.59 73.9 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.786 -0.571 . . . . 0.0 109.612 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 13.9 t -44.89 88.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 0.0 110.158 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.6 tmtt? -84.03 34.66 0.51 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.925 0.869 . . . . 0.0 109.127 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.77 -173.7 3.59 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.652 0.739 . . . . 0.0 111.009 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.562 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.99 179.02 5.41 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.399 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -165.63 144.77 5.24 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 0.0 108.931 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 67.4 Cg_endo -83.43 113.15 1.98 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.552 2.168 . . . . 0.0 114.445 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.643 ' CB ' ' H ' ' A' ' 51' ' ' ALA . . . -63.19 142.93 58.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.618 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 55.19 52.83 44.54 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.471 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER 173.88 27.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.55 -0.97 . . . . 0.0 108.711 -178.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.83 152.98 27.28 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.913 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.19 165.97 6.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.868 -179.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 2.9 Cg_exo -48.86 34.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.617 1.545 . . . . 0.0 111.627 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.913 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -155.22 54.2 0.96 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.41 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.709 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 17.1 Cg_endo -81.14 167.66 17.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.703 1.602 . . . . 0.0 111.947 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.24 -4.48 3.14 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 121.306 1.337 . . . . 0.0 111.41 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.787 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.7 t -112.92 -71.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.58 -97.97 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.787 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -58.97 -55.13 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 CA-C-N 117.9 0.85 . . . . 0.0 110.354 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' C ' HG12 ' A' ' 23' ' ' VAL . . . -48.46 -8.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.693 -0.63 . . . . 0.0 110.945 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.62 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -108.61 -48.62 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.643 -1.286 . . . . 0.0 108.8 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.36 98.4 0.02 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.2 tt0 -158.3 -22.64 0.08 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.772 ' CD2' ' N ' ' A' ' 31' ' ' GLY . 1.5 p-80 -81.12 -44.1 18.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.162 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.772 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -166.73 -10.52 0.03 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.638 ' C ' ' ND2' ' A' ' 33' ' ' ASN . . . 75.29 84.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 112.494 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.638 ' ND2' ' C ' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -155.16 70.95 0.77 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.863 -1.148 . . . . 0.0 108.916 177.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.524 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 21.7 mm -44.37 -71.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.224 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.493 ' O ' ' C ' ' A' ' 36' ' ' GLU . 10.1 tpt -41.88 -53.39 3.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.164 . . . . 0.0 109.42 -178.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.3 tp10 -44.88 -49.76 10.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.62 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -51.42 -69.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.973 1.368 . . . . 0.0 109.998 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG11 HD21 ' A' ' 42' ' ' ASN . 35.7 t -56.5 -36.06 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.557 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 35' ' ' MET . 21.0 tttt -50.66 -64.08 0.92 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.19 -32.53 64.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' ALA . 2.9 t80 -71.3 -76.63 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.392 -1.443 . . . . 0.0 107.116 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.3 m-80 -41.16 -28.14 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.792 -1.192 . . . . 0.0 110.436 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -71.35 -34.52 70.58 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.82 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -90.35 -44.62 9.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.733 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.618 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 6.8 p -59.81 -32.09 70.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.15 -44.93 24.6 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.657 ' ND2' ' O ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -59.33 -21.88 60.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.411 -0.806 . . . . 0.0 108.965 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.701 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.25 -75.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.701 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -178.49 -121.06 0.68 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.035 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.459 ' OD1' ' C ' ' A' ' 49' ' ' GLY . 0.7 OUTLIER -137.76 124.86 21.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -1.129 . . . . 0.0 108.669 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.643 ' H ' ' CB ' ' A' ' 14' ' ' ALA . . . 173.86 114.33 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.992 -1.068 . . . . 0.0 110.659 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -44.97 160.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.495 -1.378 . . . . 0.0 113.014 -178.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 12' ' ' LEU . 6.1 t -153.51 135.38 8.98 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.211 -0.931 . . . . 0.0 110.089 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 6.3 Cg_endo -66.96 108.87 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.722 1.615 . . . . 0.0 112.565 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -87.47 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.553 -1.342 . . . . 0.0 111.273 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 11.9 mt-10 -128.65 69.21 1.37 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.56 HG12 ' CZ ' ' A' ' 67' ' ' PHE . 4.9 mt -70.96 88.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.731 0.777 . . . . 0.0 110.33 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -61.97 94.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.663 ' N ' ' O ' ' A' ' 6' ' ' ALA . 25.5 mt -89.29 94.16 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.714 ' CZ ' ' N ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -84.15 179.13 7.56 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.295 1.045 . . . . 0.0 112.234 -176.133 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 1.096 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.95 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.115 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 63' ' ' ARG . 40.2 p30 -46.73 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 109.319 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 1.096 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 43.91 86.23 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -146.23 124.36 12.16 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.82 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.765 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.95 103.06 13.68 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.172 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 22.2 p -101.03 120.62 40.46 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.078 -1.013 . . . . 0.0 109.0 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.657 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.58 148.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.876 -1.14 . . . . 0.0 111.057 177.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.657 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 29.5 t -169.76 95.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.406 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -104.5 147.36 27.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.758 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.8 mptt -132.75 124.21 27.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.68 -1.263 . . . . 0.0 110.092 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.846 ' HG1' ' HG ' ' A' ' 75' ' ' SER . 15.9 p 76.08 149.17 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 CA-C-O 121.232 0.539 . . . . 0.0 109.662 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 73' ' ' PRO . 10.7 Cg_exo -42.07 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.513 2.142 . . . . 0.0 112.722 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.716 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.9 Cg_exo -38.44 172.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.518 1.479 . . . . 0.0 111.951 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 51.9 -83.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.846 ' HG ' ' HG1' ' A' ' 71' ' ' THR . 7.9 t -42.77 -23.37 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 110.11 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.657 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 14.8 p90 -43.84 -38.92 3.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.638 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.17 -19.2 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 1.2 mt -56.22 -34.63 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.666 ' CG ' ' OG ' ' A' ' 75' ' ' SER . 13.0 mmt180 -53.08 -49.68 65.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.554 ' CD ' ' C ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -57.81 -63.73 1.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -59.29 -6.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 80' ' ' LYS . . . -84.13 -80.39 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 0.0 111.762 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' C ' ' CG1' ' A' ' 96' ' ' VAL . . . 172.59 -13.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.665 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.912 -1.346 . . . . 0.0 110.082 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.474 HG13 ' H ' ' A' ' 97' ' ' GLY . 2.3 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.279 0.561 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 104.23 56.77 0.73 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.768 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.25 122.03 24.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.206 -1.173 . . . . 0.0 110.283 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.696 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.7 OUTLIER -109.55 -165.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.79 156.42 46.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 0.0 109.125 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.543 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 15.6 t-105 -48.92 -69.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.877 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.484 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.78 -53.98 21.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.565 -1.334 . . . . 0.0 110.972 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -47.12 -44.87 21.92 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.328 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -70.77 -26.03 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.431 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.663 ' O ' ' N ' ' A' ' 109' ' ' LYS . 16.0 mt -65.95 -70.5 0.24 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' LEU . 36.0 tt0 -43.7 -42.54 5.42 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.916 -1.115 . . . . 0.0 108.337 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.4 mt -63.26 -31.23 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.05 -1.031 . . . . 0.0 108.329 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.652 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.93 -26.33 16.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 105' ' ' LEU . 8.6 mttp -58.3 -73.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 0.0 108.431 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -48.69 -24.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 108.958 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.564 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -72.83 -16.6 61.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.699 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.48 65.71 76.75 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.768 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.66 -32.88 37.2 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.631 1.554 . . . . 0.0 112.11 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.543 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 2.5 t70 174.98 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.23 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.36 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.58 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -154.42 -24.97 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.655 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.793 ' CG2' ' H ' ' A' ' 118' ' ' THR . 24.8 m -65.08 -164.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.793 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.44 -73.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.95 142.13 57.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 110.011 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.6 OUTLIER -61.4 -24.86 66.81 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.237 1.018 . . . . 0.0 109.036 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.17 -38.26 90.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.6 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -69.11 -74.35 0.13 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.943 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.94 -44.4 9.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.523 -1.36 . . . . 0.0 109.22 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -48.64 -70.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.755 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.37 -39.66 3.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.693 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.9 ttm -53.0 -78.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.191 -0.943 . . . . 0.0 108.605 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.502 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 23.8 mm -48.1 -64.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.66 0.743 . . . . 0.0 110.082 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.638 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -59.95 -71.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.85 -42.56 4.97 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 126' ' ' MET . 51.8 m -54.0 -42.21 68.79 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.627 -1.514 . . . . 0.0 107.029 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -54.34 -48.72 71.08 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.758 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -44.9 -48.16 11.23 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 135' ' ' GLY . 6.1 t -53.58 -69.62 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.536 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 7.0 ttm -44.9 -5.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.579 -0.701 . . . . 0.0 109.956 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 84.02 24.96 46.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.536 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 28.6 t -107.1 165.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.952 -0.734 . . . . 0.0 109.183 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.528 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 72.8 tt0 -141.82 164.3 30.56 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.067 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.447 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.9 t -82.58 146.22 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.696 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.3 p . . . . . 0 N--CA 1.487 1.386 0 O-C-N 121.49 -0.757 . . . . 0.0 109.452 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.584 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.83 -24.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.273 -0.892 . . . . 0.0 110.089 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.593 ' O ' ' N ' ' A' ' 59' ' ' ILE . . . -161.01 115.16 2.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.59 -1.319 . . . . 0.0 110.741 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -107.64 74.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 55' ' ' VAL . 15.1 t -47.84 88.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.663 -1.273 . . . . 0.0 110.538 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.69 36.49 0.55 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.939 0.876 . . . . 0.0 109.158 179.197 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -78.04 -173.99 3.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 111.374 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.514 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.09 174.54 7.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -163.87 147.52 8.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.951 -1.093 . . . . 0.0 109.371 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.648 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 96.7 Cg_endo -86.76 128.84 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.389 2.059 . . . . 0.0 113.266 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.729 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -75.26 142.85 43.28 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.05 63.12 5.31 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.648 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 14.0 tttt 174.09 -25.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.551 ' C ' ' HG1' ' A' ' 18' ' ' THR . . . -61.65 151.92 32.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 108.368 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.883 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.64 165.9 9.39 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 5.8 Cg_exo -50.45 37.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.717 1.611 . . . . 0.0 111.638 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.883 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -167.97 55.01 0.28 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.698 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 10.9 Cg_endo -79.03 170.83 17.29 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.617 1.545 . . . . 0.0 111.781 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.17 -4.56 1.67 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.115 1.21 . . . . 0.0 110.94 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.766 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 1.9 t -108.18 -72.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.482 0.658 . . . . 0.0 110.096 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.62 -98.17 0.06 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.766 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.8 Cg_endo -59.45 -55.38 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.975 0.888 . . . . 0.0 109.988 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.51 -12.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.19 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.629 HD11 ' CD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -114.39 -40.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.775 -1.203 . . . . 0.0 108.239 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.8 92.69 0.01 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.564 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -159.06 -25.9 0.07 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 179.178 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.73 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 4.6 p80 -78.75 61.24 2.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.693 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 83.91 -9.37 63.17 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.35 84.23 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.153 -1.204 . . . . 0.0 112.104 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -157.38 123.72 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 108.731 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 mm -99.4 -63.47 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.685 -0.634 . . . . 0.0 109.831 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.66 ' O ' ' N ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -41.02 -52.58 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.755 -1.215 . . . . 0.0 109.662 -176.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.2 mm-40 -49.66 -47.25 50.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.647 -1.283 . . . . 0.0 107.831 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.646 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -52.93 -68.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.517 1.151 . . . . 0.0 109.956 178.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.67 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 23.6 t -66.08 -37.71 80.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.081 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.66 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.6 mmmt -46.12 -58.57 3.51 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.32 72.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.318 -0.864 . . . . 0.0 108.939 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 44' ' ' ALA . 3.6 t80 -71.34 -77.11 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.67 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 2.0 m-80 -41.33 -32.1 0.28 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.933 -1.104 . . . . 0.0 110.589 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.93 -33.45 73.75 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.668 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . -90.24 -47.97 7.45 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.559 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.495 ' HG1' ' N ' ' A' ' 46' ' ' ALA . 2.3 p -57.08 -29.2 63.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.47 -46.57 17.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -57.24 -21.25 32.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.406 -0.809 . . . . 0.0 108.842 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.75 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.08 -74.22 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.443 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.75 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 172.97 -156.52 24.9 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.16 145.34 24.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.02 -1.282 . . . . 0.0 108.967 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.729 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 176.25 -153.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.745 -1.222 . . . . 0.0 110.905 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 2.3 mm -146.37 139.42 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.687 ' CG1' ' HG1' ' A' ' 69' ' ' THR . 2.2 t -140.11 135.29 16.18 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.008 -1.058 . . . . 0.0 110.905 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.3 Cg_endo -71.84 105.66 1.85 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.77 1.647 . . . . 0.0 111.056 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.5 m -80.66 135.61 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.711 -1.243 . . . . 0.0 111.702 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.3 mt-10 -129.29 67.49 1.43 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.538 HG12 ' CZ ' ' A' ' 67' ' ' PHE . 4.2 mt -68.79 87.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.707 0.765 . . . . 0.0 110.218 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -61.69 94.68 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 64' ' ' SER . 5.6 mt -88.87 134.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.443 -0.786 . . . . 0.0 109.217 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.584 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -122.49 -179.65 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.316 -176.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 1.082 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.82 -85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.224 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' C ' ' A' ' 63' ' ' ARG . 20.9 t0 -46.24 39.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.542 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 1.082 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER 44.03 87.63 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.736 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -143.62 166.37 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.781 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -146.18 103.2 3.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 109.164 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 4.0 p -101.11 120.83 40.79 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.68 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 170.67 147.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.921 -1.112 . . . . 0.0 110.935 177.464 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 29.8 t -168.3 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 122.312 1.053 . . . . 0.0 108.208 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.687 ' HG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -95.06 146.98 23.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.775 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.3 mptt -132.72 127.31 34.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.217 -1.393 . . . . 0.0 110.511 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.775 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.1 p 76.0 149.15 0.12 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-O 121.242 0.544 . . . . 0.0 109.955 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' O ' ' O ' ' A' ' 73' ' ' PRO . 9.2 Cg_exo -42.83 175.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.835 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.75 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -38.66 171.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.639 1.559 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 51.33 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.75 ' N ' ' O ' ' A' ' 73' ' ' PRO . 24.8 p -43.02 -22.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.887 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.63 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 15.6 p90 -43.77 -40.54 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.559 -0.713 . . . . 0.0 109.168 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.63 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -134.59 -16.63 2.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 1.3 mt -59.28 -33.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.51 ' HE ' ' HB2' ' A' ' 75' ' ' SER . 16.3 mmt180 -55.78 -42.71 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.9 tmtt? -65.87 -66.06 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' O ' HG21 ' A' ' 99' ' ' ILE . . . -57.37 -6.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.426 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.24 -80.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.494 -0.754 . . . . 0.0 111.857 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 173.6 35.0 0.04 OUTLIER Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.45 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.484 HD13 HH11 ' A' ' 79' ' ' ARG . 3.2 mt . . . . . 0 N--CA 1.49 1.572 0 O-C-N 120.96 -1.318 . . . . 0.0 109.148 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.302 0.572 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' HG11 ' A' ' 136' ' ' VAL . . . 67.82 44.78 78.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.781 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.82 115.16 14.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -1.228 . . . . 0.0 110.216 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -108.51 178.2 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.511 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -122.66 161.96 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.057 . . . . 0.0 109.366 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.538 ' O ' HG23 ' A' ' 104' ' ' VAL . 16.0 t-105 -48.57 -70.88 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 111.33 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.539 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 3.8 tp10 -49.31 -51.59 33.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 110.934 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -48.57 -44.6 36.87 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.343 -0.848 . . . . 0.0 110.295 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.57 -25.58 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 117.726 -1.59 . . . . 0.0 107.634 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.68 ' O ' ' N ' ' A' ' 109' ' ' LYS . 16.1 mt -65.85 -71.56 0.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.539 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 23.8 mm-40 -44.18 -42.37 6.39 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 67.0 mt -65.28 -31.49 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 108.999 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -96.31 -31.0 13.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.617 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.1 mtpm? -54.45 -72.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.966 -1.084 . . . . 0.0 108.625 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -51.23 -27.68 9.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 112' ' ' MET . 10.2 tttm -84.62 64.47 8.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.784 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.551 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER 175.99 56.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.843 . . . . 0.0 109.306 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.6 Cg_endo -64.78 -55.06 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.528 1.486 . . . . 0.0 112.231 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 1.7 p-10 -162.56 9.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.164 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.8 mm? -44.97 -62.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -177.75 6.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.855 ' CG2' ' H ' ' A' ' 118' ' ' THR . 32.0 m -108.88 -164.48 0.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.943 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.855 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER 175.97 -44.39 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.3 -0.875 . . . . 0.0 109.708 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.711 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -74.74 143.88 43.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.472 -0.767 . . . . 0.0 110.359 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.581 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -65.29 -36.78 85.14 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.385 1.088 . . . . 0.0 108.514 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -61.94 -33.92 75.15 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.932 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.39 -75.4 0.14 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.92 -40.12 6.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.477 -1.389 . . . . 0.0 109.093 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -52.89 -69.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.661 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.35 -38.62 2.77 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.0 ttm -53.28 -78.04 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.511 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 23.6 mm -48.76 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.768 0.794 . . . . 0.0 109.832 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -58.95 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -40.24 3.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.7 m -57.57 -50.25 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.566 -1.549 . . . . 0.0 107.532 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -47.39 -49.05 25.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.785 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.14 -54.6 8.34 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.692 ' C ' ' H ' ' A' ' 135' ' ' GLY . 6.9 t -44.88 -68.69 0.18 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.498 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 5.5 ttp -47.23 -4.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.637 -0.664 . . . . 0.0 109.271 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.71 -27.61 7.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 43.0 t -48.6 165.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.919 -0.754 . . . . 0.0 109.183 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.514 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 63.2 mm-40 -142.38 162.01 36.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.756 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.95 161.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.789 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 61' ' ' ALA . 27.7 m -117.17 -24.41 3.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.157 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.16 107.04 4.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.689 -1.257 . . . . 0.0 110.351 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -96.31 73.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.72 ' O ' ' O ' ' A' ' 55' ' ' VAL . 31.2 t -46.47 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.8 -1.188 . . . . 0.0 110.461 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.9 OUTLIER -82.93 34.75 0.46 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.844 0.831 . . . . 0.0 108.999 179.111 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.828 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -78.11 -174.46 3.65 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.804 0.811 . . . . 0.0 111.147 -178.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.577 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -119.69 172.15 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -168.42 160.06 8.82 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.787 -1.196 . . . . 0.0 110.232 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HD2' ' CD2' ' A' ' 12' ' ' LEU . 15.1 Cg_endo -67.91 109.91 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.249 1.966 . . . . 0.0 111.635 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.76 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -69.01 41.03 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.89 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.475 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 177.08 -16.52 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.3 -1.905 . . . . 0.0 111.831 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -135.41 53.92 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.427 -1.631 . . . . 0.0 110.502 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' O ' ' ND2' ' A' ' 42' ' ' ASN . . . -73.13 157.9 36.35 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.688 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -159.85 162.96 23.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.617 -1.302 . . . . 0.0 110.726 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.02 36.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.973 1.782 . . . . 0.0 111.993 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.688 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -175.93 58.57 0.18 Allowed Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.34 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.1 Cg_endo -80.68 169.5 16.7 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.568 1.512 . . . . 0.0 111.394 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.88 -4.66 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 121.007 1.138 . . . . 0.0 110.965 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.743 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.1 t -104.94 -71.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.6 0.714 . . . . 0.0 109.964 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.69 -98.12 0.05 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.743 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.62 -55.38 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 CA-C-N 117.926 0.863 . . . . 0.0 109.867 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -43.85 -11.41 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.15 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.667 HD11 ' CD2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -116.02 -39.15 3.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.822 -1.174 . . . . 0.0 108.427 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.33 94.1 0.01 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.524 ' CD ' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -161.52 -23.28 0.05 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.677 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -81.14 64.93 6.08 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.482 ' N ' ' HG3' ' A' ' 63' ' ' ARG . . . 80.44 -5.51 63.82 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.29 80.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 111.828 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.54 ' O ' ' NE2' ' A' ' 30' ' ' HIS . 42.9 m-80 -155.95 125.01 6.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.879 -1.138 . . . . 0.0 108.657 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.5 mm -101.16 -62.9 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.686 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.87 -49.77 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.819 -1.176 . . . . 0.0 109.861 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -52.37 -50.54 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.854 -1.154 . . . . 0.0 108.181 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.667 ' CD2' HD11 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -48.85 -61.15 2.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.606 1.194 . . . . 0.0 109.076 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.483 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 98.6 t -70.52 -29.15 37.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.848 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.686 ' N ' ' O ' ' A' ' 35' ' ' MET . 40.3 tptt -54.44 -55.38 29.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.58 75.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.378 -0.826 . . . . 0.0 109.532 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.451 ' CE2' HG23 ' A' ' 45' ' ' THR . 1.3 t80 -68.97 -76.36 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 23.6 m-20 -41.79 -37.19 1.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.455 1.121 . . . . 0.0 110.804 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -63.29 -35.02 78.97 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.355 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.05 -61.54 1.66 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.545 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.76 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.3 p -44.8 -30.08 0.9 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.36 -43.21 19.36 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 44' ' ' ALA . 16.3 t-20 -55.3 -24.04 26.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.647 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.09 -85.25 0.54 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.851 -1.156 . . . . 0.0 109.934 179.483 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -161.83 -150.43 5.95 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.121 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.2 123.09 49.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.721 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -155.39 -152.87 0.41 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.499 ' N ' ' HB1' ' A' ' 14' ' ' ALA . 5.8 mm -147.19 143.89 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.555 ' CG1' ' HG1' ' A' ' 69' ' ' THR . 5.6 t -146.94 137.46 12.46 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 110.299 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.9 Cg_endo -73.03 87.24 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.842 1.694 . . . . 0.0 110.776 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.828 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.5 m -58.46 137.42 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.827 1.298 . . . . 0.0 112.231 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 32.6 mt-10 -128.09 63.61 1.4 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -63.38 88.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.66 0.743 . . . . 0.0 110.174 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.5 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.57 97.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 64' ' ' SER . 1.9 mt -100.66 146.11 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.17 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.789 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 9.6 m-85 -115.52 141.17 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.816 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.56 -30.37 5.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.153 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 7.2 t70 -52.51 1.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.816 ' H ' ' C ' ' A' ' 61' ' ' ALA . 8.8 tmm_? 71.68 69.8 0.16 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.06 0.933 . . . . 0.0 109.642 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.4 OUTLIER -148.59 125.04 10.97 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.594 ' CD1' ' ND1' ' A' ' 30' ' ' HIS . 17.4 p90 -101.04 103.86 14.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.954 -1.091 . . . . 0.0 110.187 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 58' ' ' THR . 11.2 p -99.43 124.82 44.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 108.854 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.566 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -107.97 171.35 7.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.596 -1.315 . . . . 0.0 109.368 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.705 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 90.3 t -163.17 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 112.644 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.555 ' HG1' ' CG1' ' A' ' 53' ' ' VAL . 11.0 t -154.02 118.54 4.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 115.945 -2.302 . . . . 0.0 110.754 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.812 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.92 121.43 42.3 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.766 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.6 p 76.86 151.06 0.13 Allowed Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 71' ' ' THR . 12.6 Cg_exo -40.21 175.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.551 2.167 . . . . 0.0 113.038 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.6 Cg_exo -40.51 169.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.6 1.534 . . . . 0.0 112.004 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.513 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 52.93 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.787 ' N ' ' O ' ' A' ' 73' ' ' PRO . 8.6 t -43.34 -23.62 0.07 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 110.147 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 20.5 p90 -43.6 -42.09 4.95 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.0 109.41 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.593 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.27 -14.58 2.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 3.1 mt -61.75 -31.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.768 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 2.1 mmp_? -54.82 -44.27 73.71 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.617 ' HZ2' ' CB ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -66.03 -65.59 0.66 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.442 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -57.22 -4.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.634 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.55 -79.72 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 112.156 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.64 47.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.682 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.003 -1.292 . . . . 0.0 109.195 179.37 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.453 HG13 ' N ' ' A' ' 97' ' ' GLY . 72.2 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.302 0.572 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 96' ' ' VAL . . . 69.48 60.36 5.12 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.634 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.3 mtt180 -134.7 113.54 11.78 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -1.21 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.702 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.21 179.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.47 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -124.44 155.43 38.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.024 -1.048 . . . . 0.0 109.198 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.536 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 12.0 t-105 -44.97 -70.25 0.11 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 111.244 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.511 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.32 -52.98 24.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.69 -1.257 . . . . 0.0 111.047 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -47.76 -44.6 28.31 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.272 -0.892 . . . . 0.0 110.429 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.5 -25.33 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 117.681 -1.608 . . . . 0.0 107.585 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.631 ' O ' ' N ' ' A' ' 109' ' ' LYS . 16.8 mt -66.16 -70.86 0.22 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' LEU . 78.2 tt0 -43.85 -43.66 6.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.911 -1.118 . . . . 0.0 108.34 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.9 mt -61.83 -31.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.19 -27.42 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' A' ' 105' ' ' LEU . 13.9 mttp -58.44 -73.44 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.763 -1.21 . . . . 0.0 108.304 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.604 ' N ' ' CD ' ' A' ' 110' ' ' GLN . 1.5 mp0 -44.93 -26.43 0.42 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.041 -1.037 . . . . 0.0 108.794 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 109' ' ' LYS . 13.4 tttt -73.19 -16.96 61.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.68 65.9 76.88 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.039 -1.038 . . . . 0.0 109.746 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.68 -34.76 30.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.704 1.602 . . . . 0.0 112.069 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 175.0 15.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 109.163 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.49 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 0.0 109.553 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -150.66 -24.99 0.23 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.798 ' CG2' ' H ' ' A' ' 118' ' ' THR . 23.5 m -62.97 -164.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.798 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.34 -74.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.267 -0.895 . . . . 0.0 109.933 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.78 140.44 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.183 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER -62.36 -22.34 66.03 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.204 1.002 . . . . 0.0 108.899 179.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.56 -35.39 80.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.414 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.41 -75.53 0.13 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.899 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.47 -34.15 1.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.491 -1.381 . . . . 0.0 109.27 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -58.11 -69.2 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.031 -1.043 . . . . 0.0 108.509 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.59 -44.79 6.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.703 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.0 mtt -50.29 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.101 -0.999 . . . . 0.0 108.743 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.489 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 19.7 mm -48.09 -66.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.416 -0.802 . . . . 0.0 110.053 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -58.39 -71.37 0.11 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.94 -40.72 4.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.8 m -55.36 -47.8 75.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.584 . . . . 0.0 107.582 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -50.43 -47.92 56.53 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.771 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.11 -51.99 12.92 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.702 ' C ' ' H ' ' A' ' 135' ' ' GLY . 7.0 t -45.24 -67.88 0.25 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.768 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 9.4 ttm -48.53 -2.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.702 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 88.18 -27.21 7.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.614 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 30.9 t -48.84 165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.927 -0.749 . . . . 0.0 109.326 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.528 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 40.3 mm-40 -142.27 162.37 35.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 109.767 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.27 165.02 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.702 ' N ' ' O ' ' A' ' 99' ' ' ILE . 5.1 p . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.77 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 61' ' ' ALA . 28.1 m -119.51 -24.58 3.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.77 107.73 4.51 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.422 -1.311 . . . . 0.0 110.338 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -98.86 73.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.659 ' O ' ' O ' ' A' ' 55' ' ' VAL . 32.3 t -48.03 88.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.816 -1.178 . . . . 0.0 110.653 -176.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtp? -82.47 36.06 0.47 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.791 0.805 . . . . 0.0 109.2 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.88 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.8 tp -78.31 -174.08 3.56 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.608 0.718 . . . . 0.0 111.119 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.961 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.74 177.88 5.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -167.61 155.9 8.59 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 109.945 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 15' ' ' GLY . 12.0 Cg_endo -68.83 104.55 1.18 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.037 1.824 . . . . 0.0 111.508 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.754 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -63.1 37.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.932 -1.105 . . . . 0.0 110.38 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -170.56 -26.51 0.02 OUTLIER Glycine 0 N--CA 1.493 2.467 0 C-N-CA 118.096 -2.002 . . . . 0.0 111.842 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -138.97 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.474 -1.604 . . . . 0.0 110.572 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.45 160.91 15.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.762 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.8 164.95 9.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.799 -1.188 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 4.9 Cg_exo -53.1 32.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.717 1.612 . . . . 0.0 112.026 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.68 54.16 4.56 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.221 -0.925 . . . . 0.0 110.046 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.09 155.01 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.696 1.597 . . . . 0.0 111.778 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.79 -4.69 1.49 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.006 1.137 . . . . 0.0 111.432 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.801 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 5.4 t -113.47 -68.96 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.93 -97.62 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.801 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -56.45 -55.04 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 CA-C-N 117.784 0.792 . . . . 0.0 110.479 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.473 ' C ' HG13 ' A' ' 23' ' ' VAL . . . -55.59 -4.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.598 -0.689 . . . . 0.0 111.076 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.651 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -112.11 -54.71 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.645 -1.285 . . . . 0.0 109.152 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.26 -26.5 0.96 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.499 ' C ' ' O ' ' A' ' 28' ' ' GLY . 52.0 mm-40 -42.01 -19.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.513 -1.58 . . . . 0.0 109.252 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.773 ' CD2' ' N ' ' A' ' 31' ' ' GLY . 3.6 p-80 -65.25 -48.86 71.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.788 0.804 . . . . 0.0 108.854 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.773 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -162.22 -8.26 0.04 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 71.38 72.49 0.18 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.926 -0.75 . . . . 0.0 111.47 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.24 63.07 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.499 1.142 . . . . 0.0 108.742 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.695 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.4 mm -43.12 -66.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.361 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.7 tpt -41.61 -57.7 2.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.38 -1.45 . . . . 0.0 109.009 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.8 tp10 -44.68 -50.16 10.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.77 -1.206 . . . . 0.0 107.936 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.695 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -48.27 -62.98 1.21 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.813 1.292 . . . . 0.0 108.863 178.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 42' ' ' ASN . 61.8 t -67.78 -30.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.271 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 35' ' ' MET . 19.0 tttp -52.75 -59.82 4.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.24 74.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.803 . . . . 0.0 109.512 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 1.3 t80 -69.66 -77.23 0.09 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.7 m-20 -41.77 -36.43 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.48 1.133 . . . . 0.0 110.539 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -63.27 -35.1 79.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.586 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -91.25 -57.52 2.76 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.813 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.754 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 16.2 p -48.08 -28.53 2.92 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.21 -47.88 11.08 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -50.46 -23.0 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.216 -0.927 . . . . 0.0 109.127 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.79 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.51 -85.2 0.54 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.79 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.41 -117.93 0.42 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.842 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 3.4 t0 -141.26 129.32 22.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -1.176 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.716 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -164.17 -152.81 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.174 -0.953 . . . . 0.0 110.391 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.3 mm -146.95 141.77 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.515 HG21 ' N ' ' A' ' 71' ' ' THR . 15.0 t -142.76 137.08 14.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.098 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.525 ' C ' ' O ' ' A' ' 10' ' ' LEU . 9.3 Cg_endo -74.33 88.14 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.882 1.722 . . . . 0.0 111.077 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.88 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -57.37 137.14 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 122.697 1.237 . . . . 0.0 111.946 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 66.0 tt0 -128.89 67.49 1.41 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mt -68.7 87.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.698 0.761 . . . . 0.0 110.068 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.71 100.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 64' ' ' SER . 9.0 mt -103.13 145.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.569 -0.707 . . . . 0.0 110.406 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.77 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 8.0 m-85 -116.17 140.02 49.74 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.839 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.61 -32.13 7.7 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.391 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.9 t70 -50.6 -2.3 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.839 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.9 ttm180 75.31 70.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.035 0.921 . . . . 0.0 109.951 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 36.1 t -148.71 127.5 12.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.672 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -103.3 103.82 13.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.833 -1.167 . . . . 0.0 110.399 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.1 p -99.07 124.63 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.564 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -107.6 171.56 7.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.506 -1.371 . . . . 0.0 109.321 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.722 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 98.7 t -162.56 44.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 112.813 -177.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.469 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.3 t -153.83 120.62 5.61 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.669 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.82 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -118.92 122.01 41.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.807 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.6 p 77.48 151.74 0.13 Allowed Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.138 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.8 Cg_exo -38.85 175.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.375 2.717 . . . . 0.0 114.083 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.89 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -40.68 168.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.077 0 C-N-CA 122.035 1.823 . . . . 0.0 112.308 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.78 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 48.11 -74.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.89 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -42.99 -21.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.683 -0.635 . . . . 0.0 110.755 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.78 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -44.05 -35.51 2.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.728 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.511 ' N ' ' HD1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -136.55 -16.24 1.57 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 1.2 mt -58.86 -34.13 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.786 HH11 ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.85 -38.58 70.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.3 tmtt? -69.72 -66.93 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 99' ' ' ILE . . . -55.86 -7.39 0.3 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.178 -0.951 . . . . 0.0 109.153 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.543 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -87.48 -78.27 0.31 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.676 -0.64 . . . . 0.0 111.433 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.651 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 166.2 14.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.913 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.606 ' CD1' ' NH1' ' A' ' 79' ' ' ARG . 2.6 mt . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.401 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.651 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.324 0.583 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 96.02 64.21 0.95 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 82' ' ' ALA . 5.8 mtt180 -134.09 114.82 13.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.09 -1.241 . . . . 0.0 110.304 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.7 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -103.38 179.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.493 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -124.86 154.65 40.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.003 -1.06 . . . . 0.0 109.124 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.536 ' O ' HG21 ' A' ' 104' ' ' VAL . 12.8 t-105 -44.91 -69.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 111.386 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.19 -52.22 37.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.522 -1.361 . . . . 0.0 111.004 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -48.77 -44.05 38.41 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.452 -0.78 . . . . 0.0 110.492 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.75 -26.39 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 117.726 -1.589 . . . . 0.0 107.614 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.762 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.5 mt -65.01 -71.17 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.498 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 7.4 tm-20 -44.35 -44.67 8.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.615 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -61.99 -31.91 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 108.706 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -96.66 -26.84 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.111 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.762 ' N ' ' O ' ' A' ' 105' ' ' LEU . 2.0 tptp -58.97 -73.52 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -48.91 -25.01 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 108.988 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.505 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 3.2 tmtt? -83.15 -7.39 59.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.269 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.724 ' O ' ' SD ' ' A' ' 112' ' ' MET . 2.3 ppp? -130.13 59.72 47.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.865 -1.147 . . . . 0.0 109.967 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.7 Cg_endo -61.29 -54.43 1.77 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.537 1.491 . . . . 0.0 112.305 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 174.74 -1.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -44.88 -28.82 0.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.696 -0.628 . . . . 0.0 109.717 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.489 ' N ' ' HG ' ' A' ' 115' ' ' LEU . 8.7 t30 -177.62 -14.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.96 -1.087 . . . . 0.0 109.653 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.828 ' CG2' ' H ' ' A' ' 118' ' ' THR . 31.9 m -104.02 -164.51 1.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.828 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.48 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 0.0 109.806 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 2.9 p-10 -58.0 143.07 44.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.163 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.604 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -71.92 -30.59 65.5 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.502 1.144 . . . . 0.0 108.387 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -62.91 -35.04 78.74 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.404 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.71 -76.32 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.382 -1.327 . . . . 0.0 107.556 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.89 -43.43 8.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.455 -1.403 . . . . 0.0 109.137 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.604 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -48.22 -69.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 0.0 108.64 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 129' ' ' GLY . 13.7 ttt180 -43.44 -39.6 3.35 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 130' ' ' SER . 18.5 ttm -53.95 -79.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.249 -0.907 . . . . 0.0 108.742 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.504 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 22.4 mm -47.62 -63.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.772 . . . . 0.0 110.054 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -60.46 -71.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.11 -42.97 5.47 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.0 m -52.59 -45.09 66.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.537 -1.566 . . . . 0.0 107.542 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -53.72 -48.03 69.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.592 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 3.3 tmm_? -44.94 -44.75 10.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.4 t -55.41 -69.88 0.12 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.752 ' CG ' HH21 ' A' ' 79' ' ' ARG . 5.9 ttm -44.87 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.523 -0.735 . . . . 0.0 110.073 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.32 25.56 47.27 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.603 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 28.4 t -106.31 165.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.981 -0.717 . . . . 0.0 109.126 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.515 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 50.3 mm-40 -140.41 161.89 36.61 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.901 -1.12 . . . . 0.0 110.086 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -77.84 165.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.5 p . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.772 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 61' ' ' ALA . 27.9 m -114.05 -24.35 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.17 108.29 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.65 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -95.54 73.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.724 ' O ' ' O ' ' A' ' 55' ' ' VAL . 12.2 t -45.69 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.239 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.65 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -82.78 34.58 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.952 0.882 . . . . 0.0 109.093 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.85 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.6 tp -77.08 -174.46 3.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.783 0.801 . . . . 0.0 111.003 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.693 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.52 174.22 7.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.665 ' CD1' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -171.17 158.88 5.18 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 110.411 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 15' ' ' GLY . 11.1 Cg_endo -66.61 108.69 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.197 1.932 . . . . 0.0 111.993 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.742 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -67.47 40.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -178.09 -21.0 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.527 -1.797 . . . . 0.0 111.525 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -139.92 74.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.521 -1.576 . . . . 0.0 110.259 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . . . -92.25 165.29 13.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 108.588 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.763 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.4 163.06 6.1 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.915 -1.116 . . . . 0.0 110.036 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.13 32.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.681 1.587 . . . . 0.0 111.841 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.763 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.71 54.07 4.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 110.597 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.693 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.3 Cg_endo -85.82 160.83 10.51 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.766 1.644 . . . . 0.0 111.467 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.51 -4.81 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 120.898 1.065 . . . . 0.0 111.047 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.813 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 21.2 t -115.58 -67.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.51 -97.32 0.05 OUTLIER Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.813 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.0 Cg_exo -54.05 -55.02 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 CA-C-N 117.844 0.822 . . . . 0.0 110.45 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.482 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . -60.79 -0.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.196 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.685 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.58 -58.77 2.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.717 -1.24 . . . . 0.0 109.59 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 32' ' ' ALA . . . -43.18 -18.07 0.05 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.315 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 28' ' ' GLY . 32.5 mm-40 -42.13 -21.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.255 -1.732 . . . . 0.0 108.502 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.764 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 24.6 p-80 -67.32 59.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . 84.62 -13.03 54.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.629 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 75.15 77.14 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.544 -0.974 . . . . 0.0 111.848 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 34' ' ' ILE . 1.4 m-80 -150.29 60.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.34 1.067 . . . . 0.0 108.536 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.0 mm -42.86 -65.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.623 ' O ' ' N ' ' A' ' 39' ' ' LYS . 8.2 tpt -41.95 -40.43 2.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 108.746 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -58.0 -51.2 70.66 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.685 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -47.85 -62.43 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.94 1.352 . . . . 0.0 108.951 177.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.563 HG13 HD21 ' A' ' 42' ' ' ASN . 61.0 t -67.26 -30.55 49.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.596 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -54.11 -59.46 4.62 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.33 74.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.433 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' ASN . 1.2 t80 -67.2 -75.03 0.1 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.5 m-80 -41.99 -37.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.475 1.131 . . . . 0.0 110.874 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -62.7 -35.53 80.02 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.559 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.678 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . -90.83 -56.11 3.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.878 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.742 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.0 p -50.7 -26.22 5.25 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.59 -48.1 10.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -52.61 -21.22 3.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.975 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.59 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.63 -85.22 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.56 -136.48 2.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.942 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 2.8 p30 -122.12 122.34 39.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -1.102 . . . . 0.0 109.915 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.635 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -156.08 -153.17 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.908 . . . . 0.0 110.289 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.47 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 4.8 mm -147.28 142.76 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 71' ' ' THR . 8.1 t -145.01 137.66 13.59 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 110.261 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.534 ' C ' ' O ' ' A' ' 10' ' ' LEU . 10.1 Cg_endo -73.56 86.67 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.796 1.664 . . . . 0.0 110.669 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.85 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -56.68 138.38 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-O 122.749 1.261 . . . . 0.0 112.078 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.5 mt-10 -130.52 65.67 1.53 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.44 88.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.812 0.815 . . . . 0.0 110.234 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.527 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -65.48 98.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 64' ' ' SER . 1.7 mt -102.94 147.54 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.772 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.9 m-85 -115.82 141.62 47.85 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.832 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.52 -32.72 8.37 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.304 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.27 -1.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.832 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.4 tmm_? 75.21 70.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -148.99 124.94 10.62 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' CG ' ' A' ' 65' ' ' PHE . 20.6 p90 -100.97 103.73 14.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.003 -1.061 . . . . 0.0 110.197 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 58' ' ' THR . 9.2 p -99.25 124.63 44.48 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.583 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -107.71 170.41 8.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.481 -1.387 . . . . 0.0 109.355 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.711 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 90.1 t -161.82 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 112.716 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.515 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.0 116.95 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 116.039 -2.264 . . . . 0.0 110.324 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.803 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -114.74 120.0 38.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.032 0.92 . . . . 0.0 108.701 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.779 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.94 152.26 0.13 Allowed Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.364 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 71' ' ' THR . 15.3 Cg_exo -38.15 175.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.751 2.301 . . . . 0.0 113.365 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.795 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.3 Cg_exo -42.26 168.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.761 1.641 . . . . 0.0 112.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 52.6 -77.0 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 73' ' ' PRO . 41.6 p -43.42 -24.14 0.09 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.522 -0.736 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 14.6 p90 -43.86 -41.4 5.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.676 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -131.59 -18.82 2.75 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.522 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 1.4 mt -59.87 -32.65 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' HE ' ' CB ' ' A' ' 71' ' ' THR . 14.1 mmt180 -54.91 -43.09 72.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -68.39 -66.64 0.54 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.441 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -56.14 -4.92 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.965 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.626 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -87.04 -79.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.508 -0.745 . . . . 0.0 112.018 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.36 56.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.407 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.46 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 10.2 mt . . . . . 0 N--CA 1.488 1.475 0 O-C-N 121.053 -1.263 . . . . 0.0 109.503 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.46 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 19.2 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.46 ' N ' HG13 ' A' ' 96' ' ' VAL . . . 50.98 60.92 6.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.6 mtt180 -134.74 113.54 11.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.071 -1.252 . . . . 0.0 110.686 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 -176.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.53 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -128.93 156.32 43.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 109.093 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.542 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 10.7 t-105 -44.93 -71.46 0.08 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.801 . . . . 0.0 111.176 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.13 -52.52 34.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.636 -1.29 . . . . 0.0 111.103 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.4 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.1 mt-30 -47.82 -43.66 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.383 -0.823 . . . . 0.0 110.303 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 100' ' ' THR . 2.4 m -72.56 -24.88 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.575 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.788 ' O ' ' N ' ' A' ' 109' ' ' LYS . 21.2 mt -66.0 -72.06 0.17 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 107' ' ' ILE . 11.3 tm-20 -44.28 -45.02 8.42 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.959 -1.088 . . . . 0.0 108.612 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.501 ' N ' ' OE1' ' A' ' 106' ' ' GLU . 42.1 mt -61.25 -31.67 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.046 . . . . 0.0 108.623 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -97.45 -23.68 15.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 108.984 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.9 tptp -62.43 -74.52 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 110' ' ' GLN . 2.2 mp0 -44.63 -30.15 0.87 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.022 -1.049 . . . . 0.0 108.806 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -61.82 -24.0 66.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.706 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -126.39 73.85 73.37 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 109.698 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.79 -34.4 24.44 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.551 1.501 . . . . 0.0 111.964 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.521 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 3.6 t70 175.09 11.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.036 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -49.81 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 109.606 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.764 ' ND2' ' N ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -148.76 -25.05 0.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.607 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.792 ' CG2' ' H ' ' A' ' 118' ' ' THR . 22.9 m -60.19 -164.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.537 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.792 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.58 -72.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.3 -0.875 . . . . 0.0 109.929 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.32 138.28 58.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.439 -0.788 . . . . 0.0 110.159 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -61.73 -21.53 64.59 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.282 1.039 . . . . 0.0 108.815 179.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.53 -38.49 91.2 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.54 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.88 -75.13 0.11 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.135 -1.426 . . . . 0.0 107.784 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.53 -41.64 6.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.524 -1.36 . . . . 0.0 109.392 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -51.09 -69.52 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 0.0 108.764 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.2 ttm180 -43.55 -39.94 3.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.701 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.2 ttm -53.31 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 108.579 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.513 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 24.1 mm -47.92 -63.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.438 -0.789 . . . . 0.0 109.954 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -59.97 -71.75 0.12 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.01 -41.87 4.84 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.8 m -54.35 -50.73 66.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.523 -1.575 . . . . 0.0 107.685 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -48.49 -47.49 38.63 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.0 -55.01 7.4 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.712 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.5 t -44.71 -68.59 0.19 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 2.2 ttp -46.68 -4.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.712 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.63 -31.08 5.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 29.0 t -45.43 165.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.937 -0.743 . . . . 0.0 109.194 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.528 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 35.9 mp0 -143.85 163.2 34.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.65 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.28 155.08 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p . . . . . 0 N--CA 1.487 1.411 0 O-C-N 121.628 -0.67 . . . . 0.0 109.284 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.779 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 61' ' ' ALA . 27.6 m -111.66 -24.5 3.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.3 6.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.663 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -94.99 73.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.386 -0.821 . . . . 0.0 108.827 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 55' ' ' VAL . 26.1 t -45.92 88.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.045 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.96 34.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.951 0.881 . . . . 0.0 108.901 179.281 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.792 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.53 -174.66 3.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.872 0.844 . . . . 0.0 111.268 -178.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.578 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -116.98 169.49 9.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -163.08 144.44 7.6 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.159 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.489 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 30.3 Cg_endo -79.02 126.6 7.2 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.505 2.137 . . . . 0.0 114.216 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.755 ' O ' ' N ' ' A' ' 16' ' ' LYS . . . -72.52 141.43 48.51 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.73 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 60.55 -61.24 0.01 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.1 ttpm? -60.64 37.77 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.831 -0.805 . . . . 0.0 108.831 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.704 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -119.27 151.83 37.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.9 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.79 165.77 6.89 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 -179.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 4.5 Cg_exo -49.46 36.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.696 1.598 . . . . 0.0 111.657 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.9 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -163.77 54.87 0.43 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.53 -0.732 . . . . 0.0 109.78 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.2 Cg_endo -77.93 170.16 19.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.485 1.456 . . . . 0.0 111.716 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -60.75 -4.65 3.7 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.209 1.273 . . . . 0.0 111.03 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.738 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 t -106.16 -71.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.594 0.711 . . . . 0.0 110.333 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.31 -98.37 0.05 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 -177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.738 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.3 Cg_endo -60.21 -55.4 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 CA-C-N 118.047 0.924 . . . . 0.0 109.926 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.35 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.362 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.641 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -111.87 -42.84 3.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.631 -1.293 . . . . 0.0 108.751 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.66 84.44 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tt0 -149.18 -15.34 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 65' ' ' PHE . 2.0 p80 -84.42 -37.41 21.49 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.649 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -170.91 -2.8 0.03 OUTLIER Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 81.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.606 -0.938 . . . . 0.0 112.19 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -156.8 120.86 4.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.074 . . . . 0.0 108.639 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.6 mm -96.58 -65.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 110.108 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.669 ' O ' ' N ' ' A' ' 39' ' ' LYS . 5.3 tpt -42.09 -56.97 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.715 -1.241 . . . . 0.0 109.558 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' MET . 6.5 mt-10 -46.86 -50.78 18.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.269 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.646 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -48.72 -61.61 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.644 1.212 . . . . 0.0 109.617 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.659 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 56.3 t -71.37 -30.28 39.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.979 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 35' ' ' MET . 32.6 tptt -51.54 -63.1 1.24 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.04 69.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 44' ' ' ALA . 1.9 t80 -70.32 -76.83 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.659 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 1.3 m-80 -41.37 -34.01 0.47 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.578 1.18 . . . . 0.0 110.63 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -67.39 -35.06 78.55 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.05 -43.99 9.58 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.735 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.73 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 18.1 p -61.16 -32.14 71.87 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.36 -44.74 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.23 -23.7 49.69 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.787 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.8 -74.69 0.64 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.787 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 169.83 149.35 6.28 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.124 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 49' ' ' GLY . 3.8 t70 -44.82 148.37 0.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.986 -1.303 . . . . 0.0 109.429 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.607 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 176.87 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.973 -1.079 . . . . 0.0 110.623 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.7 mm -147.16 141.78 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 71' ' ' THR . 2.8 t -144.96 133.8 11.05 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.801 -1.187 . . . . 0.0 110.888 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 5.7 Cg_endo -69.13 95.7 0.51 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.484 1.456 . . . . 0.0 110.315 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.792 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.9 m -75.84 137.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.928 1.347 . . . . 0.0 112.61 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 14.4 mt-10 -128.61 61.73 1.48 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 8' ' ' VAL . 3.6 mt -61.71 88.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.729 0.776 . . . . 0.0 109.825 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.482 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -64.23 95.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 64' ' ' SER . 12.9 mt -96.96 140.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.648 -0.657 . . . . 0.0 110.162 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.779 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.5 m-85 -111.83 138.93 47.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.824 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.08 -30.35 2.7 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -53.47 3.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.824 ' H ' ' C ' ' A' ' 61' ' ' ALA . 2.6 tmm_? 70.05 69.64 0.22 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.099 0.952 . . . . 0.0 109.436 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 3.2 m -147.86 125.87 12.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.19 104.08 14.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.052 -1.03 . . . . 0.0 110.288 -179.339 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 58' ' ' THR . 23.4 p -98.78 124.52 43.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.557 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -109.64 173.74 6.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.58 -1.325 . . . . 0.0 109.281 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.716 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 85.3 t -162.78 44.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 112.666 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.51 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 t -156.55 118.09 3.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 116.092 -2.243 . . . . 0.0 109.475 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.83 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -114.61 125.15 53.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.339 1.066 . . . . 0.0 109.328 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.83 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER 75.02 161.56 0.15 Allowed Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.22 -179.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HD2' ' CG2' ' A' ' 71' ' ' THR . 12.4 Cg_exo -41.35 175.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.469 2.112 . . . . 0.0 113.102 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.1 Cg_exo -44.08 169.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.681 1.587 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.545 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 54.8 -74.49 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.777 ' N ' ' O ' ' A' ' 73' ' ' PRO . 22.8 t -43.76 -20.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 110.055 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 26.8 p90 -43.49 -43.35 5.37 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.593 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.76 -20.42 2.55 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.563 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -55.36 -35.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.759 ' CG ' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -53.39 -57.6 10.04 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.51 ' C ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -52.04 -64.29 0.86 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.016 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -48.89 -16.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 0.0 108.463 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 78' ' ' ILE . . . -98.78 -74.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.916 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 95.59 95.12 1.74 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.964 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.817 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 7.1 mt . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.159 -1.201 . . . . 0.0 108.938 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.812 ' O ' ' N ' ' A' ' 98' ' ' ARG . 79.2 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.416 0.627 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.817 ' N ' ' CD2' ' A' ' 84' ' ' LEU . . . -43.99 72.98 0.0 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.812 ' N ' ' O ' ' A' ' 96' ' ' VAL . 2.6 mtt180 -135.65 109.74 8.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -1.077 . . . . 0.0 109.563 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.737 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.2 OUTLIER -114.01 -175.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.479 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -125.24 165.84 17.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.082 . . . . 0.0 109.666 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.511 ' O ' HG23 ' A' ' 104' ' ' VAL . 24.3 t-105 -51.01 -71.31 0.07 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.646 -0.659 . . . . 0.0 111.277 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.505 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -47.73 -50.31 25.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.766 -1.209 . . . . 0.0 110.859 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -49.86 -44.9 49.99 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -70.73 -25.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 117.535 -1.666 . . . . 0.0 107.379 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' A' ' 109' ' ' LYS . 18.8 mt -66.31 -71.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 105' ' ' LEU . 72.7 tt0 -43.74 -43.77 6.21 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.923 -1.111 . . . . 0.0 108.641 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 55.7 mt -62.79 -30.75 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.049 . . . . 0.0 108.541 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.88 -26.11 16.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.478 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -61.78 -74.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 0.0 108.396 179.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.455 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 4.6 tt0 -47.16 -20.29 0.17 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.945 . . . . 0.0 109.26 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -80.89 -9.31 59.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.856 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.52 56.43 20.63 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.045 -1.035 . . . . 0.0 109.785 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.9 Cg_endo -59.33 -33.36 97.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.585 1.523 . . . . 0.0 112.406 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.06 19.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.478 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.2 mp -54.12 -85.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.82 -11.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.801 . . . . 0.0 109.154 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.831 ' CG2' ' H ' ' A' ' 118' ' ' THR . 31.5 m -72.24 -164.57 0.15 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.831 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.8 -56.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.314 -0.866 . . . . 0.0 109.674 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 118' ' ' THR . 1.1 m-20 -80.43 134.94 36.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.582 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -55.24 -22.5 18.31 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.179 0.99 . . . . 0.0 109.019 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.6 -36.82 84.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.53 -75.75 0.11 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.481 -1.387 . . . . 0.0 107.977 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.35 -40.31 5.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.479 -1.388 . . . . 0.0 109.243 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -51.77 -68.12 0.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.026 -1.046 . . . . 0.0 108.442 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 129' ' ' GLY . 1.8 ttm180 -43.63 -43.59 5.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.713 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.34 -79.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.057 -1.027 . . . . 0.0 108.563 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.499 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 21.3 mm -48.19 -65.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -58.21 -71.49 0.11 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.93 -40.53 4.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.713 ' N ' ' O ' ' A' ' 126' ' ' MET . 45.1 m -56.3 -51.05 69.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.467 -1.608 . . . . 0.0 107.707 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -46.86 -47.74 21.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.8 -54.32 10.08 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.691 ' C ' ' H ' ' A' ' 135' ' ' GLY . 7.3 t -44.99 -70.24 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.51 ' SD ' ' HB2' ' A' ' 75' ' ' SER . 2.2 ttp -46.9 -4.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.613 -0.679 . . . . 0.0 109.355 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.691 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.71 -30.11 6.36 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 50.8 t -44.91 164.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.856 -0.791 . . . . 0.0 108.941 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.1 tm-20 -144.04 162.66 35.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 109.686 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.638 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -80.23 145.41 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.737 ' N ' ' O ' ' A' ' 99' ' ' ILE . 2.4 p . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 110.64 2.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.92 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -139.81 122.39 16.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.77 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.85 134.84 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.458 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.436 HG13 ' H ' ' A' ' 61' ' ' ALA . 27.9 m -116.5 -24.49 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.259 -0.9 . . . . 0.0 109.008 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.33 108.95 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.41 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -96.93 73.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.695 ' O ' ' O ' ' A' ' 55' ' ' VAL . 39.0 t -48.53 87.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 120.756 -1.215 . . . . 0.0 110.276 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 7' ' ' VAL . 1.6 tmmt? -82.77 36.65 0.5 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.803 0.811 . . . . 0.0 109.18 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.832 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.41 -173.94 3.54 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.775 0.798 . . . . 0.0 111.494 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -121.74 173.61 7.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -161.62 146.96 10.46 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 109.368 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.688 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 91.1 Cg_endo -87.33 126.91 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.343 2.029 . . . . 0.0 113.47 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -74.94 143.17 43.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.38 58.64 9.54 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 9.6 tttp 174.31 -1.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.807 -0.82 . . . . 0.0 108.831 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.5 153.93 24.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.902 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.68 165.95 4.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.668 -179.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 3.1 Cg_exo -49.19 34.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.57 1.513 . . . . 0.0 111.581 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.902 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.67 54.46 0.71 Allowed Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.614 -0.679 . . . . 0.0 109.245 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.717 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 13.3 Cg_endo -80.8 169.89 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.694 1.596 . . . . 0.0 111.729 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.27 -4.43 2.31 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 121.009 1.139 . . . . 0.0 111.039 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.747 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.0 t -110.68 -70.51 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.562 0.696 . . . . 0.0 110.253 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.01 -98.24 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.747 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.12 -55.57 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 CA-C-N 118.007 0.903 . . . . 0.0 109.951 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.434 ' C ' HG13 ' A' ' 23' ' ' VAL . . . -44.44 -12.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.173 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.627 HD13 ' CD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.65 -41.64 3.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.778 -1.201 . . . . 0.0 108.28 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.42 92.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 27' ' ' LEU . 43.1 mt-30 -158.5 -26.87 0.08 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.754 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.7 p80 -78.24 60.35 2.48 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.485 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 85.03 -9.87 64.91 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 84.96 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 112.163 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -157.83 122.61 4.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 108.801 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.691 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.4 mm -97.36 -63.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.609 -0.682 . . . . 0.0 109.732 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.74 -55.59 2.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.693 -1.254 . . . . 0.0 109.537 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 35' ' ' MET . 12.0 mt-10 -46.25 -45.73 17.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.498 -1.376 . . . . 0.0 107.468 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.691 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -54.18 -68.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.244 1.021 . . . . 0.0 109.636 178.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 42' ' ' ASN . 25.9 t -67.03 -38.29 81.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.681 -0.637 . . . . 0.0 110.018 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.1 tptm -45.29 -58.79 3.04 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.98 74.79 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.265 -0.897 . . . . 0.0 109.094 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 2.3 t80 -71.39 -77.26 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 120.368 -1.457 . . . . 0.0 107.124 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.2 t-20 -41.08 -33.95 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.879 -1.138 . . . . 0.0 110.739 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.33 -32.33 72.37 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.918 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.39 -48.54 7.06 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.652 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.541 ' O ' ' O ' ' A' ' 49' ' ' GLY . 1.5 p -58.92 -30.45 67.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.15 -44.78 21.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -57.81 -21.96 44.94 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.585 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.85 -72.46 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.585 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.21 -131.31 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.016 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -121.19 148.0 44.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.254 -1.145 . . . . 0.0 108.779 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.725 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 174.94 -153.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.752 -1.218 . . . . 0.0 110.929 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 2.6 mm -146.12 138.42 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 71' ' ' THR . 2.4 t -138.76 134.44 17.16 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.116 -0.99 . . . . 0.0 110.791 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -71.86 107.24 2.16 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.69 1.594 . . . . 0.0 111.012 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.832 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.1 m -81.1 136.92 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.722 -1.236 . . . . 0.0 111.464 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -130.74 68.04 1.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.551 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.1 mt -68.19 90.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.79 0.805 . . . . 0.0 110.231 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.09 96.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 64' ' ' SER . 50.2 mt -101.07 145.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.515 0.674 . . . . 0.0 110.728 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.77 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.4 m-85 -116.51 139.89 49.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.836 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.42 -32.78 5.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.147 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -50.94 -1.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.836 ' H ' ' C ' ' A' ' 61' ' ' ALA . 11.2 ttm180 75.33 68.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.952 0.882 . . . . 0.0 109.85 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 1.3 t -148.49 147.93 29.66 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.65 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 36.2 p90 -125.29 103.82 8.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.902 -1.124 . . . . 0.0 110.247 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.4 p -101.44 120.75 40.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 110.052 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.65 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.1 148.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.089 -1.007 . . . . 0.0 110.99 177.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.65 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 28.9 t -169.18 91.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.187 0.994 . . . . 0.0 108.491 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.5 147.05 24.65 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.768 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -132.25 125.15 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.397 -1.44 . . . . 0.0 110.604 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.768 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 14.8 p 76.18 150.64 0.13 Allowed Pre-proline 0 N--CA 1.493 1.68 0 CA-C-O 121.244 0.545 . . . . 0.0 109.975 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 73' ' ' PRO . 12.6 Cg_exo -40.8 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.653 2.235 . . . . 0.0 112.993 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.756 ' O ' ' N ' ' A' ' 75' ' ' SER . 25.0 Cg_exo -39.89 168.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.543 1.495 . . . . 0.0 111.905 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.55 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 54.05 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.756 ' N ' ' O ' ' A' ' 73' ' ' PRO . 11.2 t -43.05 -21.72 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.654 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 23.6 p90 -43.6 -38.76 3.17 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.77 -16.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 1.9 mt -58.27 -34.33 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.805 ' NH1' ' SD ' ' A' ' 134' ' ' MET . 0.0 OUTLIER -54.12 -49.74 68.47 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 82' ' ' ALA . 4.5 tmtt? -58.27 -64.81 0.79 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.58 -6.28 0.69 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.205 -0.934 . . . . 0.0 109.842 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.665 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -78.86 -82.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 112.216 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 178.88 32.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.957 -1.592 . . . . 0.0 110.464 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.559 ' N ' HD22 ' A' ' 84' ' ' LEU . 2.8 mt -84.78 110.25 18.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.997 -1.296 . . . . 0.0 109.392 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -156.24 -21.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.3 tttm 65.46 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 0.0 109.623 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.6 -170.0 19.83 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.44 -85.03 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -1.164 . . . . 0.0 109.566 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -119.17 96.96 5.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.499 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -120.29 159.13 48.9 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.61 -11.32 6.5 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.576 1.517 . . . . 0.0 112.34 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.29 -165.29 21.56 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.791 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 64.58 84.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -1.147 . . . . 0.0 109.493 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 8.1 tt0 -176.21 -179.46 1.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 94' ' ' GLU . 42.5 mtmt -158.67 -172.36 3.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.612 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 97' ' ' GLY . 85.6 t -133.35 153.66 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.598 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.441 ' N ' HG13 ' A' ' 96' ' ' VAL . . . 75.86 58.81 3.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.665 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.8 mtt180 -133.71 115.47 14.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.128 -1.219 . . . . 0.0 110.353 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.721 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.43 175.11 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.511 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -120.85 156.58 31.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.983 -1.073 . . . . 0.0 109.055 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.549 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 11.3 t-105 -45.18 -70.37 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 111.229 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.405 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 6.4 tp10 -50.45 -51.71 44.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.575 -1.328 . . . . 0.0 111.242 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -48.72 -44.38 38.24 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.5 m -70.88 -25.9 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.822 -1.551 . . . . 0.0 107.663 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.699 ' O ' ' N ' ' A' ' 109' ' ' LYS . 18.8 mt -65.36 -70.66 0.22 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 105' ' ' LEU . 3.1 tp10 -44.1 -45.7 8.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.935 -1.103 . . . . 0.0 108.566 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 107' ' ' ILE . 35.3 mt -61.26 -31.75 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.111 -0.993 . . . . 0.0 108.698 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.53 -25.98 16.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.347 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -58.08 -73.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 108.286 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.552 ' N ' ' CD ' ' A' ' 110' ' ' GLN . 2.4 mp0 -44.95 -26.1 0.38 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.078 -1.014 . . . . 0.0 108.794 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' LYS . 40.1 tttm -74.91 -8.29 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.803 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.59 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 7.7 ptm -132.87 62.4 61.98 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.056 -1.028 . . . . 0.0 109.861 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.473 ' HD3' ' N ' ' A' ' 112' ' ' MET . 3.0 Cg_endo -67.21 -35.06 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.565 1.51 . . . . 0.0 112.123 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 2.3 t70 174.96 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.359 -0.838 . . . . 0.0 109.107 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -47.96 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 0.0 109.575 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -151.81 -21.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.803 ' CG2' ' H ' ' A' ' 118' ' ' THR . 26.2 m -64.13 -164.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.101 -0.999 . . . . 0.0 109.616 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.803 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.48 -64.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.427 ' H ' HG21 ' A' ' 118' ' ' THR . 0.9 OUTLIER -74.93 141.27 44.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.084 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -59.93 -24.56 64.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.211 1.005 . . . . 0.0 109.12 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.5 -34.65 78.71 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -71.71 -75.18 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.045 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.59 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.0 -40.82 6.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.539 -1.351 . . . . 0.0 109.095 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -51.97 -69.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 108.647 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.658 ' O ' ' N ' ' A' ' 129' ' ' GLY . 23.1 ttt180 -43.35 -35.68 1.61 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.666 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.0 tpp -57.56 -78.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 108.778 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.652 ' O ' ' OG ' ' A' ' 130' ' ' SER . 26.9 mm -48.49 -56.99 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.0 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -67.39 -70.93 0.22 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -42.48 5.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.666 ' N ' ' O ' ' A' ' 126' ' ' MET . 54.3 p -54.72 -47.66 73.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.575 -1.544 . . . . 0.0 107.499 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -51.12 -48.53 61.73 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.785 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.01 -53.4 10.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.657 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.0 t -44.79 -67.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.805 ' SD ' ' NH1' ' A' ' 79' ' ' ARG . 11.6 ttm -49.94 -3.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 89.21 -26.05 9.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.566 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 30.4 t -49.22 165.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.736 -0.861 . . . . 0.0 109.405 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.534 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 87.8 mt-10 -142.8 162.66 34.88 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.755 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.32 165.1 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.721 ' N ' ' O ' ' A' ' 99' ' ' ILE . 6.4 p -129.17 59.91 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 157.74 -113.82 0.58 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.474 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.87 61.79 11.23 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.155 -1.203 . . . . 0.0 109.267 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' O ' ' CD ' ' A' ' 143' ' ' GLU . 2.2 Cg_endo -61.61 155.32 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.808 1.672 . . . . 0.0 112.627 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.516 ' CD ' ' O ' ' A' ' 142' ' ' PRO . 72.2 mm-40 -156.66 91.04 1.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.291 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.74 -179.91 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.564 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -159.82 -15.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 147' ' ' ALA . 1.1 p30 -81.6 29.48 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.538 ' O ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.443 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.51 71.61 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 15.5 tttt -168.92 115.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.549 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.767 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.97 138.34 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG13 ' H ' ' A' ' 61' ' ' ALA . 27.8 m -115.11 -24.45 3.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.34 100.39 3.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.041 -1.037 . . . . 0.0 110.252 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -87.86 74.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.664 ' O ' ' O ' ' A' ' 55' ' ' VAL . 11.3 t -48.22 87.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.558 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.662 ' HZ1' ' CB ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -81.83 36.29 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.897 0.856 . . . . 0.0 108.817 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.81 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -77.22 -174.46 3.24 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.725 0.774 . . . . 0.0 110.882 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.495 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.42 177.21 6.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.534 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -166.66 146.6 4.96 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 109.213 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HB2' ' CB ' ' A' ' 16' ' ' LYS . 65.8 Cg_endo -84.01 130.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.277 1.984 . . . . 0.0 113.587 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.731 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -76.16 142.77 41.48 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.684 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 51.61 55.35 20.57 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 5.5 mttp 174.53 14.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.695 -0.885 . . . . 0.0 109.212 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.13 154.74 17.08 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.862 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.86 165.74 4.07 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.005 . . . . 0.0 109.487 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 5.3 Cg_exo -51.05 32.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.457 1.438 . . . . 0.0 111.562 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.862 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -154.56 54.31 1.03 Allowed Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.64 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.732 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.84 169.06 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.725 1.617 . . . . 0.0 111.735 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.37 -4.56 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.077 1.185 . . . . 0.0 110.95 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.754 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.0 -72.62 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.796 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.49 -98.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.754 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.3 Cg_exo -59.03 -55.54 1.88 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 118.096 0.948 . . . . 0.0 110.003 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.7 -6.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.412 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.679 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -111.12 -44.07 3.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 179.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.34 88.67 0.01 OUTLIER Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.6 tt0 -150.97 -12.85 0.22 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.538 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 7.8 p-80 -87.73 -36.5 17.32 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.538 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -173.1 -1.49 0.03 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.5 ' O ' ' ND2' ' A' ' 33' ' ' ASN . . . 75.11 83.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 112.058 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 32' ' ' ALA . 31.8 m120 -157.71 120.09 3.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.982 -1.073 . . . . 0.0 108.614 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.8 mm -97.44 -65.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.689 -0.632 . . . . 0.0 109.853 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.492 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -41.42 -56.35 2.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 109.548 -177.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.3 mt-10 -44.69 -48.15 10.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.755 -1.215 . . . . 0.0 107.768 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 1.1 t80 -51.17 -68.17 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.884 1.326 . . . . 0.0 110.034 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 33.9 t -59.21 -37.2 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.805 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 7.1 ttpt -49.56 -65.7 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.08 -32.79 62.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.23 -0.918 . . . . 0.0 109.04 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.0 t80 -73.19 -78.45 0.09 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 7.4 m-20 -41.07 -32.76 0.27 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.856 -1.152 . . . . 0.0 110.745 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -70.04 -32.77 71.07 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.139 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.09 -47.17 7.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.476 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.684 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 8.7 p -59.5 -29.71 68.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.94 -45.27 20.79 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.555 ' OD1' ' O ' ' A' ' 43' ' ' ALA . 12.2 m120 -57.8 -22.14 45.69 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.601 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.32 -73.88 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.601 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -179.64 -127.82 1.15 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.05 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 14' ' ' ALA . 23.1 t70 -123.84 147.26 47.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.216 -1.167 . . . . 0.0 108.817 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.731 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 174.88 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 0.0 110.99 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 2.1 mm -146.82 139.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.403 HG11 ' OG1' ' A' ' 69' ' ' THR . 2.0 t -138.58 133.74 17.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 110.611 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -72.86 97.1 0.88 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.8 1.667 . . . . 0.0 111.03 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.81 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -70.95 134.46 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.675 1.226 . . . . 0.0 111.652 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 28.3 mt-10 -127.16 70.32 1.3 Allowed 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.568 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.2 mt -71.43 89.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.677 0.751 . . . . 0.0 110.5 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.16 95.46 0.09 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 64' ' ' SER . 95.7 mt -98.05 141.0 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.656 -0.653 . . . . 0.0 110.505 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.767 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 4.8 m-85 -115.99 139.82 49.87 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.826 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.81 -30.7 4.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.277 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 6.0 m-20 -53.47 3.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.826 ' H ' ' C ' ' A' ' 61' ' ' ALA . 49.8 mtp180 70.34 68.89 0.21 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.968 0.89 . . . . 0.0 109.793 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 9.5 p -148.97 150.98 33.78 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.2 p90 -128.18 103.76 7.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.992 -1.067 . . . . 0.0 110.105 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.609 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p -101.38 120.79 40.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.15 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.658 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 169.96 149.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.081 -1.012 . . . . 0.0 110.991 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.649 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 29.5 t -168.82 98.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.272 1.034 . . . . 0.0 108.35 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.403 ' OG1' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -107.39 148.2 29.4 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.784 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.2 mptt -133.21 125.09 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.523 -1.361 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.784 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.3 150.34 0.13 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 121.272 0.558 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' O ' ' O ' ' A' ' 73' ' ' PRO . 8.7 Cg_exo -42.88 175.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.548 2.166 . . . . 0.0 112.803 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.61 176.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.502 1.468 . . . . 0.0 111.788 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 47.87 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.774 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -43.71 -22.4 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.99 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.7 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 15.6 p90 -43.84 -37.68 2.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 0.0 108.961 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.644 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.35 -15.79 1.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.653 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 3.9 mt -60.13 -31.85 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.586 ' CD ' ' OG ' ' A' ' 75' ' ' SER . 2.2 mmp_? -56.08 -44.01 78.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.2 tmtm? -65.27 -66.76 0.5 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.407 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.5 -5.26 0.51 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.657 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.01 -80.31 0.19 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.547 -0.721 . . . . 0.0 111.582 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 166.46 53.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.285 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.446 HD12 ' NE ' ' A' ' 79' ' ' ARG . 2.0 mt -126.77 104.75 8.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.236 . . . . 0.0 109.358 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 8.3 tp10 174.86 -51.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.455 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 2.9 tmtm? 75.07 143.97 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.459 ' H ' ' HD3' ' A' ' 86' ' ' LYS . . . -153.34 -156.25 7.52 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.93 -85.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -1.139 . . . . 0.0 109.56 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -59.95 106.24 0.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.408 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -83.17 149.35 58.5 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.477 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.41 -53.75 3.18 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.449 1.433 . . . . 0.0 112.399 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 148.67 144.69 4.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.782 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 63.03 -164.94 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -1.098 . . . . 0.0 109.514 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -127.12 111.66 14.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.473 ' O ' ' CG2' ' A' ' 96' ' ' VAL . 3.3 mmmm -145.38 166.16 26.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 95' ' ' LYS . 88.5 t -157.55 164.98 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' N ' ' CG1' ' A' ' 96' ' ' VAL . . . 57.0 65.97 3.19 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.657 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.2 ttt180 -134.32 114.59 13.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 110.007 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -107.42 -169.23 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 108.976 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.436 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.4 OUTLIER -131.58 159.36 38.45 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 0.0 109.219 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.527 ' O ' HG23 ' A' ' 104' ' ' VAL . 18.2 t-105 -50.9 -68.72 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.504 -0.747 . . . . 0.0 110.87 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -51.27 -45.91 62.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.69 -1.256 . . . . 0.0 110.369 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.407 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -50.66 -47.65 58.6 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.234 -0.917 . . . . 0.0 109.777 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -70.78 -24.06 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.951 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.1 mt -66.88 -71.32 0.2 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.491 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 6.1 tm-20 -43.66 -43.12 5.66 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.891 -1.131 . . . . 0.0 108.374 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.4 mt -62.96 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.021 -1.049 . . . . 0.0 108.358 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.41 -27.36 16.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.651 ' N ' ' O ' ' A' ' 105' ' ' LEU . 17.3 mmtt -57.18 -73.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.837 -1.164 . . . . 0.0 108.124 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 109' ' ' LYS . 78.9 mt-30 -44.89 -25.01 0.26 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.006 -1.058 . . . . 0.0 108.769 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 109' ' ' LYS . 23.5 tptt -76.89 -8.25 57.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.919 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.599 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 7.5 ptm -132.27 60.87 53.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.8 Cg_endo -65.88 -40.34 16.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.559 1.506 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 6.9 t70 -178.75 8.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -46.76 -81.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -151.13 -18.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.129 -0.982 . . . . 0.0 109.699 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.817 ' CG2' ' H ' ' A' ' 118' ' ' THR . 26.4 m -65.88 -164.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.629 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.817 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.96 -62.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.266 -0.897 . . . . 0.0 109.865 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.411 ' H ' HG21 ' A' ' 118' ' ' THR . 0.8 OUTLIER -75.31 140.64 43.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -60.3 -23.8 64.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.126 0.965 . . . . 0.0 109.107 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.64 -34.29 77.94 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.78 -75.83 0.13 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.111 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.599 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.09 -31.37 1.35 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.468 -1.395 . . . . 0.0 109.268 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -60.75 -69.76 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 108.496 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.694 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.2 ttp180 -43.67 -44.1 6.22 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.631 ' O ' ' N ' ' A' ' 130' ' ' SER . 2.8 mtt -49.72 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.1 -1.0 . . . . 0.0 108.742 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.584 ' O ' ' OG ' ' A' ' 130' ' ' SER . 18.2 mm -47.28 -67.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.678 0.752 . . . . 0.0 110.076 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -55.23 -69.55 0.13 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.43 -37.29 2.49 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.631 ' N ' ' O ' ' A' ' 126' ' ' MET . 10.5 p -57.08 -54.21 49.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.445 -1.621 . . . . 0.0 107.336 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.625 ' N ' ' HG ' ' A' ' 130' ' ' SER . . . -44.98 -50.36 10.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -44.91 -55.73 5.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.169 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.698 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.8 t -44.91 -67.2 0.31 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.679 ' SD ' ' OG ' ' A' ' 75' ' ' SER . 6.8 ttp -47.79 -3.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.698 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 88.73 -24.72 11.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 31.1 t -52.74 165.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.989 -0.712 . . . . 0.0 109.347 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.553 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 41.7 mt-10 -142.99 163.28 33.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.44 143.84 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 99' ' ' ILE . 5.6 p -96.69 -7.81 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.56 -0.713 . . . . 0.0 109.292 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . -116.85 -123.68 3.47 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.472 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.95 61.95 11.08 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.354 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.4 Cg_endo -63.29 -169.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.752 1.635 . . . . 0.0 112.601 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.71 ' CG ' ' H ' ' A' ' 144' ' ' VAL . 13.7 tt0 -151.22 -175.84 5.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 109.278 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.71 ' H ' ' CG ' ' A' ' 143' ' ' GLU . 12.8 m -150.79 166.29 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 109.591 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 146' ' ' ASP . 19.0 tttp 178.46 158.68 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.396 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.456 ' H ' ' HG3' ' A' ' 145' ' ' LYS . 0.6 OUTLIER -106.18 -84.95 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.522 -179.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.65 ' C ' ' HH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -175.77 55.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.585 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' C ' ' CZ ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -126.07 114.88 18.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.2 -0.938 . . . . 0.0 109.919 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.504 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p -65.16 155.89 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 108.723 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG21 ' N ' ' A' ' 61' ' ' ALA . 27.8 m -123.66 -24.9 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.903 -1.123 . . . . 0.0 110.573 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -154.98 111.66 3.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.731 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -103.78 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.657 ' O ' ' O ' ' A' ' 55' ' ' VAL . 17.6 t -49.51 88.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.73 -1.231 . . . . 0.0 110.743 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.7 tmtp? -82.4 38.28 0.54 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.746 0.784 . . . . 0.0 109.358 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.892 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.24 -173.89 3.45 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.843 0.83 . . . . 0.0 111.437 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.98 174.83 7.33 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -167.73 159.66 9.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.85 -1.156 . . . . 0.0 110.159 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 15' ' ' GLY . 11.9 Cg_endo -68.95 109.83 2.24 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.034 1.823 . . . . 0.0 111.37 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.776 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -68.68 38.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.857 -1.152 . . . . 0.0 110.411 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.5 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -172.82 -19.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.372 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -144.37 80.39 1.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.642 -1.505 . . . . 0.0 110.408 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.53 166.05 11.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.747 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.0 164.4 4.26 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.874 -1.141 . . . . 0.0 110.086 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' C ' ' HD3' ' A' ' 21' ' ' PRO . 3.5 Cg_exo -54.11 32.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.663 1.575 . . . . 0.0 111.677 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.747 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.0 54.01 5.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.061 -1.024 . . . . 0.0 110.231 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.69 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.8 Cg_endo -84.67 155.11 11.88 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.73 1.62 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.91 -4.62 0.37 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.032 1.155 . . . . 0.0 111.136 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.77 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.9 t -111.85 -69.88 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 0.0 110.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.83 -97.73 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.77 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.8 Cg_exo -57.83 -55.66 2.2 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 CA-C-N 118.017 0.908 . . . . 0.0 110.28 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' C ' HG12 ' A' ' 23' ' ' VAL . . . -52.72 -11.83 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.628 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.634 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -96.51 -53.69 3.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.71 -1.244 . . . . 0.0 108.386 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.88 92.3 0.01 OUTLIER Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.9 tp60 -147.39 -15.05 0.39 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.557 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 4.9 p-80 -84.13 -37.37 22.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.557 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -171.57 -0.92 0.03 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 73.18 84.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.494 -1.003 . . . . 0.0 112.046 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -159.55 120.81 3.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 108.806 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.663 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 50.7 mm -94.4 -64.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.723 -0.61 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.624 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -41.0 -54.38 2.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.791 -1.193 . . . . 0.0 109.774 -176.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 35' ' ' MET . 5.5 mt-10 -48.41 -46.78 37.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.593 -1.317 . . . . 0.0 107.708 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.663 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -53.03 -68.91 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.572 1.177 . . . . 0.0 109.244 178.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 18' ' ' THR . 38.3 t -63.46 -36.84 77.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.706 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.0 mmmt -49.32 -55.55 12.44 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.11 75.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.484 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.439 ' CD2' HG23 ' A' ' 45' ' ' THR . 1.0 OUTLIER -70.13 -77.05 0.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.431 -1.418 . . . . 0.0 107.305 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 7.2 t-20 -41.52 -33.79 0.48 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -67.74 -33.88 75.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.417 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.538 ' CB ' ' NZ ' ' A' ' 70' ' ' LYS . . . -90.72 -53.18 4.52 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.714 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.776 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.8 p -53.35 -31.34 44.03 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.43 -44.71 17.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -54.69 -23.27 16.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.18 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.647 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.78 -85.3 0.53 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.182 -0.949 . . . . 0.0 109.693 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.647 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.82 -141.8 3.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.062 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -118.07 121.15 39.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -1.122 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -156.51 -153.04 0.4 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.483 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 4.6 mm -146.85 142.2 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 t -145.34 137.61 13.38 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 110.238 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -73.52 95.01 0.85 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.872 1.715 . . . . 0.0 111.52 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.892 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -61.44 138.06 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 111.354 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 26.8 tt0 -130.44 70.14 1.45 Allowed 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.614 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.6 mt -70.68 89.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.389 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 100.89 0.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 59' ' ' ILE . 21.1 mt -101.76 137.45 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.589 -0.695 . . . . 0.0 110.615 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.65 ' HH ' ' C ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -113.27 137.85 50.88 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.835 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -49.03 -30.76 6.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.583 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.6 m-20 -53.56 1.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.835 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 mtm180 71.05 69.91 0.18 Allowed 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.028 0.918 . . . . 0.0 109.953 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -151.27 126.11 9.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 18.2 p90 -102.53 103.84 14.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.093 -1.005 . . . . 0.0 110.035 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.2 121.31 41.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.1 -1.0 . . . . 0.0 110.227 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.666 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 170.38 148.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.052 . . . . 0.0 111.274 177.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.645 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 30.7 t -168.74 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.263 1.03 . . . . 0.0 108.232 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.431 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -98.07 132.4 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.602 ' O ' ' OG1' ' A' ' 71' ' ' THR . 24.5 mmtp -115.82 143.19 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.655 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 1.8 p 55.58 159.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.956 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.7 Cg_exo -38.18 175.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.887 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 75' ' ' SER . 22.8 Cg_exo -42.2 169.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.575 1.516 . . . . 0.0 112.161 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.516 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 58.73 -73.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 73' ' ' PRO . 5.6 p -43.65 -21.65 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 25.4 p90 -43.38 -42.95 4.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.366 -0.834 . . . . 0.0 109.087 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.54 -13.9 3.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.554 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 2.0 mt -61.02 -31.34 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.704 ' NH1' ' CD1' ' A' ' 84' ' ' LEU . 9.6 mmm180 -54.16 -45.81 72.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.2 tmmm? -65.21 -65.75 0.63 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.602 ' CB ' ' OE1' ' A' ' 103' ' ' GLN . . . -57.51 -5.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.671 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.643 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.81 -79.66 0.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 111.686 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 153.49 57.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.085 -1.531 . . . . 0.0 110.674 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.704 ' CD1' ' NH1' ' A' ' 79' ' ' ARG . 9.0 mt -102.66 104.8 15.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.143 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -153.35 -11.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 109.717 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.458 ' HZ2' ' HB3' ' A' ' 86' ' ' LYS . 7.0 mtpp 66.32 63.91 0.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 109.653 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 45.04 -160.68 0.12 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.63 -85.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 90' ' ' LYS . 12.7 t60 -105.78 -67.84 0.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 89' ' ' HIS . 9.6 mtmt -44.91 160.48 0.24 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.895 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.0 -51.86 8.63 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.58 1.52 . . . . 0.0 112.443 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.13 -96.89 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.78 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 59.71 39.43 21.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -1.143 . . . . 0.0 109.47 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 36.9 mt-10 -159.44 -167.76 2.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.69 -164.99 1.66 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.863 . . . . 0.0 109.436 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 97' ' ' GLY . 87.4 t -135.66 165.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.661 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 96' ' ' VAL . . . 65.53 65.64 2.8 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.2 mtt180 -132.53 115.31 15.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.269 -1.136 . . . . 0.0 109.93 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 173.31 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.549 -0.719 . . . . 0.0 109.539 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.471 HG21 ' NE2' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -113.99 150.46 33.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.042 . . . . 0.0 109.092 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.535 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.0 t-105 -46.3 -67.6 0.27 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.347 -0.846 . . . . 0.0 110.897 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.505 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.68 -49.29 57.65 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.557 -1.34 . . . . 0.0 110.68 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.602 ' OE1' ' CB ' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -48.97 -45.93 42.84 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.884 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.4 -24.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 117.979 -1.489 . . . . 0.0 107.797 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.795 ' O ' ' N ' ' A' ' 109' ' ' LYS . 19.3 mt -66.22 -71.71 0.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 105' ' ' LEU . 86.7 tt0 -43.99 -44.95 7.6 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.892 -1.13 . . . . 0.0 108.472 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 67.2 mt -61.58 -32.47 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 108.493 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -95.8 -24.71 16.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.169 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.795 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.6 tptp -63.16 -74.55 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 109' ' ' LYS . 26.1 mt-30 -44.5 -27.85 0.51 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.984 -1.073 . . . . 0.0 108.772 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 109' ' ' LYS . 33.7 tttp -66.57 -13.66 61.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.578 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 5.5 ptm -131.02 69.25 82.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.638 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -68.82 -46.63 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.68 1.587 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.534 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 40.1 p30 -171.1 6.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 108.952 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -45.02 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.798 . . . . 0.0 109.577 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.765 HD21 ' N ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -150.89 -12.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.186 -0.946 . . . . 0.0 109.649 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.848 ' CG2' ' H ' ' A' ' 118' ' ' THR . 31.8 m -77.99 -164.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.848 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER 178.56 -57.2 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.264 -0.898 . . . . 0.0 109.576 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 1.1 p30 -63.27 132.25 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.513 -0.742 . . . . 0.0 109.998 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.602 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -67.22 -28.7 68.29 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.488 1.137 . . . . 0.0 108.469 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -64.45 -34.52 78.4 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.637 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.52 -76.27 0.1 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.68 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.578 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.58 -42.1 10.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.478 -1.389 . . . . 0.0 109.339 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.602 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -50.4 -69.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 108.806 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.49 -38.57 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.612 ' O ' ' N ' ' A' ' 130' ' ' SER . 13.4 tpp -53.79 -79.22 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.603 ' O ' ' OG ' ' A' ' 130' ' ' SER . 22.9 mm -47.29 -65.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.666 0.746 . . . . 0.0 110.289 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -57.5 -69.71 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.38 -37.8 2.62 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.645 ' HG ' ' N ' ' A' ' 131' ' ' ALA . 15.9 p -57.18 -53.79 54.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.506 -1.585 . . . . 0.0 107.451 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.645 ' N ' ' HG ' ' A' ' 130' ' ' SER . . . -45.0 -50.28 10.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.785 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.65 -55.01 6.88 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.696 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.6 t -44.74 -67.29 0.3 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 7.1 ttp -47.77 -3.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.696 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 87.62 -13.9 59.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 131' ' ' ALA . 35.7 t -69.36 135.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.997 -0.707 . . . . 0.0 109.444 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.87 167.25 10.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.696 ' C ' ' H ' ' A' ' 140' ' ' GLY . 1.8 t -81.97 125.95 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.666 ' N ' ' O ' ' A' ' 99' ' ' ILE . 11.2 p -51.72 1.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.563 -0.71 . . . . 0.0 109.736 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.696 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . -159.85 -127.86 0.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 140' ' ' GLY . . . 75.09 63.02 0.27 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.211 -1.17 . . . . 0.0 109.447 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.2 Cg_endo -65.45 -165.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.76 1.64 . . . . 0.0 112.548 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.55 ' CD ' ' N ' ' A' ' 144' ' ' VAL . 8.2 tm-20 -169.99 151.51 4.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.55 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 3.1 m -150.49 -172.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.517 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.614 ' CG ' ' N ' ' A' ' 146' ' ' ASP . 19.0 ttpt -145.19 168.03 21.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.398 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.614 ' N ' ' CG ' ' A' ' 145' ' ' LYS . 0.4 OUTLIER -138.41 -84.96 0.28 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 91.74 0.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.504 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -169.07 114.89 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.591 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.761 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p -46.21 138.09 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 109.487 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.464 HG13 ' H ' ' A' ' 61' ' ' ALA . 27.7 m -113.48 -24.53 3.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.214 -0.929 . . . . 0.0 108.52 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.66 112.27 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.05 -1.032 . . . . 0.0 110.273 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.589 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.9 p -100.47 73.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.15 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.669 ' O ' ' O ' ' A' ' 55' ' ' VAL . 13.6 t -50.08 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.444 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.8 tmtp? -82.96 37.87 0.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.885 0.85 . . . . 0.0 109.168 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.815 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -77.28 -174.13 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.01 0.91 . . . . 0.0 111.395 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.6 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.73 174.94 7.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -164.42 147.06 7.29 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 0.0 109.361 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.637 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 80.0 Cg_endo -86.17 126.17 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.331 2.021 . . . . 0.0 113.213 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -72.28 143.06 48.87 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.714 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 53.01 61.86 6.5 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 8.7 tttp 174.08 -25.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.573 -0.957 . . . . 0.0 108.823 -177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 152.67 19.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.913 -1.117 . . . . 0.0 108.373 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.869 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.36 165.8 8.57 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.038 -1.039 . . . . 0.0 110.009 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 4.8 Cg_exo -50.25 36.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.721 1.614 . . . . 0.0 111.733 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.869 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.5 54.47 0.73 Allowed Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.68 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.698 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.2 Cg_endo -79.18 169.68 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.66 1.573 . . . . 0.0 111.849 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.59 -4.68 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.256 1.304 . . . . 0.0 111.29 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.779 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 5.2 t -113.23 -70.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.623 -0.673 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.07 -97.83 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.2 Cg_exo -58.72 -55.54 1.99 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 CA-C-N 117.97 0.885 . . . . 0.0 110.384 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' C ' HG12 ' A' ' 23' ' ' VAL . . . -48.77 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.643 . . . . 0.0 110.779 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.615 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -103.24 -48.44 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.261 . . . . 0.0 107.956 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.27 86.74 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.4 mt-30 -146.33 -20.12 0.44 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.673 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 6.9 p80 -79.49 -38.24 34.92 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.595 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -170.89 -4.42 0.03 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 84.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.966 . . . . 0.0 112.346 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -158.92 120.11 3.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.076 -1.015 . . . . 0.0 108.711 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.71 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 26.4 mm -93.42 -66.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.728 -0.608 . . . . 0.0 110.076 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.709 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.8 tpt -41.14 -57.71 1.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.664 -1.273 . . . . 0.0 109.728 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.5 mm-40 -44.95 -47.06 11.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.56 -1.337 . . . . 0.0 107.793 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.71 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -53.05 -68.84 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.466 1.127 . . . . 0.0 109.899 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.655 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 21.9 t -66.38 -37.7 80.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.775 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.709 ' N ' ' O ' ' A' ' 35' ' ' MET . 44.1 tptt -45.67 -61.81 1.55 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.55 69.25 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 108.85 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 3.3 t80 -70.91 -77.07 0.09 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.655 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 1.9 m-80 -41.35 -32.23 0.29 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.953 -1.092 . . . . 0.0 110.751 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -69.52 -33.22 72.5 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.93 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -90.52 -47.07 7.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.612 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.714 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 2.2 p -58.6 -31.34 67.97 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.2 -46.04 21.47 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.97 -22.46 38.36 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 0.0 108.922 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.751 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.63 -73.98 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.406 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.751 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 175.17 -154.66 18.66 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 1.8 t0 -96.28 146.49 24.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.291 . . . . 0.0 108.934 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.74 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 175.01 -153.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.816 -1.178 . . . . 0.0 110.869 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 2.2 mm -146.09 137.36 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' CG1' ' HG1' ' A' ' 69' ' ' THR . 2.6 t -137.94 136.15 19.49 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.807 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.8 Cg_endo -72.78 104.66 1.78 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.803 1.669 . . . . 0.0 111.07 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.815 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.5 m -78.34 135.98 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 111.362 -178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.5 tt0 -129.07 69.98 1.4 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.555 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.2 mt -70.24 90.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.855 0.836 . . . . 0.0 109.967 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.59 95.88 1.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 64' ' ' SER . 60.1 mt -100.11 143.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.58 -0.7 . . . . 0.0 110.672 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.761 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.6 m-85 -114.46 138.0 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.823 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -46.43 -31.45 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.227 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.29 2.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.823 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 71.87 66.92 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.137 0.97 . . . . 0.0 109.631 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.4 OUTLIER -149.17 125.15 10.63 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.1 p90 -103.75 104.16 14.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.124 -0.985 . . . . 0.0 110.139 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.87 120.92 41.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.035 . . . . 0.0 110.249 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.652 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.7 OUTLIER 170.38 148.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.962 -1.086 . . . . 0.0 111.214 177.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.652 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 29.6 t -169.39 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.254 1.026 . . . . 0.0 108.639 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.489 ' HG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -106.59 149.2 27.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.758 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -133.63 122.98 24.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.343 -1.473 . . . . 0.0 110.525 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.758 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.8 p 76.02 148.8 0.12 Allowed Pre-proline 0 N--CA 1.492 1.661 0 CA-C-O 121.272 0.558 . . . . 0.0 110.235 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.2 Cg_exo -42.32 175.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.573 2.182 . . . . 0.0 112.803 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.0 Cg_exo -38.87 174.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.498 1.466 . . . . 0.0 111.855 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.507 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 53.03 -84.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 73' ' ' PRO . 71.8 p -44.67 -23.15 0.11 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 111.36 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.684 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 14.1 p90 -43.81 -39.59 3.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.174 -0.954 . . . . 0.0 109.199 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.644 ' CD2' ' CE2' ' A' ' 76' ' ' TYR . 3.5 pp -135.05 -14.6 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.509 ' N ' HD11 ' A' ' 77' ' ' LEU . 6.6 mt -61.15 -31.22 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.753 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 10.8 mmt180 -55.38 -44.78 76.4 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -64.22 -66.89 0.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -58.51 -4.94 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.083 -1.011 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.638 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.21 -80.36 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 111.725 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 175.76 28.47 0.03 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.437 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.497 HD11 HH11 ' A' ' 79' ' ' ARG . 3.1 mt -90.27 105.05 17.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.973 -1.31 . . . . 0.0 109.135 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 34.1 tt0 -177.06 -20.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 0.0 109.347 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 9.7 tttm 75.04 -64.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.13 179.84 32.68 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -177.74 86.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -1.124 . . . . 0.0 109.453 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -147.23 -84.94 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.473 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.556 ' C ' ' H ' ' A' ' 92' ' ' GLY . 22.0 mttt -113.76 160.12 33.18 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.12 5.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.569 1.513 . . . . 0.0 112.383 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 90' ' ' LYS . . . -68.18 -53.01 24.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.803 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.8 OUTLIER 67.11 178.9 0.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -1.144 . . . . 0.0 109.452 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -146.65 -165.01 2.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 109.555 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -101.52 -164.98 1.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 20.8 t -144.28 152.24 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.556 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 136' ' ' VAL . . . 72.37 50.46 16.11 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.777 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.58 114.46 14.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.133 -1.216 . . . . 0.0 109.966 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.37 -174.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -127.51 159.8 33.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.4 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.534 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 19.3 t-105 -50.61 -69.61 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.5 -0.75 . . . . 0.0 110.84 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.49 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.24 -46.76 55.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.686 -1.259 . . . . 0.0 110.352 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.19 -47.61 45.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.689 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.3 m -72.11 -23.43 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.097 -1.441 . . . . 0.0 107.99 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' A' ' 109' ' ' LYS . 17.8 mt -68.09 -73.47 0.14 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 79.5 tt0 -44.03 -41.26 5.32 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.969 -1.082 . . . . 0.0 108.436 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.421 ' CD1' HD12 ' A' ' 77' ' ' LEU . 48.4 mt -64.6 -30.71 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.128 -0.983 . . . . 0.0 108.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -95.73 -26.86 15.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.3 mtpm? -58.54 -73.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.992 -1.067 . . . . 0.0 108.402 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 109' ' ' LYS . 64.7 mt-30 -45.99 -27.38 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 108.911 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -70.99 -17.68 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.772 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.687 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.04 67.22 79.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.143 -0.973 . . . . 0.0 109.761 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.91 -33.5 32.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.574 1.516 . . . . 0.0 112.088 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 8.0 p30 174.96 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 109.207 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.25 -77.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.552 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -150.51 -25.02 0.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.792 ' CG2' ' H ' ' A' ' 118' ' ' THR . 23.8 m -65.65 -164.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.973 . . . . 0.0 109.59 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.792 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.42 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 0.0 109.921 -179.144 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.98 141.0 57.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 110.113 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -61.37 -22.04 64.59 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.24 1.019 . . . . 0.0 108.919 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.76 -37.81 87.35 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.504 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -69.22 -75.33 0.11 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.232 -1.387 . . . . 0.0 107.83 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.43 -42.09 6.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.462 -1.399 . . . . 0.0 109.32 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -50.29 -68.76 0.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.106 -0.996 . . . . 0.0 108.609 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.696 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.71 -41.95 5.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.653 ' O ' ' N ' ' A' ' 130' ' ' SER . 4.9 tpp -52.84 -80.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.077 -1.014 . . . . 0.0 109.082 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.625 ' O ' ' OG ' ' A' ' 130' ' ' SER . 19.4 mm -46.57 -62.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.478 -0.764 . . . . 0.0 110.019 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -59.65 -69.6 0.2 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -39.07 3.38 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.669 ' HG ' ' N ' ' A' ' 131' ' ' ALA . 27.5 p -56.48 -52.0 66.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.516 -1.579 . . . . 0.0 107.592 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.669 ' N ' ' HG ' ' A' ' 130' ' ' SER . . . -46.94 -49.05 21.23 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.17 -53.98 9.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.688 ' C ' ' H ' ' A' ' 135' ' ' GLY . 9.9 t -44.83 -67.17 0.31 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.753 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 10.1 ttm -49.23 -2.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.688 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 88.07 -26.27 7.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.231 -1.947 . . . . 0.0 108.231 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.576 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 30.1 t -49.49 165.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.864 . . . . 0.0 109.47 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 39.2 mp0 -141.99 162.48 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.627 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.4 164.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.699 ' N ' ' O ' ' A' ' 99' ' ' ILE . 3.7 p -129.72 58.59 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 165.05 -116.62 0.71 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.536 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.71 58.83 14.16 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.206 -1.173 . . . . 0.0 109.317 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.1 Cg_endo -64.83 -169.38 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.702 1.602 . . . . 0.0 112.842 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.549 ' O ' ' CG1' ' A' ' 144' ' ' VAL . 82.9 mt-10 -159.01 177.85 10.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.773 . . . . 0.0 109.191 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 143' ' ' GLU . 4.3 m -163.45 170.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.594 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.415 ' CD ' ' N ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -97.11 -164.97 1.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.48 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -126.35 -85.04 0.62 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.516 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.626 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -45.79 139.04 4.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.491 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 9.0 mttt -170.58 115.11 0.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.714 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.74 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.6 p -44.89 136.76 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.542 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 61' ' ' ALA . 27.8 m -115.13 -24.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.19 -0.944 . . . . 0.0 108.478 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.75 107.59 5.39 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.258 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -95.59 73.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.714 ' O ' ' O ' ' A' ' 55' ' ' VAL . 18.1 t -46.78 89.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.662 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 7' ' ' VAL . 6.0 tmtt? -82.62 34.81 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.792 0.806 . . . . 0.0 108.909 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.845 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.36 -174.57 3.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.678 0.751 . . . . 0.0 111.17 -178.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.6 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -122.19 172.83 7.98 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 11' ' ' GLN . 0.2 OUTLIER -166.58 156.99 10.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 110.059 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 15' ' ' GLY . 11.3 Cg_endo -68.56 111.24 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.979 1.786 . . . . 0.0 111.668 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -69.85 39.22 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.982 -1.073 . . . . 0.0 110.499 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -175.0 -20.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.509 -1.805 . . . . 0.0 111.487 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -142.61 88.4 2.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.609 -1.524 . . . . 0.0 110.291 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.459 ' HB1' ' ND2' ' A' ' 42' ' ' ASN . . . -105.14 164.53 11.75 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.16 164.54 4.11 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 109.367 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.56 30.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.309 1.339 . . . . 0.0 111.781 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.74 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -151.62 54.07 1.27 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 110.02 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.74 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 19.8 Cg_endo -86.47 168.74 8.52 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.904 1.736 . . . . 0.0 111.614 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.1 -4.63 1.06 Allowed 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 120.935 1.09 . . . . 0.0 110.765 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.739 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.98 -71.25 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.477 0.656 . . . . 0.0 109.911 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.41 -98.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.739 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -59.39 -55.83 1.62 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-N 118.11 0.955 . . . . 0.0 109.961 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.67 -6.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.358 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.688 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -111.09 -44.58 3.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.77 -1.206 . . . . 0.0 108.803 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.34 84.32 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 27' ' ' LEU . 66.3 tp60 -149.07 -12.44 0.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.386 -1.067 . . . . 0.0 108.214 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.599 ' ND1' ' C ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -85.46 -37.13 20.1 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.543 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -170.21 2.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 70.75 78.6 0.18 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.84 -0.8 . . . . 0.0 111.969 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -156.54 120.57 4.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.004 -1.06 . . . . 0.0 108.688 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.593 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 30.1 mm -98.55 -63.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.724 -0.61 . . . . 0.0 109.746 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.47 ' C ' ' O ' ' A' ' 34' ' ' ILE . 4.9 tpt -41.39 -55.31 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.733 -1.229 . . . . 0.0 109.653 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' MET . 15.8 mt-10 -46.76 -48.3 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 107.741 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.613 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.8 OUTLIER -50.67 -68.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.945 1.355 . . . . 0.0 109.177 177.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG12 HD21 ' A' ' 42' ' ' ASN . 45.6 t -54.17 -34.68 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.608 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 1.5 mmmp? -56.55 -65.8 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.76 64.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.71 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.446 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -71.31 -76.74 0.1 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.5 m-80 -41.65 -34.54 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.512 1.148 . . . . 0.0 110.583 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' O ' ' CG ' ' A' ' 47' ' ' ASN . . . -66.45 -35.67 80.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.77 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.77 -52.0 5.09 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.683 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.742 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.1 p -54.32 -29.45 47.84 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.52 -47.2 12.44 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.553 ' CG ' ' O ' ' A' ' 43' ' ' ALA . 7.6 m120 -52.38 -23.24 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.318 -0.864 . . . . 0.0 108.983 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.641 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.65 -85.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.678 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.641 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.23 -135.77 1.89 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.855 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.29 125.87 44.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -1.106 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.643 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -159.4 -153.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.459 ' N ' ' HB1' ' A' ' 14' ' ' ALA . 4.5 mm -147.44 143.85 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.498 ' CG1' ' HG1' ' A' ' 69' ' ' THR . 5.9 t -145.16 136.94 12.93 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.2 Cg_endo -74.12 90.0 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.823 1.682 . . . . 0.0 110.763 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.845 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.9 m -61.98 137.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 122.783 1.278 . . . . 0.0 112.365 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.4 mt-10 -128.81 64.34 1.45 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mt -64.98 89.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.697 0.76 . . . . 0.0 110.501 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.22 96.89 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.1 mt -99.31 144.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.63 -0.669 . . . . 0.0 110.368 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.74 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 5.0 m-85 -115.81 140.3 49.36 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.85 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.75 -29.61 4.7 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.235 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 55.4 p30 -53.67 4.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.85 ' H ' ' C ' ' A' ' 61' ' ' ALA . 79.1 mtm180 69.05 68.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.985 0.898 . . . . 0.0 109.655 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 p -147.76 128.85 14.58 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -105.51 103.96 13.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.978 -1.076 . . . . 0.0 110.422 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 58' ' ' THR . 8.3 p -98.72 124.64 43.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.71 172.02 7.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.569 -1.332 . . . . 0.0 109.417 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.686 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 89.8 t -162.83 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 112.622 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.515 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.53 117.28 4.38 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.67 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.813 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.15 120.96 41.51 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.784 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.93 150.53 0.13 Allowed Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.434 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.631 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.7 Cg_exo -38.62 175.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.817 2.345 . . . . 0.0 113.35 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.763 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.72 166.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.574 1.516 . . . . 0.0 111.788 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 55.01 -76.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.763 ' N ' ' O ' ' A' ' 73' ' ' PRO . 55.3 p -43.17 -24.29 0.08 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 110.128 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.675 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 20.0 p90 -43.59 -43.16 5.5 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 0.0 109.227 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.584 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.88 -13.86 2.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.076 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 1.5 mt -62.33 -33.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.783 ' CG ' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.81 -40.81 73.27 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 82' ' ' ALA . 1.8 tmtp? -68.91 -66.33 0.59 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.76 -4.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.695 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.79 -80.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 111.958 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.01 52.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.049 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.559 HD11 ' HE ' ' A' ' 79' ' ' ARG . 18.3 mt -76.3 104.95 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.844 -1.386 . . . . 0.0 109.045 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 177.06 -24.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.035 -1.041 . . . . 0.0 109.739 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.1 mttt 64.71 61.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.485 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.78 174.95 29.98 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.11 -85.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -1.124 . . . . 0.0 109.466 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -143.29 -54.71 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.445 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -98.02 160.11 29.18 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.478 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -57.57 -16.62 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.604 1.536 . . . . 0.0 112.406 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . -103.54 174.45 22.8 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.55 ' O ' ' O ' ' A' ' 92' ' ' GLY . 10.9 mpt_? 57.13 123.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -1.13 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -145.12 176.26 9.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.7 tttt 176.99 161.52 0.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 97' ' ' GLY . 83.5 t -144.58 163.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.598 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.446 ' N ' ' CG1' ' A' ' 96' ' ' VAL . . . 72.75 63.66 2.8 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.695 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.4 mtt180 -134.72 112.48 10.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -1.205 . . . . 0.0 110.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -102.79 177.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.646 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -119.33 151.89 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 108.979 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.527 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 23.4 t-105 -45.93 -69.96 0.12 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 110.91 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.492 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 5.8 tp10 -49.23 -50.36 38.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.718 -1.239 . . . . 0.0 111.018 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.403 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 3.6 mt-30 -51.72 -42.09 62.01 Favored 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.509 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 105' ' ' LEU . 2.4 m -71.56 -26.1 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 117.46 -1.696 . . . . 0.0 107.184 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 109' ' ' LYS . 21.6 mt -65.97 -71.27 0.2 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 17.5 mm-40 -43.98 -43.15 6.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.921 -1.112 . . . . 0.0 108.534 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.8 mt -63.5 -31.87 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.592 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.598 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.63 -32.43 13.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.621 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 105' ' ' LEU . 4.7 mtpt -52.39 -71.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.835 -1.166 . . . . 0.0 108.275 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 109' ' ' LYS . 16.3 tt0 -44.76 -28.74 0.67 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 108.736 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -72.68 -6.95 47.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.75 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.577 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 7.3 ptm -134.13 63.97 63.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 109.828 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 112' ' ' MET . 4.0 Cg_endo -68.72 -41.13 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.607 1.538 . . . . 0.0 112.059 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.558 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 66.2 t0 -177.37 6.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.444 -0.785 . . . . 0.0 109.089 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.4 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.0 mm? -46.42 -83.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 109.583 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -148.66 -19.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.813 ' CG2' ' H ' ' A' ' 118' ' ' THR . 26.9 m -65.87 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.813 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.69 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.422 ' H ' HG22 ' A' ' 118' ' ' THR . 1.1 m-20 -73.01 140.41 47.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.431 -0.793 . . . . 0.0 110.121 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.583 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -59.65 -23.65 63.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.376 1.084 . . . . 0.0 108.883 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -64.15 -35.58 81.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.574 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.438 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -71.35 -75.99 0.12 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.272 -1.371 . . . . 0.0 108.072 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.577 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.01 -35.87 3.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.539 -1.351 . . . . 0.0 109.191 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -55.77 -70.4 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.022 -1.049 . . . . 0.0 108.668 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.665 ' O ' ' N ' ' A' ' 129' ' ' GLY . 20.1 ttp180 -43.51 -39.57 3.44 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.5 ttp -53.27 -78.71 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.134 -0.979 . . . . 0.0 108.53 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.502 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 22.1 mm -47.94 -63.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.481 -0.762 . . . . 0.0 109.978 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -60.74 -71.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.87 -41.91 4.72 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.22 -49.35 69.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.583 -1.539 . . . . 0.0 107.578 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -49.18 -47.83 45.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.08 -54.69 8.08 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.717 ' C ' ' H ' ' A' ' 135' ' ' GLY . 7.6 t -44.87 -68.83 0.16 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 3.4 ttp -46.0 -4.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.04 -31.77 5.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 27.1 t -45.28 165.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 3.5 tp10 -144.33 163.61 33.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.332 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.724 ' C ' ' H ' ' A' ' 140' ' ' GLY . 1.8 t -79.04 123.93 36.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.622 ' N ' ' O ' ' A' ' 99' ' ' ILE . 9.0 p -49.45 3.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.574 -0.704 . . . . 0.0 110.345 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.724 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . 156.23 -91.09 0.12 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.056 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.523 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 75.08 59.25 0.26 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.217 -1.167 . . . . 0.0 109.434 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.6 Cg_endo -65.04 -165.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.776 1.651 . . . . 0.0 112.582 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -135.55 -164.92 1.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.487 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.27 -175.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 109.487 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -173.68 -14.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.522 ' CG ' ' O ' ' A' ' 146' ' ' ASP . 4.5 p-10 -49.4 103.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.92 . . . . 0.0 109.524 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.527 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -146.57 116.61 7.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.406 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.609 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 11.3 tttt -177.72 123.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.922 . . . . 0.0 109.608 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -44.73 139.54 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 108.914 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.451 HG21 ' N ' ' A' ' 61' ' ' ALA . 28.3 m -122.31 -24.85 2.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.057 -1.027 . . . . 0.0 110.12 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.42 104.91 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.605 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -97.26 74.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.665 ' O ' ' O ' ' A' ' 55' ' ' VAL . 16.5 t -48.82 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.503 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.615 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.3 tmtp? -82.94 37.31 0.53 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.861 0.839 . . . . 0.0 109.217 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.9 tp -78.09 -174.09 3.47 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.901 0.858 . . . . 0.0 111.235 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.792 HE21 ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.26 176.56 6.35 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -164.43 146.36 6.99 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.847 -1.158 . . . . 0.0 109.299 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.665 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 74.1 Cg_endo -84.9 125.78 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.324 2.016 . . . . 0.0 113.576 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.748 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -74.41 143.77 44.61 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.478 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 51.21 56.08 16.31 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.665 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 22.1 tttp 174.35 3.93 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.733 -0.863 . . . . 0.0 109.191 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.73 153.32 21.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.892 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.5 165.78 6.15 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.976 -1.078 . . . . 0.0 110.005 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 2.7 Cg_exo -49.04 33.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.684 1.589 . . . . 0.0 111.868 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.892 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -150.85 54.34 1.41 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.536 -0.728 . . . . 0.0 109.61 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 14.5 Cg_endo -80.23 167.0 20.06 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.72 1.613 . . . . 0.0 111.898 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.61 -4.66 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.24 1.294 . . . . 0.0 111.341 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.775 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.4 t -113.34 -69.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.193 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.41 -97.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.775 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_endo -58.71 -55.29 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 CA-C-N 117.892 0.846 . . . . 0.0 110.408 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' C ' HG11 ' A' ' 23' ' ' VAL . . . -49.56 -9.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.742 -0.599 . . . . 0.0 110.782 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.63 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -106.27 -49.04 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.682 -1.261 . . . . 0.0 108.237 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.62 94.13 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 27' ' ' LEU . 51.3 tt0 -154.54 -24.41 0.12 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.724 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -77.77 -44.78 26.54 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.891 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.724 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -165.98 -11.53 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.14 82.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -1.09 . . . . 0.0 112.397 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.613 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 28.2 p30 -153.01 69.63 0.85 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.83 -1.169 . . . . 0.0 109.14 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.711 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 24.0 mm -44.32 -69.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.702 ' O ' ' N ' ' A' ' 39' ' ' LYS . 7.8 tpt -41.71 -57.38 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.582 -1.324 . . . . 0.0 108.869 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.613 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 69.9 tt0 -44.86 -49.7 10.74 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.711 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -49.58 -65.57 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.723 1.249 . . . . 0.0 109.627 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 42' ' ' ASN . 23.8 t -67.21 -35.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -46.7 -62.2 1.49 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.73 70.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 108.922 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.533 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 2.8 t80 -71.05 -77.55 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.4 t-20 -41.33 -36.91 0.89 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.825 -1.172 . . . . 0.0 110.585 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -64.72 -33.83 76.89 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.11 -59.59 2.15 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.451 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.481 HG23 ' CE2' ' A' ' 41' ' ' PHE . 1.7 p -44.53 -31.7 1.19 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.75 23.89 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -56.34 -25.17 48.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.436 -0.79 . . . . 0.0 109.405 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -111.5 -73.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.04 -1.037 . . . . 0.0 109.864 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.51 -165.81 34.73 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.944 -1.598 . . . . 0.0 111.392 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -87.22 147.15 25.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.056 -1.261 . . . . 0.0 109.082 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.748 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 174.93 -153.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.122 . . . . 0.0 110.81 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 1.9 mm -146.26 138.18 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.63 ' CG1' ' HG1' ' A' ' 69' ' ' THR . 2.4 t -137.25 135.41 19.53 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.045 -1.034 . . . . 0.0 110.776 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -73.02 102.95 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.685 1.59 . . . . 0.0 111.161 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.825 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.7 m -76.51 136.53 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.658 -1.276 . . . . 0.0 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.1 tt0 -129.88 69.76 1.43 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.587 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.3 mt -70.31 88.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.721 0.772 . . . . 0.0 110.063 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.18 95.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 59' ' ' ILE . 53.9 mt -95.27 131.15 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.575 0.703 . . . . 0.0 110.479 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.609 ' CE2' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -108.29 133.09 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.834 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -45.79 -30.89 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.567 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.53 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 27.4 p30 -53.94 2.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.834 ' H ' ' C ' ' A' ' 61' ' ' ALA . 7.5 ttp180 70.83 67.08 0.18 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.2 1.0 . . . . 0.0 110.08 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.447 ' OG ' ' OD1' ' A' ' 62' ' ' ASP . 58.7 p -150.39 124.92 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.4 p90 -102.24 103.86 14.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.041 -1.037 . . . . 0.0 109.89 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.04 120.98 40.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.189 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.655 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.34 148.78 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 0.0 111.179 177.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.709 ' CG1' ' NZ ' ' A' ' 70' ' ' LYS . 29.0 t -169.98 96.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.63 ' HG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -103.08 145.11 30.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.752 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -129.41 123.69 32.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.509 -1.369 . . . . 0.0 110.545 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.752 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.21 150.66 0.13 Allowed Pre-proline 0 N--CA 1.493 1.685 0 CA-C-O 121.175 0.512 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.4 Cg_exo -41.86 175.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.731 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.1 Cg_exo -38.9 171.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.379 1.386 . . . . 0.0 112.035 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.474 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 52.67 -80.62 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 73' ' ' PRO . 86.6 p -43.61 -23.14 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 110.019 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.64 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 16.9 p90 -44.02 -38.91 3.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.704 ' CD1' ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -136.95 -14.29 1.59 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.704 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 1.7 mt -63.39 -33.25 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.51 ' HE ' ' HB2' ' A' ' 75' ' ' SER . 14.2 mmt180 -55.1 -42.69 73.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 82' ' ' ALA . 6.2 tmtt? -64.2 -65.99 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.558 ' CB ' ' OE1' ' A' ' 103' ' ' GLN . . . -58.29 -5.3 0.47 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.71 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.65 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.93 -80.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 111.778 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.98 47.52 0.03 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.071 -1.538 . . . . 0.0 110.671 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.442 HD11 HH11 ' A' ' 79' ' ' ARG . 4.0 mt -97.42 120.27 37.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 0.0 109.132 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 87' ' ' GLY . 57.3 tt0 -160.43 58.44 0.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.529 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.563 ' O ' ' O ' ' A' ' 87' ' ' GLY . 41.3 tttm 45.84 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 56.73 126.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.685 ' O ' ' CD2' ' A' ' 89' ' ' HIS . . . 175.0 127.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -1.128 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.685 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 44.6 m-70 -171.47 -84.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.559 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.26 153.85 59.61 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.23 -35.96 98.97 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.488 1.459 . . . . 0.0 112.321 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.01 -163.54 32.38 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.811 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.9 OUTLIER 64.23 88.46 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -1.176 . . . . 0.0 109.482 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 23.2 mt-10 -137.54 108.12 6.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.442 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 94' ' ' GLU . 86.1 mttt -158.52 120.85 3.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 95' ' ' LYS . 95.5 t -157.91 161.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.456 ' H ' HG12 ' A' ' 96' ' ' VAL . . . 78.72 56.92 3.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.65 ' O ' ' O ' ' A' ' 82' ' ' ALA . 3.6 ttt180 -130.57 116.65 18.43 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.287 -1.125 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.645 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.6 168.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.527 -0.733 . . . . 0.0 109.647 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.486 HG23 ' NE2' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -109.11 151.04 26.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 108.985 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.53 ' O ' HG23 ' A' ' 104' ' ' VAL . 25.8 t-105 -45.82 -68.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.471 -0.768 . . . . 0.0 110.872 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 5.9 tp10 -51.32 -47.2 62.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.528 -1.357 . . . . 0.0 110.892 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.558 ' OE1' ' CB ' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -51.49 -43.58 62.24 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.017 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.01 -24.8 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 117.89 -1.524 . . . . 0.0 107.617 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.65 ' O ' ' N ' ' A' ' 109' ' ' LYS . 20.8 mt -66.14 -71.55 0.19 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -44.19 -44.78 8.02 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.964 -1.085 . . . . 0.0 108.515 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 55.8 mt -61.02 -31.4 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.689 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -96.03 -24.28 16.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.65 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.1 mtpt -59.57 -73.65 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 108.158 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.472 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 37.5 mt-30 -51.27 -17.94 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.815 . . . . 0.0 109.292 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.56 -8.14 58.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.5 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -133.37 57.87 29.93 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.024 -1.047 . . . . 0.0 109.748 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.99 -41.91 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.521 1.481 . . . . 0.0 112.283 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' LEU . 24.9 t70 -160.68 8.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' H ' HD13 ' A' ' 115' ' ' LEU . 4.6 mp -44.93 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 109.293 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -165.18 -4.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.237 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.812 ' CG2' ' H ' ' A' ' 118' ' ' THR . 29.8 m -74.23 -164.66 0.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.584 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.812 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.97 -57.71 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.426 ' H ' HG22 ' A' ' 118' ' ' THR . 0.7 OUTLIER -80.01 135.02 36.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.577 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -54.24 -24.78 19.96 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.183 0.992 . . . . 0.0 109.172 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.14 -36.74 85.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.535 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.65 -74.71 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.499 -1.376 . . . . 0.0 108.039 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.89 -37.65 4.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.496 -1.378 . . . . 0.0 109.136 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -55.34 -70.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 108.925 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -43.49 -38.8 3.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.698 ' O ' ' N ' ' A' ' 130' ' ' SER . 14.0 ttm -53.77 -78.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.507 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 22.3 mm -48.04 -63.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 109.97 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -59.39 -71.84 0.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.9 -42.7 5.08 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 126' ' ' MET . 58.7 m -54.74 -46.18 74.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.616 -1.52 . . . . 0.0 107.462 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -50.43 -47.55 56.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.0 tmt_? -46.83 -52.32 14.54 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -48.62 -70.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.52 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 5.6 ttm -44.51 -4.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.15 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.75 22.91 54.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.52 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 29.8 t -109.23 138.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -115.03 166.67 11.55 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.837 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.692 ' C ' ' H ' ' A' ' 140' ' ' GLY . 1.9 t -82.79 124.82 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.645 ' N ' ' O ' ' A' ' 99' ' ' ILE . 12.2 p -52.57 1.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . -159.27 -126.93 0.88 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 140' ' ' GLY . . . 75.07 66.47 0.25 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.251 -1.147 . . . . 0.0 109.364 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.65 -165.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.796 1.664 . . . . 0.0 112.48 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.28 -164.96 1.17 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.842 . . . . 0.0 109.504 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -95.3 -164.97 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.567 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.593 ' CD ' ' O ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -159.42 134.2 7.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.514 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.593 ' O ' ' CD ' ' A' ' 145' ' ' LYS . 48.6 m-20 -75.47 141.65 43.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.501 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' H1 ' ' HG2' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.275 0.56 . . . . 0.0 109.517 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.19 109.62 1.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.892 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.597 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 2.6 mtmt -150.27 125.86 10.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.855 . . . . 0.0 109.56 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.768 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.77 133.59 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 109.341 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 61' ' ' ALA . 28.5 m -116.92 -24.49 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.18 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.53 114.18 9.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.118 . . . . 0.0 110.529 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -102.55 73.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.704 ' O ' ' O ' ' A' ' 55' ' ' VAL . 7.9 t -48.56 88.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.764 -1.21 . . . . 0.0 110.606 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.9 tmtt? -82.0 36.74 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.168 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.3 mp -77.21 -174.0 3.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.59 0.709 . . . . 0.0 110.977 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.995 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.07 177.76 6.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.471 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -170.27 157.91 5.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.943 -1.098 . . . . 0.0 109.839 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 15' ' ' GLY . 10.4 Cg_endo -66.69 104.92 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.373 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.776 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -60.9 38.65 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.338 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.652 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.57 -19.42 0.02 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.488 -1.815 . . . . 0.0 111.357 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -148.39 79.7 1.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.578 -1.542 . . . . 0.0 110.705 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.471 ' HB3' ' ND2' ' A' ' 42' ' ' ASN . . . -94.96 170.16 9.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.78 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.74 164.25 4.51 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.768 -1.207 . . . . 0.0 110.494 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' C ' ' HD3' ' A' ' 21' ' ' PRO . 5.4 Cg_exo -51.75 32.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.029 1.819 . . . . 0.0 112.11 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -137.92 53.98 6.91 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.077 -1.015 . . . . 0.0 110.384 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.7 Cg_endo -85.97 163.13 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.8 1.667 . . . . 0.0 111.809 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.1 -4.81 4.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.016 1.144 . . . . 0.0 111.405 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.82 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 22.0 t -118.59 -66.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.588 -0.695 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.53 -97.23 0.05 OUTLIER Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.82 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.2 Cg_exo -54.3 -55.05 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 CA-C-N 117.876 0.838 . . . . 0.0 110.538 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . -64.22 4.7 0.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.665 . . . . 0.0 111.211 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.706 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -109.62 -64.18 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.66 -1.275 . . . . 0.0 109.797 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.58 -16.75 0.07 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 28' ' ' GLY . 22.3 tp60 -42.08 -16.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.472 -1.605 . . . . 0.0 109.528 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.71 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -65.52 -46.29 80.2 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.71 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.67 -5.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.624 ' C ' ' ND2' ' A' ' 33' ' ' ASN . . . 70.86 76.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.077 -0.661 . . . . 0.0 111.892 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.624 ' ND2' ' C ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -152.06 64.86 0.84 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.307 1.051 . . . . 0.0 108.334 177.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.571 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.5 mm -43.22 -66.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.696 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.0 tpt -41.56 -42.52 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.619 -1.3 . . . . 0.0 108.759 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.21 -49.39 76.16 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -50.91 -67.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.66 1.219 . . . . 0.0 109.093 178.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.506 HG12 HD21 ' A' ' 42' ' ' ASN . 24.8 t -63.36 -36.46 76.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.3 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.5 ttpt -48.99 -60.17 3.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.33 71.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.354 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 1.9 t80 -68.79 -76.5 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.575 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.9 m-80 -41.8 -32.9 0.44 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.399 1.095 . . . . 0.0 110.893 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.73 -34.75 77.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.611 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.82 -51.55 5.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.775 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.776 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 22.7 p -54.36 -31.48 54.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.33 -45.3 16.37 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -54.17 -22.99 12.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.394 -0.816 . . . . 0.0 109.145 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.625 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.1 -85.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.625 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.94 -144.17 3.99 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.015 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.17 119.8 37.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -1.11 . . . . 0.0 109.806 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.684 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -155.8 -152.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.855 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.476 ' N ' ' HB1' ' A' ' 14' ' ' ALA . 3.6 mm -146.26 141.83 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.46 HG21 ' N ' ' A' ' 71' ' ' THR . 6.9 t -144.32 137.5 13.98 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.911 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.55 ' C ' ' O ' ' A' ' 10' ' ' LEU . 9.6 Cg_endo -73.51 91.72 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.779 1.653 . . . . 0.0 111.482 178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.2 m -57.92 137.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.3 mt-10 -130.19 70.65 1.44 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.588 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.6 mt -70.67 90.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.856 0.836 . . . . 0.0 110.226 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 m -69.98 104.94 2.67 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 64' ' ' SER . 21.1 mt -110.33 148.23 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.494 -0.754 . . . . 0.0 110.927 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.768 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.9 m-85 -116.63 140.94 48.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.828 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.56 -32.46 5.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.267 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -51.44 -1.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.828 ' H ' ' C ' ' A' ' 61' ' ' ALA . 13.1 mtp180 75.02 70.03 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.992 0.901 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -149.44 138.08 20.96 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 42.9 p90 -115.13 103.93 11.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.963 -1.086 . . . . 0.0 110.312 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.47 121.07 41.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.089 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.634 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.37 148.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.955 -1.09 . . . . 0.0 111.211 177.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.634 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 30.8 t -168.49 79.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.16 138.15 31.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.656 ' O ' ' OG1' ' A' ' 71' ' ' THR . 8.1 mttm -122.94 140.15 53.3 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.198 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.679 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 2.2 p 57.73 158.07 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.603 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.569 ' O ' ' OG ' ' A' ' 75' ' ' SER . 12.7 Cg_exo -39.5 175.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.309 2.006 . . . . 0.0 112.691 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.715 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.9 Cg_exo -40.02 170.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.69 1.593 . . . . 0.0 112.253 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.458 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 58.07 -73.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.715 ' N ' ' O ' ' A' ' 73' ' ' PRO . 7.5 p -43.98 -25.34 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.945 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 17.4 p90 -43.61 -43.21 5.58 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.688 ' CD1' ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.85 -13.79 3.2 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.688 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 1.4 mt -63.31 -29.78 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.63 ' CG ' ' HG1' ' A' ' 71' ' ' THR . 3.6 mmt180 -54.07 -48.68 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.7 tmtt? -63.81 -66.14 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 99' ' ' ILE . . . -54.61 -6.54 0.12 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.56 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.623 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.57 -77.9 0.35 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 111.949 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 146.9 62.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.038 -1.553 . . . . 0.0 111.189 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.531 HD13 HH11 ' A' ' 79' ' ' ARG . 16.8 mt -85.01 104.95 15.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.951 -1.323 . . . . 0.0 108.901 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 87' ' ' GLY . 20.9 tt0 -155.94 23.17 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.06 -1.025 . . . . 0.0 109.722 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLU . 1.0 OUTLIER 45.04 -85.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 130.95 172.44 13.12 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.5 -84.99 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -1.173 . . . . 0.0 109.525 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -118.92 131.12 56.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -161.08 160.04 24.59 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.386 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.33 -15.28 18.45 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.577 1.518 . . . . 0.0 112.41 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.6 178.1 18.0 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.578 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 82.2 mtt180 57.76 82.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -1.084 . . . . 0.0 109.555 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.578 ' OE1' ' O ' ' A' ' 93' ' ' ARG . 5.1 tp10 -178.99 152.5 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 94' ' ' GLU . 41.3 mttt -159.9 -165.12 1.43 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.965 . . . . 0.0 109.566 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 97' ' ' GLY . 86.2 t -109.73 165.02 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.299 -0.875 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 96' ' ' VAL . . . 70.89 67.81 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.776 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.57 109.82 9.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -1.212 . . . . 0.0 110.403 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.687 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.42 175.59 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.518 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -123.34 158.38 31.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.524 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.4 t-105 -45.19 -70.86 0.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.351 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.511 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.72 -50.8 54.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.562 -1.336 . . . . 0.0 111.108 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -49.27 -43.66 43.24 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.288 -0.883 . . . . 0.0 110.35 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.35 -24.79 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.616 -1.634 . . . . 0.0 107.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.646 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.5 mt -66.32 -71.45 0.19 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.497 ' CD ' ' OE2' ' A' ' 102' ' ' GLU . 35.1 mt-10 -43.77 -43.72 6.26 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.93 -1.106 . . . . 0.0 108.461 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.65 -31.5 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 108.396 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.97 -26.77 15.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 109.62 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.646 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.8 mtpt -59.26 -73.56 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 0.0 108.211 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 3.1 tt0 -49.35 -18.27 0.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.253 -0.904 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.511 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.8 tmtt? -80.82 -10.2 59.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.581 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -132.38 55.46 17.82 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.9 Cg_endo -60.2 -40.89 55.87 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.567 1.512 . . . . 0.0 112.3 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.529 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -164.91 9.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.54 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.46 ' H ' HD11 ' A' ' 115' ' ' LEU . 4.2 mp -45.0 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.356 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -160.24 -10.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.816 ' CG2' ' H ' ' A' ' 118' ' ' THR . 29.0 m -68.65 -164.63 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.816 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.65 -57.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.422 ' H ' HG22 ' A' ' 118' ' ' THR . 1.0 OUTLIER -80.2 135.22 36.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -54.86 -23.74 19.89 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.16 0.981 . . . . 0.0 109.103 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.11 -35.8 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.47 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -71.63 -74.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.964 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.63 -39.05 4.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.342 -1.474 . . . . 0.0 109.152 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -53.5 -69.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.087 -1.008 . . . . 0.0 108.728 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.778 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -42.81 5.36 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.705 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.5 ttm -51.29 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.115 -0.991 . . . . 0.0 108.454 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.497 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 21.5 mm -48.37 -66.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.678 0.751 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -57.89 -71.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.86 -40.82 4.23 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 126' ' ' MET . 44.0 m -56.26 -51.25 68.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.518 -1.577 . . . . 0.0 107.723 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -47.14 -47.63 23.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.759 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -47.06 -54.26 10.75 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.717 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.1 t -44.77 -68.59 0.18 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.509 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 3.8 ttp -46.46 -4.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.717 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 88.73 -31.49 4.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.796 -2.122 . . . . 0.0 107.796 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 31.3 t -45.09 165.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.937 -0.743 . . . . 0.0 109.173 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.9 tm-20 -142.43 162.26 35.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.598 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.634 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -78.08 164.35 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.687 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p -131.64 58.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 161.88 -114.45 0.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.513 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.85 60.66 12.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.266 -1.138 . . . . 0.0 109.403 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.0 Cg_endo -65.6 -165.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.682 1.588 . . . . 0.0 112.682 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.539 ' O ' ' CG1' ' A' ' 144' ' ' VAL . 80.5 mt-10 -146.57 -167.85 2.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 0.0 109.351 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 143' ' ' GLU . 9.0 m -162.31 -179.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -123.27 -167.05 1.54 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.431 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 146' ' ' ASP . 6.8 p-10 -176.89 97.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 mtt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 pttt 176.4 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.649 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' C ' ' CE2' ' A' ' 60' ' ' TYR . 3.4 mttm 175.01 114.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 109.455 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.748 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.91 140.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.122 -0.986 . . . . 0.0 109.12 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.466 HG22 ' N ' ' A' ' 61' ' ' ALA . 28.0 m -121.12 -24.59 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.19 110.88 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.605 -1.309 . . . . 0.0 110.716 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.612 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -100.92 73.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.737 ' O ' ' O ' ' A' ' 55' ' ' VAL . 21.5 t -46.36 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 110.49 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.9 tmmm? -83.26 34.99 0.48 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.849 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -78.78 -174.15 3.81 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.917 0.865 . . . . 0.0 111.596 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.556 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -121.55 172.12 8.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.453 ' CD2' ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.51 160.93 4.11 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.854 -1.154 . . . . 0.0 109.857 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 12' ' ' LEU . 8.8 Cg_endo -61.53 129.41 27.91 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.042 1.828 . . . . 0.0 111.81 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.765 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -90.62 42.16 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 111.28 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.596 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 172.43 -12.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.59 70.96 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.419 . . . . 0.0 109.557 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.8 165.21 13.77 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.431 -0.793 . . . . 0.0 109.319 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.69 161.73 5.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.667 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -54.04 31.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.509 1.473 . . . . 0.0 111.466 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -144.94 54.3 2.44 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 0.0 110.265 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.698 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.3 Cg_endo -83.09 154.87 14.72 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.584 1.523 . . . . 0.0 111.544 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.58 -4.46 0.32 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.048 1.165 . . . . 0.0 111.018 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.745 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.9 t -103.77 -71.82 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.524 0.678 . . . . 0.0 110.592 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.29 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.745 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.11 -55.5 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 CA-C-N 118.048 0.924 . . . . 0.0 110.188 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -45.0 -7.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.815 -0.553 . . . . 0.0 110.657 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.745 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -108.37 -45.57 3.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.686 -1.259 . . . . 0.0 108.798 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.81 88.95 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' LEU . 2.7 tt0 -149.73 -15.19 0.27 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.617 ' ND1' ' C ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -89.46 -36.85 15.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.591 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -172.36 -1.82 0.03 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.09 82.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.96 . . . . 0.0 112.188 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.583 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 26.7 p-10 -156.74 119.22 3.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.867 -1.145 . . . . 0.0 109.08 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.2 mm -93.96 -65.26 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.4 tpt -42.72 -55.08 3.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.948 -1.095 . . . . 0.0 109.417 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' CB ' ' ND2' ' A' ' 33' ' ' ASN . 4.8 mp0 -51.01 -53.41 33.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 108.458 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.745 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -46.17 -59.11 3.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.936 1.35 . . . . 0.0 108.796 177.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 18' ' ' THR . 87.2 t -70.87 -26.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 35' ' ' MET . 23.1 tptt -56.26 -55.25 35.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.79 78.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.729 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.463 ' CZ ' ' CG1' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -67.37 -75.73 0.09 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.637 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 8.9 t-20 -41.78 -35.84 0.89 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.26 1.029 . . . . 0.0 110.715 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -62.95 -34.28 77.15 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.52 -60.33 1.91 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.502 1.144 . . . . 0.0 108.76 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.765 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 52.7 p -47.53 -28.06 2.07 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.764 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.29 -46.71 9.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -49.54 -19.92 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.239 -0.913 . . . . 0.0 108.883 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.682 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.83 -85.29 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.255 -0.903 . . . . 0.0 109.679 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.682 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -166.21 -150.8 6.48 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.912 -1.613 . . . . 0.0 110.962 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -106.39 107.81 19.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.565 -0.962 . . . . 0.0 110.037 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.612 ' CB ' ' HB2' ' A' ' 14' ' ' ALA . . . -143.48 -152.87 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 109.616 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.518 ' N ' ' HB3' ' A' ' 14' ' ' ALA . 7.1 mm -146.6 142.88 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.91 139.25 15.04 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.7 Cg_endo -75.75 91.48 1.08 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.766 1.644 . . . . 0.0 111.025 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.849 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.9 m -59.56 138.06 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 9.9 mt-10 -131.14 66.55 1.53 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.584 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.3 mt -66.53 92.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.665 0.745 . . . . 0.0 110.397 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.11 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 64' ' ' SER . 89.4 mt -103.05 142.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.509 -0.744 . . . . 0.0 110.683 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.748 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 5.6 m-85 -115.91 138.36 51.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.824 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.9 -30.75 4.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.437 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.23 1.5 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.824 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.7 OUTLIER 71.38 68.07 0.16 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.04 0.924 . . . . 0.0 109.893 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -149.47 131.24 15.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.3 p90 -108.63 104.11 13.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.049 -1.032 . . . . 0.0 110.098 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.5 121.02 41.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.978 -1.076 . . . . 0.0 110.201 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.666 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 170.21 149.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.953 -1.092 . . . . 0.0 111.283 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.662 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 30.1 t -169.69 84.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 138.7 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.817 ' O ' ' OG1' ' A' ' 71' ' ' THR . 14.8 mtmt -124.37 141.67 51.89 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.071 -1.451 . . . . 0.0 110.766 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.817 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 41.4 p 62.5 155.13 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.818 -0.552 . . . . 0.0 109.874 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.665 ' O ' ' OG ' ' A' ' 75' ' ' SER . 7.8 Cg_exo -42.09 175.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.406 2.071 . . . . 0.0 112.737 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 75' ' ' SER . 29.1 Cg_exo -38.43 170.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.494 1.462 . . . . 0.0 112.088 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.771 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 54.49 -73.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.782 ' N ' ' O ' ' A' ' 73' ' ' PRO . 21.3 p -43.42 -19.43 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.557 -0.714 . . . . 0.0 111.08 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.771 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -43.66 -41.14 4.54 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.779 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' N ' ' HD1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -133.2 -14.39 2.64 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 2.0 mt -59.19 -33.14 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.518 HH11 HD13 ' A' ' 84' ' ' LEU . 15.0 mmt180 -54.7 -42.56 71.64 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 82' ' ' ALA . 13.8 tmtt? -66.47 -66.1 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.577 ' CB ' ' OE1' ' A' ' 103' ' ' GLN . . . -57.83 -4.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.485 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.642 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.33 -79.7 0.23 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.437 -0.79 . . . . 0.0 111.694 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.602 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 167.08 45.09 0.02 OUTLIER Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.574 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.518 HD13 HH11 ' A' ' 79' ' ' ARG . 4.4 mt -99.47 105.84 17.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.346 . . . . 0.0 109.248 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 87' ' ' GLY . 5.3 tm-20 -178.07 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.631 ' N ' ' CD ' ' A' ' 85' ' ' GLU . 24.0 tptp 46.28 -85.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 0.0 109.483 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 149.41 -115.02 0.7 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.53 -85.01 0.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -1.134 . . . . 0.0 109.571 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -48.04 157.95 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -95.04 156.51 37.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.95 . . . . 0.0 109.481 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.59 -55.03 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.535 1.49 . . . . 0.0 112.367 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.689 ' O ' ' N ' ' A' ' 94' ' ' GLU . . . 131.29 115.43 1.71 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER 60.75 -57.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -1.116 . . . . 0.0 109.601 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 92' ' ' GLY . 28.5 mt-10 -44.95 161.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.558 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.61 -165.02 1.28 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.897 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t -126.87 165.02 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.669 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.431 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 93.94 66.38 1.04 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.79 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.93 114.87 14.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -103.97 177.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.778 . . . . 0.0 109.356 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.467 HG23 ' NE2' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -117.76 153.94 32.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.012 -1.055 . . . . 0.0 109.292 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.518 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 24.7 t-105 -48.12 -69.36 0.12 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.93 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.501 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.2 -46.47 54.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.696 -1.252 . . . . 0.0 110.646 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.577 ' OE1' ' CB ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -51.65 -45.07 63.22 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.041 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.3 m -72.24 -24.45 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.732 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.636 ' O ' ' N ' ' A' ' 109' ' ' LYS . 17.2 mt -66.91 -72.11 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 74.4 tt0 -43.93 -43.17 6.33 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.932 -1.105 . . . . 0.0 108.572 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.426 HG22 HD12 ' A' ' 107' ' ' ILE . 56.6 mt -62.66 -31.29 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 108.651 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.602 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -95.39 -26.94 15.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.451 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.3 mtpt -58.76 -73.36 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 108.346 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 109' ' ' LYS . 70.0 mt-30 -46.86 -25.68 0.82 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.815 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -72.8 -18.43 61.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.697 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -128.69 66.53 75.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 109.856 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.6 -41.25 26.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.501 1.468 . . . . 0.0 112.284 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.535 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 66.1 t0 -176.84 9.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.376 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.818 ' CD1' ' N ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.87 -85.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.792 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.521 ' H ' HD11 ' A' ' 115' ' ' LEU . 2.4 t30 -145.45 -21.97 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.398 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.802 ' CG2' ' H ' ' A' ' 118' ' ' THR . 25.5 m -65.84 -164.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.526 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.802 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.6 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.134 -0.979 . . . . 0.0 109.945 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.47 140.3 58.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.59 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -61.14 -22.15 64.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.255 1.026 . . . . 0.0 108.928 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.39 -38.07 88.87 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -69.42 -75.27 0.11 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.907 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.5 -43.05 7.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.405 -1.435 . . . . 0.0 109.402 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.59 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -49.69 -68.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.783 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -43.02 5.48 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.688 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.9 ttm -51.61 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -0.963 . . . . 0.0 108.74 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.492 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 21.4 mm -48.41 -64.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.674 0.749 . . . . 0.0 109.973 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -59.4 -71.47 0.12 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -39.39 3.67 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 126' ' ' MET . 36.6 m -56.33 -51.21 69.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.592 -1.534 . . . . 0.0 107.699 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.455 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -47.79 -47.66 30.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -46.62 -54.24 9.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.715 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.4 t -44.56 -67.82 0.25 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 2.9 ttp -46.64 -3.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.715 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 88.53 -24.02 13.77 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -57.47 135.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.975 -0.72 . . . . 0.0 109.387 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -112.09 164.74 12.82 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.35 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 139' ' ' VAL . 12.2 p -73.86 77.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.641 -0.662 . . . . 0.0 109.622 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.87 -75.9 2.15 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.581 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 58.43 55.07 5.96 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.228 -1.16 . . . . 0.0 109.361 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 3.8 Cg_endo -65.82 -164.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.654 1.569 . . . . 0.0 112.641 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -126.48 -165.04 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.318 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -102.58 -179.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.565 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.58 ' CG ' ' N ' ' A' ' 146' ' ' ASP . 30.7 tttp -155.42 170.44 21.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.512 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.58 ' N ' ' CG ' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -111.73 -84.92 0.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 109.542 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.447 ' HB2' ' NZ ' ' A' ' 145' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.289 0.566 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.46 49.81 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.536 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.579 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -154.89 118.59 4.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.678 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.78 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.95 134.6 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.434 HG11 ' H ' ' A' ' 61' ' ' ALA . 27.9 m -114.79 -24.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.79 113.6 9.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.328 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -101.61 73.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 109.128 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.666 ' O ' ' O ' ' A' ' 55' ' ' VAL . 6.0 t -49.11 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 O-C-N 120.646 -1.284 . . . . 0.0 110.472 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.26 36.74 0.48 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.927 0.87 . . . . 0.0 109.017 179.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.1 mp -76.23 -174.1 2.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.874 0.845 . . . . 0.0 111.045 -178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.643 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.94 176.11 7.21 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -165.81 145.96 5.5 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.968 -1.082 . . . . 0.0 109.292 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.657 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 72.1 Cg_endo -84.94 126.71 3.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.232 1.955 . . . . 0.0 113.437 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -72.61 143.47 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.721 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 51.2 54.17 24.53 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 34.1 tttt 174.48 4.01 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.729 -0.865 . . . . 0.0 109.521 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.4 156.17 21.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.895 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.95 165.64 4.03 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.915 -1.115 . . . . 0.0 110.26 -178.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 6.9 Cg_exo -47.79 33.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.925 1.75 . . . . 0.0 111.943 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.895 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -142.06 54.2 3.68 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.998 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.7 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -83.35 169.01 12.82 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.832 1.688 . . . . 0.0 112.019 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.31 -4.83 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 121.244 1.296 . . . . 0.0 111.377 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.81 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 19.5 t -119.34 -64.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.582 -0.698 . . . . 0.0 109.505 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.29 -97.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.81 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -55.57 -55.24 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 CA-C-N 117.817 0.808 . . . . 0.0 110.642 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.551 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . -60.58 1.94 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.663 -0.648 . . . . 0.0 111.213 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.721 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.41 -58.0 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.697 -1.252 . . . . 0.0 109.411 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.751 ' O ' ' N ' ' A' ' 32' ' ' ALA . . . -43.12 -17.29 0.04 OUTLIER Glycine 0 N--CA 1.485 1.948 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.531 ' C ' ' O ' ' A' ' 28' ' ' GLY . 13.0 mm100 -42.63 -27.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.176 -1.779 . . . . 0.0 107.885 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.768 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 14.2 p-80 -66.33 54.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 89.55 -18.77 44.32 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.751 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 75.19 83.06 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -1.118 . . . . 0.0 112.09 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.599 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -153.22 67.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.952 -1.092 . . . . 0.0 109.251 177.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.742 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 29.5 mm -43.85 -67.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.728 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.0 tpt -41.1 -56.93 2.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.473 -1.392 . . . . 0.0 109.218 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.599 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 18.9 tt0 -44.71 -47.64 10.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.452 -1.405 . . . . 0.0 107.631 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.742 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -51.97 -69.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.583 1.182 . . . . 0.0 109.705 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 42' ' ' ASN . 27.8 t -65.32 -36.26 77.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.484 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 35' ' ' MET . 16.0 tttt -46.08 -62.06 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.81 -33.76 68.93 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.528 ' CD2' HG21 ' A' ' 45' ' ' THR . 2.8 t80 -71.45 -78.36 0.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.1 t-20 -41.23 -30.91 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.896 -1.127 . . . . 0.0 110.679 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -70.55 -32.86 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.089 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.621 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -90.33 -45.88 8.74 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.552 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.721 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 9.4 p -60.24 -31.16 69.93 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.85 23.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.75 -22.45 46.94 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.71 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.55 -71.82 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.71 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.47 -130.04 1.5 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.123 -1.513 . . . . 0.0 111.067 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -122.64 145.81 48.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -1.187 . . . . 0.0 108.85 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.746 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 176.93 -154.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.736 -1.228 . . . . 0.0 111.192 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 51' ' ' ALA . 1.9 mp -144.25 135.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 71' ' ' THR . 2.7 t -135.36 132.66 20.05 Favored Pre-proline 0 C--N 1.296 -1.75 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.92 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 8.9 Cg_endo -71.9 103.47 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.654 1.57 . . . . 0.0 111.192 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -75.96 136.39 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.652 -1.28 . . . . 0.0 111.493 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.1 mt-10 -129.08 70.39 1.41 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.538 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.4 mt -70.55 90.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.882 0.848 . . . . 0.0 110.07 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.453 ' HB ' ' HG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -70.82 95.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.578 ' CG2' ' O ' ' A' ' 64' ' ' SER . 46.4 mt -101.57 147.67 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.659 -0.651 . . . . 0.0 110.583 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.78 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.0 m-85 -115.62 142.2 47.05 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.841 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.28 -33.15 8.32 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.238 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 56.4 p30 -50.8 -1.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.841 ' H ' ' C ' ' A' ' 61' ' ' ALA . 16.2 ttm180 75.25 70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.048 0.928 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.578 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -149.49 147.04 27.73 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.9 p90 -123.32 103.91 8.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.974 -1.079 . . . . 0.0 110.188 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.624 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.5 p -101.48 120.77 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 110.002 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.648 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.9 OUTLIER 170.3 147.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.952 -1.092 . . . . 0.0 111.295 177.415 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.648 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 29.6 t -168.52 97.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.301 1.048 . . . . 0.0 108.519 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.432 ' HG1' ' HB2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -106.01 144.02 33.32 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.746 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -128.14 131.54 48.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.461 -1.399 . . . . 0.0 111.157 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER 67.75 160.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.954 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.624 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.5 Cg_exo -38.9 175.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.686 2.257 . . . . 0.0 113.193 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.732 ' O ' ' N ' ' A' ' 75' ' ' SER . 19.9 Cg_exo -44.27 171.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.566 1.511 . . . . 0.0 112.183 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.588 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 55.2 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.835 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 60.2 p -43.02 -19.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.446 -0.784 . . . . 0.0 110.367 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 27.5 p90 -43.47 -34.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.599 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.38 -16.73 1.82 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.835 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 6.8 mt -56.71 -31.73 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 75' ' ' SER . 9.1 mmm180 -54.43 -49.0 71.01 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.4 tmtt? -62.59 -65.74 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.608 ' CB ' ' OE1' ' A' ' 103' ' ' GLN . . . -56.62 -7.92 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 109.668 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.597 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -87.96 -78.11 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 111.519 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.19 68.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.333 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mt -133.05 104.57 6.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -1.18 . . . . 0.0 109.313 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 174.85 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 109.401 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.1 tptp 62.31 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.604 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.57 -99.18 0.97 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' O ' ' CG ' ' A' ' 89' ' ' HIS . . . -150.62 117.3 5.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -1.142 . . . . 0.0 109.584 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER 174.98 165.12 0.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.438 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -59.51 160.06 15.04 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.61 ' C ' ' H ' ' A' ' 93' ' ' ARG . 3.6 Cg_exo -58.14 -54.92 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.548 1.499 . . . . 0.0 112.458 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 57.0 -0.56 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.767 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 55.65 122.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -1.155 . . . . 0.0 109.467 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -147.0 -165.27 2.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -119.67 -164.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 97' ' ' GLY . 86.0 t -151.56 146.12 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.888 . . . . 0.0 109.498 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.495 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 72.03 76.45 0.61 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 82' ' ' ALA . 14.9 ttm180 -135.36 106.23 6.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.3 -177.49 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 109.884 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.484 HG21 ' NE2' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -120.95 151.68 39.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.261 -0.899 . . . . 0.0 108.94 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.543 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 31.9 t-105 -48.28 -67.45 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 110.561 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 7.4 tp10 -50.5 -48.29 56.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.728 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.608 ' OE1' ' CB ' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -50.61 -44.01 56.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.02 -25.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 117.719 -1.593 . . . . 0.0 107.462 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.643 ' O ' ' N ' ' A' ' 109' ' ' LYS . 21.9 mt -66.26 -72.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.563 ' OE1' ' OE2' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -44.31 -43.29 7.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.089 -1.007 . . . . 0.0 108.802 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.2 mt -63.51 -31.29 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.054 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -95.75 -30.62 13.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.292 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 105' ' ' LEU . 17.4 mtpt -54.73 -72.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 108.646 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 109' ' ' LYS . 6.8 tt0 -45.59 -31.12 1.72 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.16 -0.963 . . . . 0.0 109.032 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.513 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.1 tmtt? -63.99 -15.67 59.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.752 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.496 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -128.63 70.78 80.54 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.939 -1.101 . . . . 0.0 109.71 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.66 -39.29 21.38 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.565 1.51 . . . . 0.0 112.15 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.56 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -178.21 10.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.237 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -48.24 -82.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -151.37 -22.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.813 ' CG2' ' H ' ' A' ' 118' ' ' THR . 27.0 m -59.95 -164.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.989 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.813 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -176.0 -70.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.862 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.402 ' H ' HG22 ' A' ' 118' ' ' THR . 1.0 OUTLIER -65.28 137.5 57.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.611 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -59.21 -21.41 59.45 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.277 1.037 . . . . 0.0 108.746 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -65.69 -34.29 77.85 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.589 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.56 -76.23 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.464 -1.398 . . . . 0.0 107.935 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.64 -39.08 4.75 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.439 -1.413 . . . . 0.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.611 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -53.94 -67.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.06 -1.025 . . . . 0.0 108.535 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 12.9 ttt180 -43.36 -36.74 2.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' SER . 7.3 ttm -57.24 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 108.886 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.732 ' O ' ' OG ' ' A' ' 130' ' ' SER . 30.0 mm -48.63 -57.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 110.199 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -66.62 -70.28 0.26 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -42.42 5.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.732 ' OG ' ' O ' ' A' ' 127' ' ' ILE . 54.7 p -52.86 -50.0 64.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.512 -1.581 . . . . 0.0 107.152 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.64 ' H ' ' HG ' ' A' ' 130' ' ' SER . . . -49.2 -48.62 45.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.546 ' CD ' ' C ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -44.77 -51.67 9.17 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.1 t -50.57 -68.81 0.14 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.51 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 5.5 ttp -44.95 -4.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.713 -0.617 . . . . 0.0 110.407 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.4 25.47 47.3 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 28.9 t -107.71 165.52 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.858 -0.79 . . . . 0.0 109.233 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 5.1 tt0 -139.53 162.64 34.58 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.989 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.682 ' C ' ' H ' ' A' ' 140' ' ' GLY . 1.8 t -79.07 117.73 25.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.673 ' N ' ' O ' ' A' ' 99' ' ' ILE . 7.0 p -49.86 -0.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.823 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . -140.58 -111.42 0.91 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.428 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 45.18 64.1 8.21 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.293 -1.122 . . . . 0.0 109.343 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.428 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.5 Cg_endo -61.47 -168.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.784 1.656 . . . . 0.0 112.464 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -178.49 104.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -157.94 167.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 19.4 tptm -177.14 148.39 0.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.461 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.471 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 29.1 t0 -166.19 72.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.403 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -161.22 111.68 1.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.511 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 2.8 ttmp? -177.85 125.06 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -44.7 140.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.918 . . . . 0.0 108.804 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.481 HG21 ' N ' ' A' ' 61' ' ' ALA . 28.3 m -122.59 -24.91 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 110.093 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.41 107.38 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.758 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -98.62 74.31 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.689 ' O ' ' O ' ' A' ' 55' ' ' VAL . 25.1 t -48.73 88.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.956 -1.09 . . . . 0.0 110.876 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 tmtm? -82.38 37.05 0.49 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.715 0.769 . . . . 0.0 109.315 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.881 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -80.09 -174.07 4.29 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.721 0.772 . . . . 0.0 111.461 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.785 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.93 174.77 7.35 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.462 ' CD2' ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.78 161.75 3.84 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.704 -1.247 . . . . 0.0 110.098 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD2' ' CD2' ' A' ' 12' ' ' LEU . 9.5 Cg_endo -62.2 126.6 18.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.904 1.736 . . . . 0.0 111.668 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.778 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -88.1 42.21 1.05 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.035 -1.041 . . . . 0.0 111.332 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.555 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 174.81 -12.12 0.03 OUTLIER Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.906 -1.616 . . . . 0.0 110.832 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -143.26 73.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 109.622 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.549 ' O ' ' ND2' ' A' ' 42' ' ' ASN . . . -93.2 169.66 10.23 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.193 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -175.31 162.45 2.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.021 -1.049 . . . . 0.0 109.693 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -53.97 31.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.581 1.521 . . . . 0.0 111.33 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -147.38 54.03 1.8 Allowed Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.102 -0.999 . . . . 0.0 110.083 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.735 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.3 Cg_endo -85.06 157.83 11.42 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.746 1.631 . . . . 0.0 111.522 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HG2' HE22 ' A' ' 11' ' ' GLN . 3.5 Cg_exo -52.75 -4.52 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 120.939 1.093 . . . . 0.0 110.846 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.737 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.0 t -105.08 -72.08 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 121.623 0.725 . . . . 0.0 110.296 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 23' ' ' VAL . . . 54.65 -98.33 0.05 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.737 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -59.89 -55.39 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 CA-C-N 118.004 0.902 . . . . 0.0 109.959 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -43.8 -11.98 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.266 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -113.25 -38.73 4.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.686 -1.259 . . . . 0.0 108.114 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.38 96.13 0.01 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 27' ' ' LEU . 41.2 tt0 -162.94 -22.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.688 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -83.84 65.55 8.65 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 80.54 -5.99 62.64 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.37 83.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 112.021 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 33.2 m120 -159.32 124.85 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.903 -1.123 . . . . 0.0 108.905 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 20.8 mm -101.22 -62.1 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 0.0 109.858 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.663 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.49 -47.52 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 109.749 -176.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -55.75 -48.74 74.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 0.0 107.845 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.656 ' C ' ' CD1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -49.79 -63.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.612 1.196 . . . . 0.0 108.818 178.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG11 ' N ' ' A' ' 18' ' ' THR . 98.0 t -68.55 -30.15 46.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.194 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 35' ' ' MET . 36.0 tptt -54.83 -54.57 40.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.06 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 109.634 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -67.76 -75.5 0.1 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.231 -1.543 . . . . 0.0 106.896 176.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.645 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.7 m-20 -41.5 -38.26 1.26 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.117 -0.99 . . . . 0.0 110.735 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -61.53 -33.71 74.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . . . -91.13 -57.77 2.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.591 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.778 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 40.0 p -50.75 -26.82 6.07 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.766 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.645 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.12 -45.86 10.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -52.7 -18.94 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 0.0 108.886 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.528 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.41 -85.31 0.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . -168.15 -150.47 6.6 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.89 -1.624 . . . . 0.0 110.794 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -105.62 107.43 18.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -1.005 . . . . 0.0 109.976 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.608 ' CB ' ' HB1' ' A' ' 14' ' ' ALA . . . -144.15 -152.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.854 . . . . 0.0 109.611 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 7.8 mm -146.04 143.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 71' ' ' THR . 2.2 t -143.6 137.18 14.24 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.128 -0.983 . . . . 0.0 110.497 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -74.53 91.61 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.841 1.694 . . . . 0.0 110.628 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.881 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -60.09 136.53 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 122.706 1.241 . . . . 0.0 111.662 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 30.4 tt0 -130.6 69.51 1.46 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.585 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.3 mt -71.08 90.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.719 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.73 96.02 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.1 mt -97.15 135.81 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.446 -0.784 . . . . 0.0 110.865 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.594 ' CE2' ' N ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -111.7 136.01 51.52 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.806 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -46.63 -32.94 3.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.742 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 56.0 m-20 -51.3 -2.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.806 ' H ' ' C ' ' A' ' 61' ' ' ALA . 9.7 ttm180 75.11 68.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.072 0.939 . . . . 0.0 109.74 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 10.4 m -149.72 124.97 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.717 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -102.9 103.98 14.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.157 -0.964 . . . . 0.0 110.009 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -100.55 120.51 40.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.969 -1.082 . . . . 0.0 109.911 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.662 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 169.94 150.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.956 177.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.659 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 30.6 t -169.45 78.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.404 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -84.14 148.97 26.48 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.772 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.1 mttm -136.46 134.1 37.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.906 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.772 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.3 p 75.34 150.75 0.13 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.566 ' O ' ' O ' ' A' ' 73' ' ' PRO . 7.1 Cg_exo -43.4 175.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.46 2.106 . . . . 0.0 113.149 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.805 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.0 Cg_exo -41.98 177.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.74 1.627 . . . . 0.0 112.007 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 44.91 -84.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.805 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -43.96 -15.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 109.614 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 21.1 p90 -44.15 -35.67 2.3 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.69 ' CD1' ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -139.71 -14.86 1.06 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.69 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 2.0 mt -63.1 -33.25 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.5 ' HG2' ' CB ' ' A' ' 75' ' ' SER . 1.6 mmt180 -55.44 -44.88 76.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.457 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.1 tmtp? -61.54 -65.48 0.68 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.61 -6.13 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.475 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.641 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -82.24 -81.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.45 -0.781 . . . . 0.0 111.555 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.17 34.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.549 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 84' ' ' LEU . 3.5 mt -91.38 104.7 17.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.884 -1.363 . . . . 0.0 109.031 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.677 ' OE1' ' N ' ' A' ' 86' ' ' LYS . 4.6 tm-20 174.83 -70.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.677 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 13.1 tptm 59.31 -85.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 109.559 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 48.88 87.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 174.99 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -1.179 . . . . 0.0 109.448 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.629 ' CG ' ' H ' ' A' ' 90' ' ' LYS . 11.2 t60 -126.26 -171.49 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.434 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.629 ' H ' ' CG ' ' A' ' 89' ' ' HIS . 5.6 mptp? -60.77 159.59 25.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.415 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.55 -55.04 2.34 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.578 1.519 . . . . 0.0 112.379 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.83 108.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 57.5 -164.97 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -1.137 . . . . 0.0 109.513 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -111.41 118.45 35.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.477 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.499 ' O ' ' CG2' ' A' ' 96' ' ' VAL . 8.7 mtpp -152.14 82.62 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.946 . . . . 0.0 109.527 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 95' ' ' LYS . 94.8 t -158.3 165.04 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.457 ' N ' ' CG1' ' A' ' 96' ' ' VAL . . . 72.16 60.26 4.23 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 82' ' ' ALA . 1.4 ttt180 -132.03 117.03 17.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -1.182 . . . . 0.0 110.117 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.47 -169.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.033 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.459 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.12 163.26 28.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.097 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.505 ' O ' HG21 ' A' ' 104' ' ' VAL . 23.8 t-105 -53.45 -69.5 0.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 110.643 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 7.4 tp10 -51.03 -45.31 61.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.527 -1.358 . . . . 0.0 110.427 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.3 -45.89 62.35 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.782 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.5 -22.78 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.774 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 109' ' ' LYS . 17.7 mt -68.01 -72.49 0.17 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 105' ' ' LEU . 76.3 tt0 -43.83 -43.95 6.55 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.889 -1.132 . . . . 0.0 108.508 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 62.9 mt -61.77 -31.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 108.46 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.622 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -96.69 -20.85 17.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.462 -0.774 . . . . 0.0 109.481 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 105' ' ' LEU . 26.0 mttm -62.49 -74.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.852 -1.155 . . . . 0.0 108.167 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.478 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 56.7 mt-30 -50.48 -20.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -69.4 -4.97 20.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.042 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.586 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -135.69 63.09 51.71 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.903 -1.123 . . . . 0.0 109.715 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 112' ' ' MET . 5.1 Cg_endo -71.3 -30.79 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.572 1.515 . . . . 0.0 111.883 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -166.84 4.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mp -44.84 -85.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -171.96 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.206 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.822 ' CG2' ' H ' ' A' ' 118' ' ' THR . 29.6 m -75.43 -164.39 0.33 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.822 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.81 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.691 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -94.82 130.56 41.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -58.9 -35.02 72.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.418 1.104 . . . . 0.0 108.648 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 -62.75 -33.5 75.28 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.467 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -73.3 -74.25 0.18 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.586 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.23 -37.45 4.64 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.489 -1.382 . . . . 0.0 109.019 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -56.65 -69.48 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 108.847 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.646 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.6 OUTLIER -43.38 -35.95 1.74 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.669 ' O ' ' CB ' ' A' ' 130' ' ' SER . 6.0 ttm -56.13 -76.64 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.507 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 23.9 mm -48.82 -63.48 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.689 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -60.12 -72.26 0.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.49 -41.16 4.02 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.669 ' CB ' ' O ' ' A' ' 126' ' ' MET . 60.2 m -57.91 -47.87 81.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.547 -1.561 . . . . 0.0 107.443 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -49.25 -49.72 42.05 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.785 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.71 -55.09 6.89 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.702 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.5 t -44.67 -67.45 0.28 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.478 ' CE ' ' HB2' ' A' ' 75' ' ' SER . 0.6 OUTLIER -47.4 -4.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.702 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.55 -31.11 5.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 137' ' ' GLU . 41.3 t -45.02 165.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.909 -0.759 . . . . 0.0 108.972 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.582 ' H ' HG12 ' A' ' 136' ' ' VAL . 81.0 tt0 -142.25 162.73 34.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.456 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.8 t -83.26 137.68 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.677 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.2 p -92.61 -5.95 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.455 -0.778 . . . . 0.0 109.533 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -125.72 -129.56 3.35 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 50.86 70.97 1.69 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.231 -1.158 . . . . 0.0 109.585 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.84 -164.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.668 1.579 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 144' ' ' VAL . 57.1 tt0 -157.47 160.38 38.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.445 ' N ' ' CG ' ' A' ' 143' ' ' GLU . 1.9 m -159.63 158.35 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.528 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -139.86 156.08 46.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.912 . . . . 0.0 109.451 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.03 109.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.459 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' O ' ' CD ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -159.07 109.83 2.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.618 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.528 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 1.3 tptm 177.52 121.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.738 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.79 137.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 109.417 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.441 HG12 ' H ' ' A' ' 61' ' ' ALA . 27.6 m -115.67 -24.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.44 110.18 6.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.344 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -98.16 73.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.71 ' O ' ' O ' ' A' ' 55' ' ' VAL . 35.4 t -48.52 88.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.542 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.93 36.47 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.819 0.819 . . . . 0.0 109.324 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.866 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -77.91 -174.12 3.41 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.432 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -121.35 172.49 7.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.46 ' CD2' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -169.04 161.05 8.0 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.086 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.46 ' HD2' ' CD2' ' A' ' 12' ' ' LEU . 13.8 Cg_endo -66.95 109.61 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.065 1.844 . . . . 0.0 111.316 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.756 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -67.64 41.08 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.856 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.468 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 176.6 -14.15 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.515 -1.802 . . . . 0.0 111.522 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -138.25 56.83 1.72 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.6 . . . . 0.0 110.557 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.32 160.03 30.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.669 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.41 162.37 23.72 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.681 -1.262 . . . . 0.0 110.981 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.05 38.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.087 1.858 . . . . 0.0 111.847 178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.669 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -173.06 56.77 0.21 Allowed Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.53 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.8 Cg_endo -79.76 169.02 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 121.467 1.444 . . . . 0.0 111.382 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.08 -4.68 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.071 1.181 . . . . 0.0 110.922 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.752 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.0 t -106.85 -72.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.582 0.706 . . . . 0.0 110.256 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.35 -98.01 0.05 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.752 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.59 -55.65 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 CA-C-N 118.088 0.944 . . . . 0.0 110.055 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' C ' HG12 ' A' ' 23' ' ' VAL . . . -44.79 -10.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.83 -0.544 . . . . 0.0 110.243 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.617 HD11 ' CD2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.75 -44.11 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.859 -1.151 . . . . 0.0 108.815 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.62 96.38 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 27' ' ' LEU . 10.6 tt0 -159.49 -26.68 0.07 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.717 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.4 p80 -78.74 64.17 3.67 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.7 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 81.82 -7.84 61.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 83.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -1.126 . . . . 0.0 112.097 177.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -157.97 123.69 4.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.676 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.606 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 19.8 mm -97.55 -63.71 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.049 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.614 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.0 tpt -41.29 -51.64 3.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.768 -1.208 . . . . 0.0 109.989 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.57 -48.39 57.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.667 -1.271 . . . . 0.0 108.007 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.655 ' C ' ' CD1' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -51.81 -65.83 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.535 1.16 . . . . 0.0 109.353 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 18' ' ' THR . 67.8 t -65.49 -30.03 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.915 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.4 OUTLIER -55.67 -56.1 24.38 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.14 77.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.608 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.445 ' CE2' HG21 ' A' ' 45' ' ' THR . 1.9 t80 -69.49 -76.77 0.09 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.341 -1.474 . . . . 0.0 107.155 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 9.8 t-20 -41.66 -32.36 0.37 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.971 -1.081 . . . . 0.0 110.734 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -67.84 -34.08 76.02 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.445 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -90.45 -53.39 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.603 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.756 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 27.9 p -53.51 -30.38 41.06 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.6 -45.2 16.16 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -54.15 -21.77 9.56 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.154 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.728 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.79 -85.0 0.54 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.728 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.91 -149.8 6.05 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.896 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 2.2 t0 -110.15 120.2 41.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -1.142 . . . . 0.0 109.902 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.593 ' CB ' ' HB2' ' A' ' 14' ' ' ALA . . . -153.72 -152.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.552 ' N ' ' HB3' ' A' ' 14' ' ' ALA . 6.0 mm -146.53 142.7 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 t -146.44 138.53 13.59 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 110.302 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.5 Cg_endo -73.93 93.06 0.87 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.75 1.633 . . . . 0.0 111.258 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.866 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.3 m -60.35 137.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.722 -1.236 . . . . 0.0 111.689 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.7 mt-10 -129.68 68.55 1.43 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.565 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.0 mt -68.93 93.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.859 0.838 . . . . 0.0 110.585 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.0 99.88 0.91 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 64' ' ' SER . 47.9 mt -104.46 145.08 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.537 -0.727 . . . . 0.0 110.756 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.738 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.2 m-85 -116.46 140.67 49.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.812 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.61 -33.08 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.304 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -1.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.812 ' H ' ' C ' ' A' ' 61' ' ' ALA . 36.2 mtm180 75.28 69.05 0.08 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.019 0.914 . . . . 0.0 109.727 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -148.73 148.06 29.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.669 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 39.3 p90 -125.23 103.97 8.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.277 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.2 p -101.6 120.92 41.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.655 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 170.17 146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.074 177.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.63 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 31.7 t -167.57 79.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.284 1.04 . . . . 0.0 108.348 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.426 ' HG1' ' HB3' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -87.03 136.79 32.79 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.598 ' O ' ' OG1' ' A' ' 71' ' ' THR . 5.1 mtmp? -121.0 140.62 51.66 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.227 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER 60.38 163.95 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.838 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 71' ' ' THR . 11.7 Cg_exo -41.08 175.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.099 1.866 . . . . 0.0 112.463 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.17 173.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.629 1.553 . . . . 0.0 112.499 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.751 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 56.79 -73.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 108.711 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -45.48 -17.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.716 . . . . 0.0 110.937 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.751 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 1.2 p90 -43.37 -38.63 2.8 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.889 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 76' ' ' TYR . 3.1 pp -133.65 -22.2 1.91 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 6.5 mt -54.95 -30.84 23.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.589 ' HG3' ' OG1' ' A' ' 71' ' ' THR . 6.0 mmt180 -52.65 -57.21 10.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 82' ' ' ALA . 5.3 tmtm? -52.06 -64.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -58.67 -6.53 0.75 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.813 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.582 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.34 -80.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 111.837 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.89 48.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.99 -1.576 . . . . 0.0 110.817 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.482 HD11 HH11 ' A' ' 79' ' ' ARG . 6.7 mt -83.95 104.82 14.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.316 . . . . 0.0 109.003 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' C ' ' CD ' ' A' ' 86' ' ' LYS . 37.2 tt0 -143.23 -16.37 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.706 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 86' ' ' LYS . 7.4 mptt 59.85 40.63 19.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 109.569 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 86' ' ' LYS . . . 44.99 -158.53 0.19 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.97 -84.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.541 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.457 ' O ' ' CG ' ' A' ' 89' ' ' HIS . 14.5 t-160 -146.33 67.27 1.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 109.515 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 92' ' ' GLY . 0.0 OUTLIER -120.14 161.15 40.19 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.363 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.6 -2.64 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.566 1.511 . . . . 0.0 112.464 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 90' ' ' LYS . . . 156.19 -123.26 1.29 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.807 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.9 OUTLIER 67.17 138.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -1.111 . . . . 0.0 109.407 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -122.96 163.09 21.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 0.0 109.507 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.804 ' HZ2' ' NH2' ' A' ' 98' ' ' ARG . 0.9 OUTLIER 174.98 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.393 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 97' ' ' GLY . 48.6 t -154.8 150.46 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.586 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 70.08 58.0 6.51 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.804 ' NH2' ' HZ2' ' A' ' 95' ' ' LYS . 4.2 tmm_? -131.5 110.08 10.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.172 -1.193 . . . . 0.0 110.916 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.15 -175.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.483 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -127.33 164.3 22.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.889 -1.132 . . . . 0.0 109.656 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.526 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 21.1 t-105 -51.46 -71.04 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.579 -0.7 . . . . 0.0 111.152 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -48.79 -51.12 30.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.693 -1.255 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.4 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.1 mt-30 -49.18 -44.48 42.98 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.48 -25.09 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.518 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.652 ' O ' ' N ' ' A' ' 109' ' ' LYS . 18.2 mt -66.87 -71.8 0.19 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.478 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 46.7 mt-10 -43.81 -43.08 6.0 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.922 -1.111 . . . . 0.0 108.465 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 107' ' ' ILE . 57.9 mt -62.76 -30.71 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.433 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -95.63 -25.78 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.497 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.652 ' N ' ' O ' ' A' ' 105' ' ' LEU . 8.4 mtpt -59.28 -73.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.919 -1.113 . . . . 0.0 108.362 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 109' ' ' LYS . 0.3 OUTLIER -45.35 -28.41 0.85 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.092 -1.005 . . . . 0.0 108.922 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.488 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 12.0 tttm -69.09 -19.28 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.863 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.694 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -129.65 68.9 81.13 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.092 -1.005 . . . . 0.0 109.884 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 -34.18 27.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.495 1.463 . . . . 0.0 112.072 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.532 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 3.5 t70 175.02 12.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -50.43 -77.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.631 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -149.83 -24.97 0.27 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.796 ' CG2' ' H ' ' A' ' 118' ' ' THR . 23.6 m -64.57 -164.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 0.0 109.579 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.796 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.61 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.251 -0.905 . . . . 0.0 109.935 -179.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.09 141.09 57.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.583 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -61.95 -22.72 65.87 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.243 1.021 . . . . 0.0 109.011 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.93 -38.41 90.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.526 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.92 -74.92 0.12 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.944 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.56 -43.08 7.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.46 -1.4 . . . . 0.0 109.28 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -49.12 -69.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 108.608 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.775 ' HG3' HH11 ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.58 -41.81 4.76 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.709 ' O ' ' N ' ' A' ' 130' ' ' SER . 12.0 ttm -52.32 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.187 -0.946 . . . . 0.0 108.643 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.504 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 20.5 mm -48.03 -64.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.424 -0.798 . . . . 0.0 109.848 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -59.23 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -41.75 4.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.6 m -54.91 -48.6 72.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.536 -1.567 . . . . 0.0 107.699 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -50.01 -47.71 52.92 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.672 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -45.68 -53.5 9.25 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.681 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.4 t -44.89 -67.59 0.27 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.589 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 10.7 ttm -49.42 -3.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.681 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.64 -27.26 8.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.597 HG13 ' H ' ' A' ' 137' ' ' GLU . 52.7 t -48.17 165.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.847 -0.796 . . . . 0.0 109.208 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.597 ' H ' HG13 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -142.52 162.62 35.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.711 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.2 164.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.707 ' CG1' ' O ' ' A' ' 139' ' ' VAL . 1.3 p -134.19 58.01 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 165.58 -115.73 0.65 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.496 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.7 60.17 12.93 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.237 -1.155 . . . . 0.0 109.173 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.56 ' O ' ' CG ' ' A' ' 143' ' ' GLU . 2.1 Cg_endo -61.26 165.81 12.14 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.838 1.692 . . . . 0.0 112.773 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.56 ' CG ' ' O ' ' A' ' 142' ' ' PRO . 27.1 mt-10 -165.72 98.82 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.857 . . . . 0.0 109.233 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.3 m -127.05 -174.41 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.737 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' CG ' ' N ' ' A' ' 146' ' ' ASP . 12.5 ttpt -175.61 159.81 2.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.355 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.511 ' N ' ' CG ' ' A' ' 145' ' ' LYS . 21.5 m-20 -131.47 -85.05 0.5 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -175.63 96.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.94 . . . . 0.0 109.588 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 4' ' ' VAL . 1.2 mppt? -141.72 115.49 9.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.599 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.741 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p -44.84 133.13 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.078 -1.014 . . . . 0.0 109.187 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.444 HG13 ' H ' ' A' ' 61' ' ' ALA . 28.3 m -117.79 -24.59 3.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.261 -0.9 . . . . 0.0 109.224 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.24 111.22 6.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.385 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -100.37 73.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.679 ' O ' ' O ' ' A' ' 55' ' ' VAL . 6.1 t -49.12 88.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.611 -1.305 . . . . 0.0 110.715 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? -82.04 37.24 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.843 0.83 . . . . 0.0 109.054 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.855 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.4 mp -76.8 -174.2 2.95 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.817 0.818 . . . . 0.0 111.137 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.609 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.87 175.34 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -169.81 158.46 6.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.886 -1.134 . . . . 0.0 109.993 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 15' ' ' GLY . 11.5 Cg_endo -68.01 104.95 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.935 1.757 . . . . 0.0 111.417 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.765 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -60.94 38.72 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.144 -1.023 . . . . 0.0 110.34 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.5 -18.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.526 -1.797 . . . . 0.0 111.3 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -148.38 78.99 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.507 -1.584 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.24 170.25 9.64 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.36 164.52 3.94 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.773 -1.204 . . . . 0.0 110.487 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' C ' ' HD3' ' A' ' 21' ' ' PRO . 5.4 Cg_exo -51.97 32.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.048 1.832 . . . . 0.0 112.066 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.778 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -138.2 53.93 6.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 0.0 110.415 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.702 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.5 Cg_endo -86.36 162.39 9.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.83 1.687 . . . . 0.0 111.712 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.56 -4.89 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 121.079 1.186 . . . . 0.0 111.34 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.822 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 21.5 t -118.71 -66.51 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.44 -97.16 0.05 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 4.7 Cg_exo -53.96 -55.1 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 CA-C-N 117.816 0.808 . . . . 0.0 110.585 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.616 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . -64.96 5.5 0.33 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.544 -0.723 . . . . 0.0 111.182 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.711 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -109.64 -65.17 1.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.668 -1.27 . . . . 0.0 109.855 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.69 -16.33 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' LEU . 83.5 mt-30 -41.98 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.45 -1.618 . . . . 0.0 109.571 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -64.67 -45.37 87.0 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.678 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.92 -3.53 0.04 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 69.76 76.64 0.21 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 122.187 -0.596 . . . . 0.0 111.756 177.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 34' ' ' ILE . 1.1 m120 -152.41 63.61 0.82 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.291 1.043 . . . . 0.0 108.416 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 37' ' ' PHE . 26.7 mm -43.01 -66.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.651 ' O ' ' CG ' ' A' ' 39' ' ' LYS . 4.3 tpt -41.43 -37.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.695 -1.253 . . . . 0.0 108.67 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.13 -49.13 75.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.711 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -50.38 -66.37 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.842 1.306 . . . . 0.0 109.252 177.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 42' ' ' ASN . 24.4 t -64.11 -37.65 80.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.604 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CG ' ' O ' ' A' ' 35' ' ' MET . 5.8 mmmt -47.95 -59.93 2.98 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.82 72.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.364 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.469 ' CE2' HG23 ' A' ' 45' ' ' THR . 2.6 t80 -69.6 -77.42 0.08 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 5.0 m-20 -41.6 -34.86 0.64 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.398 1.094 . . . . 0.0 110.872 -177.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -65.82 -34.15 77.49 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.497 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.599 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.29 -53.72 4.33 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.393 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.765 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 21.4 p -52.47 -27.54 16.63 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.65 -46.06 13.73 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.677 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -54.67 -21.22 10.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.744 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.03 -85.2 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.744 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.32 -137.67 2.29 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.977 -1.583 . . . . 0.0 110.909 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.512 ' O ' ' CG ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -119.95 118.35 30.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.13 . . . . 0.0 109.971 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -153.74 -153.13 0.45 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.482 ' N ' ' HB1' ' A' ' 14' ' ' ALA . 3.8 mm -146.67 141.8 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' CG1' ' OG1' ' A' ' 69' ' ' THR . 2.2 t -145.66 138.62 14.07 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' C ' ' O ' ' A' ' 10' ' ' LEU . 10.1 Cg_endo -73.93 91.0 0.93 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.85 1.7 . . . . 0.0 111.519 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.855 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.3 m -56.46 137.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.751 -1.218 . . . . 0.0 111.229 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.6 tt0 -129.24 70.81 1.41 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.587 ' HA ' ' CG ' ' A' ' 67' ' ' PHE . 4.7 mt -71.33 89.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 0.0 110.307 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.39 104.02 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 64' ' ' SER . 41.2 mt -107.64 144.44 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.509 -0.745 . . . . 0.0 110.867 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.741 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.5 m-85 -115.03 139.47 49.84 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.816 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.51 -32.89 5.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.24 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -51.07 -2.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.816 ' H ' ' C ' ' A' ' 61' ' ' ALA . 4.6 mtt180 75.24 70.1 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.913 0.863 . . . . 0.0 109.843 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 2.5 t -150.7 125.13 9.53 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.631 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 33.2 p90 -102.14 103.87 14.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.608 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -100.74 121.05 41.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.985 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.648 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.45 148.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 111.231 177.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.648 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 28.0 t -169.3 88.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.489 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -94.74 145.07 25.12 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.811 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -129.53 118.56 22.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 0.0 110.213 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.811 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 23.0 p 75.96 150.02 0.13 Allowed Pre-proline 0 N--CA 1.493 1.689 0 CA-C-O 121.231 0.539 . . . . 0.0 110.025 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -40.16 175.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.682 2.255 . . . . 0.0 113.113 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.4 Cg_exo -39.55 171.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.52 1.48 . . . . 0.0 111.913 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 75' ' ' SER . . . 51.49 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.778 ' N ' ' O ' ' A' ' 73' ' ' PRO . 17.7 p -43.64 -27.75 0.33 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.654 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 8.0 p90 -43.55 -38.11 2.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.652 ' CD1' ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -135.27 -11.39 2.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.652 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 2.0 mt -66.32 -29.85 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.707 ' CZ ' ' CD1' ' A' ' 84' ' ' LEU . 7.3 mmm180 -55.73 -40.12 72.06 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.612 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.6 tmtt? -70.78 -67.95 0.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 99' ' ' ILE . . . -53.82 -4.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.277 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.713 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.61 -78.21 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.712 . . . . 0.0 112.155 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.22 55.71 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.873 -1.632 . . . . 0.0 110.811 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.707 ' CD1' ' CZ ' ' A' ' 79' ' ' ARG . 9.0 mt -97.78 104.63 16.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.05 -1.265 . . . . 0.0 109.097 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 0.4 OUTLIER 174.74 -75.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HZ2' ' CG ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER 75.05 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.87 -100.06 2.52 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -171.7 136.31 0.93 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -1.155 . . . . 0.0 109.539 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -177.28 -69.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.461 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -68.91 160.55 77.45 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.891 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.457 ' HG2' ' NH2' ' A' ' 93' ' ' ARG . 5.1 Cg_exo -57.45 -18.61 32.37 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.529 1.486 . . . . 0.0 112.418 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 152.38 -173.63 31.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.536 ' O ' ' CD ' ' A' ' 94' ' ' GLU . 16.9 mtm180 60.2 115.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -1.106 . . . . 0.0 109.486 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.617 ' CG ' ' HZ2' ' A' ' 86' ' ' LYS . 13.4 mm-40 -145.26 -168.2 2.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.608 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -143.35 -174.66 4.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.6 t -153.08 164.46 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.913 . . . . 0.0 109.606 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' HG11 ' A' ' 136' ' ' VAL . . . 65.15 73.44 0.59 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.814 ' HG3' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.34 105.31 6.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.128 -1.219 . . . . 0.0 110.979 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.46 ' CD1' HG11 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -105.72 -167.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.027 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.515 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -137.7 159.61 41.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 108.88 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.525 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 17.8 t-105 -47.6 -71.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 110.801 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.6 tp10 -50.77 -49.21 58.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.526 -1.359 . . . . 0.0 110.895 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.603 ' O ' ' CG1' ' A' ' 107' ' ' ILE . 4.2 mt-30 -51.11 -43.7 61.16 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 110.23 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 100' ' ' THR . 2.4 m -70.9 -25.3 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.521 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.673 ' O ' ' N ' ' A' ' 109' ' ' LYS . 18.1 mt -65.7 -71.54 0.19 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -44.41 -42.36 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.854 -1.154 . . . . 0.0 108.185 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 103' ' ' GLN . 1.8 mm -60.85 -33.28 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -98.88 -23.14 15.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.439 -0.788 . . . . 0.0 109.335 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.673 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.6 mttt -57.03 -72.34 0.08 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -48.75 -34.06 11.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.592 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 112' ' ' MET . 1.2 mptp? -80.06 64.43 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.222 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.536 ' H ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER 175.02 55.54 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 0.0 109.217 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.536 ' HD3' ' H ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.38 -55.05 1.05 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.545 1.497 . . . . 0.0 112.346 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 115' ' ' LEU . 1.5 m-20 -163.53 11.46 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.83 ' CD1' ' N ' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.79 -85.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.613 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.52 ' H ' HD12 ' A' ' 115' ' ' LEU . 16.9 t30 -155.43 10.68 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.398 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.852 ' CG2' ' H ' ' A' ' 118' ' ' THR . 41.6 m -104.34 -164.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.852 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER 179.25 -55.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.199 -0.938 . . . . 0.0 110.007 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 118' ' ' THR . 3.7 m-20 -74.76 142.92 44.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.342 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -58.77 -33.15 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.221 1.01 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -60.46 -37.63 81.61 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.045 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.06 -72.72 0.2 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.872 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -46.16 -37.93 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.523 -1.361 . . . . 0.0 109.089 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -56.0 -71.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.042 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 129' ' ' GLY . 47.6 ttt180 -43.32 -34.83 1.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' SER . 15.1 ttm -56.2 -76.88 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.501 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 17.4 mm -48.37 -63.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.772 . . . . 0.0 109.785 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.499 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -59.57 -71.73 0.12 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.78 -42.66 4.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 126' ' ' MET . 57.9 m -55.49 -50.27 70.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.591 -1.535 . . . . 0.0 107.5 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -47.66 -48.72 28.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.2 tmt_? -44.82 -54.9 5.87 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.661 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -46.71 -69.26 0.14 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.505 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 7.6 ttp -45.07 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.622 -0.674 . . . . 0.0 110.639 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.06 8.62 75.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.546 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 28.2 t -88.5 165.31 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 1.3 tp10 -142.78 163.02 33.95 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.137 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.67 153.42 4.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG2' ' HG3' ' A' ' 98' ' ' ARG . 1.3 p -118.2 -8.31 11.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.252 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -122.17 -115.94 2.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.461 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.84 62.4 10.36 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.16 -1.2 . . . . 0.0 109.384 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.7 Cg_endo -60.73 177.81 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 121.688 1.592 . . . . 0.0 112.551 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -112.97 144.46 42.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 109.405 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.54 165.18 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.479 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -162.31 -14.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 109.531 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -70.81 119.3 14.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.483 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' H1 ' ' HG2' ' A' ' 1' ' ' MET . 8.4 mmt . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 147.48 50.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.464 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.741 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER 174.88 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.484 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p -82.03 156.67 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.24 -0.912 . . . . 0.0 108.911 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 61' ' ' ALA . 27.8 m -119.97 -24.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.063 -1.023 . . . . 0.0 109.621 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.401 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -154.32 101.31 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.316 -1.353 . . . . 0.0 110.635 178.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.657 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -92.36 73.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.746 ' O ' ' O ' ' A' ' 55' ' ' VAL . 24.4 t -45.53 88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.215 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.726 ' CB ' ' HZ2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -84.29 34.44 0.52 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.923 0.868 . . . . 0.0 109.019 179.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.763 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.52 -174.72 3.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.948 0.88 . . . . 0.0 111.381 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -117.19 169.41 9.48 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -163.0 144.59 7.75 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 120.544 -1.347 . . . . 0.0 110.16 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.498 ' HB2' ' CB ' ' A' ' 16' ' ' LYS . 36.5 Cg_endo -80.5 127.91 6.73 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.426 2.084 . . . . 0.0 113.97 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.735 ' O ' ' N ' ' A' ' 16' ' ' LYS . . . -72.83 141.34 47.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.737 ' C ' ' H ' ' A' ' 17' ' ' ALA . . . 61.41 -60.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 mtpp -60.46 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.801 -0.823 . . . . 0.0 108.884 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.737 ' H ' ' C ' ' A' ' 15' ' ' GLY . . . -114.4 151.42 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.73 165.93 6.87 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 -178.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 3.9 Cg_exo -49.38 36.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.723 1.615 . . . . 0.0 111.749 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.896 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -164.34 55.03 0.42 Allowed Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.631 -0.668 . . . . 0.0 109.819 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.0 Cg_endo -77.36 169.95 20.3 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.529 1.486 . . . . 0.0 111.801 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.02 -4.59 3.89 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 121.134 1.223 . . . . 0.0 110.971 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.738 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 t -105.08 -71.54 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.598 0.713 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.92 -98.41 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.738 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.5 Cg_endo -59.98 -55.41 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.972 0.886 . . . . 0.0 109.97 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.31 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.471 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.639 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -112.39 -42.49 3.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.608 -1.307 . . . . 0.0 108.703 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.5 85.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 27' ' ' LEU . 8.0 mm-40 -150.64 -13.82 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -1.102 . . . . 0.0 108.06 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.613 ' CD2' ' CE1' ' A' ' 65' ' ' PHE . 2.6 p-80 -86.21 -37.21 18.89 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.549 ' N ' ' CG ' ' A' ' 30' ' ' HIS . . . -171.87 -1.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.0 80.62 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 111.971 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -156.7 121.7 4.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.505 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.638 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.5 mm -97.9 -64.83 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.646 . . . . 0.0 110.0 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.689 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.97 -57.05 2.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.59 -1.319 . . . . 0.0 109.424 -177.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' MET . 3.7 mp0 -46.54 -51.08 16.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.99 -1.069 . . . . 0.0 108.195 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.638 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -48.15 -59.94 3.02 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.46 1.124 . . . . 0.0 109.623 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 42' ' ' ASN . 50.6 t -73.72 -30.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.95 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.1 tttp -50.09 -62.01 1.82 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.62 -33.89 73.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.469 -0.769 . . . . 0.0 108.94 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.483 ' O ' ' N ' ' A' ' 44' ' ' ALA . 2.1 t80 -70.73 -77.03 0.09 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -41.29 -34.21 0.47 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.42 1.105 . . . . 0.0 110.692 -177.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.1 -34.01 75.58 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.963 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.75 -45.55 8.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.69 ' CB ' ' H ' ' A' ' 15' ' ' GLY . 19.0 p -58.67 -29.31 66.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -80.0 -46.5 16.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.587 ' OD1' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -55.96 -23.18 30.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.784 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.83 -74.93 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.394 -0.816 . . . . 0.0 109.407 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.784 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 168.31 150.75 6.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.289 -1.434 . . . . 0.0 111.088 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 49' ' ' GLY . 1.1 m-20 -44.8 148.76 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.015 -1.285 . . . . 0.0 109.497 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.632 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 175.8 -154.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.986 -1.071 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.5 mm -146.98 141.07 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 71' ' ' THR . 2.7 t -144.32 135.59 12.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.744 -1.223 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 8.4 Cg_endo -70.96 99.82 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.624 1.55 . . . . 0.0 110.465 177.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.763 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.0 m -79.16 137.01 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 122.782 1.277 . . . . 0.0 112.262 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -128.25 61.32 1.46 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.417 ' CD1' ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -61.57 86.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.646 0.736 . . . . 0.0 109.735 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -60.59 95.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 64' ' ' SER . 46.2 mt -95.75 136.53 26.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.566 -0.708 . . . . 0.0 110.237 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.741 ' CE2' ' O ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -110.45 138.66 46.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.83 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.68 -29.43 4.4 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.573 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 19.7 t0 -53.93 3.03 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.83 ' H ' ' C ' ' A' ' 61' ' ' ALA . 50.4 mtp180 69.69 70.11 0.24 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.045 0.926 . . . . 0.0 109.624 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 18.2 m -148.25 124.9 11.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.7 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -101.5 104.13 15.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 0.0 110.204 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 p -98.3 124.58 43.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.573 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -109.4 174.02 6.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.526 -1.359 . . . . 0.0 109.349 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.701 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 97.1 t -163.11 44.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.674 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.482 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 t -155.19 126.79 7.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 115.594 -2.442 . . . . 0.0 110.276 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.85 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -124.92 128.13 48.15 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.791 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.81 151.59 0.13 Allowed Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.522 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.0 Cg_exo -40.37 175.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.504 2.136 . . . . 0.0 113.063 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.818 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.63 170.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.651 1.567 . . . . 0.0 112.125 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 49.94 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.882 ' HG ' ' NE ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -43.55 -20.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.242 179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.719 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 11.6 p90 -43.83 -42.22 5.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.65 -0.656 . . . . 0.0 109.322 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.675 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -131.66 -19.52 2.66 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 1.6 mt -59.27 -32.03 47.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.882 ' NE ' ' HG ' ' A' ' 75' ' ' SER . 12.7 mmt180 -55.42 -44.12 75.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 82' ' ' ALA . 9.5 tmtt? -66.37 -66.4 0.56 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' CB ' ' OE1' ' A' ' 103' ' ' GLN . . . -57.93 -4.84 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.667 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.66 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.16 -80.38 0.19 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 111.987 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.2 53.46 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.036 -1.554 . . . . 0.0 110.466 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.482 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 5.7 mt -118.56 106.48 12.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.039 -1.271 . . . . 0.0 109.558 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 20.8 tt0 -133.47 -4.33 2.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 2.2 tmtp? 75.14 -80.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.261 -0.899 . . . . 0.0 109.528 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 86' ' ' LYS . . . 90.28 -150.98 21.2 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.05 -85.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -1.172 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -114.48 140.38 48.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -154.18 158.68 32.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.408 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.53 -55.01 2.36 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.621 1.548 . . . . 0.0 112.366 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 178.12 -167.31 37.93 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 18.4 mtp180 60.03 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 86.8 mt-10 -157.09 156.47 32.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' CG ' ' C ' ' A' ' 94' ' ' GLU . 39.1 mttm -151.77 142.43 22.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.284 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.482 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 2.4 t -151.64 164.98 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 109.734 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.439 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 50.87 61.2 6.29 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.784 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.87 111.84 10.19 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.997 -1.296 . . . . 0.0 110.327 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.25 -177.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.48 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -125.05 159.02 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.925 -1.109 . . . . 0.0 109.351 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.51 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 22.8 t-105 -49.81 -69.54 0.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.597 -0.69 . . . . 0.0 111.042 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.639 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 9.5 tp10 -50.2 -44.74 53.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.515 ' OE1' ' CB ' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -55.31 -43.76 75.17 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.162 -0.961 . . . . 0.0 110.054 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.23 -24.32 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 117.649 -1.62 . . . . 0.0 107.656 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.653 ' O ' ' N ' ' A' ' 109' ' ' LYS . 17.1 mt -66.31 -71.72 0.19 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.639 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 20.5 mm-40 -44.08 -44.5 7.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.909 -1.119 . . . . 0.0 108.44 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 107' ' ' ILE . 65.4 mt -60.84 -32.55 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 108.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.98 -26.79 15.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.575 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.5 mttm -58.82 -73.27 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.935 -1.103 . . . . 0.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 109' ' ' LYS . 6.2 tt0 -45.24 -28.46 0.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.441 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 11.6 tttm -69.8 -18.44 63.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.58 68.13 81.15 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.031 -1.043 . . . . 0.0 109.821 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.8 -33.96 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.533 1.488 . . . . 0.0 112.088 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 174.97 15.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.77 . . . . 0.0 109.087 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.21 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.597 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -150.65 -25.03 0.23 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.793 ' CG2' ' H ' ' A' ' 118' ' ' THR . 23.5 m -64.94 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.793 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.45 -74.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.943 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.68 140.96 57.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 110.051 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.579 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -61.88 -22.65 65.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.214 1.007 . . . . 0.0 108.952 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.12 -38.42 90.6 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.57 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.69 -75.2 0.11 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.231 -1.387 . . . . 0.0 107.921 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.56 -43.02 7.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.475 -1.39 . . . . 0.0 109.292 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -49.63 -68.71 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 108.571 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.779 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.57 -42.95 5.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.682 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.21 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 108.562 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.491 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 19.9 mm -48.57 -65.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -58.81 -71.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.72 -39.04 3.36 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.9 m -57.8 -47.51 82.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.467 -1.608 . . . . 0.0 107.564 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -49.97 -48.47 52.16 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.649 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.2 tmm_? -46.62 -53.71 10.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.702 ' C ' ' H ' ' A' ' 135' ' ' GLY . 7.1 t -44.83 -68.5 0.19 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' A' ' 75' ' ' SER . 0.0 OUTLIER -47.27 -3.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.702 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 87.91 -23.67 13.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 47.4 t -53.44 165.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.849 -0.795 . . . . 0.0 109.17 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.498 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -142.66 162.58 35.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.025 -1.047 . . . . 0.0 109.723 179.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.44 ' H ' ' HG3' ' A' ' 137' ' ' GLU . 1.9 t -77.76 162.25 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.677 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p -128.2 58.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.599 -0.688 . . . . 0.0 109.184 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.47 -108.01 0.34 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.483 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.87 62.53 10.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.186 -1.185 . . . . 0.0 109.346 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.1 Cg_endo -64.87 -175.89 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.82 1.68 . . . . 0.0 112.564 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.525 ' O ' ' CG1' ' A' ' 144' ' ' VAL . 4.5 mt-10 -153.19 129.67 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 109.373 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.539 ' O ' ' CG ' ' A' ' 145' ' ' LYS . 4.0 m -162.94 166.75 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.59 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 144' ' ' VAL . 32.8 mtpt -161.45 163.57 30.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.666 ' OD1' ' N ' ' A' ' 147' ' ' ALA . 2.7 p30 -176.64 -61.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.52 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.666 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mtt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.52 96.04 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.153 -0.967 . . . . 0.0 109.584 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 4.9 tttp -168.08 115.27 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.533 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.744 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.86 138.01 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 61' ' ' ALA . 27.8 m -112.82 -24.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.19 107.28 5.73 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.168 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.642 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.9 p -94.71 73.62 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 108.94 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.729 ' O ' ' O ' ' A' ' 55' ' ' VAL . 31.7 t -45.96 88.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.192 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.54 34.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.89 0.853 . . . . 0.0 109.076 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.816 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -78.23 -174.42 3.69 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.787 0.803 . . . . 0.0 111.31 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -119.78 171.84 8.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -168.3 160.11 9.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.689 -1.257 . . . . 0.0 110.288 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HD2' ' CD2' ' A' ' 12' ' ' LEU . 13.4 Cg_endo -67.74 109.19 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.251 1.967 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.763 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -69.45 40.21 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.963 -1.086 . . . . 0.0 110.733 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.496 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 179.31 -18.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 118.277 -1.915 . . . . 0.0 111.792 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' CE ' ' OD1' ' A' ' 50' ' ' ASP . 2.1 mptt -135.82 60.74 1.67 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.405 -1.644 . . . . 0.0 110.452 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.64 158.74 26.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.68 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -161.92 163.31 19.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.688 -1.258 . . . . 0.0 110.494 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -55.47 35.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.936 1.758 . . . . 0.0 111.852 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.68 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -171.17 57.18 0.25 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.41 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.0 Cg_endo -80.5 168.45 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.453 1.435 . . . . 0.0 111.432 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 -4.61 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.126 1.218 . . . . 0.0 111.044 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.728 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 1.9 t -105.48 -72.62 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.604 0.716 . . . . 0.0 110.277 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 23' ' ' VAL . . . 54.55 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -177.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.728 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.1 Cg_endo -60.49 -55.51 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 CA-C-N 118.047 0.923 . . . . 0.0 109.854 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.37 -8.6 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.39 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.652 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -111.62 -43.21 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.686 -1.259 . . . . 0.0 108.805 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.26 84.7 0.01 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tp-100 -148.9 -8.4 0.36 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.696 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 6.0 p-80 -92.78 -36.55 12.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.639 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -171.55 2.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 71.86 75.95 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.661 -0.905 . . . . 0.0 112.058 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -154.05 121.32 5.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 108.797 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.577 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.7 mm -97.94 -63.8 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.683 -0.636 . . . . 0.0 109.952 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -42.08 -54.22 3.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.787 -1.195 . . . . 0.0 109.79 -176.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -50.08 -51.25 44.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.948 -1.095 . . . . 0.0 108.601 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -47.19 -58.89 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.773 1.273 . . . . 0.0 109.566 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 82.0 t -71.78 -30.25 37.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.212 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 35' ' ' MET . 14.2 mmtt -53.48 -55.04 28.7 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.22 -34.14 76.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.575 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.454 ' CE2' HG21 ' A' ' 45' ' ' THR . 1.4 t80 -68.32 -76.19 0.09 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 19.0 m-20 -41.81 -37.5 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.45 1.119 . . . . 0.0 110.764 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -62.73 -34.56 77.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.327 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.57 -61.59 1.64 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.888 -1.125 . . . . 0.0 108.654 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.763 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 24.6 p -44.85 -29.74 0.85 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.29 -43.39 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 44' ' ' ALA . 4.8 t-20 -54.49 -24.39 20.28 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.44 -85.22 0.54 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -159.94 -148.98 5.42 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 118.996 -1.573 . . . . 0.0 111.051 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.521 ' OD1' ' CE ' ' A' ' 16' ' ' LYS . 3.5 t70 -113.55 126.02 54.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -1.095 . . . . 0.0 109.687 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -158.92 -152.85 0.34 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.5 ' N ' ' HB1' ' A' ' 14' ' ' ALA . 5.8 mm -147.0 143.37 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 71' ' ' THR . 5.2 t -145.72 137.58 13.17 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.2 Cg_endo -73.3 86.06 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.745 1.63 . . . . 0.0 110.601 177.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.816 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.7 m -58.01 137.71 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.762 1.267 . . . . 0.0 112.321 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.3 mt-10 -128.78 63.98 1.45 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 8' ' ' VAL . 3.7 mt -64.36 90.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.812 0.815 . . . . 0.0 110.316 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -64.25 98.48 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.403 ' O ' HG21 ' A' ' 4' ' ' VAL . 9.8 mt -100.72 142.68 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.561 -0.712 . . . . 0.0 110.375 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.744 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.7 m-85 -114.34 139.93 49.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.811 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.61 -30.0 4.9 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.349 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 8.1 t70 -53.53 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.811 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 70.46 69.04 0.2 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.122 0.963 . . . . 0.0 109.627 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -148.06 125.07 11.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.678 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -101.43 104.02 14.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 110.232 -179.311 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.5 p -99.16 124.67 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.558 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 1.8 p90 -108.52 171.32 7.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.569 -1.332 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.705 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 88.8 t -162.38 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 112.691 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.482 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.2 t -154.93 118.02 4.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.048 -2.282 . . . . 0.0 110.398 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.818 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.51 120.06 38.26 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.141 0.972 . . . . 0.0 108.599 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.789 ' HG1' ' CB ' ' A' ' 75' ' ' SER . 16.2 p 76.99 151.45 0.13 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.5 Cg_exo -39.12 175.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.762 2.308 . . . . 0.0 113.351 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.5 Cg_exo -40.99 167.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.652 1.568 . . . . 0.0 111.915 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.487 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 54.67 -77.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.789 ' CB ' ' HG1' ' A' ' 71' ' ' THR . 8.0 t -43.04 -25.05 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.981 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.659 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 17.9 p90 -43.27 -41.72 4.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.485 -0.76 . . . . 0.0 109.111 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -133.07 -15.48 2.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.51 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 1.6 mt -60.21 -33.21 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.665 ' CG ' ' OG ' ' A' ' 75' ' ' SER . 1.5 mtm180 -55.46 -43.37 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -67.15 -66.23 0.58 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.433 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -58.36 -4.8 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 109.684 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.669 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.42 -79.76 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 111.554 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 154.57 56.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.408 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.431 HD23 ' CG1' ' A' ' 96' ' ' VAL . 10.8 mt -112.4 104.78 12.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.252 . . . . 0.0 109.23 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -178.86 -48.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.355 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.443 ' NZ ' ' HA2' ' A' ' 92' ' ' GLY . 13.4 mmtt 62.75 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.479 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.96 -110.19 0.43 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.94 -84.99 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -1.161 . . . . 0.0 109.484 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -154.38 82.89 1.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.913 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -101.87 160.66 25.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.22 -26.32 60.38 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.556 1.504 . . . . 0.0 112.391 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.443 ' HA2' ' NZ ' ' A' ' 86' ' ' LYS . . . 136.49 -115.79 1.34 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? 58.95 58.27 3.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -1.104 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 175.23 169.26 0.31 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.177 -0.952 . . . . 0.0 109.582 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -120.14 -164.95 1.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.479 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.431 ' CG1' HD23 ' A' ' 84' ' ' LEU . 41.1 t -149.55 165.04 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.471 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 58.45 66.51 2.75 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.777 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.16 113.11 11.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -1.166 . . . . 0.0 110.008 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.704 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.81 -173.37 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.444 HG23 ' NE2' ' A' ' 103' ' ' GLN . 0.5 OUTLIER -127.5 158.04 38.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.401 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.537 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 22.7 t-105 -49.95 -69.47 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.498 -0.751 . . . . 0.0 110.753 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 4.4 tp10 -49.78 -45.04 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.706 -1.246 . . . . 0.0 110.539 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.444 ' NE2' HG23 ' A' ' 100' ' ' THR . 0.2 OUTLIER -52.71 -46.3 67.28 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.911 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 105' ' ' LEU . 2.4 m -71.46 -24.55 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.996 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.655 ' O ' ' N ' ' A' ' 109' ' ' LYS . 18.3 mt -65.91 -71.37 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.587 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 mm-40 -43.92 -43.31 6.4 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.959 -1.088 . . . . 0.0 108.66 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 57.6 mt -63.22 -32.3 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 108.817 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.572 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.21 -27.1 16.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.332 -0.855 . . . . 0.0 109.376 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 105' ' ' LEU . 15.3 mtpt -59.78 -74.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.594 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . 71.5 mt-30 -45.04 -27.32 0.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.229 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -74.59 -10.41 59.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.927 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.649 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.38 64.03 67.54 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.65 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.5 Cg_endo -66.13 -30.67 46.51 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.647 1.565 . . . . 0.0 112.084 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.539 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 1.7 t70 175.16 10.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.188 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -48.42 -79.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.19 -21.5 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.621 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.815 ' CG2' ' H ' ' A' ' 118' ' ' THR . 27.4 m -64.69 -164.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.948 . . . . 0.0 109.585 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.815 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.75 -67.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.807 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.422 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -69.57 138.39 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.583 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -58.29 -22.66 53.68 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.204 1.002 . . . . 0.0 108.85 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.16 -35.9 82.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.539 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.48 -75.84 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.212 -1.395 . . . . 0.0 107.985 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.84 -39.29 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.47 -1.394 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -53.27 -70.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.784 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.54 -38.96 3.18 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.568 ' O ' ' HB3' ' A' ' 130' ' ' SER . 10.4 ttm -54.54 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 108.872 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.478 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 24.4 mm -46.07 -63.95 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.642 0.734 . . . . 0.0 110.46 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -58.31 -69.05 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.29 -38.29 2.72 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 126' ' ' MET . 6.0 p -55.31 -53.75 52.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.602 -1.528 . . . . 0.0 107.282 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.506 ' H ' ' HG ' ' A' ' 130' ' ' SER . . . -44.84 -50.2 10.43 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.4 tmt_? -44.77 -56.6 4.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 135' ' ' GLY . 11.2 t -46.04 -69.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.496 ' SD ' ' HB2' ' A' ' 75' ' ' SER . 4.9 ttp -44.89 -5.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.648 -0.657 . . . . 0.0 110.255 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.84 20.06 60.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 30.9 t -102.8 165.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.911 -0.758 . . . . 0.0 108.969 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.509 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 82.8 mt-10 -141.31 162.53 35.26 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.07 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -77.86 160.98 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.704 ' N ' ' O ' ' A' ' 99' ' ' ILE . 5.4 p -122.8 60.6 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 159.3 -113.75 0.58 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.47 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.84 63.03 9.5 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.177 . . . . 0.0 109.361 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.1 Cg_endo -63.89 -165.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.785 1.656 . . . . 0.0 112.697 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' CG ' ' N ' ' A' ' 144' ' ' VAL . 29.2 tt0 -172.45 167.89 5.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.36 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.612 ' N ' ' CG ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -153.93 172.78 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.477 ' CG ' ' N ' ' A' ' 146' ' ' ASP . 51.7 tttp -171.0 161.29 6.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.425 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.477 ' N ' ' CG ' ' A' ' 145' ' ' LYS . 23.9 t70 -174.59 126.6 0.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.49 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -169.33 133.52 1.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.544 ' C ' ' CE1' ' A' ' 60' ' ' TYR . 23.7 ttmt -170.9 130.34 0.8 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.644 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.714 ' N ' ' CZ ' ' A' ' 60' ' ' TYR . 1.7 p -44.72 136.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.274 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 59' ' ' ILE . 27.7 m -120.89 -24.71 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.124 -0.985 . . . . 0.0 110.107 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 59' ' ' ILE . . . -156.51 118.6 3.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.434 -1.416 . . . . 0.0 110.503 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.9 p -110.59 73.9 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.786 -0.571 . . . . 0.0 109.612 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 13.9 t -44.89 88.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 0.0 110.158 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.6 tmtt? -84.03 34.66 0.51 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.925 0.869 . . . . 0.0 109.127 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.77 -173.7 3.59 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.652 0.739 . . . . 0.0 111.009 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.562 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.99 179.02 5.41 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.399 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -165.63 144.77 5.24 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 0.0 108.931 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 67.4 Cg_endo -83.43 113.15 1.98 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.552 2.168 . . . . 0.0 114.445 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.643 ' CB ' ' H ' ' A' ' 51' ' ' ALA . . . -63.19 142.93 58.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.618 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 55.19 52.83 44.54 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.471 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER 173.88 27.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.55 -0.97 . . . . 0.0 108.711 -178.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.83 152.98 27.28 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.913 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.19 165.97 6.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.868 -179.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 2.9 Cg_exo -48.86 34.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.617 1.545 . . . . 0.0 111.627 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.913 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -155.22 54.2 0.96 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.41 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.709 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 17.1 Cg_endo -81.14 167.66 17.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.703 1.602 . . . . 0.0 111.947 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.24 -4.48 3.14 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 121.306 1.337 . . . . 0.0 111.41 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.787 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.7 t -112.92 -71.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.58 -97.97 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.787 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -58.97 -55.13 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 CA-C-N 117.9 0.85 . . . . 0.0 110.354 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' C ' HG12 ' A' ' 23' ' ' VAL . . . -48.46 -8.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.693 -0.63 . . . . 0.0 110.945 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.62 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -108.61 -48.62 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.643 -1.286 . . . . 0.0 108.8 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.36 98.4 0.02 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.2 tt0 -158.3 -22.64 0.08 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.772 ' CD2' ' N ' ' A' ' 31' ' ' GLY . 1.5 p-80 -81.12 -44.1 18.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.162 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.772 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -166.73 -10.52 0.03 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.638 ' C ' ' ND2' ' A' ' 33' ' ' ASN . . . 75.29 84.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 112.494 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.638 ' ND2' ' C ' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -155.16 70.95 0.77 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.863 -1.148 . . . . 0.0 108.916 177.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.524 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 21.7 mm -44.37 -71.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.224 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.493 ' O ' ' C ' ' A' ' 36' ' ' GLU . 10.1 tpt -41.88 -53.39 3.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.164 . . . . 0.0 109.42 -178.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.3 tp10 -44.88 -49.76 10.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.62 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -51.42 -69.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.973 1.368 . . . . 0.0 109.998 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.492 HG11 HD21 ' A' ' 42' ' ' ASN . 35.7 t -56.5 -36.06 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.557 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 35' ' ' MET . 21.0 tttt -50.66 -64.08 0.92 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.19 -32.53 64.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' ALA . 2.9 t80 -71.3 -76.63 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.392 -1.443 . . . . 0.0 107.116 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.3 m-80 -41.16 -28.14 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.792 -1.192 . . . . 0.0 110.436 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -71.35 -34.52 70.58 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.82 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -90.35 -44.62 9.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.733 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.618 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 6.8 p -59.81 -32.09 70.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.15 -44.93 24.6 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.657 ' ND2' ' O ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -59.33 -21.88 60.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.411 -0.806 . . . . 0.0 108.965 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.701 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.25 -75.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.701 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -178.49 -121.06 0.68 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.035 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.459 ' OD1' ' C ' ' A' ' 49' ' ' GLY . 0.7 OUTLIER -137.76 124.86 21.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -1.129 . . . . 0.0 108.669 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.643 ' H ' ' CB ' ' A' ' 14' ' ' ALA . . . 173.86 114.33 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.992 -1.068 . . . . 0.0 110.659 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -44.97 160.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.495 -1.378 . . . . 0.0 113.014 -178.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 12' ' ' LEU . 6.1 t -153.51 135.38 8.98 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.211 -0.931 . . . . 0.0 110.089 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 6.3 Cg_endo -66.96 108.87 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.722 1.615 . . . . 0.0 112.565 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -87.47 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.553 -1.342 . . . . 0.0 111.273 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 11.9 mt-10 -128.65 69.21 1.37 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.56 HG12 ' CZ ' ' A' ' 67' ' ' PHE . 4.9 mt -70.96 88.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.731 0.777 . . . . 0.0 110.33 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.506 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -61.97 94.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.663 ' N ' ' O ' ' A' ' 6' ' ' ALA . 25.5 mt -89.29 94.16 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.714 ' CZ ' ' N ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -84.15 179.13 7.56 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.295 1.045 . . . . 0.0 112.234 -176.133 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 1.096 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.95 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.115 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 63' ' ' ARG . 40.2 p30 -46.73 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 109.319 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 1.096 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 43.91 86.23 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -146.23 124.36 12.16 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.82 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.765 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.95 103.06 13.68 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.172 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 22.2 p -101.03 120.62 40.46 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.078 -1.013 . . . . 0.0 109.0 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.657 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.58 148.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.876 -1.14 . . . . 0.0 111.057 177.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.657 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 29.5 t -169.76 95.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.406 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -104.5 147.36 27.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.758 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.8 mptt -132.75 124.21 27.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.68 -1.263 . . . . 0.0 110.092 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.846 ' HG1' ' HG ' ' A' ' 75' ' ' SER . 15.9 p 76.08 149.17 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 CA-C-O 121.232 0.539 . . . . 0.0 109.662 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 73' ' ' PRO . 10.7 Cg_exo -42.07 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.513 2.142 . . . . 0.0 112.722 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.716 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.9 Cg_exo -38.44 172.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.518 1.479 . . . . 0.0 111.951 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 51.9 -83.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.846 ' HG ' ' HG1' ' A' ' 71' ' ' THR . 7.9 t -42.77 -23.37 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 110.11 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.657 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 14.8 p90 -43.84 -38.92 3.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.638 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.17 -19.2 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.141 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 1.2 mt -56.22 -34.63 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.666 ' CG ' ' OG ' ' A' ' 75' ' ' SER . 13.0 mmt180 -53.08 -49.68 65.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.554 ' CD ' ' C ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -57.81 -63.73 1.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -59.29 -6.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 80' ' ' LYS . . . -84.13 -80.39 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 0.0 111.762 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' C ' ' CG1' ' A' ' 96' ' ' VAL . . . 172.59 -13.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.665 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -100.66 129.8 46.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.912 -1.346 . . . . 0.0 110.082 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 1.6 tt0 -168.19 77.16 0.14 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.421 -0.799 . . . . 0.0 109.322 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.547 ' CG ' HD22 ' A' ' 47' ' ' ASN . 9.4 tttm 75.03 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.564 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 86' ' ' LYS . . . 62.15 -168.56 15.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.44 -85.05 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -1.124 . . . . 0.0 109.493 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -138.86 145.44 40.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 160.67 42.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 109.422 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.58 -40.76 70.96 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.565 1.51 . . . . 0.0 112.289 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.95 151.96 5.67 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.567 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 43.2 mtt180 62.08 98.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.567 ' OE1' ' O ' ' A' ' 93' ' ' ARG . 2.5 tp10 177.75 150.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.416 ' C ' ' CG2' ' A' ' 96' ' ' VAL . 10.2 mttm -123.7 179.52 4.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.474 HG13 ' H ' ' A' ' 97' ' ' GLY . 2.3 t -151.76 165.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 104.23 56.77 0.73 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.768 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.25 122.03 24.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.206 -1.173 . . . . 0.0 110.283 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.696 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.7 OUTLIER -109.55 -165.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.79 156.42 46.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 0.0 109.125 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.543 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 15.6 t-105 -48.92 -69.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.877 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.484 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.78 -53.98 21.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.565 -1.334 . . . . 0.0 110.972 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -47.12 -44.87 21.92 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.328 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -70.77 -26.03 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.431 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.663 ' O ' ' N ' ' A' ' 109' ' ' LYS . 16.0 mt -65.95 -70.5 0.24 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' LEU . 36.0 tt0 -43.7 -42.54 5.42 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.916 -1.115 . . . . 0.0 108.337 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.4 mt -63.26 -31.23 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.05 -1.031 . . . . 0.0 108.329 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.652 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.93 -26.33 16.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 105' ' ' LEU . 8.6 mttp -58.3 -73.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 0.0 108.431 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -48.69 -24.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 108.958 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.564 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -72.83 -16.6 61.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.699 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.48 65.71 76.75 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.768 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.66 -32.88 37.2 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.631 1.554 . . . . 0.0 112.11 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.543 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 2.5 t70 174.98 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.23 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.36 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.58 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -154.42 -24.97 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.655 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.793 ' CG2' ' H ' ' A' ' 118' ' ' THR . 24.8 m -65.08 -164.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.793 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.44 -73.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.95 142.13 57.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 110.011 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.6 OUTLIER -61.4 -24.86 66.81 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.237 1.018 . . . . 0.0 109.036 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.17 -38.26 90.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.6 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -69.11 -74.35 0.13 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.943 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.94 -44.4 9.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.523 -1.36 . . . . 0.0 109.22 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -48.64 -70.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.755 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.37 -39.66 3.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.693 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.9 ttm -53.0 -78.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.191 -0.943 . . . . 0.0 108.605 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.502 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 23.8 mm -48.1 -64.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.66 0.743 . . . . 0.0 110.082 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.638 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -59.95 -71.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.85 -42.56 4.97 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 126' ' ' MET . 51.8 m -54.0 -42.21 68.79 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.627 -1.514 . . . . 0.0 107.029 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -54.34 -48.72 71.08 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.758 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -44.9 -48.16 11.23 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 135' ' ' GLY . 6.1 t -53.58 -69.62 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.536 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 7.0 ttm -44.9 -5.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.579 -0.701 . . . . 0.0 109.956 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 84.02 24.96 46.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.536 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 28.6 t -107.1 165.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.952 -0.734 . . . . 0.0 109.183 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.528 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 72.8 tt0 -141.82 164.3 30.56 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.067 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.447 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.9 t -82.58 146.22 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.696 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.3 p -101.09 -6.63 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.49 -0.757 . . . . 0.0 109.452 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -122.99 -119.8 2.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.462 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.99 63.07 9.56 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.214 -1.168 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.0 OUTLIER -64.53 -165.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.767 1.644 . . . . 0.0 112.48 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -153.26 173.18 15.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.325 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -158.29 -179.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.124 -0.985 . . . . 0.0 109.599 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -173.48 125.84 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.457 ' N ' ' HD3' ' A' ' 145' ' ' LYS . 21.8 t70 -145.23 144.94 31.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.471 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.439 179.916 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.58 124.85 6.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.64 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 3.7 tttp -177.73 126.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.584 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -44.67 133.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 108.995 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.83 -24.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.273 -0.892 . . . . 0.0 110.089 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.593 ' O ' ' N ' ' A' ' 59' ' ' ILE . . . -161.01 115.16 2.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.59 -1.319 . . . . 0.0 110.741 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -107.64 74.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.655 ' O ' ' O ' ' A' ' 55' ' ' VAL . 15.1 t -47.84 88.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.663 -1.273 . . . . 0.0 110.538 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.69 36.49 0.55 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.939 0.876 . . . . 0.0 109.158 179.197 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -78.04 -173.99 3.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 111.374 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.514 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.09 174.54 7.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 41' ' ' PHE . 0.1 OUTLIER -163.87 147.52 8.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.951 -1.093 . . . . 0.0 109.371 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.648 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 96.7 Cg_endo -86.76 128.84 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.389 2.059 . . . . 0.0 113.266 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.729 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -75.26 142.85 43.28 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.05 63.12 5.31 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.648 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 14.0 tttt 174.09 -25.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.551 ' C ' ' HG1' ' A' ' 18' ' ' THR . . . -61.65 151.92 32.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 108.368 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.883 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.64 165.9 9.39 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 5.8 Cg_exo -50.45 37.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.717 1.611 . . . . 0.0 111.638 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.883 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -167.97 55.01 0.28 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.698 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 10.9 Cg_endo -79.03 170.83 17.29 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.617 1.545 . . . . 0.0 111.781 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.17 -4.56 1.67 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.115 1.21 . . . . 0.0 110.94 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.766 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 1.9 t -108.18 -72.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.482 0.658 . . . . 0.0 110.096 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.62 -98.17 0.06 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.766 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.8 Cg_endo -59.45 -55.38 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.975 0.888 . . . . 0.0 109.988 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.51 -12.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.19 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.629 HD11 ' CD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -114.39 -40.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.775 -1.203 . . . . 0.0 108.239 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.8 92.69 0.01 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.564 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -159.06 -25.9 0.07 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 179.178 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.73 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 4.6 p80 -78.75 61.24 2.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.693 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 83.91 -9.37 63.17 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.35 84.23 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.153 -1.204 . . . . 0.0 112.104 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -157.38 123.72 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 108.731 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 mm -99.4 -63.47 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.685 -0.634 . . . . 0.0 109.831 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.66 ' O ' ' N ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -41.02 -52.58 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.755 -1.215 . . . . 0.0 109.662 -176.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.2 mm-40 -49.66 -47.25 50.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.647 -1.283 . . . . 0.0 107.831 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.646 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -52.93 -68.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.517 1.151 . . . . 0.0 109.956 178.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.67 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 23.6 t -66.08 -37.71 80.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.081 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.66 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.6 mmmt -46.12 -58.57 3.51 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.32 72.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.318 -0.864 . . . . 0.0 108.939 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 44' ' ' ALA . 3.6 t80 -71.34 -77.11 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.67 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 2.0 m-80 -41.33 -32.1 0.28 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.933 -1.104 . . . . 0.0 110.589 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.93 -33.45 73.75 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.668 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . -90.24 -47.97 7.45 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.559 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.495 ' HG1' ' N ' ' A' ' 46' ' ' ALA . 2.3 p -57.08 -29.2 63.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.47 -46.57 17.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -57.24 -21.25 32.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.406 -0.809 . . . . 0.0 108.842 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.75 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.08 -74.22 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.443 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.75 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 172.97 -156.52 24.9 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.16 145.34 24.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.02 -1.282 . . . . 0.0 108.967 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.729 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 176.25 -153.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.745 -1.222 . . . . 0.0 110.905 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 2.3 mm -146.37 139.42 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.687 ' CG1' ' HG1' ' A' ' 69' ' ' THR . 2.2 t -140.11 135.29 16.18 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.008 -1.058 . . . . 0.0 110.905 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.3 Cg_endo -71.84 105.66 1.85 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.77 1.647 . . . . 0.0 111.056 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.5 m -80.66 135.61 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.711 -1.243 . . . . 0.0 111.702 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.3 mt-10 -129.29 67.49 1.43 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.538 HG12 ' CZ ' ' A' ' 67' ' ' PHE . 4.2 mt -68.79 87.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.707 0.765 . . . . 0.0 110.218 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 0.2 OUTLIER -61.69 94.68 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 64' ' ' SER . 5.6 mt -88.87 134.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.443 -0.786 . . . . 0.0 109.217 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CE2' ' N ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -122.49 -179.65 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.316 -176.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 1.082 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.82 -85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.224 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' C ' ' A' ' 63' ' ' ARG . 20.9 t0 -46.24 39.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.542 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 1.082 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER 44.03 87.63 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.736 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -143.62 166.37 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.781 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -146.18 103.2 3.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 109.164 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 4.0 p -101.11 120.83 40.79 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.68 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 170.67 147.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.921 -1.112 . . . . 0.0 110.935 177.464 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 29.8 t -168.3 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 122.312 1.053 . . . . 0.0 108.208 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.687 ' HG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -95.06 146.98 23.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.775 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.3 mptt -132.72 127.31 34.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.217 -1.393 . . . . 0.0 110.511 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.775 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.1 p 76.0 149.15 0.12 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-O 121.242 0.544 . . . . 0.0 109.955 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' O ' ' O ' ' A' ' 73' ' ' PRO . 9.2 Cg_exo -42.83 175.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.835 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.75 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -38.66 171.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.639 1.559 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 51.33 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.75 ' N ' ' O ' ' A' ' 73' ' ' PRO . 24.8 p -43.02 -22.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.887 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.63 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 15.6 p90 -43.77 -40.54 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.559 -0.713 . . . . 0.0 109.168 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.63 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -134.59 -16.63 2.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 1.3 mt -59.28 -33.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.51 ' HE ' ' HB2' ' A' ' 75' ' ' SER . 16.3 mmt180 -55.78 -42.71 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.9 tmtt? -65.87 -66.06 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' O ' HG21 ' A' ' 99' ' ' ILE . . . -57.37 -6.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.426 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.24 -80.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.494 -0.754 . . . . 0.0 111.857 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 173.6 35.0 0.04 OUTLIER Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.45 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.484 HD13 HH11 ' A' ' 79' ' ' ARG . 3.2 mt -92.92 109.42 20.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.96 -1.318 . . . . 0.0 109.148 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -148.69 -59.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.573 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.413 ' HB2' ' H ' ' A' ' 87' ' ' GLY . 30.9 mtmt 67.74 -82.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 86' ' ' LYS . . . 97.52 -170.4 25.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.15 -85.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -1.184 . . . . 0.0 109.45 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -116.54 107.29 14.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.403 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -144.39 154.58 57.09 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.399 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.22 -42.07 72.25 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.554 1.503 . . . . 0.0 112.416 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 135.36 -138.37 9.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 64.53 93.45 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -1.157 . . . . 0.0 109.475 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 175.17 172.32 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -134.97 -173.07 3.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.48 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 t -152.35 139.45 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.545 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' HG11 ' A' ' 136' ' ' VAL . . . 67.82 44.78 78.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.781 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.82 115.16 14.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -1.228 . . . . 0.0 110.216 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -108.51 178.2 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.511 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -122.66 161.96 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.057 . . . . 0.0 109.366 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.538 ' O ' HG23 ' A' ' 104' ' ' VAL . 16.0 t-105 -48.57 -70.88 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 111.33 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.539 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 3.8 tp10 -49.31 -51.59 33.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 110.934 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -48.57 -44.6 36.87 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.343 -0.848 . . . . 0.0 110.295 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.57 -25.58 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 117.726 -1.59 . . . . 0.0 107.634 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.68 ' O ' ' N ' ' A' ' 109' ' ' LYS . 16.1 mt -65.85 -71.56 0.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.539 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 23.8 mm-40 -44.18 -42.37 6.39 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 67.0 mt -65.28 -31.49 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 108.999 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -96.31 -31.0 13.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.617 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.68 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.1 mtpm? -54.45 -72.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.966 -1.084 . . . . 0.0 108.625 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -51.23 -27.68 9.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 112' ' ' MET . 10.2 tttm -84.62 64.47 8.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.784 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.551 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER 175.99 56.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.843 . . . . 0.0 109.306 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.6 Cg_endo -64.78 -55.06 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.528 1.486 . . . . 0.0 112.231 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 1.7 p-10 -162.56 9.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.164 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.8 mm? -44.97 -62.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -177.75 6.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.855 ' CG2' ' H ' ' A' ' 118' ' ' THR . 32.0 m -108.88 -164.48 0.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.943 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.855 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER 175.97 -44.39 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.3 -0.875 . . . . 0.0 109.708 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.711 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -74.74 143.88 43.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.472 -0.767 . . . . 0.0 110.359 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.581 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER -65.29 -36.78 85.14 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.385 1.088 . . . . 0.0 108.514 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -61.94 -33.92 75.15 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.932 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.39 -75.4 0.14 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.92 -40.12 6.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.477 -1.389 . . . . 0.0 109.093 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -52.89 -69.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.661 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.35 -38.62 2.77 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.0 ttm -53.28 -78.04 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.511 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 23.6 mm -48.76 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.768 0.794 . . . . 0.0 109.832 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -58.95 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -40.24 3.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.7 m -57.57 -50.25 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.566 -1.549 . . . . 0.0 107.532 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -47.39 -49.05 25.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.785 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.14 -54.6 8.34 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.692 ' C ' ' H ' ' A' ' 135' ' ' GLY . 6.9 t -44.88 -68.69 0.18 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.498 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 5.5 ttp -47.23 -4.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.637 -0.664 . . . . 0.0 109.271 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.692 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.71 -27.61 7.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.514 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 43.0 t -48.6 165.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.919 -0.754 . . . . 0.0 109.183 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.514 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 63.2 mm-40 -142.38 162.01 36.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.756 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.95 161.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p -128.26 59.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 161.83 -117.13 0.75 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.506 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.86 61.14 12.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.226 -1.161 . . . . 0.0 109.305 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.5 Cg_endo -65.18 -165.11 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.836 1.691 . . . . 0.0 112.688 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -146.04 -164.97 2.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 109.354 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.71 173.02 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -177.33 -12.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.155 -0.966 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 147' ' ' ALA . 25.1 t70 -45.08 144.98 1.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.495 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -116.01 120.11 38.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.399 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' C ' ' CE2' ' A' ' 60' ' ' TYR . 1.9 tttt 175.93 116.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.622 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.789 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.88 140.15 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.102 -0.999 . . . . 0.0 109.152 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.464 HG12 ' H ' ' A' ' 61' ' ' ALA . 27.7 m -117.17 -24.41 3.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.157 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.16 107.04 4.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.689 -1.257 . . . . 0.0 110.351 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -96.31 73.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.72 ' O ' ' O ' ' A' ' 55' ' ' VAL . 31.2 t -46.47 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.8 -1.188 . . . . 0.0 110.461 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.9 OUTLIER -82.93 34.75 0.46 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.844 0.831 . . . . 0.0 108.999 179.111 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.828 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -78.11 -174.46 3.65 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.804 0.811 . . . . 0.0 111.147 -178.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.577 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -119.69 172.15 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -168.42 160.06 8.82 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.787 -1.196 . . . . 0.0 110.232 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.448 ' HD2' ' CD2' ' A' ' 12' ' ' LEU . 15.1 Cg_endo -67.91 109.91 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.249 1.966 . . . . 0.0 111.635 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.76 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -69.01 41.03 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.89 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.475 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 177.08 -16.52 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.3 -1.905 . . . . 0.0 111.831 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -135.41 53.92 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.427 -1.631 . . . . 0.0 110.502 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' O ' ' ND2' ' A' ' 42' ' ' ASN . . . -73.13 157.9 36.35 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.688 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -159.85 162.96 23.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.617 -1.302 . . . . 0.0 110.726 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.02 36.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.973 1.782 . . . . 0.0 111.993 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.688 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -175.93 58.57 0.18 Allowed Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.34 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.1 Cg_endo -80.68 169.5 16.7 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.568 1.512 . . . . 0.0 111.394 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.88 -4.66 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 121.007 1.138 . . . . 0.0 110.965 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.743 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.1 t -104.94 -71.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.6 0.714 . . . . 0.0 109.964 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.69 -98.12 0.05 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.743 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.62 -55.38 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 CA-C-N 117.926 0.863 . . . . 0.0 109.867 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' PRO . . . -43.85 -11.41 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.15 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.667 HD11 ' CD2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -116.02 -39.15 3.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.822 -1.174 . . . . 0.0 108.427 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.33 94.1 0.01 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.524 ' CD ' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -161.52 -23.28 0.05 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.677 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -81.14 64.93 6.08 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.482 ' N ' ' HG3' ' A' ' 63' ' ' ARG . . . 80.44 -5.51 63.82 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.29 80.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 111.828 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.54 ' O ' ' NE2' ' A' ' 30' ' ' HIS . 42.9 m-80 -155.95 125.01 6.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.879 -1.138 . . . . 0.0 108.657 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.5 mm -101.16 -62.9 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.686 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.87 -49.77 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.819 -1.176 . . . . 0.0 109.861 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -52.37 -50.54 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.854 -1.154 . . . . 0.0 108.181 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.667 ' CD2' HD11 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -48.85 -61.15 2.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.606 1.194 . . . . 0.0 109.076 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.483 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 98.6 t -70.52 -29.15 37.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.848 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.686 ' N ' ' O ' ' A' ' 35' ' ' MET . 40.3 tptt -54.44 -55.38 29.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.58 75.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.378 -0.826 . . . . 0.0 109.532 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.451 ' CE2' HG23 ' A' ' 45' ' ' THR . 1.3 t80 -68.97 -76.36 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 23.6 m-20 -41.79 -37.19 1.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.455 1.121 . . . . 0.0 110.804 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -63.29 -35.02 78.97 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.355 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.05 -61.54 1.66 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.545 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.76 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.3 p -44.8 -30.08 0.9 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.36 -43.21 19.36 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 44' ' ' ALA . 16.3 t-20 -55.3 -24.04 26.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.647 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.09 -85.25 0.54 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.851 -1.156 . . . . 0.0 109.934 179.483 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -161.83 -150.43 5.95 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.121 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.2 123.09 49.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.721 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -155.39 -152.87 0.41 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.499 ' N ' ' HB1' ' A' ' 14' ' ' ALA . 5.8 mm -147.19 143.89 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.555 ' CG1' ' HG1' ' A' ' 69' ' ' THR . 5.6 t -146.94 137.46 12.46 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 110.299 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.9 Cg_endo -73.03 87.24 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.842 1.694 . . . . 0.0 110.776 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.828 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.5 m -58.46 137.42 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.827 1.298 . . . . 0.0 112.231 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 32.6 mt-10 -128.09 63.61 1.4 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.435 ' HB ' ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -63.38 88.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.66 0.743 . . . . 0.0 110.174 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.5 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.57 97.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 64' ' ' SER . 1.9 mt -100.66 146.11 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.17 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.789 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 9.6 m-85 -115.52 141.17 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.816 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.56 -30.37 5.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.153 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 7.2 t70 -52.51 1.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.816 ' H ' ' C ' ' A' ' 61' ' ' ALA . 8.8 tmm_? 71.68 69.8 0.16 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.06 0.933 . . . . 0.0 109.642 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.4 OUTLIER -148.59 125.04 10.97 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.594 ' CD1' ' ND1' ' A' ' 30' ' ' HIS . 17.4 p90 -101.04 103.86 14.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.954 -1.091 . . . . 0.0 110.187 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 58' ' ' THR . 11.2 p -99.43 124.82 44.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 108.854 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.566 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -107.97 171.35 7.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.596 -1.315 . . . . 0.0 109.368 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.705 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 90.3 t -163.17 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 112.644 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.555 ' HG1' ' CG1' ' A' ' 53' ' ' VAL . 11.0 t -154.02 118.54 4.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 115.945 -2.302 . . . . 0.0 110.754 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.812 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.92 121.43 42.3 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.766 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.6 p 76.86 151.06 0.13 Allowed Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 71' ' ' THR . 12.6 Cg_exo -40.21 175.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.551 2.167 . . . . 0.0 113.038 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.6 Cg_exo -40.51 169.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.6 1.534 . . . . 0.0 112.004 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.513 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 52.93 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.787 ' N ' ' O ' ' A' ' 73' ' ' PRO . 8.6 t -43.34 -23.62 0.07 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 110.147 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.686 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 20.5 p90 -43.6 -42.09 4.95 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.0 109.41 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.593 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.27 -14.58 2.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.494 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 3.1 mt -61.75 -31.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.768 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 2.1 mmp_? -54.82 -44.27 73.71 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.617 ' HZ2' ' CB ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -66.03 -65.59 0.66 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.442 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -57.22 -4.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.634 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.55 -79.72 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 112.156 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.64 47.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.682 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' A' ' 85' ' ' GLU . 5.4 mt -97.44 105.4 17.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.003 -1.292 . . . . 0.0 109.195 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 84' ' ' LEU . 89.4 mt-10 -156.14 -25.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.571 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.421 ' HB2' ' H ' ' A' ' 87' ' ' GLY . 73.2 mttt 64.26 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 109.535 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 86' ' ' LYS . . . 103.0 -175.17 23.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.98 -85.07 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -1.161 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -93.0 118.1 30.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.7 151.17 65.44 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.436 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.61 -52.93 5.9 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.491 1.461 . . . . 0.0 112.412 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.94 -164.99 32.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 61.84 152.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.119 . . . . 0.0 109.527 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 1.8 tp10 -171.24 128.78 0.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.459 ' CG ' ' O ' ' A' ' 94' ' ' GLU . 42.1 mttm -156.65 167.86 29.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 109.321 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.453 HG13 ' N ' ' A' ' 97' ' ' GLY . 72.2 t -156.39 156.57 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 109.653 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.453 ' N ' HG13 ' A' ' 96' ' ' VAL . . . 69.48 60.36 5.12 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.634 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.3 mtt180 -134.7 113.54 11.78 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -1.21 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.702 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.21 179.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.47 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -124.44 155.43 38.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.024 -1.048 . . . . 0.0 109.198 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.536 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 12.0 t-105 -44.97 -70.25 0.11 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 111.244 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.511 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.32 -52.98 24.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.69 -1.257 . . . . 0.0 111.047 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -47.76 -44.6 28.31 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.272 -0.892 . . . . 0.0 110.429 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.5 -25.33 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 117.681 -1.608 . . . . 0.0 107.585 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.631 ' O ' ' N ' ' A' ' 109' ' ' LYS . 16.8 mt -66.16 -70.86 0.22 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' LEU . 78.2 tt0 -43.85 -43.66 6.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.911 -1.118 . . . . 0.0 108.34 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.9 mt -61.83 -31.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.19 -27.42 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' A' ' 105' ' ' LEU . 13.9 mttp -58.44 -73.44 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.763 -1.21 . . . . 0.0 108.304 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.604 ' N ' ' CD ' ' A' ' 110' ' ' GLN . 1.5 mp0 -44.93 -26.43 0.42 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.041 -1.037 . . . . 0.0 108.794 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 109' ' ' LYS . 13.4 tttt -73.19 -16.96 61.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.68 65.9 76.88 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.039 -1.038 . . . . 0.0 109.746 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.68 -34.76 30.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.704 1.602 . . . . 0.0 112.069 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 175.0 15.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 109.163 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -55.49 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 0.0 109.553 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -150.66 -24.99 0.23 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.798 ' CG2' ' H ' ' A' ' 118' ' ' THR . 23.5 m -62.97 -164.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.798 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.34 -74.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.267 -0.895 . . . . 0.0 109.933 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.78 140.44 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.183 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.7 OUTLIER -62.36 -22.34 66.03 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.204 1.002 . . . . 0.0 108.899 179.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.56 -35.39 80.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.414 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.41 -75.53 0.13 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.899 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.47 -34.15 1.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.491 -1.381 . . . . 0.0 109.27 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -58.11 -69.2 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.031 -1.043 . . . . 0.0 108.509 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.59 -44.79 6.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.703 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.0 mtt -50.29 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.101 -0.999 . . . . 0.0 108.743 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.489 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 19.7 mm -48.09 -66.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.416 -0.802 . . . . 0.0 110.053 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.5 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -58.39 -71.37 0.11 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.94 -40.72 4.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.8 m -55.36 -47.8 75.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.584 . . . . 0.0 107.582 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -50.43 -47.92 56.53 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.771 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.11 -51.99 12.92 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.702 ' C ' ' H ' ' A' ' 135' ' ' GLY . 7.0 t -45.24 -67.88 0.25 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.768 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 9.4 ttm -48.53 -2.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.702 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 88.18 -27.21 7.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.614 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 30.9 t -48.84 165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.927 -0.749 . . . . 0.0 109.326 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.528 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 40.3 mm-40 -142.27 162.37 35.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 109.767 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.27 165.02 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.702 ' N ' ' O ' ' A' ' 99' ' ' ILE . 5.1 p -128.74 59.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 158.79 -112.8 0.54 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.474 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.85 61.98 10.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.162 -1.199 . . . . 0.0 109.293 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.8 Cg_endo -62.51 -165.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.822 1.681 . . . . 0.0 112.644 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.32 111.27 1.65 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 109.499 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -158.03 120.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -153.07 133.4 13.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -141.83 -60.63 0.47 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.46 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.84 87.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.878 . . . . 0.0 109.439 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' C ' ' CE2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER 176.94 118.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.89 . . . . 0.0 109.544 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.77 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.77 142.15 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 109.101 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 61' ' ' ALA . 28.1 m -119.51 -24.58 3.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.77 107.73 4.51 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.422 -1.311 . . . . 0.0 110.338 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -98.86 73.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.659 ' O ' ' O ' ' A' ' 55' ' ' VAL . 32.3 t -48.03 88.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.816 -1.178 . . . . 0.0 110.653 -176.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtp? -82.47 36.06 0.47 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.791 0.805 . . . . 0.0 109.2 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.88 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.8 tp -78.31 -174.08 3.56 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.608 0.718 . . . . 0.0 111.119 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.961 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.74 177.88 5.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -167.61 155.9 8.59 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 109.945 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 15' ' ' GLY . 12.0 Cg_endo -68.83 104.55 1.18 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.037 1.824 . . . . 0.0 111.508 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.754 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -63.1 37.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.932 -1.105 . . . . 0.0 110.38 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -170.56 -26.51 0.02 OUTLIER Glycine 0 N--CA 1.493 2.467 0 C-N-CA 118.096 -2.002 . . . . 0.0 111.842 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -138.97 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.474 -1.604 . . . . 0.0 110.572 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.45 160.91 15.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.762 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.8 164.95 9.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.799 -1.188 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 4.9 Cg_exo -53.1 32.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.717 1.612 . . . . 0.0 112.026 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.68 54.16 4.56 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.221 -0.925 . . . . 0.0 110.046 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.09 155.01 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.696 1.597 . . . . 0.0 111.778 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.79 -4.69 1.49 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.006 1.137 . . . . 0.0 111.432 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.801 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 5.4 t -113.47 -68.96 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.93 -97.62 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.801 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -56.45 -55.04 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 CA-C-N 117.784 0.792 . . . . 0.0 110.479 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.473 ' C ' HG13 ' A' ' 23' ' ' VAL . . . -55.59 -4.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.598 -0.689 . . . . 0.0 111.076 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.651 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -112.11 -54.71 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.645 -1.285 . . . . 0.0 109.152 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.26 -26.5 0.96 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.499 ' C ' ' O ' ' A' ' 28' ' ' GLY . 52.0 mm-40 -42.01 -19.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.513 -1.58 . . . . 0.0 109.252 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.773 ' CD2' ' N ' ' A' ' 31' ' ' GLY . 3.6 p-80 -65.25 -48.86 71.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.788 0.804 . . . . 0.0 108.854 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.773 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -162.22 -8.26 0.04 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 71.38 72.49 0.18 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.926 -0.75 . . . . 0.0 111.47 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.24 63.07 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.499 1.142 . . . . 0.0 108.742 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.695 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.4 mm -43.12 -66.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.361 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.7 tpt -41.61 -57.7 2.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.38 -1.45 . . . . 0.0 109.009 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.8 tp10 -44.68 -50.16 10.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.77 -1.206 . . . . 0.0 107.936 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.695 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -48.27 -62.98 1.21 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.813 1.292 . . . . 0.0 108.863 178.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 42' ' ' ASN . 61.8 t -67.78 -30.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.271 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 35' ' ' MET . 19.0 tttp -52.75 -59.82 4.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.24 74.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.803 . . . . 0.0 109.512 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 1.3 t80 -69.66 -77.23 0.09 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.7 m-20 -41.77 -36.43 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.48 1.133 . . . . 0.0 110.539 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -63.27 -35.1 79.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.586 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -91.25 -57.52 2.76 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.813 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.754 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 16.2 p -48.08 -28.53 2.92 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.21 -47.88 11.08 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -50.46 -23.0 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.216 -0.927 . . . . 0.0 109.127 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.79 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.51 -85.2 0.54 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.79 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.41 -117.93 0.42 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.842 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 3.4 t0 -141.26 129.32 22.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -1.176 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.716 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -164.17 -152.81 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.174 -0.953 . . . . 0.0 110.391 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 3.3 mm -146.95 141.77 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.515 HG21 ' N ' ' A' ' 71' ' ' THR . 15.0 t -142.76 137.08 14.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.098 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.525 ' C ' ' O ' ' A' ' 10' ' ' LEU . 9.3 Cg_endo -74.33 88.14 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.882 1.722 . . . . 0.0 111.077 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.88 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -57.37 137.14 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 122.697 1.237 . . . . 0.0 111.946 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 66.0 tt0 -128.89 67.49 1.41 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mt -68.7 87.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.698 0.761 . . . . 0.0 110.068 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.71 100.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 64' ' ' SER . 9.0 mt -103.13 145.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.569 -0.707 . . . . 0.0 110.406 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.77 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 8.0 m-85 -116.17 140.02 49.74 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.839 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.61 -32.13 7.7 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.391 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.9 t70 -50.6 -2.3 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.839 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.9 ttm180 75.31 70.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.035 0.921 . . . . 0.0 109.951 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 36.1 t -148.71 127.5 12.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.672 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -103.3 103.82 13.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.833 -1.167 . . . . 0.0 110.399 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.1 p -99.07 124.63 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.564 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -107.6 171.56 7.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.506 -1.371 . . . . 0.0 109.321 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.722 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 98.7 t -162.56 44.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 112.813 -177.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.469 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.3 t -153.83 120.62 5.61 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.669 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.82 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -118.92 122.01 41.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.807 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.6 p 77.48 151.74 0.13 Allowed Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.138 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.8 Cg_exo -38.85 175.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.375 2.717 . . . . 0.0 114.083 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.89 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -40.68 168.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.077 0 C-N-CA 122.035 1.823 . . . . 0.0 112.308 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.78 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 48.11 -74.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.89 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -42.99 -21.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.683 -0.635 . . . . 0.0 110.755 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.78 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -44.05 -35.51 2.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.728 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.511 ' N ' ' HD1' ' A' ' 76' ' ' TYR . 0.2 OUTLIER -136.55 -16.24 1.57 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 1.2 mt -58.86 -34.13 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.786 HH11 ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.85 -38.58 70.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.3 tmtt? -69.72 -66.93 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 99' ' ' ILE . . . -55.86 -7.39 0.3 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.178 -0.951 . . . . 0.0 109.153 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.543 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -87.48 -78.27 0.31 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.676 -0.64 . . . . 0.0 111.433 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.651 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 166.2 14.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.913 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.606 ' CD1' ' NH1' ' A' ' 79' ' ' ARG . 2.6 mt -85.07 117.39 24.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.401 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 87' ' ' GLY . 41.8 tp10 179.67 -84.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.436 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 24.6 mttt 44.96 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.93 . . . . 0.0 109.551 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 168.44 -98.83 0.14 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.91 -85.02 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -1.169 . . . . 0.0 109.539 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -78.05 175.84 9.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -140.38 150.61 61.65 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.56 -53.44 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.514 1.476 . . . . 0.0 112.328 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.42 140.22 3.64 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.781 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 65.11 97.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.148 . . . . 0.0 109.503 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.563 ' OE1' ' O ' ' A' ' 93' ' ' ARG . 4.0 tp10 178.78 152.55 0.34 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.558 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.438 ' C ' ' CG2' ' A' ' 96' ' ' VAL . 8.0 tttp -121.17 169.59 10.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.651 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t -152.24 165.03 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 96.02 64.21 0.95 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 82' ' ' ALA . 5.8 mtt180 -134.09 114.82 13.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.09 -1.241 . . . . 0.0 110.304 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.7 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -103.38 179.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.493 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -124.86 154.65 40.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.003 -1.06 . . . . 0.0 109.124 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.536 ' O ' HG21 ' A' ' 104' ' ' VAL . 12.8 t-105 -44.91 -69.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 111.386 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.19 -52.22 37.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.522 -1.361 . . . . 0.0 111.004 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -48.77 -44.05 38.41 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.452 -0.78 . . . . 0.0 110.492 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.75 -26.39 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 117.726 -1.589 . . . . 0.0 107.614 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.762 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.5 mt -65.01 -71.17 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.498 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 7.4 tm-20 -44.35 -44.67 8.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.615 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -61.99 -31.91 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 108.706 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -96.66 -26.84 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.111 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.762 ' N ' ' O ' ' A' ' 105' ' ' LEU . 2.0 tptp -58.97 -73.52 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -48.91 -25.01 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 108.988 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.505 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 3.2 tmtt? -83.15 -7.39 59.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.269 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.724 ' O ' ' SD ' ' A' ' 112' ' ' MET . 2.3 ppp? -130.13 59.72 47.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.865 -1.147 . . . . 0.0 109.967 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.7 Cg_endo -61.29 -54.43 1.77 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.537 1.491 . . . . 0.0 112.305 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 174.74 -1.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -44.88 -28.82 0.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.696 -0.628 . . . . 0.0 109.717 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.489 ' N ' ' HG ' ' A' ' 115' ' ' LEU . 8.7 t30 -177.62 -14.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.96 -1.087 . . . . 0.0 109.653 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.828 ' CG2' ' H ' ' A' ' 118' ' ' THR . 31.9 m -104.02 -164.51 1.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.828 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.48 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 0.0 109.806 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 2.9 p-10 -58.0 143.07 44.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.163 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.604 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.4 OUTLIER -71.92 -30.59 65.5 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.502 1.144 . . . . 0.0 108.387 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -62.91 -35.04 78.74 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.404 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.71 -76.32 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.382 -1.327 . . . . 0.0 107.556 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.89 -43.43 8.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.455 -1.403 . . . . 0.0 109.137 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.604 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -48.22 -69.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 0.0 108.64 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 129' ' ' GLY . 13.7 ttt180 -43.44 -39.6 3.35 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 130' ' ' SER . 18.5 ttm -53.95 -79.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.249 -0.907 . . . . 0.0 108.742 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.504 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 22.4 mm -47.62 -63.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.772 . . . . 0.0 110.054 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 131' ' ' ALA . . . -60.46 -71.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.11 -42.97 5.47 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.0 m -52.59 -45.09 66.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.537 -1.566 . . . . 0.0 107.542 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 128' ' ' ALA . . . -53.72 -48.03 69.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.592 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 3.3 tmm_? -44.94 -44.75 10.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.4 t -55.41 -69.88 0.12 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.752 ' CG ' HH21 ' A' ' 79' ' ' ARG . 5.9 ttm -44.87 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.523 -0.735 . . . . 0.0 110.073 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.32 25.56 47.27 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.603 ' CG2' ' SD ' ' A' ' 134' ' ' MET . 28.4 t -106.31 165.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.981 -0.717 . . . . 0.0 109.126 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.515 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 50.3 mm-40 -140.41 161.89 36.61 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.901 -1.12 . . . . 0.0 110.086 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -77.84 165.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.5 p -129.99 59.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 160.74 -112.91 0.54 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.51 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.91 60.51 12.86 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.238 -1.154 . . . . 0.0 109.365 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.3 Cg_endo -64.73 -164.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.732 1.622 . . . . 0.0 112.691 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -138.54 -164.93 1.72 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -154.24 135.39 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 0.0 109.554 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -179.64 116.74 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.449 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 147' ' ' ALA . 22.1 m-20 -138.78 145.01 39.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 9.3 pttm -142.49 115.47 8.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.539 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -165.32 114.96 1.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.707 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.772 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -45.23 138.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 109.278 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 61' ' ' ALA . 27.9 m -114.05 -24.35 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.17 108.29 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.65 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -95.54 73.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.724 ' O ' ' O ' ' A' ' 55' ' ' VAL . 12.2 t -45.69 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.239 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.65 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -82.78 34.58 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.952 0.882 . . . . 0.0 109.093 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.85 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.6 tp -77.08 -174.46 3.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.783 0.801 . . . . 0.0 111.003 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.693 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.52 174.22 7.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.665 ' CD1' ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -171.17 158.88 5.18 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 110.411 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 15' ' ' GLY . 11.1 Cg_endo -66.61 108.69 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.197 1.932 . . . . 0.0 111.993 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' C ' ' HB ' ' A' ' 45' ' ' THR . . . -67.47 40.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 13' ' ' PRO . . . -178.09 -21.0 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.527 -1.797 . . . . 0.0 111.525 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -139.92 74.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.521 -1.576 . . . . 0.0 110.259 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . . . -92.25 165.29 13.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 108.588 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.763 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.4 163.06 6.1 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.915 -1.116 . . . . 0.0 110.036 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -53.13 32.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.681 1.587 . . . . 0.0 111.841 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.763 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.71 54.07 4.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 110.597 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.693 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.3 Cg_endo -85.82 160.83 10.51 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.766 1.644 . . . . 0.0 111.467 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.51 -4.81 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 120.898 1.065 . . . . 0.0 111.047 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.813 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 21.2 t -115.58 -67.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.51 -97.32 0.05 OUTLIER Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.813 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.0 Cg_exo -54.05 -55.02 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 CA-C-N 117.844 0.822 . . . . 0.0 110.45 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.482 ' C ' ' CG1' ' A' ' 23' ' ' VAL . . . -60.79 -0.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.196 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.685 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.58 -58.77 2.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.717 -1.24 . . . . 0.0 109.59 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 32' ' ' ALA . . . -43.18 -18.07 0.05 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.315 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 28' ' ' GLY . 32.5 mm-40 -42.13 -21.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.255 -1.732 . . . . 0.0 108.502 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.764 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 24.6 p-80 -67.32 59.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 29' ' ' GLN . . . 84.62 -13.03 54.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.629 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 75.15 77.14 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.544 -0.974 . . . . 0.0 111.848 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 34' ' ' ILE . 1.4 m-80 -150.29 60.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.34 1.067 . . . . 0.0 108.536 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.0 mm -42.86 -65.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.623 ' O ' ' N ' ' A' ' 39' ' ' LYS . 8.2 tpt -41.95 -40.43 2.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 108.746 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -58.0 -51.2 70.66 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.685 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -47.85 -62.43 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.94 1.352 . . . . 0.0 108.951 177.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.563 HG13 HD21 ' A' ' 42' ' ' ASN . 61.0 t -67.26 -30.55 49.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.596 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -54.11 -59.46 4.62 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.33 74.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.433 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' ASN . 1.2 t80 -67.2 -75.03 0.1 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.5 m-80 -41.99 -37.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.475 1.131 . . . . 0.0 110.874 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -62.7 -35.53 80.02 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.559 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.678 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . -90.83 -56.11 3.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.878 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.742 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.0 p -50.7 -26.22 5.25 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.59 -48.1 10.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -52.61 -21.22 3.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.975 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.59 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.63 -85.22 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.56 -136.48 2.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.942 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 2.8 p30 -122.12 122.34 39.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -1.102 . . . . 0.0 109.915 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.635 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . -156.08 -153.17 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.908 . . . . 0.0 110.289 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.47 ' N ' ' HB2' ' A' ' 14' ' ' ALA . 4.8 mm -147.28 142.76 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 71' ' ' THR . 8.1 t -145.01 137.66 13.59 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 110.261 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.534 ' C ' ' O ' ' A' ' 10' ' ' LEU . 10.1 Cg_endo -73.56 86.67 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.796 1.664 . . . . 0.0 110.669 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.85 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -56.68 138.38 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-O 122.749 1.261 . . . . 0.0 112.078 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.5 mt-10 -130.52 65.67 1.53 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 mt -65.44 88.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.812 0.815 . . . . 0.0 110.234 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.527 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -65.48 98.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 64' ' ' SER . 1.7 mt -102.94 147.54 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.772 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.9 m-85 -115.82 141.62 47.85 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.832 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.52 -32.72 8.37 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.304 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.27 -1.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.832 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.4 tmm_? 75.21 70.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -148.99 124.94 10.62 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' CG ' ' A' ' 65' ' ' PHE . 20.6 p90 -100.97 103.73 14.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.003 -1.061 . . . . 0.0 110.197 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 58' ' ' THR . 9.2 p -99.25 124.63 44.48 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.583 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -107.71 170.41 8.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.481 -1.387 . . . . 0.0 109.355 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.711 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 90.1 t -161.82 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 112.716 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.515 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.0 116.95 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 116.039 -2.264 . . . . 0.0 110.324 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.803 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -114.74 120.0 38.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.032 0.92 . . . . 0.0 108.701 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.779 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.94 152.26 0.13 Allowed Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.364 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 71' ' ' THR . 15.3 Cg_exo -38.15 175.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.751 2.301 . . . . 0.0 113.365 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.795 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.3 Cg_exo -42.26 168.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.761 1.641 . . . . 0.0 112.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 52.6 -77.0 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 73' ' ' PRO . 41.6 p -43.42 -24.14 0.09 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.522 -0.736 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 14.6 p90 -43.86 -41.4 5.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.676 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -131.59 -18.82 2.75 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.522 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 1.4 mt -59.87 -32.65 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' HE ' ' CB ' ' A' ' 71' ' ' THR . 14.1 mmt180 -54.91 -43.09 72.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -68.39 -66.64 0.54 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.441 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -56.14 -4.92 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.965 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.626 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -87.04 -79.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.508 -0.745 . . . . 0.0 112.018 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.36 56.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.407 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.46 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 10.2 mt -118.35 104.82 11.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.053 -1.263 . . . . 0.0 109.503 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 87' ' ' GLY . 34.9 tt0 179.57 -33.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.404 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.2 mttm 58.13 -85.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 92.16 -135.23 12.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.88 -84.98 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -1.181 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -81.31 122.23 27.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -113.18 158.92 36.76 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.415 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.54 -52.25 5.81 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.577 1.518 . . . . 0.0 112.403 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.569 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 155.58 136.94 2.27 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.784 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 53.71 115.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -1.105 . . . . 0.0 109.471 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 95' ' ' LYS . 1.7 tm-20 -165.41 164.56 19.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.473 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.625 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 5.3 tptp -143.91 -164.96 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.46 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 19.2 t -121.64 163.67 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.47 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.46 ' N ' HG13 ' A' ' 96' ' ' VAL . . . 50.98 60.92 6.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.6 mtt180 -134.74 113.54 11.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.071 -1.252 . . . . 0.0 110.686 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 -176.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.53 ' O ' HG11 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -128.93 156.32 43.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 109.093 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.542 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 10.7 t-105 -44.93 -71.46 0.08 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.801 . . . . 0.0 111.176 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.13 -52.52 34.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.636 -1.29 . . . . 0.0 111.103 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.4 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.1 mt-30 -47.82 -43.66 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.383 -0.823 . . . . 0.0 110.303 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 100' ' ' THR . 2.4 m -72.56 -24.88 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.575 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.788 ' O ' ' N ' ' A' ' 109' ' ' LYS . 21.2 mt -66.0 -72.06 0.17 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 107' ' ' ILE . 11.3 tm-20 -44.28 -45.02 8.42 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.959 -1.088 . . . . 0.0 108.612 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.501 ' N ' ' OE1' ' A' ' 106' ' ' GLU . 42.1 mt -61.25 -31.67 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.046 . . . . 0.0 108.623 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -97.45 -23.68 15.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 108.984 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.9 tptp -62.43 -74.52 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 110' ' ' GLN . 2.2 mp0 -44.63 -30.15 0.87 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.022 -1.049 . . . . 0.0 108.806 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -61.82 -24.0 66.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.706 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -126.39 73.85 73.37 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 109.698 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.79 -34.4 24.44 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.551 1.501 . . . . 0.0 111.964 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.521 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 3.6 t70 175.09 11.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.036 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -49.81 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 109.606 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.764 ' ND2' ' N ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -148.76 -25.05 0.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.607 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.792 ' CG2' ' H ' ' A' ' 118' ' ' THR . 22.9 m -60.19 -164.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.537 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.792 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.58 -72.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.3 -0.875 . . . . 0.0 109.929 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.32 138.28 58.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.439 -0.788 . . . . 0.0 110.159 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.584 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -61.73 -21.53 64.59 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.282 1.039 . . . . 0.0 108.815 179.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.53 -38.49 91.2 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.54 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.88 -75.13 0.11 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.135 -1.426 . . . . 0.0 107.784 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.53 -41.64 6.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.524 -1.36 . . . . 0.0 109.392 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -51.09 -69.52 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 0.0 108.764 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.2 ttm180 -43.55 -39.94 3.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.701 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.2 ttm -53.31 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 108.579 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.513 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 24.1 mm -47.92 -63.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.438 -0.789 . . . . 0.0 109.954 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -59.97 -71.75 0.12 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.01 -41.87 4.84 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.8 m -54.35 -50.73 66.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.523 -1.575 . . . . 0.0 107.685 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.472 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -48.49 -47.49 38.63 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.0 -55.01 7.4 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.712 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.5 t -44.71 -68.59 0.19 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 2.2 ttp -46.68 -4.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.712 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.63 -31.08 5.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 29.0 t -45.43 165.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.937 -0.743 . . . . 0.0 109.194 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.528 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 35.9 mp0 -143.85 163.2 34.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.65 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.28 155.08 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p -115.94 -10.01 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.628 -0.67 . . . . 0.0 109.284 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . -115.6 -124.37 3.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.503 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.94 60.35 13.07 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.16 . . . . 0.0 109.371 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.2 Cg_endo -64.41 -165.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.78 1.653 . . . . 0.0 112.642 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -136.6 -164.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.842 . . . . 0.0 109.38 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.76 164.21 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.96 . . . . 0.0 109.541 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -178.33 82.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 146' ' ' ASP . 58.5 p-10 -177.37 76.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.479 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.57 98.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.589 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 27.8 ttpt -178.54 124.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 109.674 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.779 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.75 126.2 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.535 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 61' ' ' ALA . 27.6 m -111.66 -24.5 3.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.3 6.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.663 ' O ' ' N ' ' A' ' 9' ' ' LYS . 1.8 p -94.99 73.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.386 -0.821 . . . . 0.0 108.827 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 55' ' ' VAL . 26.1 t -45.92 88.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.045 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.96 34.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.951 0.881 . . . . 0.0 108.901 179.281 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.792 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.53 -174.66 3.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.872 0.844 . . . . 0.0 111.268 -178.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.578 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -116.98 169.49 9.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -163.08 144.44 7.6 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.159 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.489 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 30.3 Cg_endo -79.02 126.6 7.2 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.505 2.137 . . . . 0.0 114.216 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.755 ' O ' ' N ' ' A' ' 16' ' ' LYS . . . -72.52 141.43 48.51 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.73 ' H ' ' HG1' ' A' ' 45' ' ' THR . . . 60.55 -61.24 0.01 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.1 ttpm? -60.64 37.77 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.831 -0.805 . . . . 0.0 108.831 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.704 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -119.27 151.83 37.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.9 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.79 165.77 6.89 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 -179.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 18' ' ' THR . 4.5 Cg_exo -49.46 36.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.696 1.598 . . . . 0.0 111.657 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.9 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -163.77 54.87 0.43 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.53 -0.732 . . . . 0.0 109.78 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.2 Cg_endo -77.93 170.16 19.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.485 1.456 . . . . 0.0 111.716 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -60.75 -4.65 3.7 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.209 1.273 . . . . 0.0 111.03 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.738 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 t -106.16 -71.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.594 0.711 . . . . 0.0 110.333 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.31 -98.37 0.05 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 -177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.738 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.3 Cg_endo -60.21 -55.4 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 CA-C-N 118.047 0.924 . . . . 0.0 109.926 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.35 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.362 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.641 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -111.87 -42.84 3.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.631 -1.293 . . . . 0.0 108.751 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.66 84.44 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tt0 -149.18 -15.34 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 65' ' ' PHE . 2.0 p80 -84.42 -37.41 21.49 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.649 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -170.91 -2.8 0.03 OUTLIER Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 81.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.606 -0.938 . . . . 0.0 112.19 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -156.8 120.86 4.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.074 . . . . 0.0 108.639 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.6 mm -96.58 -65.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 110.108 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.669 ' O ' ' N ' ' A' ' 39' ' ' LYS . 5.3 tpt -42.09 -56.97 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.715 -1.241 . . . . 0.0 109.558 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' MET . 6.5 mt-10 -46.86 -50.78 18.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.269 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.646 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -48.72 -61.61 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.644 1.212 . . . . 0.0 109.617 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.659 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 56.3 t -71.37 -30.28 39.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.979 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 35' ' ' MET . 32.6 tptt -51.54 -63.1 1.24 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.04 69.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 44' ' ' ALA . 1.9 t80 -70.32 -76.83 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.659 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 1.3 m-80 -41.37 -34.01 0.47 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.578 1.18 . . . . 0.0 110.63 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -67.39 -35.06 78.55 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.05 -43.99 9.58 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.735 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.73 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 18.1 p -61.16 -32.14 71.87 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.36 -44.74 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.23 -23.7 49.69 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.787 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.8 -74.69 0.64 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.787 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 169.83 149.35 6.28 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.124 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 49' ' ' GLY . 3.8 t70 -44.82 148.37 0.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.986 -1.303 . . . . 0.0 109.429 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.607 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 176.87 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.973 -1.079 . . . . 0.0 110.623 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.7 mm -147.16 141.78 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 71' ' ' THR . 2.8 t -144.96 133.8 11.05 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.801 -1.187 . . . . 0.0 110.888 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 5.7 Cg_endo -69.13 95.7 0.51 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.484 1.456 . . . . 0.0 110.315 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.792 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.9 m -75.84 137.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.928 1.347 . . . . 0.0 112.61 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 14.4 mt-10 -128.61 61.73 1.48 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 8' ' ' VAL . 3.6 mt -61.71 88.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.729 0.776 . . . . 0.0 109.825 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.482 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -64.23 95.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 64' ' ' SER . 12.9 mt -96.96 140.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.648 -0.657 . . . . 0.0 110.162 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.779 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.5 m-85 -111.83 138.93 47.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.824 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.08 -30.35 2.7 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -53.47 3.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.824 ' H ' ' C ' ' A' ' 61' ' ' ALA . 2.6 tmm_? 70.05 69.64 0.22 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.099 0.952 . . . . 0.0 109.436 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 3.2 m -147.86 125.87 12.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.19 104.08 14.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.052 -1.03 . . . . 0.0 110.288 -179.339 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 58' ' ' THR . 23.4 p -98.78 124.52 43.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.557 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -109.64 173.74 6.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.58 -1.325 . . . . 0.0 109.281 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.716 ' CG1' ' O ' ' A' ' 68' ' ' VAL . 85.3 t -162.78 44.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 112.666 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.51 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 t -156.55 118.09 3.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 116.092 -2.243 . . . . 0.0 109.475 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.83 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -114.61 125.15 53.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.339 1.066 . . . . 0.0 109.328 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.83 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER 75.02 161.56 0.15 Allowed Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.22 -179.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.478 ' HD2' ' CG2' ' A' ' 71' ' ' THR . 12.4 Cg_exo -41.35 175.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.469 2.112 . . . . 0.0 113.102 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.1 Cg_exo -44.08 169.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.681 1.587 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.545 ' O ' ' CD1' ' A' ' 76' ' ' TYR . . . 54.8 -74.49 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.777 ' N ' ' O ' ' A' ' 73' ' ' PRO . 22.8 t -43.76 -20.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 110.055 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 26.8 p90 -43.49 -43.35 5.37 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.593 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.76 -20.42 2.55 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.563 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -55.36 -35.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.759 ' CG ' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -53.39 -57.6 10.04 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.51 ' C ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -52.04 -64.29 0.86 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.016 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB1' ' CG2' ' A' ' 99' ' ' ILE . . . -48.89 -16.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 0.0 108.463 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 78' ' ' ILE . . . -98.78 -74.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.916 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 95.59 95.12 1.74 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.964 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.817 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 7.1 mt -118.88 105.0 11.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -1.201 . . . . 0.0 108.938 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.69 ' O ' ' N ' ' A' ' 87' ' ' GLY . 73.2 mm-40 -153.2 16.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.104 -0.998 . . . . 0.0 109.819 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 23.5 tttt 45.04 -85.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.155 -0.966 . . . . 0.0 109.386 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 124.31 121.81 2.62 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 89' ' ' HIS . . . -68.21 -62.9 1.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -1.162 . . . . 0.0 109.341 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.579 ' O ' ' O ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -51.92 -164.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.315 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 89' ' ' HIS . 15.0 mttm -44.85 159.55 0.26 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 0.0 109.314 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.4 -54.99 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.557 1.505 . . . . 0.0 112.552 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.04 -39.23 2.97 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.562 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 3.1 mpt_? 58.77 55.41 4.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -1.102 . . . . 0.0 109.622 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.562 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 32.0 mt-10 -164.74 48.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 109.619 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.576 ' C ' ' O ' ' A' ' 83' ' ' GLY . 34.2 mttp -163.28 72.6 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.812 ' O ' ' N ' ' A' ' 98' ' ' ARG . 79.2 t -159.85 166.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 110.439 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.817 ' N ' ' CD2' ' A' ' 84' ' ' LEU . . . -43.99 72.98 0.0 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.812 ' N ' ' O ' ' A' ' 96' ' ' VAL . 2.6 mtt180 -135.65 109.74 8.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -1.077 . . . . 0.0 109.563 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.737 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.2 OUTLIER -114.01 -175.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.479 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -125.24 165.84 17.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.082 . . . . 0.0 109.666 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.511 ' O ' HG23 ' A' ' 104' ' ' VAL . 24.3 t-105 -51.01 -71.31 0.07 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.646 -0.659 . . . . 0.0 111.277 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.505 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -47.73 -50.31 25.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.766 -1.209 . . . . 0.0 110.859 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -49.86 -44.9 49.99 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -70.73 -25.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 117.535 -1.666 . . . . 0.0 107.379 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' A' ' 109' ' ' LYS . 18.8 mt -66.31 -71.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 105' ' ' LEU . 72.7 tt0 -43.74 -43.77 6.21 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.923 -1.111 . . . . 0.0 108.641 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 55.7 mt -62.79 -30.75 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.049 . . . . 0.0 108.541 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 105' ' ' LEU . . . -94.88 -26.11 16.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.478 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -61.78 -74.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 0.0 108.396 179.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.455 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 4.6 tt0 -47.16 -20.29 0.17 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.945 . . . . 0.0 109.26 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -80.89 -9.31 59.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.856 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.52 56.43 20.63 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.045 -1.035 . . . . 0.0 109.785 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.9 Cg_endo -59.33 -33.36 97.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.585 1.523 . . . . 0.0 112.406 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.06 19.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.478 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.2 mp -54.12 -85.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.82 -11.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.801 . . . . 0.0 109.154 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.831 ' CG2' ' H ' ' A' ' 118' ' ' THR . 31.5 m -72.24 -164.57 0.15 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.831 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.8 -56.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.314 -0.866 . . . . 0.0 109.674 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 118' ' ' THR . 1.1 m-20 -80.43 134.94 36.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.582 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 0.5 OUTLIER -55.24 -22.5 18.31 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.179 0.99 . . . . 0.0 109.019 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.6 -36.82 84.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.53 -75.75 0.11 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.481 -1.387 . . . . 0.0 107.977 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 122' ' ' ALA . . . -44.35 -40.31 5.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.479 -1.388 . . . . 0.0 109.243 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 120' ' ' LEU . . . -51.77 -68.12 0.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.026 -1.046 . . . . 0.0 108.442 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 129' ' ' GLY . 1.8 ttm180 -43.63 -43.59 5.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.713 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.34 -79.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.057 -1.027 . . . . 0.0 108.563 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.499 ' CG1' ' CB ' ' A' ' 108' ' ' ALA . 21.3 mm -48.19 -65.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 129' ' ' GLY . . . -58.21 -71.49 0.11 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.93 -40.53 4.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.713 ' N ' ' O ' ' A' ' 126' ' ' MET . 45.1 m -56.3 -51.05 69.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.467 -1.608 . . . . 0.0 107.707 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 132' ' ' ARG . . . -46.86 -47.74 21.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.8 -54.32 10.08 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.691 ' C ' ' H ' ' A' ' 135' ' ' GLY . 7.3 t -44.99 -70.24 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.51 ' SD ' ' HB2' ' A' ' 75' ' ' SER . 2.2 ttp -46.9 -4.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.613 -0.679 . . . . 0.0 109.355 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.691 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 90.71 -30.11 6.36 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 50.8 t -44.91 164.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.856 -0.791 . . . . 0.0 108.941 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.1 tm-20 -144.04 162.66 35.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 109.686 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.638 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -80.23 145.41 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.737 ' N ' ' O ' ' A' ' 99' ' ' ILE . 2.4 p -110.01 61.99 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.26 -117.76 0.79 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.473 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.72 61.4 11.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.148 -1.207 . . . . 0.0 109.269 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.564 ' O ' ' CG ' ' A' ' 143' ' ' GLU . 2.0 Cg_endo -61.74 156.62 47.06 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.724 1.616 . . . . 0.0 112.689 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.564 ' CG ' ' O ' ' A' ' 142' ' ' PRO . 19.5 mt-10 -165.7 87.96 0.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -0.86 . . . . 0.0 109.351 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.3 m -156.38 146.23 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 175.03 138.56 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.845 . . . . 0.0 109.401 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 147' ' ' ALA . 28.7 m-20 -133.95 134.85 43.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.55 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.515 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.786 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.308 0.575 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -116.5 -24.49 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.259 -0.9 . . . . 0.0 109.008 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.33 108.95 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.41 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -96.93 73.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.787 ' HB ' HD12 ' A' ' 57' ' ' ILE . 39.0 t -48.53 87.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 120.756 -1.215 . . . . 0.0 110.276 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 7' ' ' VAL . 1.6 tmmt? -82.77 36.65 0.5 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.803 0.811 . . . . 0.0 109.18 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.013 HD22 HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.41 -173.94 3.54 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.775 0.798 . . . . 0.0 111.494 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 1.1 pm0 -121.74 173.61 7.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.752 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -161.62 146.96 10.46 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 109.368 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.699 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 91.1 Cg_endo -87.33 126.91 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.343 2.029 . . . . 0.0 113.47 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.099 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.94 143.17 43.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.38 58.64 9.54 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.699 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 9.6 tttp 174.31 -1.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.807 -0.82 . . . . 0.0 108.831 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 18' ' ' THR . . . -83.5 153.93 24.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.902 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.68 165.95 4.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.668 -179.155 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.1 Cg_exo -49.19 34.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.57 1.513 . . . . 0.0 111.581 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.902 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.67 54.46 0.71 Allowed Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.614 -0.679 . . . . 0.0 109.245 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 13.3 Cg_endo -80.8 169.89 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.694 1.596 . . . . 0.0 111.729 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.27 -4.43 2.31 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 121.009 1.139 . . . . 0.0 111.039 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.013 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -110.68 -70.51 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.562 0.696 . . . . 0.0 110.253 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.01 -98.24 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.12 -55.57 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 CA-C-N 118.007 0.903 . . . . 0.0 109.951 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.654 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.44 -12.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.173 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.006 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.65 -41.64 3.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.778 -1.201 . . . . 0.0 108.28 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.42 92.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 27' ' ' LEU . 43.1 mt-30 -158.5 -26.87 0.08 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.754 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.7 p80 -78.24 60.35 2.48 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.485 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.68 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 85.03 -9.87 64.91 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 84.96 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 112.163 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -157.83 122.61 4.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 108.801 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.4 mm -97.36 -63.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.609 -0.682 . . . . 0.0 109.732 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.74 -55.59 2.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.693 -1.254 . . . . 0.0 109.537 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 35' ' ' MET . 12.0 mt-10 -46.25 -45.73 17.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.498 -1.376 . . . . 0.0 107.468 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 1.006 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -54.18 -68.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.244 1.021 . . . . 0.0 109.636 178.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 42' ' ' ASN . 25.9 t -67.03 -38.29 81.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.681 -0.637 . . . . 0.0 110.018 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.1 tptm -45.29 -58.79 3.04 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.98 74.79 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.265 -0.897 . . . . 0.0 109.094 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.673 ' O ' HG23 ' A' ' 45' ' ' THR . 2.3 t80 -71.39 -77.26 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 120.368 -1.457 . . . . 0.0 107.124 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.2 t-20 -41.08 -33.95 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.879 -1.138 . . . . 0.0 110.739 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.33 -32.33 72.37 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.918 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.39 -48.54 7.06 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.652 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 41' ' ' PHE . 1.5 p -58.92 -30.45 67.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.15 -44.78 21.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -57.81 -21.96 44.94 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.558 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.85 -72.46 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.558 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.21 -131.31 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.016 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 4.7 p-10 -121.19 148.0 44.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.254 -1.145 . . . . 0.0 108.779 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.099 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.94 -153.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.752 -1.218 . . . . 0.0 110.929 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.6 mm -146.12 138.42 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 71' ' ' THR . 2.4 t -138.76 134.44 17.16 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.116 -0.99 . . . . 0.0 110.791 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -71.86 107.24 2.16 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.69 1.594 . . . . 0.0 111.012 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.832 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.1 m -81.1 136.92 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.722 -1.236 . . . . 0.0 111.464 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -130.74 68.04 1.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.787 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.1 mt -68.19 90.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.79 0.805 . . . . 0.0 110.231 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.09 96.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.644 HG13 HG22 ' A' ' 57' ' ' ILE . 50.2 mt -101.07 145.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.515 0.674 . . . . 0.0 110.728 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.786 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.4 m-85 -116.51 139.89 49.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.802 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.42 -32.78 5.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.147 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -50.94 -1.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.79 ' H ' ' C ' ' A' ' 61' ' ' ALA . 11.2 ttm180 75.33 68.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.952 0.882 . . . . 0.0 109.85 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 1.3 t -148.49 147.93 29.66 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.65 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 36.2 p90 -125.29 103.82 8.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.902 -1.124 . . . . 0.0 110.247 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.4 p -101.44 120.75 40.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 110.052 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.937 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.1 148.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.089 -1.007 . . . . 0.0 110.99 177.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 67' ' ' PHE . 28.9 t -169.18 91.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.187 0.994 . . . . 0.0 108.491 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -97.5 147.05 24.65 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.752 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -132.25 125.15 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.397 -1.44 . . . . 0.0 110.604 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.752 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 14.8 p 76.18 150.64 0.13 Allowed Pre-proline 0 N--CA 1.493 1.68 0 CA-C-O 121.244 0.545 . . . . 0.0 109.975 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 73' ' ' PRO . 12.6 Cg_exo -40.8 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.653 2.235 . . . . 0.0 112.993 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.756 ' O ' ' N ' ' A' ' 75' ' ' SER . 25.0 Cg_exo -39.89 168.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.543 1.495 . . . . 0.0 111.905 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.917 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.05 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.832 ' HG ' ' HG3' ' A' ' 79' ' ' ARG . 11.2 t -43.05 -21.72 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.079 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 23.6 p90 -43.6 -38.76 3.17 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.079 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.77 -16.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.917 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.9 mt -58.27 -34.33 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.832 ' HG3' ' HG ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -54.12 -49.74 68.47 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 82' ' ' ALA . 4.5 tmtt? -58.27 -64.81 0.79 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.58 -6.28 0.69 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.205 -0.934 . . . . 0.0 109.842 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.812 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -78.86 -82.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 112.216 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 178.88 32.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.957 -1.592 . . . . 0.0 110.464 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.607 HD11 ' CD ' ' A' ' 79' ' ' ARG . 2.8 mt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 120.997 -1.296 . . . . 0.0 109.392 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.217 0.532 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.812 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 75.86 58.81 3.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.665 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.8 mtt180 -133.71 115.47 14.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.128 -1.219 . . . . 0.0 110.353 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.721 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.43 175.11 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.815 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -120.85 156.58 31.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.983 -1.073 . . . . 0.0 109.055 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.3 t-105 -45.18 -70.37 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 111.229 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.405 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 6.4 tp10 -50.45 -51.71 44.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.575 -1.328 . . . . 0.0 111.242 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.406 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 4.8 mt-30 -48.72 -44.38 38.24 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.5 m -70.88 -25.9 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.822 -1.551 . . . . 0.0 107.663 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.967 HD13 HD13 ' A' ' 120' ' ' LEU . 18.8 mt -65.36 -70.66 0.22 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 105' ' ' LEU . 3.1 tp10 -44.1 -45.7 8.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.935 -1.103 . . . . 0.0 108.566 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.818 HG12 HD11 ' A' ' 77' ' ' LEU . 35.3 mt -61.26 -31.75 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.111 -0.993 . . . . 0.0 108.698 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.816 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.53 -25.98 16.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.347 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -58.08 -73.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 108.286 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.552 ' CD ' ' N ' ' A' ' 110' ' ' GLN . 1.2 mp0 -44.95 -26.1 0.38 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.078 -1.014 . . . . 0.0 108.794 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' LYS . 40.1 tttm -74.91 -8.29 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.803 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.59 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 7.7 ptm -132.87 62.4 61.98 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.056 -1.028 . . . . 0.0 109.861 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 112' ' ' MET . 3.0 Cg_endo -67.21 -35.06 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.565 1.51 . . . . 0.0 112.123 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.513 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 2.3 t70 174.96 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.359 -0.838 . . . . 0.0 109.107 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.2 mm? -47.96 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 0.0 109.575 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -151.81 -21.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.02 HG22 ' H ' ' A' ' 118' ' ' THR . 26.2 m -64.13 -164.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.101 -0.999 . . . . 0.0 109.616 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.02 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.48 -64.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 0.9 OUTLIER -74.93 141.27 44.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.084 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.967 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -59.93 -24.56 64.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.211 1.005 . . . . 0.0 109.12 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.5 -34.65 78.71 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.71 -75.18 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.045 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.59 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.0 -40.82 6.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.539 -1.351 . . . . 0.0 109.095 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.97 -69.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 108.647 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.658 ' O ' ' N ' ' A' ' 129' ' ' GLY . 23.1 ttt180 -43.35 -35.68 1.61 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.666 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.0 tpp -57.56 -78.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 108.778 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.816 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 26.9 mm -48.49 -56.99 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.0 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -67.39 -70.93 0.22 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -42.48 5.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.666 ' N ' ' O ' ' A' ' 126' ' ' MET . 54.3 p -54.72 -47.66 73.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.575 -1.544 . . . . 0.0 107.499 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -51.12 -48.53 61.73 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.791 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.01 -53.4 10.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.0 t -44.79 -67.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.805 ' SD ' ' NH1' ' A' ' 79' ' ' ARG . 11.6 ttm -49.94 -3.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 89.21 -26.05 9.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.677 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.4 t -49.22 165.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.736 -0.861 . . . . 0.0 109.405 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 136' ' ' VAL . 87.8 mt-10 -142.8 162.66 34.88 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.755 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.32 165.1 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.871 ' O ' HG13 ' A' ' 139' ' ' VAL . 6.4 p . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.767 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.338 0.589 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -115.11 -24.45 3.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.34 100.39 3.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.041 -1.037 . . . . 0.0 110.252 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -87.86 74.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.919 HG13 HD12 ' A' ' 10' ' ' LEU . 11.3 t -48.22 87.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.558 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.681 ' HB3' ' HZ3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -81.83 36.29 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.897 0.856 . . . . 0.0 108.817 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.919 HD12 HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -77.22 -174.46 3.24 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.725 0.774 . . . . 0.0 110.882 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 3.6 pm0 -127.42 177.21 6.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.556 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -166.66 146.6 4.96 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 109.213 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.485 ' HA ' HD13 ' A' ' 52' ' ' ILE . 65.8 Cg_endo -84.01 130.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.277 1.984 . . . . 0.0 113.587 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.072 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -76.16 142.77 41.48 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.492 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 51.61 55.35 20.57 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 5.5 mttp 174.53 14.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.695 -0.885 . . . . 0.0 109.212 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 18' ' ' THR . . . -96.13 154.74 17.08 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.862 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.86 165.74 4.07 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.005 . . . . 0.0 109.487 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HA ' HG21 ' A' ' 34' ' ' ILE . 5.3 Cg_exo -51.05 32.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.457 1.438 . . . . 0.0 111.562 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.862 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -154.56 54.31 1.03 Allowed Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.64 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.739 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.84 169.06 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.725 1.617 . . . . 0.0 111.735 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.37 -4.56 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.077 1.185 . . . . 0.0 110.95 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.748 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.0 -72.62 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.796 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.49 -98.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.748 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.3 Cg_exo -59.03 -55.54 1.88 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 118.096 0.948 . . . . 0.0 110.003 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.652 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -44.7 -6.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.412 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.862 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -111.12 -44.07 3.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 179.432 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.34 88.67 0.01 OUTLIER Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.6 tt0 -150.97 -12.85 0.22 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.538 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 7.8 p-80 -87.73 -36.5 17.32 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -173.1 -1.49 0.03 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.11 83.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 112.058 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 32' ' ' ALA . 31.8 m120 -157.71 120.09 3.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.982 -1.073 . . . . 0.0 108.614 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.565 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.8 mm -97.44 -65.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.689 -0.632 . . . . 0.0 109.853 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.492 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -41.42 -56.35 2.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 109.548 -177.208 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.3 mt-10 -44.69 -48.15 10.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.755 -1.215 . . . . 0.0 107.768 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.862 ' CE2' HD12 ' A' ' 27' ' ' LEU . 1.1 t80 -51.17 -68.17 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.884 1.326 . . . . 0.0 110.034 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 33.9 t -59.21 -37.2 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.805 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 7.1 ttpt -49.56 -65.7 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.08 -32.79 62.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.23 -0.918 . . . . 0.0 109.04 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.0 t80 -73.19 -78.45 0.09 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 7.4 m-20 -41.07 -32.76 0.27 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.856 -1.152 . . . . 0.0 110.745 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -70.04 -32.77 71.07 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.139 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.09 -47.17 7.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.476 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.556 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 8.7 p -59.5 -29.71 68.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.94 -45.27 20.79 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.555 ' OD1' ' O ' ' A' ' 43' ' ' ALA . 12.2 m120 -57.8 -22.14 45.69 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.573 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.32 -73.88 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.573 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -179.64 -127.82 1.15 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.05 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 23.1 t70 -123.84 147.26 47.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.216 -1.167 . . . . 0.0 108.817 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.072 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.88 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 0.0 110.99 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.1 mm -146.82 139.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 71' ' ' THR . 2.0 t -138.58 133.74 17.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 110.611 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -72.86 97.1 0.88 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.8 1.667 . . . . 0.0 111.03 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.81 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -70.95 134.46 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.675 1.226 . . . . 0.0 111.652 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 28.3 mt-10 -127.16 70.32 1.3 Allowed 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.725 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -71.43 89.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.677 0.751 . . . . 0.0 110.5 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.16 95.46 0.09 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 57' ' ' ILE . 95.7 mt -98.05 141.0 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.656 -0.653 . . . . 0.0 110.505 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.767 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 4.8 m-85 -115.99 139.82 49.87 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.835 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.81 -30.7 4.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.277 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 6.0 m-20 -53.47 3.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.81 ' H ' ' C ' ' A' ' 61' ' ' ALA . 49.8 mtp180 70.34 68.89 0.21 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.968 0.89 . . . . 0.0 109.793 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 9.5 p -148.97 150.98 33.78 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.2 p90 -128.18 103.76 7.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.992 -1.067 . . . . 0.0 110.105 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p -101.38 120.79 40.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.15 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.933 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 169.96 149.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.081 -1.012 . . . . 0.0 110.991 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.5 t -168.82 98.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.272 1.034 . . . . 0.0 108.35 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.39 148.2 29.4 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.78 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.2 mptt -133.21 125.09 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.523 -1.361 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.78 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.3 150.34 0.13 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 121.272 0.558 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' O ' ' O ' ' A' ' 73' ' ' PRO . 8.7 Cg_exo -42.88 175.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.548 2.166 . . . . 0.0 112.803 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.61 176.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.502 1.468 . . . . 0.0 111.788 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 47.87 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.774 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -43.71 -22.4 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.99 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.981 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 15.6 p90 -43.84 -37.68 2.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 0.0 108.961 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.981 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.35 -15.79 1.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.919 HD12 ' HB1' ' A' ' 74' ' ' ALA . 3.9 mt -60.13 -31.85 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.707 ' HB3' HD12 ' A' ' 84' ' ' LEU . 2.2 mmp_? -56.08 -44.01 78.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.2 tmtm? -65.27 -66.76 0.5 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.746 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.5 -5.26 0.51 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.01 -80.31 0.19 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.547 -0.721 . . . . 0.0 111.582 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.752 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 166.46 53.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.285 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 83' ' ' GLY . 2.0 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.236 . . . . 0.0 109.358 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.58 HG12 ' N ' ' A' ' 97' ' ' GLY . 88.5 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.258 0.551 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.58 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 57.0 65.97 3.19 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.657 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.2 ttt180 -134.32 114.59 13.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 110.007 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -107.42 -169.23 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 108.976 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.644 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.4 OUTLIER -131.58 159.36 38.45 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 0.0 109.219 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.679 ' O ' HG22 ' A' ' 104' ' ' VAL . 18.2 t-105 -50.9 -68.72 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.504 -0.747 . . . . 0.0 110.87 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -51.27 -45.91 62.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.69 -1.256 . . . . 0.0 110.369 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.746 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -50.66 -47.65 58.6 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.234 -0.917 . . . . 0.0 109.777 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.836 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.78 -24.06 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.951 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 120' ' ' LEU . 13.1 mt -66.88 -71.32 0.2 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.491 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 6.1 tm-20 -43.66 -43.12 5.66 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.891 -1.131 . . . . 0.0 108.374 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 77' ' ' LEU . 49.4 mt -62.96 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.021 -1.049 . . . . 0.0 108.358 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.807 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.41 -27.36 16.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.656 ' HE2' HD11 ' A' ' 120' ' ' LEU . 17.3 mmtt -57.18 -73.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.837 -1.164 . . . . 0.0 108.124 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 109' ' ' LYS . 78.9 mt-30 -44.89 -25.01 0.26 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.006 -1.058 . . . . 0.0 108.769 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 109' ' ' LYS . 23.5 tptt -76.89 -8.25 57.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.919 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 123' ' ' ALA . 7.5 ptm -132.27 60.87 53.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.8 Cg_endo -65.88 -40.34 16.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.559 1.506 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 6.9 t70 -178.75 8.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.0 mm? -46.76 -81.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -151.13 -18.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.129 -0.982 . . . . 0.0 109.699 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.019 HG22 ' H ' ' A' ' 118' ' ' THR . 26.4 m -65.88 -164.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.629 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.019 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.96 -62.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.266 -0.897 . . . . 0.0 109.865 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 118' ' ' THR . 0.8 OUTLIER -75.31 140.64 43.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -60.3 -23.8 64.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.126 0.965 . . . . 0.0 109.107 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.64 -34.29 77.94 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.52 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.78 -75.83 0.13 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.111 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.623 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -45.09 -31.37 1.35 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.468 -1.395 . . . . 0.0 109.268 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -60.75 -69.76 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 108.496 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.694 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.2 ttp180 -43.67 -44.1 6.22 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.631 ' O ' ' N ' ' A' ' 130' ' ' SER . 2.8 mtt -49.72 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.1 -1.0 . . . . 0.0 108.742 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.807 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 18.2 mm -47.28 -67.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.678 0.752 . . . . 0.0 110.076 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.836 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -55.23 -69.55 0.13 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.43 -37.29 2.49 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.631 ' N ' ' O ' ' A' ' 126' ' ' MET . 10.5 p -57.08 -54.21 49.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.445 -1.621 . . . . 0.0 107.336 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.743 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -44.98 -50.36 10.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -44.91 -55.73 5.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.169 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.8 t -44.91 -67.2 0.31 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.679 ' SD ' ' OG ' ' A' ' 75' ' ' SER . 6.8 ttp -47.79 -3.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.73 -24.72 11.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.743 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 31.1 t -52.74 165.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.989 -0.712 . . . . 0.0 109.347 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.586 ' N ' HG12 ' A' ' 136' ' ' VAL . 41.7 mt-10 -142.99 163.28 33.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.44 143.84 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 99' ' ' ILE . 5.6 p . . . . . 0 N--CA 1.487 1.386 0 O-C-N 121.56 -0.713 . . . . 0.0 109.292 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.516 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.026 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -123.66 -24.9 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.903 -1.123 . . . . 0.0 110.573 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -154.98 111.66 3.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.731 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -103.78 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.767 ' HB ' HD12 ' A' ' 57' ' ' ILE . 17.6 t -49.51 88.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.73 -1.231 . . . . 0.0 110.743 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.7 tmtp? -82.4 38.28 0.54 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.746 0.784 . . . . 0.0 109.358 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.892 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.24 -173.89 3.45 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.843 0.83 . . . . 0.0 111.437 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.691 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 2.1 pm0 -123.98 174.83 7.33 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.719 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -167.73 159.66 9.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.85 -1.156 . . . . 0.0 110.159 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.719 ' HD2' HD23 ' A' ' 12' ' ' LEU . 11.9 Cg_endo -68.95 109.83 2.24 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.034 1.823 . . . . 0.0 111.37 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.823 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -68.68 38.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.857 -1.152 . . . . 0.0 110.411 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.524 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -172.82 -19.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.372 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -144.37 80.39 1.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.642 -1.505 . . . . 0.0 110.408 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.673 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -96.53 166.05 11.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.747 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.0 164.4 4.26 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.874 -1.141 . . . . 0.0 110.086 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' HG21 ' A' ' 34' ' ' ILE . 3.5 Cg_exo -54.11 32.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.663 1.575 . . . . 0.0 111.677 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.747 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.0 54.01 5.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.061 -1.024 . . . . 0.0 110.231 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.8 Cg_endo -84.67 155.11 11.88 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.73 1.62 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.91 -4.62 0.37 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.032 1.155 . . . . 0.0 111.136 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.828 HG12 ' N ' ' A' ' 27' ' ' LEU . 2.9 t -111.85 -69.88 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 0.0 110.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.83 -97.73 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.774 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.8 Cg_exo -57.83 -55.66 2.2 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 CA-C-N 118.017 0.908 . . . . 0.0 110.28 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.628 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -52.72 -11.83 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.628 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.828 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -96.51 -53.69 3.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.71 -1.244 . . . . 0.0 108.386 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.88 92.3 0.01 OUTLIER Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.9 tp60 -147.39 -15.05 0.39 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.557 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 4.9 p-80 -84.13 -37.37 22.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -171.57 -0.92 0.03 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 73.18 84.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.494 -1.003 . . . . 0.0 112.046 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -159.55 120.81 3.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 108.806 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.677 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 50.7 mm -94.4 -64.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.723 -0.61 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.57 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -41.0 -54.38 2.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.791 -1.193 . . . . 0.0 109.774 -176.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 35' ' ' MET . 5.5 mt-10 -48.41 -46.78 37.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.593 -1.317 . . . . 0.0 107.708 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.719 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -53.03 -68.91 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.572 1.177 . . . . 0.0 109.244 178.317 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.673 HG13 ' CB ' ' A' ' 17' ' ' ALA . 38.3 t -63.46 -36.84 77.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.706 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.0 mmmt -49.32 -55.55 12.44 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.11 75.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.484 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.612 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.0 OUTLIER -70.13 -77.05 0.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.431 -1.418 . . . . 0.0 107.305 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 7.2 t-20 -41.52 -33.79 0.48 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.74 -33.88 75.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.417 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.891 ' HB1' ' NZ ' ' A' ' 70' ' ' LYS . . . -90.72 -53.18 4.52 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.714 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.792 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.8 p -53.35 -31.34 44.03 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.43 -44.71 17.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -54.69 -23.27 16.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.18 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.603 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.78 -85.3 0.53 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.182 -0.949 . . . . 0.0 109.693 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.603 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.82 -141.8 3.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.062 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -118.07 121.15 39.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -1.122 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.823 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.51 -153.04 0.4 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.583 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.6 mm -146.85 142.2 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 14' ' ' ALA . 3.7 t -145.34 137.61 13.38 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 110.238 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -73.52 95.01 0.85 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.872 1.715 . . . . 0.0 111.52 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.892 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -61.44 138.06 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 111.354 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 26.8 tt0 -130.44 70.14 1.45 Allowed 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.767 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.6 mt -70.68 89.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.389 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 100.89 0.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' A' ' 6' ' ' ALA . 21.1 mt -101.76 137.45 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.589 -0.695 . . . . 0.0 110.615 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.516 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -113.27 137.85 50.88 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 1.026 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -49.03 -30.76 6.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.583 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.6 m-20 -53.56 1.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.807 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 mtm180 71.05 69.91 0.18 Allowed 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.028 0.918 . . . . 0.0 109.953 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 4.4 m -151.27 126.11 9.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 18.2 p90 -102.53 103.84 14.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.093 -1.005 . . . . 0.0 110.035 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.2 121.31 41.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.1 -1.0 . . . . 0.0 110.227 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.932 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.38 148.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.052 . . . . 0.0 111.274 177.371 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.7 t -168.74 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.263 1.03 . . . . 0.0 108.232 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -98.07 132.4 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.891 ' NZ ' ' HB1' ' A' ' 44' ' ' ALA . 24.5 mmtp -115.82 143.19 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.655 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 1.8 p 55.58 159.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.956 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.7 Cg_exo -38.18 175.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.887 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 75' ' ' SER . 22.8 Cg_exo -42.2 169.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.575 1.516 . . . . 0.0 112.161 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.984 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 58.73 -73.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 73' ' ' PRO . 5.6 p -43.65 -21.65 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.097 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 25.4 p90 -43.38 -42.95 4.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.366 -0.834 . . . . 0.0 109.087 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.097 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.54 -13.9 3.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.984 HD12 ' HB1' ' A' ' 74' ' ' ALA . 2.0 mt -61.02 -31.34 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.704 ' NH1' ' CD1' ' A' ' 84' ' ' LEU . 9.6 mmm180 -54.16 -45.81 72.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.2 tmmm? -65.21 -65.75 0.63 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.751 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.51 -5.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.671 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.643 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.81 -79.66 0.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 111.686 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.402 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 153.49 57.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.085 -1.531 . . . . 0.0 110.674 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.704 ' CD1' ' NH1' ' A' ' 79' ' ' ARG . 9.0 mt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.143 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 97' ' ' GLY . 87.4 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.273 0.559 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.589 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 65.53 65.64 2.8 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.2 mtt180 -132.53 115.31 15.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.269 -1.136 . . . . 0.0 109.93 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.728 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 173.31 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.549 -0.719 . . . . 0.0 109.539 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.72 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -113.99 150.46 33.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.042 . . . . 0.0 109.092 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.719 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.0 t-105 -46.3 -67.6 0.27 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.347 -0.846 . . . . 0.0 110.897 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.505 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.68 -49.29 57.65 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.557 -1.34 . . . . 0.0 110.68 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.751 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -48.97 -45.93 42.84 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.884 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.82 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.4 -24.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 117.979 -1.489 . . . . 0.0 107.797 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.795 ' O ' ' N ' ' A' ' 109' ' ' LYS . 19.3 mt -66.22 -71.71 0.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 105' ' ' LEU . 86.7 tt0 -43.99 -44.95 7.6 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.892 -1.13 . . . . 0.0 108.472 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.588 HG12 HD11 ' A' ' 77' ' ' LEU . 67.2 mt -61.58 -32.47 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 108.493 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.819 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.8 -24.71 16.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.169 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.795 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.6 tptp -63.16 -74.55 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 109' ' ' LYS . 90.2 mt-30 -44.5 -27.85 0.51 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.984 -1.073 . . . . 0.0 108.772 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 109' ' ' LYS . 33.7 tttp -66.57 -13.66 61.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.578 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 5.5 ptm -131.02 69.25 82.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.638 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -68.82 -46.63 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.68 1.587 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' A' ' 114' ' ' ASP . 40.1 p30 -171.1 6.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 108.952 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.401 ' H ' ' H ' ' A' ' 114' ' ' ASP . 2.7 mm? -45.02 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.798 . . . . 0.0 109.577 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 117' ' ' THR . 8.0 p-10 -150.89 -12.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.186 -0.946 . . . . 0.0 109.649 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.026 HG22 ' H ' ' A' ' 118' ' ' THR . 31.8 m -77.99 -164.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.026 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 178.56 -57.2 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.264 -0.898 . . . . 0.0 109.576 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.63 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 1.1 p30 -63.27 132.25 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.513 -0.742 . . . . 0.0 109.998 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.675 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -67.22 -28.7 68.29 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.488 1.137 . . . . 0.0 108.469 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -64.45 -34.52 78.4 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.637 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.52 -76.27 0.1 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.68 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.578 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.58 -42.1 10.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.478 -1.389 . . . . 0.0 109.339 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -50.4 -69.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 108.806 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.49 -38.57 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.597 ' O ' ' HB3' ' A' ' 130' ' ' SER . 13.4 tpp -53.79 -79.22 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.819 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.9 mm -47.29 -65.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.666 0.746 . . . . 0.0 110.289 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.82 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -57.5 -69.71 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.38 -37.8 2.62 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.597 ' HB3' ' O ' ' A' ' 126' ' ' MET . 15.9 p -57.18 -53.79 54.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.506 -1.585 . . . . 0.0 107.451 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.779 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -45.0 -50.28 10.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.791 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.65 -55.01 6.88 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.313 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.6 t -44.74 -67.29 0.3 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.631 ' HG2' HG23 ' A' ' 136' ' ' VAL . 7.1 ttp -47.77 -3.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.62 -13.9 59.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.779 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 35.7 t -69.36 135.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.997 -0.707 . . . . 0.0 109.444 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.87 167.25 10.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.97 125.95 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 99' ' ' ILE . 11.2 p . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.563 -0.71 . . . . 0.0 109.736 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.778 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.7 m -113.48 -24.53 3.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.214 -0.929 . . . . 0.0 108.52 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.66 112.27 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.05 -1.032 . . . . 0.0 110.273 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -100.47 73.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.15 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.78 ' HB ' HD12 ' A' ' 57' ' ' ILE . 13.6 t -50.08 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.444 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.8 tmtp? -82.96 37.87 0.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.885 0.85 . . . . 0.0 109.168 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.815 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -77.28 -174.13 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.01 0.91 . . . . 0.0 111.395 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 1.6 pm0 -123.73 174.94 7.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.729 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -164.42 147.06 7.29 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 0.0 109.361 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.65 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 80.0 Cg_endo -86.17 126.17 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.331 2.021 . . . . 0.0 113.213 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.28 143.06 48.87 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.01 61.86 6.5 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 8.7 tttp 174.08 -25.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.573 -0.957 . . . . 0.0 108.823 -177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 18' ' ' THR . . . -59.05 152.67 19.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.913 -1.117 . . . . 0.0 108.373 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.869 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.36 165.8 8.57 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.038 -1.039 . . . . 0.0 110.009 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.8 Cg_exo -50.25 36.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.721 1.614 . . . . 0.0 111.733 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.869 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.5 54.47 0.73 Allowed Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.68 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.2 Cg_endo -79.18 169.68 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.66 1.573 . . . . 0.0 111.849 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.59 -4.68 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.256 1.304 . . . . 0.0 111.29 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 26' ' ' ALA . 5.2 t -113.23 -70.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.623 -0.673 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.07 -97.83 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.783 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.2 Cg_exo -58.72 -55.54 1.99 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 CA-C-N 117.97 0.885 . . . . 0.0 110.384 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.794 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -48.77 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.643 . . . . 0.0 110.779 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.843 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -103.24 -48.44 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.261 . . . . 0.0 107.956 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.27 86.74 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.4 mt-30 -146.33 -20.12 0.44 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.673 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 6.9 p80 -79.49 -38.24 34.92 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -170.89 -4.42 0.03 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 84.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.966 . . . . 0.0 112.346 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -158.92 120.11 3.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.076 -1.015 . . . . 0.0 108.711 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.726 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 26.4 mm -93.42 -66.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.728 -0.608 . . . . 0.0 110.076 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.658 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.8 tpt -41.14 -57.71 1.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.664 -1.273 . . . . 0.0 109.728 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.5 mm-40 -44.95 -47.06 11.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.56 -1.337 . . . . 0.0 107.793 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.843 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -53.05 -68.84 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.466 1.127 . . . . 0.0 109.899 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 42' ' ' ASN . 21.9 t -66.38 -37.7 80.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.775 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.658 ' N ' ' O ' ' A' ' 35' ' ' MET . 44.1 tptt -45.67 -61.81 1.55 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.55 69.25 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 108.85 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.688 ' O ' HG23 ' A' ' 45' ' ' THR . 3.3 t80 -70.91 -77.07 0.09 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.8 m120 -41.35 -32.23 0.29 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.953 -1.092 . . . . 0.0 110.751 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -69.52 -33.22 72.5 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.93 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.732 ' HB1' ' HZ3' ' A' ' 70' ' ' LYS . . . -90.52 -47.07 7.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.612 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 41' ' ' PHE . 2.2 p -58.6 -31.34 67.97 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.2 -46.04 21.47 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -56.97 -22.46 38.36 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 0.0 108.922 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.724 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.63 -73.98 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.406 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.724 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 175.17 -154.66 18.66 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.8 t0 -96.28 146.49 24.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.291 . . . . 0.0 108.934 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.078 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 175.01 -153.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.816 -1.178 . . . . 0.0 110.869 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.2 mm -146.09 137.36 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 71' ' ' THR . 2.6 t -137.94 136.15 19.49 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.807 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.8 Cg_endo -72.78 104.66 1.78 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.803 1.669 . . . . 0.0 111.07 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.815 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.5 m -78.34 135.98 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 111.362 -178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.5 tt0 -129.07 69.98 1.4 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.78 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -70.24 90.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.855 0.836 . . . . 0.0 109.967 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.403 HG22 HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -70.59 95.88 1.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 64' ' ' SER . 60.1 mt -100.11 143.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.58 -0.7 . . . . 0.0 110.672 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.778 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.6 m-85 -114.46 138.0 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -46.43 -31.45 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.227 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.29 2.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.776 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 71.87 66.92 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.137 0.97 . . . . 0.0 109.631 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.4 OUTLIER -149.17 125.15 10.63 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.1 p90 -103.75 104.16 14.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.124 -0.985 . . . . 0.0 110.139 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.618 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.87 120.92 41.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.035 . . . . 0.0 110.249 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.945 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.7 OUTLIER 170.38 148.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.962 -1.086 . . . . 0.0 111.214 177.242 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.6 t -169.39 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.254 1.026 . . . . 0.0 108.639 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.59 149.2 27.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.746 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -133.63 122.98 24.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.343 -1.473 . . . . 0.0 110.525 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.8 p 76.02 148.8 0.12 Allowed Pre-proline 0 N--CA 1.492 1.661 0 CA-C-O 121.272 0.558 . . . . 0.0 110.235 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.2 Cg_exo -42.32 175.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.573 2.182 . . . . 0.0 112.803 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.0 Cg_exo -38.87 174.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.498 1.466 . . . . 0.0 111.855 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 53.03 -84.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 73' ' ' PRO . 71.8 p -44.67 -23.15 0.11 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 111.36 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.675 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 14.1 p90 -43.81 -39.59 3.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.174 -0.954 . . . . 0.0 109.199 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.854 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.5 pp -135.05 -14.6 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.012 HD12 ' HB1' ' A' ' 74' ' ' ALA . 6.6 mt -61.15 -31.22 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.753 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 10.8 mmt180 -55.38 -44.78 76.4 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HZ3' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -64.22 -66.89 0.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.695 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.51 -4.94 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.083 -1.011 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.21 -80.36 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 111.725 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 175.76 28.47 0.03 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.548 HD11 HH11 ' A' ' 79' ' ' ARG . 3.1 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.973 -1.31 . . . . 0.0 109.135 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 20.8 t . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.305 0.574 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.433 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 72.37 50.46 16.11 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.789 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.58 114.46 14.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.133 -1.216 . . . . 0.0 109.966 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.37 -174.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.649 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -127.51 159.8 33.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.4 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.678 ' O ' HG22 ' A' ' 104' ' ' VAL . 19.3 t-105 -50.61 -69.61 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.5 -0.75 . . . . 0.0 110.84 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.49 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.24 -46.76 55.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.686 -1.259 . . . . 0.0 110.352 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.695 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -49.19 -47.61 45.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.689 -179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.821 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.3 m -72.11 -23.43 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.097 -1.441 . . . . 0.0 107.99 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 120' ' ' LEU . 17.8 mt -68.09 -73.47 0.14 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 79.5 tt0 -44.03 -41.26 5.32 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.969 -1.082 . . . . 0.0 108.436 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.588 HD13 HD11 ' A' ' 77' ' ' LEU . 48.4 mt -64.6 -30.71 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.128 -0.983 . . . . 0.0 108.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.809 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.73 -26.86 15.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.3 mtpm? -58.54 -73.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.992 -1.067 . . . . 0.0 108.402 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 109' ' ' LYS . 34.0 mt-30 -45.99 -27.38 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 108.911 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 113' ' ' PRO . 12.5 tttt -70.99 -17.68 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.772 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.687 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.04 67.22 79.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.143 -0.973 . . . . 0.0 109.761 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 111' ' ' LYS . 2.4 Cg_endo -66.91 -33.5 32.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.574 1.516 . . . . 0.0 112.088 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 8.0 p30 174.96 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 109.207 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.25 -77.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.552 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -150.51 -25.02 0.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.037 HG22 ' H ' ' A' ' 118' ' ' THR . 23.8 m -65.65 -164.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.973 . . . . 0.0 109.59 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.037 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.42 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 0.0 109.921 -179.144 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -60.98 141.0 57.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 110.113 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.37 -22.04 64.59 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.24 1.019 . . . . 0.0 108.919 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.76 -37.81 87.35 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.504 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.548 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.22 -75.33 0.11 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.232 -1.387 . . . . 0.0 107.83 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.642 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.43 -42.09 6.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.462 -1.399 . . . . 0.0 109.32 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -50.29 -68.76 0.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.106 -0.996 . . . . 0.0 108.609 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.696 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.71 -41.95 5.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 130' ' ' SER . 4.9 tpp -52.84 -80.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.077 -1.014 . . . . 0.0 109.082 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.809 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.4 mm -46.57 -62.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.478 -0.764 . . . . 0.0 110.019 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.821 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.65 -69.6 0.2 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -39.07 3.38 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 126' ' ' MET . 27.5 p -56.48 -52.0 66.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.516 -1.579 . . . . 0.0 107.592 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.646 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -46.94 -49.05 21.23 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.17 -53.98 9.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.648 ' C ' ' H ' ' A' ' 135' ' ' GLY . 9.9 t -44.83 -67.17 0.31 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.753 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 10.1 ttm -49.23 -2.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 88.07 -26.27 7.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.231 -1.947 . . . . 0.0 108.231 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.646 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.1 t -49.49 165.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.864 . . . . 0.0 109.47 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.571 ' N ' HG12 ' A' ' 136' ' ' VAL . 39.2 mp0 -141.99 162.48 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.627 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.4 164.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.928 ' O ' HG13 ' A' ' 139' ' ' VAL . 3.7 p . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.748 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.292 0.568 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.875 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -115.13 -24.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.19 -0.944 . . . . 0.0 108.478 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.75 107.59 5.39 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.258 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -95.59 73.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.831 HG13 HD12 ' A' ' 10' ' ' LEU . 18.1 t -46.78 89.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.662 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 7' ' ' VAL . 6.0 tmtt? -82.62 34.81 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.792 0.806 . . . . 0.0 108.909 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.845 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.36 -174.57 3.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.678 0.751 . . . . 0.0 111.17 -178.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 2.6 pm0 -122.19 172.83 7.98 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -166.58 156.99 10.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 110.059 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.612 ' HA ' HD13 ' A' ' 52' ' ' ILE . 11.3 Cg_endo -68.56 111.24 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.979 1.786 . . . . 0.0 111.668 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.816 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -69.85 39.22 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.982 -1.073 . . . . 0.0 110.499 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.464 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -175.0 -20.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.509 -1.805 . . . . 0.0 111.487 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -142.61 88.4 2.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.609 -1.524 . . . . 0.0 110.291 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 18' ' ' THR . . . -105.14 164.53 11.75 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.16 164.54 4.11 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 109.367 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HA ' HG21 ' A' ' 34' ' ' ILE . 2.7 Cg_endo -55.56 30.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.309 1.339 . . . . 0.0 111.781 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.756 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -151.62 54.07 1.27 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 110.02 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.756 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 19.8 Cg_endo -86.47 168.74 8.52 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.904 1.736 . . . . 0.0 111.614 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.1 -4.63 1.06 Allowed 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 120.935 1.09 . . . . 0.0 110.765 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.732 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.98 -71.25 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.477 0.656 . . . . 0.0 109.911 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 54.41 -98.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.732 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -59.39 -55.83 1.62 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-N 118.11 0.955 . . . . 0.0 109.961 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -44.67 -6.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.358 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -111.09 -44.58 3.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.77 -1.206 . . . . 0.0 108.803 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.34 84.32 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 27' ' ' LEU . 66.3 tp60 -149.07 -12.44 0.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.386 -1.067 . . . . 0.0 108.214 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.599 ' C ' ' ND1' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -85.46 -37.13 20.1 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -170.21 2.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 70.75 78.6 0.18 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.84 -0.8 . . . . 0.0 111.969 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -156.54 120.57 4.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.004 -1.06 . . . . 0.0 108.688 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 30.1 mm -98.55 -63.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.724 -0.61 . . . . 0.0 109.746 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.47 ' C ' ' O ' ' A' ' 34' ' ' ILE . 4.9 tpt -41.39 -55.31 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.733 -1.229 . . . . 0.0 109.653 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' MET . 15.8 mt-10 -46.76 -48.3 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 107.741 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -50.67 -68.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.945 1.355 . . . . 0.0 109.177 177.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 17' ' ' ALA . 45.6 t -54.17 -34.68 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.608 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 1.5 mmmp? -56.55 -65.8 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.76 64.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.71 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -71.31 -76.74 0.1 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.1 m120 -41.65 -34.54 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.512 1.148 . . . . 0.0 110.583 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' O ' ' CG ' ' A' ' 47' ' ' ASN . . . -66.45 -35.67 80.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.77 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.77 -52.0 5.09 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.683 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.761 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.1 p -54.32 -29.45 47.84 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.52 -47.2 12.44 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.553 ' CG ' ' O ' ' A' ' 43' ' ' ALA . 96.2 m-20 -52.38 -23.24 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.318 -0.864 . . . . 0.0 108.983 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.597 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.65 -85.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.678 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.597 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.23 -135.77 1.89 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.855 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.29 125.87 44.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -1.106 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.816 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -159.4 -153.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.612 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.5 mm -147.44 143.85 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.515 HG22 ' C ' ' A' ' 71' ' ' THR . 5.9 t -145.16 136.94 12.93 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.2 Cg_endo -74.12 90.0 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.823 1.682 . . . . 0.0 110.763 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.845 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.9 m -61.98 137.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 122.783 1.278 . . . . 0.0 112.365 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.4 mt-10 -128.81 64.34 1.45 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.766 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.0 mt -64.98 89.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.697 0.76 . . . . 0.0 110.501 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.22 96.89 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.537 HG13 HG22 ' A' ' 57' ' ' ILE . 36.1 mt -99.31 144.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.63 -0.669 . . . . 0.0 110.368 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.748 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 5.0 m-85 -115.81 140.3 49.36 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.875 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.75 -29.61 4.7 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.235 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 55.4 p30 -53.67 4.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.834 ' H ' ' C ' ' A' ' 61' ' ' ALA . 79.1 mtm180 69.05 68.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.985 0.898 . . . . 0.0 109.655 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 p -147.76 128.85 14.58 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -105.51 103.96 13.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.978 -1.076 . . . . 0.0 110.422 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 58' ' ' THR . 8.3 p -98.72 124.64 43.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.71 172.02 7.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.569 -1.332 . . . . 0.0 109.417 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.975 HG12 ' O ' ' A' ' 68' ' ' VAL . 89.8 t -162.83 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 112.622 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.535 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.53 117.28 4.38 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.67 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.813 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.15 120.96 41.51 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.784 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.93 150.53 0.13 Allowed Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.434 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.61 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.7 Cg_exo -38.62 175.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.817 2.345 . . . . 0.0 113.35 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.763 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.72 166.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.574 1.516 . . . . 0.0 111.788 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.987 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 55.01 -76.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.763 ' N ' ' O ' ' A' ' 73' ' ' PRO . 55.3 p -43.17 -24.29 0.08 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 110.128 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.087 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 20.0 p90 -43.59 -43.16 5.5 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 0.0 109.227 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.087 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.88 -13.86 2.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.076 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.987 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.5 mt -62.33 -33.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.799 ' CG ' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.81 -40.81 73.27 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 82' ' ' ALA . 1.8 tmtp? -68.91 -66.33 0.59 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.76 -4.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.695 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.79 -80.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 111.958 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 152.01 52.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.049 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.672 HD11 ' CD ' ' A' ' 79' ' ' ARG . 18.3 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 120.844 -1.386 . . . . 0.0 109.045 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 97' ' ' GLY . 83.5 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.313 0.578 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.57 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 72.75 63.66 2.8 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.695 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.4 mtt180 -134.72 112.48 10.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -1.205 . . . . 0.0 110.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.798 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -102.79 177.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.646 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.703 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -119.33 151.89 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 108.979 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.693 ' O ' HG22 ' A' ' 104' ' ' VAL . 23.4 t-105 -45.93 -69.96 0.12 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 110.91 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.492 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 5.8 tp10 -49.23 -50.36 38.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.718 -1.239 . . . . 0.0 111.018 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.41 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 3.6 mt-30 -51.72 -42.09 62.01 Favored 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.509 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.753 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.56 -26.1 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 117.46 -1.696 . . . . 0.0 107.184 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.896 HD13 HD13 ' A' ' 120' ' ' LEU . 21.6 mt -65.97 -71.27 0.2 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 17.5 mm-40 -43.98 -43.15 6.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.921 -1.112 . . . . 0.0 108.534 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.787 HG12 HD11 ' A' ' 77' ' ' LEU . 52.8 mt -63.5 -31.87 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.592 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.804 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.63 -32.43 13.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.621 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.726 ' HG2' HD21 ' A' ' 120' ' ' LEU . 4.7 mtpt -52.39 -71.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.835 -1.166 . . . . 0.0 108.275 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 109' ' ' LYS . 16.3 tt0 -44.76 -28.74 0.67 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 108.736 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -72.68 -6.95 47.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.75 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.589 ' SD ' ' HB3' ' A' ' 123' ' ' ALA . 7.3 ptm -134.13 63.97 63.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 109.828 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 112' ' ' MET . 4.0 Cg_endo -68.72 -41.13 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.607 1.538 . . . . 0.0 112.059 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.558 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 66.2 t0 -177.37 6.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.444 -0.785 . . . . 0.0 109.089 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.0 mm? -46.42 -83.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 109.583 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -148.66 -19.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.049 HG22 ' H ' ' A' ' 118' ' ' THR . 26.9 m -65.87 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.049 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.69 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.517 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -73.01 140.41 47.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.431 -0.793 . . . . 0.0 110.121 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.896 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -59.65 -23.65 63.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.376 1.084 . . . . 0.0 108.883 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -64.15 -35.58 81.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.574 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.552 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.35 -75.99 0.12 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.272 -1.371 . . . . 0.0 108.072 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.589 ' HB3' ' SD ' ' A' ' 112' ' ' MET . . . -45.01 -35.87 3.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.539 -1.351 . . . . 0.0 109.191 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -55.77 -70.4 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.022 -1.049 . . . . 0.0 108.668 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.665 ' O ' ' N ' ' A' ' 129' ' ' GLY . 20.1 ttp180 -43.51 -39.57 3.44 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.5 ttp -53.27 -78.71 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.134 -0.979 . . . . 0.0 108.53 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.804 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.1 mm -47.94 -63.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.481 -0.762 . . . . 0.0 109.978 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.74 -71.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.87 -41.91 4.72 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.22 -49.35 69.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.583 -1.539 . . . . 0.0 107.578 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.716 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.18 -47.83 45.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.08 -54.69 8.08 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.71 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.6 t -44.87 -68.83 0.16 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.662 ' HG2' HG23 ' A' ' 136' ' ' VAL . 3.4 ttp -46.0 -4.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.71 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.04 -31.77 5.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.716 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 27.1 t -45.28 165.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' N ' HG12 ' A' ' 136' ' ' VAL . 3.5 tp10 -144.33 163.61 33.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.332 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.04 123.93 36.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 99' ' ' ILE . 9.0 p . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.574 -0.704 . . . . 0.0 110.345 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.563 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.064 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -122.31 -24.85 2.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.057 -1.027 . . . . 0.0 110.12 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -155.42 104.91 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.605 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -97.26 74.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.787 ' HB ' HD12 ' A' ' 57' ' ' ILE . 16.5 t -48.82 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.503 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.615 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.3 tmtp? -82.94 37.31 0.53 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.861 0.839 . . . . 0.0 109.217 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.9 tp -78.09 -174.09 3.47 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.901 0.858 . . . . 0.0 111.235 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.653 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -124.26 176.56 6.35 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.697 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -164.43 146.36 6.99 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.847 -1.158 . . . . 0.0 109.299 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 74.1 Cg_endo -84.9 125.78 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.324 2.016 . . . . 0.0 113.576 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.058 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.41 143.77 44.61 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.21 56.08 16.31 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 22.1 tttp 174.35 3.93 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.733 -0.863 . . . . 0.0 109.191 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 18' ' ' THR . . . -86.73 153.32 21.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.892 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.5 165.78 6.15 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.976 -1.078 . . . . 0.0 110.005 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.7 Cg_exo -49.04 33.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.684 1.589 . . . . 0.0 111.868 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.892 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -150.85 54.34 1.41 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.536 -0.728 . . . . 0.0 109.61 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 14.5 Cg_endo -80.23 167.0 20.06 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.72 1.613 . . . . 0.0 111.898 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.61 -4.66 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.24 1.294 . . . . 0.0 111.341 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.779 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.4 t -113.34 -69.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.193 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.41 -97.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_endo -58.71 -55.29 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 CA-C-N 117.892 0.846 . . . . 0.0 110.408 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.774 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -49.56 -9.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.742 -0.599 . . . . 0.0 110.782 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.865 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -106.27 -49.04 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.682 -1.261 . . . . 0.0 108.237 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.62 94.13 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 27' ' ' LEU . 51.3 tt0 -154.54 -24.41 0.12 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.724 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -77.77 -44.78 26.54 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.891 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.724 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -165.98 -11.53 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.14 82.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -1.09 . . . . 0.0 112.397 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.613 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 28.2 p30 -153.01 69.63 0.85 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.83 -1.169 . . . . 0.0 109.14 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.728 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 24.0 mm -44.32 -69.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.702 ' O ' ' N ' ' A' ' 39' ' ' LYS . 7.8 tpt -41.71 -57.38 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.582 -1.324 . . . . 0.0 108.869 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.613 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 69.9 tt0 -44.86 -49.7 10.74 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.865 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -49.58 -65.57 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.723 1.249 . . . . 0.0 109.627 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 42' ' ' ASN . 23.8 t -67.21 -35.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -46.7 -62.2 1.49 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.309 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.73 70.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 108.922 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' THR . 2.8 t80 -71.05 -77.55 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.4 t-20 -41.33 -36.91 0.89 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.825 -1.172 . . . . 0.0 110.585 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -64.72 -33.83 76.89 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.11 -59.59 2.15 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.451 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 41' ' ' PHE . 1.7 p -44.53 -31.7 1.19 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.75 23.89 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -56.34 -25.17 48.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.436 -0.79 . . . . 0.0 109.405 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.55 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -111.5 -73.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.04 -1.037 . . . . 0.0 109.864 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.51 -165.81 34.73 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.944 -1.598 . . . . 0.0 111.392 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.5 p30 -87.22 147.15 25.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.056 -1.261 . . . . 0.0 109.082 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.058 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.93 -153.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.122 . . . . 0.0 110.81 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 13' ' ' PRO . 1.9 mm -146.26 138.18 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 71' ' ' THR . 2.4 t -137.25 135.41 19.53 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.045 -1.034 . . . . 0.0 110.776 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -73.02 102.95 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.685 1.59 . . . . 0.0 111.161 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.825 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.7 m -76.51 136.53 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.658 -1.276 . . . . 0.0 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.1 tt0 -129.88 69.76 1.43 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.787 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -70.31 88.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.721 0.772 . . . . 0.0 110.063 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.43 ' HB ' ' HG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -64.18 95.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 53.9 mt -95.27 131.15 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.575 0.703 . . . . 0.0 110.479 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.563 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -108.29 133.09 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 1.064 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -45.79 -30.89 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.567 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.53 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 27.4 p30 -53.94 2.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.791 ' H ' ' C ' ' A' ' 61' ' ' ALA . 7.5 ttp180 70.83 67.08 0.18 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.2 1.0 . . . . 0.0 110.08 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 p -150.39 124.92 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.4 p90 -102.24 103.86 14.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.041 -1.037 . . . . 0.0 109.89 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.609 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.04 120.98 40.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.189 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.954 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.34 148.78 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 0.0 111.179 177.259 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.0 t -169.98 96.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.08 145.11 30.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.752 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -129.41 123.69 32.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.509 -1.369 . . . . 0.0 110.545 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.752 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.21 150.66 0.13 Allowed Pre-proline 0 N--CA 1.493 1.685 0 CA-C-O 121.175 0.512 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.4 Cg_exo -41.86 175.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.731 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.1 Cg_exo -38.9 171.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.379 1.386 . . . . 0.0 112.035 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.973 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.67 -80.62 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 73' ' ' PRO . 86.6 p -43.61 -23.14 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 110.019 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.053 ' CE1' HD12 ' A' ' 77' ' ' LEU . 16.9 p90 -44.02 -38.91 3.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.243 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -136.95 -14.29 1.59 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.243 ' N ' HD13 ' A' ' 77' ' ' LEU . 1.7 mt -63.39 -33.25 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.567 ' CD ' HG21 ' A' ' 71' ' ' THR . 14.2 mmt180 -55.1 -42.69 73.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 82' ' ' ALA . 6.2 tmtt? -64.2 -65.99 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.67 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.29 -5.3 0.47 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.71 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.65 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.93 -80.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 111.778 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.663 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 167.98 47.52 0.03 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.071 -1.538 . . . . 0.0 110.671 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.467 HD11 ' CD ' ' A' ' 79' ' ' ARG . 4.0 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 0.0 109.132 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 83' ' ' GLY . 95.5 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.269 0.557 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.524 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 78.72 56.92 3.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.65 ' O ' ' O ' ' A' ' 82' ' ' ALA . 3.6 ttt180 -130.57 116.65 18.43 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.287 -1.125 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.682 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.6 168.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.527 -0.733 . . . . 0.0 109.647 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.741 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -109.11 151.04 26.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 108.985 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 104' ' ' VAL . 25.8 t-105 -45.82 -68.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.471 -0.768 . . . . 0.0 110.872 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.414 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 5.9 tp10 -51.32 -47.2 62.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.528 -1.357 . . . . 0.0 110.892 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.67 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -51.49 -43.58 62.24 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.017 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.776 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.01 -24.8 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 117.89 -1.524 . . . . 0.0 107.617 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.876 HD13 HD13 ' A' ' 120' ' ' LEU . 20.8 mt -66.14 -71.55 0.19 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -44.19 -44.78 8.02 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.964 -1.085 . . . . 0.0 108.515 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.773 HG12 HD21 ' A' ' 77' ' ' LEU . 55.8 mt -61.02 -31.4 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.689 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.827 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.03 -24.28 16.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.687 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.1 mtpt -59.57 -73.65 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 108.158 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.47 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 37.5 mt-30 -51.27 -17.94 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.815 . . . . 0.0 109.292 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.56 -8.14 58.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.52 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -133.37 57.87 29.93 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.024 -1.047 . . . . 0.0 109.748 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.99 -41.91 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.521 1.481 . . . . 0.0 112.283 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' LEU . 24.9 t70 -160.68 8.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.44 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.6 mp -44.93 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 109.293 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.427 ' H ' ' H ' ' A' ' 117' ' ' THR . 10.5 t30 -165.18 -4.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.237 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.031 HG22 ' H ' ' A' ' 118' ' ' THR . 29.8 m -74.23 -164.66 0.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.584 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.031 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.97 -57.71 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 118' ' ' THR . 0.7 OUTLIER -80.01 135.02 36.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.876 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -54.24 -24.78 19.96 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.183 0.992 . . . . 0.0 109.172 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.14 -36.74 85.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.535 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.641 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.65 -74.71 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.499 -1.376 . . . . 0.0 108.039 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.59 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.89 -37.65 4.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.496 -1.378 . . . . 0.0 109.136 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -55.34 -70.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 108.925 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -43.49 -38.8 3.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.698 ' O ' ' N ' ' A' ' 130' ' ' SER . 14.0 ttm -53.77 -78.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.827 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.3 mm -48.04 -63.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 109.97 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.776 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.39 -71.84 0.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.9 -42.7 5.08 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 126' ' ' MET . 58.7 m -54.74 -46.18 74.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.616 -1.52 . . . . 0.0 107.462 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.738 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -50.43 -47.55 56.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.0 tmt_? -46.83 -52.32 14.54 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -48.62 -70.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.52 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 5.6 ttm -44.51 -4.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.15 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.75 22.91 54.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.738 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 29.8 t -109.23 138.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -115.03 166.67 11.55 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.837 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -82.79 124.82 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' A' ' 100' ' ' THR . 12.2 p . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.783 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.737 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.5 m -116.92 -24.49 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.18 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.53 114.18 9.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.118 . . . . 0.0 110.529 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -102.55 73.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.78 ' HB ' HD12 ' A' ' 57' ' ' ILE . 7.9 t -48.56 88.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.764 -1.21 . . . . 0.0 110.606 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.9 tmtt? -82.0 36.74 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.168 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.3 mp -77.21 -174.0 3.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.59 0.709 . . . . 0.0 110.977 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.622 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 1.1 pm0 -127.07 177.76 6.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -170.27 157.91 5.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.943 -1.098 . . . . 0.0 109.839 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.674 ' O ' ' N ' ' A' ' 15' ' ' GLY . 10.4 Cg_endo -66.69 104.92 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.373 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.813 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -60.9 38.65 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.338 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.57 -19.42 0.02 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.488 -1.815 . . . . 0.0 111.357 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 10.4 tttm -148.39 79.7 1.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.578 -1.542 . . . . 0.0 110.705 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.771 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -94.96 170.16 9.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.78 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.74 164.25 4.51 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.768 -1.207 . . . . 0.0 110.494 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.4 Cg_exo -51.75 32.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.029 1.819 . . . . 0.0 112.11 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -137.92 53.98 6.91 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.077 -1.015 . . . . 0.0 110.384 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.713 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.7 Cg_endo -85.97 163.13 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.8 1.667 . . . . 0.0 111.809 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.1 -4.81 4.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.016 1.144 . . . . 0.0 111.405 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.815 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 22.0 t -118.59 -66.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.588 -0.695 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.53 -97.23 0.05 OUTLIER Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.815 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.2 Cg_exo -54.3 -55.05 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 CA-C-N 117.876 0.838 . . . . 0.0 110.538 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -64.22 4.7 0.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.665 . . . . 0.0 111.211 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.752 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -109.62 -64.18 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.66 -1.275 . . . . 0.0 109.797 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.58 -16.75 0.07 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 27' ' ' LEU . 22.3 tp60 -42.08 -16.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.472 -1.605 . . . . 0.0 109.528 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.71 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -65.52 -46.29 80.2 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.71 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.67 -5.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 70.86 76.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.077 -0.661 . . . . 0.0 111.892 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.475 ' OD1' ' C ' ' A' ' 32' ' ' ALA . 1.2 m120 -152.06 64.86 0.84 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.307 1.051 . . . . 0.0 108.334 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.5 mm -43.22 -66.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.643 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.0 tpt -41.56 -42.52 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.619 -1.3 . . . . 0.0 108.759 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.21 -49.39 76.16 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -50.91 -67.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.66 1.219 . . . . 0.0 109.093 178.018 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 17' ' ' ALA . 24.8 t -63.36 -36.46 76.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.3 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.5 ttpt -48.99 -60.17 3.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.33 71.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.354 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.64 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.9 t80 -68.79 -76.5 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.575 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.8 m120 -41.8 -32.9 0.44 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.399 1.095 . . . . 0.0 110.893 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.73 -34.75 77.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.611 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.82 -51.55 5.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.775 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.791 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 22.7 p -54.36 -31.48 54.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.33 -45.3 16.37 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -54.17 -22.99 12.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.394 -0.816 . . . . 0.0 109.145 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.58 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.1 -85.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.58 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.94 -144.17 3.99 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.015 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.17 119.8 37.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -1.11 . . . . 0.0 109.806 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.813 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -155.8 -152.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.855 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.595 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.6 mm -146.26 141.83 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 14' ' ' ALA . 6.9 t -144.32 137.5 13.98 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.911 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.6 Cg_endo -73.51 91.72 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.779 1.653 . . . . 0.0 111.482 178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.2 m -57.92 137.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.3 mt-10 -130.19 70.65 1.44 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.78 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.6 mt -70.67 90.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.856 0.836 . . . . 0.0 110.226 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 m -69.98 104.94 2.67 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 64' ' ' SER . 21.1 mt -110.33 148.23 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.494 -0.754 . . . . 0.0 110.927 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.783 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.9 m-85 -116.63 140.94 48.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.785 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.56 -32.46 5.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.267 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -51.44 -1.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.785 ' H ' ' C ' ' A' ' 61' ' ' ALA . 13.1 mtp180 75.02 70.03 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.992 0.901 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -149.44 138.08 20.96 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 42.9 p90 -115.13 103.93 11.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.963 -1.086 . . . . 0.0 110.312 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.47 121.07 41.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.089 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.911 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.37 148.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.955 -1.09 . . . . 0.0 111.211 177.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.8 t -168.49 79.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 69' ' ' THR . 1.0 OUTLIER -87.16 138.15 31.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.656 ' O ' ' OG1' ' A' ' 71' ' ' THR . 8.1 mttm -122.94 140.15 53.3 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.198 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.679 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 2.2 p 57.73 158.07 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.603 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.565 ' O ' ' O ' ' A' ' 71' ' ' THR . 12.7 Cg_exo -39.5 175.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.309 2.006 . . . . 0.0 112.691 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.715 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.9 Cg_exo -40.02 170.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.69 1.593 . . . . 0.0 112.253 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.897 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 58.07 -73.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.715 ' N ' ' O ' ' A' ' 73' ' ' PRO . 7.5 p -43.98 -25.34 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.945 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.055 ' CE1' HD12 ' A' ' 77' ' ' LEU . 17.4 p90 -43.61 -43.21 5.58 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.237 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.85 -13.79 3.2 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.237 ' N ' HD13 ' A' ' 77' ' ' LEU . 1.4 mt -63.31 -29.78 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.76 ' CD ' HD11 ' A' ' 84' ' ' LEU . 3.6 mmt180 -54.07 -48.68 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.7 tmtt? -63.81 -66.14 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.61 -6.54 0.12 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.623 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.57 -77.9 0.35 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 111.949 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 146.9 62.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.038 -1.553 . . . . 0.0 111.189 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.76 HD11 ' CD ' ' A' ' 79' ' ' ARG . 16.8 mt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.951 -1.323 . . . . 0.0 108.901 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 97' ' ' GLY . 86.2 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.271 0.557 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.588 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 70.89 67.81 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.788 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.57 109.82 9.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -1.212 . . . . 0.0 110.403 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.687 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.42 175.59 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.786 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -123.34 158.38 31.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.687 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.4 t-105 -45.19 -70.86 0.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.351 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.511 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.72 -50.8 54.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.562 -1.336 . . . . 0.0 111.108 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.0 mt-30 -49.27 -43.66 43.24 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.288 -0.883 . . . . 0.0 110.35 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.35 -24.79 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.616 -1.634 . . . . 0.0 107.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 120' ' ' LEU . 13.5 mt -66.32 -71.45 0.19 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.497 ' CD ' ' OE2' ' A' ' 102' ' ' GLU . 35.1 mt-10 -43.77 -43.72 6.26 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.93 -1.106 . . . . 0.0 108.461 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.683 HG12 HD21 ' A' ' 77' ' ' LEU . 55.2 mt -61.65 -31.5 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 108.396 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.815 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.97 -26.77 15.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 109.62 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.8 mtpt -59.26 -73.56 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 0.0 108.211 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 12.3 tt0 -49.35 -18.27 0.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.253 -0.904 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.511 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.8 tmtt? -80.82 -10.2 59.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.581 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -132.38 55.46 17.82 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.9 Cg_endo -60.2 -40.89 55.87 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.567 1.512 . . . . 0.0 112.3 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.529 ' C ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -164.91 9.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.54 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.459 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.2 mp -45.0 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.356 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -160.24 -10.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.024 HG22 ' H ' ' A' ' 118' ' ' THR . 29.0 m -68.65 -164.63 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.024 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.65 -57.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -80.2 135.22 36.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -54.86 -23.74 19.89 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.16 0.981 . . . . 0.0 109.103 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.11 -35.8 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.47 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.627 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.63 -74.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.964 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.644 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.63 -39.05 4.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.342 -1.474 . . . . 0.0 109.152 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.5 -69.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.087 -1.008 . . . . 0.0 108.728 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.79 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -42.81 5.36 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.705 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.5 ttm -51.29 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.115 -0.991 . . . . 0.0 108.454 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.815 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.5 mm -48.37 -66.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.678 0.751 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.884 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -57.89 -71.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.86 -40.82 4.23 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 126' ' ' MET . 44.0 m -56.26 -51.25 68.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.518 -1.577 . . . . 0.0 107.723 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.14 -47.63 23.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.767 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -47.06 -54.26 10.75 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.701 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.1 t -44.77 -68.59 0.18 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.656 ' HG2' HG23 ' A' ' 136' ' ' VAL . 3.8 ttp -46.46 -4.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.73 -31.49 4.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.796 -2.122 . . . . 0.0 107.796 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.656 HG23 ' HG2' ' A' ' 134' ' ' MET . 31.3 t -45.09 165.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.937 -0.743 . . . . 0.0 109.173 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.9 tm-20 -142.43 162.26 35.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.598 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.587 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -78.08 164.35 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.899 ' O ' HG13 ' A' ' 139' ' ' VAL . 4.1 p . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.748 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.924 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.0 m -121.12 -24.59 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.19 110.88 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.605 -1.309 . . . . 0.0 110.716 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -100.92 73.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.827 ' HB ' HD12 ' A' ' 57' ' ' ILE . 21.5 t -46.36 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 110.49 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.9 tmmm? -83.26 34.99 0.48 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.091 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.78 -174.15 3.81 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.917 0.865 . . . . 0.0 111.596 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 1.3 pm0 -121.55 172.12 8.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.51 160.93 4.11 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.854 -1.154 . . . . 0.0 109.857 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.79 ' HD2' HD23 ' A' ' 12' ' ' LEU . 8.8 Cg_endo -61.53 129.41 27.91 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.042 1.828 . . . . 0.0 111.81 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.83 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -90.62 42.16 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 111.28 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.621 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 172.43 -12.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.59 70.96 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.419 . . . . 0.0 109.557 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.642 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -90.8 165.21 13.77 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.431 -0.793 . . . . 0.0 109.319 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.69 161.73 5.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.667 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -54.04 31.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.509 1.473 . . . . 0.0 111.466 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -144.94 54.3 2.44 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 0.0 110.265 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.3 Cg_endo -83.09 154.87 14.72 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.584 1.523 . . . . 0.0 111.544 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.58 -4.46 0.32 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.048 1.165 . . . . 0.0 111.018 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.091 HG22 HD22 ' A' ' 10' ' ' LEU . 2.9 t -103.77 -71.82 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.524 0.678 . . . . 0.0 110.592 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.29 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.741 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.11 -55.5 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 CA-C-N 118.048 0.924 . . . . 0.0 110.188 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.587 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -45.0 -7.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.815 -0.553 . . . . 0.0 110.657 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.745 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -108.37 -45.57 3.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.686 -1.259 . . . . 0.0 108.798 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.81 88.95 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' LEU . 2.7 tt0 -149.73 -15.19 0.27 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.617 ' C ' ' ND1' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -89.46 -36.85 15.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -172.36 -1.82 0.03 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.09 82.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.96 . . . . 0.0 112.188 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.583 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 26.7 p-10 -156.74 119.22 3.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.867 -1.145 . . . . 0.0 109.08 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.2 mm -93.96 -65.26 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.4 tpt -42.72 -55.08 3.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.948 -1.095 . . . . 0.0 109.417 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' CB ' ' ND2' ' A' ' 33' ' ' ASN . 4.8 mp0 -51.01 -53.41 33.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 108.458 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.745 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -46.17 -59.11 3.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.936 1.35 . . . . 0.0 108.796 177.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 17' ' ' ALA . 87.2 t -70.87 -26.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 35' ' ' MET . 23.1 tptt -56.26 -55.25 35.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.79 78.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.729 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CD2' HG21 ' A' ' 45' ' ' THR . 0.6 OUTLIER -67.37 -75.73 0.09 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.637 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 8.9 t-20 -41.78 -35.84 0.89 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.26 1.029 . . . . 0.0 110.715 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -62.95 -34.28 77.15 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.52 -60.33 1.91 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.502 1.144 . . . . 0.0 108.76 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.786 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 52.7 p -47.53 -28.06 2.07 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.764 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.29 -46.71 9.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -49.54 -19.92 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.239 -0.913 . . . . 0.0 108.883 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.645 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.83 -85.29 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.255 -0.903 . . . . 0.0 109.679 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.645 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -166.21 -150.8 6.48 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.912 -1.613 . . . . 0.0 110.962 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HA3' ' A' ' 15' ' ' GLY . 21.4 m-20 -106.39 107.81 19.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.565 -0.962 . . . . 0.0 110.037 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.83 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -143.48 -152.87 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 109.616 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 13' ' ' PRO . 7.1 mm -146.6 142.88 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 71' ' ' THR . 1.6 t -144.91 139.25 15.04 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.7 Cg_endo -75.75 91.48 1.08 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.766 1.644 . . . . 0.0 111.025 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.849 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.9 m -59.56 138.06 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 9.9 mt-10 -131.14 66.55 1.53 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.827 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -66.53 92.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.665 0.745 . . . . 0.0 110.397 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.11 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 64' ' ' SER . 89.4 mt -103.05 142.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.509 -0.744 . . . . 0.0 110.683 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.748 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 5.6 m-85 -115.91 138.36 51.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.924 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.9 -30.75 4.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.437 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.23 1.5 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.809 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.7 OUTLIER 71.38 68.07 0.16 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.04 0.924 . . . . 0.0 109.893 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -149.47 131.24 15.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.195 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.3 p90 -108.63 104.11 13.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.049 -1.032 . . . . 0.0 110.098 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.5 121.02 41.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.978 -1.076 . . . . 0.0 110.201 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.95 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.21 149.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.953 -1.092 . . . . 0.0 111.283 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.1 t -169.69 84.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 138.7 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.816 ' O ' ' OG1' ' A' ' 71' ' ' THR . 14.8 mtmt -124.37 141.67 51.89 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.071 -1.451 . . . . 0.0 110.766 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.816 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 41.4 p 62.5 155.13 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.818 -0.552 . . . . 0.0 109.874 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' O ' ' OG ' ' A' ' 75' ' ' SER . 7.8 Cg_exo -42.09 175.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.406 2.071 . . . . 0.0 112.737 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 75' ' ' SER . 29.1 Cg_exo -38.43 170.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.494 1.462 . . . . 0.0 112.088 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.49 -73.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.782 ' N ' ' O ' ' A' ' 73' ' ' PRO . 21.3 p -43.42 -19.43 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.557 -0.714 . . . . 0.0 111.08 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.771 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -43.66 -41.14 4.54 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.779 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -133.2 -14.39 2.64 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.867 HD12 ' HB1' ' A' ' 74' ' ' ALA . 2.0 mt -59.19 -33.14 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.61 ' CD ' HG21 ' A' ' 71' ' ' THR . 15.0 mmt180 -54.7 -42.56 71.64 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 82' ' ' ALA . 13.8 tmtt? -66.47 -66.1 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.833 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.83 -4.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.485 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.642 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.33 -79.7 0.23 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.437 -0.79 . . . . 0.0 111.694 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.602 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 167.08 45.09 0.02 OUTLIER Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.574 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.526 HD11 HH11 ' A' ' 79' ' ' ARG . 4.4 mt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.346 . . . . 0.0 109.248 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.252 0.549 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.94 66.38 1.04 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.802 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.93 114.87 14.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.705 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -103.97 177.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.778 . . . . 0.0 109.356 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.782 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -117.76 153.94 32.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.012 -1.055 . . . . 0.0 109.292 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.672 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.7 t-105 -48.12 -69.36 0.12 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.93 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.501 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.2 -46.47 54.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.696 -1.252 . . . . 0.0 110.646 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.833 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -51.65 -45.07 63.22 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.041 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.872 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.3 m -72.24 -24.45 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.732 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.913 HD13 HD13 ' A' ' 120' ' ' LEU . 17.2 mt -66.91 -72.11 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 74.4 tt0 -43.93 -43.17 6.33 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.932 -1.105 . . . . 0.0 108.572 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.6 mt -62.66 -31.29 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 108.651 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.819 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.39 -26.94 15.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.451 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.3 mtpt -58.76 -73.36 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 108.346 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 109' ' ' LYS . 70.0 mt-30 -46.86 -25.68 0.82 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.815 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' A' ' 113' ' ' PRO . 27.7 tptt -72.8 -18.43 61.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.697 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -128.69 66.53 75.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 109.856 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -63.6 -41.25 26.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.501 1.468 . . . . 0.0 112.284 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 66.1 t0 -176.84 9.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.376 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 1.1 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.87 -85.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.792 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -145.45 -21.97 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.398 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.054 HG22 ' H ' ' A' ' 118' ' ' THR . 25.5 m -65.84 -164.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.526 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.054 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.6 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.134 -0.979 . . . . 0.0 109.945 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.536 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -61.47 140.3 58.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.913 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.14 -22.15 64.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.255 1.026 . . . . 0.0 108.928 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.39 -38.07 88.87 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.525 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.42 -75.27 0.11 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.907 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.596 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.5 -43.05 7.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.405 -1.435 . . . . 0.0 109.402 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.69 -68.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.793 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -43.02 5.48 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.688 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.9 ttm -51.61 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -0.963 . . . . 0.0 108.74 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.819 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.4 mm -48.41 -64.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.674 0.749 . . . . 0.0 109.973 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.872 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.4 -71.47 0.12 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -39.39 3.67 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 126' ' ' MET . 36.6 m -56.33 -51.21 69.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.592 -1.534 . . . . 0.0 107.699 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.696 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.79 -47.66 30.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -46.62 -54.24 9.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.4 t -44.56 -67.82 0.25 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.624 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.9 ttp -46.64 -3.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.53 -24.02 13.77 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.696 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 27.2 t -57.47 135.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.975 -0.72 . . . . 0.0 109.387 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -112.09 164.74 12.82 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.35 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.837 ' O ' HG13 ' A' ' 139' ' ' VAL . 12.2 p . . . . . 0 C--N 1.303 -1.455 0 O-C-N 121.641 -0.662 . . . . 0.0 109.622 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.795 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.282 0.563 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -114.79 -24.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.79 113.6 9.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.328 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -101.61 73.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 109.128 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.783 ' HB ' HD12 ' A' ' 57' ' ' ILE . 6.0 t -49.11 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 O-C-N 120.646 -1.284 . . . . 0.0 110.472 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.26 36.74 0.48 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.927 0.87 . . . . 0.0 109.017 179.004 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.1 mp -76.23 -174.1 2.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.874 0.845 . . . . 0.0 111.045 -178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -125.94 176.11 7.21 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.674 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -165.81 145.96 5.5 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.968 -1.082 . . . . 0.0 109.292 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.669 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 72.1 Cg_endo -84.94 126.71 3.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.232 1.955 . . . . 0.0 113.437 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.61 143.47 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 51.2 54.17 24.53 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.669 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 34.1 tttt 174.48 4.01 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.729 -0.865 . . . . 0.0 109.521 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 18' ' ' THR . . . -84.4 156.17 21.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.895 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.95 165.64 4.03 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.915 -1.115 . . . . 0.0 110.26 -178.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HD2' HG22 ' A' ' 18' ' ' THR . 6.9 Cg_exo -47.79 33.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.925 1.75 . . . . 0.0 111.943 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.895 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -142.06 54.2 3.68 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.998 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.716 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -83.35 169.01 12.82 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.832 1.688 . . . . 0.0 112.019 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.31 -4.83 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 121.244 1.296 . . . . 0.0 111.377 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 26' ' ' ALA . 19.5 t -119.34 -64.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.582 -0.698 . . . . 0.0 109.505 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.29 -97.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.803 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -55.57 -55.24 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 CA-C-N 117.817 0.808 . . . . 0.0 110.642 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -60.58 1.94 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.663 -0.648 . . . . 0.0 111.213 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.752 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.41 -58.0 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.697 -1.252 . . . . 0.0 109.411 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.751 ' O ' ' N ' ' A' ' 32' ' ' ALA . . . -43.12 -17.29 0.04 OUTLIER Glycine 0 N--CA 1.485 1.948 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.531 ' C ' ' O ' ' A' ' 28' ' ' GLY . 13.0 mm100 -42.63 -27.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.176 -1.779 . . . . 0.0 107.885 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.768 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 14.2 p-80 -66.33 54.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 89.55 -18.77 44.32 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.751 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 75.19 83.06 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -1.118 . . . . 0.0 112.09 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.599 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -153.22 67.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.952 -1.092 . . . . 0.0 109.251 177.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 29.5 mm -43.85 -67.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.728 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.0 tpt -41.1 -56.93 2.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.473 -1.392 . . . . 0.0 109.218 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.599 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 18.9 tt0 -44.71 -47.64 10.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.452 -1.405 . . . . 0.0 107.631 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.756 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -51.97 -69.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.583 1.182 . . . . 0.0 109.705 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 42' ' ' ASN . 27.8 t -65.32 -36.26 77.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.484 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 35' ' ' MET . 16.0 tttt -46.08 -62.06 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.81 -33.76 68.93 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 2.8 t80 -71.45 -78.36 0.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.1 t-20 -41.23 -30.91 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.896 -1.127 . . . . 0.0 110.679 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -70.55 -32.86 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.089 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB1' ' HZ2' ' A' ' 70' ' ' LYS . . . -90.33 -45.88 8.74 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.552 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.584 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 9.4 p -60.24 -31.16 69.93 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.85 23.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.75 -22.45 46.94 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.685 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.55 -71.82 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.685 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.47 -130.04 1.5 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.123 -1.513 . . . . 0.0 111.067 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -122.64 145.81 48.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -1.187 . . . . 0.0 108.85 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.078 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.93 -154.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.736 -1.228 . . . . 0.0 111.192 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.072 HD12 ' C ' ' A' ' 51' ' ' ALA . 1.9 mp -144.25 135.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 71' ' ' THR . 2.7 t -135.36 132.66 20.05 Favored Pre-proline 0 C--N 1.296 -1.75 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.92 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 8.9 Cg_endo -71.9 103.47 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.654 1.57 . . . . 0.0 111.192 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -75.96 136.39 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.652 -1.28 . . . . 0.0 111.493 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.1 mt-10 -129.08 70.39 1.41 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.4 mt -70.55 90.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.882 0.848 . . . . 0.0 110.07 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.455 ' HB ' ' HG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -70.82 95.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.919 HG23 ' O ' ' A' ' 64' ' ' SER . 46.4 mt -101.57 147.67 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.659 -0.651 . . . . 0.0 110.583 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.795 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.0 m-85 -115.62 142.2 47.05 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.28 -33.15 8.32 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.238 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 56.4 p30 -50.8 -1.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.797 ' H ' ' C ' ' A' ' 61' ' ' ALA . 16.2 ttm180 75.25 70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.048 0.928 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.919 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -149.49 147.04 27.73 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.9 p90 -123.32 103.91 8.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.974 -1.079 . . . . 0.0 110.188 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.5 p -101.48 120.77 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 110.002 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.922 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.9 OUTLIER 170.3 147.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.952 -1.092 . . . . 0.0 111.295 177.415 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.6 t -168.52 97.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.301 1.048 . . . . 0.0 108.519 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.01 144.02 33.32 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.733 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -128.14 131.54 48.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.461 -1.399 . . . . 0.0 111.157 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.733 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER 67.75 160.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.954 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.624 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.5 Cg_exo -38.9 175.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.686 2.257 . . . . 0.0 113.193 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.732 ' O ' ' N ' ' A' ' 75' ' ' SER . 19.9 Cg_exo -44.27 171.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.566 1.511 . . . . 0.0 112.183 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.642 ' HB1' ' CD1' ' A' ' 78' ' ' ILE . . . 55.2 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.88 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 60.2 p -43.02 -19.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.446 -0.784 . . . . 0.0 110.367 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.854 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 27.5 p90 -43.47 -34.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.854 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.38 -16.73 1.82 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.226 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.88 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 6.8 mt -56.71 -31.73 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 75' ' ' SER . 9.1 mmm180 -54.43 -49.0 71.01 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.4 tmtt? -62.59 -65.74 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.708 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -56.62 -7.92 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 109.668 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.96 -78.11 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 111.519 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.852 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 147.19 68.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.333 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 83' ' ' GLY . 2.7 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.194 -1.18 . . . . 0.0 109.313 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.456 HG13 HD22 ' A' ' 84' ' ' LEU . 86.0 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.899 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 72.03 76.45 0.61 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 82' ' ' ALA . 14.9 ttm180 -135.36 106.23 6.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.3 -177.49 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 109.884 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.805 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -120.95 151.68 39.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.261 -0.899 . . . . 0.0 108.94 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.705 ' O ' HG22 ' A' ' 104' ' ' VAL . 31.9 t-105 -48.28 -67.45 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 110.561 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 7.4 tp10 -50.5 -48.29 56.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.728 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.708 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -50.61 -44.01 56.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.02 -25.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 117.719 -1.593 . . . . 0.0 107.462 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 120' ' ' LEU . 21.9 mt -66.26 -72.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.563 ' OE1' ' OE2' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -44.31 -43.29 7.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.089 -1.007 . . . . 0.0 108.802 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.822 HG12 HD11 ' A' ' 77' ' ' LEU . 60.2 mt -63.51 -31.29 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.054 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.75 -30.62 13.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.292 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.681 ' N ' ' O ' ' A' ' 105' ' ' LEU . 17.4 mtpt -54.73 -72.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 108.646 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 109' ' ' LYS . 30.0 tt0 -45.59 -31.12 1.72 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.16 -0.963 . . . . 0.0 109.032 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.513 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.1 tmtt? -63.99 -15.67 59.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.752 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.496 ' CG ' ' O ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -128.63 70.78 80.54 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.939 -1.101 . . . . 0.0 109.71 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.66 -39.29 21.38 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.565 1.51 . . . . 0.0 112.15 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.56 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -178.21 10.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.237 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -48.24 -82.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -151.37 -22.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.07 HG22 ' H ' ' A' ' 118' ' ' THR . 27.0 m -59.95 -164.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.989 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.07 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -176.0 -70.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.862 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.551 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -65.28 137.5 57.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -59.21 -21.41 59.45 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.277 1.037 . . . . 0.0 108.746 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -65.69 -34.29 77.85 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.589 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.524 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.56 -76.23 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.464 -1.398 . . . . 0.0 107.935 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.64 -39.08 4.75 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.439 -1.413 . . . . 0.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.94 -67.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.06 -1.025 . . . . 0.0 108.535 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 12.9 ttt180 -43.36 -36.74 2.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.623 ' O ' ' N ' ' A' ' 130' ' ' SER . 7.3 ttm -57.24 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 108.886 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 30.0 mm -48.63 -57.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 110.199 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.681 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -66.62 -70.28 0.26 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -42.42 5.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.732 ' OG ' ' O ' ' A' ' 127' ' ' ILE . 54.7 p -52.86 -50.0 64.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.512 -1.581 . . . . 0.0 107.152 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.752 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.2 -48.62 45.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.559 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -44.77 -51.67 9.17 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.1 t -50.57 -68.81 0.14 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.534 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 5.5 ttp -44.95 -4.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.713 -0.617 . . . . 0.0 110.407 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.4 25.47 47.3 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.899 HG22 ' HA3' ' A' ' 97' ' ' GLY . 28.9 t -107.71 165.52 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.858 -0.79 . . . . 0.0 109.233 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . 5.1 tt0 -139.53 162.64 34.58 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.989 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.07 117.73 25.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.805 HG12 ' HA ' ' A' ' 100' ' ' THR . 7.0 p . . . . . 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.823 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.582 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.998 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -122.59 -24.91 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 110.093 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.41 107.38 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.758 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.62 74.31 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.827 ' HB ' HD12 ' A' ' 57' ' ' ILE . 25.1 t -48.73 88.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.956 -1.09 . . . . 0.0 110.876 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 tmtm? -82.38 37.05 0.49 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.715 0.769 . . . . 0.0 109.315 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.127 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -80.09 -174.07 4.29 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.721 0.772 . . . . 0.0 111.461 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.635 ' OE1' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.93 174.77 7.35 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.085 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.804 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.78 161.75 3.84 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.704 -1.247 . . . . 0.0 110.098 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.804 ' HD2' HD23 ' A' ' 12' ' ' LEU . 9.5 Cg_endo -62.2 126.6 18.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.904 1.736 . . . . 0.0 111.668 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.82 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -88.1 42.21 1.05 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.035 -1.041 . . . . 0.0 111.332 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.579 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 174.81 -12.12 0.03 OUTLIER Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.906 -1.616 . . . . 0.0 110.832 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -143.26 73.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 109.622 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.653 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -93.2 169.66 10.23 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.193 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -175.31 162.45 2.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.021 -1.049 . . . . 0.0 109.693 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.1 Cg_exo -53.97 31.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.581 1.521 . . . . 0.0 111.33 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -147.38 54.03 1.8 Allowed Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.102 -0.999 . . . . 0.0 110.083 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.738 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.3 Cg_endo -85.06 157.83 11.42 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.746 1.631 . . . . 0.0 111.522 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -52.75 -4.52 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 120.939 1.093 . . . . 0.0 110.846 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.127 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -105.08 -72.08 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 121.623 0.725 . . . . 0.0 110.296 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.65 -98.33 0.05 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -59.89 -55.39 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 CA-C-N 118.004 0.902 . . . . 0.0 109.959 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -43.8 -11.98 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.266 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.861 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.25 -38.73 4.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.686 -1.259 . . . . 0.0 108.114 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.38 96.13 0.01 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 27' ' ' LEU . 41.2 tt0 -162.94 -22.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.688 ' O ' ' CD2' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -83.84 65.55 8.65 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.679 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 80.54 -5.99 62.64 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.37 83.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 112.021 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 33.2 m120 -159.32 124.85 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.903 -1.123 . . . . 0.0 108.905 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.565 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 20.8 mm -101.22 -62.1 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 0.0 109.858 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.663 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.49 -47.52 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 109.749 -176.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -55.75 -48.74 74.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 0.0 107.845 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.861 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -49.79 -63.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.612 1.196 . . . . 0.0 108.818 178.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.653 HG13 ' CB ' ' A' ' 17' ' ' ALA . 98.0 t -68.55 -30.15 46.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.194 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 35' ' ' MET . 36.0 tptt -54.83 -54.57 40.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.06 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 109.634 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.532 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.0 OUTLIER -67.76 -75.5 0.1 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.231 -1.543 . . . . 0.0 106.896 176.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.645 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.7 m-20 -41.5 -38.26 1.26 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.117 -0.99 . . . . 0.0 110.735 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -61.53 -33.71 74.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.712 ' HB1' ' NZ ' ' A' ' 70' ' ' LYS . . . -91.13 -57.77 2.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.591 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.802 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 40.0 p -50.75 -26.82 6.07 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.766 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.645 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.12 -45.86 10.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -52.7 -18.94 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 0.0 108.886 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.48 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.41 -85.31 0.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . -168.15 -150.47 6.6 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.89 -1.624 . . . . 0.0 110.794 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -105.62 107.43 18.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -1.005 . . . . 0.0 109.976 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.82 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -144.15 -152.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.854 . . . . 0.0 109.611 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 13' ' ' PRO . 7.8 mm -146.04 143.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 14' ' ' ALA . 2.2 t -143.6 137.18 14.24 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.128 -0.983 . . . . 0.0 110.497 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -74.53 91.61 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.841 1.694 . . . . 0.0 110.628 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.881 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -60.09 136.53 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 122.706 1.241 . . . . 0.0 111.662 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 30.4 tt0 -130.6 69.51 1.46 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.827 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -71.08 90.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.719 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.73 96.02 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.1 mt -97.15 135.81 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.446 -0.784 . . . . 0.0 110.865 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -111.7 136.01 51.52 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.998 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -46.63 -32.94 3.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.742 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 56.0 m-20 -51.3 -2.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.789 ' H ' ' C ' ' A' ' 61' ' ' ALA . 9.7 ttm180 75.11 68.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.072 0.939 . . . . 0.0 109.74 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 10.4 m -149.72 124.97 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.717 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -102.9 103.98 14.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.157 -0.964 . . . . 0.0 110.009 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -100.55 120.51 40.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.969 -1.082 . . . . 0.0 109.911 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.941 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 169.94 150.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.956 177.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.6 t -169.45 78.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -84.14 148.97 26.48 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.766 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.1 mttm -136.46 134.1 37.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.906 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.766 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.3 p 75.34 150.75 0.13 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.646 ' HD3' ' HB1' ' A' ' 51' ' ' ALA . 7.1 Cg_exo -43.4 175.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.46 2.106 . . . . 0.0 113.149 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.805 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.0 Cg_exo -41.98 177.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.74 1.627 . . . . 0.0 112.007 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 44.91 -84.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.805 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -43.96 -15.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 109.614 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.948 ' CE1' HD12 ' A' ' 77' ' ' LEU . 21.1 p90 -44.15 -35.67 2.3 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.218 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -139.71 -14.86 1.06 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.218 ' N ' HD13 ' A' ' 77' ' ' LEU . 2.0 mt -63.1 -33.25 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.578 ' HG3' HG21 ' A' ' 71' ' ' THR . 1.6 mmt180 -55.44 -44.88 76.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.1 tmtp? -61.54 -65.48 0.68 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.487 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -59.61 -6.13 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.475 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.641 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -82.24 -81.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.45 -0.781 . . . . 0.0 111.555 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.17 34.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.549 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.574 HD11 ' CD ' ' A' ' 79' ' ' ARG . 3.5 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.884 -1.363 . . . . 0.0 109.031 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 97' ' ' GLY . 94.8 t . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.31 0.576 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.593 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 72.16 60.26 4.23 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 82' ' ' ALA . 1.4 ttt180 -132.03 117.03 17.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -1.182 . . . . 0.0 110.117 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.47 -169.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.033 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.724 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.12 163.26 28.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.097 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.686 ' O ' HG22 ' A' ' 104' ' ' VAL . 23.8 t-105 -53.45 -69.5 0.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 110.643 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.454 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 7.4 tp10 -51.03 -45.31 61.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.527 -1.358 . . . . 0.0 110.427 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.487 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -51.3 -45.89 62.35 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.782 -179.353 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.5 -22.78 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.774 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.75 HD13 HD13 ' A' ' 120' ' ' LEU . 17.7 mt -68.01 -72.49 0.17 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 105' ' ' LEU . 76.3 tt0 -43.83 -43.95 6.55 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.889 -1.132 . . . . 0.0 108.508 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.724 HG12 HD21 ' A' ' 77' ' ' LEU . 62.9 mt -61.77 -31.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 108.46 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.823 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.69 -20.85 17.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.462 -0.774 . . . . 0.0 109.481 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 105' ' ' LEU . 26.0 mttm -62.49 -74.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.852 -1.155 . . . . 0.0 108.167 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.464 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 56.7 mt-30 -50.48 -20.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.585 ' HD3' HD11 ' A' ' 127' ' ' ILE . 17.7 tttt -69.4 -4.97 20.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.042 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.586 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -135.69 63.09 51.71 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.903 -1.123 . . . . 0.0 109.715 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 112' ' ' MET . 5.1 Cg_endo -71.3 -30.79 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.572 1.515 . . . . 0.0 111.883 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -166.84 4.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mp -44.84 -85.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -171.96 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.206 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.033 HG22 ' H ' ' A' ' 118' ' ' THR . 29.6 m -75.43 -164.39 0.33 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.033 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.81 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.083 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.691 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -94.82 130.56 41.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.75 HD13 HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -58.9 -35.02 72.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.418 1.104 . . . . 0.0 108.648 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.465 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 50.7 mp0 -62.75 -33.5 75.28 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.467 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -73.3 -74.25 0.18 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.586 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.23 -37.45 4.64 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.489 -1.382 . . . . 0.0 109.019 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -56.65 -69.48 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 108.847 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.646 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.6 OUTLIER -43.38 -35.95 1.74 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.669 ' O ' ' CB ' ' A' ' 130' ' ' SER . 6.0 ttm -56.13 -76.64 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.823 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.9 mm -48.82 -63.48 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.689 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.12 -72.26 0.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.49 -41.16 4.02 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.669 ' CB ' ' O ' ' A' ' 126' ' ' MET . 60.2 m -57.91 -47.87 81.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.547 -1.561 . . . . 0.0 107.443 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.538 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.25 -49.72 42.05 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.794 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.71 -55.09 6.89 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.669 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.5 t -44.67 -67.45 0.28 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.499 ' CE ' ' HB2' ' A' ' 75' ' ' SER . 0.6 OUTLIER -47.4 -4.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.669 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.55 -31.11 5.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 137' ' ' GLU . 41.3 t -45.02 165.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.909 -0.759 . . . . 0.0 108.972 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.57 ' N ' HG12 ' A' ' 136' ' ' VAL . 81.0 tt0 -142.25 162.73 34.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.8 t -83.26 137.68 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.677 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.2 p . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.455 -0.778 . . . . 0.0 109.533 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.753 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.6 m -115.67 -24.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.44 110.18 6.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.344 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.16 73.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 57' ' ' ILE . 35.4 t -48.52 88.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.542 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.93 36.47 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.819 0.819 . . . . 0.0 109.324 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.016 HD22 HG22 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -77.91 -174.12 3.41 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.432 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.669 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 1.5 pm0 -121.35 172.49 7.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.803 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -169.04 161.05 8.0 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.086 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.803 ' HD2' HD23 ' A' ' 12' ' ' LEU . 13.8 Cg_endo -66.95 109.61 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.065 1.844 . . . . 0.0 111.316 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.829 ' HB3' ' C ' ' A' ' 51' ' ' ALA . . . -67.64 41.08 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.856 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.491 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 176.6 -14.15 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.515 -1.802 . . . . 0.0 111.522 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 17.0 tttt -138.25 56.83 1.72 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.6 . . . . 0.0 110.557 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.711 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -75.32 160.03 30.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.669 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.41 162.37 23.72 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.681 -1.262 . . . . 0.0 110.981 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 18' ' ' THR . 1.2 Cg_endo -57.05 38.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.087 1.858 . . . . 0.0 111.847 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.669 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -173.06 56.77 0.21 Allowed Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.53 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.653 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.8 Cg_endo -79.76 169.02 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 121.467 1.444 . . . . 0.0 111.382 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.08 -4.68 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.071 1.181 . . . . 0.0 110.922 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.016 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -106.85 -72.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.582 0.706 . . . . 0.0 110.256 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.35 -98.01 0.05 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.743 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.59 -55.65 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 CA-C-N 118.088 0.944 . . . . 0.0 110.055 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.647 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.79 -10.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.83 -0.544 . . . . 0.0 110.243 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.839 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.75 -44.11 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.859 -1.151 . . . . 0.0 108.815 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.62 96.38 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 27' ' ' LEU . 10.6 tt0 -159.49 -26.68 0.07 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.717 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.4 p80 -78.74 64.17 3.67 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.7 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.661 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 81.82 -7.84 61.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 83.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -1.126 . . . . 0.0 112.097 177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -157.97 123.69 4.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.676 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 19.8 mm -97.55 -63.71 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.049 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.614 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.0 tpt -41.29 -51.64 3.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.768 -1.208 . . . . 0.0 109.989 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.57 -48.39 57.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.667 -1.271 . . . . 0.0 108.007 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.839 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -51.81 -65.83 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.535 1.16 . . . . 0.0 109.353 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.711 HG13 ' CB ' ' A' ' 17' ' ' ALA . 67.8 t -65.49 -30.03 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.915 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.4 OUTLIER -55.67 -56.1 24.38 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.836 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.14 77.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.608 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.607 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.9 t80 -69.49 -76.77 0.09 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.341 -1.474 . . . . 0.0 107.155 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 9.8 t-20 -41.66 -32.36 0.37 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.971 -1.081 . . . . 0.0 110.734 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.84 -34.08 76.02 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HB1' ' HD3' ' A' ' 70' ' ' LYS . . . -90.45 -53.39 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.603 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.774 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 27.9 p -53.51 -30.38 41.06 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.6 -45.2 16.16 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -54.15 -21.77 9.56 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.154 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.702 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.79 -85.0 0.54 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.702 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.91 -149.8 6.05 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.896 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 2.2 t0 -110.15 120.2 41.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -1.142 . . . . 0.0 109.902 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.829 ' C ' ' HB3' ' A' ' 14' ' ' ALA . . . -153.72 -152.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 13' ' ' PRO . 6.0 mm -146.53 142.7 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 14' ' ' ALA . 4.6 t -146.44 138.53 13.59 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 110.302 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.5 Cg_endo -73.93 93.06 0.87 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.75 1.633 . . . . 0.0 111.258 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.866 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.3 m -60.35 137.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.722 -1.236 . . . . 0.0 111.689 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.7 mt-10 -129.68 68.55 1.43 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.75 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.0 mt -68.93 93.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.859 0.838 . . . . 0.0 110.585 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.0 99.88 0.91 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 57' ' ' ILE . 47.9 mt -104.46 145.08 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.537 -0.727 . . . . 0.0 110.756 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.753 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.2 m-85 -116.46 140.67 49.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.781 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.61 -33.08 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.304 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -1.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.781 ' H ' ' C ' ' A' ' 61' ' ' ALA . 36.2 mtm180 75.28 69.05 0.08 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.019 0.914 . . . . 0.0 109.727 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -148.73 148.06 29.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.473 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.669 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 39.3 p90 -125.23 103.97 8.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.277 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.2 p -101.6 120.92 41.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.9 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.17 146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.074 177.458 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 67' ' ' PHE . 31.7 t -167.57 79.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.284 1.04 . . . . 0.0 108.348 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 69' ' ' THR . 0.7 OUTLIER -87.03 136.79 32.79 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.625 ' O ' ' OG1' ' A' ' 71' ' ' THR . 5.1 mtmp? -121.0 140.62 51.66 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.227 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.625 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER 60.38 163.95 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.838 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 71' ' ' THR . 11.7 Cg_exo -41.08 175.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.099 1.866 . . . . 0.0 112.463 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.17 173.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.629 1.553 . . . . 0.0 112.499 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.972 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 56.79 -73.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 108.711 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -45.48 -17.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.716 . . . . 0.0 110.937 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.751 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 1.2 p90 -43.37 -38.63 2.8 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.889 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.579 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.1 pp -133.65 -22.2 1.91 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.972 HD12 ' HB1' ' A' ' 74' ' ' ALA . 6.5 mt -54.95 -30.84 23.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.716 ' CD ' HD11 ' A' ' 84' ' ' LEU . 6.0 mmt180 -52.65 -57.21 10.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 82' ' ' ALA . 5.3 tmtm? -52.06 -64.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.67 -6.53 0.75 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.813 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.801 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -83.34 -80.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 111.837 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.89 48.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.99 -1.576 . . . . 0.0 110.817 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.716 HD11 ' CD ' ' A' ' 79' ' ' ARG . 6.7 mt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.316 . . . . 0.0 109.003 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.268 0.556 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.801 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 70.08 58.0 6.51 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.582 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.2 tmm_? -131.5 110.08 10.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.172 -1.193 . . . . 0.0 110.916 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.15 -175.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.738 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -127.33 164.3 22.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.889 -1.132 . . . . 0.0 109.656 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.701 ' O ' HG22 ' A' ' 104' ' ' VAL . 21.1 t-105 -51.46 -71.04 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.579 -0.7 . . . . 0.0 111.152 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 3.9 tp10 -48.79 -51.12 30.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.693 -1.255 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.41 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.1 mt-30 -49.18 -44.48 42.98 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.885 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.48 -25.09 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.518 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 120' ' ' LEU . 18.2 mt -66.87 -71.8 0.19 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.478 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 46.7 mt-10 -43.81 -43.08 6.0 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.922 -1.111 . . . . 0.0 108.465 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' A' ' 77' ' ' LEU . 57.9 mt -62.76 -30.71 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.433 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.803 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.63 -25.78 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.497 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 105' ' ' LEU . 8.4 mtpt -59.28 -73.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.919 -1.113 . . . . 0.0 108.362 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 109' ' ' LYS . 1.9 tp60 -45.35 -28.41 0.85 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.092 -1.005 . . . . 0.0 108.922 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.451 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 12.0 tttm -69.09 -19.28 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.863 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.694 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -129.65 68.9 81.13 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.092 -1.005 . . . . 0.0 109.884 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 -34.18 27.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.495 1.463 . . . . 0.0 112.072 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 3.5 t70 175.02 12.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.0 mm? -50.43 -77.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -149.83 -24.97 0.27 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.058 HG22 ' H ' ' A' ' 118' ' ' THR . 23.6 m -64.57 -164.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 0.0 109.579 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.058 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.61 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.251 -0.905 . . . . 0.0 109.935 -179.206 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 118' ' ' THR . 1.3 m-20 -61.09 141.09 57.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.95 -22.72 65.87 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.243 1.021 . . . . 0.0 109.011 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.93 -38.41 90.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.526 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.47 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -68.92 -74.92 0.12 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.944 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.576 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.56 -43.08 7.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.46 -1.4 . . . . 0.0 109.28 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.12 -69.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 108.608 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HG3' HH11 ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.58 -41.81 4.76 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.709 ' O ' ' N ' ' A' ' 130' ' ' SER . 12.0 ttm -52.32 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.187 -0.946 . . . . 0.0 108.643 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.803 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 20.5 mm -48.03 -64.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.424 -0.798 . . . . 0.0 109.848 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.885 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.23 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -41.75 4.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.6 m -54.91 -48.6 72.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.536 -1.567 . . . . 0.0 107.699 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -50.01 -47.71 52.92 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.672 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -45.68 -53.5 9.25 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.631 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.4 t -44.89 -67.59 0.27 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.649 ' SD ' HG23 ' A' ' 136' ' ' VAL . 10.7 ttm -49.42 -3.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 89.64 -27.26 8.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.649 HG23 ' SD ' ' A' ' 134' ' ' MET . 52.7 t -48.17 165.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.847 -0.796 . . . . 0.0 109.208 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.583 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -142.52 162.62 35.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.711 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.2 164.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.897 ' O ' HG13 ' A' ' 139' ' ' VAL . 1.3 p . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.758 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.812 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -117.79 -24.59 3.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.261 -0.9 . . . . 0.0 109.224 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.24 111.22 6.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.385 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -100.37 73.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.779 ' HB ' HD12 ' A' ' 57' ' ' ILE . 6.1 t -49.12 88.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.611 -1.305 . . . . 0.0 110.715 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? -82.04 37.24 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.843 0.83 . . . . 0.0 109.054 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.855 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.4 mp -76.8 -174.2 2.95 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.817 0.818 . . . . 0.0 111.137 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.626 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -125.87 175.34 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.66 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -169.81 158.46 6.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.886 -1.134 . . . . 0.0 109.993 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.674 ' O ' ' N ' ' A' ' 15' ' ' GLY . 11.5 Cg_endo -68.01 104.95 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.935 1.757 . . . . 0.0 111.417 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.812 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -60.94 38.72 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.144 -1.023 . . . . 0.0 110.34 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.5 -18.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.526 -1.797 . . . . 0.0 111.3 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -148.38 78.99 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.507 -1.584 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.733 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -94.24 170.25 9.64 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.36 164.52 3.94 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.773 -1.204 . . . . 0.0 110.487 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.4 Cg_exo -51.97 32.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.048 1.832 . . . . 0.0 112.066 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.778 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -138.2 53.93 6.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 0.0 110.415 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.717 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.5 Cg_endo -86.36 162.39 9.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.83 1.687 . . . . 0.0 111.712 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.56 -4.89 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 121.079 1.186 . . . . 0.0 111.34 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.813 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 21.5 t -118.71 -66.51 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 56.44 -97.16 0.05 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.813 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 4.7 Cg_exo -53.96 -55.1 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 CA-C-N 117.816 0.808 . . . . 0.0 110.585 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.797 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -64.96 5.5 0.33 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.544 -0.723 . . . . 0.0 111.182 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.744 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -109.64 -65.17 1.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.668 -1.27 . . . . 0.0 109.855 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.69 -16.33 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' LEU . 83.5 mt-30 -41.98 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.45 -1.618 . . . . 0.0 109.571 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -64.67 -45.37 87.0 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.678 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.92 -3.53 0.04 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 69.76 76.64 0.21 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 122.187 -0.596 . . . . 0.0 111.756 177.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 34' ' ' ILE . 1.1 m120 -152.41 63.61 0.82 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.291 1.043 . . . . 0.0 108.416 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 37' ' ' PHE . 26.7 mm -43.01 -66.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.651 ' O ' ' CG ' ' A' ' 39' ' ' LYS . 4.3 tpt -41.43 -37.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.695 -1.253 . . . . 0.0 108.67 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.13 -49.13 75.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.711 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -50.38 -66.37 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.842 1.306 . . . . 0.0 109.252 177.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 17' ' ' ALA . 24.4 t -64.11 -37.65 80.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.604 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CG ' ' O ' ' A' ' 35' ' ' MET . 5.8 mmmt -47.95 -59.93 2.98 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.82 72.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.364 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 45' ' ' THR . 2.6 t80 -69.6 -77.42 0.08 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 5.0 m-20 -41.6 -34.86 0.64 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.398 1.094 . . . . 0.0 110.872 -177.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -65.82 -34.15 77.49 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.497 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.599 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.29 -53.72 4.33 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.393 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 21.4 p -52.47 -27.54 16.63 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.65 -46.06 13.73 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.677 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -54.67 -21.22 10.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.692 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.03 -85.2 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.692 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.32 -137.67 2.29 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.977 -1.583 . . . . 0.0 110.909 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.512 ' O ' ' CG ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -119.95 118.35 30.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.13 . . . . 0.0 109.971 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.812 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -153.74 -153.13 0.45 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.602 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.8 mm -146.67 141.8 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 14' ' ' ALA . 2.2 t -145.66 138.62 14.07 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.1 Cg_endo -73.93 91.0 0.93 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.85 1.7 . . . . 0.0 111.519 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.855 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.3 m -56.46 137.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.751 -1.218 . . . . 0.0 111.229 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.6 tt0 -129.24 70.81 1.41 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.779 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.7 mt -71.33 89.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 0.0 110.307 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.39 104.02 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 64' ' ' SER . 41.2 mt -107.64 144.44 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.509 -0.745 . . . . 0.0 110.867 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.758 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.5 m-85 -115.03 139.47 49.84 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.812 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.51 -32.89 5.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.24 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -51.07 -2.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.792 ' H ' ' C ' ' A' ' 61' ' ' ALA . 4.6 mtt180 75.24 70.1 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.913 0.863 . . . . 0.0 109.843 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 2.5 t -150.7 125.13 9.53 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.631 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 33.2 p90 -102.14 103.87 14.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -100.74 121.05 41.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.985 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.937 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.45 148.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 111.231 177.564 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 67' ' ' PHE . 28.0 t -169.3 88.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.489 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -94.74 145.07 25.12 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.8 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -129.53 118.56 22.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 0.0 110.213 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 1.018 HG21 ' NE ' ' A' ' 79' ' ' ARG . 23.0 p 75.96 150.02 0.13 Allowed Pre-proline 0 N--CA 1.493 1.689 0 CA-C-O 121.231 0.539 . . . . 0.0 110.025 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -40.16 175.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.682 2.255 . . . . 0.0 113.113 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.4 Cg_exo -39.55 171.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.52 1.48 . . . . 0.0 111.913 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.883 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.49 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.778 ' N ' ' O ' ' A' ' 73' ' ' PRO . 17.7 p -43.64 -27.75 0.33 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.043 ' CE1' HD12 ' A' ' 77' ' ' LEU . 8.0 p90 -43.55 -38.11 2.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.182 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -135.27 -11.39 2.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.182 ' N ' HD13 ' A' ' 77' ' ' LEU . 2.0 mt -66.32 -29.85 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 1.018 ' NE ' HG21 ' A' ' 71' ' ' THR . 7.3 mmm180 -55.73 -40.12 72.06 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.565 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.6 tmtt? -70.78 -67.95 0.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.405 ' N ' ' HD3' ' A' ' 80' ' ' LYS . . . -53.82 -4.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.277 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.713 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.61 -78.21 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.712 . . . . 0.0 112.155 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.22 55.71 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.873 -1.632 . . . . 0.0 110.811 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.707 ' CD1' ' CZ ' ' A' ' 79' ' ' ARG . 9.0 mt . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.05 -1.265 . . . . 0.0 109.097 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 97' ' ' GLY . 24.6 t . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.362 0.601 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.814 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 65.15 73.44 0.59 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.821 ' HG3' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.34 105.31 6.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.128 -1.219 . . . . 0.0 110.979 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.669 HD12 ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -105.72 -167.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.027 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.761 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -137.7 159.61 41.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 108.88 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.685 ' O ' HG22 ' A' ' 104' ' ' VAL . 17.8 t-105 -47.6 -71.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 110.801 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.465 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.6 tp10 -50.77 -49.21 58.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.526 -1.359 . . . . 0.0 110.895 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.603 ' O ' ' CG1' ' A' ' 107' ' ' ILE . 4.2 mt-30 -51.11 -43.7 61.16 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 110.23 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 100' ' ' THR . 2.4 m -70.9 -25.3 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.521 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 120' ' ' LEU . 18.1 mt -65.7 -71.54 0.19 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -44.41 -42.36 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.854 -1.154 . . . . 0.0 108.185 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.093 ' CD1' HD21 ' A' ' 77' ' ' LEU . 1.8 mm -60.85 -33.28 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.82 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -98.88 -23.14 15.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.439 -0.788 . . . . 0.0 109.335 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.673 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.6 mttt -57.03 -72.34 0.08 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -48.75 -34.06 11.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.592 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 112' ' ' MET . 1.2 mptp? -80.06 64.43 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.222 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.584 ' HA ' HD11 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 175.02 55.54 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 0.0 109.217 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.553 ' HD3' ' H ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.38 -55.05 1.05 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.545 1.497 . . . . 0.0 112.346 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 115' ' ' LEU . 1.5 m-20 -163.53 11.46 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 1.077 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.79 -85.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.613 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -155.43 10.68 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.398 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.0 HG22 ' H ' ' A' ' 118' ' ' THR . 41.6 m -104.34 -164.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.0 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 179.25 -55.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.199 -0.938 . . . . 0.0 110.007 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.491 ' H ' HG23 ' A' ' 118' ' ' THR . 3.7 m-20 -74.76 142.92 44.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.342 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -58.77 -33.15 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.221 1.01 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -60.46 -37.63 81.61 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.045 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.06 -72.72 0.2 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.872 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.493 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -46.16 -37.93 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.523 -1.361 . . . . 0.0 109.089 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -56.0 -71.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.042 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 129' ' ' GLY . 47.6 ttt180 -43.32 -34.83 1.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' SER . 15.1 ttm -56.2 -76.88 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.82 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 17.4 mm -48.37 -63.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.772 . . . . 0.0 109.785 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.57 -71.73 0.12 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.78 -42.66 4.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 126' ' ' MET . 57.9 m -55.49 -50.27 70.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.591 -1.535 . . . . 0.0 107.5 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.819 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.66 -48.72 28.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.2 tmt_? -44.82 -54.9 5.87 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.661 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -46.71 -69.26 0.14 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.606 ' HG2' HG23 ' A' ' 136' ' ' VAL . 7.6 ttp -45.07 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.622 -0.674 . . . . 0.0 110.639 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.06 8.62 75.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.819 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.2 t -88.5 165.31 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.3 tp10 -142.78 163.02 33.95 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.137 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.67 153.42 4.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 99' ' ' ILE . 1.3 p . . . . . 0 C--N 1.3 -1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.252 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.491 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.028 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -119.97 -24.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.063 -1.023 . . . . 0.0 109.621 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -154.32 101.31 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.316 -1.353 . . . . 0.0 110.635 178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -92.36 73.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.773 ' HB ' HD12 ' A' ' 57' ' ' ILE . 24.4 t -45.53 88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.215 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.657 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -84.29 34.44 0.52 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.923 0.868 . . . . 0.0 109.019 179.387 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.908 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.52 -174.72 3.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.948 0.88 . . . . 0.0 111.381 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.561 ' O ' HD12 ' A' ' 12' ' ' LEU . 1.4 pm0 -117.19 169.41 9.48 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -163.0 144.59 7.75 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 120.544 -1.347 . . . . 0.0 110.16 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.64 ' HA ' HD13 ' A' ' 52' ' ' ILE . 36.5 Cg_endo -80.5 127.91 6.73 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.426 2.084 . . . . 0.0 113.97 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.084 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.83 141.34 47.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.713 ' C ' ' H ' ' A' ' 17' ' ' ALA . . . 61.41 -60.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 mtpp -60.46 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.801 -0.823 . . . . 0.0 108.884 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.713 ' H ' ' C ' ' A' ' 15' ' ' GLY . . . -114.4 151.42 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.73 165.93 6.87 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 -178.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.9 Cg_exo -49.38 36.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.723 1.615 . . . . 0.0 111.749 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.896 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -164.34 55.03 0.42 Allowed Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.631 -0.668 . . . . 0.0 109.819 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.679 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.0 Cg_endo -77.36 169.95 20.3 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.529 1.486 . . . . 0.0 111.801 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.02 -4.59 3.89 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 121.134 1.223 . . . . 0.0 110.971 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.908 HG22 ' CD2' ' A' ' 10' ' ' LEU . 2.2 t -105.08 -71.54 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.598 0.713 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.92 -98.41 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.5 Cg_endo -59.98 -55.41 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.972 0.886 . . . . 0.0 109.97 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.596 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.31 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.471 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.921 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -112.39 -42.49 3.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.608 -1.307 . . . . 0.0 108.703 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.5 85.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 27' ' ' LEU . 8.0 mm-40 -150.64 -13.82 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -1.102 . . . . 0.0 108.06 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.811 ' CE1' ' CE1' ' A' ' 65' ' ' PHE . 1.3 p80 -86.21 -37.21 18.89 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -171.87 -1.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.0 80.62 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 111.971 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -156.7 121.7 4.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.505 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.5 mm -97.9 -64.83 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.646 . . . . 0.0 110.0 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.689 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.97 -57.05 2.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.59 -1.319 . . . . 0.0 109.424 -177.113 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' MET . 3.7 mp0 -46.54 -51.08 16.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.99 -1.069 . . . . 0.0 108.195 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.921 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -48.15 -59.94 3.02 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.46 1.124 . . . . 0.0 109.623 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 42' ' ' ASN . 50.6 t -73.72 -30.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.95 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.1 tttp -50.09 -62.01 1.82 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.62 -33.89 73.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.469 -0.769 . . . . 0.0 108.94 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 44' ' ' ALA . 2.1 t80 -70.73 -77.03 0.09 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -41.29 -34.21 0.47 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.42 1.105 . . . . 0.0 110.692 -177.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.1 -34.01 75.58 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.963 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.75 -45.55 8.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.695 ' CB ' ' H ' ' A' ' 15' ' ' GLY . 19.0 p -58.67 -29.31 66.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -80.0 -46.5 16.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.587 ' OD1' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -55.96 -23.18 30.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.762 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.83 -74.93 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.394 -0.816 . . . . 0.0 109.407 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.762 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 168.31 150.75 6.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.289 -1.434 . . . . 0.0 111.088 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.1 m-20 -44.8 148.76 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.015 -1.285 . . . . 0.0 109.497 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.084 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 175.8 -154.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.986 -1.071 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.5 mm -146.98 141.07 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 71' ' ' THR . 2.7 t -144.32 135.59 12.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.744 -1.223 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.622 ' O ' HG21 ' A' ' 69' ' ' THR . 8.4 Cg_endo -70.96 99.82 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.624 1.55 . . . . 0.0 110.465 177.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.763 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.0 m -79.16 137.01 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 122.782 1.277 . . . . 0.0 112.262 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -128.25 61.32 1.46 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.172 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.773 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -61.57 86.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.646 0.736 . . . . 0.0 109.735 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.41 ' HB ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -60.59 95.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.562 HG13 HG22 ' A' ' 57' ' ' ILE . 46.2 mt -95.75 136.53 26.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.566 -0.708 . . . . 0.0 110.237 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -110.45 138.66 46.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.311 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 1.028 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.68 -29.43 4.4 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.573 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 19.7 t0 -53.93 3.03 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.853 ' H ' ' C ' ' A' ' 61' ' ' ALA . 50.4 mtp180 69.69 70.11 0.24 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.045 0.926 . . . . 0.0 109.624 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 18.2 m -148.25 124.9 11.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.811 ' CE1' ' CE1' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -101.5 104.13 15.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 0.0 110.204 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.41 ' OG1' ' HB ' ' A' ' 58' ' ' THR . 21.9 p -98.3 124.58 43.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.594 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -109.4 174.02 6.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.526 -1.359 . . . . 0.0 109.349 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.004 HG12 ' O ' ' A' ' 68' ' ' VAL . 97.1 t -163.11 44.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.674 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.622 HG21 ' O ' ' A' ' 54' ' ' PRO . 1.2 t -155.19 126.79 7.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 115.594 -2.442 . . . . 0.0 110.276 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.85 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -124.92 128.13 48.15 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.791 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.81 151.59 0.13 Allowed Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.522 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.0 Cg_exo -40.37 175.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.504 2.136 . . . . 0.0 113.063 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.818 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.63 170.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.651 1.567 . . . . 0.0 112.125 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.695 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 49.94 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.818 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -43.55 -20.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.242 179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 11.6 p90 -43.83 -42.22 5.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.65 -0.656 . . . . 0.0 109.322 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.878 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.66 -19.52 2.66 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.878 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.6 mt -59.27 -32.03 47.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.643 ' HB3' HD12 ' A' ' 84' ' ' LEU . 12.7 mmt180 -55.42 -44.12 75.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 82' ' ' ALA . 9.5 tmtt? -66.37 -66.4 0.56 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.667 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.93 -4.84 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.667 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.16 -80.38 0.19 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 111.987 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.451 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 163.2 53.46 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.036 -1.554 . . . . 0.0 110.466 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.643 HD12 ' HB3' ' A' ' 79' ' ' ARG . 5.7 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.039 -1.271 . . . . 0.0 109.558 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.559 HG12 ' CD2' ' A' ' 84' ' ' LEU . 2.4 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.34 0.59 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 50.87 61.2 6.29 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.797 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.87 111.84 10.19 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.997 -1.296 . . . . 0.0 110.327 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.25 -177.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.703 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -125.05 159.02 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.925 -1.109 . . . . 0.0 109.351 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.668 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.8 t-105 -49.81 -69.54 0.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.597 -0.69 . . . . 0.0 111.042 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.639 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 9.5 tp10 -50.2 -44.74 53.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.667 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -55.31 -43.76 75.17 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.162 -0.961 . . . . 0.0 110.054 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.23 -24.32 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 117.649 -1.62 . . . . 0.0 107.656 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 120' ' ' LEU . 17.1 mt -66.31 -71.72 0.19 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.639 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 20.5 mm-40 -44.08 -44.5 7.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.909 -1.119 . . . . 0.0 108.44 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.728 ' CD1' HD21 ' A' ' 77' ' ' LEU . 65.4 mt -60.84 -32.55 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 108.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.815 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.98 -26.79 15.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.575 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.5 mttm -58.82 -73.27 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.935 -1.103 . . . . 0.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 109' ' ' LYS . 6.2 tt0 -45.24 -28.46 0.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.431 ' HE3' ' SD ' ' A' ' 126' ' ' MET . 11.6 tttm -69.8 -18.44 63.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.58 68.13 81.15 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.031 -1.043 . . . . 0.0 109.821 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.8 -33.96 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.533 1.488 . . . . 0.0 112.088 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER 174.97 15.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.77 . . . . 0.0 109.087 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.5 mm? -54.21 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.597 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -150.65 -25.03 0.23 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.066 HG22 ' H ' ' A' ' 118' ' ' THR . 23.5 m -64.94 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.066 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.45 -74.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.943 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.523 ' H ' HG23 ' A' ' 118' ' ' THR . 1.2 m-20 -60.68 140.96 57.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 110.051 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.88 -22.65 65.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.214 1.007 . . . . 0.0 108.952 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.12 -38.42 90.6 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.57 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.483 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -68.69 -75.2 0.11 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.231 -1.387 . . . . 0.0 107.921 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.605 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.56 -43.02 7.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.475 -1.39 . . . . 0.0 109.292 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.63 -68.71 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 108.571 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.784 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.57 -42.95 5.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.682 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.21 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 108.562 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.815 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.9 mm -48.57 -65.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.873 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.81 -71.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.72 -39.04 3.36 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.9 m -57.8 -47.51 82.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.467 -1.608 . . . . 0.0 107.564 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.611 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.97 -48.47 52.16 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.649 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.2 tmm_? -46.62 -53.71 10.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.676 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.1 t -44.83 -68.5 0.19 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 75' ' ' SER . 0.0 OUTLIER -47.27 -3.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.91 -23.67 13.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.611 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 47.4 t -53.44 165.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.849 -0.795 . . . . 0.0 109.17 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -142.66 162.58 35.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.025 -1.047 . . . . 0.0 109.723 179.518 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.76 162.25 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.884 ' O ' HG13 ' A' ' 139' ' ' VAL . 4.1 p . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.599 -0.688 . . . . 0.0 109.184 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.744 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -112.82 -24.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.19 107.28 5.73 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.168 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.808 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -94.71 73.62 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 108.94 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.73 ' HB ' HD12 ' A' ' 57' ' ' ILE . 31.7 t -45.96 88.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.192 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.54 34.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.89 0.853 . . . . 0.0 109.076 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.993 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.23 -174.42 3.69 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.787 0.803 . . . . 0.0 111.31 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -119.78 171.84 8.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.781 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -168.3 160.11 9.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.689 -1.257 . . . . 0.0 110.288 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.781 ' HD2' HD23 ' A' ' 12' ' ' LEU . 13.4 Cg_endo -67.74 109.19 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.251 1.967 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.812 ' HB3' ' C ' ' A' ' 51' ' ' ALA . . . -69.45 40.21 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.963 -1.086 . . . . 0.0 110.733 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.52 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 179.31 -18.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 118.277 -1.915 . . . . 0.0 111.792 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' CE ' ' OD1' ' A' ' 50' ' ' ASP . 2.1 mptt -135.82 60.74 1.67 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.405 -1.644 . . . . 0.0 110.452 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.705 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -79.64 158.74 26.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.724 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -161.92 163.31 19.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.688 -1.258 . . . . 0.0 110.494 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.0 Cg_endo -55.47 35.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.936 1.758 . . . . 0.0 111.852 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.724 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -171.17 57.18 0.25 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.41 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.0 Cg_endo -80.5 168.45 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.453 1.435 . . . . 0.0 111.432 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 -4.61 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.126 1.218 . . . . 0.0 111.044 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.993 HG22 HD22 ' A' ' 10' ' ' LEU . 1.9 t -105.48 -72.62 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.604 0.716 . . . . 0.0 110.277 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.55 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.725 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.1 Cg_endo -60.49 -55.51 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 CA-C-N 118.047 0.923 . . . . 0.0 109.854 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.37 -8.6 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.39 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.808 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -111.62 -43.21 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.686 -1.259 . . . . 0.0 108.805 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.26 84.7 0.01 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tp-100 -148.9 -8.4 0.36 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.696 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 8.8 p80 -92.78 -36.55 12.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -171.55 2.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 71.86 75.95 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.661 -0.905 . . . . 0.0 112.058 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -154.05 121.32 5.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 108.797 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.7 mm -97.94 -63.8 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.683 -0.636 . . . . 0.0 109.952 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -42.08 -54.22 3.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.787 -1.195 . . . . 0.0 109.79 -176.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -50.08 -51.25 44.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.948 -1.095 . . . . 0.0 108.601 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.808 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -47.19 -58.89 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.773 1.273 . . . . 0.0 109.566 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 17' ' ' ALA . 82.0 t -71.78 -30.25 37.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.212 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.2 mmtt -53.48 -55.04 28.7 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.22 -34.14 76.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.575 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.4 t80 -68.32 -76.19 0.09 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 19.0 m-20 -41.81 -37.5 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.45 1.119 . . . . 0.0 110.764 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -62.73 -34.56 77.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.327 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.57 -61.59 1.64 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.888 -1.125 . . . . 0.0 108.654 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 24.6 p -44.85 -29.74 0.85 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.29 -43.39 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 44' ' ' ALA . 50.0 t30 -54.49 -24.39 20.28 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.44 -85.22 0.54 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -159.94 -148.98 5.42 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 118.996 -1.573 . . . . 0.0 111.051 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.521 ' OD1' ' CE ' ' A' ' 16' ' ' LYS . 3.5 t70 -113.55 126.02 54.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -1.095 . . . . 0.0 109.687 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.812 ' C ' ' HB3' ' A' ' 14' ' ' ALA . . . -158.92 -152.85 0.34 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 13' ' ' PRO . 5.8 mm -147.0 143.37 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 14' ' ' ALA . 5.2 t -145.72 137.58 13.17 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.2 Cg_endo -73.3 86.06 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.745 1.63 . . . . 0.0 110.601 177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.816 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.7 m -58.01 137.71 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.762 1.267 . . . . 0.0 112.321 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.3 mt-10 -128.78 63.98 1.45 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.73 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.7 mt -64.36 90.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.812 0.815 . . . . 0.0 110.316 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.505 HG22 HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -64.25 98.48 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.55 HG13 HG22 ' A' ' 57' ' ' ILE . 9.8 mt -100.72 142.68 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.561 -0.712 . . . . 0.0 110.375 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.744 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.7 m-85 -114.34 139.93 49.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.838 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.61 -30.0 4.9 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.349 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 8.1 t70 -53.53 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.838 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 70.46 69.04 0.2 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.122 0.963 . . . . 0.0 109.627 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -148.06 125.07 11.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.678 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -101.43 104.02 14.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 110.232 -179.311 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.5 p -99.16 124.67 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.558 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 1.8 p90 -108.52 171.32 7.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.569 -1.332 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.985 HG12 ' O ' ' A' ' 68' ' ' VAL . 88.8 t -162.38 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 112.691 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 69' ' ' THR . 11.2 t -154.93 118.02 4.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.048 -2.282 . . . . 0.0 110.398 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.818 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.51 120.06 38.26 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.141 0.972 . . . . 0.0 108.599 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.877 HG21 ' CD ' ' A' ' 79' ' ' ARG . 16.2 p 76.99 151.45 0.13 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.5 Cg_exo -39.12 175.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.762 2.308 . . . . 0.0 113.351 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.5 Cg_exo -40.99 167.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.652 1.568 . . . . 0.0 111.915 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.0 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.67 -77.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.776 ' N ' ' O ' ' A' ' 73' ' ' PRO . 8.0 t -43.04 -25.05 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.981 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.049 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 17.9 p90 -43.27 -41.72 4.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.485 -0.76 . . . . 0.0 109.111 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.049 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -133.07 -15.48 2.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.0 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.6 mt -60.21 -33.21 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.877 ' CD ' HG21 ' A' ' 71' ' ' THR . 1.5 mtm180 -55.46 -43.37 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -67.15 -66.23 0.58 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.795 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.36 -4.8 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 109.684 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.42 -79.76 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 111.554 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.508 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 154.57 56.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.408 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.508 HD23 ' C ' ' A' ' 83' ' ' GLY . 10.8 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.252 . . . . 0.0 109.23 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 97' ' ' GLY . 41.1 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.315 0.578 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.541 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 58.45 66.51 2.75 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.787 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.16 113.11 11.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -1.166 . . . . 0.0 110.008 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.704 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.81 -173.37 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.647 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -127.5 158.04 38.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.401 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.664 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.7 t-105 -49.95 -69.47 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.498 -0.751 . . . . 0.0 110.753 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 4.4 tp10 -49.78 -45.04 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.706 -1.246 . . . . 0.0 110.539 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.795 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -52.71 -46.3 67.28 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.911 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.46 -24.55 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.996 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.951 HD13 HD13 ' A' ' 120' ' ' LEU . 18.3 mt -65.91 -71.37 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.587 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 mm-40 -43.92 -43.31 6.4 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.959 -1.088 . . . . 0.0 108.66 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.76 HG12 HD11 ' A' ' 77' ' ' LEU . 57.6 mt -63.22 -32.3 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 108.817 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.21 -27.1 16.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.332 -0.855 . . . . 0.0 109.376 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 105' ' ' LEU . 15.3 mtpt -59.78 -74.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.594 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . 71.5 mt-30 -45.04 -27.32 0.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.229 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -74.59 -10.41 59.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.927 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.649 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.38 64.03 67.54 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.65 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.5 Cg_endo -66.13 -30.67 46.51 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.647 1.565 . . . . 0.0 112.084 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 1.7 t70 175.16 10.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.188 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -48.42 -79.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.19 -21.5 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.621 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.049 HG22 ' H ' ' A' ' 118' ' ' THR . 27.4 m -64.69 -164.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.948 . . . . 0.0 109.585 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.049 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.75 -67.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.807 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.529 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -69.57 138.39 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.951 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -58.29 -22.66 53.68 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.204 1.002 . . . . 0.0 108.85 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.16 -35.9 82.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.539 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.596 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.48 -75.84 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.212 -1.395 . . . . 0.0 107.985 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.84 -39.29 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.47 -1.394 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.27 -70.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.794 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.54 -38.96 3.18 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' SER . 10.4 ttm -54.54 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 108.872 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 24.4 mm -46.07 -63.95 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.642 0.734 . . . . 0.0 110.46 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.31 -69.05 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.29 -38.29 2.72 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 126' ' ' MET . 6.0 p -55.31 -53.75 52.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.602 -1.528 . . . . 0.0 107.282 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.81 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -44.84 -50.2 10.43 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.4 tmt_? -44.77 -56.6 4.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 135' ' ' GLY . 11.2 t -46.04 -69.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 136' ' ' VAL . 4.9 ttp -44.89 -5.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.648 -0.657 . . . . 0.0 110.255 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.84 20.06 60.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.81 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.9 t -102.8 165.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.911 -0.758 . . . . 0.0 108.969 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.539 ' N ' HG12 ' A' ' 136' ' ' VAL . 82.8 mt-10 -141.31 162.53 35.26 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.07 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.86 160.98 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.891 ' O ' HG13 ' A' ' 139' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.714 ' N ' ' CZ ' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 59' ' ' ILE . 27.7 m -120.89 -24.71 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.124 -0.985 . . . . 0.0 110.107 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.684 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -156.51 118.6 3.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.434 -1.416 . . . . 0.0 110.503 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -110.59 73.9 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.786 -0.571 . . . . 0.0 109.612 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.693 ' O ' ' O ' ' A' ' 55' ' ' VAL . 13.9 t -44.89 88.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 0.0 110.158 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.6 tmtt? -84.03 34.66 0.51 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.925 0.869 . . . . 0.0 109.127 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.77 -173.7 3.59 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.652 0.739 . . . . 0.0 111.009 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 5.2 pm0 -125.99 179.02 5.41 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.665 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -165.63 144.77 5.24 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 0.0 108.931 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.804 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 67.4 Cg_endo -83.43 113.15 1.98 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.552 2.168 . . . . 0.0 114.445 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.972 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -63.19 142.93 58.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.497 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 55.19 52.83 44.54 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER 173.88 27.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.55 -0.97 . . . . 0.0 108.711 -178.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 18' ' ' THR . . . -111.83 152.98 27.28 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.913 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.19 165.97 6.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.868 -179.054 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.9 Cg_exo -48.86 34.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.617 1.545 . . . . 0.0 111.627 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.913 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -155.22 54.2 0.96 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.41 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.717 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 17.1 Cg_endo -81.14 167.66 17.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.703 1.602 . . . . 0.0 111.947 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.24 -4.48 3.14 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 121.306 1.337 . . . . 0.0 111.41 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.78 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.7 t -112.92 -71.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.58 -97.97 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.78 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -58.97 -55.13 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 CA-C-N 117.9 0.85 . . . . 0.0 110.354 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.676 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -48.46 -8.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.693 -0.63 . . . . 0.0 110.945 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.698 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -108.61 -48.62 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.643 -1.286 . . . . 0.0 108.8 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.36 98.4 0.02 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.2 tt0 -158.3 -22.64 0.08 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.685 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -81.12 -44.1 18.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.162 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.688 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -166.73 -10.52 0.03 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.29 84.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 112.494 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.491 ' OD1' ' C ' ' A' ' 32' ' ' ALA . 5.0 m120 -155.16 70.95 0.77 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.863 -1.148 . . . . 0.0 108.916 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 21.7 mm -44.37 -71.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.224 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.493 ' O ' ' C ' ' A' ' 36' ' ' GLU . 10.1 tpt -41.88 -53.39 3.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.164 . . . . 0.0 109.42 -178.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.3 tp10 -44.88 -49.76 10.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.698 ' CE2' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -51.42 -69.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.973 1.368 . . . . 0.0 109.998 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 42' ' ' ASN . 35.7 t -56.5 -36.06 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.557 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -50.66 -64.08 0.92 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.19 -32.53 64.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.9 t80 -71.3 -76.63 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.392 -1.443 . . . . 0.0 107.116 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.8 m120 -41.16 -28.14 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.792 -1.192 . . . . 0.0 110.436 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -71.35 -34.52 70.58 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.82 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -90.35 -44.62 9.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.733 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.591 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 6.8 p -59.81 -32.09 70.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.15 -44.93 24.6 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.507 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 36.7 t-20 -59.33 -21.88 60.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.411 -0.806 . . . . 0.0 108.965 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.658 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.25 -75.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.658 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -178.49 -121.06 0.68 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.035 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.7 OUTLIER -137.76 124.86 21.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -1.129 . . . . 0.0 108.669 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.972 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . 173.86 114.33 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.992 -1.068 . . . . 0.0 110.659 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.804 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -44.97 160.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.495 -1.378 . . . . 0.0 113.014 -178.298 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 12' ' ' LEU . 6.1 t -153.51 135.38 8.98 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.211 -0.931 . . . . 0.0 110.089 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 69' ' ' THR . 6.3 Cg_endo -66.96 108.87 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.722 1.615 . . . . 0.0 112.565 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -87.47 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.553 -1.342 . . . . 0.0 111.273 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.687 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 11.9 mt-10 -128.65 69.21 1.37 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.656 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.9 mt -70.96 88.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.731 0.777 . . . . 0.0 110.33 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -61.97 94.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 25.5 mt -89.29 94.16 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.714 ' CZ ' ' N ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -84.15 179.13 7.56 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.295 1.045 . . . . 0.0 112.234 -176.133 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 1.096 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.95 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.115 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 63' ' ' ARG . 40.2 p30 -46.73 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 109.319 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 1.096 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 43.91 86.23 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -146.23 124.36 12.16 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.82 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.765 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.95 103.06 13.68 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.172 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 22.2 p -101.03 120.62 40.46 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.078 -1.013 . . . . 0.0 109.0 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.954 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.58 148.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.876 -1.14 . . . . 0.0 111.057 177.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.5 t -169.76 95.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.684 HG21 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -104.5 147.36 27.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.756 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.8 mptt -132.75 124.21 27.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.68 -1.263 . . . . 0.0 110.092 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.756 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.9 p 76.08 149.17 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 CA-C-O 121.232 0.539 . . . . 0.0 109.662 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 73' ' ' PRO . 10.7 Cg_exo -42.07 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.513 2.142 . . . . 0.0 112.722 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.716 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.9 Cg_exo -38.44 172.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.518 1.479 . . . . 0.0 111.951 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.606 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.9 -83.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.763 ' HG ' ' HG3' ' A' ' 79' ' ' ARG . 7.9 t -42.77 -23.37 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 110.11 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.982 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 14.8 p90 -43.84 -38.92 3.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.982 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.17 -19.2 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.141 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.952 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.2 mt -56.22 -34.63 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.763 ' HG3' ' HG ' ' A' ' 75' ' ' SER . 13.0 mmt180 -53.08 -49.68 65.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.554 ' CD ' ' C ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -57.81 -63.73 1.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -59.29 -6.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 79' ' ' ARG . . . -84.13 -80.39 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 0.0 111.762 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' C ' ' CG1' ' A' ' 96' ' ' VAL . . . 172.59 -13.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.665 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.763 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.912 -1.346 . . . . 0.0 110.082 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.718 HG12 HD23 ' A' ' 84' ' ' LEU . 2.3 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.279 0.561 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.472 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 104.23 56.77 0.73 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.773 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.25 122.03 24.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.206 -1.173 . . . . 0.0 110.283 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.805 HD12 ' CG1' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -109.55 -165.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.742 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.79 156.42 46.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 0.0 109.125 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.735 ' O ' HG22 ' A' ' 104' ' ' VAL . 15.6 t-105 -48.92 -69.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.877 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.484 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.78 -53.98 21.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.565 -1.334 . . . . 0.0 110.972 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 4.2 mt-30 -47.12 -44.87 21.92 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.328 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.77 -26.03 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.431 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 120' ' ' LEU . 16.0 mt -65.95 -70.5 0.24 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' LEU . 36.0 tt0 -43.7 -42.54 5.42 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.916 -1.115 . . . . 0.0 108.337 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.693 HG12 HD11 ' A' ' 77' ' ' LEU . 41.4 mt -63.26 -31.23 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.05 -1.031 . . . . 0.0 108.329 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.93 -26.33 16.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.77 ' HE3' HD11 ' A' ' 120' ' ' LEU . 8.6 mttp -58.3 -73.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 0.0 108.431 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -48.69 -24.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 108.958 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.564 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -72.83 -16.6 61.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.699 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.48 65.71 76.75 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.768 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.66 -32.88 37.2 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.631 1.554 . . . . 0.0 112.11 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.543 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 2.5 t70 174.98 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.23 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.409 ' H ' ' H ' ' A' ' 114' ' ' ASP . 2.8 mm? -51.36 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.58 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -154.42 -24.97 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.655 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.005 HG22 ' H ' ' A' ' 118' ' ' THR . 24.8 m -65.08 -164.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.005 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.44 -73.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.518 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -61.95 142.13 57.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 110.011 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -61.4 -24.86 66.81 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.237 1.018 . . . . 0.0 109.036 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.17 -38.26 90.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.6 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.567 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.11 -74.35 0.13 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.943 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.94 -44.4 9.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.523 -1.36 . . . . 0.0 109.22 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -48.64 -70.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.765 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.37 -39.66 3.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.693 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.9 ttm -53.0 -78.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.191 -0.943 . . . . 0.0 108.605 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.8 mm -48.1 -64.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.66 0.743 . . . . 0.0 110.082 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.826 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.95 -71.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.85 -42.56 4.97 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 126' ' ' MET . 51.8 m -54.0 -42.21 68.79 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.627 -1.514 . . . . 0.0 107.029 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.74 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -54.34 -48.72 71.08 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.763 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -44.9 -48.16 11.23 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 135' ' ' GLY . 6.1 t -53.58 -69.62 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.536 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 7.0 ttm -44.9 -5.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.579 -0.701 . . . . 0.0 109.956 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 84.02 24.96 46.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.74 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.6 t -107.1 165.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.952 -0.734 . . . . 0.0 109.183 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 136' ' ' VAL . 72.8 tt0 -141.82 164.3 30.56 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.067 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.9 t -82.58 146.22 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.706 HG23 ' HD3' ' A' ' 98' ' ' ARG . 4.3 p . . . . . 0 N--CA 1.487 1.386 0 O-C-N 121.49 -0.757 . . . . 0.0 109.452 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.594 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 60' ' ' TYR . 27.5 m -120.83 -24.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.273 -0.892 . . . . 0.0 110.089 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.704 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -161.01 115.16 2.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.59 -1.319 . . . . 0.0 110.741 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -107.64 74.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.802 ' HB ' HD12 ' A' ' 57' ' ' ILE . 15.1 t -47.84 88.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.663 -1.273 . . . . 0.0 110.538 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.69 36.49 0.55 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.939 0.876 . . . . 0.0 109.158 179.197 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.886 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -78.04 -173.99 3.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 111.374 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 3.3 pm0 -123.09 174.54 7.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.711 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -163.87 147.52 8.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.951 -1.093 . . . . 0.0 109.371 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.664 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 96.7 Cg_endo -86.76 128.84 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.389 2.059 . . . . 0.0 113.266 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.079 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -75.26 142.85 43.28 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.05 63.12 5.31 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.664 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 14.0 tttt 174.09 -25.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.65 151.92 32.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 108.368 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.883 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.64 165.9 9.39 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.8 Cg_exo -50.45 37.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.717 1.611 . . . . 0.0 111.638 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.883 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -167.97 55.01 0.28 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 10.9 Cg_endo -79.03 170.83 17.29 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.617 1.545 . . . . 0.0 111.781 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.17 -4.56 1.67 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.115 1.21 . . . . 0.0 110.94 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.886 HG22 ' CD2' ' A' ' 10' ' ' LEU . 1.9 t -108.18 -72.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.482 0.658 . . . . 0.0 110.096 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.62 -98.17 0.06 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.761 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.8 Cg_endo -59.45 -55.38 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.975 0.888 . . . . 0.0 109.988 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.67 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.51 -12.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.19 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.977 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -114.39 -40.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.775 -1.203 . . . . 0.0 108.239 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.8 92.69 0.01 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.564 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -159.06 -25.9 0.07 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 179.178 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.73 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 4.6 p80 -78.75 61.24 2.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.693 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.685 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 83.91 -9.37 63.17 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.35 84.23 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.153 -1.204 . . . . 0.0 112.104 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -157.38 123.72 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 108.731 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.659 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 mm -99.4 -63.47 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.685 -0.634 . . . . 0.0 109.831 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.66 ' O ' ' N ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -41.02 -52.58 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.755 -1.215 . . . . 0.0 109.662 -176.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.2 mm-40 -49.66 -47.25 50.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.647 -1.283 . . . . 0.0 107.831 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.977 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -52.93 -68.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.517 1.151 . . . . 0.0 109.956 178.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' ASN . 23.6 t -66.08 -37.71 80.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.081 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.66 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.6 mmmt -46.12 -58.57 3.51 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.32 72.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.318 -0.864 . . . . 0.0 108.939 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' THR . 3.6 t80 -71.34 -77.11 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.0 m120 -41.33 -32.1 0.28 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.933 -1.104 . . . . 0.0 110.589 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.93 -33.45 73.75 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.521 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.24 -47.97 7.45 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.559 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 41' ' ' PHE . 2.3 p -57.08 -29.2 63.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.47 -46.57 17.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' OD1' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -57.24 -21.25 32.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.406 -0.809 . . . . 0.0 108.842 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.722 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.08 -74.22 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.443 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.722 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 172.97 -156.52 24.9 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 8.1 t70 -93.16 145.34 24.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.02 -1.282 . . . . 0.0 108.967 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.079 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.25 -153.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.745 -1.222 . . . . 0.0 110.905 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.3 mm -146.37 139.42 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 71' ' ' THR . 2.2 t -140.11 135.29 16.18 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.008 -1.058 . . . . 0.0 110.905 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.3 Cg_endo -71.84 105.66 1.85 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.77 1.647 . . . . 0.0 111.056 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.5 m -80.66 135.61 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.711 -1.243 . . . . 0.0 111.702 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.3 mt-10 -129.29 67.49 1.43 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.802 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -68.79 87.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.707 0.765 . . . . 0.0 110.218 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -61.69 94.68 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 64' ' ' SER . 5.6 mt -88.87 134.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.443 -0.786 . . . . 0.0 109.217 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -122.49 -179.65 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.316 -176.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 1.082 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.82 -85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.224 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' C ' ' A' ' 63' ' ' ARG . 20.9 t0 -46.24 39.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.542 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 1.082 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER 44.03 87.63 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.754 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -143.62 166.37 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.781 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -146.18 103.2 3.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 109.164 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 4.0 p -101.11 120.83 40.79 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.92 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.67 147.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.921 -1.112 . . . . 0.0 110.935 177.464 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.8 t -168.3 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 122.312 1.053 . . . . 0.0 108.208 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -95.06 146.98 23.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.607 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.787 ' NZ ' HG13 ' A' ' 68' ' ' VAL . 2.3 mptt -132.72 127.31 34.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.217 -1.393 . . . . 0.0 110.511 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.768 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.1 p 76.0 149.15 0.12 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-O 121.242 0.544 . . . . 0.0 109.955 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' O ' ' O ' ' A' ' 73' ' ' PRO . 9.2 Cg_exo -42.83 175.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.835 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.75 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -38.66 171.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.639 1.559 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.698 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.33 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.75 ' N ' ' O ' ' A' ' 73' ' ' PRO . 24.8 p -43.02 -22.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.887 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.003 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 15.6 p90 -43.77 -40.54 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.559 -0.713 . . . . 0.0 109.168 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.003 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -134.59 -16.63 2.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.077 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.885 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.3 mt -59.28 -33.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.629 ' HG3' HG21 ' A' ' 71' ' ' THR . 16.3 mmt180 -55.78 -42.71 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.9 tmtt? -65.87 -66.06 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.37 -6.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.426 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.24 -80.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.494 -0.754 . . . . 0.0 111.857 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 173.6 35.0 0.04 OUTLIER Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.45 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.509 HD11 HH11 ' A' ' 79' ' ' ARG . 3.2 mt . . . . . 0 N--CA 1.49 1.572 0 O-C-N 120.96 -1.318 . . . . 0.0 109.148 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.302 0.572 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.449 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 67.82 44.78 78.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.792 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.82 115.16 14.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -1.228 . . . . 0.0 110.216 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -108.51 178.2 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.787 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -122.66 161.96 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.057 . . . . 0.0 109.366 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.713 ' O ' HG22 ' A' ' 104' ' ' VAL . 16.0 t-105 -48.57 -70.88 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 111.33 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.539 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 3.8 tp10 -49.31 -51.59 33.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 110.934 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.407 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.2 mt-30 -48.57 -44.6 36.87 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.343 -0.848 . . . . 0.0 110.295 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.57 -25.58 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 117.726 -1.59 . . . . 0.0 107.634 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.749 HD13 HD13 ' A' ' 120' ' ' LEU . 16.1 mt -65.85 -71.56 0.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.539 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 23.8 mm-40 -44.18 -42.37 6.39 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 77' ' ' LEU . 67.0 mt -65.28 -31.49 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 108.999 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.814 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.31 -31.0 13.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.617 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.691 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.1 mtpm? -54.45 -72.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.966 -1.084 . . . . 0.0 108.625 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -51.23 -27.68 9.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' MET . 10.2 tttm -84.62 64.47 8.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.784 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.566 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER 175.99 56.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.843 . . . . 0.0 109.306 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.6 Cg_endo -64.78 -55.06 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.528 1.486 . . . . 0.0 112.231 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 1.7 p-10 -162.56 9.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.164 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.8 mm? -44.97 -62.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -177.75 6.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.04 HG22 ' H ' ' A' ' 118' ' ' THR . 32.0 m -108.88 -164.48 0.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.943 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.04 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 175.97 -44.39 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.3 -0.875 . . . . 0.0 109.708 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.711 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -74.74 143.88 43.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.472 -0.767 . . . . 0.0 110.359 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.749 HD13 HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -65.29 -36.78 85.14 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.385 1.088 . . . . 0.0 108.514 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -61.94 -33.92 75.15 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.932 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.39 -75.4 0.14 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.456 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.92 -40.12 6.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.477 -1.389 . . . . 0.0 109.093 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -52.89 -69.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.661 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.35 -38.62 2.77 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.0 ttm -53.28 -78.04 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.814 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.6 mm -48.76 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.768 0.794 . . . . 0.0 109.832 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.95 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -40.24 3.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.7 m -57.57 -50.25 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.566 -1.549 . . . . 0.0 107.532 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.654 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.39 -49.05 25.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.79 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.14 -54.6 8.34 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.663 ' O ' ' N ' ' A' ' 135' ' ' GLY . 6.9 t -44.88 -68.69 0.18 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.682 ' HG2' HG23 ' A' ' 136' ' ' VAL . 5.5 ttp -47.23 -4.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.637 -0.664 . . . . 0.0 109.271 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.71 -27.61 7.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.682 HG23 ' HG2' ' A' ' 134' ' ' MET . 43.0 t -48.6 165.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.919 -0.754 . . . . 0.0 109.183 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.565 ' N ' HG12 ' A' ' 136' ' ' VAL . 63.2 mm-40 -142.38 162.01 36.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.756 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.95 161.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.903 ' O ' HG13 ' A' ' 139' ' ' VAL . 4.1 p . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.789 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.937 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.7 m -117.17 -24.41 3.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.157 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.16 107.04 4.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.689 -1.257 . . . . 0.0 110.351 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -96.31 73.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.748 ' HB ' HD12 ' A' ' 57' ' ' ILE . 31.2 t -46.47 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.8 -1.188 . . . . 0.0 110.461 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.9 OUTLIER -82.93 34.75 0.46 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.844 0.831 . . . . 0.0 108.999 179.111 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.983 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.11 -174.46 3.65 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.804 0.811 . . . . 0.0 111.147 -178.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 2.3 pm0 -119.69 172.15 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.774 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -168.42 160.06 8.82 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.787 -1.196 . . . . 0.0 110.232 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.774 ' HD2' HD23 ' A' ' 12' ' ' LEU . 15.1 Cg_endo -67.91 109.91 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.249 1.966 . . . . 0.0 111.635 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.804 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -69.01 41.03 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.89 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 177.08 -16.52 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.3 -1.905 . . . . 0.0 111.831 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -135.41 53.92 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.427 -1.631 . . . . 0.0 110.502 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.716 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -73.13 157.9 36.35 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -159.85 162.96 23.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.617 -1.302 . . . . 0.0 110.726 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.0 Cg_endo -56.02 36.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.973 1.782 . . . . 0.0 111.993 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -175.93 58.57 0.18 Allowed Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.34 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.1 Cg_endo -80.68 169.5 16.7 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.568 1.512 . . . . 0.0 111.394 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.88 -4.66 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 121.007 1.138 . . . . 0.0 110.965 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.983 HG22 HD22 ' A' ' 10' ' ' LEU . 2.1 t -104.94 -71.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.6 0.714 . . . . 0.0 109.964 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.69 -98.12 0.05 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.62 -55.38 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 CA-C-N 117.926 0.863 . . . . 0.0 109.867 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.645 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -43.85 -11.41 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.15 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.87 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -116.02 -39.15 3.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.822 -1.174 . . . . 0.0 108.427 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.33 94.1 0.01 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.524 ' O ' ' CD ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -161.52 -23.28 0.05 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.677 ' O ' ' CD2' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -81.14 64.93 6.08 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 80.44 -5.51 63.82 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.29 80.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 111.828 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.54 ' O ' ' NE2' ' A' ' 30' ' ' HIS . 42.9 m-80 -155.95 125.01 6.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.879 -1.138 . . . . 0.0 108.657 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.5 mm -101.16 -62.9 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.686 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.87 -49.77 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.819 -1.176 . . . . 0.0 109.861 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -52.37 -50.54 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.854 -1.154 . . . . 0.0 108.181 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.87 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -48.85 -61.15 2.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.606 1.194 . . . . 0.0 109.076 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.716 HG13 ' CB ' ' A' ' 17' ' ' ALA . 98.6 t -70.52 -29.15 37.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.848 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.686 ' N ' ' O ' ' A' ' 35' ' ' MET . 40.3 tptt -54.44 -55.38 29.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.58 75.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.378 -0.826 . . . . 0.0 109.532 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.3 t80 -68.97 -76.36 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 23.6 m-20 -41.79 -37.19 1.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.455 1.121 . . . . 0.0 110.804 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -63.29 -35.02 78.97 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.355 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.05 -61.54 1.66 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.545 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.3 p -44.8 -30.08 0.9 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.36 -43.21 19.36 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 44' ' ' ALA . 16.3 t-20 -55.3 -24.04 26.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.647 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.09 -85.25 0.54 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.851 -1.156 . . . . 0.0 109.934 179.483 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -161.83 -150.43 5.95 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.121 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.2 123.09 49.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.721 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.804 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -155.39 -152.87 0.41 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 13' ' ' PRO . 5.8 mm -147.19 143.89 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 14' ' ' ALA . 5.6 t -146.94 137.46 12.46 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 110.299 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.9 Cg_endo -73.03 87.24 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.842 1.694 . . . . 0.0 110.776 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.828 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.5 m -58.46 137.42 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.827 1.298 . . . . 0.0 112.231 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 32.6 mt-10 -128.09 63.61 1.4 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.748 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -63.38 88.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.66 0.743 . . . . 0.0 110.174 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.485 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.57 97.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 57' ' ' ILE . 1.9 mt -100.66 146.11 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.17 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.789 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 9.6 m-85 -115.52 141.17 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.937 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.56 -30.37 5.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.153 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 7.2 t70 -52.51 1.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.842 ' H ' ' C ' ' A' ' 61' ' ' ALA . 8.8 tmm_? 71.68 69.8 0.16 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.06 0.933 . . . . 0.0 109.642 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -148.59 125.04 10.97 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.594 ' CD1' ' ND1' ' A' ' 30' ' ' HIS . 17.4 p90 -101.04 103.86 14.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.954 -1.091 . . . . 0.0 110.187 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 58' ' ' THR . 11.2 p -99.43 124.82 44.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 108.854 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.566 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -107.97 171.35 7.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.596 -1.315 . . . . 0.0 109.368 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.994 HG12 ' O ' ' A' ' 68' ' ' VAL . 90.3 t -163.17 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 112.644 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.519 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.0 t -154.02 118.54 4.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 115.945 -2.302 . . . . 0.0 110.754 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.812 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.92 121.43 42.3 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.76 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.6 p 76.86 151.06 0.13 Allowed Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 71' ' ' THR . 12.6 Cg_exo -40.21 175.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.551 2.167 . . . . 0.0 113.038 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.6 Cg_exo -40.51 169.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.6 1.534 . . . . 0.0 112.004 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.934 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.93 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.787 ' N ' ' O ' ' A' ' 73' ' ' PRO . 8.6 t -43.34 -23.62 0.07 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 110.147 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.07 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 20.5 p90 -43.6 -42.09 4.95 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.0 109.41 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.07 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.27 -14.58 2.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.407 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.934 HD12 ' HB1' ' A' ' 74' ' ' ALA . 3.1 mt -61.75 -31.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.768 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 2.1 mmp_? -54.82 -44.27 73.71 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HZ3' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -66.03 -65.59 0.66 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.445 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -57.22 -4.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.634 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.55 -79.72 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 112.156 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.417 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 163.64 47.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.682 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 84' ' ' LEU . 5.4 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.003 -1.292 . . . . 0.0 109.195 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 97' ' ' GLY . 72.2 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.302 0.572 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 69.48 60.36 5.12 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.634 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.3 mtt180 -134.7 113.54 11.78 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -1.21 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.702 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.21 179.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.727 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -124.44 155.43 38.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.024 -1.048 . . . . 0.0 109.198 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.715 ' O ' HG22 ' A' ' 104' ' ' VAL . 12.0 t-105 -44.97 -70.25 0.11 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 111.244 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.511 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.32 -52.98 24.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.69 -1.257 . . . . 0.0 111.047 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.3 mt-30 -47.76 -44.6 28.31 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.272 -0.892 . . . . 0.0 110.429 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.9 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.5 -25.33 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 117.681 -1.608 . . . . 0.0 107.585 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 120' ' ' LEU . 16.8 mt -66.16 -70.86 0.22 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' LEU . 78.2 tt0 -43.85 -43.66 6.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.911 -1.118 . . . . 0.0 108.34 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 77' ' ' LEU . 46.9 mt -61.83 -31.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.812 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.19 -27.42 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.783 ' HE3' HD11 ' A' ' 120' ' ' LEU . 13.9 mttp -58.44 -73.44 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.763 -1.21 . . . . 0.0 108.304 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.604 ' CD ' ' N ' ' A' ' 110' ' ' GLN . 1.5 mp0 -44.93 -26.43 0.42 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.041 -1.037 . . . . 0.0 108.794 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 109' ' ' LYS . 13.4 tttt -73.19 -16.96 61.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.68 65.9 76.88 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.039 -1.038 . . . . 0.0 109.746 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.68 -34.76 30.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.704 1.602 . . . . 0.0 112.069 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER 175.0 15.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 109.163 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.403 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.3 mm? -55.49 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 0.0 109.553 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -150.66 -24.99 0.23 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.053 HG22 ' H ' ' A' ' 118' ' ' THR . 23.5 m -62.97 -164.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.053 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.34 -74.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.267 -0.895 . . . . 0.0 109.933 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.524 ' H ' HG23 ' A' ' 118' ' ' THR . 1.9 m-20 -61.78 140.44 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.183 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -62.36 -22.34 66.03 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.204 1.002 . . . . 0.0 108.899 179.492 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.56 -35.39 80.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.414 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.41 -75.53 0.13 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.899 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.47 -34.15 1.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.491 -1.381 . . . . 0.0 109.27 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -58.11 -69.2 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.031 -1.043 . . . . 0.0 108.509 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.59 -44.79 6.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.703 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.0 mtt -50.29 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.101 -0.999 . . . . 0.0 108.743 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.812 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.7 mm -48.09 -66.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.416 -0.802 . . . . 0.0 110.053 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.9 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.39 -71.37 0.11 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.94 -40.72 4.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.8 m -55.36 -47.8 75.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.584 . . . . 0.0 107.582 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.567 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -50.43 -47.92 56.53 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.782 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.11 -51.99 12.92 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.668 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.0 t -45.24 -67.88 0.25 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.768 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 9.4 ttm -48.53 -2.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.18 -27.21 7.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.672 HG23 ' SD ' ' A' ' 134' ' ' MET . 30.9 t -48.84 165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.927 -0.749 . . . . 0.0 109.326 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' N ' HG12 ' A' ' 136' ' ' VAL . 40.3 mm-40 -142.27 162.37 35.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 109.767 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.27 165.02 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.905 ' O ' HG13 ' A' ' 139' ' ' VAL . 5.1 p . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.77 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.983 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.1 m -119.51 -24.58 3.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.77 107.73 4.51 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.422 -1.311 . . . . 0.0 110.338 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.86 73.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.755 ' HB ' HD12 ' A' ' 57' ' ' ILE . 32.3 t -48.03 88.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.816 -1.178 . . . . 0.0 110.653 -176.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtp? -82.47 36.06 0.47 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.791 0.805 . . . . 0.0 109.2 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.88 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.8 tp -78.31 -174.08 3.56 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.608 0.718 . . . . 0.0 111.119 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.59 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 1.2 pm0 -124.74 177.88 5.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.597 HD13 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -167.61 155.9 8.59 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 109.945 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 15' ' ' GLY . 12.0 Cg_endo -68.83 104.55 1.18 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.037 1.824 . . . . 0.0 111.508 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.802 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -63.1 37.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.932 -1.105 . . . . 0.0 110.38 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -170.56 -26.51 0.02 OUTLIER Glycine 0 N--CA 1.493 2.467 0 C-N-CA 118.096 -2.002 . . . . 0.0 111.842 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 15' ' ' GLY . 2.9 mttm -138.97 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.474 -1.604 . . . . 0.0 110.572 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.659 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -90.45 160.91 15.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.762 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.8 164.95 9.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.799 -1.188 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.468 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.9 Cg_exo -53.1 32.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.717 1.612 . . . . 0.0 112.026 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.68 54.16 4.56 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.221 -0.925 . . . . 0.0 110.046 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.09 155.01 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.696 1.597 . . . . 0.0 111.778 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.79 -4.69 1.49 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.006 1.137 . . . . 0.0 111.432 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.799 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 5.4 t -113.47 -68.96 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.93 -97.62 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.799 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -56.45 -55.04 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 CA-C-N 117.784 0.792 . . . . 0.0 110.479 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.724 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -55.59 -4.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.598 -0.689 . . . . 0.0 111.076 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -112.11 -54.71 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.645 -1.285 . . . . 0.0 109.152 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.26 -26.5 0.96 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.499 ' C ' ' O ' ' A' ' 28' ' ' GLY . 52.0 mm-40 -42.01 -19.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.513 -1.58 . . . . 0.0 109.252 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.773 ' CD2' ' N ' ' A' ' 31' ' ' GLY . 3.6 p-80 -65.25 -48.86 71.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.788 0.804 . . . . 0.0 108.854 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.773 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -162.22 -8.26 0.04 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 71.38 72.49 0.18 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.926 -0.75 . . . . 0.0 111.47 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.24 63.07 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.499 1.142 . . . . 0.0 108.742 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.4 mm -43.12 -66.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.361 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.7 tpt -41.61 -57.7 2.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.38 -1.45 . . . . 0.0 109.009 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.8 tp10 -44.68 -50.16 10.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.77 -1.206 . . . . 0.0 107.936 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -48.27 -62.98 1.21 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.813 1.292 . . . . 0.0 108.863 178.117 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 17' ' ' ALA . 61.8 t -67.78 -30.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.271 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 35' ' ' MET . 19.0 tttp -52.75 -59.82 4.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.24 74.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.803 . . . . 0.0 109.512 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.683 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.3 t80 -69.66 -77.23 0.09 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.7 m-20 -41.77 -36.43 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.48 1.133 . . . . 0.0 110.539 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -63.27 -35.1 79.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.586 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -91.25 -57.52 2.76 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.813 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.772 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 16.2 p -48.08 -28.53 2.92 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.21 -47.88 11.08 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -50.46 -23.0 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.216 -0.927 . . . . 0.0 109.127 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.759 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.51 -85.2 0.54 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.759 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.41 -117.93 0.42 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.842 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 3.4 t0 -141.26 129.32 22.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -1.176 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.802 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -164.17 -152.81 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.174 -0.953 . . . . 0.0 110.391 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.585 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.3 mm -146.95 141.77 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.622 HG22 ' C ' ' A' ' 71' ' ' THR . 15.0 t -142.76 137.08 14.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.098 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.3 Cg_endo -74.33 88.14 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.882 1.722 . . . . 0.0 111.077 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.88 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -57.37 137.14 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 122.697 1.237 . . . . 0.0 111.946 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 66.0 tt0 -128.89 67.49 1.41 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.755 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.1 mt -68.7 87.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.698 0.761 . . . . 0.0 110.068 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.71 100.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 57' ' ' ILE . 9.0 mt -103.13 145.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.569 -0.707 . . . . 0.0 110.406 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.77 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 8.0 m-85 -116.17 140.02 49.74 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.983 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.61 -32.13 7.7 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.391 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.9 t70 -50.6 -2.3 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.797 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.9 ttm180 75.31 70.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.035 0.921 . . . . 0.0 109.951 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 36.1 t -148.71 127.5 12.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.672 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -103.3 103.82 13.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.833 -1.167 . . . . 0.0 110.399 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.1 p -99.07 124.63 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -107.6 171.56 7.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.506 -1.371 . . . . 0.0 109.321 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.971 HG12 ' O ' ' A' ' 68' ' ' VAL . 98.7 t -162.56 44.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 112.813 -177.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.483 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.3 t -153.83 120.62 5.61 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.669 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.82 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -118.92 122.01 41.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.807 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.6 p 77.48 151.74 0.13 Allowed Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.138 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.514 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 13.8 Cg_exo -38.85 175.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.375 2.717 . . . . 0.0 114.083 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.89 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -40.68 168.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.077 0 C-N-CA 122.035 1.823 . . . . 0.0 112.308 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.78 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 48.11 -74.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.89 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -42.99 -21.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.683 -0.635 . . . . 0.0 110.755 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.78 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -44.05 -35.51 2.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.728 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.978 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -136.55 -16.24 1.57 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.978 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.2 mt -58.86 -34.13 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.828 HH11 ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.85 -38.58 70.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.3 tmtt? -69.72 -66.93 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.86 -7.39 0.3 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.178 -0.951 . . . . 0.0 109.153 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.48 -78.27 0.31 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.676 -0.64 . . . . 0.0 111.433 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.651 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 166.2 14.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.913 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.784 HD12 ' NH1' ' A' ' 79' ' ' ARG . 2.6 mt . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.401 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.651 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.324 0.583 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 96.02 64.21 0.95 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 82' ' ' ALA . 5.8 mtt180 -134.09 114.82 13.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.09 -1.241 . . . . 0.0 110.304 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.7 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -103.38 179.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.715 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -124.86 154.65 40.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.003 -1.06 . . . . 0.0 109.124 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.682 ' O ' HG22 ' A' ' 104' ' ' VAL . 12.8 t-105 -44.91 -69.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 111.386 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.19 -52.22 37.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.522 -1.361 . . . . 0.0 111.004 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.1 mt-30 -48.77 -44.05 38.41 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.452 -0.78 . . . . 0.0 110.492 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.75 -26.39 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 117.726 -1.589 . . . . 0.0 107.614 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.927 HD13 HD13 ' A' ' 120' ' ' LEU . 13.5 mt -65.01 -71.17 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.498 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 7.4 tm-20 -44.35 -44.67 8.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.615 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 77' ' ' LEU . 63.7 mt -61.99 -31.91 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 108.706 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.837 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.66 -26.84 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.111 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.776 ' N ' ' O ' ' A' ' 105' ' ' LEU . 2.0 tptp -58.97 -73.52 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -48.91 -25.01 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 108.988 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.505 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 3.2 tmtt? -83.15 -7.39 59.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.269 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.724 ' O ' ' SD ' ' A' ' 112' ' ' MET . 2.3 ppp? -130.13 59.72 47.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.865 -1.147 . . . . 0.0 109.967 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.7 Cg_endo -61.29 -54.43 1.77 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.537 1.491 . . . . 0.0 112.305 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER 174.74 -1.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.612 ' O ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -44.88 -28.82 0.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.696 -0.628 . . . . 0.0 109.717 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.482 ' N ' ' HG ' ' A' ' 115' ' ' LEU . 8.7 t30 -177.62 -14.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.96 -1.087 . . . . 0.0 109.653 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.043 HG22 ' H ' ' A' ' 118' ' ' THR . 31.9 m -104.02 -164.51 1.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.043 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.48 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 0.0 109.806 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.735 ' OD2' ' HB2' ' A' ' 122' ' ' ALA . 2.9 p-10 -58.0 143.07 44.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.163 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.927 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -71.92 -30.59 65.5 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.502 1.144 . . . . 0.0 108.387 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -62.91 -35.04 78.74 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.404 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.735 ' HB2' ' OD2' ' A' ' 119' ' ' ASP . . . -70.71 -76.32 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.382 -1.327 . . . . 0.0 107.556 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.89 -43.43 8.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.455 -1.403 . . . . 0.0 109.137 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -48.22 -69.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 0.0 108.64 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 129' ' ' GLY . 13.7 ttt180 -43.44 -39.6 3.35 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 130' ' ' SER . 18.5 ttm -53.95 -79.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.249 -0.907 . . . . 0.0 108.742 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.837 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.4 mm -47.62 -63.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.772 . . . . 0.0 110.054 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.709 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.46 -71.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.11 -42.97 5.47 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.0 m -52.59 -45.09 66.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.537 -1.566 . . . . 0.0 107.542 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.662 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -53.72 -48.03 69.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.607 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 3.3 tmm_? -44.94 -44.75 10.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.4 t -55.41 -69.88 0.12 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.771 ' CG ' HH21 ' A' ' 79' ' ' ARG . 5.9 ttm -44.87 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.523 -0.735 . . . . 0.0 110.073 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.32 25.56 47.27 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.662 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.4 t -106.31 165.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.981 -0.717 . . . . 0.0 109.126 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.536 ' N ' HG12 ' A' ' 136' ' ' VAL . 50.3 mm-40 -140.41 161.89 36.61 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.901 -1.12 . . . . 0.0 110.086 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.84 165.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.899 ' O ' HG13 ' A' ' 139' ' ' VAL . 4.5 p . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.772 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -114.05 -24.35 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.17 108.29 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -95.54 73.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.737 ' HB ' HD12 ' A' ' 57' ' ' ILE . 12.2 t -45.69 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.239 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.65 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -82.78 34.58 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.952 0.882 . . . . 0.0 109.093 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.85 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.6 tp -77.08 -174.46 3.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.783 0.801 . . . . 0.0 111.003 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 1.066 ' O ' HD12 ' A' ' 12' ' ' LEU . 2.1 pm0 -123.52 174.22 7.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.066 HD12 ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -171.17 158.88 5.18 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 110.411 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HA ' HD13 ' A' ' 52' ' ' ILE . 11.1 Cg_endo -66.61 108.69 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.197 1.932 . . . . 0.0 111.993 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.804 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -67.47 40.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.457 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -178.09 -21.0 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.527 -1.797 . . . . 0.0 111.525 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -139.92 74.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.521 -1.576 . . . . 0.0 110.259 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.784 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -92.25 165.29 13.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 108.588 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.763 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.4 163.06 6.1 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.915 -1.116 . . . . 0.0 110.036 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HA ' HG21 ' A' ' 34' ' ' ILE . 5.5 Cg_exo -53.13 32.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.681 1.587 . . . . 0.0 111.841 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.763 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.71 54.07 4.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 110.597 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.3 Cg_endo -85.82 160.83 10.51 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.766 1.644 . . . . 0.0 111.467 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.51 -4.81 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 120.898 1.065 . . . . 0.0 111.047 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 26' ' ' ALA . 21.2 t -115.58 -67.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.482 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 56.51 -97.32 0.05 OUTLIER Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.808 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.0 Cg_exo -54.05 -55.02 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 CA-C-N 117.844 0.822 . . . . 0.0 110.45 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -60.79 -0.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.196 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.685 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.58 -58.77 2.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.717 -1.24 . . . . 0.0 109.59 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.667 ' HA2' ' CD2' ' A' ' 30' ' ' HIS . . . -43.18 -18.07 0.05 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.315 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 28' ' ' GLY . 32.5 mm-40 -42.13 -21.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.255 -1.732 . . . . 0.0 108.502 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.764 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 6.3 p80 -67.32 59.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.653 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 84.62 -13.03 54.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.15 77.14 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.544 -0.974 . . . . 0.0 111.848 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 34' ' ' ILE . 1.7 m120 -150.29 60.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.34 1.067 . . . . 0.0 108.536 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.0 mm -42.86 -65.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.623 ' O ' ' N ' ' A' ' 39' ' ' LYS . 8.2 tpt -41.95 -40.43 2.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 108.746 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -58.0 -51.2 70.66 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.685 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -47.85 -62.43 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.94 1.352 . . . . 0.0 108.951 177.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 17' ' ' ALA . 61.0 t -67.26 -30.55 49.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.596 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -54.11 -59.46 4.62 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.33 74.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.433 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.2 t80 -67.2 -75.03 0.1 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.2 m120 -41.99 -37.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.475 1.131 . . . . 0.0 110.874 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -62.7 -35.53 80.02 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.559 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.528 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.83 -56.11 3.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.878 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.756 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.0 p -50.7 -26.22 5.25 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.59 -48.1 10.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.528 ' OD1' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -52.61 -21.22 3.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.975 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.545 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.63 -85.22 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.545 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.56 -136.48 2.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.942 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.505 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 2.8 p30 -122.12 122.34 39.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -1.102 . . . . 0.0 109.915 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.804 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.08 -153.17 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.908 . . . . 0.0 110.289 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.8 mm -147.28 142.76 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.547 HG22 ' C ' ' A' ' 71' ' ' THR . 8.1 t -145.01 137.66 13.59 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 110.261 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.1 Cg_endo -73.56 86.67 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.796 1.664 . . . . 0.0 110.669 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.85 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -56.68 138.38 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-O 122.749 1.261 . . . . 0.0 112.078 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.5 mt-10 -130.52 65.67 1.53 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.737 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.4 mt -65.44 88.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.812 0.815 . . . . 0.0 110.234 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.559 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -65.48 98.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.663 HG12 HG22 ' A' ' 57' ' ' ILE . 1.7 mt -102.94 147.54 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.772 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.9 m-85 -115.82 141.62 47.85 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.802 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.52 -32.72 8.37 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.304 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.27 -1.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.794 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.4 tmm_? 75.21 70.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -148.99 124.94 10.62 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' CG ' ' A' ' 65' ' ' PHE . 20.6 p90 -100.97 103.73 14.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.003 -1.061 . . . . 0.0 110.197 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 58' ' ' THR . 9.2 p -99.25 124.63 44.48 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -107.71 170.41 8.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.481 -1.387 . . . . 0.0 109.355 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.963 HG12 ' O ' ' A' ' 68' ' ' VAL . 90.1 t -161.82 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 112.716 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.535 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.0 116.95 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 116.039 -2.264 . . . . 0.0 110.324 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.803 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -114.74 120.0 38.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.032 0.92 . . . . 0.0 108.701 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.779 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.94 152.26 0.13 Allowed Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.364 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 71' ' ' THR . 15.3 Cg_exo -38.15 175.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.751 2.301 . . . . 0.0 113.365 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.795 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.3 Cg_exo -42.26 168.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.761 1.641 . . . . 0.0 112.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.902 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.6 -77.0 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 73' ' ' PRO . 41.6 p -43.42 -24.14 0.09 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.522 -0.736 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 14.6 p90 -43.86 -41.4 5.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.59 -18.82 2.75 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.902 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.4 mt -59.87 -32.65 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 84' ' ' LEU . 14.1 mmt180 -54.91 -43.09 72.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.526 ' CD ' ' C ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -68.39 -66.64 0.54 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -56.14 -4.92 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.965 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.04 -79.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.508 -0.745 . . . . 0.0 112.018 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.486 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 159.36 56.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.407 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 79' ' ' ARG . 10.2 mt . . . . . 0 N--CA 1.488 1.475 0 O-C-N 121.053 -1.263 . . . . 0.0 109.503 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 97' ' ' GLY . 19.2 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 50.98 60.92 6.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.6 mtt180 -134.74 113.54 11.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.071 -1.252 . . . . 0.0 110.686 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 -176.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.651 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -128.93 156.32 43.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 109.093 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.712 ' O ' HG22 ' A' ' 104' ' ' VAL . 10.7 t-105 -44.93 -71.46 0.08 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.801 . . . . 0.0 111.176 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.13 -52.52 34.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.636 -1.29 . . . . 0.0 111.103 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.1 mt-30 -47.82 -43.66 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.383 -0.823 . . . . 0.0 110.303 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.56 -24.88 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.575 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.869 HD13 HD13 ' A' ' 120' ' ' LEU . 21.2 mt -66.0 -72.06 0.17 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 107' ' ' ILE . 11.3 tm-20 -44.28 -45.02 8.42 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.959 -1.088 . . . . 0.0 108.612 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.764 ' CD1' HD21 ' A' ' 77' ' ' LEU . 42.1 mt -61.25 -31.67 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.046 . . . . 0.0 108.623 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.847 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -97.45 -23.68 15.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 108.984 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.9 tptp -62.43 -74.52 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.456 ' CD ' ' N ' ' A' ' 110' ' ' GLN . 1.7 mp0 -44.63 -30.15 0.87 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.022 -1.049 . . . . 0.0 108.806 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -61.82 -24.0 66.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.706 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -126.39 73.85 73.37 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 109.698 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.79 -34.4 24.44 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.551 1.501 . . . . 0.0 111.964 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 3.6 t70 175.09 11.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.036 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 115' ' ' LEU . 2.4 mm? -49.81 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 109.606 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 117' ' ' THR . 5.6 p-10 -148.76 -25.05 0.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.607 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.057 HG22 ' H ' ' A' ' 118' ' ' THR . 22.9 m -60.19 -164.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.537 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.057 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.58 -72.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.3 -0.875 . . . . 0.0 109.929 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.53 ' H ' HG23 ' A' ' 118' ' ' THR . 4.8 m-20 -65.32 138.28 58.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.439 -0.788 . . . . 0.0 110.159 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.869 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -61.73 -21.53 64.59 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.282 1.039 . . . . 0.0 108.815 179.398 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.53 -38.49 91.2 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.54 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.88 -75.13 0.11 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.135 -1.426 . . . . 0.0 107.784 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.53 -41.64 6.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.524 -1.36 . . . . 0.0 109.392 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.09 -69.52 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 0.0 108.764 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.2 ttm180 -43.55 -39.94 3.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.701 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.2 ttm -53.31 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 108.579 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.847 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 24.1 mm -47.92 -63.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.438 -0.789 . . . . 0.0 109.954 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.805 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.97 -71.75 0.12 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.01 -41.87 4.84 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.8 m -54.35 -50.73 66.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.523 -1.575 . . . . 0.0 107.685 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.734 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -48.49 -47.49 38.63 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.0 -55.01 7.4 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.5 t -44.71 -68.59 0.19 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.652 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.2 ttp -46.68 -4.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.63 -31.08 5.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.734 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 29.0 t -45.43 165.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.937 -0.743 . . . . 0.0 109.194 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.547 ' N ' HG12 ' A' ' 136' ' ' VAL . 35.9 mp0 -143.85 163.2 34.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.65 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -79.28 155.08 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p . . . . . 0 N--CA 1.487 1.411 0 O-C-N 121.628 -0.67 . . . . 0.0 109.284 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.794 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.6 m -111.66 -24.5 3.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.3 6.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -94.99 73.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.386 -0.821 . . . . 0.0 108.827 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 55' ' ' VAL . 26.1 t -45.92 88.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.045 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.96 34.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.951 0.881 . . . . 0.0 108.901 179.281 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.921 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.53 -174.66 3.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.872 0.844 . . . . 0.0 111.268 -178.791 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 1.5 pm0 -116.98 169.49 9.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.569 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -163.08 144.44 7.6 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.159 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HA ' HD13 ' A' ' 52' ' ' ILE . 30.3 Cg_endo -79.02 126.6 7.2 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.505 2.137 . . . . 0.0 114.216 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.079 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.52 141.43 48.51 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 60.55 -61.24 0.01 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.1 ttpm? -60.64 37.77 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.831 -0.805 . . . . 0.0 108.831 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.704 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -119.27 151.83 37.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.9 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.79 165.77 6.89 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 -179.08 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.5 Cg_exo -49.46 36.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.696 1.598 . . . . 0.0 111.657 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.9 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -163.77 54.87 0.43 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.53 -0.732 . . . . 0.0 109.78 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.2 Cg_endo -77.93 170.16 19.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.485 1.456 . . . . 0.0 111.716 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -60.75 -4.65 3.7 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.209 1.273 . . . . 0.0 111.03 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.921 HG22 ' CD2' ' A' ' 10' ' ' LEU . 2.2 t -106.16 -71.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.594 0.711 . . . . 0.0 110.333 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.31 -98.37 0.05 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 -177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.3 Cg_endo -60.21 -55.4 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 CA-C-N 118.047 0.924 . . . . 0.0 109.926 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.35 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.362 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.89 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -111.87 -42.84 3.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.631 -1.293 . . . . 0.0 108.751 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.66 84.44 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tt0 -149.18 -15.34 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 65' ' ' PHE . 2.0 p80 -84.42 -37.41 21.49 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.649 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -170.91 -2.8 0.03 OUTLIER Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 81.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.606 -0.938 . . . . 0.0 112.19 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -156.8 120.86 4.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.074 . . . . 0.0 108.639 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.6 mm -96.58 -65.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 110.108 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.669 ' O ' ' N ' ' A' ' 39' ' ' LYS . 5.3 tpt -42.09 -56.97 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.715 -1.241 . . . . 0.0 109.558 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' MET . 6.5 mt-10 -46.86 -50.78 18.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.269 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.89 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -48.72 -61.61 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.644 1.212 . . . . 0.0 109.617 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 42' ' ' ASN . 56.3 t -71.37 -30.28 39.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.979 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 35' ' ' MET . 32.6 tptt -51.54 -63.1 1.24 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.04 69.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 45' ' ' THR . 1.9 t80 -70.32 -76.83 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.623 ' N ' ' O ' ' A' ' 38' ' ' VAL . 1.9 m120 -41.37 -34.01 0.47 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.578 1.18 . . . . 0.0 110.63 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -67.39 -35.06 78.55 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.05 -43.99 9.58 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.735 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.697 ' CB ' ' H ' ' A' ' 15' ' ' GLY . 18.1 p -61.16 -32.14 71.87 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.36 -44.74 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -57.23 -23.7 49.69 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.763 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.8 -74.69 0.64 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.763 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 169.83 149.35 6.28 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.124 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.8 t70 -44.82 148.37 0.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.986 -1.303 . . . . 0.0 109.429 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.079 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.87 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.973 -1.079 . . . . 0.0 110.623 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.641 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.7 mm -147.16 141.78 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 71' ' ' THR . 2.8 t -144.96 133.8 11.05 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.801 -1.187 . . . . 0.0 110.888 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 5.7 Cg_endo -69.13 95.7 0.51 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.484 1.456 . . . . 0.0 110.315 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.792 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.9 m -75.84 137.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.928 1.347 . . . . 0.0 112.61 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 14.4 mt-10 -128.61 61.73 1.48 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.723 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.6 mt -61.71 88.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.729 0.776 . . . . 0.0 109.825 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.489 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -64.23 95.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.654 HG13 HG22 ' A' ' 57' ' ' ILE . 12.9 mt -96.96 140.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.648 -0.657 . . . . 0.0 110.162 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.794 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.5 m-85 -111.83 138.93 47.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.843 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.08 -30.35 2.7 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -53.47 3.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.241 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.843 ' H ' ' C ' ' A' ' 61' ' ' ALA . 2.6 tmm_? 70.05 69.64 0.22 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.099 0.952 . . . . 0.0 109.436 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 3.2 m -147.86 125.87 12.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.19 104.08 14.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.052 -1.03 . . . . 0.0 110.288 -179.339 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.433 ' OG1' ' HB ' ' A' ' 58' ' ' THR . 23.4 p -98.78 124.52 43.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.557 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -109.64 173.74 6.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.58 -1.325 . . . . 0.0 109.281 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.974 HG12 ' O ' ' A' ' 68' ' ' VAL . 85.3 t -162.78 44.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 112.666 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.529 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 t -156.55 118.09 3.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 116.092 -2.243 . . . . 0.0 109.475 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.821 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -114.61 125.15 53.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.339 1.066 . . . . 0.0 109.328 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 1.027 HG21 ' CZ ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 75.02 161.56 0.15 Allowed Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.22 -179.069 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.681 ' HD2' HG22 ' A' ' 71' ' ' THR . 12.4 Cg_exo -41.35 175.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.469 2.112 . . . . 0.0 113.102 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.1 Cg_exo -44.08 169.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.681 1.587 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.863 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.8 -74.49 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.777 ' N ' ' O ' ' A' ' 73' ' ' PRO . 22.8 t -43.76 -20.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 110.055 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 1.093 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 26.8 p90 -43.49 -43.35 5.37 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.093 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.76 -20.42 2.55 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.895 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -55.36 -35.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.451 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 1.027 ' CZ ' HG21 ' A' ' 71' ' ' THR . 0.0 OUTLIER -53.39 -57.6 10.04 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.51 ' C ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -52.04 -64.29 0.86 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.016 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.68 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -48.89 -16.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 0.0 108.463 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.864 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -98.78 -74.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.916 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 95.59 95.12 1.74 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.964 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.817 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 7.1 mt . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.159 -1.201 . . . . 0.0 108.938 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.812 ' O ' ' N ' ' A' ' 98' ' ' ARG . 79.2 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.416 0.627 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.864 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . -43.99 72.98 0.0 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.812 ' N ' ' O ' ' A' ' 96' ' ' VAL . 2.6 mtt180 -135.65 109.74 8.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -1.077 . . . . 0.0 109.563 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.828 HD13 HG12 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.01 -175.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.759 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -125.24 165.84 17.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.082 . . . . 0.0 109.666 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.688 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.3 t-105 -51.01 -71.31 0.07 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.646 -0.659 . . . . 0.0 111.277 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.505 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.0 tp10 -47.73 -50.31 25.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.766 -1.209 . . . . 0.0 110.859 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -49.86 -44.9 49.99 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.902 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.73 -25.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 117.535 -1.666 . . . . 0.0 107.379 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.954 HD13 HD13 ' A' ' 120' ' ' LEU . 18.8 mt -66.31 -71.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 105' ' ' LEU . 72.7 tt0 -43.74 -43.77 6.21 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.923 -1.111 . . . . 0.0 108.641 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.724 HG12 HD11 ' A' ' 77' ' ' LEU . 55.7 mt -62.79 -30.75 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.049 . . . . 0.0 108.541 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.799 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.88 -26.11 16.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.478 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -61.78 -74.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 0.0 108.396 179.119 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.453 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 19.7 tt0 -47.16 -20.29 0.17 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.945 . . . . 0.0 109.26 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -80.89 -9.31 59.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.856 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.52 56.43 20.63 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.045 -1.035 . . . . 0.0 109.785 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.9 Cg_endo -59.33 -33.36 97.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.585 1.523 . . . . 0.0 112.406 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.06 19.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.479 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.2 mp -54.12 -85.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.82 -11.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.801 . . . . 0.0 109.154 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 1.037 HG22 ' H ' ' A' ' 118' ' ' THR . 31.5 m -72.24 -164.57 0.15 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 1.037 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.8 -56.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.314 -0.866 . . . . 0.0 109.674 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.444 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -80.43 134.94 36.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.954 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -55.24 -22.5 18.31 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.179 0.99 . . . . 0.0 109.019 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.6 -36.82 84.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.63 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.53 -75.75 0.11 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.481 -1.387 . . . . 0.0 107.977 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.635 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.35 -40.31 5.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.479 -1.388 . . . . 0.0 109.243 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.77 -68.12 0.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.026 -1.046 . . . . 0.0 108.442 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 129' ' ' GLY . 1.8 ttm180 -43.63 -43.59 5.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.713 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.34 -79.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.057 -1.027 . . . . 0.0 108.563 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.799 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.3 mm -48.19 -65.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.21 -71.49 0.11 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.93 -40.53 4.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.713 ' N ' ' O ' ' A' ' 126' ' ' MET . 45.1 m -56.3 -51.05 69.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.467 -1.608 . . . . 0.0 107.707 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.716 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -46.86 -47.74 21.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.8 -54.32 10.08 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.3 t -44.99 -70.24 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.701 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.2 ttp -46.9 -4.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.613 -0.679 . . . . 0.0 109.355 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.71 -30.11 6.36 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.716 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 50.8 t -44.91 164.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.856 -0.791 . . . . 0.0 108.941 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.1 tm-20 -144.04 162.66 35.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 109.686 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.617 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -80.23 145.41 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.962 ' O ' HG13 ' A' ' 139' ' ' VAL . 2.4 p . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 110.64 2.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.92 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -139.81 122.39 16.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.786 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.85 134.84 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.458 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -116.5 -24.49 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.259 -0.9 . . . . 0.0 109.008 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.33 108.95 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.41 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -96.93 73.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.787 ' HB ' HD12 ' A' ' 57' ' ' ILE . 39.0 t -48.53 87.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 120.756 -1.215 . . . . 0.0 110.276 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 7' ' ' VAL . 1.6 tmmt? -82.77 36.65 0.5 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.803 0.811 . . . . 0.0 109.18 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.013 HD22 HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.41 -173.94 3.54 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.775 0.798 . . . . 0.0 111.494 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 1.1 pm0 -121.74 173.61 7.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.752 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -161.62 146.96 10.46 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 109.368 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.699 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 91.1 Cg_endo -87.33 126.91 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.343 2.029 . . . . 0.0 113.47 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.099 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.94 143.17 43.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.38 58.64 9.54 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.699 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 9.6 tttp 174.31 -1.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.807 -0.82 . . . . 0.0 108.831 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 18' ' ' THR . . . -83.5 153.93 24.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.902 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.68 165.95 4.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.668 -179.155 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.1 Cg_exo -49.19 34.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.57 1.513 . . . . 0.0 111.581 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.902 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.67 54.46 0.71 Allowed Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.614 -0.679 . . . . 0.0 109.245 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 13.3 Cg_endo -80.8 169.89 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.694 1.596 . . . . 0.0 111.729 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.27 -4.43 2.31 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 121.009 1.139 . . . . 0.0 111.039 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.013 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -110.68 -70.51 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.562 0.696 . . . . 0.0 110.253 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.01 -98.24 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.12 -55.57 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 CA-C-N 118.007 0.903 . . . . 0.0 109.951 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.654 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.44 -12.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.173 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.006 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.65 -41.64 3.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.778 -1.201 . . . . 0.0 108.28 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.42 92.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 27' ' ' LEU . 43.1 mt-30 -158.5 -26.87 0.08 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.754 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.7 p80 -78.24 60.35 2.48 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.485 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.68 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 85.03 -9.87 64.91 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 84.96 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 112.163 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -157.83 122.61 4.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 108.801 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.4 mm -97.36 -63.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.609 -0.682 . . . . 0.0 109.732 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.74 -55.59 2.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.693 -1.254 . . . . 0.0 109.537 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 35' ' ' MET . 12.0 mt-10 -46.25 -45.73 17.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.498 -1.376 . . . . 0.0 107.468 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 1.006 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -54.18 -68.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.244 1.021 . . . . 0.0 109.636 178.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 42' ' ' ASN . 25.9 t -67.03 -38.29 81.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.681 -0.637 . . . . 0.0 110.018 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.1 tptm -45.29 -58.79 3.04 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.98 74.79 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.265 -0.897 . . . . 0.0 109.094 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.673 ' O ' HG23 ' A' ' 45' ' ' THR . 2.3 t80 -71.39 -77.26 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 120.368 -1.457 . . . . 0.0 107.124 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.2 t-20 -41.08 -33.95 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.879 -1.138 . . . . 0.0 110.739 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.33 -32.33 72.37 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.918 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.39 -48.54 7.06 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.652 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 41' ' ' PHE . 1.5 p -58.92 -30.45 67.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.15 -44.78 21.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -57.81 -21.96 44.94 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.558 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.85 -72.46 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.558 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.21 -131.31 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.016 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 4.7 p-10 -121.19 148.0 44.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.254 -1.145 . . . . 0.0 108.779 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.099 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.94 -153.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.752 -1.218 . . . . 0.0 110.929 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.6 mm -146.12 138.42 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 71' ' ' THR . 2.4 t -138.76 134.44 17.16 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.116 -0.99 . . . . 0.0 110.791 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -71.86 107.24 2.16 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.69 1.594 . . . . 0.0 111.012 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.832 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.1 m -81.1 136.92 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.722 -1.236 . . . . 0.0 111.464 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -130.74 68.04 1.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.787 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.1 mt -68.19 90.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.79 0.805 . . . . 0.0 110.231 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.09 96.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.644 HG13 HG22 ' A' ' 57' ' ' ILE . 50.2 mt -101.07 145.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.515 0.674 . . . . 0.0 110.728 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.786 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.4 m-85 -116.51 139.89 49.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.802 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.42 -32.78 5.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.147 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -50.94 -1.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.79 ' H ' ' C ' ' A' ' 61' ' ' ALA . 11.2 ttm180 75.33 68.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.952 0.882 . . . . 0.0 109.85 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 1.3 t -148.49 147.93 29.66 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.65 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 36.2 p90 -125.29 103.82 8.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.902 -1.124 . . . . 0.0 110.247 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.4 p -101.44 120.75 40.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 110.052 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.937 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.1 148.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.089 -1.007 . . . . 0.0 110.99 177.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 67' ' ' PHE . 28.9 t -169.18 91.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.187 0.994 . . . . 0.0 108.491 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -97.5 147.05 24.65 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.752 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -132.25 125.15 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.397 -1.44 . . . . 0.0 110.604 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.752 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 14.8 p 76.18 150.64 0.13 Allowed Pre-proline 0 N--CA 1.493 1.68 0 CA-C-O 121.244 0.545 . . . . 0.0 109.975 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 73' ' ' PRO . 12.6 Cg_exo -40.8 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.653 2.235 . . . . 0.0 112.993 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.756 ' O ' ' N ' ' A' ' 75' ' ' SER . 25.0 Cg_exo -39.89 168.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.543 1.495 . . . . 0.0 111.905 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.917 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.05 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.832 ' HG ' ' HG3' ' A' ' 79' ' ' ARG . 11.2 t -43.05 -21.72 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.079 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 23.6 p90 -43.6 -38.76 3.17 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.079 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.77 -16.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.917 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.9 mt -58.27 -34.33 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.832 ' HG3' ' HG ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -54.12 -49.74 68.47 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 82' ' ' ALA . 4.5 tmtt? -58.27 -64.81 0.79 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.58 -6.28 0.69 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.205 -0.934 . . . . 0.0 109.842 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.812 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -78.86 -82.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 112.216 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 178.88 32.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.957 -1.592 . . . . 0.0 110.464 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.607 HD11 ' CD ' ' A' ' 79' ' ' ARG . 2.8 mt -84.78 110.25 18.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.997 -1.296 . . . . 0.0 109.392 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -156.24 -21.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.3 tttm 65.46 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 0.0 109.623 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.6 -170.0 19.83 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.44 -85.03 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -1.164 . . . . 0.0 109.566 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -119.17 96.96 5.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.499 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -120.29 159.13 48.9 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.61 -11.32 6.5 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.576 1.517 . . . . 0.0 112.34 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.29 -165.29 21.56 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.803 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 64.58 84.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -1.147 . . . . 0.0 109.493 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 8.1 tt0 -176.21 -179.46 1.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 94' ' ' GLU . 42.5 mtmt -158.67 -172.36 3.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.612 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.6 t -133.35 153.66 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.598 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.812 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 75.86 58.81 3.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.665 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.8 mtt180 -133.71 115.47 14.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.128 -1.219 . . . . 0.0 110.353 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.721 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.43 175.11 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.815 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -120.85 156.58 31.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.983 -1.073 . . . . 0.0 109.055 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.3 t-105 -45.18 -70.37 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 111.229 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.405 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 6.4 tp10 -50.45 -51.71 44.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.575 -1.328 . . . . 0.0 111.242 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.406 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 4.8 mt-30 -48.72 -44.38 38.24 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.5 m -70.88 -25.9 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.822 -1.551 . . . . 0.0 107.663 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.967 HD13 HD13 ' A' ' 120' ' ' LEU . 18.8 mt -65.36 -70.66 0.22 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 105' ' ' LEU . 3.1 tp10 -44.1 -45.7 8.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.935 -1.103 . . . . 0.0 108.566 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.818 HG12 HD11 ' A' ' 77' ' ' LEU . 35.3 mt -61.26 -31.75 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.111 -0.993 . . . . 0.0 108.698 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.816 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.53 -25.98 16.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.347 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -58.08 -73.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 108.286 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.552 ' CD ' ' N ' ' A' ' 110' ' ' GLN . 1.2 mp0 -44.95 -26.1 0.38 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.078 -1.014 . . . . 0.0 108.794 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' LYS . 40.1 tttm -74.91 -8.29 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.803 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.59 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 7.7 ptm -132.87 62.4 61.98 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.056 -1.028 . . . . 0.0 109.861 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 112' ' ' MET . 3.0 Cg_endo -67.21 -35.06 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.565 1.51 . . . . 0.0 112.123 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.513 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 2.3 t70 174.96 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.359 -0.838 . . . . 0.0 109.107 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.2 mm? -47.96 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 0.0 109.575 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -151.81 -21.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.02 HG22 ' H ' ' A' ' 118' ' ' THR . 26.2 m -64.13 -164.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.101 -0.999 . . . . 0.0 109.616 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.02 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.48 -64.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 0.9 OUTLIER -74.93 141.27 44.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.084 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.967 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -59.93 -24.56 64.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.211 1.005 . . . . 0.0 109.12 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.5 -34.65 78.71 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.71 -75.18 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.045 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.59 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.0 -40.82 6.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.539 -1.351 . . . . 0.0 109.095 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.97 -69.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 108.647 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.658 ' O ' ' N ' ' A' ' 129' ' ' GLY . 23.1 ttt180 -43.35 -35.68 1.61 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.666 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.0 tpp -57.56 -78.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 108.778 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.816 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 26.9 mm -48.49 -56.99 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.0 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -67.39 -70.93 0.22 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -42.48 5.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.666 ' N ' ' O ' ' A' ' 126' ' ' MET . 54.3 p -54.72 -47.66 73.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.575 -1.544 . . . . 0.0 107.499 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -51.12 -48.53 61.73 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.791 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.01 -53.4 10.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.0 t -44.79 -67.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.805 ' SD ' ' NH1' ' A' ' 79' ' ' ARG . 11.6 ttm -49.94 -3.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 89.21 -26.05 9.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.677 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.4 t -49.22 165.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.736 -0.861 . . . . 0.0 109.405 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 136' ' ' VAL . 87.8 mt-10 -142.8 162.66 34.88 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.755 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.32 165.1 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.871 ' O ' HG13 ' A' ' 139' ' ' VAL . 6.4 p -129.17 59.91 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 157.74 -113.82 0.58 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.87 61.79 11.23 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.155 -1.203 . . . . 0.0 109.267 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' O ' ' CD ' ' A' ' 143' ' ' GLU . 2.2 Cg_endo -61.61 155.32 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.808 1.672 . . . . 0.0 112.627 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.516 ' CD ' ' O ' ' A' ' 142' ' ' PRO . 72.2 mm-40 -156.66 91.04 1.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.291 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.74 -179.91 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.564 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -159.82 -15.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 147' ' ' ALA . 1.1 p30 -81.6 29.48 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.538 ' O ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.443 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.51 71.61 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 15.5 tttt -168.92 115.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.549 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.767 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.97 138.34 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -115.11 -24.45 3.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.34 100.39 3.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.041 -1.037 . . . . 0.0 110.252 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -87.86 74.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.919 HG13 HD12 ' A' ' 10' ' ' LEU . 11.3 t -48.22 87.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.558 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.681 ' HB3' ' HZ3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -81.83 36.29 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.897 0.856 . . . . 0.0 108.817 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.919 HD12 HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -77.22 -174.46 3.24 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.725 0.774 . . . . 0.0 110.882 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 3.6 pm0 -127.42 177.21 6.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.556 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -166.66 146.6 4.96 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 109.213 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.485 ' HA ' HD13 ' A' ' 52' ' ' ILE . 65.8 Cg_endo -84.01 130.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.277 1.984 . . . . 0.0 113.587 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.072 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -76.16 142.77 41.48 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.492 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 51.61 55.35 20.57 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 5.5 mttp 174.53 14.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.695 -0.885 . . . . 0.0 109.212 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 18' ' ' THR . . . -96.13 154.74 17.08 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.862 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.86 165.74 4.07 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.005 . . . . 0.0 109.487 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HA ' HG21 ' A' ' 34' ' ' ILE . 5.3 Cg_exo -51.05 32.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.457 1.438 . . . . 0.0 111.562 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.862 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -154.56 54.31 1.03 Allowed Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.64 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.739 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.84 169.06 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.725 1.617 . . . . 0.0 111.735 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.37 -4.56 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.077 1.185 . . . . 0.0 110.95 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.748 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.0 -72.62 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.796 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.49 -98.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.748 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.3 Cg_exo -59.03 -55.54 1.88 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 118.096 0.948 . . . . 0.0 110.003 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.652 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -44.7 -6.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.412 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.862 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -111.12 -44.07 3.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 179.432 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.34 88.67 0.01 OUTLIER Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.6 tt0 -150.97 -12.85 0.22 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.538 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 7.8 p-80 -87.73 -36.5 17.32 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -173.1 -1.49 0.03 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.11 83.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 112.058 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 32' ' ' ALA . 31.8 m120 -157.71 120.09 3.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.982 -1.073 . . . . 0.0 108.614 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.565 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.8 mm -97.44 -65.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.689 -0.632 . . . . 0.0 109.853 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.492 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -41.42 -56.35 2.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 109.548 -177.208 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.3 mt-10 -44.69 -48.15 10.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.755 -1.215 . . . . 0.0 107.768 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.862 ' CE2' HD12 ' A' ' 27' ' ' LEU . 1.1 t80 -51.17 -68.17 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.884 1.326 . . . . 0.0 110.034 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 33.9 t -59.21 -37.2 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.805 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 7.1 ttpt -49.56 -65.7 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.08 -32.79 62.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.23 -0.918 . . . . 0.0 109.04 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.0 t80 -73.19 -78.45 0.09 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 7.4 m-20 -41.07 -32.76 0.27 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.856 -1.152 . . . . 0.0 110.745 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -70.04 -32.77 71.07 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.139 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.09 -47.17 7.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.476 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.556 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 8.7 p -59.5 -29.71 68.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.94 -45.27 20.79 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.555 ' OD1' ' O ' ' A' ' 43' ' ' ALA . 12.2 m120 -57.8 -22.14 45.69 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.573 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.32 -73.88 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.573 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -179.64 -127.82 1.15 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.05 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 23.1 t70 -123.84 147.26 47.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.216 -1.167 . . . . 0.0 108.817 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.072 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.88 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 0.0 110.99 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.1 mm -146.82 139.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 71' ' ' THR . 2.0 t -138.58 133.74 17.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 110.611 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -72.86 97.1 0.88 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.8 1.667 . . . . 0.0 111.03 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.81 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -70.95 134.46 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.675 1.226 . . . . 0.0 111.652 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 28.3 mt-10 -127.16 70.32 1.3 Allowed 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.725 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -71.43 89.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.677 0.751 . . . . 0.0 110.5 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.16 95.46 0.09 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 57' ' ' ILE . 95.7 mt -98.05 141.0 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.656 -0.653 . . . . 0.0 110.505 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.767 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 4.8 m-85 -115.99 139.82 49.87 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.835 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.81 -30.7 4.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.277 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 6.0 m-20 -53.47 3.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.81 ' H ' ' C ' ' A' ' 61' ' ' ALA . 49.8 mtp180 70.34 68.89 0.21 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.968 0.89 . . . . 0.0 109.793 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 9.5 p -148.97 150.98 33.78 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.2 p90 -128.18 103.76 7.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.992 -1.067 . . . . 0.0 110.105 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p -101.38 120.79 40.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.15 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.933 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 169.96 149.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.081 -1.012 . . . . 0.0 110.991 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.5 t -168.82 98.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.272 1.034 . . . . 0.0 108.35 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.39 148.2 29.4 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.78 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.2 mptt -133.21 125.09 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.523 -1.361 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.78 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.3 150.34 0.13 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 121.272 0.558 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' O ' ' O ' ' A' ' 73' ' ' PRO . 8.7 Cg_exo -42.88 175.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.548 2.166 . . . . 0.0 112.803 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.61 176.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.502 1.468 . . . . 0.0 111.788 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 47.87 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.774 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -43.71 -22.4 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.99 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.981 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 15.6 p90 -43.84 -37.68 2.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 0.0 108.961 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.981 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.35 -15.79 1.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.919 HD12 ' HB1' ' A' ' 74' ' ' ALA . 3.9 mt -60.13 -31.85 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.707 ' HB3' HD12 ' A' ' 84' ' ' LEU . 2.2 mmp_? -56.08 -44.01 78.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.2 tmtm? -65.27 -66.76 0.5 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.746 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.5 -5.26 0.51 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.01 -80.31 0.19 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.547 -0.721 . . . . 0.0 111.582 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.752 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 166.46 53.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.285 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 83' ' ' GLY . 2.0 mt -126.77 104.75 8.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.236 . . . . 0.0 109.358 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 8.3 tp10 174.86 -51.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.455 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 2.9 tmtm? 75.07 143.97 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 86' ' ' LYS . . . -153.34 -156.25 7.52 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.93 -85.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -1.139 . . . . 0.0 109.56 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -59.95 106.24 0.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.408 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' H ' ' HG3' ' A' ' 90' ' ' LYS . 13.3 mttp -83.17 149.35 58.5 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.477 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.41 -53.75 3.18 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.449 1.433 . . . . 0.0 112.399 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 148.67 144.69 4.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.792 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 63.03 -164.94 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -1.098 . . . . 0.0 109.514 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -127.12 111.66 14.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.478 ' C ' HG23 ' A' ' 96' ' ' VAL . 3.3 mmmm -145.38 166.16 26.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.58 HG12 ' N ' ' A' ' 97' ' ' GLY . 88.5 t -157.55 164.98 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.58 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 57.0 65.97 3.19 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.657 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.2 ttt180 -134.32 114.59 13.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 110.007 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -107.42 -169.23 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 108.976 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.644 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.4 OUTLIER -131.58 159.36 38.45 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 0.0 109.219 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.679 ' O ' HG22 ' A' ' 104' ' ' VAL . 18.2 t-105 -50.9 -68.72 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.504 -0.747 . . . . 0.0 110.87 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -51.27 -45.91 62.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.69 -1.256 . . . . 0.0 110.369 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.746 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -50.66 -47.65 58.6 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.234 -0.917 . . . . 0.0 109.777 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.836 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.78 -24.06 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.951 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 120' ' ' LEU . 13.1 mt -66.88 -71.32 0.2 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.491 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 6.1 tm-20 -43.66 -43.12 5.66 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.891 -1.131 . . . . 0.0 108.374 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 77' ' ' LEU . 49.4 mt -62.96 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.021 -1.049 . . . . 0.0 108.358 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.807 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.41 -27.36 16.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.656 ' HE2' HD11 ' A' ' 120' ' ' LEU . 17.3 mmtt -57.18 -73.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.837 -1.164 . . . . 0.0 108.124 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 109' ' ' LYS . 78.9 mt-30 -44.89 -25.01 0.26 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.006 -1.058 . . . . 0.0 108.769 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 109' ' ' LYS . 23.5 tptt -76.89 -8.25 57.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.919 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 123' ' ' ALA . 7.5 ptm -132.27 60.87 53.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.8 Cg_endo -65.88 -40.34 16.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.559 1.506 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 6.9 t70 -178.75 8.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.0 mm? -46.76 -81.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -151.13 -18.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.129 -0.982 . . . . 0.0 109.699 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.019 HG22 ' H ' ' A' ' 118' ' ' THR . 26.4 m -65.88 -164.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.629 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.019 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.96 -62.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.266 -0.897 . . . . 0.0 109.865 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 118' ' ' THR . 0.8 OUTLIER -75.31 140.64 43.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -60.3 -23.8 64.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.126 0.965 . . . . 0.0 109.107 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.64 -34.29 77.94 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.52 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.78 -75.83 0.13 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.111 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.623 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -45.09 -31.37 1.35 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.468 -1.395 . . . . 0.0 109.268 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -60.75 -69.76 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 108.496 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.694 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.2 ttp180 -43.67 -44.1 6.22 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.631 ' O ' ' N ' ' A' ' 130' ' ' SER . 2.8 mtt -49.72 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.1 -1.0 . . . . 0.0 108.742 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.807 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 18.2 mm -47.28 -67.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.678 0.752 . . . . 0.0 110.076 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.836 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -55.23 -69.55 0.13 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.43 -37.29 2.49 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.631 ' N ' ' O ' ' A' ' 126' ' ' MET . 10.5 p -57.08 -54.21 49.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.445 -1.621 . . . . 0.0 107.336 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.743 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -44.98 -50.36 10.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -44.91 -55.73 5.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.169 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.8 t -44.91 -67.2 0.31 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.679 ' SD ' ' OG ' ' A' ' 75' ' ' SER . 6.8 ttp -47.79 -3.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.73 -24.72 11.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.743 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 31.1 t -52.74 165.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.989 -0.712 . . . . 0.0 109.347 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.586 ' N ' HG12 ' A' ' 136' ' ' VAL . 41.7 mt-10 -142.99 163.28 33.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.44 143.84 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 99' ' ' ILE . 5.6 p -96.69 -7.81 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.56 -0.713 . . . . 0.0 109.292 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . -116.85 -123.68 3.47 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.95 61.95 11.08 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.354 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.4 Cg_endo -63.29 -169.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.752 1.635 . . . . 0.0 112.601 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.676 ' CG ' ' H ' ' A' ' 144' ' ' VAL . 13.7 tt0 -151.22 -175.84 5.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 109.278 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.676 ' H ' ' CG ' ' A' ' 143' ' ' GLU . 12.8 m -150.79 166.29 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 109.591 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 19.0 tttp 178.46 158.68 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.396 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -106.18 -84.95 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' C ' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -175.77 55.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.585 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' C ' ' CZ ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -126.07 114.88 18.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.2 -0.938 . . . . 0.0 109.919 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.516 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p -65.16 155.89 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 108.723 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.026 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -123.66 -24.9 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.903 -1.123 . . . . 0.0 110.573 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -154.98 111.66 3.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.731 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -103.78 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.767 ' HB ' HD12 ' A' ' 57' ' ' ILE . 17.6 t -49.51 88.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.73 -1.231 . . . . 0.0 110.743 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.7 tmtp? -82.4 38.28 0.54 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.746 0.784 . . . . 0.0 109.358 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.892 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.24 -173.89 3.45 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.843 0.83 . . . . 0.0 111.437 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.691 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 2.1 pm0 -123.98 174.83 7.33 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.719 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -167.73 159.66 9.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.85 -1.156 . . . . 0.0 110.159 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.719 ' HD2' HD23 ' A' ' 12' ' ' LEU . 11.9 Cg_endo -68.95 109.83 2.24 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.034 1.823 . . . . 0.0 111.37 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.823 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -68.68 38.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.857 -1.152 . . . . 0.0 110.411 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.524 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -172.82 -19.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.372 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -144.37 80.39 1.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.642 -1.505 . . . . 0.0 110.408 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.673 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -96.53 166.05 11.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.747 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.0 164.4 4.26 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.874 -1.141 . . . . 0.0 110.086 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' HG21 ' A' ' 34' ' ' ILE . 3.5 Cg_exo -54.11 32.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.663 1.575 . . . . 0.0 111.677 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.747 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.0 54.01 5.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.061 -1.024 . . . . 0.0 110.231 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.8 Cg_endo -84.67 155.11 11.88 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.73 1.62 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.91 -4.62 0.37 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.032 1.155 . . . . 0.0 111.136 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.828 HG12 ' N ' ' A' ' 27' ' ' LEU . 2.9 t -111.85 -69.88 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 0.0 110.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.83 -97.73 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.774 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.8 Cg_exo -57.83 -55.66 2.2 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 CA-C-N 118.017 0.908 . . . . 0.0 110.28 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.628 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -52.72 -11.83 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.628 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.828 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -96.51 -53.69 3.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.71 -1.244 . . . . 0.0 108.386 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.88 92.3 0.01 OUTLIER Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.9 tp60 -147.39 -15.05 0.39 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.557 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 4.9 p-80 -84.13 -37.37 22.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -171.57 -0.92 0.03 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 73.18 84.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.494 -1.003 . . . . 0.0 112.046 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -159.55 120.81 3.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 108.806 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.677 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 50.7 mm -94.4 -64.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.723 -0.61 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.57 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -41.0 -54.38 2.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.791 -1.193 . . . . 0.0 109.774 -176.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 35' ' ' MET . 5.5 mt-10 -48.41 -46.78 37.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.593 -1.317 . . . . 0.0 107.708 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.719 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -53.03 -68.91 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.572 1.177 . . . . 0.0 109.244 178.317 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.673 HG13 ' CB ' ' A' ' 17' ' ' ALA . 38.3 t -63.46 -36.84 77.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.706 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.0 mmmt -49.32 -55.55 12.44 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.11 75.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.484 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.612 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.0 OUTLIER -70.13 -77.05 0.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.431 -1.418 . . . . 0.0 107.305 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 7.2 t-20 -41.52 -33.79 0.48 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.74 -33.88 75.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.417 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.891 ' HB1' ' NZ ' ' A' ' 70' ' ' LYS . . . -90.72 -53.18 4.52 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.714 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.792 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.8 p -53.35 -31.34 44.03 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.43 -44.71 17.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -54.69 -23.27 16.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.18 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.603 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.78 -85.3 0.53 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.182 -0.949 . . . . 0.0 109.693 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.603 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.82 -141.8 3.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.062 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -118.07 121.15 39.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -1.122 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.823 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.51 -153.04 0.4 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.583 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.6 mm -146.85 142.2 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 14' ' ' ALA . 3.7 t -145.34 137.61 13.38 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 110.238 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -73.52 95.01 0.85 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.872 1.715 . . . . 0.0 111.52 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.892 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -61.44 138.06 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 111.354 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 26.8 tt0 -130.44 70.14 1.45 Allowed 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.767 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.6 mt -70.68 89.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.389 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 100.89 0.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' A' ' 6' ' ' ALA . 21.1 mt -101.76 137.45 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.589 -0.695 . . . . 0.0 110.615 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.554 ' OH ' ' C ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -113.27 137.85 50.88 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 1.026 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -49.03 -30.76 6.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.583 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.6 m-20 -53.56 1.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.807 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 mtm180 71.05 69.91 0.18 Allowed 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.028 0.918 . . . . 0.0 109.953 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 4.4 m -151.27 126.11 9.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 18.2 p90 -102.53 103.84 14.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.093 -1.005 . . . . 0.0 110.035 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.2 121.31 41.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.1 -1.0 . . . . 0.0 110.227 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.932 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.38 148.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.052 . . . . 0.0 111.274 177.371 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.7 t -168.74 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.263 1.03 . . . . 0.0 108.232 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -98.07 132.4 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.891 ' NZ ' ' HB1' ' A' ' 44' ' ' ALA . 24.5 mmtp -115.82 143.19 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.655 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 1.8 p 55.58 159.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.956 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.7 Cg_exo -38.18 175.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.887 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 75' ' ' SER . 22.8 Cg_exo -42.2 169.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.575 1.516 . . . . 0.0 112.161 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.984 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 58.73 -73.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 73' ' ' PRO . 5.6 p -43.65 -21.65 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.097 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 25.4 p90 -43.38 -42.95 4.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.366 -0.834 . . . . 0.0 109.087 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.097 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.54 -13.9 3.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.984 HD12 ' HB1' ' A' ' 74' ' ' ALA . 2.0 mt -61.02 -31.34 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.704 ' NH1' ' CD1' ' A' ' 84' ' ' LEU . 9.6 mmm180 -54.16 -45.81 72.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.2 tmmm? -65.21 -65.75 0.63 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.751 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.51 -5.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.671 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.643 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.81 -79.66 0.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 111.686 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.402 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 153.49 57.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.085 -1.531 . . . . 0.0 110.674 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.704 ' CD1' ' NH1' ' A' ' 79' ' ' ARG . 9.0 mt -102.66 104.8 15.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.143 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -153.35 -11.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 109.717 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.499 ' HZ1' ' HB3' ' A' ' 86' ' ' LYS . 7.0 mtpp 66.32 63.91 0.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 109.653 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 45.04 -160.68 0.12 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.63 -85.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 90' ' ' LYS . 8.0 t-80 -105.78 -67.84 0.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 89' ' ' HIS . 9.6 mtmt -44.91 160.48 0.24 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.895 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.0 -51.86 8.63 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.58 1.52 . . . . 0.0 112.443 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.13 -96.89 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.786 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 59.71 39.43 21.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -1.143 . . . . 0.0 109.47 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 36.9 mt-10 -159.44 -167.76 2.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.69 -164.99 1.66 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.863 . . . . 0.0 109.436 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 97' ' ' GLY . 87.4 t -135.66 165.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.661 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.589 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 65.53 65.64 2.8 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.2 mtt180 -132.53 115.31 15.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.269 -1.136 . . . . 0.0 109.93 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.728 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 173.31 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.549 -0.719 . . . . 0.0 109.539 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.72 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -113.99 150.46 33.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.042 . . . . 0.0 109.092 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.719 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.0 t-105 -46.3 -67.6 0.27 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.347 -0.846 . . . . 0.0 110.897 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.505 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.68 -49.29 57.65 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.557 -1.34 . . . . 0.0 110.68 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.751 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -48.97 -45.93 42.84 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.884 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.82 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.4 -24.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 117.979 -1.489 . . . . 0.0 107.797 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.795 ' O ' ' N ' ' A' ' 109' ' ' LYS . 19.3 mt -66.22 -71.71 0.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 105' ' ' LEU . 86.7 tt0 -43.99 -44.95 7.6 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.892 -1.13 . . . . 0.0 108.472 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.588 HG12 HD11 ' A' ' 77' ' ' LEU . 67.2 mt -61.58 -32.47 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 108.493 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.819 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.8 -24.71 16.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.169 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.795 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.6 tptp -63.16 -74.55 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 109' ' ' LYS . 90.2 mt-30 -44.5 -27.85 0.51 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.984 -1.073 . . . . 0.0 108.772 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 109' ' ' LYS . 33.7 tttp -66.57 -13.66 61.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.578 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 5.5 ptm -131.02 69.25 82.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.638 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -68.82 -46.63 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.68 1.587 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' A' ' 114' ' ' ASP . 40.1 p30 -171.1 6.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 108.952 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.401 ' H ' ' H ' ' A' ' 114' ' ' ASP . 2.7 mm? -45.02 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.798 . . . . 0.0 109.577 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 117' ' ' THR . 8.0 p-10 -150.89 -12.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.186 -0.946 . . . . 0.0 109.649 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.026 HG22 ' H ' ' A' ' 118' ' ' THR . 31.8 m -77.99 -164.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.026 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 178.56 -57.2 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.264 -0.898 . . . . 0.0 109.576 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.63 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 1.1 p30 -63.27 132.25 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.513 -0.742 . . . . 0.0 109.998 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.675 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -67.22 -28.7 68.29 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.488 1.137 . . . . 0.0 108.469 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -64.45 -34.52 78.4 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.637 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.52 -76.27 0.1 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.68 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.578 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.58 -42.1 10.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.478 -1.389 . . . . 0.0 109.339 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -50.4 -69.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 108.806 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.49 -38.57 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.597 ' O ' ' HB3' ' A' ' 130' ' ' SER . 13.4 tpp -53.79 -79.22 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.819 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.9 mm -47.29 -65.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.666 0.746 . . . . 0.0 110.289 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.82 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -57.5 -69.71 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.38 -37.8 2.62 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.597 ' HB3' ' O ' ' A' ' 126' ' ' MET . 15.9 p -57.18 -53.79 54.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.506 -1.585 . . . . 0.0 107.451 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.779 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -45.0 -50.28 10.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.791 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.65 -55.01 6.88 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.313 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.6 t -44.74 -67.29 0.3 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.631 ' HG2' HG23 ' A' ' 136' ' ' VAL . 7.1 ttp -47.77 -3.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.62 -13.9 59.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.779 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 35.7 t -69.36 135.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.997 -0.707 . . . . 0.0 109.444 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.87 167.25 10.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.647 ' C ' ' H ' ' A' ' 140' ' ' GLY . 1.8 t -81.97 125.95 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 99' ' ' ILE . 11.2 p -51.72 1.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.563 -0.71 . . . . 0.0 109.736 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.69 ' O ' ' HB3' ' A' ' 141' ' ' ALA . . . -159.85 -127.86 0.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . 75.09 63.02 0.27 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.211 -1.17 . . . . 0.0 109.447 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.2 Cg_endo -65.45 -165.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.76 1.64 . . . . 0.0 112.548 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.55 ' CD ' ' N ' ' A' ' 144' ' ' VAL . 8.2 tm-20 -169.99 151.51 4.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.55 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 3.1 m -150.49 -172.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.517 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.614 ' CG ' ' N ' ' A' ' 146' ' ' ASP . 19.0 ttpt -145.19 168.03 21.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.398 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 0.4 OUTLIER -138.41 -84.96 0.28 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 91.74 0.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.504 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -169.07 114.89 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.591 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.778 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p -46.21 138.09 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 109.487 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.7 m -113.48 -24.53 3.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.214 -0.929 . . . . 0.0 108.52 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.66 112.27 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.05 -1.032 . . . . 0.0 110.273 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -100.47 73.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.15 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.78 ' HB ' HD12 ' A' ' 57' ' ' ILE . 13.6 t -50.08 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.444 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.8 tmtp? -82.96 37.87 0.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.885 0.85 . . . . 0.0 109.168 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.815 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -77.28 -174.13 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.01 0.91 . . . . 0.0 111.395 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 1.6 pm0 -123.73 174.94 7.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.729 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -164.42 147.06 7.29 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 0.0 109.361 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.65 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 80.0 Cg_endo -86.17 126.17 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.331 2.021 . . . . 0.0 113.213 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.28 143.06 48.87 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.01 61.86 6.5 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 8.7 tttp 174.08 -25.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.573 -0.957 . . . . 0.0 108.823 -177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 18' ' ' THR . . . -59.05 152.67 19.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.913 -1.117 . . . . 0.0 108.373 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.869 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.36 165.8 8.57 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.038 -1.039 . . . . 0.0 110.009 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.8 Cg_exo -50.25 36.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.721 1.614 . . . . 0.0 111.733 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.869 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.5 54.47 0.73 Allowed Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.68 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.2 Cg_endo -79.18 169.68 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.66 1.573 . . . . 0.0 111.849 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.59 -4.68 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.256 1.304 . . . . 0.0 111.29 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 26' ' ' ALA . 5.2 t -113.23 -70.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.623 -0.673 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.07 -97.83 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.783 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.2 Cg_exo -58.72 -55.54 1.99 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 CA-C-N 117.97 0.885 . . . . 0.0 110.384 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.794 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -48.77 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.643 . . . . 0.0 110.779 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.843 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -103.24 -48.44 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.261 . . . . 0.0 107.956 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.27 86.74 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.4 mt-30 -146.33 -20.12 0.44 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.673 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 6.9 p80 -79.49 -38.24 34.92 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -170.89 -4.42 0.03 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 84.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.966 . . . . 0.0 112.346 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -158.92 120.11 3.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.076 -1.015 . . . . 0.0 108.711 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.726 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 26.4 mm -93.42 -66.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.728 -0.608 . . . . 0.0 110.076 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.658 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.8 tpt -41.14 -57.71 1.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.664 -1.273 . . . . 0.0 109.728 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.5 mm-40 -44.95 -47.06 11.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.56 -1.337 . . . . 0.0 107.793 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.843 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -53.05 -68.84 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.466 1.127 . . . . 0.0 109.899 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 42' ' ' ASN . 21.9 t -66.38 -37.7 80.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.775 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.658 ' N ' ' O ' ' A' ' 35' ' ' MET . 44.1 tptt -45.67 -61.81 1.55 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.55 69.25 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 108.85 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.688 ' O ' HG23 ' A' ' 45' ' ' THR . 3.3 t80 -70.91 -77.07 0.09 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.8 m120 -41.35 -32.23 0.29 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.953 -1.092 . . . . 0.0 110.751 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -69.52 -33.22 72.5 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.93 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.732 ' HB1' ' HZ3' ' A' ' 70' ' ' LYS . . . -90.52 -47.07 7.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.612 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 41' ' ' PHE . 2.2 p -58.6 -31.34 67.97 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.2 -46.04 21.47 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -56.97 -22.46 38.36 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 0.0 108.922 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.724 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.63 -73.98 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.406 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.724 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 175.17 -154.66 18.66 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.8 t0 -96.28 146.49 24.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.291 . . . . 0.0 108.934 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.078 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 175.01 -153.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.816 -1.178 . . . . 0.0 110.869 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.2 mm -146.09 137.36 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 71' ' ' THR . 2.6 t -137.94 136.15 19.49 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.807 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.8 Cg_endo -72.78 104.66 1.78 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.803 1.669 . . . . 0.0 111.07 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.815 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.5 m -78.34 135.98 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 111.362 -178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.5 tt0 -129.07 69.98 1.4 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.78 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -70.24 90.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.855 0.836 . . . . 0.0 109.967 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.403 HG22 HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -70.59 95.88 1.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 64' ' ' SER . 60.1 mt -100.11 143.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.58 -0.7 . . . . 0.0 110.672 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.778 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.6 m-85 -114.46 138.0 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -46.43 -31.45 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.227 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.29 2.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.776 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 71.87 66.92 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.137 0.97 . . . . 0.0 109.631 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.4 OUTLIER -149.17 125.15 10.63 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.1 p90 -103.75 104.16 14.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.124 -0.985 . . . . 0.0 110.139 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.618 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.87 120.92 41.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.035 . . . . 0.0 110.249 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.945 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.7 OUTLIER 170.38 148.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.962 -1.086 . . . . 0.0 111.214 177.242 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.6 t -169.39 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.254 1.026 . . . . 0.0 108.639 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.59 149.2 27.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.746 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -133.63 122.98 24.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.343 -1.473 . . . . 0.0 110.525 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.8 p 76.02 148.8 0.12 Allowed Pre-proline 0 N--CA 1.492 1.661 0 CA-C-O 121.272 0.558 . . . . 0.0 110.235 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.2 Cg_exo -42.32 175.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.573 2.182 . . . . 0.0 112.803 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.0 Cg_exo -38.87 174.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.498 1.466 . . . . 0.0 111.855 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 53.03 -84.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 73' ' ' PRO . 71.8 p -44.67 -23.15 0.11 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 111.36 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.675 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 14.1 p90 -43.81 -39.59 3.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.174 -0.954 . . . . 0.0 109.199 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.854 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.5 pp -135.05 -14.6 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.012 HD12 ' HB1' ' A' ' 74' ' ' ALA . 6.6 mt -61.15 -31.22 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.753 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 10.8 mmt180 -55.38 -44.78 76.4 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HZ3' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -64.22 -66.89 0.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.695 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.51 -4.94 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.083 -1.011 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.21 -80.36 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 111.725 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 175.76 28.47 0.03 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.548 HD11 HH11 ' A' ' 79' ' ' ARG . 3.1 mt -90.27 105.05 17.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.973 -1.31 . . . . 0.0 109.135 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 34.1 tt0 -177.06 -20.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 0.0 109.347 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 9.7 tttm 75.04 -64.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.13 179.84 32.68 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -177.74 86.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -1.124 . . . . 0.0 109.453 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -147.23 -84.94 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.473 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' A' ' 92' ' ' GLY . 22.0 mttt -113.76 160.12 33.18 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.12 5.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.569 1.513 . . . . 0.0 112.383 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 90' ' ' LYS . . . -68.18 -53.01 24.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.817 ' HG3' HH11 ' A' ' 93' ' ' ARG . 0.8 OUTLIER 67.11 178.9 0.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -1.144 . . . . 0.0 109.452 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -146.65 -165.01 2.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 109.555 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -101.52 -164.98 1.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 20.8 t -144.28 152.24 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.556 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.433 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 72.37 50.46 16.11 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.789 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.58 114.46 14.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.133 -1.216 . . . . 0.0 109.966 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.37 -174.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.649 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -127.51 159.8 33.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.4 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.678 ' O ' HG22 ' A' ' 104' ' ' VAL . 19.3 t-105 -50.61 -69.61 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.5 -0.75 . . . . 0.0 110.84 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.49 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.24 -46.76 55.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.686 -1.259 . . . . 0.0 110.352 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.695 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -49.19 -47.61 45.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.689 -179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.821 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.3 m -72.11 -23.43 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.097 -1.441 . . . . 0.0 107.99 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 120' ' ' LEU . 17.8 mt -68.09 -73.47 0.14 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 79.5 tt0 -44.03 -41.26 5.32 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.969 -1.082 . . . . 0.0 108.436 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.588 HD13 HD11 ' A' ' 77' ' ' LEU . 48.4 mt -64.6 -30.71 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.128 -0.983 . . . . 0.0 108.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.809 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.73 -26.86 15.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.3 mtpm? -58.54 -73.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.992 -1.067 . . . . 0.0 108.402 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 109' ' ' LYS . 34.0 mt-30 -45.99 -27.38 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 108.911 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 113' ' ' PRO . 12.5 tttt -70.99 -17.68 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.772 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.687 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.04 67.22 79.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.143 -0.973 . . . . 0.0 109.761 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 111' ' ' LYS . 2.4 Cg_endo -66.91 -33.5 32.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.574 1.516 . . . . 0.0 112.088 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 8.0 p30 174.96 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 109.207 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.25 -77.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.552 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -150.51 -25.02 0.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.037 HG22 ' H ' ' A' ' 118' ' ' THR . 23.8 m -65.65 -164.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.973 . . . . 0.0 109.59 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.037 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.42 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 0.0 109.921 -179.144 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -60.98 141.0 57.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 110.113 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.37 -22.04 64.59 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.24 1.019 . . . . 0.0 108.919 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.76 -37.81 87.35 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.504 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.548 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.22 -75.33 0.11 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.232 -1.387 . . . . 0.0 107.83 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.642 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.43 -42.09 6.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.462 -1.399 . . . . 0.0 109.32 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -50.29 -68.76 0.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.106 -0.996 . . . . 0.0 108.609 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.696 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.71 -41.95 5.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 130' ' ' SER . 4.9 tpp -52.84 -80.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.077 -1.014 . . . . 0.0 109.082 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.809 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.4 mm -46.57 -62.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.478 -0.764 . . . . 0.0 110.019 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.821 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.65 -69.6 0.2 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -39.07 3.38 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 126' ' ' MET . 27.5 p -56.48 -52.0 66.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.516 -1.579 . . . . 0.0 107.592 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.646 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -46.94 -49.05 21.23 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.17 -53.98 9.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.648 ' C ' ' H ' ' A' ' 135' ' ' GLY . 9.9 t -44.83 -67.17 0.31 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.753 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 10.1 ttm -49.23 -2.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 88.07 -26.27 7.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.231 -1.947 . . . . 0.0 108.231 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.646 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.1 t -49.49 165.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.864 . . . . 0.0 109.47 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.571 ' N ' HG12 ' A' ' 136' ' ' VAL . 39.2 mp0 -141.99 162.48 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.627 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.4 164.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.928 ' O ' HG13 ' A' ' 139' ' ' VAL . 3.7 p -129.72 58.59 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 165.05 -116.62 0.71 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.71 58.83 14.16 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.206 -1.173 . . . . 0.0 109.317 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.1 Cg_endo -64.83 -169.38 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.702 1.602 . . . . 0.0 112.842 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.758 ' O ' HG13 ' A' ' 144' ' ' VAL . 82.9 mt-10 -159.01 177.85 10.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.773 . . . . 0.0 109.191 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 143' ' ' GLU . 4.3 m -163.45 170.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.594 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.415 ' CD ' ' N ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -97.11 -164.97 1.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.48 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 54.4 m-20 -126.35 -85.04 0.62 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.516 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.509 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.626 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -45.79 139.04 4.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.491 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 9.0 mttt -170.58 115.11 0.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.714 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.748 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.89 136.76 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.542 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.875 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -115.13 -24.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.19 -0.944 . . . . 0.0 108.478 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.75 107.59 5.39 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.258 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -95.59 73.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.831 HG13 HD12 ' A' ' 10' ' ' LEU . 18.1 t -46.78 89.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.662 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 7' ' ' VAL . 6.0 tmtt? -82.62 34.81 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.792 0.806 . . . . 0.0 108.909 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.845 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.36 -174.57 3.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.678 0.751 . . . . 0.0 111.17 -178.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 2.6 pm0 -122.19 172.83 7.98 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -166.58 156.99 10.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 110.059 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.612 ' HA ' HD13 ' A' ' 52' ' ' ILE . 11.3 Cg_endo -68.56 111.24 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.979 1.786 . . . . 0.0 111.668 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.816 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -69.85 39.22 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.982 -1.073 . . . . 0.0 110.499 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.464 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -175.0 -20.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.509 -1.805 . . . . 0.0 111.487 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -142.61 88.4 2.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.609 -1.524 . . . . 0.0 110.291 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 18' ' ' THR . . . -105.14 164.53 11.75 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.16 164.54 4.11 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 109.367 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HA ' HG21 ' A' ' 34' ' ' ILE . 2.7 Cg_endo -55.56 30.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.309 1.339 . . . . 0.0 111.781 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.756 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -151.62 54.07 1.27 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 110.02 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.756 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 19.8 Cg_endo -86.47 168.74 8.52 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.904 1.736 . . . . 0.0 111.614 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.1 -4.63 1.06 Allowed 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 120.935 1.09 . . . . 0.0 110.765 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.732 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.98 -71.25 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.477 0.656 . . . . 0.0 109.911 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 54.41 -98.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.732 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -59.39 -55.83 1.62 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-N 118.11 0.955 . . . . 0.0 109.961 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -44.67 -6.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.358 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -111.09 -44.58 3.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.77 -1.206 . . . . 0.0 108.803 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.34 84.32 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 27' ' ' LEU . 66.3 tp60 -149.07 -12.44 0.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.386 -1.067 . . . . 0.0 108.214 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.599 ' C ' ' ND1' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -85.46 -37.13 20.1 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -170.21 2.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 70.75 78.6 0.18 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.84 -0.8 . . . . 0.0 111.969 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -156.54 120.57 4.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.004 -1.06 . . . . 0.0 108.688 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 30.1 mm -98.55 -63.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.724 -0.61 . . . . 0.0 109.746 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.47 ' C ' ' O ' ' A' ' 34' ' ' ILE . 4.9 tpt -41.39 -55.31 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.733 -1.229 . . . . 0.0 109.653 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' MET . 15.8 mt-10 -46.76 -48.3 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 107.741 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -50.67 -68.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.945 1.355 . . . . 0.0 109.177 177.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 17' ' ' ALA . 45.6 t -54.17 -34.68 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.608 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 1.5 mmmp? -56.55 -65.8 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.76 64.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.71 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -71.31 -76.74 0.1 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.1 m120 -41.65 -34.54 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.512 1.148 . . . . 0.0 110.583 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' O ' ' CG ' ' A' ' 47' ' ' ASN . . . -66.45 -35.67 80.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.77 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.77 -52.0 5.09 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.683 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.761 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.1 p -54.32 -29.45 47.84 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.52 -47.2 12.44 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.553 ' CG ' ' O ' ' A' ' 43' ' ' ALA . 96.2 m-20 -52.38 -23.24 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.318 -0.864 . . . . 0.0 108.983 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.597 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.65 -85.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.678 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.597 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.23 -135.77 1.89 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.855 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.29 125.87 44.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -1.106 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.816 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -159.4 -153.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.612 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.5 mm -147.44 143.85 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.515 HG22 ' C ' ' A' ' 71' ' ' THR . 5.9 t -145.16 136.94 12.93 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.2 Cg_endo -74.12 90.0 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.823 1.682 . . . . 0.0 110.763 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.845 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.9 m -61.98 137.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 122.783 1.278 . . . . 0.0 112.365 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.4 mt-10 -128.81 64.34 1.45 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.766 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.0 mt -64.98 89.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.697 0.76 . . . . 0.0 110.501 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.22 96.89 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.537 HG13 HG22 ' A' ' 57' ' ' ILE . 36.1 mt -99.31 144.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.63 -0.669 . . . . 0.0 110.368 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.748 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 5.0 m-85 -115.81 140.3 49.36 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.875 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.75 -29.61 4.7 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.235 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 55.4 p30 -53.67 4.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.834 ' H ' ' C ' ' A' ' 61' ' ' ALA . 79.1 mtm180 69.05 68.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.985 0.898 . . . . 0.0 109.655 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 p -147.76 128.85 14.58 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -105.51 103.96 13.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.978 -1.076 . . . . 0.0 110.422 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 58' ' ' THR . 8.3 p -98.72 124.64 43.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.71 172.02 7.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.569 -1.332 . . . . 0.0 109.417 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.975 HG12 ' O ' ' A' ' 68' ' ' VAL . 89.8 t -162.83 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 112.622 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.535 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.53 117.28 4.38 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.67 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.813 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.15 120.96 41.51 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.784 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.93 150.53 0.13 Allowed Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.434 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.61 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.7 Cg_exo -38.62 175.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.817 2.345 . . . . 0.0 113.35 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.763 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.72 166.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.574 1.516 . . . . 0.0 111.788 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.987 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 55.01 -76.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.763 ' N ' ' O ' ' A' ' 73' ' ' PRO . 55.3 p -43.17 -24.29 0.08 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 110.128 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.087 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 20.0 p90 -43.59 -43.16 5.5 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 0.0 109.227 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.087 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.88 -13.86 2.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.076 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.987 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.5 mt -62.33 -33.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.799 ' CG ' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.81 -40.81 73.27 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 82' ' ' ALA . 1.8 tmtp? -68.91 -66.33 0.59 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.76 -4.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.695 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.79 -80.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 111.958 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 152.01 52.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.049 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.672 HD11 ' CD ' ' A' ' 79' ' ' ARG . 18.3 mt -76.3 104.95 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.844 -1.386 . . . . 0.0 109.045 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 177.06 -24.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.035 -1.041 . . . . 0.0 109.739 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.48 ' H ' HG22 ' A' ' 96' ' ' VAL . 9.1 mttt 64.71 61.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.485 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.78 174.95 29.98 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.11 -85.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -1.124 . . . . 0.0 109.466 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -143.29 -54.71 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.445 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -98.02 160.11 29.18 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.478 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -57.57 -16.62 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.604 1.536 . . . . 0.0 112.406 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . -103.54 174.45 22.8 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.55 ' O ' ' O ' ' A' ' 92' ' ' GLY . 10.9 mpt_? 57.13 123.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -1.13 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -145.12 176.26 9.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.7 tttt 176.99 161.52 0.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 97' ' ' GLY . 83.5 t -144.58 163.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.598 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.57 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 72.75 63.66 2.8 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.695 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.4 mtt180 -134.72 112.48 10.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -1.205 . . . . 0.0 110.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.798 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -102.79 177.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.646 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.703 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -119.33 151.89 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 108.979 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.693 ' O ' HG22 ' A' ' 104' ' ' VAL . 23.4 t-105 -45.93 -69.96 0.12 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 110.91 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.492 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 5.8 tp10 -49.23 -50.36 38.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.718 -1.239 . . . . 0.0 111.018 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.41 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 3.6 mt-30 -51.72 -42.09 62.01 Favored 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.509 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.753 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.56 -26.1 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 117.46 -1.696 . . . . 0.0 107.184 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.896 HD13 HD13 ' A' ' 120' ' ' LEU . 21.6 mt -65.97 -71.27 0.2 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 17.5 mm-40 -43.98 -43.15 6.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.921 -1.112 . . . . 0.0 108.534 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.787 HG12 HD11 ' A' ' 77' ' ' LEU . 52.8 mt -63.5 -31.87 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.592 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.804 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.63 -32.43 13.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.621 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.726 ' HG2' HD21 ' A' ' 120' ' ' LEU . 4.7 mtpt -52.39 -71.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.835 -1.166 . . . . 0.0 108.275 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 109' ' ' LYS . 16.3 tt0 -44.76 -28.74 0.67 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 108.736 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -72.68 -6.95 47.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.75 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.589 ' SD ' ' HB3' ' A' ' 123' ' ' ALA . 7.3 ptm -134.13 63.97 63.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 109.828 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 112' ' ' MET . 4.0 Cg_endo -68.72 -41.13 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.607 1.538 . . . . 0.0 112.059 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.558 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 66.2 t0 -177.37 6.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.444 -0.785 . . . . 0.0 109.089 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.0 mm? -46.42 -83.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 109.583 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -148.66 -19.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.049 HG22 ' H ' ' A' ' 118' ' ' THR . 26.9 m -65.87 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.049 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.69 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.517 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -73.01 140.41 47.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.431 -0.793 . . . . 0.0 110.121 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.896 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -59.65 -23.65 63.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.376 1.084 . . . . 0.0 108.883 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -64.15 -35.58 81.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.574 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.552 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.35 -75.99 0.12 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.272 -1.371 . . . . 0.0 108.072 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.589 ' HB3' ' SD ' ' A' ' 112' ' ' MET . . . -45.01 -35.87 3.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.539 -1.351 . . . . 0.0 109.191 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -55.77 -70.4 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.022 -1.049 . . . . 0.0 108.668 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.665 ' O ' ' N ' ' A' ' 129' ' ' GLY . 20.1 ttp180 -43.51 -39.57 3.44 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.5 ttp -53.27 -78.71 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.134 -0.979 . . . . 0.0 108.53 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.804 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.1 mm -47.94 -63.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.481 -0.762 . . . . 0.0 109.978 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.74 -71.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.87 -41.91 4.72 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.22 -49.35 69.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.583 -1.539 . . . . 0.0 107.578 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.716 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.18 -47.83 45.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.08 -54.69 8.08 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.71 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.6 t -44.87 -68.83 0.16 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.662 ' HG2' HG23 ' A' ' 136' ' ' VAL . 3.4 ttp -46.0 -4.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.71 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.04 -31.77 5.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.716 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 27.1 t -45.28 165.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' N ' HG12 ' A' ' 136' ' ' VAL . 3.5 tp10 -144.33 163.61 33.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.332 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 140' ' ' GLY . 1.8 t -79.04 123.93 36.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 99' ' ' ILE . 9.0 p -49.45 3.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.574 -0.704 . . . . 0.0 110.345 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 138' ' ' VAL . . . 156.23 -91.09 0.12 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.056 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . 75.08 59.25 0.26 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.217 -1.167 . . . . 0.0 109.434 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.6 Cg_endo -65.04 -165.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.776 1.651 . . . . 0.0 112.582 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -135.55 -164.92 1.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.487 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.27 -175.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 109.487 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -173.68 -14.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 146' ' ' ASP . 4.5 p-10 -49.4 103.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.92 . . . . 0.0 109.524 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.527 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -146.57 116.61 7.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.406 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.609 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 11.3 tttt -177.72 123.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.922 . . . . 0.0 109.608 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.563 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -44.73 139.54 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 108.914 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.064 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -122.31 -24.85 2.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.057 -1.027 . . . . 0.0 110.12 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -155.42 104.91 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.605 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -97.26 74.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.787 ' HB ' HD12 ' A' ' 57' ' ' ILE . 16.5 t -48.82 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.503 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.615 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.3 tmtp? -82.94 37.31 0.53 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.861 0.839 . . . . 0.0 109.217 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.9 tp -78.09 -174.09 3.47 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.901 0.858 . . . . 0.0 111.235 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.653 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -124.26 176.56 6.35 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.697 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -164.43 146.36 6.99 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.847 -1.158 . . . . 0.0 109.299 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 74.1 Cg_endo -84.9 125.78 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.324 2.016 . . . . 0.0 113.576 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.058 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.41 143.77 44.61 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.21 56.08 16.31 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 22.1 tttp 174.35 3.93 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.733 -0.863 . . . . 0.0 109.191 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 18' ' ' THR . . . -86.73 153.32 21.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.892 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.5 165.78 6.15 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.976 -1.078 . . . . 0.0 110.005 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.7 Cg_exo -49.04 33.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.684 1.589 . . . . 0.0 111.868 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.892 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -150.85 54.34 1.41 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.536 -0.728 . . . . 0.0 109.61 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 14.5 Cg_endo -80.23 167.0 20.06 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.72 1.613 . . . . 0.0 111.898 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.61 -4.66 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.24 1.294 . . . . 0.0 111.341 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.779 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.4 t -113.34 -69.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.193 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.41 -97.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_endo -58.71 -55.29 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 CA-C-N 117.892 0.846 . . . . 0.0 110.408 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.774 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -49.56 -9.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.742 -0.599 . . . . 0.0 110.782 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.865 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -106.27 -49.04 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.682 -1.261 . . . . 0.0 108.237 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.62 94.13 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 27' ' ' LEU . 51.3 tt0 -154.54 -24.41 0.12 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.724 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -77.77 -44.78 26.54 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.891 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.724 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -165.98 -11.53 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.14 82.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -1.09 . . . . 0.0 112.397 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.613 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 28.2 p30 -153.01 69.63 0.85 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.83 -1.169 . . . . 0.0 109.14 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.728 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 24.0 mm -44.32 -69.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.702 ' O ' ' N ' ' A' ' 39' ' ' LYS . 7.8 tpt -41.71 -57.38 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.582 -1.324 . . . . 0.0 108.869 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.613 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 69.9 tt0 -44.86 -49.7 10.74 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.865 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -49.58 -65.57 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.723 1.249 . . . . 0.0 109.627 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 42' ' ' ASN . 23.8 t -67.21 -35.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -46.7 -62.2 1.49 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.73 70.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 108.922 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' THR . 2.8 t80 -71.05 -77.55 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.4 t-20 -41.33 -36.91 0.89 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.825 -1.172 . . . . 0.0 110.585 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -64.72 -33.83 76.89 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.11 -59.59 2.15 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.451 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 41' ' ' PHE . 1.7 p -44.53 -31.7 1.19 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.75 23.89 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -56.34 -25.17 48.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.436 -0.79 . . . . 0.0 109.405 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.55 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -111.5 -73.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.04 -1.037 . . . . 0.0 109.864 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.51 -165.81 34.73 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.944 -1.598 . . . . 0.0 111.392 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.5 p30 -87.22 147.15 25.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.056 -1.261 . . . . 0.0 109.082 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.058 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.93 -153.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.122 . . . . 0.0 110.81 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 13' ' ' PRO . 1.9 mm -146.26 138.18 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 71' ' ' THR . 2.4 t -137.25 135.41 19.53 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.045 -1.034 . . . . 0.0 110.776 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -73.02 102.95 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.685 1.59 . . . . 0.0 111.161 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.825 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.7 m -76.51 136.53 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.658 -1.276 . . . . 0.0 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.1 tt0 -129.88 69.76 1.43 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.787 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -70.31 88.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.721 0.772 . . . . 0.0 110.063 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.43 ' HB ' ' HG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -64.18 95.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 53.9 mt -95.27 131.15 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.575 0.703 . . . . 0.0 110.479 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.609 ' CE2' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -108.29 133.09 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 1.064 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -45.79 -30.89 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.567 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.53 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 27.4 p30 -53.94 2.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.791 ' H ' ' C ' ' A' ' 61' ' ' ALA . 7.5 ttp180 70.83 67.08 0.18 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.2 1.0 . . . . 0.0 110.08 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 p -150.39 124.92 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.4 p90 -102.24 103.86 14.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.041 -1.037 . . . . 0.0 109.89 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.609 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.04 120.98 40.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.189 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.954 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.34 148.78 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 0.0 111.179 177.259 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.0 t -169.98 96.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.08 145.11 30.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.752 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -129.41 123.69 32.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.509 -1.369 . . . . 0.0 110.545 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.752 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.21 150.66 0.13 Allowed Pre-proline 0 N--CA 1.493 1.685 0 CA-C-O 121.175 0.512 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.4 Cg_exo -41.86 175.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.731 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.1 Cg_exo -38.9 171.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.379 1.386 . . . . 0.0 112.035 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.973 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.67 -80.62 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 73' ' ' PRO . 86.6 p -43.61 -23.14 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 110.019 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.053 ' CE1' HD12 ' A' ' 77' ' ' LEU . 16.9 p90 -44.02 -38.91 3.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.243 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -136.95 -14.29 1.59 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.243 ' N ' HD13 ' A' ' 77' ' ' LEU . 1.7 mt -63.39 -33.25 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.567 ' CD ' HG21 ' A' ' 71' ' ' THR . 14.2 mmt180 -55.1 -42.69 73.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 82' ' ' ALA . 6.2 tmtt? -64.2 -65.99 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.67 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.29 -5.3 0.47 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.71 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.65 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.93 -80.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 111.778 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.663 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 167.98 47.52 0.03 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.071 -1.538 . . . . 0.0 110.671 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.467 HD11 ' CD ' ' A' ' 79' ' ' ARG . 4.0 mt -97.42 120.27 37.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 0.0 109.132 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 87' ' ' GLY . 57.3 tt0 -160.43 58.44 0.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.529 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.563 ' O ' ' O ' ' A' ' 87' ' ' GLY . 41.3 tttm 45.84 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 56.73 126.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.684 ' O ' ' CG ' ' A' ' 89' ' ' HIS . . . 175.0 127.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -1.128 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.684 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 17.1 m80 -171.47 -84.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.559 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.26 153.85 59.61 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.23 -35.96 98.97 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.488 1.459 . . . . 0.0 112.321 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.01 -163.54 32.38 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.825 ' HG3' HH11 ' A' ' 93' ' ' ARG . 0.9 OUTLIER 64.23 88.46 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -1.176 . . . . 0.0 109.482 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 23.2 mt-10 -137.54 108.12 6.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.442 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 94' ' ' GLU . 86.1 mttt -158.52 120.85 3.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 83' ' ' GLY . 95.5 t -157.91 161.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.524 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 78.72 56.92 3.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.65 ' O ' ' O ' ' A' ' 82' ' ' ALA . 3.6 ttt180 -130.57 116.65 18.43 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.287 -1.125 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.682 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.6 168.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.527 -0.733 . . . . 0.0 109.647 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.741 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -109.11 151.04 26.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 108.985 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 104' ' ' VAL . 25.8 t-105 -45.82 -68.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.471 -0.768 . . . . 0.0 110.872 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 5.9 tp10 -51.32 -47.2 62.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.528 -1.357 . . . . 0.0 110.892 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.67 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -51.49 -43.58 62.24 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.017 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.776 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.01 -24.8 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 117.89 -1.524 . . . . 0.0 107.617 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.876 HD13 HD13 ' A' ' 120' ' ' LEU . 20.8 mt -66.14 -71.55 0.19 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -44.19 -44.78 8.02 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.964 -1.085 . . . . 0.0 108.515 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.773 HG12 HD21 ' A' ' 77' ' ' LEU . 55.8 mt -61.02 -31.4 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.689 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.827 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.03 -24.28 16.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.687 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.1 mtpt -59.57 -73.65 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 108.158 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.47 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 37.5 mt-30 -51.27 -17.94 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.815 . . . . 0.0 109.292 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.56 -8.14 58.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.52 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -133.37 57.87 29.93 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.024 -1.047 . . . . 0.0 109.748 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.99 -41.91 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.521 1.481 . . . . 0.0 112.283 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' LEU . 24.9 t70 -160.68 8.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.6 mp -44.93 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 109.293 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.427 ' H ' ' H ' ' A' ' 117' ' ' THR . 10.5 t30 -165.18 -4.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.237 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.031 HG22 ' H ' ' A' ' 118' ' ' THR . 29.8 m -74.23 -164.66 0.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.584 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.031 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.97 -57.71 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 118' ' ' THR . 0.7 OUTLIER -80.01 135.02 36.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.876 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -54.24 -24.78 19.96 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.183 0.992 . . . . 0.0 109.172 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.14 -36.74 85.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.535 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.641 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.65 -74.71 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.499 -1.376 . . . . 0.0 108.039 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.59 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.89 -37.65 4.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.496 -1.378 . . . . 0.0 109.136 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -55.34 -70.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 108.925 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -43.49 -38.8 3.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.698 ' O ' ' N ' ' A' ' 130' ' ' SER . 14.0 ttm -53.77 -78.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.827 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.3 mm -48.04 -63.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 109.97 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.776 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.39 -71.84 0.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.9 -42.7 5.08 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 126' ' ' MET . 58.7 m -54.74 -46.18 74.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.616 -1.52 . . . . 0.0 107.462 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.738 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -50.43 -47.55 56.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.0 tmt_? -46.83 -52.32 14.54 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -48.62 -70.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.52 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 5.6 ttm -44.51 -4.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.15 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.75 22.91 54.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.738 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 29.8 t -109.23 138.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -115.03 166.67 11.55 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.837 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.645 ' C ' ' H ' ' A' ' 140' ' ' GLY . 1.9 t -82.79 124.82 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' A' ' 100' ' ' THR . 12.2 p -52.57 1.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.689 ' O ' ' HB3' ' A' ' 141' ' ' ALA . . . -159.27 -126.93 0.88 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . 75.07 66.47 0.25 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.251 -1.147 . . . . 0.0 109.364 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.9 Cg_endo -62.65 -165.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.796 1.664 . . . . 0.0 112.48 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.28 -164.96 1.17 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.842 . . . . 0.0 109.504 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 145' ' ' LYS . 3.1 m -95.3 -164.97 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.567 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.593 ' CD ' ' O ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -159.42 134.2 7.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.514 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.593 ' O ' ' CD ' ' A' ' 145' ' ' LYS . 48.6 m-20 -75.47 141.65 43.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.501 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.275 0.56 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.19 109.62 1.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.892 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.597 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 2.6 mtmt -150.27 125.86 10.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.855 . . . . 0.0 109.56 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.783 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.77 133.59 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 109.341 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.737 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.5 m -116.92 -24.49 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.18 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.53 114.18 9.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.118 . . . . 0.0 110.529 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -102.55 73.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.78 ' HB ' HD12 ' A' ' 57' ' ' ILE . 7.9 t -48.56 88.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.764 -1.21 . . . . 0.0 110.606 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.9 tmtt? -82.0 36.74 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.168 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.3 mp -77.21 -174.0 3.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.59 0.709 . . . . 0.0 110.977 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.622 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 1.1 pm0 -127.07 177.76 6.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -170.27 157.91 5.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.943 -1.098 . . . . 0.0 109.839 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.674 ' O ' ' N ' ' A' ' 15' ' ' GLY . 10.4 Cg_endo -66.69 104.92 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.373 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.813 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -60.9 38.65 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.338 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.57 -19.42 0.02 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.488 -1.815 . . . . 0.0 111.357 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 10.4 tttm -148.39 79.7 1.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.578 -1.542 . . . . 0.0 110.705 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.771 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -94.96 170.16 9.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.78 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.74 164.25 4.51 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.768 -1.207 . . . . 0.0 110.494 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.4 Cg_exo -51.75 32.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.029 1.819 . . . . 0.0 112.11 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -137.92 53.98 6.91 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.077 -1.015 . . . . 0.0 110.384 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.713 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.7 Cg_endo -85.97 163.13 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.8 1.667 . . . . 0.0 111.809 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.1 -4.81 4.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.016 1.144 . . . . 0.0 111.405 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.815 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 22.0 t -118.59 -66.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.588 -0.695 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.53 -97.23 0.05 OUTLIER Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.815 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.2 Cg_exo -54.3 -55.05 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 CA-C-N 117.876 0.838 . . . . 0.0 110.538 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -64.22 4.7 0.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.665 . . . . 0.0 111.211 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.752 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -109.62 -64.18 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.66 -1.275 . . . . 0.0 109.797 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.58 -16.75 0.07 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 27' ' ' LEU . 22.3 tp60 -42.08 -16.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.472 -1.605 . . . . 0.0 109.528 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.71 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -65.52 -46.29 80.2 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.71 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.67 -5.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 70.86 76.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.077 -0.661 . . . . 0.0 111.892 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.475 ' OD1' ' C ' ' A' ' 32' ' ' ALA . 1.2 m120 -152.06 64.86 0.84 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.307 1.051 . . . . 0.0 108.334 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.5 mm -43.22 -66.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.643 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.0 tpt -41.56 -42.52 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.619 -1.3 . . . . 0.0 108.759 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.21 -49.39 76.16 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -50.91 -67.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.66 1.219 . . . . 0.0 109.093 178.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 17' ' ' ALA . 24.8 t -63.36 -36.46 76.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.3 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.5 ttpt -48.99 -60.17 3.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.33 71.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.354 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.64 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.9 t80 -68.79 -76.5 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.575 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.8 m120 -41.8 -32.9 0.44 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.399 1.095 . . . . 0.0 110.893 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.73 -34.75 77.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.611 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.82 -51.55 5.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.775 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.791 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 22.7 p -54.36 -31.48 54.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.33 -45.3 16.37 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -54.17 -22.99 12.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.394 -0.816 . . . . 0.0 109.145 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.58 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.1 -85.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.58 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.94 -144.17 3.99 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.015 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.17 119.8 37.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -1.11 . . . . 0.0 109.806 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.813 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -155.8 -152.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.855 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.595 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.6 mm -146.26 141.83 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 14' ' ' ALA . 6.9 t -144.32 137.5 13.98 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.911 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.6 Cg_endo -73.51 91.72 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.779 1.653 . . . . 0.0 111.482 178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.2 m -57.92 137.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.3 mt-10 -130.19 70.65 1.44 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.78 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.6 mt -70.67 90.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.856 0.836 . . . . 0.0 110.226 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 m -69.98 104.94 2.67 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 64' ' ' SER . 21.1 mt -110.33 148.23 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.494 -0.754 . . . . 0.0 110.927 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.783 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.9 m-85 -116.63 140.94 48.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.785 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.56 -32.46 5.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.267 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -51.44 -1.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.785 ' H ' ' C ' ' A' ' 61' ' ' ALA . 13.1 mtp180 75.02 70.03 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.992 0.901 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -149.44 138.08 20.96 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 42.9 p90 -115.13 103.93 11.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.963 -1.086 . . . . 0.0 110.312 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.47 121.07 41.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.089 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.911 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.37 148.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.955 -1.09 . . . . 0.0 111.211 177.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.8 t -168.49 79.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 69' ' ' THR . 1.0 OUTLIER -87.16 138.15 31.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.656 ' O ' ' OG1' ' A' ' 71' ' ' THR . 8.1 mttm -122.94 140.15 53.3 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.198 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.679 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 2.2 p 57.73 158.07 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.603 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.565 ' O ' ' O ' ' A' ' 71' ' ' THR . 12.7 Cg_exo -39.5 175.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.309 2.006 . . . . 0.0 112.691 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.715 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.9 Cg_exo -40.02 170.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.69 1.593 . . . . 0.0 112.253 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.897 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 58.07 -73.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.715 ' N ' ' O ' ' A' ' 73' ' ' PRO . 7.5 p -43.98 -25.34 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.945 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.055 ' CE1' HD12 ' A' ' 77' ' ' LEU . 17.4 p90 -43.61 -43.21 5.58 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.237 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.85 -13.79 3.2 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.237 ' N ' HD13 ' A' ' 77' ' ' LEU . 1.4 mt -63.31 -29.78 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.76 ' CD ' HD11 ' A' ' 84' ' ' LEU . 3.6 mmt180 -54.07 -48.68 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.7 tmtt? -63.81 -66.14 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.61 -6.54 0.12 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.623 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.57 -77.9 0.35 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 111.949 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 146.9 62.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.038 -1.553 . . . . 0.0 111.189 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.76 HD11 ' CD ' ' A' ' 79' ' ' ARG . 16.8 mt -85.01 104.95 15.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.951 -1.323 . . . . 0.0 108.901 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 87' ' ' GLY . 20.9 tt0 -155.94 23.17 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.06 -1.025 . . . . 0.0 109.722 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLU . 1.0 OUTLIER 45.04 -85.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 130.95 172.44 13.12 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.5 -84.99 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -1.173 . . . . 0.0 109.525 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -118.92 131.12 56.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -161.08 160.04 24.59 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.386 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.33 -15.28 18.45 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.577 1.518 . . . . 0.0 112.41 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.6 178.1 18.0 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.578 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 82.2 mtt180 57.76 82.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -1.084 . . . . 0.0 109.555 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.578 ' OE1' ' O ' ' A' ' 93' ' ' ARG . 5.1 tp10 -178.99 152.5 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 94' ' ' GLU . 41.3 mttt -159.9 -165.12 1.43 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.965 . . . . 0.0 109.566 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 97' ' ' GLY . 86.2 t -109.73 165.02 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.299 -0.875 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.588 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 70.89 67.81 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.788 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.57 109.82 9.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -1.212 . . . . 0.0 110.403 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.687 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.42 175.59 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.786 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -123.34 158.38 31.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.687 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.4 t-105 -45.19 -70.86 0.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.351 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.511 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.72 -50.8 54.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.562 -1.336 . . . . 0.0 111.108 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.0 mt-30 -49.27 -43.66 43.24 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.288 -0.883 . . . . 0.0 110.35 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.35 -24.79 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.616 -1.634 . . . . 0.0 107.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 120' ' ' LEU . 13.5 mt -66.32 -71.45 0.19 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.497 ' CD ' ' OE2' ' A' ' 102' ' ' GLU . 35.1 mt-10 -43.77 -43.72 6.26 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.93 -1.106 . . . . 0.0 108.461 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.683 HG12 HD21 ' A' ' 77' ' ' LEU . 55.2 mt -61.65 -31.5 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 108.396 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.815 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.97 -26.77 15.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 109.62 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.8 mtpt -59.26 -73.56 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 0.0 108.211 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 12.3 tt0 -49.35 -18.27 0.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.253 -0.904 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.511 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.8 tmtt? -80.82 -10.2 59.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.581 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -132.38 55.46 17.82 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.9 Cg_endo -60.2 -40.89 55.87 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.567 1.512 . . . . 0.0 112.3 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.529 ' C ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -164.91 9.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.54 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.459 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.2 mp -45.0 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.356 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -160.24 -10.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.024 HG22 ' H ' ' A' ' 118' ' ' THR . 29.0 m -68.65 -164.63 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.024 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.65 -57.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -80.2 135.22 36.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -54.86 -23.74 19.89 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.16 0.981 . . . . 0.0 109.103 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.11 -35.8 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.47 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.627 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.63 -74.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.964 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.644 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.63 -39.05 4.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.342 -1.474 . . . . 0.0 109.152 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.5 -69.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.087 -1.008 . . . . 0.0 108.728 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.79 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -42.81 5.36 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.705 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.5 ttm -51.29 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.115 -0.991 . . . . 0.0 108.454 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.815 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.5 mm -48.37 -66.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.678 0.751 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.884 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -57.89 -71.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.86 -40.82 4.23 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 126' ' ' MET . 44.0 m -56.26 -51.25 68.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.518 -1.577 . . . . 0.0 107.723 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.14 -47.63 23.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.767 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -47.06 -54.26 10.75 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.701 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.1 t -44.77 -68.59 0.18 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.656 ' HG2' HG23 ' A' ' 136' ' ' VAL . 3.8 ttp -46.46 -4.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.73 -31.49 4.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.796 -2.122 . . . . 0.0 107.796 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.656 HG23 ' HG2' ' A' ' 134' ' ' MET . 31.3 t -45.09 165.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.937 -0.743 . . . . 0.0 109.173 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.9 tm-20 -142.43 162.26 35.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.598 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.587 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -78.08 164.35 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.899 ' O ' HG13 ' A' ' 139' ' ' VAL . 4.1 p -131.64 58.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 161.88 -114.45 0.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.523 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.85 60.66 12.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.266 -1.138 . . . . 0.0 109.403 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.0 Cg_endo -65.6 -165.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.682 1.588 . . . . 0.0 112.682 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.71 ' O ' HG13 ' A' ' 144' ' ' VAL . 80.5 mt-10 -146.57 -167.85 2.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 0.0 109.351 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 143' ' ' GLU . 9.0 m -162.31 -179.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -123.27 -167.05 1.54 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.431 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.531 ' O ' ' CG ' ' A' ' 146' ' ' ASP . 6.8 p-10 -176.89 97.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 mtt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 pttt 176.4 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.649 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' C ' ' CE2' ' A' ' 60' ' ' TYR . 3.4 mttm 175.01 114.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 109.455 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.748 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.91 140.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.122 -0.986 . . . . 0.0 109.12 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.924 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.0 m -121.12 -24.59 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.19 110.88 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.605 -1.309 . . . . 0.0 110.716 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -100.92 73.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.827 ' HB ' HD12 ' A' ' 57' ' ' ILE . 21.5 t -46.36 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 110.49 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.9 tmmm? -83.26 34.99 0.48 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.091 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.78 -174.15 3.81 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.917 0.865 . . . . 0.0 111.596 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 1.3 pm0 -121.55 172.12 8.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.51 160.93 4.11 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.854 -1.154 . . . . 0.0 109.857 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.79 ' HD2' HD23 ' A' ' 12' ' ' LEU . 8.8 Cg_endo -61.53 129.41 27.91 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.042 1.828 . . . . 0.0 111.81 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.83 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -90.62 42.16 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 111.28 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.621 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 172.43 -12.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.59 70.96 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.419 . . . . 0.0 109.557 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.642 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -90.8 165.21 13.77 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.431 -0.793 . . . . 0.0 109.319 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.69 161.73 5.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.667 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -54.04 31.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.509 1.473 . . . . 0.0 111.466 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -144.94 54.3 2.44 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 0.0 110.265 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.3 Cg_endo -83.09 154.87 14.72 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.584 1.523 . . . . 0.0 111.544 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.58 -4.46 0.32 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.048 1.165 . . . . 0.0 111.018 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.091 HG22 HD22 ' A' ' 10' ' ' LEU . 2.9 t -103.77 -71.82 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.524 0.678 . . . . 0.0 110.592 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.29 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.741 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.11 -55.5 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 CA-C-N 118.048 0.924 . . . . 0.0 110.188 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.587 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -45.0 -7.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.815 -0.553 . . . . 0.0 110.657 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.745 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -108.37 -45.57 3.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.686 -1.259 . . . . 0.0 108.798 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.81 88.95 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' LEU . 2.7 tt0 -149.73 -15.19 0.27 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.617 ' C ' ' ND1' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -89.46 -36.85 15.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -172.36 -1.82 0.03 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.09 82.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.96 . . . . 0.0 112.188 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.583 ' O ' ' OD1' ' A' ' 33' ' ' ASN . 26.7 p-10 -156.74 119.22 3.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.867 -1.145 . . . . 0.0 109.08 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.2 mm -93.96 -65.26 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.4 tpt -42.72 -55.08 3.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.948 -1.095 . . . . 0.0 109.417 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' CB ' ' ND2' ' A' ' 33' ' ' ASN . 4.8 mp0 -51.01 -53.41 33.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 108.458 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.745 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -46.17 -59.11 3.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.936 1.35 . . . . 0.0 108.796 177.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 17' ' ' ALA . 87.2 t -70.87 -26.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 35' ' ' MET . 23.1 tptt -56.26 -55.25 35.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.79 78.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.729 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CD2' HG21 ' A' ' 45' ' ' THR . 0.6 OUTLIER -67.37 -75.73 0.09 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.637 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 8.9 t-20 -41.78 -35.84 0.89 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.26 1.029 . . . . 0.0 110.715 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -62.95 -34.28 77.15 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.52 -60.33 1.91 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.502 1.144 . . . . 0.0 108.76 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.786 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 52.7 p -47.53 -28.06 2.07 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.764 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.29 -46.71 9.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -49.54 -19.92 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.239 -0.913 . . . . 0.0 108.883 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.645 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.83 -85.29 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.255 -0.903 . . . . 0.0 109.679 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.645 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -166.21 -150.8 6.48 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.912 -1.613 . . . . 0.0 110.962 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HA3' ' A' ' 15' ' ' GLY . 21.4 m-20 -106.39 107.81 19.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.565 -0.962 . . . . 0.0 110.037 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.83 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -143.48 -152.87 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 109.616 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 13' ' ' PRO . 7.1 mm -146.6 142.88 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 71' ' ' THR . 1.6 t -144.91 139.25 15.04 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.7 Cg_endo -75.75 91.48 1.08 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.766 1.644 . . . . 0.0 111.025 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.849 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.9 m -59.56 138.06 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 9.9 mt-10 -131.14 66.55 1.53 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.827 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -66.53 92.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.665 0.745 . . . . 0.0 110.397 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.11 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 64' ' ' SER . 89.4 mt -103.05 142.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.509 -0.744 . . . . 0.0 110.683 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.748 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 5.6 m-85 -115.91 138.36 51.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.924 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.9 -30.75 4.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.437 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.23 1.5 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.809 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.7 OUTLIER 71.38 68.07 0.16 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.04 0.924 . . . . 0.0 109.893 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -149.47 131.24 15.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.195 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.3 p90 -108.63 104.11 13.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.049 -1.032 . . . . 0.0 110.098 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.5 121.02 41.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.978 -1.076 . . . . 0.0 110.201 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.95 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.21 149.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.953 -1.092 . . . . 0.0 111.283 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.1 t -169.69 84.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 138.7 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.816 ' O ' ' OG1' ' A' ' 71' ' ' THR . 14.8 mtmt -124.37 141.67 51.89 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.071 -1.451 . . . . 0.0 110.766 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.816 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 41.4 p 62.5 155.13 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.818 -0.552 . . . . 0.0 109.874 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' O ' ' OG ' ' A' ' 75' ' ' SER . 7.8 Cg_exo -42.09 175.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.406 2.071 . . . . 0.0 112.737 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 75' ' ' SER . 29.1 Cg_exo -38.43 170.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.494 1.462 . . . . 0.0 112.088 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.49 -73.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.782 ' N ' ' O ' ' A' ' 73' ' ' PRO . 21.3 p -43.42 -19.43 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.557 -0.714 . . . . 0.0 111.08 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.771 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -43.66 -41.14 4.54 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.779 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -133.2 -14.39 2.64 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.867 HD12 ' HB1' ' A' ' 74' ' ' ALA . 2.0 mt -59.19 -33.14 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.61 ' CD ' HG21 ' A' ' 71' ' ' THR . 15.0 mmt180 -54.7 -42.56 71.64 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 82' ' ' ALA . 13.8 tmtt? -66.47 -66.1 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.833 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.83 -4.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.485 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.642 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.33 -79.7 0.23 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.437 -0.79 . . . . 0.0 111.694 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.602 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 167.08 45.09 0.02 OUTLIER Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.574 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.526 HD11 HH11 ' A' ' 79' ' ' ARG . 4.4 mt -99.47 105.84 17.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.346 . . . . 0.0 109.248 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 87' ' ' GLY . 5.3 tm-20 -178.07 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.631 ' N ' ' CD ' ' A' ' 85' ' ' GLU . 24.0 tptp 46.28 -85.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 0.0 109.483 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 149.41 -115.02 0.7 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.53 -85.01 0.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -1.134 . . . . 0.0 109.571 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -48.04 157.95 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -95.04 156.51 37.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.95 . . . . 0.0 109.481 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.59 -55.03 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.535 1.49 . . . . 0.0 112.367 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.689 ' O ' ' N ' ' A' ' 94' ' ' GLU . . . 131.29 115.43 1.71 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER 60.75 -57.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -1.116 . . . . 0.0 109.601 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 92' ' ' GLY . 28.5 mt-10 -44.95 161.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.558 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.61 -165.02 1.28 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.897 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t -126.87 165.02 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.669 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.94 66.38 1.04 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.802 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.93 114.87 14.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.705 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -103.97 177.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.778 . . . . 0.0 109.356 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.782 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -117.76 153.94 32.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.012 -1.055 . . . . 0.0 109.292 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.672 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.7 t-105 -48.12 -69.36 0.12 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.93 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.501 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.2 -46.47 54.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.696 -1.252 . . . . 0.0 110.646 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.833 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -51.65 -45.07 63.22 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.041 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.872 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.3 m -72.24 -24.45 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.732 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.913 HD13 HD13 ' A' ' 120' ' ' LEU . 17.2 mt -66.91 -72.11 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 74.4 tt0 -43.93 -43.17 6.33 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.932 -1.105 . . . . 0.0 108.572 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.6 mt -62.66 -31.29 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 108.651 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.819 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.39 -26.94 15.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.451 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.3 mtpt -58.76 -73.36 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 108.346 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 109' ' ' LYS . 70.0 mt-30 -46.86 -25.68 0.82 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.815 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' A' ' 113' ' ' PRO . 27.7 tptt -72.8 -18.43 61.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.697 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -128.69 66.53 75.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 109.856 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -63.6 -41.25 26.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.501 1.468 . . . . 0.0 112.284 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 66.1 t0 -176.84 9.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.376 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 1.1 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.87 -85.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.792 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -145.45 -21.97 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.398 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.054 HG22 ' H ' ' A' ' 118' ' ' THR . 25.5 m -65.84 -164.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.526 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.054 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.6 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.134 -0.979 . . . . 0.0 109.945 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.536 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -61.47 140.3 58.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.913 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.14 -22.15 64.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.255 1.026 . . . . 0.0 108.928 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.39 -38.07 88.87 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.525 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.42 -75.27 0.11 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.907 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.596 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.5 -43.05 7.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.405 -1.435 . . . . 0.0 109.402 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.69 -68.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.793 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -43.02 5.48 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.688 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.9 ttm -51.61 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -0.963 . . . . 0.0 108.74 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.819 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.4 mm -48.41 -64.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.674 0.749 . . . . 0.0 109.973 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.872 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.4 -71.47 0.12 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -39.39 3.67 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 126' ' ' MET . 36.6 m -56.33 -51.21 69.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.592 -1.534 . . . . 0.0 107.699 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.696 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.79 -47.66 30.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -46.62 -54.24 9.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.4 t -44.56 -67.82 0.25 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.624 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.9 ttp -46.64 -3.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.53 -24.02 13.77 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.696 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 27.2 t -57.47 135.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.975 -0.72 . . . . 0.0 109.387 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -112.09 164.74 12.82 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.493 ' CG1' ' HB2' ' A' ' 141' ' ' ALA . 1.8 t -80.35 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.837 ' O ' HG13 ' A' ' 139' ' ' VAL . 12.2 p -73.86 77.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.641 -0.662 . . . . 0.0 109.622 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.87 -75.9 2.15 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.597 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 58.43 55.07 5.96 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.228 -1.16 . . . . 0.0 109.361 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 3.8 Cg_endo -65.82 -164.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.654 1.569 . . . . 0.0 112.641 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -126.48 -165.04 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.318 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -102.58 -179.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.565 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.908 ' NZ ' ' HB2' ' A' ' 147' ' ' ALA . 30.7 tttp -155.42 170.44 21.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.512 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.58 ' N ' ' CG ' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -111.73 -84.92 0.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 109.542 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.908 ' HB2' ' NZ ' ' A' ' 145' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.289 0.566 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.46 49.81 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.536 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.579 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -154.89 118.59 4.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.678 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.795 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.95 134.6 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -114.79 -24.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.79 113.6 9.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.328 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -101.61 73.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 109.128 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.783 ' HB ' HD12 ' A' ' 57' ' ' ILE . 6.0 t -49.11 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 O-C-N 120.646 -1.284 . . . . 0.0 110.472 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.26 36.74 0.48 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.927 0.87 . . . . 0.0 109.017 179.004 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.1 mp -76.23 -174.1 2.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.874 0.845 . . . . 0.0 111.045 -178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -125.94 176.11 7.21 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.674 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -165.81 145.96 5.5 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.968 -1.082 . . . . 0.0 109.292 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.669 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 72.1 Cg_endo -84.94 126.71 3.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.232 1.955 . . . . 0.0 113.437 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.61 143.47 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 51.2 54.17 24.53 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.669 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 34.1 tttt 174.48 4.01 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.729 -0.865 . . . . 0.0 109.521 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 18' ' ' THR . . . -84.4 156.17 21.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.895 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.95 165.64 4.03 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.915 -1.115 . . . . 0.0 110.26 -178.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HD2' HG22 ' A' ' 18' ' ' THR . 6.9 Cg_exo -47.79 33.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.925 1.75 . . . . 0.0 111.943 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.895 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -142.06 54.2 3.68 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.998 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.716 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -83.35 169.01 12.82 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.832 1.688 . . . . 0.0 112.019 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.31 -4.83 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 121.244 1.296 . . . . 0.0 111.377 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 26' ' ' ALA . 19.5 t -119.34 -64.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.582 -0.698 . . . . 0.0 109.505 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.29 -97.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.803 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -55.57 -55.24 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 CA-C-N 117.817 0.808 . . . . 0.0 110.642 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -60.58 1.94 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.663 -0.648 . . . . 0.0 111.213 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.752 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.41 -58.0 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.697 -1.252 . . . . 0.0 109.411 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.751 ' O ' ' N ' ' A' ' 32' ' ' ALA . . . -43.12 -17.29 0.04 OUTLIER Glycine 0 N--CA 1.485 1.948 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.531 ' C ' ' O ' ' A' ' 28' ' ' GLY . 13.0 mm100 -42.63 -27.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.176 -1.779 . . . . 0.0 107.885 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.768 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 14.2 p-80 -66.33 54.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 89.55 -18.77 44.32 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.751 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 75.19 83.06 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -1.118 . . . . 0.0 112.09 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.599 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -153.22 67.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.952 -1.092 . . . . 0.0 109.251 177.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 29.5 mm -43.85 -67.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.728 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.0 tpt -41.1 -56.93 2.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.473 -1.392 . . . . 0.0 109.218 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.599 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 18.9 tt0 -44.71 -47.64 10.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.452 -1.405 . . . . 0.0 107.631 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.756 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -51.97 -69.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.583 1.182 . . . . 0.0 109.705 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 42' ' ' ASN . 27.8 t -65.32 -36.26 77.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.484 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 35' ' ' MET . 16.0 tttt -46.08 -62.06 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.81 -33.76 68.93 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 2.8 t80 -71.45 -78.36 0.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.1 t-20 -41.23 -30.91 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.896 -1.127 . . . . 0.0 110.679 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -70.55 -32.86 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.089 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB1' ' HZ2' ' A' ' 70' ' ' LYS . . . -90.33 -45.88 8.74 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.552 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.584 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 9.4 p -60.24 -31.16 69.93 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.85 23.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.75 -22.45 46.94 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.685 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.55 -71.82 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.685 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.47 -130.04 1.5 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.123 -1.513 . . . . 0.0 111.067 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -122.64 145.81 48.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -1.187 . . . . 0.0 108.85 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.078 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.93 -154.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.736 -1.228 . . . . 0.0 111.192 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.072 HD12 ' C ' ' A' ' 51' ' ' ALA . 1.9 mp -144.25 135.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 71' ' ' THR . 2.7 t -135.36 132.66 20.05 Favored Pre-proline 0 C--N 1.296 -1.75 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.92 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 8.9 Cg_endo -71.9 103.47 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.654 1.57 . . . . 0.0 111.192 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -75.96 136.39 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.652 -1.28 . . . . 0.0 111.493 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.1 mt-10 -129.08 70.39 1.41 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.4 mt -70.55 90.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.882 0.848 . . . . 0.0 110.07 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.455 ' HB ' ' HG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -70.82 95.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.919 HG23 ' O ' ' A' ' 64' ' ' SER . 46.4 mt -101.57 147.67 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.659 -0.651 . . . . 0.0 110.583 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.795 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.0 m-85 -115.62 142.2 47.05 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.28 -33.15 8.32 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.238 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 56.4 p30 -50.8 -1.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.797 ' H ' ' C ' ' A' ' 61' ' ' ALA . 16.2 ttm180 75.25 70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.048 0.928 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.919 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -149.49 147.04 27.73 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.9 p90 -123.32 103.91 8.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.974 -1.079 . . . . 0.0 110.188 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.5 p -101.48 120.77 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 110.002 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.922 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.9 OUTLIER 170.3 147.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.952 -1.092 . . . . 0.0 111.295 177.415 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.6 t -168.52 97.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.301 1.048 . . . . 0.0 108.519 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.01 144.02 33.32 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.733 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -128.14 131.54 48.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.461 -1.399 . . . . 0.0 111.157 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.733 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER 67.75 160.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.954 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.624 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.5 Cg_exo -38.9 175.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.686 2.257 . . . . 0.0 113.193 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.732 ' O ' ' N ' ' A' ' 75' ' ' SER . 19.9 Cg_exo -44.27 171.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.566 1.511 . . . . 0.0 112.183 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.642 ' HB1' ' CD1' ' A' ' 78' ' ' ILE . . . 55.2 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.88 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 60.2 p -43.02 -19.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.446 -0.784 . . . . 0.0 110.367 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.854 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 27.5 p90 -43.47 -34.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.854 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.38 -16.73 1.82 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.226 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.88 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 6.8 mt -56.71 -31.73 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 75' ' ' SER . 9.1 mmm180 -54.43 -49.0 71.01 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.4 tmtt? -62.59 -65.74 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.708 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -56.62 -7.92 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 109.668 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.96 -78.11 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 111.519 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.852 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 147.19 68.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.333 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 83' ' ' GLY . 2.7 mt -133.05 104.57 6.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -1.18 . . . . 0.0 109.313 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 174.85 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 109.401 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.1 tptp 62.31 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.604 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.57 -99.18 0.97 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' O ' ' CG ' ' A' ' 89' ' ' HIS . . . -150.62 117.3 5.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -1.142 . . . . 0.0 109.584 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER 174.98 165.12 0.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.438 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -59.51 160.06 15.04 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' A' ' 93' ' ' ARG . 3.6 Cg_exo -58.14 -54.92 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.548 1.499 . . . . 0.0 112.458 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 57.0 -0.56 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.778 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 55.65 122.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -1.155 . . . . 0.0 109.467 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -147.0 -165.27 2.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -119.67 -164.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.456 HG13 HD22 ' A' ' 84' ' ' LEU . 86.0 t -151.56 146.12 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.888 . . . . 0.0 109.498 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.899 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 72.03 76.45 0.61 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 82' ' ' ALA . 14.9 ttm180 -135.36 106.23 6.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.3 -177.49 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 109.884 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.805 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -120.95 151.68 39.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.261 -0.899 . . . . 0.0 108.94 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.705 ' O ' HG22 ' A' ' 104' ' ' VAL . 31.9 t-105 -48.28 -67.45 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 110.561 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 7.4 tp10 -50.5 -48.29 56.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.728 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.708 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -50.61 -44.01 56.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.02 -25.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 117.719 -1.593 . . . . 0.0 107.462 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 120' ' ' LEU . 21.9 mt -66.26 -72.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.563 ' OE1' ' OE2' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -44.31 -43.29 7.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.089 -1.007 . . . . 0.0 108.802 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.822 HG12 HD11 ' A' ' 77' ' ' LEU . 60.2 mt -63.51 -31.29 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.054 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.75 -30.62 13.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.292 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.681 ' N ' ' O ' ' A' ' 105' ' ' LEU . 17.4 mtpt -54.73 -72.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 108.646 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 109' ' ' LYS . 30.0 tt0 -45.59 -31.12 1.72 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.16 -0.963 . . . . 0.0 109.032 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.513 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.1 tmtt? -63.99 -15.67 59.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.752 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.496 ' CG ' ' O ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -128.63 70.78 80.54 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.939 -1.101 . . . . 0.0 109.71 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.66 -39.29 21.38 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.565 1.51 . . . . 0.0 112.15 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.56 ' OD1' ' O ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -178.21 10.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.237 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -48.24 -82.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -151.37 -22.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.07 HG22 ' H ' ' A' ' 118' ' ' THR . 27.0 m -59.95 -164.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.989 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.07 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -176.0 -70.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.862 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.551 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -65.28 137.5 57.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -59.21 -21.41 59.45 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.277 1.037 . . . . 0.0 108.746 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -65.69 -34.29 77.85 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.589 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.524 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.56 -76.23 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.464 -1.398 . . . . 0.0 107.935 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.64 -39.08 4.75 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.439 -1.413 . . . . 0.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.94 -67.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.06 -1.025 . . . . 0.0 108.535 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 12.9 ttt180 -43.36 -36.74 2.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.623 ' O ' ' N ' ' A' ' 130' ' ' SER . 7.3 ttm -57.24 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 108.886 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 30.0 mm -48.63 -57.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 110.199 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.681 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -66.62 -70.28 0.26 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -42.42 5.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.732 ' OG ' ' O ' ' A' ' 127' ' ' ILE . 54.7 p -52.86 -50.0 64.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.512 -1.581 . . . . 0.0 107.152 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.752 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.2 -48.62 45.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.559 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -44.77 -51.67 9.17 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.1 t -50.57 -68.81 0.14 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.534 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 5.5 ttp -44.95 -4.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.713 -0.617 . . . . 0.0 110.407 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.4 25.47 47.3 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.899 HG22 ' HA3' ' A' ' 97' ' ' GLY . 28.9 t -107.71 165.52 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.858 -0.79 . . . . 0.0 109.233 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . 5.1 tt0 -139.53 162.64 34.58 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.989 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.65 ' C ' ' H ' ' A' ' 140' ' ' GLY . 1.8 t -79.07 117.73 25.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.805 HG12 ' HA ' ' A' ' 100' ' ' THR . 7.0 p -49.86 -0.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.823 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.65 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . -140.58 -111.42 0.91 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.442 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 45.18 64.1 8.21 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.293 -1.122 . . . . 0.0 109.343 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.5 Cg_endo -61.47 -168.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.784 1.656 . . . . 0.0 112.464 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 144' ' ' VAL . 23.8 tt0 -178.49 104.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -157.94 167.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 19.4 tptm -177.14 148.39 0.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.461 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.471 ' OD1' ' C ' ' A' ' 146' ' ' ASP . 29.1 t0 -166.19 72.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.403 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -161.22 111.68 1.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.511 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 2.8 ttmp? -177.85 125.06 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.582 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -44.7 140.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.918 . . . . 0.0 108.804 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.998 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -122.59 -24.91 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 110.093 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.41 107.38 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.758 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.62 74.31 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.827 ' HB ' HD12 ' A' ' 57' ' ' ILE . 25.1 t -48.73 88.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.956 -1.09 . . . . 0.0 110.876 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 tmtm? -82.38 37.05 0.49 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.715 0.769 . . . . 0.0 109.315 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.127 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -80.09 -174.07 4.29 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.721 0.772 . . . . 0.0 111.461 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.635 ' OE1' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.93 174.77 7.35 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.085 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.804 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.78 161.75 3.84 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.704 -1.247 . . . . 0.0 110.098 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.804 ' HD2' HD23 ' A' ' 12' ' ' LEU . 9.5 Cg_endo -62.2 126.6 18.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.904 1.736 . . . . 0.0 111.668 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.82 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -88.1 42.21 1.05 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.035 -1.041 . . . . 0.0 111.332 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.579 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 174.81 -12.12 0.03 OUTLIER Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.906 -1.616 . . . . 0.0 110.832 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -143.26 73.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 109.622 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.653 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -93.2 169.66 10.23 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.193 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -175.31 162.45 2.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.021 -1.049 . . . . 0.0 109.693 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.1 Cg_exo -53.97 31.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.581 1.521 . . . . 0.0 111.33 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -147.38 54.03 1.8 Allowed Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.102 -0.999 . . . . 0.0 110.083 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.738 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.3 Cg_endo -85.06 157.83 11.42 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.746 1.631 . . . . 0.0 111.522 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -52.75 -4.52 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 120.939 1.093 . . . . 0.0 110.846 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.127 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -105.08 -72.08 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 121.623 0.725 . . . . 0.0 110.296 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.65 -98.33 0.05 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -59.89 -55.39 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 CA-C-N 118.004 0.902 . . . . 0.0 109.959 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -43.8 -11.98 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.266 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.861 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.25 -38.73 4.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.686 -1.259 . . . . 0.0 108.114 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.38 96.13 0.01 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 27' ' ' LEU . 41.2 tt0 -162.94 -22.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.688 ' O ' ' CD2' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -83.84 65.55 8.65 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.679 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 80.54 -5.99 62.64 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.37 83.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 112.021 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 33.2 m120 -159.32 124.85 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.903 -1.123 . . . . 0.0 108.905 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.565 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 20.8 mm -101.22 -62.1 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 0.0 109.858 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.663 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.49 -47.52 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 109.749 -176.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -55.75 -48.74 74.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 0.0 107.845 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.861 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -49.79 -63.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.612 1.196 . . . . 0.0 108.818 178.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.653 HG13 ' CB ' ' A' ' 17' ' ' ALA . 98.0 t -68.55 -30.15 46.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.194 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 35' ' ' MET . 36.0 tptt -54.83 -54.57 40.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.06 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 109.634 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.532 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.0 OUTLIER -67.76 -75.5 0.1 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.231 -1.543 . . . . 0.0 106.896 176.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.645 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.7 m-20 -41.5 -38.26 1.26 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.117 -0.99 . . . . 0.0 110.735 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -61.53 -33.71 74.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.712 ' HB1' ' NZ ' ' A' ' 70' ' ' LYS . . . -91.13 -57.77 2.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.591 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.802 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 40.0 p -50.75 -26.82 6.07 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.766 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.645 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.12 -45.86 10.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -52.7 -18.94 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 0.0 108.886 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.48 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.41 -85.31 0.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . -168.15 -150.47 6.6 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.89 -1.624 . . . . 0.0 110.794 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -105.62 107.43 18.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -1.005 . . . . 0.0 109.976 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.82 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -144.15 -152.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.854 . . . . 0.0 109.611 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 13' ' ' PRO . 7.8 mm -146.04 143.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 14' ' ' ALA . 2.2 t -143.6 137.18 14.24 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.128 -0.983 . . . . 0.0 110.497 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -74.53 91.61 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.841 1.694 . . . . 0.0 110.628 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.881 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -60.09 136.53 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 122.706 1.241 . . . . 0.0 111.662 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 30.4 tt0 -130.6 69.51 1.46 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.827 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -71.08 90.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.719 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.73 96.02 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.1 mt -97.15 135.81 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.446 -0.784 . . . . 0.0 110.865 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.594 ' CE2' ' N ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -111.7 136.01 51.52 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.998 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -46.63 -32.94 3.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.742 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 56.0 m-20 -51.3 -2.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.789 ' H ' ' C ' ' A' ' 61' ' ' ALA . 9.7 ttm180 75.11 68.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.072 0.939 . . . . 0.0 109.74 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 10.4 m -149.72 124.97 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.717 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -102.9 103.98 14.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.157 -0.964 . . . . 0.0 110.009 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -100.55 120.51 40.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.969 -1.082 . . . . 0.0 109.911 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.941 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 169.94 150.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.956 177.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.6 t -169.45 78.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -84.14 148.97 26.48 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.766 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.1 mttm -136.46 134.1 37.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.906 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.766 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.3 p 75.34 150.75 0.13 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.646 ' HD3' ' HB1' ' A' ' 51' ' ' ALA . 7.1 Cg_exo -43.4 175.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.46 2.106 . . . . 0.0 113.149 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.805 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.0 Cg_exo -41.98 177.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.74 1.627 . . . . 0.0 112.007 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 44.91 -84.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.805 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -43.96 -15.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 109.614 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.948 ' CE1' HD12 ' A' ' 77' ' ' LEU . 21.1 p90 -44.15 -35.67 2.3 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.218 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -139.71 -14.86 1.06 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.218 ' N ' HD13 ' A' ' 77' ' ' LEU . 2.0 mt -63.1 -33.25 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.578 ' HG3' HG21 ' A' ' 71' ' ' THR . 1.6 mmt180 -55.44 -44.88 76.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.1 tmtp? -61.54 -65.48 0.68 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.487 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -59.61 -6.13 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.475 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.641 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -82.24 -81.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.45 -0.781 . . . . 0.0 111.555 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.17 34.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.549 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.574 HD11 ' CD ' ' A' ' 79' ' ' ARG . 3.5 mt -91.38 104.7 17.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.884 -1.363 . . . . 0.0 109.031 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.677 ' OE1' ' N ' ' A' ' 86' ' ' LYS . 4.6 tm-20 174.83 -70.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.677 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 13.1 tptm 59.31 -85.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 109.559 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' ALA . . . 48.88 87.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 87' ' ' GLY . . . 174.99 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -1.179 . . . . 0.0 109.448 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.595 ' CG ' ' H ' ' A' ' 90' ' ' LYS . 11.2 t60 -126.26 -171.49 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.434 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.595 ' H ' ' CG ' ' A' ' 89' ' ' HIS . 5.6 mptp? -60.77 159.59 25.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.415 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.55 -55.04 2.34 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.578 1.519 . . . . 0.0 112.379 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.83 108.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 57.5 -164.97 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -1.137 . . . . 0.0 109.513 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -111.41 118.45 35.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.477 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.499 ' O ' ' CG2' ' A' ' 96' ' ' VAL . 8.7 mtpp -152.14 82.62 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.946 . . . . 0.0 109.527 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 97' ' ' GLY . 94.8 t -158.3 165.04 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.593 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 72.16 60.26 4.23 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 82' ' ' ALA . 1.4 ttt180 -132.03 117.03 17.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -1.182 . . . . 0.0 110.117 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.47 -169.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.033 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.724 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.12 163.26 28.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.097 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.686 ' O ' HG22 ' A' ' 104' ' ' VAL . 23.8 t-105 -53.45 -69.5 0.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 110.643 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 7.4 tp10 -51.03 -45.31 61.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.527 -1.358 . . . . 0.0 110.427 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.487 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -51.3 -45.89 62.35 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.782 -179.353 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.5 -22.78 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.774 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.75 HD13 HD13 ' A' ' 120' ' ' LEU . 17.7 mt -68.01 -72.49 0.17 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 105' ' ' LEU . 76.3 tt0 -43.83 -43.95 6.55 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.889 -1.132 . . . . 0.0 108.508 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.724 HG12 HD21 ' A' ' 77' ' ' LEU . 62.9 mt -61.77 -31.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 108.46 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.823 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.69 -20.85 17.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.462 -0.774 . . . . 0.0 109.481 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 105' ' ' LEU . 26.0 mttm -62.49 -74.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.852 -1.155 . . . . 0.0 108.167 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.464 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 56.7 mt-30 -50.48 -20.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.585 ' HD3' HD11 ' A' ' 127' ' ' ILE . 17.7 tttt -69.4 -4.97 20.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.042 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.586 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -135.69 63.09 51.71 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.903 -1.123 . . . . 0.0 109.715 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 112' ' ' MET . 5.1 Cg_endo -71.3 -30.79 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.572 1.515 . . . . 0.0 111.883 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -166.84 4.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mp -44.84 -85.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -171.96 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.206 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.033 HG22 ' H ' ' A' ' 118' ' ' THR . 29.6 m -75.43 -164.39 0.33 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.033 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.81 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.083 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.691 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -94.82 130.56 41.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.75 HD13 HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -58.9 -35.02 72.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.418 1.104 . . . . 0.0 108.648 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.465 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 50.7 mp0 -62.75 -33.5 75.28 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.467 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -73.3 -74.25 0.18 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.586 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.23 -37.45 4.64 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.489 -1.382 . . . . 0.0 109.019 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -56.65 -69.48 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 108.847 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.646 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.6 OUTLIER -43.38 -35.95 1.74 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.669 ' O ' ' CB ' ' A' ' 130' ' ' SER . 6.0 ttm -56.13 -76.64 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.823 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.9 mm -48.82 -63.48 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.689 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.12 -72.26 0.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.49 -41.16 4.02 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.669 ' CB ' ' O ' ' A' ' 126' ' ' MET . 60.2 m -57.91 -47.87 81.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.547 -1.561 . . . . 0.0 107.443 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.538 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.25 -49.72 42.05 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.794 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.71 -55.09 6.89 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.669 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.5 t -44.67 -67.45 0.28 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.499 ' CE ' ' HB2' ' A' ' 75' ' ' SER . 0.6 OUTLIER -47.4 -4.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.669 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.55 -31.11 5.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 137' ' ' GLU . 41.3 t -45.02 165.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.909 -0.759 . . . . 0.0 108.972 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.57 ' N ' HG12 ' A' ' 136' ' ' VAL . 81.0 tt0 -142.25 162.73 34.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.8 t -83.26 137.68 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.677 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.2 p -92.61 -5.95 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.455 -0.778 . . . . 0.0 109.533 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -125.72 -129.56 3.35 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 50.86 70.97 1.69 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.231 -1.158 . . . . 0.0 109.585 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.84 -164.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.668 1.579 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.625 ' O ' HG13 ' A' ' 144' ' ' VAL . 57.1 tt0 -157.47 160.38 38.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 143' ' ' GLU . 1.9 m -159.63 158.35 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.528 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -139.86 156.08 46.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.912 . . . . 0.0 109.451 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.03 109.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.459 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' O ' ' CD ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -159.07 109.83 2.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.618 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.528 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 1.3 tptm 177.52 121.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.753 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.79 137.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 109.417 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.6 m -115.67 -24.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.44 110.18 6.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.344 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.16 73.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 57' ' ' ILE . 35.4 t -48.52 88.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.542 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.93 36.47 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.819 0.819 . . . . 0.0 109.324 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.016 HD22 HG22 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -77.91 -174.12 3.41 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.432 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.669 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 1.5 pm0 -121.35 172.49 7.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.803 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -169.04 161.05 8.0 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.086 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.803 ' HD2' HD23 ' A' ' 12' ' ' LEU . 13.8 Cg_endo -66.95 109.61 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.065 1.844 . . . . 0.0 111.316 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.829 ' HB3' ' C ' ' A' ' 51' ' ' ALA . . . -67.64 41.08 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.856 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.491 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 176.6 -14.15 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.515 -1.802 . . . . 0.0 111.522 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 17.0 tttt -138.25 56.83 1.72 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.6 . . . . 0.0 110.557 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.711 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -75.32 160.03 30.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.669 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.41 162.37 23.72 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.681 -1.262 . . . . 0.0 110.981 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 18' ' ' THR . 1.2 Cg_endo -57.05 38.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.087 1.858 . . . . 0.0 111.847 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.669 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -173.06 56.77 0.21 Allowed Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.53 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.653 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.8 Cg_endo -79.76 169.02 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 121.467 1.444 . . . . 0.0 111.382 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.08 -4.68 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.071 1.181 . . . . 0.0 110.922 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.016 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -106.85 -72.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.582 0.706 . . . . 0.0 110.256 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.35 -98.01 0.05 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.743 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.59 -55.65 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 CA-C-N 118.088 0.944 . . . . 0.0 110.055 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.647 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.79 -10.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.83 -0.544 . . . . 0.0 110.243 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.839 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.75 -44.11 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.859 -1.151 . . . . 0.0 108.815 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.62 96.38 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 27' ' ' LEU . 10.6 tt0 -159.49 -26.68 0.07 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.717 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.4 p80 -78.74 64.17 3.67 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.7 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.661 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 81.82 -7.84 61.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 83.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -1.126 . . . . 0.0 112.097 177.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -157.97 123.69 4.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.676 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 19.8 mm -97.55 -63.71 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.049 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.614 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.0 tpt -41.29 -51.64 3.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.768 -1.208 . . . . 0.0 109.989 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.57 -48.39 57.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.667 -1.271 . . . . 0.0 108.007 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.839 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -51.81 -65.83 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.535 1.16 . . . . 0.0 109.353 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.711 HG13 ' CB ' ' A' ' 17' ' ' ALA . 67.8 t -65.49 -30.03 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.915 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.4 OUTLIER -55.67 -56.1 24.38 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.14 77.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.608 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.607 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.9 t80 -69.49 -76.77 0.09 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.341 -1.474 . . . . 0.0 107.155 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 9.8 t-20 -41.66 -32.36 0.37 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.971 -1.081 . . . . 0.0 110.734 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.84 -34.08 76.02 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HB1' ' HD3' ' A' ' 70' ' ' LYS . . . -90.45 -53.39 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.603 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.774 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 27.9 p -53.51 -30.38 41.06 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.6 -45.2 16.16 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -54.15 -21.77 9.56 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.154 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.702 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.79 -85.0 0.54 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.702 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.91 -149.8 6.05 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.896 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 2.2 t0 -110.15 120.2 41.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -1.142 . . . . 0.0 109.902 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.829 ' C ' ' HB3' ' A' ' 14' ' ' ALA . . . -153.72 -152.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 13' ' ' PRO . 6.0 mm -146.53 142.7 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 14' ' ' ALA . 4.6 t -146.44 138.53 13.59 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 110.302 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.5 Cg_endo -73.93 93.06 0.87 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.75 1.633 . . . . 0.0 111.258 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.866 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.3 m -60.35 137.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.722 -1.236 . . . . 0.0 111.689 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.7 mt-10 -129.68 68.55 1.43 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.75 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.0 mt -68.93 93.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.859 0.838 . . . . 0.0 110.585 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.0 99.88 0.91 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 57' ' ' ILE . 47.9 mt -104.46 145.08 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.537 -0.727 . . . . 0.0 110.756 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.753 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.2 m-85 -116.46 140.67 49.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.781 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.61 -33.08 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.304 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -1.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.781 ' H ' ' C ' ' A' ' 61' ' ' ALA . 36.2 mtm180 75.28 69.05 0.08 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.019 0.914 . . . . 0.0 109.727 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -148.73 148.06 29.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.473 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.669 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 39.3 p90 -125.23 103.97 8.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.277 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.2 p -101.6 120.92 41.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.9 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.17 146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.074 177.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 67' ' ' PHE . 31.7 t -167.57 79.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.284 1.04 . . . . 0.0 108.348 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 69' ' ' THR . 0.7 OUTLIER -87.03 136.79 32.79 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.625 ' O ' ' OG1' ' A' ' 71' ' ' THR . 5.1 mtmp? -121.0 140.62 51.66 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.227 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.625 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER 60.38 163.95 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.838 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 71' ' ' THR . 11.7 Cg_exo -41.08 175.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.099 1.866 . . . . 0.0 112.463 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.17 173.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.629 1.553 . . . . 0.0 112.499 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.972 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 56.79 -73.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 108.711 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -45.48 -17.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.716 . . . . 0.0 110.937 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.751 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 1.2 p90 -43.37 -38.63 2.8 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.889 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.579 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.1 pp -133.65 -22.2 1.91 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.972 HD12 ' HB1' ' A' ' 74' ' ' ALA . 6.5 mt -54.95 -30.84 23.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.716 ' CD ' HD11 ' A' ' 84' ' ' LEU . 6.0 mmt180 -52.65 -57.21 10.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 82' ' ' ALA . 5.3 tmtm? -52.06 -64.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.67 -6.53 0.75 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.813 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.801 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -83.34 -80.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 111.837 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.89 48.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.99 -1.576 . . . . 0.0 110.817 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.716 HD11 ' CD ' ' A' ' 79' ' ' ARG . 6.7 mt -83.95 104.82 14.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.316 . . . . 0.0 109.003 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' C ' ' CD ' ' A' ' 86' ' ' LYS . 37.2 tt0 -143.23 -16.37 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.706 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 86' ' ' LYS . 7.4 mptt 59.85 40.63 19.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 109.569 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 86' ' ' LYS . . . 44.99 -158.53 0.19 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.97 -84.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.541 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.457 ' O ' ' CG ' ' A' ' 89' ' ' HIS . 0.5 OUTLIER -146.33 67.27 1.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 109.515 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.14 161.15 40.19 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.363 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.6 -2.64 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.566 1.511 . . . . 0.0 112.464 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.19 -123.26 1.29 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.817 ' HG3' HH11 ' A' ' 93' ' ' ARG . 0.9 OUTLIER 67.17 138.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -1.111 . . . . 0.0 109.407 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -122.96 163.09 21.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 0.0 109.507 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.734 ' NZ ' ' NH2' ' A' ' 98' ' ' ARG . 0.9 OUTLIER 174.98 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.393 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.448 HG23 ' C ' ' A' ' 95' ' ' LYS . 48.6 t -154.8 150.46 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.586 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.801 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 70.08 58.0 6.51 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.734 ' NH2' ' NZ ' ' A' ' 95' ' ' LYS . 4.2 tmm_? -131.5 110.08 10.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.172 -1.193 . . . . 0.0 110.916 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.15 -175.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.738 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -127.33 164.3 22.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.889 -1.132 . . . . 0.0 109.656 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.701 ' O ' HG22 ' A' ' 104' ' ' VAL . 21.1 t-105 -51.46 -71.04 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.579 -0.7 . . . . 0.0 111.152 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 3.9 tp10 -48.79 -51.12 30.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.693 -1.255 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.41 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.1 mt-30 -49.18 -44.48 42.98 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.885 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.48 -25.09 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.518 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 120' ' ' LEU . 18.2 mt -66.87 -71.8 0.19 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.478 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 46.7 mt-10 -43.81 -43.08 6.0 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.922 -1.111 . . . . 0.0 108.465 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' A' ' 77' ' ' LEU . 57.9 mt -62.76 -30.71 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.433 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.803 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.63 -25.78 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.497 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 105' ' ' LEU . 8.4 mtpt -59.28 -73.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.919 -1.113 . . . . 0.0 108.362 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 109' ' ' LYS . 1.9 tp60 -45.35 -28.41 0.85 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.092 -1.005 . . . . 0.0 108.922 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.451 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 12.0 tttm -69.09 -19.28 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.863 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.694 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -129.65 68.9 81.13 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.092 -1.005 . . . . 0.0 109.884 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 -34.18 27.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.495 1.463 . . . . 0.0 112.072 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 3.5 t70 175.02 12.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.0 mm? -50.43 -77.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -149.83 -24.97 0.27 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.058 HG22 ' H ' ' A' ' 118' ' ' THR . 23.6 m -64.57 -164.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 0.0 109.579 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.058 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.61 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.251 -0.905 . . . . 0.0 109.935 -179.206 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 118' ' ' THR . 1.3 m-20 -61.09 141.09 57.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.95 -22.72 65.87 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.243 1.021 . . . . 0.0 109.011 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.93 -38.41 90.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.526 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.47 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -68.92 -74.92 0.12 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.944 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.576 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.56 -43.08 7.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.46 -1.4 . . . . 0.0 109.28 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.12 -69.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 108.608 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HG3' HH11 ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.58 -41.81 4.76 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.709 ' O ' ' N ' ' A' ' 130' ' ' SER . 12.0 ttm -52.32 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.187 -0.946 . . . . 0.0 108.643 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.803 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 20.5 mm -48.03 -64.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.424 -0.798 . . . . 0.0 109.848 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.885 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.23 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -41.75 4.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.6 m -54.91 -48.6 72.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.536 -1.567 . . . . 0.0 107.699 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -50.01 -47.71 52.92 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.672 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -45.68 -53.5 9.25 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.631 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.4 t -44.89 -67.59 0.27 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.649 ' SD ' HG23 ' A' ' 136' ' ' VAL . 10.7 ttm -49.42 -3.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 89.64 -27.26 8.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.649 HG23 ' SD ' ' A' ' 134' ' ' MET . 52.7 t -48.17 165.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.847 -0.796 . . . . 0.0 109.208 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.583 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -142.52 162.62 35.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.711 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.2 164.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.897 ' O ' HG13 ' A' ' 139' ' ' VAL . 1.3 p -134.19 58.01 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 165.58 -115.73 0.65 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.511 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.7 60.17 12.93 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.237 -1.155 . . . . 0.0 109.173 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.56 ' O ' ' CG ' ' A' ' 143' ' ' GLU . 2.1 Cg_endo -61.26 165.81 12.14 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.838 1.692 . . . . 0.0 112.773 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.56 ' CG ' ' O ' ' A' ' 142' ' ' PRO . 27.1 mt-10 -165.72 98.82 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.857 . . . . 0.0 109.233 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.3 m -127.05 -174.41 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.737 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' CG ' ' N ' ' A' ' 146' ' ' ASP . 12.5 ttpt -175.61 159.81 2.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.355 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.684 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 21.5 m-20 -131.47 -85.05 0.5 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -175.63 96.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.94 . . . . 0.0 109.588 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 4' ' ' VAL . 1.2 mppt? -141.72 115.49 9.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.599 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.758 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p -44.84 133.13 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.078 -1.014 . . . . 0.0 109.187 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.812 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -117.79 -24.59 3.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.261 -0.9 . . . . 0.0 109.224 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.24 111.22 6.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.385 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -100.37 73.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.779 ' HB ' HD12 ' A' ' 57' ' ' ILE . 6.1 t -49.12 88.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.611 -1.305 . . . . 0.0 110.715 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? -82.04 37.24 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.843 0.83 . . . . 0.0 109.054 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.855 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.4 mp -76.8 -174.2 2.95 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.817 0.818 . . . . 0.0 111.137 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.626 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -125.87 175.34 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.66 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -169.81 158.46 6.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.886 -1.134 . . . . 0.0 109.993 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.674 ' O ' ' N ' ' A' ' 15' ' ' GLY . 11.5 Cg_endo -68.01 104.95 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.935 1.757 . . . . 0.0 111.417 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.812 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -60.94 38.72 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.144 -1.023 . . . . 0.0 110.34 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.5 -18.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.526 -1.797 . . . . 0.0 111.3 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -148.38 78.99 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.507 -1.584 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.733 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -94.24 170.25 9.64 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.36 164.52 3.94 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.773 -1.204 . . . . 0.0 110.487 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.4 Cg_exo -51.97 32.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.048 1.832 . . . . 0.0 112.066 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.778 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -138.2 53.93 6.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 0.0 110.415 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.717 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.5 Cg_endo -86.36 162.39 9.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.83 1.687 . . . . 0.0 111.712 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.56 -4.89 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 121.079 1.186 . . . . 0.0 111.34 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.813 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 21.5 t -118.71 -66.51 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 56.44 -97.16 0.05 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.813 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 4.7 Cg_exo -53.96 -55.1 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 CA-C-N 117.816 0.808 . . . . 0.0 110.585 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.797 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -64.96 5.5 0.33 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.544 -0.723 . . . . 0.0 111.182 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.744 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -109.64 -65.17 1.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.668 -1.27 . . . . 0.0 109.855 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.69 -16.33 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' LEU . 83.5 mt-30 -41.98 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.45 -1.618 . . . . 0.0 109.571 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -64.67 -45.37 87.0 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.678 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.92 -3.53 0.04 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 69.76 76.64 0.21 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 122.187 -0.596 . . . . 0.0 111.756 177.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 34' ' ' ILE . 1.1 m120 -152.41 63.61 0.82 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.291 1.043 . . . . 0.0 108.416 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 37' ' ' PHE . 26.7 mm -43.01 -66.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.651 ' O ' ' CG ' ' A' ' 39' ' ' LYS . 4.3 tpt -41.43 -37.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.695 -1.253 . . . . 0.0 108.67 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.13 -49.13 75.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.711 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -50.38 -66.37 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.842 1.306 . . . . 0.0 109.252 177.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 17' ' ' ALA . 24.4 t -64.11 -37.65 80.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.604 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CG ' ' O ' ' A' ' 35' ' ' MET . 5.8 mmmt -47.95 -59.93 2.98 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.82 72.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.364 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 45' ' ' THR . 2.6 t80 -69.6 -77.42 0.08 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 5.0 m-20 -41.6 -34.86 0.64 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.398 1.094 . . . . 0.0 110.872 -177.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -65.82 -34.15 77.49 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.497 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.599 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.29 -53.72 4.33 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.393 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 21.4 p -52.47 -27.54 16.63 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.65 -46.06 13.73 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.677 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -54.67 -21.22 10.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.692 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.03 -85.2 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.692 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.32 -137.67 2.29 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.977 -1.583 . . . . 0.0 110.909 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.512 ' O ' ' CG ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -119.95 118.35 30.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.13 . . . . 0.0 109.971 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.812 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -153.74 -153.13 0.45 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.602 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.8 mm -146.67 141.8 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 14' ' ' ALA . 2.2 t -145.66 138.62 14.07 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.1 Cg_endo -73.93 91.0 0.93 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.85 1.7 . . . . 0.0 111.519 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.855 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.3 m -56.46 137.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.751 -1.218 . . . . 0.0 111.229 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.6 tt0 -129.24 70.81 1.41 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.779 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.7 mt -71.33 89.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 0.0 110.307 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.39 104.02 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 64' ' ' SER . 41.2 mt -107.64 144.44 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.509 -0.745 . . . . 0.0 110.867 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.758 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.5 m-85 -115.03 139.47 49.84 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.812 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.51 -32.89 5.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.24 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -51.07 -2.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.792 ' H ' ' C ' ' A' ' 61' ' ' ALA . 4.6 mtt180 75.24 70.1 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.913 0.863 . . . . 0.0 109.843 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 2.5 t -150.7 125.13 9.53 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.631 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 33.2 p90 -102.14 103.87 14.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -100.74 121.05 41.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.985 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.937 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.45 148.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 111.231 177.564 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 67' ' ' PHE . 28.0 t -169.3 88.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.489 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -94.74 145.07 25.12 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.8 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -129.53 118.56 22.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 0.0 110.213 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 1.018 HG21 ' NE ' ' A' ' 79' ' ' ARG . 23.0 p 75.96 150.02 0.13 Allowed Pre-proline 0 N--CA 1.493 1.689 0 CA-C-O 121.231 0.539 . . . . 0.0 110.025 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -40.16 175.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.682 2.255 . . . . 0.0 113.113 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.4 Cg_exo -39.55 171.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.52 1.48 . . . . 0.0 111.913 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.883 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.49 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.778 ' N ' ' O ' ' A' ' 73' ' ' PRO . 17.7 p -43.64 -27.75 0.33 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.043 ' CE1' HD12 ' A' ' 77' ' ' LEU . 8.0 p90 -43.55 -38.11 2.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.182 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -135.27 -11.39 2.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.182 ' N ' HD13 ' A' ' 77' ' ' LEU . 2.0 mt -66.32 -29.85 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 1.018 ' NE ' HG21 ' A' ' 71' ' ' THR . 7.3 mmm180 -55.73 -40.12 72.06 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.565 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.6 tmtt? -70.78 -67.95 0.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.405 ' N ' ' HD3' ' A' ' 80' ' ' LYS . . . -53.82 -4.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.277 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.713 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.61 -78.21 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.712 . . . . 0.0 112.155 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.22 55.71 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.873 -1.632 . . . . 0.0 110.811 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.707 ' CD1' ' CZ ' ' A' ' 79' ' ' ARG . 9.0 mt -97.78 104.63 16.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.05 -1.265 . . . . 0.0 109.097 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 0.4 OUTLIER 174.74 -75.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' NZ ' ' CD ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER 75.05 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.87 -100.06 2.52 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -171.7 136.31 0.93 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -1.155 . . . . 0.0 109.539 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -177.28 -69.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.461 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -68.91 160.55 77.45 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.891 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.451 ' HG2' ' NH2' ' A' ' 93' ' ' ARG . 5.1 Cg_exo -57.45 -18.61 32.37 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.529 1.486 . . . . 0.0 112.418 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 152.38 -173.63 31.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.536 ' O ' ' CD ' ' A' ' 94' ' ' GLU . 16.9 mtm180 60.2 115.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -1.106 . . . . 0.0 109.486 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.536 ' CD ' ' O ' ' A' ' 93' ' ' ARG . 13.4 mm-40 -145.26 -168.2 2.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.608 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' C ' HG23 ' A' ' 96' ' ' VAL . 40.2 mttp -143.35 -174.66 4.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 97' ' ' GLY . 24.6 t -153.08 164.46 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.913 . . . . 0.0 109.606 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.814 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 65.15 73.44 0.59 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.821 ' HG3' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.34 105.31 6.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.128 -1.219 . . . . 0.0 110.979 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.669 HD12 ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -105.72 -167.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.027 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.761 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -137.7 159.61 41.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 108.88 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.685 ' O ' HG22 ' A' ' 104' ' ' VAL . 17.8 t-105 -47.6 -71.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 110.801 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.465 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.6 tp10 -50.77 -49.21 58.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.526 -1.359 . . . . 0.0 110.895 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.603 ' O ' ' CG1' ' A' ' 107' ' ' ILE . 4.2 mt-30 -51.11 -43.7 61.16 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 110.23 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 100' ' ' THR . 2.4 m -70.9 -25.3 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.521 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 120' ' ' LEU . 18.1 mt -65.7 -71.54 0.19 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -44.41 -42.36 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.854 -1.154 . . . . 0.0 108.185 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.093 ' CD1' HD21 ' A' ' 77' ' ' LEU . 1.8 mm -60.85 -33.28 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.82 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -98.88 -23.14 15.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.439 -0.788 . . . . 0.0 109.335 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.673 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.6 mttt -57.03 -72.34 0.08 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -48.75 -34.06 11.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.592 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 112' ' ' MET . 1.2 mptp? -80.06 64.43 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.222 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.584 ' HA ' HD11 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 175.02 55.54 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 0.0 109.217 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.553 ' HD3' ' H ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.38 -55.05 1.05 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.545 1.497 . . . . 0.0 112.346 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 115' ' ' LEU . 1.5 m-20 -163.53 11.46 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 1.077 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.79 -85.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.613 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -155.43 10.68 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.398 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.0 HG22 ' H ' ' A' ' 118' ' ' THR . 41.6 m -104.34 -164.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.0 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 179.25 -55.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.199 -0.938 . . . . 0.0 110.007 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.491 ' H ' HG23 ' A' ' 118' ' ' THR . 3.7 m-20 -74.76 142.92 44.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.342 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -58.77 -33.15 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.221 1.01 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -60.46 -37.63 81.61 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.045 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.06 -72.72 0.2 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.872 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.493 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -46.16 -37.93 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.523 -1.361 . . . . 0.0 109.089 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -56.0 -71.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.042 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 129' ' ' GLY . 47.6 ttt180 -43.32 -34.83 1.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' SER . 15.1 ttm -56.2 -76.88 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.82 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 17.4 mm -48.37 -63.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.772 . . . . 0.0 109.785 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.57 -71.73 0.12 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.78 -42.66 4.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 126' ' ' MET . 57.9 m -55.49 -50.27 70.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.591 -1.535 . . . . 0.0 107.5 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.819 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.66 -48.72 28.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.2 tmt_? -44.82 -54.9 5.87 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.661 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -46.71 -69.26 0.14 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.606 ' HG2' HG23 ' A' ' 136' ' ' VAL . 7.6 ttp -45.07 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.622 -0.674 . . . . 0.0 110.639 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.06 8.62 75.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.819 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.2 t -88.5 165.31 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.3 tp10 -142.78 163.02 33.95 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.137 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.67 153.42 4.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 99' ' ' ILE . 1.3 p -118.2 -8.31 11.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.252 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -122.17 -115.94 2.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.472 ' N ' ' HB2' ' A' ' 101' ' ' TRP . . . 44.84 62.4 10.36 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.16 -1.2 . . . . 0.0 109.384 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.7 Cg_endo -60.73 177.81 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 121.688 1.592 . . . . 0.0 112.551 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -112.97 144.46 42.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 109.405 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.54 165.18 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.479 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -162.31 -14.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 109.531 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -70.81 119.3 14.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.483 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 147.48 50.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.464 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.741 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER 174.88 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.491 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p -82.03 156.67 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.24 -0.912 . . . . 0.0 108.911 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.028 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -119.97 -24.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.063 -1.023 . . . . 0.0 109.621 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -154.32 101.31 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.316 -1.353 . . . . 0.0 110.635 178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -92.36 73.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.773 ' HB ' HD12 ' A' ' 57' ' ' ILE . 24.4 t -45.53 88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.215 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.657 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -84.29 34.44 0.52 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.923 0.868 . . . . 0.0 109.019 179.387 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.908 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.52 -174.72 3.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.948 0.88 . . . . 0.0 111.381 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.561 ' O ' HD12 ' A' ' 12' ' ' LEU . 1.4 pm0 -117.19 169.41 9.48 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -163.0 144.59 7.75 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 120.544 -1.347 . . . . 0.0 110.16 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.64 ' HA ' HD13 ' A' ' 52' ' ' ILE . 36.5 Cg_endo -80.5 127.91 6.73 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.426 2.084 . . . . 0.0 113.97 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.084 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.83 141.34 47.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.713 ' C ' ' H ' ' A' ' 17' ' ' ALA . . . 61.41 -60.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 mtpp -60.46 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.801 -0.823 . . . . 0.0 108.884 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.713 ' H ' ' C ' ' A' ' 15' ' ' GLY . . . -114.4 151.42 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.73 165.93 6.87 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 -178.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.9 Cg_exo -49.38 36.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.723 1.615 . . . . 0.0 111.749 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.896 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -164.34 55.03 0.42 Allowed Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.631 -0.668 . . . . 0.0 109.819 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.679 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.0 Cg_endo -77.36 169.95 20.3 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.529 1.486 . . . . 0.0 111.801 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.02 -4.59 3.89 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 121.134 1.223 . . . . 0.0 110.971 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.908 HG22 ' CD2' ' A' ' 10' ' ' LEU . 2.2 t -105.08 -71.54 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.598 0.713 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.92 -98.41 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.5 Cg_endo -59.98 -55.41 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.972 0.886 . . . . 0.0 109.97 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.596 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.31 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.471 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.921 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -112.39 -42.49 3.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.608 -1.307 . . . . 0.0 108.703 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.5 85.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 27' ' ' LEU . 8.0 mm-40 -150.64 -13.82 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -1.102 . . . . 0.0 108.06 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.811 ' CE1' ' CE1' ' A' ' 65' ' ' PHE . 1.3 p80 -86.21 -37.21 18.89 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -171.87 -1.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.0 80.62 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 111.971 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -156.7 121.7 4.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.505 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.5 mm -97.9 -64.83 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.646 . . . . 0.0 110.0 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.689 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.97 -57.05 2.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.59 -1.319 . . . . 0.0 109.424 -177.113 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' MET . 3.7 mp0 -46.54 -51.08 16.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.99 -1.069 . . . . 0.0 108.195 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.921 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -48.15 -59.94 3.02 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.46 1.124 . . . . 0.0 109.623 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 42' ' ' ASN . 50.6 t -73.72 -30.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.95 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.1 tttp -50.09 -62.01 1.82 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.62 -33.89 73.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.469 -0.769 . . . . 0.0 108.94 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 44' ' ' ALA . 2.1 t80 -70.73 -77.03 0.09 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -41.29 -34.21 0.47 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.42 1.105 . . . . 0.0 110.692 -177.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.1 -34.01 75.58 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.963 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.75 -45.55 8.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.695 ' CB ' ' H ' ' A' ' 15' ' ' GLY . 19.0 p -58.67 -29.31 66.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -80.0 -46.5 16.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.587 ' OD1' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -55.96 -23.18 30.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.762 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.83 -74.93 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.394 -0.816 . . . . 0.0 109.407 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.762 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 168.31 150.75 6.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.289 -1.434 . . . . 0.0 111.088 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.1 m-20 -44.8 148.76 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.015 -1.285 . . . . 0.0 109.497 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.084 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 175.8 -154.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.986 -1.071 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.5 mm -146.98 141.07 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 71' ' ' THR . 2.7 t -144.32 135.59 12.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.744 -1.223 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.622 ' O ' HG21 ' A' ' 69' ' ' THR . 8.4 Cg_endo -70.96 99.82 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.624 1.55 . . . . 0.0 110.465 177.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.763 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.0 m -79.16 137.01 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 122.782 1.277 . . . . 0.0 112.262 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -128.25 61.32 1.46 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.172 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.773 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -61.57 86.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.646 0.736 . . . . 0.0 109.735 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.41 ' HB ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -60.59 95.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.562 HG13 HG22 ' A' ' 57' ' ' ILE . 46.2 mt -95.75 136.53 26.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.566 -0.708 . . . . 0.0 110.237 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.741 ' CE2' ' O ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -110.45 138.66 46.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 1.028 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.68 -29.43 4.4 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.573 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 19.7 t0 -53.93 3.03 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.853 ' H ' ' C ' ' A' ' 61' ' ' ALA . 50.4 mtp180 69.69 70.11 0.24 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.045 0.926 . . . . 0.0 109.624 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 18.2 m -148.25 124.9 11.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.811 ' CE1' ' CE1' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -101.5 104.13 15.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 0.0 110.204 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.41 ' OG1' ' HB ' ' A' ' 58' ' ' THR . 21.9 p -98.3 124.58 43.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.594 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -109.4 174.02 6.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.526 -1.359 . . . . 0.0 109.349 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.004 HG12 ' O ' ' A' ' 68' ' ' VAL . 97.1 t -163.11 44.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.674 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.622 HG21 ' O ' ' A' ' 54' ' ' PRO . 1.2 t -155.19 126.79 7.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 115.594 -2.442 . . . . 0.0 110.276 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.85 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -124.92 128.13 48.15 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.791 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.81 151.59 0.13 Allowed Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.522 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.0 Cg_exo -40.37 175.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.504 2.136 . . . . 0.0 113.063 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.818 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.63 170.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.651 1.567 . . . . 0.0 112.125 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.695 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 49.94 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.818 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -43.55 -20.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.242 179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 11.6 p90 -43.83 -42.22 5.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.65 -0.656 . . . . 0.0 109.322 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.878 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.66 -19.52 2.66 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.878 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.6 mt -59.27 -32.03 47.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.643 ' HB3' HD12 ' A' ' 84' ' ' LEU . 12.7 mmt180 -55.42 -44.12 75.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 82' ' ' ALA . 9.5 tmtt? -66.37 -66.4 0.56 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.667 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.93 -4.84 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.667 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.16 -80.38 0.19 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 111.987 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.451 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 163.2 53.46 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.036 -1.554 . . . . 0.0 110.466 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.643 HD12 ' HB3' ' A' ' 79' ' ' ARG . 5.7 mt -118.56 106.48 12.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.039 -1.271 . . . . 0.0 109.558 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 20.8 tt0 -133.47 -4.33 2.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 2.2 tmtp? 75.14 -80.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.261 -0.899 . . . . 0.0 109.528 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.28 -150.98 21.2 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.05 -85.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -1.172 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -114.48 140.38 48.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -154.18 158.68 32.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.408 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.53 -55.01 2.36 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.621 1.548 . . . . 0.0 112.366 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 178.12 -167.31 37.93 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 18.4 mtp180 60.03 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 86.8 mt-10 -157.09 156.47 32.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' CG ' ' C ' ' A' ' 94' ' ' GLU . 39.1 mttm -151.77 142.43 22.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.284 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.559 HG12 ' CD2' ' A' ' 84' ' ' LEU . 2.4 t -151.64 164.98 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 109.734 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 50.87 61.2 6.29 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.797 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.87 111.84 10.19 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.997 -1.296 . . . . 0.0 110.327 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.25 -177.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.703 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -125.05 159.02 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.925 -1.109 . . . . 0.0 109.351 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.668 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.8 t-105 -49.81 -69.54 0.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.597 -0.69 . . . . 0.0 111.042 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.639 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 9.5 tp10 -50.2 -44.74 53.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.667 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -55.31 -43.76 75.17 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.162 -0.961 . . . . 0.0 110.054 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.23 -24.32 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 117.649 -1.62 . . . . 0.0 107.656 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 120' ' ' LEU . 17.1 mt -66.31 -71.72 0.19 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.639 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 20.5 mm-40 -44.08 -44.5 7.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.909 -1.119 . . . . 0.0 108.44 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.728 ' CD1' HD21 ' A' ' 77' ' ' LEU . 65.4 mt -60.84 -32.55 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 108.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.815 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.98 -26.79 15.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.575 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.5 mttm -58.82 -73.27 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.935 -1.103 . . . . 0.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 109' ' ' LYS . 6.2 tt0 -45.24 -28.46 0.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.431 ' HE3' ' SD ' ' A' ' 126' ' ' MET . 11.6 tttm -69.8 -18.44 63.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.58 68.13 81.15 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.031 -1.043 . . . . 0.0 109.821 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.8 -33.96 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.533 1.488 . . . . 0.0 112.088 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER 174.97 15.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.77 . . . . 0.0 109.087 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.5 mm? -54.21 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.597 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -150.65 -25.03 0.23 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.066 HG22 ' H ' ' A' ' 118' ' ' THR . 23.5 m -64.94 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.066 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.45 -74.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.943 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.523 ' H ' HG23 ' A' ' 118' ' ' THR . 1.2 m-20 -60.68 140.96 57.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 110.051 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.88 -22.65 65.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.214 1.007 . . . . 0.0 108.952 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.12 -38.42 90.6 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.57 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.483 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -68.69 -75.2 0.11 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.231 -1.387 . . . . 0.0 107.921 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.605 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.56 -43.02 7.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.475 -1.39 . . . . 0.0 109.292 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.63 -68.71 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 108.571 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.784 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.57 -42.95 5.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.682 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.21 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 108.562 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.815 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.9 mm -48.57 -65.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.873 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.81 -71.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.72 -39.04 3.36 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.9 m -57.8 -47.51 82.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.467 -1.608 . . . . 0.0 107.564 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.611 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.97 -48.47 52.16 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.649 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.2 tmm_? -46.62 -53.71 10.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.676 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.1 t -44.83 -68.5 0.19 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 75' ' ' SER . 0.0 OUTLIER -47.27 -3.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.91 -23.67 13.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.611 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 47.4 t -53.44 165.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.849 -0.795 . . . . 0.0 109.17 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -142.66 162.58 35.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.025 -1.047 . . . . 0.0 109.723 179.518 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.76 162.25 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.884 ' O ' HG13 ' A' ' 139' ' ' VAL . 4.1 p -128.2 58.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.599 -0.688 . . . . 0.0 109.184 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.47 -108.01 0.34 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 101' ' ' TRP . . . 44.87 62.53 10.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.186 -1.185 . . . . 0.0 109.346 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.1 Cg_endo -64.87 -175.89 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.82 1.68 . . . . 0.0 112.564 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.743 ' O ' HG13 ' A' ' 144' ' ' VAL . 4.5 mt-10 -153.19 129.67 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 109.373 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.743 HG13 ' O ' ' A' ' 143' ' ' GLU . 4.0 m -162.94 166.75 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.59 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 144' ' ' VAL . 32.8 mtpt -161.45 163.57 30.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.666 ' OD1' ' N ' ' A' ' 147' ' ' ALA . 2.7 p30 -176.64 -61.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.52 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.666 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mtt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.52 96.04 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.153 -0.967 . . . . 0.0 109.584 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 4.9 tttp -168.08 115.27 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.533 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.744 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.86 138.01 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -112.82 -24.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.19 107.28 5.73 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.168 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.808 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -94.71 73.62 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 108.94 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.73 ' HB ' HD12 ' A' ' 57' ' ' ILE . 31.7 t -45.96 88.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.192 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.54 34.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.89 0.853 . . . . 0.0 109.076 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.993 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.23 -174.42 3.69 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.787 0.803 . . . . 0.0 111.31 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -119.78 171.84 8.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.781 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -168.3 160.11 9.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.689 -1.257 . . . . 0.0 110.288 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.781 ' HD2' HD23 ' A' ' 12' ' ' LEU . 13.4 Cg_endo -67.74 109.19 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.251 1.967 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.812 ' HB3' ' C ' ' A' ' 51' ' ' ALA . . . -69.45 40.21 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.963 -1.086 . . . . 0.0 110.733 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.52 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 179.31 -18.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 118.277 -1.915 . . . . 0.0 111.792 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' CE ' ' OD1' ' A' ' 50' ' ' ASP . 2.1 mptt -135.82 60.74 1.67 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.405 -1.644 . . . . 0.0 110.452 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.705 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -79.64 158.74 26.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.724 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -161.92 163.31 19.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.688 -1.258 . . . . 0.0 110.494 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.0 Cg_endo -55.47 35.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.936 1.758 . . . . 0.0 111.852 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.724 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -171.17 57.18 0.25 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.41 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.0 Cg_endo -80.5 168.45 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.453 1.435 . . . . 0.0 111.432 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 -4.61 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.126 1.218 . . . . 0.0 111.044 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.993 HG22 HD22 ' A' ' 10' ' ' LEU . 1.9 t -105.48 -72.62 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.604 0.716 . . . . 0.0 110.277 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.55 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.725 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.1 Cg_endo -60.49 -55.51 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 CA-C-N 118.047 0.923 . . . . 0.0 109.854 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.37 -8.6 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.39 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.808 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -111.62 -43.21 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.686 -1.259 . . . . 0.0 108.805 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.26 84.7 0.01 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tp-100 -148.9 -8.4 0.36 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.696 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 8.8 p80 -92.78 -36.55 12.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -171.55 2.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 71.86 75.95 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.661 -0.905 . . . . 0.0 112.058 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -154.05 121.32 5.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 108.797 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.7 mm -97.94 -63.8 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.683 -0.636 . . . . 0.0 109.952 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -42.08 -54.22 3.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.787 -1.195 . . . . 0.0 109.79 -176.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -50.08 -51.25 44.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.948 -1.095 . . . . 0.0 108.601 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.808 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -47.19 -58.89 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.773 1.273 . . . . 0.0 109.566 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 17' ' ' ALA . 82.0 t -71.78 -30.25 37.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.212 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.2 mmtt -53.48 -55.04 28.7 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.22 -34.14 76.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.575 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.4 t80 -68.32 -76.19 0.09 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 19.0 m-20 -41.81 -37.5 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.45 1.119 . . . . 0.0 110.764 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -62.73 -34.56 77.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.327 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.57 -61.59 1.64 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.888 -1.125 . . . . 0.0 108.654 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 24.6 p -44.85 -29.74 0.85 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.29 -43.39 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 44' ' ' ALA . 50.0 t30 -54.49 -24.39 20.28 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.44 -85.22 0.54 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -159.94 -148.98 5.42 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 118.996 -1.573 . . . . 0.0 111.051 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.521 ' OD1' ' CE ' ' A' ' 16' ' ' LYS . 3.5 t70 -113.55 126.02 54.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -1.095 . . . . 0.0 109.687 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.812 ' C ' ' HB3' ' A' ' 14' ' ' ALA . . . -158.92 -152.85 0.34 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 13' ' ' PRO . 5.8 mm -147.0 143.37 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 14' ' ' ALA . 5.2 t -145.72 137.58 13.17 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.2 Cg_endo -73.3 86.06 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.745 1.63 . . . . 0.0 110.601 177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.816 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.7 m -58.01 137.71 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.762 1.267 . . . . 0.0 112.321 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.3 mt-10 -128.78 63.98 1.45 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.73 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.7 mt -64.36 90.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.812 0.815 . . . . 0.0 110.316 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.505 HG22 HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -64.25 98.48 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.55 HG13 HG22 ' A' ' 57' ' ' ILE . 9.8 mt -100.72 142.68 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.561 -0.712 . . . . 0.0 110.375 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.744 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.7 m-85 -114.34 139.93 49.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.838 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.61 -30.0 4.9 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.349 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 8.1 t70 -53.53 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.838 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 70.46 69.04 0.2 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.122 0.963 . . . . 0.0 109.627 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -148.06 125.07 11.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.678 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -101.43 104.02 14.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 110.232 -179.311 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.5 p -99.16 124.67 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.558 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 1.8 p90 -108.52 171.32 7.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.569 -1.332 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.985 HG12 ' O ' ' A' ' 68' ' ' VAL . 88.8 t -162.38 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 112.691 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 69' ' ' THR . 11.2 t -154.93 118.02 4.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.048 -2.282 . . . . 0.0 110.398 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.818 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.51 120.06 38.26 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.141 0.972 . . . . 0.0 108.599 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.877 HG21 ' CD ' ' A' ' 79' ' ' ARG . 16.2 p 76.99 151.45 0.13 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.5 Cg_exo -39.12 175.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.762 2.308 . . . . 0.0 113.351 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.5 Cg_exo -40.99 167.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.652 1.568 . . . . 0.0 111.915 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.0 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.67 -77.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.776 ' N ' ' O ' ' A' ' 73' ' ' PRO . 8.0 t -43.04 -25.05 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.981 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.049 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 17.9 p90 -43.27 -41.72 4.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.485 -0.76 . . . . 0.0 109.111 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.049 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -133.07 -15.48 2.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.0 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.6 mt -60.21 -33.21 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.877 ' CD ' HG21 ' A' ' 71' ' ' THR . 1.5 mtm180 -55.46 -43.37 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -67.15 -66.23 0.58 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.795 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.36 -4.8 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 109.684 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.42 -79.76 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 111.554 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.508 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 154.57 56.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.408 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.508 HD23 ' C ' ' A' ' 83' ' ' GLY . 10.8 mt -112.4 104.78 12.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.252 . . . . 0.0 109.23 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -178.86 -48.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.355 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.442 ' NZ ' ' HA2' ' A' ' 92' ' ' GLY . 13.4 mmtt 62.75 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.479 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.96 -110.19 0.43 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.94 -84.99 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -1.161 . . . . 0.0 109.484 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -154.38 82.89 1.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.913 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -101.87 160.66 25.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.22 -26.32 60.38 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.556 1.504 . . . . 0.0 112.391 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.442 ' HA2' ' NZ ' ' A' ' 86' ' ' LYS . . . 136.49 -115.79 1.34 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? 58.95 58.27 3.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -1.104 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 175.23 169.26 0.31 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.177 -0.952 . . . . 0.0 109.582 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -120.14 -164.95 1.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.479 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 97' ' ' GLY . 41.1 t -149.55 165.04 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.541 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 58.45 66.51 2.75 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.787 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.16 113.11 11.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -1.166 . . . . 0.0 110.008 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.704 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.81 -173.37 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.647 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -127.5 158.04 38.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.401 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.664 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.7 t-105 -49.95 -69.47 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.498 -0.751 . . . . 0.0 110.753 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 4.4 tp10 -49.78 -45.04 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.706 -1.246 . . . . 0.0 110.539 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.795 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -52.71 -46.3 67.28 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.911 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.46 -24.55 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.996 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.951 HD13 HD13 ' A' ' 120' ' ' LEU . 18.3 mt -65.91 -71.37 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.587 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 mm-40 -43.92 -43.31 6.4 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.959 -1.088 . . . . 0.0 108.66 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.76 HG12 HD11 ' A' ' 77' ' ' LEU . 57.6 mt -63.22 -32.3 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 108.817 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.21 -27.1 16.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.332 -0.855 . . . . 0.0 109.376 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 105' ' ' LEU . 15.3 mtpt -59.78 -74.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.594 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . 71.5 mt-30 -45.04 -27.32 0.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.229 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -74.59 -10.41 59.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.927 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.649 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.38 64.03 67.54 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.65 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.5 Cg_endo -66.13 -30.67 46.51 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.647 1.565 . . . . 0.0 112.084 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.539 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 1.7 t70 175.16 10.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.188 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -48.42 -79.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.19 -21.5 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.621 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.049 HG22 ' H ' ' A' ' 118' ' ' THR . 27.4 m -64.69 -164.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.948 . . . . 0.0 109.585 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.049 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.75 -67.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.807 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.529 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -69.57 138.39 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.951 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -58.29 -22.66 53.68 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.204 1.002 . . . . 0.0 108.85 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.16 -35.9 82.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.539 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.596 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.48 -75.84 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.212 -1.395 . . . . 0.0 107.985 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.84 -39.29 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.47 -1.394 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.27 -70.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.794 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.54 -38.96 3.18 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' SER . 10.4 ttm -54.54 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 108.872 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 24.4 mm -46.07 -63.95 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.642 0.734 . . . . 0.0 110.46 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.31 -69.05 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.29 -38.29 2.72 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 126' ' ' MET . 6.0 p -55.31 -53.75 52.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.602 -1.528 . . . . 0.0 107.282 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.81 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -44.84 -50.2 10.43 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.4 tmt_? -44.77 -56.6 4.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 135' ' ' GLY . 11.2 t -46.04 -69.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 136' ' ' VAL . 4.9 ttp -44.89 -5.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.648 -0.657 . . . . 0.0 110.255 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.84 20.06 60.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.81 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.9 t -102.8 165.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.911 -0.758 . . . . 0.0 108.969 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.539 ' N ' HG12 ' A' ' 136' ' ' VAL . 82.8 mt-10 -141.31 162.53 35.26 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.07 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.86 160.98 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.891 ' O ' HG13 ' A' ' 139' ' ' VAL . 5.4 p -122.8 60.6 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 159.3 -113.75 0.58 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.481 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.84 63.03 9.5 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.177 . . . . 0.0 109.361 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.1 Cg_endo -63.89 -165.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.785 1.656 . . . . 0.0 112.697 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' CG ' ' N ' ' A' ' 144' ' ' VAL . 29.2 tt0 -172.45 167.89 5.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.36 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.612 ' N ' ' CG ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -153.93 172.78 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.477 ' CG ' ' N ' ' A' ' 146' ' ' ASP . 51.7 tttp -171.0 161.29 6.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.425 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.477 ' N ' ' CG ' ' A' ' 145' ' ' LYS . 23.9 t70 -174.59 126.6 0.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.49 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -169.33 133.52 1.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.544 ' C ' ' CE1' ' A' ' 60' ' ' TYR . 23.7 ttmt -170.9 130.34 0.8 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.644 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.714 ' N ' ' CZ ' ' A' ' 60' ' ' TYR . 1.7 p -44.72 136.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.274 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 59' ' ' ILE . 27.7 m -120.89 -24.71 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.124 -0.985 . . . . 0.0 110.107 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.684 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -156.51 118.6 3.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.434 -1.416 . . . . 0.0 110.503 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -110.59 73.9 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.786 -0.571 . . . . 0.0 109.612 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.693 ' O ' ' O ' ' A' ' 55' ' ' VAL . 13.9 t -44.89 88.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 0.0 110.158 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.6 tmtt? -84.03 34.66 0.51 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.925 0.869 . . . . 0.0 109.127 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.77 -173.7 3.59 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.652 0.739 . . . . 0.0 111.009 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 5.2 pm0 -125.99 179.02 5.41 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.665 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -165.63 144.77 5.24 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 0.0 108.931 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.804 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 67.4 Cg_endo -83.43 113.15 1.98 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.552 2.168 . . . . 0.0 114.445 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.972 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -63.19 142.93 58.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.497 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 55.19 52.83 44.54 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER 173.88 27.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.55 -0.97 . . . . 0.0 108.711 -178.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 18' ' ' THR . . . -111.83 152.98 27.28 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.913 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.19 165.97 6.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.868 -179.054 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.9 Cg_exo -48.86 34.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.617 1.545 . . . . 0.0 111.627 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.913 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -155.22 54.2 0.96 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.41 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.717 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 17.1 Cg_endo -81.14 167.66 17.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.703 1.602 . . . . 0.0 111.947 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.24 -4.48 3.14 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 121.306 1.337 . . . . 0.0 111.41 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.78 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.7 t -112.92 -71.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.58 -97.97 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.78 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -58.97 -55.13 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 CA-C-N 117.9 0.85 . . . . 0.0 110.354 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.676 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -48.46 -8.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.693 -0.63 . . . . 0.0 110.945 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.698 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -108.61 -48.62 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.643 -1.286 . . . . 0.0 108.8 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.36 98.4 0.02 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.2 tt0 -158.3 -22.64 0.08 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.685 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -81.12 -44.1 18.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.162 179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.688 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -166.73 -10.52 0.03 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.29 84.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 112.494 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.491 ' OD1' ' C ' ' A' ' 32' ' ' ALA . 5.0 m120 -155.16 70.95 0.77 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.863 -1.148 . . . . 0.0 108.916 177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 21.7 mm -44.37 -71.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.224 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.493 ' O ' ' C ' ' A' ' 36' ' ' GLU . 10.1 tpt -41.88 -53.39 3.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.164 . . . . 0.0 109.42 -178.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.3 tp10 -44.88 -49.76 10.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.698 ' CE2' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -51.42 -69.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.973 1.368 . . . . 0.0 109.998 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 42' ' ' ASN . 35.7 t -56.5 -36.06 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.557 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -50.66 -64.08 0.92 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.19 -32.53 64.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.9 t80 -71.3 -76.63 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.392 -1.443 . . . . 0.0 107.116 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.8 m120 -41.16 -28.14 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.792 -1.192 . . . . 0.0 110.436 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -71.35 -34.52 70.58 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.82 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -90.35 -44.62 9.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.733 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.591 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 6.8 p -59.81 -32.09 70.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.15 -44.93 24.6 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.738 HD22 ' HG3' ' A' ' 86' ' ' LYS . 36.7 t-20 -59.33 -21.88 60.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.411 -0.806 . . . . 0.0 108.965 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.658 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.25 -75.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.658 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -178.49 -121.06 0.68 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.035 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.7 OUTLIER -137.76 124.86 21.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -1.129 . . . . 0.0 108.669 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.972 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . 173.86 114.33 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.992 -1.068 . . . . 0.0 110.659 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.804 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -44.97 160.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.495 -1.378 . . . . 0.0 113.014 -178.298 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 12' ' ' LEU . 6.1 t -153.51 135.38 8.98 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.211 -0.931 . . . . 0.0 110.089 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 69' ' ' THR . 6.3 Cg_endo -66.96 108.87 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.722 1.615 . . . . 0.0 112.565 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -87.47 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.553 -1.342 . . . . 0.0 111.273 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.687 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 11.9 mt-10 -128.65 69.21 1.37 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.656 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.9 mt -70.96 88.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.731 0.777 . . . . 0.0 110.33 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -61.97 94.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 25.5 mt -89.29 94.16 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.714 ' CZ ' ' N ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -84.15 179.13 7.56 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.295 1.045 . . . . 0.0 112.234 -176.133 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 1.096 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.95 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.115 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 63' ' ' ARG . 40.2 p30 -46.73 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 109.319 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 1.096 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 43.91 86.23 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -146.23 124.36 12.16 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.82 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.765 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.95 103.06 13.68 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.172 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 22.2 p -101.03 120.62 40.46 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.078 -1.013 . . . . 0.0 109.0 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.954 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.58 148.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.876 -1.14 . . . . 0.0 111.057 177.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.5 t -169.76 95.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.684 HG21 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -104.5 147.36 27.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.756 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.8 mptt -132.75 124.21 27.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.68 -1.263 . . . . 0.0 110.092 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.756 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.9 p 76.08 149.17 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 CA-C-O 121.232 0.539 . . . . 0.0 109.662 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 73' ' ' PRO . 10.7 Cg_exo -42.07 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.513 2.142 . . . . 0.0 112.722 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.716 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.9 Cg_exo -38.44 172.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.518 1.479 . . . . 0.0 111.951 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.606 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.9 -83.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.763 ' HG ' ' HG3' ' A' ' 79' ' ' ARG . 7.9 t -42.77 -23.37 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 110.11 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.982 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 14.8 p90 -43.84 -38.92 3.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.982 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.17 -19.2 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.141 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.952 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.2 mt -56.22 -34.63 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.763 ' HG3' ' HG ' ' A' ' 75' ' ' SER . 13.0 mmt180 -53.08 -49.68 65.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.554 ' CD ' ' C ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -57.81 -63.73 1.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -59.29 -6.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 79' ' ' ARG . . . -84.13 -80.39 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 0.0 111.762 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' C ' ' CG1' ' A' ' 96' ' ' VAL . . . 172.59 -13.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.665 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.763 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -100.66 129.8 46.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.912 -1.346 . . . . 0.0 110.082 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 1.6 tt0 -168.19 77.16 0.14 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.421 -0.799 . . . . 0.0 109.322 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.738 ' HG3' HD22 ' A' ' 47' ' ' ASN . 9.4 tttm 75.03 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.564 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.15 -168.56 15.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.44 -85.05 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -1.124 . . . . 0.0 109.493 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -138.86 145.44 40.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 160.67 42.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 109.422 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.58 -40.76 70.96 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.565 1.51 . . . . 0.0 112.289 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.95 151.96 5.67 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.567 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 43.2 mtt180 62.08 98.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.567 ' OE1' ' O ' ' A' ' 93' ' ' ARG . 2.5 tp10 177.75 150.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.416 ' C ' ' CG2' ' A' ' 96' ' ' VAL . 10.2 mttm -123.7 179.52 4.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.718 HG12 HD23 ' A' ' 84' ' ' LEU . 2.3 t -151.76 165.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.472 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 104.23 56.77 0.73 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.773 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.25 122.03 24.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.206 -1.173 . . . . 0.0 110.283 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.805 HD12 ' CG1' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -109.55 -165.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.742 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.79 156.42 46.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 0.0 109.125 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.735 ' O ' HG22 ' A' ' 104' ' ' VAL . 15.6 t-105 -48.92 -69.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.877 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.484 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.78 -53.98 21.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.565 -1.334 . . . . 0.0 110.972 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 4.2 mt-30 -47.12 -44.87 21.92 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.328 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.77 -26.03 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.431 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 120' ' ' LEU . 16.0 mt -65.95 -70.5 0.24 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' LEU . 36.0 tt0 -43.7 -42.54 5.42 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.916 -1.115 . . . . 0.0 108.337 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.693 HG12 HD11 ' A' ' 77' ' ' LEU . 41.4 mt -63.26 -31.23 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.05 -1.031 . . . . 0.0 108.329 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.93 -26.33 16.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.77 ' HE3' HD11 ' A' ' 120' ' ' LEU . 8.6 mttp -58.3 -73.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 0.0 108.431 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -48.69 -24.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 108.958 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.564 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -72.83 -16.6 61.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.699 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.48 65.71 76.75 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.768 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.66 -32.88 37.2 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.631 1.554 . . . . 0.0 112.11 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.543 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 2.5 t70 174.98 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.23 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.409 ' H ' ' H ' ' A' ' 114' ' ' ASP . 2.8 mm? -51.36 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.58 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -154.42 -24.97 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.655 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.005 HG22 ' H ' ' A' ' 118' ' ' THR . 24.8 m -65.08 -164.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.005 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.44 -73.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.518 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -61.95 142.13 57.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 110.011 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -61.4 -24.86 66.81 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.237 1.018 . . . . 0.0 109.036 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.17 -38.26 90.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.6 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.567 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.11 -74.35 0.13 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.943 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.94 -44.4 9.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.523 -1.36 . . . . 0.0 109.22 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -48.64 -70.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.765 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.37 -39.66 3.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.693 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.9 ttm -53.0 -78.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.191 -0.943 . . . . 0.0 108.605 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.8 mm -48.1 -64.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.66 0.743 . . . . 0.0 110.082 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.826 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.95 -71.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.85 -42.56 4.97 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 126' ' ' MET . 51.8 m -54.0 -42.21 68.79 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.627 -1.514 . . . . 0.0 107.029 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.74 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -54.34 -48.72 71.08 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.763 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -44.9 -48.16 11.23 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 135' ' ' GLY . 6.1 t -53.58 -69.62 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.536 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 7.0 ttm -44.9 -5.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.579 -0.701 . . . . 0.0 109.956 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 84.02 24.96 46.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.74 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.6 t -107.1 165.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.952 -0.734 . . . . 0.0 109.183 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 136' ' ' VAL . 72.8 tt0 -141.82 164.3 30.56 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.067 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.9 t -82.58 146.22 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.706 HG23 ' HD3' ' A' ' 98' ' ' ARG . 4.3 p -101.09 -6.63 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.49 -0.757 . . . . 0.0 109.452 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -122.99 -119.8 2.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.99 63.07 9.56 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.214 -1.168 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.0 OUTLIER -64.53 -165.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.767 1.644 . . . . 0.0 112.48 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.572 ' O ' HG13 ' A' ' 144' ' ' VAL . 96.9 mt-10 -153.26 173.18 15.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.325 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -158.29 -179.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.124 -0.985 . . . . 0.0 109.599 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -173.48 125.84 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' N ' ' HD3' ' A' ' 145' ' ' LYS . 21.8 t70 -145.23 144.94 31.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.471 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.439 179.916 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.58 124.85 6.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.64 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 3.7 tttp -177.73 126.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.594 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -44.67 133.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 108.995 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 60' ' ' TYR . 27.5 m -120.83 -24.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.273 -0.892 . . . . 0.0 110.089 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.704 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -161.01 115.16 2.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.59 -1.319 . . . . 0.0 110.741 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -107.64 74.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.802 ' HB ' HD12 ' A' ' 57' ' ' ILE . 15.1 t -47.84 88.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.663 -1.273 . . . . 0.0 110.538 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.69 36.49 0.55 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.939 0.876 . . . . 0.0 109.158 179.197 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.886 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -78.04 -173.99 3.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 111.374 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 3.3 pm0 -123.09 174.54 7.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.711 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -163.87 147.52 8.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.951 -1.093 . . . . 0.0 109.371 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.664 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 96.7 Cg_endo -86.76 128.84 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.389 2.059 . . . . 0.0 113.266 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.079 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -75.26 142.85 43.28 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.05 63.12 5.31 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.664 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 14.0 tttt 174.09 -25.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.65 151.92 32.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 108.368 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.883 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.64 165.9 9.39 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.8 Cg_exo -50.45 37.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.717 1.611 . . . . 0.0 111.638 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.883 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -167.97 55.01 0.28 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 10.9 Cg_endo -79.03 170.83 17.29 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.617 1.545 . . . . 0.0 111.781 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.17 -4.56 1.67 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.115 1.21 . . . . 0.0 110.94 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.886 HG22 ' CD2' ' A' ' 10' ' ' LEU . 1.9 t -108.18 -72.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.482 0.658 . . . . 0.0 110.096 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.62 -98.17 0.06 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.761 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.8 Cg_endo -59.45 -55.38 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.975 0.888 . . . . 0.0 109.988 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.67 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.51 -12.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.19 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.977 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -114.39 -40.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.775 -1.203 . . . . 0.0 108.239 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.8 92.69 0.01 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.564 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -159.06 -25.9 0.07 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 179.178 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.73 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 4.6 p80 -78.75 61.24 2.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.693 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.685 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 83.91 -9.37 63.17 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.35 84.23 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.153 -1.204 . . . . 0.0 112.104 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -157.38 123.72 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 108.731 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.659 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 mm -99.4 -63.47 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.685 -0.634 . . . . 0.0 109.831 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.66 ' O ' ' N ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -41.02 -52.58 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.755 -1.215 . . . . 0.0 109.662 -176.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.2 mm-40 -49.66 -47.25 50.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.647 -1.283 . . . . 0.0 107.831 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.977 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -52.93 -68.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.517 1.151 . . . . 0.0 109.956 178.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 42' ' ' ASN . 23.6 t -66.08 -37.71 80.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.081 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.66 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.6 mmmt -46.12 -58.57 3.51 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.32 72.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.318 -0.864 . . . . 0.0 108.939 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' THR . 3.6 t80 -71.34 -77.11 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.0 m120 -41.33 -32.1 0.28 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.933 -1.104 . . . . 0.0 110.589 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.93 -33.45 73.75 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.521 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.24 -47.97 7.45 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.559 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 41' ' ' PHE . 2.3 p -57.08 -29.2 63.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.47 -46.57 17.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' OD1' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -57.24 -21.25 32.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.406 -0.809 . . . . 0.0 108.842 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.722 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.08 -74.22 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.443 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.722 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 172.97 -156.52 24.9 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 8.1 t70 -93.16 145.34 24.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.02 -1.282 . . . . 0.0 108.967 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.079 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.25 -153.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.745 -1.222 . . . . 0.0 110.905 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.3 mm -146.37 139.42 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 71' ' ' THR . 2.2 t -140.11 135.29 16.18 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.008 -1.058 . . . . 0.0 110.905 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.3 Cg_endo -71.84 105.66 1.85 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.77 1.647 . . . . 0.0 111.056 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.5 m -80.66 135.61 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.711 -1.243 . . . . 0.0 111.702 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.3 mt-10 -129.29 67.49 1.43 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.802 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -68.79 87.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.707 0.765 . . . . 0.0 110.218 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -61.69 94.68 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 64' ' ' SER . 5.6 mt -88.87 134.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.443 -0.786 . . . . 0.0 109.217 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CE2' ' N ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -122.49 -179.65 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.316 -176.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 1.082 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.82 -85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.224 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' C ' ' A' ' 63' ' ' ARG . 20.9 t0 -46.24 39.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.542 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 1.082 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER 44.03 87.63 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.754 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -143.62 166.37 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.781 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -146.18 103.2 3.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 109.164 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 4.0 p -101.11 120.83 40.79 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.92 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.67 147.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.921 -1.112 . . . . 0.0 110.935 177.464 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.8 t -168.3 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 122.312 1.053 . . . . 0.0 108.208 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -95.06 146.98 23.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.607 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.787 ' NZ ' HG13 ' A' ' 68' ' ' VAL . 2.3 mptt -132.72 127.31 34.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.217 -1.393 . . . . 0.0 110.511 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.768 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.1 p 76.0 149.15 0.12 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-O 121.242 0.544 . . . . 0.0 109.955 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' O ' ' O ' ' A' ' 73' ' ' PRO . 9.2 Cg_exo -42.83 175.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.835 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.75 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -38.66 171.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.639 1.559 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.698 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.33 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.75 ' N ' ' O ' ' A' ' 73' ' ' PRO . 24.8 p -43.02 -22.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.887 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.003 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 15.6 p90 -43.77 -40.54 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.559 -0.713 . . . . 0.0 109.168 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.003 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -134.59 -16.63 2.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.077 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.885 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.3 mt -59.28 -33.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.629 ' HG3' HG21 ' A' ' 71' ' ' THR . 16.3 mmt180 -55.78 -42.71 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.9 tmtt? -65.87 -66.06 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.37 -6.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.426 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.24 -80.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.494 -0.754 . . . . 0.0 111.857 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 173.6 35.0 0.04 OUTLIER Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.45 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.509 HD11 HH11 ' A' ' 79' ' ' ARG . 3.2 mt -92.92 109.42 20.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.96 -1.318 . . . . 0.0 109.148 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -148.69 -59.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.573 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt 67.74 -82.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.52 -170.4 25.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.15 -85.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -1.184 . . . . 0.0 109.45 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -116.54 107.29 14.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.403 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -144.39 154.58 57.09 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.399 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.22 -42.07 72.25 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.554 1.503 . . . . 0.0 112.416 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 135.36 -138.37 9.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 64.53 93.45 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -1.157 . . . . 0.0 109.475 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 175.17 172.32 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -134.97 -173.07 3.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.48 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 t -152.35 139.45 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.545 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.449 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 67.82 44.78 78.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.792 ' CG ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.82 115.16 14.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -1.228 . . . . 0.0 110.216 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -108.51 178.2 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.787 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -122.66 161.96 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.057 . . . . 0.0 109.366 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.713 ' O ' HG22 ' A' ' 104' ' ' VAL . 16.0 t-105 -48.57 -70.88 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 111.33 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.539 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 3.8 tp10 -49.31 -51.59 33.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 110.934 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.407 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.2 mt-30 -48.57 -44.6 36.87 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.343 -0.848 . . . . 0.0 110.295 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.57 -25.58 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 117.726 -1.59 . . . . 0.0 107.634 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.749 HD13 HD13 ' A' ' 120' ' ' LEU . 16.1 mt -65.85 -71.56 0.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.539 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 23.8 mm-40 -44.18 -42.37 6.39 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 77' ' ' LEU . 67.0 mt -65.28 -31.49 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 108.999 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.814 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.31 -31.0 13.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.617 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.691 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.1 mtpm? -54.45 -72.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.966 -1.084 . . . . 0.0 108.625 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -51.23 -27.68 9.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' MET . 10.2 tttm -84.62 64.47 8.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.784 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.566 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER 175.99 56.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.843 . . . . 0.0 109.306 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.6 Cg_endo -64.78 -55.06 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.528 1.486 . . . . 0.0 112.231 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 1.7 p-10 -162.56 9.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.164 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.8 mm? -44.97 -62.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -177.75 6.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.04 HG22 ' H ' ' A' ' 118' ' ' THR . 32.0 m -108.88 -164.48 0.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.943 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.04 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 175.97 -44.39 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.3 -0.875 . . . . 0.0 109.708 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.711 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -74.74 143.88 43.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.472 -0.767 . . . . 0.0 110.359 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.749 HD13 HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -65.29 -36.78 85.14 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.385 1.088 . . . . 0.0 108.514 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -61.94 -33.92 75.15 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.932 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.39 -75.4 0.14 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.456 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.92 -40.12 6.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.477 -1.389 . . . . 0.0 109.093 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -52.89 -69.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.661 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.35 -38.62 2.77 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.0 ttm -53.28 -78.04 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.814 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.6 mm -48.76 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.768 0.794 . . . . 0.0 109.832 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.95 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -40.24 3.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.7 m -57.57 -50.25 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.566 -1.549 . . . . 0.0 107.532 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.654 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.39 -49.05 25.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.79 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.14 -54.6 8.34 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.663 ' O ' ' N ' ' A' ' 135' ' ' GLY . 6.9 t -44.88 -68.69 0.18 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.682 ' HG2' HG23 ' A' ' 136' ' ' VAL . 5.5 ttp -47.23 -4.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.637 -0.664 . . . . 0.0 109.271 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.71 -27.61 7.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.682 HG23 ' HG2' ' A' ' 134' ' ' MET . 43.0 t -48.6 165.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.919 -0.754 . . . . 0.0 109.183 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.565 ' N ' HG12 ' A' ' 136' ' ' VAL . 63.2 mm-40 -142.38 162.01 36.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.756 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.95 161.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.903 ' O ' HG13 ' A' ' 139' ' ' VAL . 4.1 p -128.26 59.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 161.83 -117.13 0.75 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.517 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.86 61.14 12.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.226 -1.161 . . . . 0.0 109.305 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.5 Cg_endo -65.18 -165.11 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.836 1.691 . . . . 0.0 112.688 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -146.04 -164.97 2.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 109.354 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.71 173.02 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -177.33 -12.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.155 -0.966 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 147' ' ' ALA . 25.1 t70 -45.08 144.98 1.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.495 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -116.01 120.11 38.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.399 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' C ' ' CE2' ' A' ' 60' ' ' TYR . 1.9 tttt 175.93 116.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.622 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.789 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.88 140.15 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.102 -0.999 . . . . 0.0 109.152 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.937 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.7 m -117.17 -24.41 3.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.157 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.16 107.04 4.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.689 -1.257 . . . . 0.0 110.351 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -96.31 73.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.748 ' HB ' HD12 ' A' ' 57' ' ' ILE . 31.2 t -46.47 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.8 -1.188 . . . . 0.0 110.461 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.9 OUTLIER -82.93 34.75 0.46 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.844 0.831 . . . . 0.0 108.999 179.111 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.983 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.11 -174.46 3.65 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.804 0.811 . . . . 0.0 111.147 -178.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 2.3 pm0 -119.69 172.15 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.774 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -168.42 160.06 8.82 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.787 -1.196 . . . . 0.0 110.232 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.774 ' HD2' HD23 ' A' ' 12' ' ' LEU . 15.1 Cg_endo -67.91 109.91 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.249 1.966 . . . . 0.0 111.635 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.804 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -69.01 41.03 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.89 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 177.08 -16.52 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.3 -1.905 . . . . 0.0 111.831 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -135.41 53.92 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.427 -1.631 . . . . 0.0 110.502 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.716 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -73.13 157.9 36.35 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -159.85 162.96 23.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.617 -1.302 . . . . 0.0 110.726 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.0 Cg_endo -56.02 36.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.973 1.782 . . . . 0.0 111.993 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -175.93 58.57 0.18 Allowed Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.34 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.1 Cg_endo -80.68 169.5 16.7 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.568 1.512 . . . . 0.0 111.394 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.88 -4.66 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 121.007 1.138 . . . . 0.0 110.965 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.983 HG22 HD22 ' A' ' 10' ' ' LEU . 2.1 t -104.94 -71.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.6 0.714 . . . . 0.0 109.964 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.69 -98.12 0.05 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.62 -55.38 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 CA-C-N 117.926 0.863 . . . . 0.0 109.867 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.645 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -43.85 -11.41 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.15 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.87 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -116.02 -39.15 3.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.822 -1.174 . . . . 0.0 108.427 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.33 94.1 0.01 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.524 ' O ' ' CD ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -161.52 -23.28 0.05 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.677 ' O ' ' CD2' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -81.14 64.93 6.08 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 80.44 -5.51 63.82 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.29 80.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 111.828 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.54 ' O ' ' NE2' ' A' ' 30' ' ' HIS . 42.9 m-80 -155.95 125.01 6.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.879 -1.138 . . . . 0.0 108.657 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.5 mm -101.16 -62.9 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.686 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.87 -49.77 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.819 -1.176 . . . . 0.0 109.861 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -52.37 -50.54 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.854 -1.154 . . . . 0.0 108.181 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.87 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -48.85 -61.15 2.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.606 1.194 . . . . 0.0 109.076 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.716 HG13 ' CB ' ' A' ' 17' ' ' ALA . 98.6 t -70.52 -29.15 37.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.848 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.686 ' N ' ' O ' ' A' ' 35' ' ' MET . 40.3 tptt -54.44 -55.38 29.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.58 75.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.378 -0.826 . . . . 0.0 109.532 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.3 t80 -68.97 -76.36 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 23.6 m-20 -41.79 -37.19 1.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.455 1.121 . . . . 0.0 110.804 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -63.29 -35.02 78.97 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.355 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.05 -61.54 1.66 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.545 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.3 p -44.8 -30.08 0.9 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.36 -43.21 19.36 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 44' ' ' ALA . 16.3 t-20 -55.3 -24.04 26.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.647 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.09 -85.25 0.54 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.851 -1.156 . . . . 0.0 109.934 179.483 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -161.83 -150.43 5.95 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.121 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.2 123.09 49.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.721 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.804 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -155.39 -152.87 0.41 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 13' ' ' PRO . 5.8 mm -147.19 143.89 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 14' ' ' ALA . 5.6 t -146.94 137.46 12.46 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 110.299 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.9 Cg_endo -73.03 87.24 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.842 1.694 . . . . 0.0 110.776 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.828 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.5 m -58.46 137.42 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.827 1.298 . . . . 0.0 112.231 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 32.6 mt-10 -128.09 63.61 1.4 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.748 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -63.38 88.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.66 0.743 . . . . 0.0 110.174 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.485 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.57 97.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 57' ' ' ILE . 1.9 mt -100.66 146.11 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.17 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.789 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 9.6 m-85 -115.52 141.17 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.937 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.56 -30.37 5.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.153 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 7.2 t70 -52.51 1.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.842 ' H ' ' C ' ' A' ' 61' ' ' ALA . 8.8 tmm_? 71.68 69.8 0.16 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.06 0.933 . . . . 0.0 109.642 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -148.59 125.04 10.97 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.594 ' CD1' ' ND1' ' A' ' 30' ' ' HIS . 17.4 p90 -101.04 103.86 14.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.954 -1.091 . . . . 0.0 110.187 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 58' ' ' THR . 11.2 p -99.43 124.82 44.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 108.854 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.566 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -107.97 171.35 7.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.596 -1.315 . . . . 0.0 109.368 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.994 HG12 ' O ' ' A' ' 68' ' ' VAL . 90.3 t -163.17 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 112.644 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.519 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.0 t -154.02 118.54 4.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 115.945 -2.302 . . . . 0.0 110.754 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.812 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.92 121.43 42.3 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.76 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.6 p 76.86 151.06 0.13 Allowed Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 71' ' ' THR . 12.6 Cg_exo -40.21 175.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.551 2.167 . . . . 0.0 113.038 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.6 Cg_exo -40.51 169.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.6 1.534 . . . . 0.0 112.004 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.934 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.93 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.787 ' N ' ' O ' ' A' ' 73' ' ' PRO . 8.6 t -43.34 -23.62 0.07 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 110.147 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.07 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 20.5 p90 -43.6 -42.09 4.95 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.0 109.41 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.07 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.27 -14.58 2.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.934 HD12 ' HB1' ' A' ' 74' ' ' ALA . 3.1 mt -61.75 -31.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.768 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 2.1 mmp_? -54.82 -44.27 73.71 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HZ3' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -66.03 -65.59 0.66 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.445 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -57.22 -4.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.634 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.55 -79.72 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 112.156 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.417 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 163.64 47.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.682 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 84' ' ' LEU . 5.4 mt -97.44 105.4 17.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.003 -1.292 . . . . 0.0 109.195 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 84' ' ' LEU . 89.4 mt-10 -156.14 -25.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.571 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.2 mttt 64.26 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.0 -175.17 23.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.98 -85.07 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -1.161 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -93.0 118.1 30.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.7 151.17 65.44 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.436 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.61 -52.93 5.9 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.491 1.461 . . . . 0.0 112.412 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.94 -164.99 32.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 61.84 152.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.119 . . . . 0.0 109.527 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 1.8 tp10 -171.24 128.78 0.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.468 ' C ' HG23 ' A' ' 96' ' ' VAL . 42.1 mttm -156.65 167.86 29.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 109.321 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.468 HG23 ' C ' ' A' ' 95' ' ' LYS . 72.2 t -156.39 156.57 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 109.653 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 69.48 60.36 5.12 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.634 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.3 mtt180 -134.7 113.54 11.78 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -1.21 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.702 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.21 179.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.727 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -124.44 155.43 38.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.024 -1.048 . . . . 0.0 109.198 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.715 ' O ' HG22 ' A' ' 104' ' ' VAL . 12.0 t-105 -44.97 -70.25 0.11 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 111.244 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.511 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.32 -52.98 24.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.69 -1.257 . . . . 0.0 111.047 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.3 mt-30 -47.76 -44.6 28.31 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.272 -0.892 . . . . 0.0 110.429 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.9 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.5 -25.33 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 117.681 -1.608 . . . . 0.0 107.585 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 120' ' ' LEU . 16.8 mt -66.16 -70.86 0.22 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' LEU . 78.2 tt0 -43.85 -43.66 6.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.911 -1.118 . . . . 0.0 108.34 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 77' ' ' LEU . 46.9 mt -61.83 -31.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.812 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.19 -27.42 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.783 ' HE3' HD11 ' A' ' 120' ' ' LEU . 13.9 mttp -58.44 -73.44 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.763 -1.21 . . . . 0.0 108.304 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.604 ' CD ' ' N ' ' A' ' 110' ' ' GLN . 1.5 mp0 -44.93 -26.43 0.42 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.041 -1.037 . . . . 0.0 108.794 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 109' ' ' LYS . 13.4 tttt -73.19 -16.96 61.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.68 65.9 76.88 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.039 -1.038 . . . . 0.0 109.746 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.68 -34.76 30.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.704 1.602 . . . . 0.0 112.069 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER 175.0 15.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 109.163 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.403 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.3 mm? -55.49 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 0.0 109.553 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -150.66 -24.99 0.23 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.053 HG22 ' H ' ' A' ' 118' ' ' THR . 23.5 m -62.97 -164.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.053 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.34 -74.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.267 -0.895 . . . . 0.0 109.933 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.524 ' H ' HG23 ' A' ' 118' ' ' THR . 1.9 m-20 -61.78 140.44 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.183 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -62.36 -22.34 66.03 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.204 1.002 . . . . 0.0 108.899 179.492 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.56 -35.39 80.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.414 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.41 -75.53 0.13 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.899 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.47 -34.15 1.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.491 -1.381 . . . . 0.0 109.27 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -58.11 -69.2 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.031 -1.043 . . . . 0.0 108.509 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.59 -44.79 6.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.703 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.0 mtt -50.29 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.101 -0.999 . . . . 0.0 108.743 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.812 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.7 mm -48.09 -66.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.416 -0.802 . . . . 0.0 110.053 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.9 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.39 -71.37 0.11 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.94 -40.72 4.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.8 m -55.36 -47.8 75.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.584 . . . . 0.0 107.582 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.567 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -50.43 -47.92 56.53 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.782 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.11 -51.99 12.92 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.668 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.0 t -45.24 -67.88 0.25 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.768 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 9.4 ttm -48.53 -2.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.18 -27.21 7.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.672 HG23 ' SD ' ' A' ' 134' ' ' MET . 30.9 t -48.84 165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.927 -0.749 . . . . 0.0 109.326 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' N ' HG12 ' A' ' 136' ' ' VAL . 40.3 mm-40 -142.27 162.37 35.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 109.767 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.27 165.02 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.905 ' O ' HG13 ' A' ' 139' ' ' VAL . 5.1 p -128.74 59.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 158.79 -112.8 0.54 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.85 61.98 10.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.162 -1.199 . . . . 0.0 109.293 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.8 Cg_endo -62.51 -165.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.822 1.681 . . . . 0.0 112.644 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.566 ' O ' HG13 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -161.32 111.27 1.65 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 109.499 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 143' ' ' GLU . 0.7 OUTLIER -158.03 120.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -153.07 133.4 13.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 22.2 m-20 -141.83 -60.63 0.47 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.84 87.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.878 . . . . 0.0 109.439 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' C ' ' CE2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER 176.94 118.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.89 . . . . 0.0 109.544 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.77 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.77 142.15 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 109.101 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.983 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.1 m -119.51 -24.58 3.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.77 107.73 4.51 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.422 -1.311 . . . . 0.0 110.338 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.86 73.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.755 ' HB ' HD12 ' A' ' 57' ' ' ILE . 32.3 t -48.03 88.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.816 -1.178 . . . . 0.0 110.653 -176.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtp? -82.47 36.06 0.47 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.791 0.805 . . . . 0.0 109.2 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.88 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.8 tp -78.31 -174.08 3.56 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.608 0.718 . . . . 0.0 111.119 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.59 ' OE1' ' N ' ' A' ' 11' ' ' GLN . 1.2 pm0 -124.74 177.88 5.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.597 HD13 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -167.61 155.9 8.59 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 109.945 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 15' ' ' GLY . 12.0 Cg_endo -68.83 104.55 1.18 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.037 1.824 . . . . 0.0 111.508 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.802 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -63.1 37.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.932 -1.105 . . . . 0.0 110.38 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -170.56 -26.51 0.02 OUTLIER Glycine 0 N--CA 1.493 2.467 0 C-N-CA 118.096 -2.002 . . . . 0.0 111.842 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 15' ' ' GLY . 2.9 mttm -138.97 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.474 -1.604 . . . . 0.0 110.572 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.659 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -90.45 160.91 15.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.762 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.8 164.95 9.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.799 -1.188 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.468 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.9 Cg_exo -53.1 32.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.717 1.612 . . . . 0.0 112.026 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.68 54.16 4.56 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.221 -0.925 . . . . 0.0 110.046 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.09 155.01 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.696 1.597 . . . . 0.0 111.778 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.79 -4.69 1.49 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.006 1.137 . . . . 0.0 111.432 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.799 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 5.4 t -113.47 -68.96 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.93 -97.62 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.799 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -56.45 -55.04 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 CA-C-N 117.784 0.792 . . . . 0.0 110.479 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.724 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -55.59 -4.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.598 -0.689 . . . . 0.0 111.076 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -112.11 -54.71 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.645 -1.285 . . . . 0.0 109.152 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.26 -26.5 0.96 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.499 ' C ' ' O ' ' A' ' 28' ' ' GLY . 52.0 mm-40 -42.01 -19.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.513 -1.58 . . . . 0.0 109.252 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.773 ' CD2' ' N ' ' A' ' 31' ' ' GLY . 3.6 p-80 -65.25 -48.86 71.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.788 0.804 . . . . 0.0 108.854 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.773 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -162.22 -8.26 0.04 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 71.38 72.49 0.18 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.926 -0.75 . . . . 0.0 111.47 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.24 63.07 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.499 1.142 . . . . 0.0 108.742 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.4 mm -43.12 -66.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.361 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.7 tpt -41.61 -57.7 2.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.38 -1.45 . . . . 0.0 109.009 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.8 tp10 -44.68 -50.16 10.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.77 -1.206 . . . . 0.0 107.936 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -48.27 -62.98 1.21 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.813 1.292 . . . . 0.0 108.863 178.117 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 17' ' ' ALA . 61.8 t -67.78 -30.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.271 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 35' ' ' MET . 19.0 tttp -52.75 -59.82 4.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.24 74.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.803 . . . . 0.0 109.512 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.683 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.3 t80 -69.66 -77.23 0.09 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.7 m-20 -41.77 -36.43 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.48 1.133 . . . . 0.0 110.539 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -63.27 -35.1 79.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.586 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -91.25 -57.52 2.76 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.813 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.772 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 16.2 p -48.08 -28.53 2.92 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.21 -47.88 11.08 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -50.46 -23.0 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.216 -0.927 . . . . 0.0 109.127 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.759 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.51 -85.2 0.54 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.759 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.41 -117.93 0.42 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.842 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 3.4 t0 -141.26 129.32 22.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -1.176 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.802 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -164.17 -152.81 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.174 -0.953 . . . . 0.0 110.391 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.585 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.3 mm -146.95 141.77 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.622 HG22 ' C ' ' A' ' 71' ' ' THR . 15.0 t -142.76 137.08 14.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.098 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.3 Cg_endo -74.33 88.14 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.882 1.722 . . . . 0.0 111.077 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.88 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -57.37 137.14 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 122.697 1.237 . . . . 0.0 111.946 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 66.0 tt0 -128.89 67.49 1.41 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.755 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.1 mt -68.7 87.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.698 0.761 . . . . 0.0 110.068 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.71 100.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 57' ' ' ILE . 9.0 mt -103.13 145.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.569 -0.707 . . . . 0.0 110.406 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.77 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 8.0 m-85 -116.17 140.02 49.74 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.983 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.61 -32.13 7.7 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.391 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.9 t70 -50.6 -2.3 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.797 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.9 ttm180 75.31 70.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.035 0.921 . . . . 0.0 109.951 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 36.1 t -148.71 127.5 12.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.672 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -103.3 103.82 13.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.833 -1.167 . . . . 0.0 110.399 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.1 p -99.07 124.63 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -107.6 171.56 7.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.506 -1.371 . . . . 0.0 109.321 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.971 HG12 ' O ' ' A' ' 68' ' ' VAL . 98.7 t -162.56 44.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 112.813 -177.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.483 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.3 t -153.83 120.62 5.61 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.669 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.82 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -118.92 122.01 41.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.807 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.6 p 77.48 151.74 0.13 Allowed Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.138 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.514 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 13.8 Cg_exo -38.85 175.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.375 2.717 . . . . 0.0 114.083 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.89 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -40.68 168.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.077 0 C-N-CA 122.035 1.823 . . . . 0.0 112.308 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.78 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 48.11 -74.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.89 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -42.99 -21.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.683 -0.635 . . . . 0.0 110.755 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.78 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -44.05 -35.51 2.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.728 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.978 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -136.55 -16.24 1.57 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.978 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.2 mt -58.86 -34.13 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.828 HH11 ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.85 -38.58 70.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.3 tmtt? -69.72 -66.93 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.86 -7.39 0.3 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.178 -0.951 . . . . 0.0 109.153 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.48 -78.27 0.31 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.676 -0.64 . . . . 0.0 111.433 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.651 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 166.2 14.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.913 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.784 HD12 ' NH1' ' A' ' 79' ' ' ARG . 2.6 mt -85.07 117.39 24.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.401 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 87' ' ' GLY . 41.8 tp10 179.67 -84.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 24.6 mttt 44.96 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.93 . . . . 0.0 109.551 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 168.44 -98.83 0.14 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.91 -85.02 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -1.169 . . . . 0.0 109.539 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -78.05 175.84 9.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -140.38 150.61 61.65 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.56 -53.44 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.514 1.476 . . . . 0.0 112.328 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.42 140.22 3.64 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.795 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 65.11 97.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.148 . . . . 0.0 109.503 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.563 ' OE1' ' O ' ' A' ' 93' ' ' ARG . 4.0 tp10 178.78 152.55 0.34 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.558 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.438 ' C ' ' CG2' ' A' ' 96' ' ' VAL . 8.0 tttp -121.17 169.59 10.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.651 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t -152.24 165.03 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 96.02 64.21 0.95 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 82' ' ' ALA . 5.8 mtt180 -134.09 114.82 13.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.09 -1.241 . . . . 0.0 110.304 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.7 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -103.38 179.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.715 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -124.86 154.65 40.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.003 -1.06 . . . . 0.0 109.124 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.682 ' O ' HG22 ' A' ' 104' ' ' VAL . 12.8 t-105 -44.91 -69.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 111.386 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.19 -52.22 37.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.522 -1.361 . . . . 0.0 111.004 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.1 mt-30 -48.77 -44.05 38.41 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.452 -0.78 . . . . 0.0 110.492 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.75 -26.39 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 117.726 -1.589 . . . . 0.0 107.614 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.927 HD13 HD13 ' A' ' 120' ' ' LEU . 13.5 mt -65.01 -71.17 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.498 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 7.4 tm-20 -44.35 -44.67 8.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.615 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 77' ' ' LEU . 63.7 mt -61.99 -31.91 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 108.706 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.837 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.66 -26.84 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.111 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.776 ' N ' ' O ' ' A' ' 105' ' ' LEU . 2.0 tptp -58.97 -73.52 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -48.91 -25.01 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 108.988 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.505 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 3.2 tmtt? -83.15 -7.39 59.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.269 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.724 ' O ' ' SD ' ' A' ' 112' ' ' MET . 2.3 ppp? -130.13 59.72 47.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.865 -1.147 . . . . 0.0 109.967 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.7 Cg_endo -61.29 -54.43 1.77 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.537 1.491 . . . . 0.0 112.305 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER 174.74 -1.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.612 ' O ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -44.88 -28.82 0.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.696 -0.628 . . . . 0.0 109.717 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.482 ' N ' ' HG ' ' A' ' 115' ' ' LEU . 8.7 t30 -177.62 -14.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.96 -1.087 . . . . 0.0 109.653 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.043 HG22 ' H ' ' A' ' 118' ' ' THR . 31.9 m -104.02 -164.51 1.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.043 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.48 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 0.0 109.806 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.735 ' OD2' ' HB2' ' A' ' 122' ' ' ALA . 2.9 p-10 -58.0 143.07 44.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.163 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.927 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -71.92 -30.59 65.5 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.502 1.144 . . . . 0.0 108.387 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -62.91 -35.04 78.74 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.404 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.735 ' HB2' ' OD2' ' A' ' 119' ' ' ASP . . . -70.71 -76.32 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.382 -1.327 . . . . 0.0 107.556 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.89 -43.43 8.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.455 -1.403 . . . . 0.0 109.137 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -48.22 -69.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 0.0 108.64 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 129' ' ' GLY . 13.7 ttt180 -43.44 -39.6 3.35 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 130' ' ' SER . 18.5 ttm -53.95 -79.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.249 -0.907 . . . . 0.0 108.742 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.837 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.4 mm -47.62 -63.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.772 . . . . 0.0 110.054 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.709 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.46 -71.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.11 -42.97 5.47 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.0 m -52.59 -45.09 66.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.537 -1.566 . . . . 0.0 107.542 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.662 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -53.72 -48.03 69.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.607 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 3.3 tmm_? -44.94 -44.75 10.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.4 t -55.41 -69.88 0.12 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.771 ' CG ' HH21 ' A' ' 79' ' ' ARG . 5.9 ttm -44.87 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.523 -0.735 . . . . 0.0 110.073 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.32 25.56 47.27 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.662 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.4 t -106.31 165.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.981 -0.717 . . . . 0.0 109.126 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' N ' HG12 ' A' ' 136' ' ' VAL . 50.3 mm-40 -140.41 161.89 36.61 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.901 -1.12 . . . . 0.0 110.086 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.84 165.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.899 ' O ' HG13 ' A' ' 139' ' ' VAL . 4.5 p -129.99 59.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 160.74 -112.91 0.54 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.523 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.91 60.51 12.86 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.238 -1.154 . . . . 0.0 109.365 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.3 Cg_endo -64.73 -164.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.732 1.622 . . . . 0.0 112.691 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.444 ' O ' HG13 ' A' ' 144' ' ' VAL . 3.0 mm-40 -138.54 -164.93 1.72 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -154.24 135.39 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 0.0 109.554 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -179.64 116.74 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.449 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 147' ' ' ALA . 22.1 m-20 -138.78 145.01 39.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 9.3 pttm -142.49 115.47 8.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.539 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -165.32 114.96 1.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.707 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.772 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -45.23 138.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 109.278 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -114.05 -24.35 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.17 108.29 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -95.54 73.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.737 ' HB ' HD12 ' A' ' 57' ' ' ILE . 12.2 t -45.69 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.239 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.65 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -82.78 34.58 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.952 0.882 . . . . 0.0 109.093 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.85 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.6 tp -77.08 -174.46 3.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.783 0.801 . . . . 0.0 111.003 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 1.066 ' O ' HD12 ' A' ' 12' ' ' LEU . 2.1 pm0 -123.52 174.22 7.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.066 HD12 ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -171.17 158.88 5.18 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 110.411 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HA ' HD13 ' A' ' 52' ' ' ILE . 11.1 Cg_endo -66.61 108.69 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.197 1.932 . . . . 0.0 111.993 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.804 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -67.47 40.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.457 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -178.09 -21.0 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.527 -1.797 . . . . 0.0 111.525 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -139.92 74.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.521 -1.576 . . . . 0.0 110.259 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.784 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -92.25 165.29 13.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 108.588 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.763 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.4 163.06 6.1 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.915 -1.116 . . . . 0.0 110.036 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HA ' HG21 ' A' ' 34' ' ' ILE . 5.5 Cg_exo -53.13 32.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.681 1.587 . . . . 0.0 111.841 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.763 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.71 54.07 4.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 110.597 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.3 Cg_endo -85.82 160.83 10.51 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.766 1.644 . . . . 0.0 111.467 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.51 -4.81 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 120.898 1.065 . . . . 0.0 111.047 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 26' ' ' ALA . 21.2 t -115.58 -67.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.482 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 56.51 -97.32 0.05 OUTLIER Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.808 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.0 Cg_exo -54.05 -55.02 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 CA-C-N 117.844 0.822 . . . . 0.0 110.45 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -60.79 -0.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.196 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.685 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.58 -58.77 2.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.717 -1.24 . . . . 0.0 109.59 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.667 ' HA2' ' CD2' ' A' ' 30' ' ' HIS . . . -43.18 -18.07 0.05 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.315 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 28' ' ' GLY . 32.5 mm-40 -42.13 -21.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.255 -1.732 . . . . 0.0 108.502 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.764 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 6.3 p80 -67.32 59.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.653 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 84.62 -13.03 54.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.15 77.14 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.544 -0.974 . . . . 0.0 111.848 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 34' ' ' ILE . 1.7 m120 -150.29 60.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.34 1.067 . . . . 0.0 108.536 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.0 mm -42.86 -65.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.623 ' O ' ' N ' ' A' ' 39' ' ' LYS . 8.2 tpt -41.95 -40.43 2.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 108.746 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -58.0 -51.2 70.66 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.685 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -47.85 -62.43 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.94 1.352 . . . . 0.0 108.951 177.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 17' ' ' ALA . 61.0 t -67.26 -30.55 49.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.596 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -54.11 -59.46 4.62 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.33 74.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.433 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.2 t80 -67.2 -75.03 0.1 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.2 m120 -41.99 -37.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.475 1.131 . . . . 0.0 110.874 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -62.7 -35.53 80.02 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.559 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.528 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.83 -56.11 3.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.878 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.756 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.0 p -50.7 -26.22 5.25 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.59 -48.1 10.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.528 ' OD1' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -52.61 -21.22 3.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.975 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.545 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.63 -85.22 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.545 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.56 -136.48 2.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.942 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.505 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 2.8 p30 -122.12 122.34 39.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -1.102 . . . . 0.0 109.915 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.804 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.08 -153.17 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.908 . . . . 0.0 110.289 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.8 mm -147.28 142.76 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.547 HG22 ' C ' ' A' ' 71' ' ' THR . 8.1 t -145.01 137.66 13.59 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 110.261 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.1 Cg_endo -73.56 86.67 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.796 1.664 . . . . 0.0 110.669 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.85 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -56.68 138.38 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-O 122.749 1.261 . . . . 0.0 112.078 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.5 mt-10 -130.52 65.67 1.53 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.737 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.4 mt -65.44 88.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.812 0.815 . . . . 0.0 110.234 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.559 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -65.48 98.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.663 HG12 HG22 ' A' ' 57' ' ' ILE . 1.7 mt -102.94 147.54 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.772 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.9 m-85 -115.82 141.62 47.85 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.802 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.52 -32.72 8.37 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.304 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.27 -1.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.794 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.4 tmm_? 75.21 70.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -148.99 124.94 10.62 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' CG ' ' A' ' 65' ' ' PHE . 20.6 p90 -100.97 103.73 14.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.003 -1.061 . . . . 0.0 110.197 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 58' ' ' THR . 9.2 p -99.25 124.63 44.48 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -107.71 170.41 8.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.481 -1.387 . . . . 0.0 109.355 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.963 HG12 ' O ' ' A' ' 68' ' ' VAL . 90.1 t -161.82 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 112.716 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.535 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.0 116.95 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 116.039 -2.264 . . . . 0.0 110.324 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.803 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -114.74 120.0 38.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.032 0.92 . . . . 0.0 108.701 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.779 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.94 152.26 0.13 Allowed Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.364 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 71' ' ' THR . 15.3 Cg_exo -38.15 175.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.751 2.301 . . . . 0.0 113.365 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.795 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.3 Cg_exo -42.26 168.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.761 1.641 . . . . 0.0 112.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.902 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.6 -77.0 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 73' ' ' PRO . 41.6 p -43.42 -24.14 0.09 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.522 -0.736 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 14.6 p90 -43.86 -41.4 5.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.59 -18.82 2.75 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.902 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.4 mt -59.87 -32.65 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 84' ' ' LEU . 14.1 mmt180 -54.91 -43.09 72.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.526 ' CD ' ' C ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -68.39 -66.64 0.54 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -56.14 -4.92 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.965 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.04 -79.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.508 -0.745 . . . . 0.0 112.018 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.486 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 159.36 56.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.407 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 79' ' ' ARG . 10.2 mt -118.35 104.82 11.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.053 -1.263 . . . . 0.0 109.503 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 87' ' ' GLY . 34.9 tt0 179.57 -33.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.404 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.2 mttm 58.13 -85.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 92.16 -135.23 12.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.88 -84.98 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -1.181 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -81.31 122.23 27.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -113.18 158.92 36.76 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.415 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.54 -52.25 5.81 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.577 1.518 . . . . 0.0 112.403 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.569 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 155.58 136.94 2.27 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.792 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 53.71 115.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -1.105 . . . . 0.0 109.471 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 95' ' ' LYS . 1.7 tm-20 -165.41 164.56 19.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.473 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.631 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 5.3 tptp -143.91 -164.96 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 97' ' ' GLY . 19.2 t -121.64 163.67 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.47 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 50.98 60.92 6.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.6 mtt180 -134.74 113.54 11.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.071 -1.252 . . . . 0.0 110.686 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 -176.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.651 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -128.93 156.32 43.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 109.093 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.712 ' O ' HG22 ' A' ' 104' ' ' VAL . 10.7 t-105 -44.93 -71.46 0.08 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.801 . . . . 0.0 111.176 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.13 -52.52 34.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.636 -1.29 . . . . 0.0 111.103 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.1 mt-30 -47.82 -43.66 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.383 -0.823 . . . . 0.0 110.303 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.56 -24.88 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.575 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.869 HD13 HD13 ' A' ' 120' ' ' LEU . 21.2 mt -66.0 -72.06 0.17 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 107' ' ' ILE . 11.3 tm-20 -44.28 -45.02 8.42 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.959 -1.088 . . . . 0.0 108.612 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.764 ' CD1' HD21 ' A' ' 77' ' ' LEU . 42.1 mt -61.25 -31.67 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.046 . . . . 0.0 108.623 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.847 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -97.45 -23.68 15.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 108.984 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.9 tptp -62.43 -74.52 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.456 ' CD ' ' N ' ' A' ' 110' ' ' GLN . 1.7 mp0 -44.63 -30.15 0.87 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.022 -1.049 . . . . 0.0 108.806 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -61.82 -24.0 66.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.706 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -126.39 73.85 73.37 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 109.698 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.79 -34.4 24.44 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.551 1.501 . . . . 0.0 111.964 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 114' ' ' ASP . 3.6 t70 175.09 11.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.036 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 115' ' ' LEU . 2.4 mm? -49.81 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 109.606 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 117' ' ' THR . 5.6 p-10 -148.76 -25.05 0.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.607 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.057 HG22 ' H ' ' A' ' 118' ' ' THR . 22.9 m -60.19 -164.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.537 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.057 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.58 -72.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.3 -0.875 . . . . 0.0 109.929 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.53 ' H ' HG23 ' A' ' 118' ' ' THR . 4.8 m-20 -65.32 138.28 58.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.439 -0.788 . . . . 0.0 110.159 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.869 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -61.73 -21.53 64.59 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.282 1.039 . . . . 0.0 108.815 179.398 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.53 -38.49 91.2 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.54 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.88 -75.13 0.11 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.135 -1.426 . . . . 0.0 107.784 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.53 -41.64 6.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.524 -1.36 . . . . 0.0 109.392 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.09 -69.52 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 0.0 108.764 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.2 ttm180 -43.55 -39.94 3.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.701 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.2 ttm -53.31 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 108.579 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.847 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 24.1 mm -47.92 -63.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.438 -0.789 . . . . 0.0 109.954 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.805 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.97 -71.75 0.12 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.01 -41.87 4.84 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.8 m -54.35 -50.73 66.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.523 -1.575 . . . . 0.0 107.685 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.734 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -48.49 -47.49 38.63 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.0 -55.01 7.4 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.5 t -44.71 -68.59 0.19 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.652 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.2 ttp -46.68 -4.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.63 -31.08 5.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.734 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 29.0 t -45.43 165.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.937 -0.743 . . . . 0.0 109.194 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.547 ' N ' HG12 ' A' ' 136' ' ' VAL . 35.9 mp0 -143.85 163.2 34.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.65 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -79.28 155.08 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p -115.94 -10.01 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.628 -0.67 . . . . 0.0 109.284 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . -115.6 -124.37 3.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.515 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.94 60.35 13.07 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.16 . . . . 0.0 109.371 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.2 Cg_endo -64.41 -165.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.78 1.653 . . . . 0.0 112.642 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -136.6 -164.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.842 . . . . 0.0 109.38 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.76 164.21 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.96 . . . . 0.0 109.541 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -178.33 82.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 146' ' ' ASP . 58.5 p-10 -177.37 76.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.479 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.57 98.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.589 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 27.8 ttpt -178.54 124.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 109.674 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.794 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.75 126.2 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.535 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.6 m -111.66 -24.5 3.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.3 6.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -94.99 73.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.386 -0.821 . . . . 0.0 108.827 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 55' ' ' VAL . 26.1 t -45.92 88.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.045 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.96 34.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.951 0.881 . . . . 0.0 108.901 179.281 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.921 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.53 -174.66 3.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.872 0.844 . . . . 0.0 111.268 -178.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 1.5 pm0 -116.98 169.49 9.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.569 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -163.08 144.44 7.6 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.159 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HA ' HD13 ' A' ' 52' ' ' ILE . 30.3 Cg_endo -79.02 126.6 7.2 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.505 2.137 . . . . 0.0 114.216 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.079 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.52 141.43 48.51 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 60.55 -61.24 0.01 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.1 ttpm? -60.64 37.77 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.831 -0.805 . . . . 0.0 108.831 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.704 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -119.27 151.83 37.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.9 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.79 165.77 6.89 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 -179.08 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.5 Cg_exo -49.46 36.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.696 1.598 . . . . 0.0 111.657 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.9 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -163.77 54.87 0.43 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.53 -0.732 . . . . 0.0 109.78 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.2 Cg_endo -77.93 170.16 19.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.485 1.456 . . . . 0.0 111.716 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -60.75 -4.65 3.7 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.209 1.273 . . . . 0.0 111.03 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.921 HG22 ' CD2' ' A' ' 10' ' ' LEU . 2.2 t -106.16 -71.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.594 0.711 . . . . 0.0 110.333 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.31 -98.37 0.05 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 -177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.3 Cg_endo -60.21 -55.4 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 CA-C-N 118.047 0.924 . . . . 0.0 109.926 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.35 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.362 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.89 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -111.87 -42.84 3.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.631 -1.293 . . . . 0.0 108.751 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.66 84.44 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tt0 -149.18 -15.34 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 65' ' ' PHE . 2.0 p80 -84.42 -37.41 21.49 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.649 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -170.91 -2.8 0.03 OUTLIER Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 81.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.606 -0.938 . . . . 0.0 112.19 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -156.8 120.86 4.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.074 . . . . 0.0 108.639 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.6 mm -96.58 -65.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 110.108 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.669 ' O ' ' N ' ' A' ' 39' ' ' LYS . 5.3 tpt -42.09 -56.97 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.715 -1.241 . . . . 0.0 109.558 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' MET . 6.5 mt-10 -46.86 -50.78 18.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.269 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.89 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -48.72 -61.61 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.644 1.212 . . . . 0.0 109.617 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 42' ' ' ASN . 56.3 t -71.37 -30.28 39.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.979 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 35' ' ' MET . 32.6 tptt -51.54 -63.1 1.24 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.04 69.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 45' ' ' THR . 1.9 t80 -70.32 -76.83 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.623 ' N ' ' O ' ' A' ' 38' ' ' VAL . 1.9 m120 -41.37 -34.01 0.47 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.578 1.18 . . . . 0.0 110.63 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -67.39 -35.06 78.55 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.05 -43.99 9.58 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.735 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.697 ' CB ' ' H ' ' A' ' 15' ' ' GLY . 18.1 p -61.16 -32.14 71.87 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.36 -44.74 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -57.23 -23.7 49.69 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.763 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.8 -74.69 0.64 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.763 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 169.83 149.35 6.28 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.124 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.8 t70 -44.82 148.37 0.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.986 -1.303 . . . . 0.0 109.429 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.079 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.87 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.973 -1.079 . . . . 0.0 110.623 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.641 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.7 mm -147.16 141.78 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 71' ' ' THR . 2.8 t -144.96 133.8 11.05 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.801 -1.187 . . . . 0.0 110.888 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 5.7 Cg_endo -69.13 95.7 0.51 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.484 1.456 . . . . 0.0 110.315 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.792 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.9 m -75.84 137.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.928 1.347 . . . . 0.0 112.61 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 14.4 mt-10 -128.61 61.73 1.48 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.723 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.6 mt -61.71 88.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.729 0.776 . . . . 0.0 109.825 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.489 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -64.23 95.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.654 HG13 HG22 ' A' ' 57' ' ' ILE . 12.9 mt -96.96 140.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.648 -0.657 . . . . 0.0 110.162 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.794 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.5 m-85 -111.83 138.93 47.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.843 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.08 -30.35 2.7 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -53.47 3.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.241 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.843 ' H ' ' C ' ' A' ' 61' ' ' ALA . 2.6 tmm_? 70.05 69.64 0.22 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.099 0.952 . . . . 0.0 109.436 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 3.2 m -147.86 125.87 12.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.19 104.08 14.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.052 -1.03 . . . . 0.0 110.288 -179.339 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.433 ' OG1' ' HB ' ' A' ' 58' ' ' THR . 23.4 p -98.78 124.52 43.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.557 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -109.64 173.74 6.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.58 -1.325 . . . . 0.0 109.281 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.974 HG12 ' O ' ' A' ' 68' ' ' VAL . 85.3 t -162.78 44.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 112.666 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.529 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 t -156.55 118.09 3.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 116.092 -2.243 . . . . 0.0 109.475 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.821 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -114.61 125.15 53.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.339 1.066 . . . . 0.0 109.328 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 1.027 HG21 ' CZ ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 75.02 161.56 0.15 Allowed Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.22 -179.069 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.681 ' HD2' HG22 ' A' ' 71' ' ' THR . 12.4 Cg_exo -41.35 175.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.469 2.112 . . . . 0.0 113.102 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.1 Cg_exo -44.08 169.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.681 1.587 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.863 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.8 -74.49 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.777 ' N ' ' O ' ' A' ' 73' ' ' PRO . 22.8 t -43.76 -20.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 110.055 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 1.093 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 26.8 p90 -43.49 -43.35 5.37 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.093 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.76 -20.42 2.55 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.895 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -55.36 -35.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.451 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 1.027 ' CZ ' HG21 ' A' ' 71' ' ' THR . 0.0 OUTLIER -53.39 -57.6 10.04 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.51 ' C ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -52.04 -64.29 0.86 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.016 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.68 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -48.89 -16.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 0.0 108.463 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.864 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -98.78 -74.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.916 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 95.59 95.12 1.74 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.964 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.817 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 7.1 mt -118.88 105.0 11.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -1.201 . . . . 0.0 108.938 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.69 ' O ' ' N ' ' A' ' 87' ' ' GLY . 73.2 mm-40 -153.2 16.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.104 -0.998 . . . . 0.0 109.819 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 23.5 tttt 45.04 -85.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.155 -0.966 . . . . 0.0 109.386 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 124.31 121.81 2.62 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 89' ' ' HIS . . . -68.21 -62.9 1.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -1.162 . . . . 0.0 109.341 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.579 ' O ' ' O ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -51.92 -164.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.315 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 89' ' ' HIS . 15.0 mttm -44.85 159.55 0.26 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 0.0 109.314 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.4 -54.99 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.557 1.505 . . . . 0.0 112.552 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.04 -39.23 2.97 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.562 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 3.1 mpt_? 58.77 55.41 4.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -1.102 . . . . 0.0 109.622 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.562 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 32.0 mt-10 -164.74 48.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 109.619 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.612 ' O ' HG23 ' A' ' 96' ' ' VAL . 34.2 mttp -163.28 72.6 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.812 ' O ' ' N ' ' A' ' 98' ' ' ARG . 79.2 t -159.85 166.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 110.439 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.864 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . -43.99 72.98 0.0 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.812 ' N ' ' O ' ' A' ' 96' ' ' VAL . 2.6 mtt180 -135.65 109.74 8.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -1.077 . . . . 0.0 109.563 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.828 HD13 HG12 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.01 -175.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.759 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -125.24 165.84 17.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.082 . . . . 0.0 109.666 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.688 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.3 t-105 -51.01 -71.31 0.07 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.646 -0.659 . . . . 0.0 111.277 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.505 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 4.0 tp10 -47.73 -50.31 25.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.766 -1.209 . . . . 0.0 110.859 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -49.86 -44.9 49.99 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.902 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.73 -25.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 117.535 -1.666 . . . . 0.0 107.379 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.954 HD13 HD13 ' A' ' 120' ' ' LEU . 18.8 mt -66.31 -71.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 105' ' ' LEU . 72.7 tt0 -43.74 -43.77 6.21 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.923 -1.111 . . . . 0.0 108.641 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.724 HG12 HD11 ' A' ' 77' ' ' LEU . 55.7 mt -62.79 -30.75 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.049 . . . . 0.0 108.541 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.799 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.88 -26.11 16.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.478 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -61.78 -74.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 0.0 108.396 179.119 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.453 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 19.7 tt0 -47.16 -20.29 0.17 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.945 . . . . 0.0 109.26 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -80.89 -9.31 59.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.856 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.52 56.43 20.63 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.045 -1.035 . . . . 0.0 109.785 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.9 Cg_endo -59.33 -33.36 97.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.585 1.523 . . . . 0.0 112.406 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.06 19.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.479 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.2 mp -54.12 -85.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.82 -11.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.801 . . . . 0.0 109.154 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.037 HG22 ' H ' ' A' ' 118' ' ' THR . 31.5 m -72.24 -164.57 0.15 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.037 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.8 -56.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.314 -0.866 . . . . 0.0 109.674 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.444 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -80.43 134.94 36.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.954 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -55.24 -22.5 18.31 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.179 0.99 . . . . 0.0 109.019 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.6 -36.82 84.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.63 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.53 -75.75 0.11 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.481 -1.387 . . . . 0.0 107.977 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.635 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.35 -40.31 5.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.479 -1.388 . . . . 0.0 109.243 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.77 -68.12 0.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.026 -1.046 . . . . 0.0 108.442 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 129' ' ' GLY . 1.8 ttm180 -43.63 -43.59 5.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.713 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.34 -79.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.057 -1.027 . . . . 0.0 108.563 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.799 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.3 mm -48.19 -65.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.21 -71.49 0.11 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.93 -40.53 4.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.713 ' N ' ' O ' ' A' ' 126' ' ' MET . 45.1 m -56.3 -51.05 69.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.467 -1.608 . . . . 0.0 107.707 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.716 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -46.86 -47.74 21.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.8 -54.32 10.08 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.3 t -44.99 -70.24 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.701 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.2 ttp -46.9 -4.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.613 -0.679 . . . . 0.0 109.355 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.71 -30.11 6.36 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.716 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 50.8 t -44.91 164.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.856 -0.791 . . . . 0.0 108.941 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.1 tm-20 -144.04 162.66 35.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 109.686 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.617 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -80.23 145.41 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.962 ' O ' HG13 ' A' ' 139' ' ' VAL . 2.4 p -110.01 61.99 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.26 -117.76 0.79 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.72 61.4 11.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.148 -1.207 . . . . 0.0 109.269 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.564 ' O ' ' CG ' ' A' ' 143' ' ' GLU . 2.0 Cg_endo -61.74 156.62 47.06 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.724 1.616 . . . . 0.0 112.689 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.564 ' CG ' ' O ' ' A' ' 142' ' ' PRO . 19.5 mt-10 -165.7 87.96 0.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -0.86 . . . . 0.0 109.351 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 143' ' ' GLU . 5.3 m -156.38 146.23 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 175.03 138.56 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.845 . . . . 0.0 109.401 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 147' ' ' ALA . 28.7 m-20 -133.95 134.85 43.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.55 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.515 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.786 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.308 0.575 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -116.5 -24.49 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.259 -0.9 . . . . 0.0 109.008 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.33 108.95 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.41 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -96.93 73.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.787 ' HB ' HD12 ' A' ' 57' ' ' ILE . 39.0 t -48.53 87.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 120.756 -1.215 . . . . 0.0 110.276 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 7' ' ' VAL . 1.6 tmmt? -82.77 36.65 0.5 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.803 0.811 . . . . 0.0 109.18 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.013 HD22 HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.41 -173.94 3.54 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.775 0.798 . . . . 0.0 111.494 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -121.74 173.61 7.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.752 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -161.62 146.96 10.46 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 109.368 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.699 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 91.1 Cg_endo -87.33 126.91 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.343 2.029 . . . . 0.0 113.47 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.099 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.94 143.17 43.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.38 58.64 9.54 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.699 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 9.6 tttp 174.31 -1.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.807 -0.82 . . . . 0.0 108.831 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 18' ' ' THR . . . -83.5 153.93 24.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.902 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.68 165.95 4.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.668 -179.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.1 Cg_exo -49.19 34.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.57 1.513 . . . . 0.0 111.581 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.902 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.67 54.46 0.71 Allowed Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.614 -0.679 . . . . 0.0 109.245 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 13.3 Cg_endo -80.8 169.89 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.694 1.596 . . . . 0.0 111.729 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.27 -4.43 2.31 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 121.009 1.139 . . . . 0.0 111.039 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.013 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -110.68 -70.51 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.562 0.696 . . . . 0.0 110.253 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.01 -98.24 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.12 -55.57 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 CA-C-N 118.007 0.903 . . . . 0.0 109.951 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.654 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.44 -12.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.173 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.006 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.65 -41.64 3.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.778 -1.201 . . . . 0.0 108.28 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.42 92.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 27' ' ' LEU . 43.1 mt-30 -158.5 -26.87 0.08 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.754 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.7 p80 -78.24 60.35 2.48 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.485 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.68 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 85.03 -9.87 64.91 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 84.96 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 112.163 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -157.83 122.61 4.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 108.801 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.4 mm -97.36 -63.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.609 -0.682 . . . . 0.0 109.732 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.74 -55.59 2.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.693 -1.254 . . . . 0.0 109.537 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 35' ' ' MET . 12.0 mt-10 -46.25 -45.73 17.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.498 -1.376 . . . . 0.0 107.468 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 1.006 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -54.18 -68.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.244 1.021 . . . . 0.0 109.636 178.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 42' ' ' ASN . 25.9 t -67.03 -38.29 81.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.681 -0.637 . . . . 0.0 110.018 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.1 tptm -45.29 -58.79 3.04 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.98 74.79 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.265 -0.897 . . . . 0.0 109.094 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.673 ' O ' HG23 ' A' ' 45' ' ' THR . 2.3 t80 -71.39 -77.26 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 120.368 -1.457 . . . . 0.0 107.124 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.2 t-20 -41.08 -33.95 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.879 -1.138 . . . . 0.0 110.739 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.33 -32.33 72.37 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.918 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.39 -48.54 7.06 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.652 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 41' ' ' PHE . 1.5 p -58.92 -30.45 67.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.15 -44.78 21.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -57.81 -21.96 44.94 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.558 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.85 -72.46 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.558 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.21 -131.31 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.016 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 4.7 p-10 -121.19 148.0 44.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.254 -1.145 . . . . 0.0 108.779 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.099 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.94 -153.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.752 -1.218 . . . . 0.0 110.929 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.6 mm -146.12 138.42 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 71' ' ' THR . 2.4 t -138.76 134.44 17.16 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.116 -0.99 . . . . 0.0 110.791 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -71.86 107.24 2.16 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.69 1.594 . . . . 0.0 111.012 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.832 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.1 m -81.1 136.92 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.722 -1.236 . . . . 0.0 111.464 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -130.74 68.04 1.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.787 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.1 mt -68.19 90.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.79 0.805 . . . . 0.0 110.231 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.09 96.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.644 HG13 HG22 ' A' ' 57' ' ' ILE . 50.2 mt -101.07 145.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.515 0.674 . . . . 0.0 110.728 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.786 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.4 m-85 -116.51 139.89 49.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.802 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.42 -32.78 5.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.147 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -50.94 -1.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.79 ' H ' ' C ' ' A' ' 61' ' ' ALA . 11.2 ttm180 75.33 68.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.952 0.882 . . . . 0.0 109.85 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 1.3 t -148.49 147.93 29.66 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.65 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 36.2 p90 -125.29 103.82 8.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.902 -1.124 . . . . 0.0 110.247 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.4 p -101.44 120.75 40.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 110.052 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.937 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.1 148.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.089 -1.007 . . . . 0.0 110.99 177.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 67' ' ' PHE . 28.9 t -169.18 91.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.187 0.994 . . . . 0.0 108.491 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -97.5 147.05 24.65 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.752 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -132.25 125.15 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.397 -1.44 . . . . 0.0 110.604 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.752 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 14.8 p 76.18 150.64 0.13 Allowed Pre-proline 0 N--CA 1.493 1.68 0 CA-C-O 121.244 0.545 . . . . 0.0 109.975 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 73' ' ' PRO . 12.6 Cg_exo -40.8 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.653 2.235 . . . . 0.0 112.993 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.756 ' O ' ' N ' ' A' ' 75' ' ' SER . 25.0 Cg_exo -39.89 168.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.543 1.495 . . . . 0.0 111.905 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.917 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.05 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.832 ' HG ' ' HG3' ' A' ' 79' ' ' ARG . 11.2 t -43.05 -21.72 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.079 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 23.6 p90 -43.6 -38.76 3.17 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.079 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.77 -16.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.917 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.9 mt -58.27 -34.33 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.832 ' HG3' ' HG ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -54.12 -49.74 68.47 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 82' ' ' ALA . 4.5 tmtt? -58.27 -64.81 0.79 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.58 -6.28 0.69 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.205 -0.934 . . . . 0.0 109.842 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.812 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -78.86 -82.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 112.216 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 178.88 32.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.957 -1.592 . . . . 0.0 110.464 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.607 HD11 ' CD ' ' A' ' 79' ' ' ARG . 2.8 mt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 120.997 -1.296 . . . . 0.0 109.392 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.217 0.532 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.812 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 75.86 58.81 3.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.665 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.8 mtt180 -133.71 115.47 14.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.128 -1.219 . . . . 0.0 110.353 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.721 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.43 175.11 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.815 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -120.85 156.58 31.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.983 -1.073 . . . . 0.0 109.055 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.3 t-105 -45.18 -70.37 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 111.229 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.405 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 6.4 tp10 -50.45 -51.71 44.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.575 -1.328 . . . . 0.0 111.242 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.406 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 4.8 mt-30 -48.72 -44.38 38.24 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.5 m -70.88 -25.9 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.822 -1.551 . . . . 0.0 107.663 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.967 HD13 HD13 ' A' ' 120' ' ' LEU . 18.8 mt -65.36 -70.66 0.22 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 105' ' ' LEU . 3.1 tp10 -44.1 -45.7 8.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.935 -1.103 . . . . 0.0 108.566 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.818 HG12 HD11 ' A' ' 77' ' ' LEU . 35.3 mt -61.26 -31.75 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.111 -0.993 . . . . 0.0 108.698 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.816 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.53 -25.98 16.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.347 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -58.08 -73.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 108.286 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.552 ' N ' ' CD ' ' A' ' 110' ' ' GLN . 2.4 mp0 -44.95 -26.1 0.38 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.078 -1.014 . . . . 0.0 108.794 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' LYS . 40.1 tttm -74.91 -8.29 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.803 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.59 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 7.7 ptm -132.87 62.4 61.98 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.056 -1.028 . . . . 0.0 109.861 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 112' ' ' MET . 3.0 Cg_endo -67.21 -35.06 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.565 1.51 . . . . 0.0 112.123 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 2.3 t70 174.96 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.359 -0.838 . . . . 0.0 109.107 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.2 mm? -47.96 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 0.0 109.575 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -151.81 -21.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.02 HG22 ' H ' ' A' ' 118' ' ' THR . 26.2 m -64.13 -164.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.101 -0.999 . . . . 0.0 109.616 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.02 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.48 -64.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 0.9 OUTLIER -74.93 141.27 44.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.084 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.967 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -59.93 -24.56 64.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.211 1.005 . . . . 0.0 109.12 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.5 -34.65 78.71 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.71 -75.18 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.045 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.59 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.0 -40.82 6.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.539 -1.351 . . . . 0.0 109.095 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.97 -69.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 108.647 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.658 ' O ' ' N ' ' A' ' 129' ' ' GLY . 23.1 ttt180 -43.35 -35.68 1.61 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.666 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.0 tpp -57.56 -78.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 108.778 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.816 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 26.9 mm -48.49 -56.99 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.0 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -67.39 -70.93 0.22 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -42.48 5.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.666 ' N ' ' O ' ' A' ' 126' ' ' MET . 54.3 p -54.72 -47.66 73.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.575 -1.544 . . . . 0.0 107.499 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -51.12 -48.53 61.73 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.791 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.01 -53.4 10.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.0 t -44.79 -67.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.805 ' SD ' ' NH1' ' A' ' 79' ' ' ARG . 11.6 ttm -49.94 -3.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 89.21 -26.05 9.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.677 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.4 t -49.22 165.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.736 -0.861 . . . . 0.0 109.405 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 136' ' ' VAL . 87.8 mt-10 -142.8 162.66 34.88 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.755 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.32 165.1 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 139' ' ' VAL . 6.4 p . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.767 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.338 0.589 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -115.11 -24.45 3.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.34 100.39 3.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.041 -1.037 . . . . 0.0 110.252 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -87.86 74.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.919 HG13 HD12 ' A' ' 10' ' ' LEU . 11.3 t -48.22 87.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.558 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.681 ' HZ3' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -81.83 36.29 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.897 0.856 . . . . 0.0 108.817 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.919 HD12 HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -77.22 -174.46 3.24 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.725 0.774 . . . . 0.0 110.882 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -127.42 177.21 6.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.556 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -166.66 146.6 4.96 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 109.213 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.485 ' HA ' HD13 ' A' ' 52' ' ' ILE . 65.8 Cg_endo -84.01 130.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.277 1.984 . . . . 0.0 113.587 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.072 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -76.16 142.77 41.48 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.492 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 51.61 55.35 20.57 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 5.5 mttp 174.53 14.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.695 -0.885 . . . . 0.0 109.212 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 18' ' ' THR . . . -96.13 154.74 17.08 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.862 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.86 165.74 4.07 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.005 . . . . 0.0 109.487 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HA ' HG21 ' A' ' 34' ' ' ILE . 5.3 Cg_exo -51.05 32.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.457 1.438 . . . . 0.0 111.562 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.862 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -154.56 54.31 1.03 Allowed Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.64 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.739 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.84 169.06 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.725 1.617 . . . . 0.0 111.735 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.37 -4.56 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.077 1.185 . . . . 0.0 110.95 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.748 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.0 -72.62 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.796 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.49 -98.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.748 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.3 Cg_exo -59.03 -55.54 1.88 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 118.096 0.948 . . . . 0.0 110.003 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.652 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -44.7 -6.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.412 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.862 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -111.12 -44.07 3.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 179.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.34 88.67 0.01 OUTLIER Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.6 tt0 -150.97 -12.85 0.22 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.538 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 7.8 p-80 -87.73 -36.5 17.32 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -173.1 -1.49 0.03 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.11 83.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 112.058 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 32' ' ' ALA . 31.8 m120 -157.71 120.09 3.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.982 -1.073 . . . . 0.0 108.614 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.565 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.8 mm -97.44 -65.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.689 -0.632 . . . . 0.0 109.853 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.492 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -41.42 -56.35 2.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 109.548 -177.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.3 mt-10 -44.69 -48.15 10.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.755 -1.215 . . . . 0.0 107.768 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.862 ' CE2' HD12 ' A' ' 27' ' ' LEU . 1.1 t80 -51.17 -68.17 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.884 1.326 . . . . 0.0 110.034 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 33.9 t -59.21 -37.2 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.805 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 7.1 ttpt -49.56 -65.7 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.08 -32.79 62.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.23 -0.918 . . . . 0.0 109.04 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.0 t80 -73.19 -78.45 0.09 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 7.4 m-20 -41.07 -32.76 0.27 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.856 -1.152 . . . . 0.0 110.745 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -70.04 -32.77 71.07 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.139 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.09 -47.17 7.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.476 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.556 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 8.7 p -59.5 -29.71 68.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.94 -45.27 20.79 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.555 ' OD1' ' O ' ' A' ' 43' ' ' ALA . 12.2 m120 -57.8 -22.14 45.69 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.573 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.32 -73.88 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.573 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -179.64 -127.82 1.15 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.05 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 23.1 t70 -123.84 147.26 47.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.216 -1.167 . . . . 0.0 108.817 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.072 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.88 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 0.0 110.99 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.1 mm -146.82 139.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 71' ' ' THR . 2.0 t -138.58 133.74 17.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 110.611 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -72.86 97.1 0.88 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.8 1.667 . . . . 0.0 111.03 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.81 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -70.95 134.46 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.675 1.226 . . . . 0.0 111.652 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 28.3 mt-10 -127.16 70.32 1.3 Allowed 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.725 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -71.43 89.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.677 0.751 . . . . 0.0 110.5 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.16 95.46 0.09 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 57' ' ' ILE . 95.7 mt -98.05 141.0 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.656 -0.653 . . . . 0.0 110.505 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.767 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 4.8 m-85 -115.99 139.82 49.87 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.835 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.81 -30.7 4.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.277 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 6.0 m-20 -53.47 3.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.81 ' H ' ' C ' ' A' ' 61' ' ' ALA . 49.8 mtp180 70.34 68.89 0.21 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.968 0.89 . . . . 0.0 109.793 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 9.5 p -148.97 150.98 33.78 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.2 p90 -128.18 103.76 7.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.992 -1.067 . . . . 0.0 110.105 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p -101.38 120.79 40.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.15 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.933 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 169.96 149.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.081 -1.012 . . . . 0.0 110.991 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.5 t -168.82 98.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.272 1.034 . . . . 0.0 108.35 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.39 148.2 29.4 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.78 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.2 mptt -133.21 125.09 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.523 -1.361 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.78 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.3 150.34 0.13 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 121.272 0.558 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' O ' ' O ' ' A' ' 73' ' ' PRO . 8.7 Cg_exo -42.88 175.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.548 2.166 . . . . 0.0 112.803 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.61 176.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.502 1.468 . . . . 0.0 111.788 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 47.87 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.774 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -43.71 -22.4 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.99 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.981 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 15.6 p90 -43.84 -37.68 2.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 0.0 108.961 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.981 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.35 -15.79 1.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.919 HD12 ' HB1' ' A' ' 74' ' ' ALA . 3.9 mt -60.13 -31.85 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.707 ' HB3' HD12 ' A' ' 84' ' ' LEU . 2.2 mmp_? -56.08 -44.01 78.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.2 tmtm? -65.27 -66.76 0.5 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.746 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.5 -5.26 0.51 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.01 -80.31 0.19 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.547 -0.721 . . . . 0.0 111.582 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.752 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 166.46 53.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.285 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 83' ' ' GLY . 2.0 mt . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.236 . . . . 0.0 109.358 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.58 HG12 ' N ' ' A' ' 97' ' ' GLY . 88.5 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.258 0.551 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.58 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 57.0 65.97 3.19 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.657 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.2 ttt180 -134.32 114.59 13.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 110.007 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -107.42 -169.23 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 108.976 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.644 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.4 OUTLIER -131.58 159.36 38.45 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 0.0 109.219 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.679 ' O ' HG22 ' A' ' 104' ' ' VAL . 18.2 t-105 -50.9 -68.72 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.504 -0.747 . . . . 0.0 110.87 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -51.27 -45.91 62.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.69 -1.256 . . . . 0.0 110.369 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.746 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -50.66 -47.65 58.6 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.234 -0.917 . . . . 0.0 109.777 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.836 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.78 -24.06 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.951 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 120' ' ' LEU . 13.1 mt -66.88 -71.32 0.2 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.491 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 6.1 tm-20 -43.66 -43.12 5.66 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.891 -1.131 . . . . 0.0 108.374 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 77' ' ' LEU . 49.4 mt -62.96 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.021 -1.049 . . . . 0.0 108.358 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.807 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.41 -27.36 16.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.656 ' HE2' HD11 ' A' ' 120' ' ' LEU . 17.3 mmtt -57.18 -73.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.837 -1.164 . . . . 0.0 108.124 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 109' ' ' LYS . 78.9 mt-30 -44.89 -25.01 0.26 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.006 -1.058 . . . . 0.0 108.769 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 109' ' ' LYS . 23.5 tptt -76.89 -8.25 57.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.919 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 123' ' ' ALA . 7.5 ptm -132.27 60.87 53.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.8 Cg_endo -65.88 -40.34 16.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.559 1.506 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.452 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 6.9 t70 -178.75 8.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.0 mm? -46.76 -81.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -151.13 -18.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.129 -0.982 . . . . 0.0 109.699 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.019 HG22 ' H ' ' A' ' 118' ' ' THR . 26.4 m -65.88 -164.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.629 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.019 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.96 -62.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.266 -0.897 . . . . 0.0 109.865 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 118' ' ' THR . 0.8 OUTLIER -75.31 140.64 43.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -60.3 -23.8 64.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.126 0.965 . . . . 0.0 109.107 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.64 -34.29 77.94 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.52 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.78 -75.83 0.13 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.111 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.623 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -45.09 -31.37 1.35 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.468 -1.395 . . . . 0.0 109.268 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -60.75 -69.76 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 108.496 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.694 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.2 ttp180 -43.67 -44.1 6.22 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.631 ' O ' ' N ' ' A' ' 130' ' ' SER . 2.8 mtt -49.72 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.1 -1.0 . . . . 0.0 108.742 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.807 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 18.2 mm -47.28 -67.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.678 0.752 . . . . 0.0 110.076 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.836 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -55.23 -69.55 0.13 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.43 -37.29 2.49 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.631 ' N ' ' O ' ' A' ' 126' ' ' MET . 10.5 p -57.08 -54.21 49.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.445 -1.621 . . . . 0.0 107.336 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.743 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -44.98 -50.36 10.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -44.91 -55.73 5.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.169 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.8 t -44.91 -67.2 0.31 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.679 ' SD ' ' OG ' ' A' ' 75' ' ' SER . 6.8 ttp -47.79 -3.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.73 -24.72 11.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.743 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 31.1 t -52.74 165.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.989 -0.712 . . . . 0.0 109.347 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.586 ' N ' HG12 ' A' ' 136' ' ' VAL . 41.7 mt-10 -142.99 163.28 33.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.44 143.84 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 99' ' ' ILE . 5.6 p . . . . . 0 N--CA 1.487 1.386 0 O-C-N 121.56 -0.713 . . . . 0.0 109.292 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.516 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.026 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -123.66 -24.9 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.903 -1.123 . . . . 0.0 110.573 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -154.98 111.66 3.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.731 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -103.78 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.767 ' HB ' HD12 ' A' ' 57' ' ' ILE . 17.6 t -49.51 88.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.73 -1.231 . . . . 0.0 110.743 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.7 tmtp? -82.4 38.28 0.54 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.746 0.784 . . . . 0.0 109.358 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.892 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.24 -173.89 3.45 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.843 0.83 . . . . 0.0 111.437 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.691 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.98 174.83 7.33 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.719 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -167.73 159.66 9.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.85 -1.156 . . . . 0.0 110.159 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.719 ' HD2' HD23 ' A' ' 12' ' ' LEU . 11.9 Cg_endo -68.95 109.83 2.24 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.034 1.823 . . . . 0.0 111.37 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.823 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -68.68 38.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.857 -1.152 . . . . 0.0 110.411 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.524 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -172.82 -19.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.372 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -144.37 80.39 1.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.642 -1.505 . . . . 0.0 110.408 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.673 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -96.53 166.05 11.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.747 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.0 164.4 4.26 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.874 -1.141 . . . . 0.0 110.086 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' HG21 ' A' ' 34' ' ' ILE . 3.5 Cg_exo -54.11 32.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.663 1.575 . . . . 0.0 111.677 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.747 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.0 54.01 5.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.061 -1.024 . . . . 0.0 110.231 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.8 Cg_endo -84.67 155.11 11.88 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.73 1.62 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.91 -4.62 0.37 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.032 1.155 . . . . 0.0 111.136 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.828 HG12 ' N ' ' A' ' 27' ' ' LEU . 2.9 t -111.85 -69.88 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 0.0 110.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.83 -97.73 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.774 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.8 Cg_exo -57.83 -55.66 2.2 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 CA-C-N 118.017 0.908 . . . . 0.0 110.28 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.628 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -52.72 -11.83 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.628 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.828 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -96.51 -53.69 3.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.71 -1.244 . . . . 0.0 108.386 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.88 92.3 0.01 OUTLIER Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.9 tp60 -147.39 -15.05 0.39 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.557 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 4.9 p-80 -84.13 -37.37 22.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -171.57 -0.92 0.03 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 73.18 84.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.494 -1.003 . . . . 0.0 112.046 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -159.55 120.81 3.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 108.806 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.677 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 50.7 mm -94.4 -64.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.723 -0.61 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.57 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -41.0 -54.38 2.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.791 -1.193 . . . . 0.0 109.774 -176.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 35' ' ' MET . 5.5 mt-10 -48.41 -46.78 37.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.593 -1.317 . . . . 0.0 107.708 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.719 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -53.03 -68.91 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.572 1.177 . . . . 0.0 109.244 178.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.673 HG13 ' CB ' ' A' ' 17' ' ' ALA . 38.3 t -63.46 -36.84 77.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.706 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.0 mmmt -49.32 -55.55 12.44 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.11 75.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.484 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.612 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.0 OUTLIER -70.13 -77.05 0.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.431 -1.418 . . . . 0.0 107.305 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 7.2 t-20 -41.52 -33.79 0.48 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.74 -33.88 75.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.417 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.891 ' HB1' ' NZ ' ' A' ' 70' ' ' LYS . . . -90.72 -53.18 4.52 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.714 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.792 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.8 p -53.35 -31.34 44.03 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.43 -44.71 17.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -54.69 -23.27 16.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.18 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.603 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.78 -85.3 0.53 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.182 -0.949 . . . . 0.0 109.693 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.603 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.82 -141.8 3.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.062 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -118.07 121.15 39.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -1.122 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.823 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.51 -153.04 0.4 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.583 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.6 mm -146.85 142.2 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 14' ' ' ALA . 3.7 t -145.34 137.61 13.38 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 110.238 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -73.52 95.01 0.85 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.872 1.715 . . . . 0.0 111.52 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.892 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -61.44 138.06 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 111.354 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 26.8 tt0 -130.44 70.14 1.45 Allowed 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.767 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.6 mt -70.68 89.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.389 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 100.89 0.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' A' ' 6' ' ' ALA . 21.1 mt -101.76 137.45 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.589 -0.695 . . . . 0.0 110.615 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.516 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -113.27 137.85 50.88 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 1.026 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -49.03 -30.76 6.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.583 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.6 m-20 -53.56 1.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.807 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 mtm180 71.05 69.91 0.18 Allowed 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.028 0.918 . . . . 0.0 109.953 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 4.4 m -151.27 126.11 9.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 18.2 p90 -102.53 103.84 14.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.093 -1.005 . . . . 0.0 110.035 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.2 121.31 41.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.1 -1.0 . . . . 0.0 110.227 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.932 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.38 148.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.052 . . . . 0.0 111.274 177.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.7 t -168.74 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.263 1.03 . . . . 0.0 108.232 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -98.07 132.4 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.891 ' NZ ' ' HB1' ' A' ' 44' ' ' ALA . 24.5 mmtp -115.82 143.19 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.655 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 1.8 p 55.58 159.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.956 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.7 Cg_exo -38.18 175.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.887 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 75' ' ' SER . 22.8 Cg_exo -42.2 169.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.575 1.516 . . . . 0.0 112.161 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.984 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 58.73 -73.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 73' ' ' PRO . 5.6 p -43.65 -21.65 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.097 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 25.4 p90 -43.38 -42.95 4.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.366 -0.834 . . . . 0.0 109.087 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.097 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.54 -13.9 3.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.984 HD12 ' HB1' ' A' ' 74' ' ' ALA . 2.0 mt -61.02 -31.34 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.704 ' NH1' ' CD1' ' A' ' 84' ' ' LEU . 9.6 mmm180 -54.16 -45.81 72.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.2 tmmm? -65.21 -65.75 0.63 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.751 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.51 -5.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.671 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.643 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.81 -79.66 0.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 111.686 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.402 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 153.49 57.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.085 -1.531 . . . . 0.0 110.674 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.704 ' CD1' ' NH1' ' A' ' 79' ' ' ARG . 9.0 mt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.143 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 97' ' ' GLY . 87.4 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.273 0.559 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.589 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 65.53 65.64 2.8 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.2 mtt180 -132.53 115.31 15.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.269 -1.136 . . . . 0.0 109.93 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.728 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 173.31 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.549 -0.719 . . . . 0.0 109.539 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.72 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -113.99 150.46 33.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.042 . . . . 0.0 109.092 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.719 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.0 t-105 -46.3 -67.6 0.27 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.347 -0.846 . . . . 0.0 110.897 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.505 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.68 -49.29 57.65 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.557 -1.34 . . . . 0.0 110.68 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.751 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -48.97 -45.93 42.84 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.884 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.82 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.4 -24.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 117.979 -1.489 . . . . 0.0 107.797 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.795 ' O ' ' N ' ' A' ' 109' ' ' LYS . 19.3 mt -66.22 -71.71 0.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 105' ' ' LEU . 86.7 tt0 -43.99 -44.95 7.6 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.892 -1.13 . . . . 0.0 108.472 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.588 HG12 HD11 ' A' ' 77' ' ' LEU . 67.2 mt -61.58 -32.47 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 108.493 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.819 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.8 -24.71 16.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.169 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.795 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.6 tptp -63.16 -74.55 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 109' ' ' LYS . 26.1 mt-30 -44.5 -27.85 0.51 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.984 -1.073 . . . . 0.0 108.772 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 109' ' ' LYS . 33.7 tttp -66.57 -13.66 61.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.578 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 5.5 ptm -131.02 69.25 82.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.638 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -68.82 -46.63 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.68 1.587 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.534 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 40.1 p30 -171.1 6.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 108.952 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.401 ' H ' ' H ' ' A' ' 114' ' ' ASP . 2.7 mm? -45.02 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.798 . . . . 0.0 109.577 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.782 HD22 ' N ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -150.89 -12.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.186 -0.946 . . . . 0.0 109.649 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.026 HG22 ' H ' ' A' ' 118' ' ' THR . 31.8 m -77.99 -164.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.026 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 178.56 -57.2 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.264 -0.898 . . . . 0.0 109.576 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 1.1 p30 -63.27 132.25 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.513 -0.742 . . . . 0.0 109.998 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.675 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -67.22 -28.7 68.29 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.488 1.137 . . . . 0.0 108.469 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -64.45 -34.52 78.4 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.637 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.52 -76.27 0.1 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.68 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.578 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.58 -42.1 10.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.478 -1.389 . . . . 0.0 109.339 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -50.4 -69.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 108.806 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.49 -38.57 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.597 ' O ' ' HB3' ' A' ' 130' ' ' SER . 13.4 tpp -53.79 -79.22 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.819 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.9 mm -47.29 -65.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.666 0.746 . . . . 0.0 110.289 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.82 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -57.5 -69.71 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.38 -37.8 2.62 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.597 ' HB3' ' O ' ' A' ' 126' ' ' MET . 15.9 p -57.18 -53.79 54.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.506 -1.585 . . . . 0.0 107.451 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.779 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -45.0 -50.28 10.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.791 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.65 -55.01 6.88 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.6 t -44.74 -67.29 0.3 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.631 ' HG2' HG23 ' A' ' 136' ' ' VAL . 7.1 ttp -47.77 -3.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.62 -13.9 59.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.779 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 35.7 t -69.36 135.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.997 -0.707 . . . . 0.0 109.444 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.87 167.25 10.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.97 125.95 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 99' ' ' ILE . 11.2 p . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.563 -0.71 . . . . 0.0 109.736 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.778 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.7 m -113.48 -24.53 3.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.214 -0.929 . . . . 0.0 108.52 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.66 112.27 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.05 -1.032 . . . . 0.0 110.273 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -100.47 73.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.15 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.78 ' HB ' HD12 ' A' ' 57' ' ' ILE . 13.6 t -50.08 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.444 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.8 tmtp? -82.96 37.87 0.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.885 0.85 . . . . 0.0 109.168 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.815 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -77.28 -174.13 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.01 0.91 . . . . 0.0 111.395 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.73 174.94 7.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.729 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -164.42 147.06 7.29 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 0.0 109.361 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.65 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 80.0 Cg_endo -86.17 126.17 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.331 2.021 . . . . 0.0 113.213 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.28 143.06 48.87 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.01 61.86 6.5 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 8.7 tttp 174.08 -25.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.573 -0.957 . . . . 0.0 108.823 -177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 18' ' ' THR . . . -59.05 152.67 19.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.913 -1.117 . . . . 0.0 108.373 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.869 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.36 165.8 8.57 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.038 -1.039 . . . . 0.0 110.009 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.8 Cg_exo -50.25 36.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.721 1.614 . . . . 0.0 111.733 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.869 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.5 54.47 0.73 Allowed Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.68 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.2 Cg_endo -79.18 169.68 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.66 1.573 . . . . 0.0 111.849 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.59 -4.68 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.256 1.304 . . . . 0.0 111.29 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 26' ' ' ALA . 5.2 t -113.23 -70.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.623 -0.673 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.07 -97.83 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.783 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.2 Cg_exo -58.72 -55.54 1.99 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 CA-C-N 117.97 0.885 . . . . 0.0 110.384 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.794 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -48.77 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.643 . . . . 0.0 110.779 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.843 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -103.24 -48.44 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.261 . . . . 0.0 107.956 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.27 86.74 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.4 mt-30 -146.33 -20.12 0.44 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.673 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 6.9 p80 -79.49 -38.24 34.92 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -170.89 -4.42 0.03 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 84.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.966 . . . . 0.0 112.346 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -158.92 120.11 3.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.076 -1.015 . . . . 0.0 108.711 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.726 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 26.4 mm -93.42 -66.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.728 -0.608 . . . . 0.0 110.076 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.658 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.8 tpt -41.14 -57.71 1.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.664 -1.273 . . . . 0.0 109.728 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.5 mm-40 -44.95 -47.06 11.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.56 -1.337 . . . . 0.0 107.793 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.843 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -53.05 -68.84 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.466 1.127 . . . . 0.0 109.899 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.655 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 21.9 t -66.38 -37.7 80.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.775 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.658 ' N ' ' O ' ' A' ' 35' ' ' MET . 44.1 tptt -45.67 -61.81 1.55 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.55 69.25 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 108.85 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.688 ' O ' HG23 ' A' ' 45' ' ' THR . 3.3 t80 -70.91 -77.07 0.09 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.655 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 1.9 m-80 -41.35 -32.23 0.29 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.953 -1.092 . . . . 0.0 110.751 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -69.52 -33.22 72.5 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.93 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.732 ' HB1' ' HZ3' ' A' ' 70' ' ' LYS . . . -90.52 -47.07 7.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.612 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 41' ' ' PHE . 2.2 p -58.6 -31.34 67.97 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.2 -46.04 21.47 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.97 -22.46 38.36 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 0.0 108.922 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.724 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.63 -73.98 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.406 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.724 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 175.17 -154.66 18.66 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.8 t0 -96.28 146.49 24.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.291 . . . . 0.0 108.934 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.078 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 175.01 -153.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.816 -1.178 . . . . 0.0 110.869 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.2 mm -146.09 137.36 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 71' ' ' THR . 2.6 t -137.94 136.15 19.49 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.807 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.8 Cg_endo -72.78 104.66 1.78 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.803 1.669 . . . . 0.0 111.07 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.815 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.5 m -78.34 135.98 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 111.362 -178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.5 tt0 -129.07 69.98 1.4 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.78 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -70.24 90.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.855 0.836 . . . . 0.0 109.967 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.403 HG22 HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -70.59 95.88 1.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 64' ' ' SER . 60.1 mt -100.11 143.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.58 -0.7 . . . . 0.0 110.672 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.778 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.6 m-85 -114.46 138.0 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -46.43 -31.45 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.227 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.29 2.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.776 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 71.87 66.92 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.137 0.97 . . . . 0.0 109.631 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.4 OUTLIER -149.17 125.15 10.63 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.1 p90 -103.75 104.16 14.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.124 -0.985 . . . . 0.0 110.139 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.618 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.87 120.92 41.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.035 . . . . 0.0 110.249 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.945 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.7 OUTLIER 170.38 148.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.962 -1.086 . . . . 0.0 111.214 177.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.6 t -169.39 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.254 1.026 . . . . 0.0 108.639 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.59 149.2 27.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.746 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -133.63 122.98 24.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.343 -1.473 . . . . 0.0 110.525 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.8 p 76.02 148.8 0.12 Allowed Pre-proline 0 N--CA 1.492 1.661 0 CA-C-O 121.272 0.558 . . . . 0.0 110.235 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.2 Cg_exo -42.32 175.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.573 2.182 . . . . 0.0 112.803 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.0 Cg_exo -38.87 174.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.498 1.466 . . . . 0.0 111.855 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 53.03 -84.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 73' ' ' PRO . 71.8 p -44.67 -23.15 0.11 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 111.36 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.675 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 14.1 p90 -43.81 -39.59 3.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.174 -0.954 . . . . 0.0 109.199 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.854 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.5 pp -135.05 -14.6 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.012 HD12 ' HB1' ' A' ' 74' ' ' ALA . 6.6 mt -61.15 -31.22 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.753 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 10.8 mmt180 -55.38 -44.78 76.4 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HZ3' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -64.22 -66.89 0.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.695 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.51 -4.94 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.083 -1.011 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.21 -80.36 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 111.725 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 175.76 28.47 0.03 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.548 HD11 HH11 ' A' ' 79' ' ' ARG . 3.1 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.973 -1.31 . . . . 0.0 109.135 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 20.8 t . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.305 0.574 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.433 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 72.37 50.46 16.11 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.789 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.58 114.46 14.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.133 -1.216 . . . . 0.0 109.966 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.37 -174.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.649 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -127.51 159.8 33.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.4 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.678 ' O ' HG22 ' A' ' 104' ' ' VAL . 19.3 t-105 -50.61 -69.61 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.5 -0.75 . . . . 0.0 110.84 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.49 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.24 -46.76 55.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.686 -1.259 . . . . 0.0 110.352 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.695 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -49.19 -47.61 45.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.689 -179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.821 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.3 m -72.11 -23.43 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.097 -1.441 . . . . 0.0 107.99 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 120' ' ' LEU . 17.8 mt -68.09 -73.47 0.14 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 79.5 tt0 -44.03 -41.26 5.32 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.969 -1.082 . . . . 0.0 108.436 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.588 HD13 HD11 ' A' ' 77' ' ' LEU . 48.4 mt -64.6 -30.71 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.128 -0.983 . . . . 0.0 108.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.809 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.73 -26.86 15.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.3 mtpm? -58.54 -73.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.992 -1.067 . . . . 0.0 108.402 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 109' ' ' LYS . 64.7 mt-30 -45.99 -27.38 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 108.911 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 113' ' ' PRO . 12.5 tttt -70.99 -17.68 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.772 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.687 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.04 67.22 79.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.143 -0.973 . . . . 0.0 109.761 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 111' ' ' LYS . 2.4 Cg_endo -66.91 -33.5 32.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.574 1.516 . . . . 0.0 112.088 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 8.0 p30 174.96 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 109.207 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.25 -77.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.552 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -150.51 -25.02 0.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.037 HG22 ' H ' ' A' ' 118' ' ' THR . 23.8 m -65.65 -164.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.973 . . . . 0.0 109.59 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.037 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.42 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 0.0 109.921 -179.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -60.98 141.0 57.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 110.113 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.37 -22.04 64.59 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.24 1.019 . . . . 0.0 108.919 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.76 -37.81 87.35 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.504 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.548 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.22 -75.33 0.11 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.232 -1.387 . . . . 0.0 107.83 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.642 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.43 -42.09 6.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.462 -1.399 . . . . 0.0 109.32 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -50.29 -68.76 0.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.106 -0.996 . . . . 0.0 108.609 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.696 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.71 -41.95 5.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 130' ' ' SER . 4.9 tpp -52.84 -80.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.077 -1.014 . . . . 0.0 109.082 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.809 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.4 mm -46.57 -62.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.478 -0.764 . . . . 0.0 110.019 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.821 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.65 -69.6 0.2 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -39.07 3.38 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 126' ' ' MET . 27.5 p -56.48 -52.0 66.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.516 -1.579 . . . . 0.0 107.592 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.646 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -46.94 -49.05 21.23 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.17 -53.98 9.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.648 ' C ' ' H ' ' A' ' 135' ' ' GLY . 9.9 t -44.83 -67.17 0.31 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.753 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 10.1 ttm -49.23 -2.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 88.07 -26.27 7.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.231 -1.947 . . . . 0.0 108.231 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.646 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.1 t -49.49 165.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.864 . . . . 0.0 109.47 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.571 ' N ' HG12 ' A' ' 136' ' ' VAL . 39.2 mp0 -141.99 162.48 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.627 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.4 164.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.928 HG13 ' O ' ' A' ' 139' ' ' VAL . 3.7 p . . . . . 0 N--CA 1.487 1.416 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.748 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.292 0.568 . . . . 0.0 109.542 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.875 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -115.13 -24.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.19 -0.944 . . . . 0.0 108.478 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.75 107.59 5.39 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.258 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -95.59 73.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.831 HG13 HD12 ' A' ' 10' ' ' LEU . 18.1 t -46.78 89.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.662 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 7' ' ' VAL . 6.0 tmtt? -82.62 34.81 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.792 0.806 . . . . 0.0 108.909 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.845 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.36 -174.57 3.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.678 0.751 . . . . 0.0 111.17 -178.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.6 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -122.19 172.83 7.98 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -166.58 156.99 10.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 110.059 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.612 ' HA ' HD13 ' A' ' 52' ' ' ILE . 11.3 Cg_endo -68.56 111.24 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.979 1.786 . . . . 0.0 111.668 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.816 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -69.85 39.22 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.982 -1.073 . . . . 0.0 110.499 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.464 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -175.0 -20.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.509 -1.805 . . . . 0.0 111.487 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -142.61 88.4 2.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.609 -1.524 . . . . 0.0 110.291 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 18' ' ' THR . . . -105.14 164.53 11.75 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.16 164.54 4.11 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 109.367 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HA ' HG21 ' A' ' 34' ' ' ILE . 2.7 Cg_endo -55.56 30.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.309 1.339 . . . . 0.0 111.781 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.756 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -151.62 54.07 1.27 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 110.02 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.756 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 19.8 Cg_endo -86.47 168.74 8.52 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.904 1.736 . . . . 0.0 111.614 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.1 -4.63 1.06 Allowed 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 120.935 1.09 . . . . 0.0 110.765 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.732 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.98 -71.25 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.477 0.656 . . . . 0.0 109.911 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 54.41 -98.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.732 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -59.39 -55.83 1.62 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-N 118.11 0.955 . . . . 0.0 109.961 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -44.67 -6.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.358 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -111.09 -44.58 3.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.77 -1.206 . . . . 0.0 108.803 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.34 84.32 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 27' ' ' LEU . 66.3 tp60 -149.07 -12.44 0.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.386 -1.067 . . . . 0.0 108.214 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.599 ' ND1' ' C ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -85.46 -37.13 20.1 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -170.21 2.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 70.75 78.6 0.18 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.84 -0.8 . . . . 0.0 111.969 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -156.54 120.57 4.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.004 -1.06 . . . . 0.0 108.688 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 30.1 mm -98.55 -63.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.724 -0.61 . . . . 0.0 109.746 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.47 ' C ' ' O ' ' A' ' 34' ' ' ILE . 4.9 tpt -41.39 -55.31 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.733 -1.229 . . . . 0.0 109.653 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' MET . 15.8 mt-10 -46.76 -48.3 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 107.741 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -50.67 -68.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.945 1.355 . . . . 0.0 109.177 177.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 17' ' ' ALA . 45.6 t -54.17 -34.68 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.608 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 1.5 mmmp? -56.55 -65.8 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.76 64.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.71 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -71.31 -76.74 0.1 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.5 m-80 -41.65 -34.54 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.512 1.148 . . . . 0.0 110.583 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' O ' ' CG ' ' A' ' 47' ' ' ASN . . . -66.45 -35.67 80.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.77 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.77 -52.0 5.09 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.683 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.761 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.1 p -54.32 -29.45 47.84 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.52 -47.2 12.44 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.553 ' CG ' ' O ' ' A' ' 43' ' ' ALA . 7.6 m120 -52.38 -23.24 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.318 -0.864 . . . . 0.0 108.983 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.597 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.65 -85.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.678 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.597 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.23 -135.77 1.89 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.855 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.29 125.87 44.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -1.106 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.816 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -159.4 -153.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.612 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.5 mm -147.44 143.85 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.515 HG22 ' C ' ' A' ' 71' ' ' THR . 5.9 t -145.16 136.94 12.93 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.2 Cg_endo -74.12 90.0 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.823 1.682 . . . . 0.0 110.763 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.845 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.9 m -61.98 137.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 122.783 1.278 . . . . 0.0 112.365 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.4 mt-10 -128.81 64.34 1.45 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.766 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.0 mt -64.98 89.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.697 0.76 . . . . 0.0 110.501 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.22 96.89 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.537 HG13 HG22 ' A' ' 57' ' ' ILE . 36.1 mt -99.31 144.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.63 -0.669 . . . . 0.0 110.368 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.748 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 5.0 m-85 -115.81 140.3 49.36 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.875 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.75 -29.61 4.7 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.235 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 55.4 p30 -53.67 4.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.834 ' H ' ' C ' ' A' ' 61' ' ' ALA . 79.1 mtm180 69.05 68.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.985 0.898 . . . . 0.0 109.655 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 p -147.76 128.85 14.58 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -105.51 103.96 13.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.978 -1.076 . . . . 0.0 110.422 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 58' ' ' THR . 8.3 p -98.72 124.64 43.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.71 172.02 7.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.569 -1.332 . . . . 0.0 109.417 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.975 HG12 ' O ' ' A' ' 68' ' ' VAL . 89.8 t -162.83 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 112.622 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.535 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.53 117.28 4.38 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.67 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.813 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.15 120.96 41.51 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.784 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.93 150.53 0.13 Allowed Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.434 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.61 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.7 Cg_exo -38.62 175.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.817 2.345 . . . . 0.0 113.35 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.763 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.72 166.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.574 1.516 . . . . 0.0 111.788 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.987 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 55.01 -76.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.763 ' N ' ' O ' ' A' ' 73' ' ' PRO . 55.3 p -43.17 -24.29 0.08 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 110.128 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.087 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 20.0 p90 -43.59 -43.16 5.5 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 0.0 109.227 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.087 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.88 -13.86 2.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.987 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.5 mt -62.33 -33.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.799 ' CG ' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.81 -40.81 73.27 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 82' ' ' ALA . 1.8 tmtp? -68.91 -66.33 0.59 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.76 -4.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.695 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.79 -80.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 111.958 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 152.01 52.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.049 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.672 HD11 ' CD ' ' A' ' 79' ' ' ARG . 18.3 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 120.844 -1.386 . . . . 0.0 109.045 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 97' ' ' GLY . 83.5 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.313 0.578 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.57 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 72.75 63.66 2.8 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.695 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.4 mtt180 -134.72 112.48 10.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -1.205 . . . . 0.0 110.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.798 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -102.79 177.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.646 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.703 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -119.33 151.89 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 108.979 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.693 ' O ' HG22 ' A' ' 104' ' ' VAL . 23.4 t-105 -45.93 -69.96 0.12 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 110.91 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.492 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 5.8 tp10 -49.23 -50.36 38.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.718 -1.239 . . . . 0.0 111.018 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.41 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 3.6 mt-30 -51.72 -42.09 62.01 Favored 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.509 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.753 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.56 -26.1 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 117.46 -1.696 . . . . 0.0 107.184 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.896 HD13 HD13 ' A' ' 120' ' ' LEU . 21.6 mt -65.97 -71.27 0.2 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 17.5 mm-40 -43.98 -43.15 6.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.921 -1.112 . . . . 0.0 108.534 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.787 HG12 HD11 ' A' ' 77' ' ' LEU . 52.8 mt -63.5 -31.87 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.592 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.804 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.63 -32.43 13.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.621 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.726 ' HG2' HD21 ' A' ' 120' ' ' LEU . 4.7 mtpt -52.39 -71.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.835 -1.166 . . . . 0.0 108.275 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 109' ' ' LYS . 16.3 tt0 -44.76 -28.74 0.67 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 108.736 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -72.68 -6.95 47.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.75 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.589 ' SD ' ' HB3' ' A' ' 123' ' ' ALA . 7.3 ptm -134.13 63.97 63.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 109.828 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 112' ' ' MET . 4.0 Cg_endo -68.72 -41.13 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.607 1.538 . . . . 0.0 112.059 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.558 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 66.2 t0 -177.37 6.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.444 -0.785 . . . . 0.0 109.089 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.0 mm? -46.42 -83.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 109.583 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -148.66 -19.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.049 HG22 ' H ' ' A' ' 118' ' ' THR . 26.9 m -65.87 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.049 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.69 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.517 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -73.01 140.41 47.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.431 -0.793 . . . . 0.0 110.121 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.896 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -59.65 -23.65 63.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.376 1.084 . . . . 0.0 108.883 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -64.15 -35.58 81.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.574 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.552 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.35 -75.99 0.12 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.272 -1.371 . . . . 0.0 108.072 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.589 ' HB3' ' SD ' ' A' ' 112' ' ' MET . . . -45.01 -35.87 3.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.539 -1.351 . . . . 0.0 109.191 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -55.77 -70.4 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.022 -1.049 . . . . 0.0 108.668 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.665 ' O ' ' N ' ' A' ' 129' ' ' GLY . 20.1 ttp180 -43.51 -39.57 3.44 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.5 ttp -53.27 -78.71 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.134 -0.979 . . . . 0.0 108.53 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.804 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.1 mm -47.94 -63.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.481 -0.762 . . . . 0.0 109.978 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.74 -71.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.87 -41.91 4.72 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.22 -49.35 69.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.583 -1.539 . . . . 0.0 107.578 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.716 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.18 -47.83 45.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.08 -54.69 8.08 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.71 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.6 t -44.87 -68.83 0.16 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.662 ' HG2' HG23 ' A' ' 136' ' ' VAL . 3.4 ttp -46.0 -4.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.71 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.04 -31.77 5.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.716 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 27.1 t -45.28 165.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' N ' HG12 ' A' ' 136' ' ' VAL . 3.5 tp10 -144.33 163.61 33.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.332 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.04 123.93 36.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 99' ' ' ILE . 9.0 p . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.574 -0.704 . . . . 0.0 110.345 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.563 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.064 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -122.31 -24.85 2.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.057 -1.027 . . . . 0.0 110.12 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -155.42 104.91 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.605 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -97.26 74.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.787 ' HB ' HD12 ' A' ' 57' ' ' ILE . 16.5 t -48.82 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.503 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.615 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.3 tmtp? -82.94 37.31 0.53 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.861 0.839 . . . . 0.0 109.217 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.9 tp -78.09 -174.09 3.47 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.901 0.858 . . . . 0.0 111.235 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.858 HE21 ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.26 176.56 6.35 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.697 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -164.43 146.36 6.99 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.847 -1.158 . . . . 0.0 109.299 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 74.1 Cg_endo -84.9 125.78 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.324 2.016 . . . . 0.0 113.576 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.058 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.41 143.77 44.61 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.21 56.08 16.31 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 22.1 tttp 174.35 3.93 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.733 -0.863 . . . . 0.0 109.191 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 18' ' ' THR . . . -86.73 153.32 21.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.892 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.5 165.78 6.15 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.976 -1.078 . . . . 0.0 110.005 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.7 Cg_exo -49.04 33.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.684 1.589 . . . . 0.0 111.868 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.892 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -150.85 54.34 1.41 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.536 -0.728 . . . . 0.0 109.61 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 14.5 Cg_endo -80.23 167.0 20.06 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.72 1.613 . . . . 0.0 111.898 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.61 -4.66 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.24 1.294 . . . . 0.0 111.341 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.779 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.4 t -113.34 -69.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.193 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.41 -97.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_endo -58.71 -55.29 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 CA-C-N 117.892 0.846 . . . . 0.0 110.408 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.774 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -49.56 -9.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.742 -0.599 . . . . 0.0 110.782 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.865 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -106.27 -49.04 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.682 -1.261 . . . . 0.0 108.237 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.62 94.13 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 27' ' ' LEU . 51.3 tt0 -154.54 -24.41 0.12 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.724 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -77.77 -44.78 26.54 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.891 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.724 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -165.98 -11.53 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.14 82.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -1.09 . . . . 0.0 112.397 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.613 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 28.2 p30 -153.01 69.63 0.85 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.83 -1.169 . . . . 0.0 109.14 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.728 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 24.0 mm -44.32 -69.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.702 ' O ' ' N ' ' A' ' 39' ' ' LYS . 7.8 tpt -41.71 -57.38 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.582 -1.324 . . . . 0.0 108.869 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.613 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 69.9 tt0 -44.86 -49.7 10.74 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.865 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -49.58 -65.57 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.723 1.249 . . . . 0.0 109.627 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 42' ' ' ASN . 23.8 t -67.21 -35.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -46.7 -62.2 1.49 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.73 70.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 108.922 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' THR . 2.8 t80 -71.05 -77.55 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.4 t-20 -41.33 -36.91 0.89 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.825 -1.172 . . . . 0.0 110.585 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -64.72 -33.83 76.89 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.11 -59.59 2.15 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.451 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 41' ' ' PHE . 1.7 p -44.53 -31.7 1.19 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.75 23.89 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -56.34 -25.17 48.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.436 -0.79 . . . . 0.0 109.405 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.55 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -111.5 -73.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.04 -1.037 . . . . 0.0 109.864 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.51 -165.81 34.73 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.944 -1.598 . . . . 0.0 111.392 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.5 p30 -87.22 147.15 25.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.056 -1.261 . . . . 0.0 109.082 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.058 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.93 -153.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.122 . . . . 0.0 110.81 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 13' ' ' PRO . 1.9 mm -146.26 138.18 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 71' ' ' THR . 2.4 t -137.25 135.41 19.53 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.045 -1.034 . . . . 0.0 110.776 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -73.02 102.95 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.685 1.59 . . . . 0.0 111.161 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.825 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.7 m -76.51 136.53 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.658 -1.276 . . . . 0.0 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.1 tt0 -129.88 69.76 1.43 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.787 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -70.31 88.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.721 0.772 . . . . 0.0 110.063 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.43 ' HB ' ' HG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -64.18 95.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 53.9 mt -95.27 131.15 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.575 0.703 . . . . 0.0 110.479 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.563 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -108.29 133.09 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 1.064 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -45.79 -30.89 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.567 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.53 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 27.4 p30 -53.94 2.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.791 ' H ' ' C ' ' A' ' 61' ' ' ALA . 7.5 ttp180 70.83 67.08 0.18 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.2 1.0 . . . . 0.0 110.08 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 p -150.39 124.92 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.4 p90 -102.24 103.86 14.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.041 -1.037 . . . . 0.0 109.89 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.609 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.04 120.98 40.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.189 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.954 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.34 148.78 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 0.0 111.179 177.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.0 t -169.98 96.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.08 145.11 30.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.752 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -129.41 123.69 32.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.509 -1.369 . . . . 0.0 110.545 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.752 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.21 150.66 0.13 Allowed Pre-proline 0 N--CA 1.493 1.685 0 CA-C-O 121.175 0.512 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.4 Cg_exo -41.86 175.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.731 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.1 Cg_exo -38.9 171.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.379 1.386 . . . . 0.0 112.035 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.973 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.67 -80.62 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 73' ' ' PRO . 86.6 p -43.61 -23.14 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 110.019 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.053 ' CE1' HD12 ' A' ' 77' ' ' LEU . 16.9 p90 -44.02 -38.91 3.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.243 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -136.95 -14.29 1.59 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.243 ' N ' HD13 ' A' ' 77' ' ' LEU . 1.7 mt -63.39 -33.25 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.567 ' CD ' HG21 ' A' ' 71' ' ' THR . 14.2 mmt180 -55.1 -42.69 73.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 82' ' ' ALA . 6.2 tmtt? -64.2 -65.99 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.67 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.29 -5.3 0.47 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.71 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.65 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.93 -80.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 111.778 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.663 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 167.98 47.52 0.03 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.071 -1.538 . . . . 0.0 110.671 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.467 HD11 ' CD ' ' A' ' 79' ' ' ARG . 4.0 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 0.0 109.132 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 83' ' ' GLY . 95.5 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.269 0.557 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.524 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 78.72 56.92 3.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.65 ' O ' ' O ' ' A' ' 82' ' ' ALA . 3.6 ttt180 -130.57 116.65 18.43 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.287 -1.125 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.682 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.6 168.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.527 -0.733 . . . . 0.0 109.647 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.741 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -109.11 151.04 26.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 108.985 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 104' ' ' VAL . 25.8 t-105 -45.82 -68.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.471 -0.768 . . . . 0.0 110.872 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.414 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 5.9 tp10 -51.32 -47.2 62.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.528 -1.357 . . . . 0.0 110.892 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.67 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -51.49 -43.58 62.24 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.017 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.776 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.01 -24.8 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 117.89 -1.524 . . . . 0.0 107.617 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.876 HD13 HD13 ' A' ' 120' ' ' LEU . 20.8 mt -66.14 -71.55 0.19 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -44.19 -44.78 8.02 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.964 -1.085 . . . . 0.0 108.515 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.773 HG12 HD21 ' A' ' 77' ' ' LEU . 55.8 mt -61.02 -31.4 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.689 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.827 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.03 -24.28 16.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.687 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.1 mtpt -59.57 -73.65 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 108.158 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.47 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 37.5 mt-30 -51.27 -17.94 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.815 . . . . 0.0 109.292 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.56 -8.14 58.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.52 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -133.37 57.87 29.93 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.024 -1.047 . . . . 0.0 109.748 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.99 -41.91 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.521 1.481 . . . . 0.0 112.283 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' LEU . 24.9 t70 -160.68 8.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.44 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.6 mp -44.93 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 109.293 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.427 ' H ' ' H ' ' A' ' 117' ' ' THR . 10.5 t30 -165.18 -4.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.237 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.031 HG22 ' H ' ' A' ' 118' ' ' THR . 29.8 m -74.23 -164.66 0.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.584 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.031 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.97 -57.71 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 118' ' ' THR . 0.7 OUTLIER -80.01 135.02 36.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.876 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -54.24 -24.78 19.96 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.183 0.992 . . . . 0.0 109.172 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.14 -36.74 85.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.535 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.641 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.65 -74.71 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.499 -1.376 . . . . 0.0 108.039 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.59 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.89 -37.65 4.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.496 -1.378 . . . . 0.0 109.136 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -55.34 -70.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 108.925 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -43.49 -38.8 3.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.698 ' O ' ' N ' ' A' ' 130' ' ' SER . 14.0 ttm -53.77 -78.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.827 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.3 mm -48.04 -63.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 109.97 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.776 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.39 -71.84 0.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.9 -42.7 5.08 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 126' ' ' MET . 58.7 m -54.74 -46.18 74.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.616 -1.52 . . . . 0.0 107.462 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.738 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -50.43 -47.55 56.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.0 tmt_? -46.83 -52.32 14.54 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -48.62 -70.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.52 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 5.6 ttm -44.51 -4.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.15 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.75 22.91 54.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.738 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 29.8 t -109.23 138.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -115.03 166.67 11.55 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.837 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -82.79 124.82 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' A' ' 100' ' ' THR . 12.2 p . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.783 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.737 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.5 m -116.92 -24.49 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.18 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.53 114.18 9.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.118 . . . . 0.0 110.529 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -102.55 73.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.78 ' HB ' HD12 ' A' ' 57' ' ' ILE . 7.9 t -48.56 88.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.764 -1.21 . . . . 0.0 110.606 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.9 tmtt? -82.0 36.74 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.168 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.3 mp -77.21 -174.0 3.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.59 0.709 . . . . 0.0 110.977 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 1.09 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.07 177.76 6.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -170.27 157.91 5.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.943 -1.098 . . . . 0.0 109.839 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.674 ' O ' ' N ' ' A' ' 15' ' ' GLY . 10.4 Cg_endo -66.69 104.92 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.373 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.813 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -60.9 38.65 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.338 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.57 -19.42 0.02 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.488 -1.815 . . . . 0.0 111.357 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 10.4 tttm -148.39 79.7 1.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.578 -1.542 . . . . 0.0 110.705 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.771 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -94.96 170.16 9.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.78 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.74 164.25 4.51 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.768 -1.207 . . . . 0.0 110.494 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.4 Cg_exo -51.75 32.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.029 1.819 . . . . 0.0 112.11 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -137.92 53.98 6.91 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.077 -1.015 . . . . 0.0 110.384 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.713 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.7 Cg_endo -85.97 163.13 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.8 1.667 . . . . 0.0 111.809 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.1 -4.81 4.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.016 1.144 . . . . 0.0 111.405 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.815 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 22.0 t -118.59 -66.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.588 -0.695 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.53 -97.23 0.05 OUTLIER Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.815 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.2 Cg_exo -54.3 -55.05 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 CA-C-N 117.876 0.838 . . . . 0.0 110.538 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -64.22 4.7 0.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.665 . . . . 0.0 111.211 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.752 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -109.62 -64.18 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.66 -1.275 . . . . 0.0 109.797 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.58 -16.75 0.07 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 28' ' ' GLY . 22.3 tp60 -42.08 -16.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.472 -1.605 . . . . 0.0 109.528 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.71 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -65.52 -46.29 80.2 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.71 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.67 -5.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.624 ' C ' ' ND2' ' A' ' 33' ' ' ASN . . . 70.86 76.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.077 -0.661 . . . . 0.0 111.892 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.624 ' ND2' ' C ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -152.06 64.86 0.84 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.307 1.051 . . . . 0.0 108.334 177.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.5 mm -43.22 -66.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.643 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.0 tpt -41.56 -42.52 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.619 -1.3 . . . . 0.0 108.759 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.21 -49.39 76.16 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -50.91 -67.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.66 1.219 . . . . 0.0 109.093 178.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 17' ' ' ALA . 24.8 t -63.36 -36.46 76.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.3 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.5 ttpt -48.99 -60.17 3.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.33 71.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.354 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.64 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.9 t80 -68.79 -76.5 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.575 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.9 m-80 -41.8 -32.9 0.44 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.399 1.095 . . . . 0.0 110.893 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.73 -34.75 77.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.611 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.82 -51.55 5.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.775 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.791 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 22.7 p -54.36 -31.48 54.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.33 -45.3 16.37 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -54.17 -22.99 12.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.394 -0.816 . . . . 0.0 109.145 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.58 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.1 -85.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.58 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.94 -144.17 3.99 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.015 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.17 119.8 37.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -1.11 . . . . 0.0 109.806 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.813 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -155.8 -152.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.855 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.595 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.6 mm -146.26 141.83 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 14' ' ' ALA . 6.9 t -144.32 137.5 13.98 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.911 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.6 Cg_endo -73.51 91.72 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.779 1.653 . . . . 0.0 111.482 178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.2 m -57.92 137.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.3 mt-10 -130.19 70.65 1.44 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.78 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.6 mt -70.67 90.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.856 0.836 . . . . 0.0 110.226 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 m -69.98 104.94 2.67 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 64' ' ' SER . 21.1 mt -110.33 148.23 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.494 -0.754 . . . . 0.0 110.927 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.783 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.9 m-85 -116.63 140.94 48.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.785 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.56 -32.46 5.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.267 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -51.44 -1.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.785 ' H ' ' C ' ' A' ' 61' ' ' ALA . 13.1 mtp180 75.02 70.03 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.992 0.901 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -149.44 138.08 20.96 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 42.9 p90 -115.13 103.93 11.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.963 -1.086 . . . . 0.0 110.312 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.47 121.07 41.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.089 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.911 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.37 148.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.955 -1.09 . . . . 0.0 111.211 177.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.8 t -168.49 79.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -87.16 138.15 31.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.656 ' O ' ' OG1' ' A' ' 71' ' ' THR . 8.1 mttm -122.94 140.15 53.3 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.198 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.679 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 2.2 p 57.73 158.07 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.603 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.565 ' O ' ' O ' ' A' ' 71' ' ' THR . 12.7 Cg_exo -39.5 175.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.309 2.006 . . . . 0.0 112.691 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.715 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.9 Cg_exo -40.02 170.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.69 1.593 . . . . 0.0 112.253 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.897 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 58.07 -73.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.715 ' N ' ' O ' ' A' ' 73' ' ' PRO . 7.5 p -43.98 -25.34 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.945 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.055 ' CE1' HD12 ' A' ' 77' ' ' LEU . 17.4 p90 -43.61 -43.21 5.58 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.237 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.85 -13.79 3.2 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.237 ' N ' HD13 ' A' ' 77' ' ' LEU . 1.4 mt -63.31 -29.78 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.76 ' CD ' HD11 ' A' ' 84' ' ' LEU . 3.6 mmt180 -54.07 -48.68 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.7 tmtt? -63.81 -66.14 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.61 -6.54 0.12 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.623 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.57 -77.9 0.35 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 111.949 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 146.9 62.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.038 -1.553 . . . . 0.0 111.189 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.76 HD11 ' CD ' ' A' ' 79' ' ' ARG . 16.8 mt . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.951 -1.323 . . . . 0.0 108.901 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 97' ' ' GLY . 86.2 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.271 0.557 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.588 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 70.89 67.81 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.788 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.57 109.82 9.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -1.212 . . . . 0.0 110.403 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.687 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.42 175.59 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.786 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -123.34 158.38 31.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.687 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.4 t-105 -45.19 -70.86 0.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.351 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.511 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.72 -50.8 54.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.562 -1.336 . . . . 0.0 111.108 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.0 mt-30 -49.27 -43.66 43.24 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.288 -0.883 . . . . 0.0 110.35 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.35 -24.79 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.616 -1.634 . . . . 0.0 107.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 120' ' ' LEU . 13.5 mt -66.32 -71.45 0.19 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.497 ' CD ' ' OE2' ' A' ' 102' ' ' GLU . 35.1 mt-10 -43.77 -43.72 6.26 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.93 -1.106 . . . . 0.0 108.461 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.683 HG12 HD21 ' A' ' 77' ' ' LEU . 55.2 mt -61.65 -31.5 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 108.396 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.815 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.97 -26.77 15.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 109.62 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.8 mtpt -59.26 -73.56 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 0.0 108.211 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 3.1 tt0 -49.35 -18.27 0.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.253 -0.904 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.511 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.8 tmtt? -80.82 -10.2 59.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.581 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -132.38 55.46 17.82 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.9 Cg_endo -60.2 -40.89 55.87 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.567 1.512 . . . . 0.0 112.3 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.529 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -164.91 9.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.54 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.459 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.2 mp -45.0 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.356 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -160.24 -10.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.024 HG22 ' H ' ' A' ' 118' ' ' THR . 29.0 m -68.65 -164.63 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.024 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.65 -57.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -80.2 135.22 36.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -54.86 -23.74 19.89 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.16 0.981 . . . . 0.0 109.103 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.11 -35.8 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.47 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.627 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.63 -74.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.964 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.644 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.63 -39.05 4.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.342 -1.474 . . . . 0.0 109.152 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.5 -69.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.087 -1.008 . . . . 0.0 108.728 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.79 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -42.81 5.36 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.705 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.5 ttm -51.29 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.115 -0.991 . . . . 0.0 108.454 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.815 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.5 mm -48.37 -66.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.678 0.751 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.884 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -57.89 -71.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.86 -40.82 4.23 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 126' ' ' MET . 44.0 m -56.26 -51.25 68.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.518 -1.577 . . . . 0.0 107.723 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.14 -47.63 23.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.767 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -47.06 -54.26 10.75 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.701 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.1 t -44.77 -68.59 0.18 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.656 ' HG2' HG23 ' A' ' 136' ' ' VAL . 3.8 ttp -46.46 -4.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.73 -31.49 4.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.796 -2.122 . . . . 0.0 107.796 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.656 HG23 ' HG2' ' A' ' 134' ' ' MET . 31.3 t -45.09 165.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.937 -0.743 . . . . 0.0 109.173 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.9 tm-20 -142.43 162.26 35.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.598 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.587 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -78.08 164.35 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 139' ' ' VAL . 4.1 p . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.748 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.924 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.0 m -121.12 -24.59 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.19 110.88 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.605 -1.309 . . . . 0.0 110.716 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -100.92 73.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.827 ' HB ' HD12 ' A' ' 57' ' ' ILE . 21.5 t -46.36 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 110.49 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.9 tmmm? -83.26 34.99 0.48 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.091 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.78 -174.15 3.81 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.917 0.865 . . . . 0.0 111.596 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -121.55 172.12 8.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.51 160.93 4.11 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.854 -1.154 . . . . 0.0 109.857 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.79 ' HD2' HD23 ' A' ' 12' ' ' LEU . 8.8 Cg_endo -61.53 129.41 27.91 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.042 1.828 . . . . 0.0 111.81 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.83 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -90.62 42.16 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 111.28 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.621 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 172.43 -12.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.59 70.96 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.419 . . . . 0.0 109.557 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.642 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -90.8 165.21 13.77 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.431 -0.793 . . . . 0.0 109.319 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.69 161.73 5.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.667 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -54.04 31.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.509 1.473 . . . . 0.0 111.466 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -144.94 54.3 2.44 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 0.0 110.265 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.3 Cg_endo -83.09 154.87 14.72 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.584 1.523 . . . . 0.0 111.544 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.58 -4.46 0.32 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.048 1.165 . . . . 0.0 111.018 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.091 HG22 HD22 ' A' ' 10' ' ' LEU . 2.9 t -103.77 -71.82 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.524 0.678 . . . . 0.0 110.592 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.29 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.741 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.11 -55.5 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 CA-C-N 118.048 0.924 . . . . 0.0 110.188 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.587 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -45.0 -7.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.815 -0.553 . . . . 0.0 110.657 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.745 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -108.37 -45.57 3.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.686 -1.259 . . . . 0.0 108.798 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.81 88.95 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' LEU . 2.7 tt0 -149.73 -15.19 0.27 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.617 ' ND1' ' C ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -89.46 -36.85 15.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -172.36 -1.82 0.03 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.09 82.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.96 . . . . 0.0 112.188 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.583 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 26.7 p-10 -156.74 119.22 3.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.867 -1.145 . . . . 0.0 109.08 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.2 mm -93.96 -65.26 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.4 tpt -42.72 -55.08 3.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.948 -1.095 . . . . 0.0 109.417 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.498 ' CB ' ' ND2' ' A' ' 33' ' ' ASN . 4.8 mp0 -51.01 -53.41 33.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 108.458 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.745 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -46.17 -59.11 3.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.936 1.35 . . . . 0.0 108.796 177.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 17' ' ' ALA . 87.2 t -70.87 -26.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 35' ' ' MET . 23.1 tptt -56.26 -55.25 35.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.79 78.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.729 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CD2' HG21 ' A' ' 45' ' ' THR . 0.6 OUTLIER -67.37 -75.73 0.09 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.637 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 8.9 t-20 -41.78 -35.84 0.89 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.26 1.029 . . . . 0.0 110.715 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -62.95 -34.28 77.15 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.52 -60.33 1.91 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.502 1.144 . . . . 0.0 108.76 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.786 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 52.7 p -47.53 -28.06 2.07 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.764 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.29 -46.71 9.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -49.54 -19.92 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.239 -0.913 . . . . 0.0 108.883 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.645 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.83 -85.29 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.255 -0.903 . . . . 0.0 109.679 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.645 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -166.21 -150.8 6.48 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.912 -1.613 . . . . 0.0 110.962 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HA3' ' A' ' 15' ' ' GLY . 21.4 m-20 -106.39 107.81 19.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.565 -0.962 . . . . 0.0 110.037 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.83 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -143.48 -152.87 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 109.616 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 13' ' ' PRO . 7.1 mm -146.6 142.88 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 71' ' ' THR . 1.6 t -144.91 139.25 15.04 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.7 Cg_endo -75.75 91.48 1.08 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.766 1.644 . . . . 0.0 111.025 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.849 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.9 m -59.56 138.06 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 9.9 mt-10 -131.14 66.55 1.53 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.827 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -66.53 92.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.665 0.745 . . . . 0.0 110.397 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.11 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 64' ' ' SER . 89.4 mt -103.05 142.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.509 -0.744 . . . . 0.0 110.683 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.748 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 5.6 m-85 -115.91 138.36 51.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.924 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.9 -30.75 4.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.437 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.23 1.5 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.809 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.7 OUTLIER 71.38 68.07 0.16 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.04 0.924 . . . . 0.0 109.893 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -149.47 131.24 15.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.3 p90 -108.63 104.11 13.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.049 -1.032 . . . . 0.0 110.098 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.5 121.02 41.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.978 -1.076 . . . . 0.0 110.201 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.95 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.21 149.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.953 -1.092 . . . . 0.0 111.283 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.1 t -169.69 84.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 138.7 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.816 ' O ' ' OG1' ' A' ' 71' ' ' THR . 14.8 mtmt -124.37 141.67 51.89 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.071 -1.451 . . . . 0.0 110.766 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.816 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 41.4 p 62.5 155.13 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.818 -0.552 . . . . 0.0 109.874 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' O ' ' OG ' ' A' ' 75' ' ' SER . 7.8 Cg_exo -42.09 175.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.406 2.071 . . . . 0.0 112.737 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 75' ' ' SER . 29.1 Cg_exo -38.43 170.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.494 1.462 . . . . 0.0 112.088 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.49 -73.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.782 ' N ' ' O ' ' A' ' 73' ' ' PRO . 21.3 p -43.42 -19.43 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.557 -0.714 . . . . 0.0 111.08 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.771 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -43.66 -41.14 4.54 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.779 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -133.2 -14.39 2.64 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.867 HD12 ' HB1' ' A' ' 74' ' ' ALA . 2.0 mt -59.19 -33.14 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.61 ' CD ' HG21 ' A' ' 71' ' ' THR . 15.0 mmt180 -54.7 -42.56 71.64 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 82' ' ' ALA . 13.8 tmtt? -66.47 -66.1 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.833 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.83 -4.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.485 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.642 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.33 -79.7 0.23 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.437 -0.79 . . . . 0.0 111.694 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.602 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 167.08 45.09 0.02 OUTLIER Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.574 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.526 HD11 HH11 ' A' ' 79' ' ' ARG . 4.4 mt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.346 . . . . 0.0 109.248 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.252 0.549 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.94 66.38 1.04 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.802 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.93 114.87 14.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.705 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -103.97 177.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.778 . . . . 0.0 109.356 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.782 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -117.76 153.94 32.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.012 -1.055 . . . . 0.0 109.292 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.672 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.7 t-105 -48.12 -69.36 0.12 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.93 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.501 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.2 -46.47 54.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.696 -1.252 . . . . 0.0 110.646 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.833 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -51.65 -45.07 63.22 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.041 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.872 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.3 m -72.24 -24.45 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.732 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.913 HD13 HD13 ' A' ' 120' ' ' LEU . 17.2 mt -66.91 -72.11 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 74.4 tt0 -43.93 -43.17 6.33 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.932 -1.105 . . . . 0.0 108.572 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.6 mt -62.66 -31.29 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 108.651 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.819 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.39 -26.94 15.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.451 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.3 mtpt -58.76 -73.36 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 108.346 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 109' ' ' LYS . 70.0 mt-30 -46.86 -25.68 0.82 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.815 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' A' ' 113' ' ' PRO . 27.7 tptt -72.8 -18.43 61.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.697 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -128.69 66.53 75.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 109.856 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -63.6 -41.25 26.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.501 1.468 . . . . 0.0 112.284 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.535 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 66.1 t0 -176.84 9.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.376 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 1.1 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.87 -85.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.792 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -145.45 -21.97 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.398 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.054 HG22 ' H ' ' A' ' 118' ' ' THR . 25.5 m -65.84 -164.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.526 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.054 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.6 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.134 -0.979 . . . . 0.0 109.945 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.536 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -61.47 140.3 58.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.913 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.14 -22.15 64.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.255 1.026 . . . . 0.0 108.928 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.39 -38.07 88.87 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.525 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.42 -75.27 0.11 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.907 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.596 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.5 -43.05 7.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.405 -1.435 . . . . 0.0 109.402 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.69 -68.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.793 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -43.02 5.48 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.688 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.9 ttm -51.61 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -0.963 . . . . 0.0 108.74 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.819 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.4 mm -48.41 -64.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.674 0.749 . . . . 0.0 109.973 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.872 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.4 -71.47 0.12 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -39.39 3.67 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 126' ' ' MET . 36.6 m -56.33 -51.21 69.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.592 -1.534 . . . . 0.0 107.699 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.696 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.79 -47.66 30.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -46.62 -54.24 9.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.4 t -44.56 -67.82 0.25 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.624 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.9 ttp -46.64 -3.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.53 -24.02 13.77 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.696 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 27.2 t -57.47 135.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.975 -0.72 . . . . 0.0 109.387 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -112.09 164.74 12.82 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.35 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.837 HG13 ' O ' ' A' ' 139' ' ' VAL . 12.2 p . . . . . 0 C--N 1.303 -1.455 0 O-C-N 121.641 -0.662 . . . . 0.0 109.622 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.795 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.282 0.563 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -114.79 -24.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.79 113.6 9.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.328 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -101.61 73.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 109.128 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.783 ' HB ' HD12 ' A' ' 57' ' ' ILE . 6.0 t -49.11 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 O-C-N 120.646 -1.284 . . . . 0.0 110.472 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.26 36.74 0.48 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.927 0.87 . . . . 0.0 109.017 179.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.1 mp -76.23 -174.1 2.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.874 0.845 . . . . 0.0 111.045 -178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.643 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.94 176.11 7.21 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.674 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -165.81 145.96 5.5 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.968 -1.082 . . . . 0.0 109.292 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.669 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 72.1 Cg_endo -84.94 126.71 3.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.232 1.955 . . . . 0.0 113.437 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.61 143.47 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 51.2 54.17 24.53 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.669 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 34.1 tttt 174.48 4.01 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.729 -0.865 . . . . 0.0 109.521 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 18' ' ' THR . . . -84.4 156.17 21.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.895 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.95 165.64 4.03 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.915 -1.115 . . . . 0.0 110.26 -178.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HD2' HG22 ' A' ' 18' ' ' THR . 6.9 Cg_exo -47.79 33.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.925 1.75 . . . . 0.0 111.943 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.895 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -142.06 54.2 3.68 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.998 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.716 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -83.35 169.01 12.82 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.832 1.688 . . . . 0.0 112.019 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.31 -4.83 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 121.244 1.296 . . . . 0.0 111.377 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 26' ' ' ALA . 19.5 t -119.34 -64.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.582 -0.698 . . . . 0.0 109.505 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.29 -97.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.803 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -55.57 -55.24 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 CA-C-N 117.817 0.808 . . . . 0.0 110.642 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -60.58 1.94 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.663 -0.648 . . . . 0.0 111.213 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.752 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.41 -58.0 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.697 -1.252 . . . . 0.0 109.411 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.751 ' O ' ' N ' ' A' ' 32' ' ' ALA . . . -43.12 -17.29 0.04 OUTLIER Glycine 0 N--CA 1.485 1.948 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.531 ' C ' ' O ' ' A' ' 28' ' ' GLY . 13.0 mm100 -42.63 -27.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.176 -1.779 . . . . 0.0 107.885 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.768 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 14.2 p-80 -66.33 54.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 89.55 -18.77 44.32 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.751 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 75.19 83.06 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -1.118 . . . . 0.0 112.09 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.599 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -153.22 67.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.952 -1.092 . . . . 0.0 109.251 177.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 29.5 mm -43.85 -67.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.728 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.0 tpt -41.1 -56.93 2.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.473 -1.392 . . . . 0.0 109.218 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.599 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 18.9 tt0 -44.71 -47.64 10.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.452 -1.405 . . . . 0.0 107.631 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.756 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -51.97 -69.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.583 1.182 . . . . 0.0 109.705 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 42' ' ' ASN . 27.8 t -65.32 -36.26 77.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.484 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 35' ' ' MET . 16.0 tttt -46.08 -62.06 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.81 -33.76 68.93 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 2.8 t80 -71.45 -78.36 0.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.1 t-20 -41.23 -30.91 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.896 -1.127 . . . . 0.0 110.679 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -70.55 -32.86 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.089 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB1' ' HZ2' ' A' ' 70' ' ' LYS . . . -90.33 -45.88 8.74 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.552 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.584 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 9.4 p -60.24 -31.16 69.93 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.85 23.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.75 -22.45 46.94 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.685 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.55 -71.82 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.685 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.47 -130.04 1.5 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.123 -1.513 . . . . 0.0 111.067 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -122.64 145.81 48.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -1.187 . . . . 0.0 108.85 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.078 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.93 -154.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.736 -1.228 . . . . 0.0 111.192 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.072 HD12 ' C ' ' A' ' 51' ' ' ALA . 1.9 mp -144.25 135.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 71' ' ' THR . 2.7 t -135.36 132.66 20.05 Favored Pre-proline 0 C--N 1.296 -1.75 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.92 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 8.9 Cg_endo -71.9 103.47 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.654 1.57 . . . . 0.0 111.192 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -75.96 136.39 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.652 -1.28 . . . . 0.0 111.493 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.1 mt-10 -129.08 70.39 1.41 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.4 mt -70.55 90.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.882 0.848 . . . . 0.0 110.07 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.455 ' HB ' ' HG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -70.82 95.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.919 HG23 ' O ' ' A' ' 64' ' ' SER . 46.4 mt -101.57 147.67 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.659 -0.651 . . . . 0.0 110.583 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.795 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.0 m-85 -115.62 142.2 47.05 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.28 -33.15 8.32 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.238 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 56.4 p30 -50.8 -1.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.797 ' H ' ' C ' ' A' ' 61' ' ' ALA . 16.2 ttm180 75.25 70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.048 0.928 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.919 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -149.49 147.04 27.73 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.9 p90 -123.32 103.91 8.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.974 -1.079 . . . . 0.0 110.188 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.5 p -101.48 120.77 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 110.002 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.922 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.9 OUTLIER 170.3 147.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.952 -1.092 . . . . 0.0 111.295 177.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.6 t -168.52 97.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.301 1.048 . . . . 0.0 108.519 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.01 144.02 33.32 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.733 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -128.14 131.54 48.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.461 -1.399 . . . . 0.0 111.157 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.733 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER 67.75 160.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.954 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.624 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.5 Cg_exo -38.9 175.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.686 2.257 . . . . 0.0 113.193 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.732 ' O ' ' N ' ' A' ' 75' ' ' SER . 19.9 Cg_exo -44.27 171.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.566 1.511 . . . . 0.0 112.183 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.642 ' HB1' ' CD1' ' A' ' 78' ' ' ILE . . . 55.2 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.88 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 60.2 p -43.02 -19.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.446 -0.784 . . . . 0.0 110.367 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.854 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 27.5 p90 -43.47 -34.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.854 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.38 -16.73 1.82 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.88 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 6.8 mt -56.71 -31.73 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 75' ' ' SER . 9.1 mmm180 -54.43 -49.0 71.01 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.4 tmtt? -62.59 -65.74 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.708 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -56.62 -7.92 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 109.668 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.96 -78.11 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 111.519 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.852 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 147.19 68.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.333 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 83' ' ' GLY . 2.7 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.194 -1.18 . . . . 0.0 109.313 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.456 HG13 HD22 ' A' ' 84' ' ' LEU . 86.0 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.899 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 72.03 76.45 0.61 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 82' ' ' ALA . 14.9 ttm180 -135.36 106.23 6.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.3 -177.49 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 109.884 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.805 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -120.95 151.68 39.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.261 -0.899 . . . . 0.0 108.94 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.705 ' O ' HG22 ' A' ' 104' ' ' VAL . 31.9 t-105 -48.28 -67.45 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 110.561 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.563 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 7.4 tp10 -50.5 -48.29 56.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.728 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.708 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -50.61 -44.01 56.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.02 -25.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 117.719 -1.593 . . . . 0.0 107.462 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 120' ' ' LEU . 21.9 mt -66.26 -72.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.563 ' OE1' ' OE2' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -44.31 -43.29 7.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.089 -1.007 . . . . 0.0 108.802 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.822 HG12 HD11 ' A' ' 77' ' ' LEU . 60.2 mt -63.51 -31.29 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.054 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.75 -30.62 13.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.292 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.681 ' N ' ' O ' ' A' ' 105' ' ' LEU . 17.4 mtpt -54.73 -72.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 108.646 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 109' ' ' LYS . 6.8 tt0 -45.59 -31.12 1.72 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.16 -0.963 . . . . 0.0 109.032 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.513 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.1 tmtt? -63.99 -15.67 59.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.752 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.496 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -128.63 70.78 80.54 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.939 -1.101 . . . . 0.0 109.71 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.66 -39.29 21.38 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.565 1.51 . . . . 0.0 112.15 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.56 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -178.21 10.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.237 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -48.24 -82.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -151.37 -22.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.07 HG22 ' H ' ' A' ' 118' ' ' THR . 27.0 m -59.95 -164.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.989 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.07 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -176.0 -70.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.862 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.551 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -65.28 137.5 57.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -59.21 -21.41 59.45 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.277 1.037 . . . . 0.0 108.746 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -65.69 -34.29 77.85 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.589 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.524 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.56 -76.23 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.464 -1.398 . . . . 0.0 107.935 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.64 -39.08 4.75 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.439 -1.413 . . . . 0.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.94 -67.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.06 -1.025 . . . . 0.0 108.535 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 12.9 ttt180 -43.36 -36.74 2.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.623 ' O ' ' N ' ' A' ' 130' ' ' SER . 7.3 ttm -57.24 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 108.886 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 30.0 mm -48.63 -57.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 110.199 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.681 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -66.62 -70.28 0.26 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -42.42 5.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.732 ' OG ' ' O ' ' A' ' 127' ' ' ILE . 54.7 p -52.86 -50.0 64.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.512 -1.581 . . . . 0.0 107.152 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.752 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.2 -48.62 45.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.559 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -44.77 -51.67 9.17 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.1 t -50.57 -68.81 0.14 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.534 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 5.5 ttp -44.95 -4.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.713 -0.617 . . . . 0.0 110.407 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.4 25.47 47.3 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.899 HG22 ' HA3' ' A' ' 97' ' ' GLY . 28.9 t -107.71 165.52 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.858 -0.79 . . . . 0.0 109.233 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . 5.1 tt0 -139.53 162.64 34.58 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.989 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.07 117.73 25.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.805 HG12 ' HA ' ' A' ' 100' ' ' THR . 7.0 p . . . . . 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.823 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.582 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.998 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -122.59 -24.91 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 110.093 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.41 107.38 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.758 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.62 74.31 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.827 ' HB ' HD12 ' A' ' 57' ' ' ILE . 25.1 t -48.73 88.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.956 -1.09 . . . . 0.0 110.876 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 tmtm? -82.38 37.05 0.49 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.715 0.769 . . . . 0.0 109.315 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.127 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -80.09 -174.07 4.29 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.721 0.772 . . . . 0.0 111.461 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.827 HE21 ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.93 174.77 7.35 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.804 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.78 161.75 3.84 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.704 -1.247 . . . . 0.0 110.098 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.804 ' HD2' HD23 ' A' ' 12' ' ' LEU . 9.5 Cg_endo -62.2 126.6 18.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.904 1.736 . . . . 0.0 111.668 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.82 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -88.1 42.21 1.05 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.035 -1.041 . . . . 0.0 111.332 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.579 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 174.81 -12.12 0.03 OUTLIER Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.906 -1.616 . . . . 0.0 110.832 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -143.26 73.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 109.622 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.653 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -93.2 169.66 10.23 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.193 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -175.31 162.45 2.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.021 -1.049 . . . . 0.0 109.693 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.1 Cg_exo -53.97 31.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.581 1.521 . . . . 0.0 111.33 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -147.38 54.03 1.8 Allowed Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.102 -0.999 . . . . 0.0 110.083 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.738 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.3 Cg_endo -85.06 157.83 11.42 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.746 1.631 . . . . 0.0 111.522 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.466 ' HG2' HE22 ' A' ' 11' ' ' GLN . 3.5 Cg_exo -52.75 -4.52 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 120.939 1.093 . . . . 0.0 110.846 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.127 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -105.08 -72.08 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 121.623 0.725 . . . . 0.0 110.296 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.65 -98.33 0.05 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -59.89 -55.39 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 CA-C-N 118.004 0.902 . . . . 0.0 109.959 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -43.8 -11.98 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.266 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.861 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.25 -38.73 4.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.686 -1.259 . . . . 0.0 108.114 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.38 96.13 0.01 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 27' ' ' LEU . 41.2 tt0 -162.94 -22.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.688 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -83.84 65.55 8.65 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.679 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 80.54 -5.99 62.64 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.37 83.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 112.021 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 33.2 m120 -159.32 124.85 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.903 -1.123 . . . . 0.0 108.905 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.565 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 20.8 mm -101.22 -62.1 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 0.0 109.858 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.663 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.49 -47.52 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 109.749 -176.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -55.75 -48.74 74.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 0.0 107.845 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.861 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -49.79 -63.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.612 1.196 . . . . 0.0 108.818 178.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.653 HG13 ' CB ' ' A' ' 17' ' ' ALA . 98.0 t -68.55 -30.15 46.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.194 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 35' ' ' MET . 36.0 tptt -54.83 -54.57 40.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.06 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 109.634 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.532 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.0 OUTLIER -67.76 -75.5 0.1 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.231 -1.543 . . . . 0.0 106.896 176.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.645 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.7 m-20 -41.5 -38.26 1.26 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.117 -0.99 . . . . 0.0 110.735 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -61.53 -33.71 74.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.712 ' HB1' ' NZ ' ' A' ' 70' ' ' LYS . . . -91.13 -57.77 2.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.591 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.802 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 40.0 p -50.75 -26.82 6.07 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.766 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.645 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.12 -45.86 10.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -52.7 -18.94 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 0.0 108.886 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.48 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.41 -85.31 0.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . -168.15 -150.47 6.6 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.89 -1.624 . . . . 0.0 110.794 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -105.62 107.43 18.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -1.005 . . . . 0.0 109.976 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.82 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -144.15 -152.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.854 . . . . 0.0 109.611 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 13' ' ' PRO . 7.8 mm -146.04 143.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 14' ' ' ALA . 2.2 t -143.6 137.18 14.24 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.128 -0.983 . . . . 0.0 110.497 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -74.53 91.61 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.841 1.694 . . . . 0.0 110.628 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.881 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -60.09 136.53 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 122.706 1.241 . . . . 0.0 111.662 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 30.4 tt0 -130.6 69.51 1.46 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.827 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -71.08 90.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.719 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.73 96.02 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.1 mt -97.15 135.81 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.446 -0.784 . . . . 0.0 110.865 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -111.7 136.01 51.52 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.998 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -46.63 -32.94 3.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.742 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 56.0 m-20 -51.3 -2.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.789 ' H ' ' C ' ' A' ' 61' ' ' ALA . 9.7 ttm180 75.11 68.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.072 0.939 . . . . 0.0 109.74 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 10.4 m -149.72 124.97 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.717 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -102.9 103.98 14.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.157 -0.964 . . . . 0.0 110.009 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -100.55 120.51 40.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.969 -1.082 . . . . 0.0 109.911 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.941 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 169.94 150.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.956 177.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.6 t -169.45 78.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -84.14 148.97 26.48 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.766 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.1 mttm -136.46 134.1 37.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.906 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.766 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.3 p 75.34 150.75 0.13 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.646 ' HD3' ' HB1' ' A' ' 51' ' ' ALA . 7.1 Cg_exo -43.4 175.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.46 2.106 . . . . 0.0 113.149 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.805 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.0 Cg_exo -41.98 177.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.74 1.627 . . . . 0.0 112.007 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 44.91 -84.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.805 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -43.96 -15.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 109.614 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.948 ' CE1' HD12 ' A' ' 77' ' ' LEU . 21.1 p90 -44.15 -35.67 2.3 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.218 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -139.71 -14.86 1.06 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.218 ' N ' HD13 ' A' ' 77' ' ' LEU . 2.0 mt -63.1 -33.25 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.578 ' HG3' HG21 ' A' ' 71' ' ' THR . 1.6 mmt180 -55.44 -44.88 76.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.1 tmtp? -61.54 -65.48 0.68 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.487 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -59.61 -6.13 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.475 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.641 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -82.24 -81.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.45 -0.781 . . . . 0.0 111.555 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.17 34.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.549 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.574 HD11 ' CD ' ' A' ' 79' ' ' ARG . 3.5 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 120.884 -1.363 . . . . 0.0 109.031 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 97' ' ' GLY . 94.8 t . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.31 0.576 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.593 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 72.16 60.26 4.23 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 82' ' ' ALA . 1.4 ttt180 -132.03 117.03 17.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -1.182 . . . . 0.0 110.117 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.47 -169.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.033 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.724 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.12 163.26 28.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.097 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.686 ' O ' HG22 ' A' ' 104' ' ' VAL . 23.8 t-105 -53.45 -69.5 0.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 110.643 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.454 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 7.4 tp10 -51.03 -45.31 61.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.527 -1.358 . . . . 0.0 110.427 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.487 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -51.3 -45.89 62.35 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.782 -179.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.5 -22.78 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.774 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.75 HD13 HD13 ' A' ' 120' ' ' LEU . 17.7 mt -68.01 -72.49 0.17 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 105' ' ' LEU . 76.3 tt0 -43.83 -43.95 6.55 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.889 -1.132 . . . . 0.0 108.508 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.724 HG12 HD21 ' A' ' 77' ' ' LEU . 62.9 mt -61.77 -31.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 108.46 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.823 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.69 -20.85 17.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.462 -0.774 . . . . 0.0 109.481 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 105' ' ' LEU . 26.0 mttm -62.49 -74.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.852 -1.155 . . . . 0.0 108.167 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.464 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 56.7 mt-30 -50.48 -20.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.585 ' HD3' HD11 ' A' ' 127' ' ' ILE . 17.7 tttt -69.4 -4.97 20.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.042 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.586 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -135.69 63.09 51.71 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.903 -1.123 . . . . 0.0 109.715 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 112' ' ' MET . 5.1 Cg_endo -71.3 -30.79 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.572 1.515 . . . . 0.0 111.883 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -166.84 4.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mp -44.84 -85.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -171.96 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.206 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.033 HG22 ' H ' ' A' ' 118' ' ' THR . 29.6 m -75.43 -164.39 0.33 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.033 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.81 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.691 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -94.82 130.56 41.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.75 HD13 HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -58.9 -35.02 72.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.418 1.104 . . . . 0.0 108.648 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 50.7 mp0 -62.75 -33.5 75.28 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.467 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -73.3 -74.25 0.18 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.586 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.23 -37.45 4.64 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.489 -1.382 . . . . 0.0 109.019 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -56.65 -69.48 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 108.847 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.646 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.6 OUTLIER -43.38 -35.95 1.74 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.669 ' O ' ' CB ' ' A' ' 130' ' ' SER . 6.0 ttm -56.13 -76.64 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.823 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.9 mm -48.82 -63.48 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.689 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.12 -72.26 0.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.49 -41.16 4.02 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.669 ' CB ' ' O ' ' A' ' 126' ' ' MET . 60.2 m -57.91 -47.87 81.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.547 -1.561 . . . . 0.0 107.443 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.538 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.25 -49.72 42.05 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.794 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.71 -55.09 6.89 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.669 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.5 t -44.67 -67.45 0.28 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.499 ' CE ' ' HB2' ' A' ' 75' ' ' SER . 0.6 OUTLIER -47.4 -4.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.669 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.55 -31.11 5.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 137' ' ' GLU . 41.3 t -45.02 165.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.909 -0.759 . . . . 0.0 108.972 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.57 ' N ' HG12 ' A' ' 136' ' ' VAL . 81.0 tt0 -142.25 162.73 34.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.8 t -83.26 137.68 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.677 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.2 p . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.455 -0.778 . . . . 0.0 109.533 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.753 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.6 m -115.67 -24.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.44 110.18 6.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.344 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.16 73.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 57' ' ' ILE . 35.4 t -48.52 88.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.542 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.93 36.47 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.819 0.819 . . . . 0.0 109.324 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.016 HD22 HG22 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -77.91 -174.12 3.41 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.432 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.669 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -121.35 172.49 7.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.803 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -169.04 161.05 8.0 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.086 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.803 ' HD2' HD23 ' A' ' 12' ' ' LEU . 13.8 Cg_endo -66.95 109.61 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.065 1.844 . . . . 0.0 111.316 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.829 ' HB3' ' C ' ' A' ' 51' ' ' ALA . . . -67.64 41.08 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.856 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.491 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 176.6 -14.15 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.515 -1.802 . . . . 0.0 111.522 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 17.0 tttt -138.25 56.83 1.72 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.6 . . . . 0.0 110.557 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.711 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -75.32 160.03 30.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.669 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.41 162.37 23.72 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.681 -1.262 . . . . 0.0 110.981 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 18' ' ' THR . 1.2 Cg_endo -57.05 38.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.087 1.858 . . . . 0.0 111.847 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.669 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -173.06 56.77 0.21 Allowed Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.53 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.653 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.8 Cg_endo -79.76 169.02 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 121.467 1.444 . . . . 0.0 111.382 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.08 -4.68 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.071 1.181 . . . . 0.0 110.922 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.016 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -106.85 -72.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.582 0.706 . . . . 0.0 110.256 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.35 -98.01 0.05 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.743 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.59 -55.65 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 CA-C-N 118.088 0.944 . . . . 0.0 110.055 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.647 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.79 -10.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.83 -0.544 . . . . 0.0 110.243 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.839 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.75 -44.11 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.859 -1.151 . . . . 0.0 108.815 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.62 96.38 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 27' ' ' LEU . 10.6 tt0 -159.49 -26.68 0.07 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.717 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.4 p80 -78.74 64.17 3.67 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.7 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.661 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 81.82 -7.84 61.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 83.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -1.126 . . . . 0.0 112.097 177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -157.97 123.69 4.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.676 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 19.8 mm -97.55 -63.71 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.049 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.614 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.0 tpt -41.29 -51.64 3.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.768 -1.208 . . . . 0.0 109.989 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.57 -48.39 57.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.667 -1.271 . . . . 0.0 108.007 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.839 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -51.81 -65.83 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.535 1.16 . . . . 0.0 109.353 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.711 HG13 ' CB ' ' A' ' 17' ' ' ALA . 67.8 t -65.49 -30.03 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.915 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.4 OUTLIER -55.67 -56.1 24.38 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.14 77.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.608 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.607 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.9 t80 -69.49 -76.77 0.09 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.341 -1.474 . . . . 0.0 107.155 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 9.8 t-20 -41.66 -32.36 0.37 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.971 -1.081 . . . . 0.0 110.734 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.84 -34.08 76.02 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HB1' ' HD3' ' A' ' 70' ' ' LYS . . . -90.45 -53.39 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.603 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.774 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 27.9 p -53.51 -30.38 41.06 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.6 -45.2 16.16 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -54.15 -21.77 9.56 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.154 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.702 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.79 -85.0 0.54 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.702 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.91 -149.8 6.05 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.896 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 2.2 t0 -110.15 120.2 41.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -1.142 . . . . 0.0 109.902 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.829 ' C ' ' HB3' ' A' ' 14' ' ' ALA . . . -153.72 -152.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 13' ' ' PRO . 6.0 mm -146.53 142.7 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 14' ' ' ALA . 4.6 t -146.44 138.53 13.59 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 110.302 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.5 Cg_endo -73.93 93.06 0.87 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.75 1.633 . . . . 0.0 111.258 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.866 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.3 m -60.35 137.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.722 -1.236 . . . . 0.0 111.689 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.7 mt-10 -129.68 68.55 1.43 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.75 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.0 mt -68.93 93.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.859 0.838 . . . . 0.0 110.585 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.0 99.88 0.91 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 57' ' ' ILE . 47.9 mt -104.46 145.08 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.537 -0.727 . . . . 0.0 110.756 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.753 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.2 m-85 -116.46 140.67 49.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.781 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.61 -33.08 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.304 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -1.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.781 ' H ' ' C ' ' A' ' 61' ' ' ALA . 36.2 mtm180 75.28 69.05 0.08 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.019 0.914 . . . . 0.0 109.727 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -148.73 148.06 29.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.669 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 39.3 p90 -125.23 103.97 8.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.277 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.2 p -101.6 120.92 41.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.9 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.17 146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.074 177.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 67' ' ' PHE . 31.7 t -167.57 79.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.284 1.04 . . . . 0.0 108.348 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 69' ' ' THR . 0.7 OUTLIER -87.03 136.79 32.79 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.625 ' O ' ' OG1' ' A' ' 71' ' ' THR . 5.1 mtmp? -121.0 140.62 51.66 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.227 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.625 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER 60.38 163.95 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.838 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 71' ' ' THR . 11.7 Cg_exo -41.08 175.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.099 1.866 . . . . 0.0 112.463 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.17 173.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.629 1.553 . . . . 0.0 112.499 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.972 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 56.79 -73.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 108.711 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -45.48 -17.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.716 . . . . 0.0 110.937 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.751 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 1.2 p90 -43.37 -38.63 2.8 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.889 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.579 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.1 pp -133.65 -22.2 1.91 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.972 HD12 ' HB1' ' A' ' 74' ' ' ALA . 6.5 mt -54.95 -30.84 23.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.716 ' CD ' HD11 ' A' ' 84' ' ' LEU . 6.0 mmt180 -52.65 -57.21 10.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 82' ' ' ALA . 5.3 tmtm? -52.06 -64.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.67 -6.53 0.75 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.813 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.801 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -83.34 -80.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 111.837 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.89 48.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.99 -1.576 . . . . 0.0 110.817 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.716 HD11 ' CD ' ' A' ' 79' ' ' ARG . 6.7 mt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.316 . . . . 0.0 109.003 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.268 0.556 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.801 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 70.08 58.0 6.51 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.582 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.2 tmm_? -131.5 110.08 10.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.172 -1.193 . . . . 0.0 110.916 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.15 -175.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.738 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -127.33 164.3 22.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.889 -1.132 . . . . 0.0 109.656 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.701 ' O ' HG22 ' A' ' 104' ' ' VAL . 21.1 t-105 -51.46 -71.04 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.579 -0.7 . . . . 0.0 111.152 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -48.79 -51.12 30.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.693 -1.255 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.41 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.1 mt-30 -49.18 -44.48 42.98 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.885 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.48 -25.09 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.518 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 120' ' ' LEU . 18.2 mt -66.87 -71.8 0.19 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.478 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 46.7 mt-10 -43.81 -43.08 6.0 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.922 -1.111 . . . . 0.0 108.465 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' A' ' 77' ' ' LEU . 57.9 mt -62.76 -30.71 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.433 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.803 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.63 -25.78 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.497 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 105' ' ' LEU . 8.4 mtpt -59.28 -73.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.919 -1.113 . . . . 0.0 108.362 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 110' ' ' GLN . 0.3 OUTLIER -45.35 -28.41 0.85 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.092 -1.005 . . . . 0.0 108.922 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.451 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 12.0 tttm -69.09 -19.28 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.863 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.694 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -129.65 68.9 81.13 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.092 -1.005 . . . . 0.0 109.884 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 -34.18 27.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.495 1.463 . . . . 0.0 112.072 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.532 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 3.5 t70 175.02 12.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.0 mm? -50.43 -77.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -149.83 -24.97 0.27 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.058 HG22 ' H ' ' A' ' 118' ' ' THR . 23.6 m -64.57 -164.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 0.0 109.579 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.058 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.61 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.251 -0.905 . . . . 0.0 109.935 -179.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 118' ' ' THR . 1.3 m-20 -61.09 141.09 57.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.95 -22.72 65.87 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.243 1.021 . . . . 0.0 109.011 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.93 -38.41 90.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.526 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.47 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -68.92 -74.92 0.12 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.944 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.576 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.56 -43.08 7.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.46 -1.4 . . . . 0.0 109.28 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.12 -69.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 108.608 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HG3' HH11 ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.58 -41.81 4.76 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.709 ' O ' ' N ' ' A' ' 130' ' ' SER . 12.0 ttm -52.32 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.187 -0.946 . . . . 0.0 108.643 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.803 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 20.5 mm -48.03 -64.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.424 -0.798 . . . . 0.0 109.848 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.885 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.23 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -41.75 4.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.6 m -54.91 -48.6 72.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.536 -1.567 . . . . 0.0 107.699 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -50.01 -47.71 52.92 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.672 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -45.68 -53.5 9.25 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.631 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.4 t -44.89 -67.59 0.27 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.649 ' SD ' HG23 ' A' ' 136' ' ' VAL . 10.7 ttm -49.42 -3.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 89.64 -27.26 8.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.649 HG23 ' SD ' ' A' ' 134' ' ' MET . 52.7 t -48.17 165.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.847 -0.796 . . . . 0.0 109.208 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.583 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -142.52 162.62 35.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.711 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.2 164.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 139' ' ' VAL . 1.3 p . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.758 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.812 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -117.79 -24.59 3.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.261 -0.9 . . . . 0.0 109.224 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.24 111.22 6.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.385 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -100.37 73.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.779 ' HB ' HD12 ' A' ' 57' ' ' ILE . 6.1 t -49.12 88.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.611 -1.305 . . . . 0.0 110.715 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? -82.04 37.24 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.843 0.83 . . . . 0.0 109.054 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.855 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.4 mp -76.8 -174.2 2.95 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.817 0.818 . . . . 0.0 111.137 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.626 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -125.87 175.34 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.66 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -169.81 158.46 6.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.886 -1.134 . . . . 0.0 109.993 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.674 ' O ' ' N ' ' A' ' 15' ' ' GLY . 11.5 Cg_endo -68.01 104.95 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.935 1.757 . . . . 0.0 111.417 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.812 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -60.94 38.72 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.144 -1.023 . . . . 0.0 110.34 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.5 -18.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.526 -1.797 . . . . 0.0 111.3 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -148.38 78.99 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.507 -1.584 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.733 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -94.24 170.25 9.64 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.36 164.52 3.94 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.773 -1.204 . . . . 0.0 110.487 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.4 Cg_exo -51.97 32.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.048 1.832 . . . . 0.0 112.066 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.778 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -138.2 53.93 6.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 0.0 110.415 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.717 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.5 Cg_endo -86.36 162.39 9.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.83 1.687 . . . . 0.0 111.712 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.56 -4.89 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 121.079 1.186 . . . . 0.0 111.34 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.813 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 21.5 t -118.71 -66.51 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 56.44 -97.16 0.05 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.813 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 4.7 Cg_exo -53.96 -55.1 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 CA-C-N 117.816 0.808 . . . . 0.0 110.585 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.797 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -64.96 5.5 0.33 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.544 -0.723 . . . . 0.0 111.182 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.744 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -109.64 -65.17 1.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.668 -1.27 . . . . 0.0 109.855 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.69 -16.33 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' LEU . 83.5 mt-30 -41.98 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.45 -1.618 . . . . 0.0 109.571 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -64.67 -45.37 87.0 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.678 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.92 -3.53 0.04 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 69.76 76.64 0.21 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 122.187 -0.596 . . . . 0.0 111.756 177.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 34' ' ' ILE . 1.1 m120 -152.41 63.61 0.82 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.291 1.043 . . . . 0.0 108.416 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 37' ' ' PHE . 26.7 mm -43.01 -66.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.651 ' O ' ' CG ' ' A' ' 39' ' ' LYS . 4.3 tpt -41.43 -37.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.695 -1.253 . . . . 0.0 108.67 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.13 -49.13 75.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.711 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -50.38 -66.37 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.842 1.306 . . . . 0.0 109.252 177.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 17' ' ' ALA . 24.4 t -64.11 -37.65 80.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.604 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CG ' ' O ' ' A' ' 35' ' ' MET . 5.8 mmmt -47.95 -59.93 2.98 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.82 72.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.364 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 45' ' ' THR . 2.6 t80 -69.6 -77.42 0.08 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 5.0 m-20 -41.6 -34.86 0.64 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.398 1.094 . . . . 0.0 110.872 -177.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -65.82 -34.15 77.49 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.497 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.599 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.29 -53.72 4.33 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.393 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 21.4 p -52.47 -27.54 16.63 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.65 -46.06 13.73 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.677 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -54.67 -21.22 10.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.692 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.03 -85.2 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.692 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.32 -137.67 2.29 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.977 -1.583 . . . . 0.0 110.909 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.512 ' O ' ' CG ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -119.95 118.35 30.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.13 . . . . 0.0 109.971 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.812 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -153.74 -153.13 0.45 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.602 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.8 mm -146.67 141.8 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 14' ' ' ALA . 2.2 t -145.66 138.62 14.07 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.1 Cg_endo -73.93 91.0 0.93 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.85 1.7 . . . . 0.0 111.519 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.855 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.3 m -56.46 137.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.751 -1.218 . . . . 0.0 111.229 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.6 tt0 -129.24 70.81 1.41 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.779 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.7 mt -71.33 89.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 0.0 110.307 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.39 104.02 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 64' ' ' SER . 41.2 mt -107.64 144.44 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.509 -0.745 . . . . 0.0 110.867 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.758 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.5 m-85 -115.03 139.47 49.84 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.812 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.51 -32.89 5.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.24 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -51.07 -2.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.792 ' H ' ' C ' ' A' ' 61' ' ' ALA . 4.6 mtt180 75.24 70.1 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.913 0.863 . . . . 0.0 109.843 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 2.5 t -150.7 125.13 9.53 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.631 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 33.2 p90 -102.14 103.87 14.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -100.74 121.05 41.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.985 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.937 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.45 148.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 111.231 177.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 67' ' ' PHE . 28.0 t -169.3 88.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.489 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -94.74 145.07 25.12 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.8 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -129.53 118.56 22.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 0.0 110.213 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 1.018 HG21 ' NE ' ' A' ' 79' ' ' ARG . 23.0 p 75.96 150.02 0.13 Allowed Pre-proline 0 N--CA 1.493 1.689 0 CA-C-O 121.231 0.539 . . . . 0.0 110.025 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -40.16 175.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.682 2.255 . . . . 0.0 113.113 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.4 Cg_exo -39.55 171.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.52 1.48 . . . . 0.0 111.913 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.883 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.49 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.778 ' N ' ' O ' ' A' ' 73' ' ' PRO . 17.7 p -43.64 -27.75 0.33 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.043 ' CE1' HD12 ' A' ' 77' ' ' LEU . 8.0 p90 -43.55 -38.11 2.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.182 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -135.27 -11.39 2.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.182 ' N ' HD13 ' A' ' 77' ' ' LEU . 2.0 mt -66.32 -29.85 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 1.018 ' NE ' HG21 ' A' ' 71' ' ' THR . 7.3 mmm180 -55.73 -40.12 72.06 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.565 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.6 tmtt? -70.78 -67.95 0.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.405 ' N ' ' HD3' ' A' ' 80' ' ' LYS . . . -53.82 -4.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.277 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.713 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.61 -78.21 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.712 . . . . 0.0 112.155 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.22 55.71 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.873 -1.632 . . . . 0.0 110.811 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.707 ' CD1' ' CZ ' ' A' ' 79' ' ' ARG . 9.0 mt . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.05 -1.265 . . . . 0.0 109.097 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 97' ' ' GLY . 24.6 t . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.362 0.601 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.814 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 65.15 73.44 0.59 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.821 ' HG3' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.34 105.31 6.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.128 -1.219 . . . . 0.0 110.979 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.669 HD12 ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -105.72 -167.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.027 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.761 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -137.7 159.61 41.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 108.88 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.685 ' O ' HG22 ' A' ' 104' ' ' VAL . 17.8 t-105 -47.6 -71.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 110.801 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.6 tp10 -50.77 -49.21 58.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.526 -1.359 . . . . 0.0 110.895 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.603 ' O ' ' CG1' ' A' ' 107' ' ' ILE . 4.2 mt-30 -51.11 -43.7 61.16 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 110.23 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 100' ' ' THR . 2.4 m -70.9 -25.3 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.521 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 120' ' ' LEU . 18.1 mt -65.7 -71.54 0.19 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -44.41 -42.36 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.854 -1.154 . . . . 0.0 108.185 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.093 ' CD1' HD21 ' A' ' 77' ' ' LEU . 1.8 mm -60.85 -33.28 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.82 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -98.88 -23.14 15.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.439 -0.788 . . . . 0.0 109.335 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.673 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.6 mttt -57.03 -72.34 0.08 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -48.75 -34.06 11.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.592 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 112' ' ' MET . 1.2 mptp? -80.06 64.43 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.222 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.584 ' HA ' HD11 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 175.02 55.54 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 0.0 109.217 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.553 ' HD3' ' H ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.38 -55.05 1.05 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.545 1.497 . . . . 0.0 112.346 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 115' ' ' LEU . 1.5 m-20 -163.53 11.46 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 1.077 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.79 -85.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.613 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -155.43 10.68 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.398 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.0 HG22 ' H ' ' A' ' 118' ' ' THR . 41.6 m -104.34 -164.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.0 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 179.25 -55.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.199 -0.938 . . . . 0.0 110.007 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.491 ' H ' HG23 ' A' ' 118' ' ' THR . 3.7 m-20 -74.76 142.92 44.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.342 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -58.77 -33.15 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.221 1.01 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -60.46 -37.63 81.61 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.045 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.06 -72.72 0.2 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.872 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.493 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -46.16 -37.93 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.523 -1.361 . . . . 0.0 109.089 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -56.0 -71.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.042 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 129' ' ' GLY . 47.6 ttt180 -43.32 -34.83 1.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' SER . 15.1 ttm -56.2 -76.88 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.82 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 17.4 mm -48.37 -63.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.772 . . . . 0.0 109.785 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.57 -71.73 0.12 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.78 -42.66 4.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 126' ' ' MET . 57.9 m -55.49 -50.27 70.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.591 -1.535 . . . . 0.0 107.5 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.819 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.66 -48.72 28.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.2 tmt_? -44.82 -54.9 5.87 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.661 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -46.71 -69.26 0.14 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.606 ' HG2' HG23 ' A' ' 136' ' ' VAL . 7.6 ttp -45.07 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.622 -0.674 . . . . 0.0 110.639 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.06 8.62 75.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.819 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.2 t -88.5 165.31 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.3 tp10 -142.78 163.02 33.95 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.137 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.67 153.42 4.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 99' ' ' ILE . 1.3 p . . . . . 0 C--N 1.3 -1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.252 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.491 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.028 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -119.97 -24.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.063 -1.023 . . . . 0.0 109.621 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -154.32 101.31 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.316 -1.353 . . . . 0.0 110.635 178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -92.36 73.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.773 ' HB ' HD12 ' A' ' 57' ' ' ILE . 24.4 t -45.53 88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.215 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.657 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -84.29 34.44 0.52 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.923 0.868 . . . . 0.0 109.019 179.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.908 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.52 -174.72 3.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.948 0.88 . . . . 0.0 111.381 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.561 ' O ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -117.19 169.41 9.48 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -163.0 144.59 7.75 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 120.544 -1.347 . . . . 0.0 110.16 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.64 ' HA ' HD13 ' A' ' 52' ' ' ILE . 36.5 Cg_endo -80.5 127.91 6.73 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.426 2.084 . . . . 0.0 113.97 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.084 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.83 141.34 47.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.713 ' C ' ' H ' ' A' ' 17' ' ' ALA . . . 61.41 -60.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 mtpp -60.46 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.801 -0.823 . . . . 0.0 108.884 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.713 ' H ' ' C ' ' A' ' 15' ' ' GLY . . . -114.4 151.42 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.73 165.93 6.87 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 -178.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.9 Cg_exo -49.38 36.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.723 1.615 . . . . 0.0 111.749 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.896 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -164.34 55.03 0.42 Allowed Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.631 -0.668 . . . . 0.0 109.819 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.679 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.0 Cg_endo -77.36 169.95 20.3 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.529 1.486 . . . . 0.0 111.801 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.02 -4.59 3.89 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 121.134 1.223 . . . . 0.0 110.971 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.908 HG22 ' CD2' ' A' ' 10' ' ' LEU . 2.2 t -105.08 -71.54 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.598 0.713 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.92 -98.41 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.5 Cg_endo -59.98 -55.41 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.972 0.886 . . . . 0.0 109.97 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.596 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.31 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.471 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.921 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -112.39 -42.49 3.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.608 -1.307 . . . . 0.0 108.703 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.5 85.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 27' ' ' LEU . 8.0 mm-40 -150.64 -13.82 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -1.102 . . . . 0.0 108.06 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.613 ' CD2' ' CE1' ' A' ' 65' ' ' PHE . 2.6 p-80 -86.21 -37.21 18.89 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -171.87 -1.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.0 80.62 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 111.971 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -156.7 121.7 4.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.505 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.5 mm -97.9 -64.83 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.646 . . . . 0.0 110.0 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.689 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.97 -57.05 2.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.59 -1.319 . . . . 0.0 109.424 -177.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' MET . 3.7 mp0 -46.54 -51.08 16.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.99 -1.069 . . . . 0.0 108.195 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.921 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -48.15 -59.94 3.02 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.46 1.124 . . . . 0.0 109.623 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 42' ' ' ASN . 50.6 t -73.72 -30.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.95 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.1 tttp -50.09 -62.01 1.82 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.62 -33.89 73.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.469 -0.769 . . . . 0.0 108.94 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 44' ' ' ALA . 2.1 t80 -70.73 -77.03 0.09 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -41.29 -34.21 0.47 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.42 1.105 . . . . 0.0 110.692 -177.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.1 -34.01 75.58 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.963 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.75 -45.55 8.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.695 ' CB ' ' H ' ' A' ' 15' ' ' GLY . 19.0 p -58.67 -29.31 66.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -80.0 -46.5 16.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.587 ' OD1' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -55.96 -23.18 30.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.762 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.83 -74.93 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.394 -0.816 . . . . 0.0 109.407 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.762 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 168.31 150.75 6.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.289 -1.434 . . . . 0.0 111.088 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.1 m-20 -44.8 148.76 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.015 -1.285 . . . . 0.0 109.497 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.084 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 175.8 -154.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.986 -1.071 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.5 mm -146.98 141.07 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 71' ' ' THR . 2.7 t -144.32 135.59 12.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.744 -1.223 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.622 ' O ' HG21 ' A' ' 69' ' ' THR . 8.4 Cg_endo -70.96 99.82 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.624 1.55 . . . . 0.0 110.465 177.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.763 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.0 m -79.16 137.01 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 122.782 1.277 . . . . 0.0 112.262 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -128.25 61.32 1.46 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.773 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -61.57 86.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.646 0.736 . . . . 0.0 109.735 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.41 ' HB ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -60.59 95.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.562 HG13 HG22 ' A' ' 57' ' ' ILE . 46.2 mt -95.75 136.53 26.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.566 -0.708 . . . . 0.0 110.237 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.491 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -110.45 138.66 46.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 1.028 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.68 -29.43 4.4 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.573 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 19.7 t0 -53.93 3.03 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.853 ' H ' ' C ' ' A' ' 61' ' ' ALA . 50.4 mtp180 69.69 70.11 0.24 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.045 0.926 . . . . 0.0 109.624 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 18.2 m -148.25 124.9 11.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.7 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -101.5 104.13 15.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 0.0 110.204 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.41 ' OG1' ' HB ' ' A' ' 58' ' ' THR . 21.9 p -98.3 124.58 43.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.594 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -109.4 174.02 6.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.526 -1.359 . . . . 0.0 109.349 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.004 HG12 ' O ' ' A' ' 68' ' ' VAL . 97.1 t -163.11 44.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.674 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.622 HG21 ' O ' ' A' ' 54' ' ' PRO . 1.2 t -155.19 126.79 7.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 115.594 -2.442 . . . . 0.0 110.276 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.85 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -124.92 128.13 48.15 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.791 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.81 151.59 0.13 Allowed Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.522 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.0 Cg_exo -40.37 175.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.504 2.136 . . . . 0.0 113.063 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.818 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.63 170.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.651 1.567 . . . . 0.0 112.125 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.695 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 49.94 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.818 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -43.55 -20.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.242 179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 11.6 p90 -43.83 -42.22 5.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.65 -0.656 . . . . 0.0 109.322 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.878 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.66 -19.52 2.66 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.878 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.6 mt -59.27 -32.03 47.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.643 ' HB3' HD12 ' A' ' 84' ' ' LEU . 12.7 mmt180 -55.42 -44.12 75.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 82' ' ' ALA . 9.5 tmtt? -66.37 -66.4 0.56 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.667 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.93 -4.84 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.667 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.16 -80.38 0.19 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 111.987 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.451 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 163.2 53.46 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.036 -1.554 . . . . 0.0 110.466 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.643 HD12 ' HB3' ' A' ' 79' ' ' ARG . 5.7 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.039 -1.271 . . . . 0.0 109.558 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.559 HG12 ' CD2' ' A' ' 84' ' ' LEU . 2.4 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.34 0.59 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 50.87 61.2 6.29 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.797 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.87 111.84 10.19 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.997 -1.296 . . . . 0.0 110.327 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.25 -177.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.703 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -125.05 159.02 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.925 -1.109 . . . . 0.0 109.351 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.668 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.8 t-105 -49.81 -69.54 0.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.597 -0.69 . . . . 0.0 111.042 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.639 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 9.5 tp10 -50.2 -44.74 53.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.667 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -55.31 -43.76 75.17 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.162 -0.961 . . . . 0.0 110.054 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.23 -24.32 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 117.649 -1.62 . . . . 0.0 107.656 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 120' ' ' LEU . 17.1 mt -66.31 -71.72 0.19 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.639 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 20.5 mm-40 -44.08 -44.5 7.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.909 -1.119 . . . . 0.0 108.44 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.728 ' CD1' HD21 ' A' ' 77' ' ' LEU . 65.4 mt -60.84 -32.55 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 108.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.815 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.98 -26.79 15.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.575 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.5 mttm -58.82 -73.27 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.935 -1.103 . . . . 0.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 109' ' ' LYS . 6.2 tt0 -45.24 -28.46 0.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.431 ' HE3' ' SD ' ' A' ' 126' ' ' MET . 11.6 tttm -69.8 -18.44 63.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.58 68.13 81.15 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.031 -1.043 . . . . 0.0 109.821 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.8 -33.96 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.533 1.488 . . . . 0.0 112.088 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER 174.97 15.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.77 . . . . 0.0 109.087 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.5 mm? -54.21 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.597 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -150.65 -25.03 0.23 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.066 HG22 ' H ' ' A' ' 118' ' ' THR . 23.5 m -64.94 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.066 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.45 -74.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.943 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.523 ' H ' HG23 ' A' ' 118' ' ' THR . 1.2 m-20 -60.68 140.96 57.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 110.051 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.88 -22.65 65.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.214 1.007 . . . . 0.0 108.952 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.12 -38.42 90.6 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.57 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.483 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -68.69 -75.2 0.11 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.231 -1.387 . . . . 0.0 107.921 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.605 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.56 -43.02 7.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.475 -1.39 . . . . 0.0 109.292 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.63 -68.71 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 108.571 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.784 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.57 -42.95 5.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.682 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.21 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 108.562 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.815 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.9 mm -48.57 -65.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.873 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.81 -71.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.72 -39.04 3.36 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.9 m -57.8 -47.51 82.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.467 -1.608 . . . . 0.0 107.564 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.611 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.97 -48.47 52.16 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.649 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.2 tmm_? -46.62 -53.71 10.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.676 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.1 t -44.83 -68.5 0.19 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 75' ' ' SER . 0.0 OUTLIER -47.27 -3.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.91 -23.67 13.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.611 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 47.4 t -53.44 165.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.849 -0.795 . . . . 0.0 109.17 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -142.66 162.58 35.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.025 -1.047 . . . . 0.0 109.723 179.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.76 162.25 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.884 HG13 ' O ' ' A' ' 139' ' ' VAL . 4.1 p . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.599 -0.688 . . . . 0.0 109.184 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.744 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -112.82 -24.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.19 107.28 5.73 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.168 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.808 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -94.71 73.62 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 108.94 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.73 ' HB ' HD12 ' A' ' 57' ' ' ILE . 31.7 t -45.96 88.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.192 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.54 34.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.89 0.853 . . . . 0.0 109.076 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.993 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.23 -174.42 3.69 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.787 0.803 . . . . 0.0 111.31 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -119.78 171.84 8.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.781 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -168.3 160.11 9.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.689 -1.257 . . . . 0.0 110.288 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.781 ' HD2' HD23 ' A' ' 12' ' ' LEU . 13.4 Cg_endo -67.74 109.19 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.251 1.967 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.812 ' HB3' ' C ' ' A' ' 51' ' ' ALA . . . -69.45 40.21 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.963 -1.086 . . . . 0.0 110.733 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.52 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 179.31 -18.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 118.277 -1.915 . . . . 0.0 111.792 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' CE ' ' OD1' ' A' ' 50' ' ' ASP . 2.1 mptt -135.82 60.74 1.67 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.405 -1.644 . . . . 0.0 110.452 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.705 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -79.64 158.74 26.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.724 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -161.92 163.31 19.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.688 -1.258 . . . . 0.0 110.494 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.0 Cg_endo -55.47 35.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.936 1.758 . . . . 0.0 111.852 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.724 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -171.17 57.18 0.25 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.41 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.0 Cg_endo -80.5 168.45 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.453 1.435 . . . . 0.0 111.432 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 -4.61 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.126 1.218 . . . . 0.0 111.044 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.993 HG22 HD22 ' A' ' 10' ' ' LEU . 1.9 t -105.48 -72.62 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.604 0.716 . . . . 0.0 110.277 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.55 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.725 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.1 Cg_endo -60.49 -55.51 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 CA-C-N 118.047 0.923 . . . . 0.0 109.854 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.37 -8.6 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.39 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.808 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -111.62 -43.21 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.686 -1.259 . . . . 0.0 108.805 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.26 84.7 0.01 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tp-100 -148.9 -8.4 0.36 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.696 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 6.0 p-80 -92.78 -36.55 12.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.639 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -171.55 2.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 71.86 75.95 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.661 -0.905 . . . . 0.0 112.058 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -154.05 121.32 5.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 108.797 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.7 mm -97.94 -63.8 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.683 -0.636 . . . . 0.0 109.952 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -42.08 -54.22 3.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.787 -1.195 . . . . 0.0 109.79 -176.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -50.08 -51.25 44.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.948 -1.095 . . . . 0.0 108.601 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.808 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -47.19 -58.89 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.773 1.273 . . . . 0.0 109.566 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 17' ' ' ALA . 82.0 t -71.78 -30.25 37.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.212 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.2 mmtt -53.48 -55.04 28.7 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.22 -34.14 76.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.575 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.4 t80 -68.32 -76.19 0.09 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 19.0 m-20 -41.81 -37.5 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.45 1.119 . . . . 0.0 110.764 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -62.73 -34.56 77.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.327 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.57 -61.59 1.64 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.888 -1.125 . . . . 0.0 108.654 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 24.6 p -44.85 -29.74 0.85 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.29 -43.39 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 44' ' ' ALA . 4.8 t-20 -54.49 -24.39 20.28 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.44 -85.22 0.54 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -159.94 -148.98 5.42 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 118.996 -1.573 . . . . 0.0 111.051 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.521 ' OD1' ' CE ' ' A' ' 16' ' ' LYS . 3.5 t70 -113.55 126.02 54.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -1.095 . . . . 0.0 109.687 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.812 ' C ' ' HB3' ' A' ' 14' ' ' ALA . . . -158.92 -152.85 0.34 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 13' ' ' PRO . 5.8 mm -147.0 143.37 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 14' ' ' ALA . 5.2 t -145.72 137.58 13.17 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.2 Cg_endo -73.3 86.06 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.745 1.63 . . . . 0.0 110.601 177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.816 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.7 m -58.01 137.71 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.762 1.267 . . . . 0.0 112.321 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.3 mt-10 -128.78 63.98 1.45 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.73 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.7 mt -64.36 90.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.812 0.815 . . . . 0.0 110.316 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.505 HG22 HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -64.25 98.48 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.55 HG13 HG22 ' A' ' 57' ' ' ILE . 9.8 mt -100.72 142.68 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.561 -0.712 . . . . 0.0 110.375 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.744 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.7 m-85 -114.34 139.93 49.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.838 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.61 -30.0 4.9 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.349 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 8.1 t70 -53.53 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.838 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 70.46 69.04 0.2 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.122 0.963 . . . . 0.0 109.627 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -148.06 125.07 11.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.678 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -101.43 104.02 14.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 110.232 -179.311 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.5 p -99.16 124.67 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.558 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 1.8 p90 -108.52 171.32 7.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.569 -1.332 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.985 HG12 ' O ' ' A' ' 68' ' ' VAL . 88.8 t -162.38 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 112.691 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 69' ' ' THR . 11.2 t -154.93 118.02 4.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.048 -2.282 . . . . 0.0 110.398 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.818 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.51 120.06 38.26 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.141 0.972 . . . . 0.0 108.599 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.877 HG21 ' CD ' ' A' ' 79' ' ' ARG . 16.2 p 76.99 151.45 0.13 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.5 Cg_exo -39.12 175.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.762 2.308 . . . . 0.0 113.351 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.5 Cg_exo -40.99 167.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.652 1.568 . . . . 0.0 111.915 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.0 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.67 -77.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.776 ' N ' ' O ' ' A' ' 73' ' ' PRO . 8.0 t -43.04 -25.05 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.981 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.049 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 17.9 p90 -43.27 -41.72 4.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.485 -0.76 . . . . 0.0 109.111 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.049 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -133.07 -15.48 2.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.0 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.6 mt -60.21 -33.21 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.877 ' CD ' HG21 ' A' ' 71' ' ' THR . 1.5 mtm180 -55.46 -43.37 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -67.15 -66.23 0.58 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.795 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.36 -4.8 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 109.684 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.42 -79.76 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 111.554 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.508 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 154.57 56.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.408 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.508 HD23 ' C ' ' A' ' 83' ' ' GLY . 10.8 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.252 . . . . 0.0 109.23 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 97' ' ' GLY . 41.1 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.315 0.578 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.541 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 58.45 66.51 2.75 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.787 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.16 113.11 11.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -1.166 . . . . 0.0 110.008 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.704 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.81 -173.37 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.647 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -127.5 158.04 38.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.401 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.664 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.7 t-105 -49.95 -69.47 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.498 -0.751 . . . . 0.0 110.753 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 4.4 tp10 -49.78 -45.04 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.706 -1.246 . . . . 0.0 110.539 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.795 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -52.71 -46.3 67.28 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.911 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.46 -24.55 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.996 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.951 HD13 HD13 ' A' ' 120' ' ' LEU . 18.3 mt -65.91 -71.37 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.587 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 mm-40 -43.92 -43.31 6.4 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.959 -1.088 . . . . 0.0 108.66 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.76 HG12 HD11 ' A' ' 77' ' ' LEU . 57.6 mt -63.22 -32.3 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 108.817 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.21 -27.1 16.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.332 -0.855 . . . . 0.0 109.376 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 105' ' ' LEU . 15.3 mtpt -59.78 -74.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.594 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . 71.5 mt-30 -45.04 -27.32 0.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.229 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -74.59 -10.41 59.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.927 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.649 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.38 64.03 67.54 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.65 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.5 Cg_endo -66.13 -30.67 46.51 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.647 1.565 . . . . 0.0 112.084 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.539 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 1.7 t70 175.16 10.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.188 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -48.42 -79.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.19 -21.5 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.621 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.049 HG22 ' H ' ' A' ' 118' ' ' THR . 27.4 m -64.69 -164.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.948 . . . . 0.0 109.585 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.049 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.75 -67.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.807 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.529 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -69.57 138.39 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.951 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -58.29 -22.66 53.68 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.204 1.002 . . . . 0.0 108.85 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.16 -35.9 82.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.539 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.596 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.48 -75.84 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.212 -1.395 . . . . 0.0 107.985 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.84 -39.29 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.47 -1.394 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.27 -70.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.794 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.54 -38.96 3.18 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' SER . 10.4 ttm -54.54 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 108.872 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 24.4 mm -46.07 -63.95 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.642 0.734 . . . . 0.0 110.46 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.31 -69.05 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.29 -38.29 2.72 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 126' ' ' MET . 6.0 p -55.31 -53.75 52.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.602 -1.528 . . . . 0.0 107.282 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.81 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -44.84 -50.2 10.43 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.4 tmt_? -44.77 -56.6 4.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 135' ' ' GLY . 11.2 t -46.04 -69.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 136' ' ' VAL . 4.9 ttp -44.89 -5.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.648 -0.657 . . . . 0.0 110.255 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.84 20.06 60.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.81 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.9 t -102.8 165.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.911 -0.758 . . . . 0.0 108.969 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.539 ' N ' HG12 ' A' ' 136' ' ' VAL . 82.8 mt-10 -141.31 162.53 35.26 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.07 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.86 160.98 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.891 HG13 ' O ' ' A' ' 139' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.714 ' N ' ' CZ ' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 59' ' ' ILE . 27.7 m -120.89 -24.71 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.124 -0.985 . . . . 0.0 110.107 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.684 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -156.51 118.6 3.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.434 -1.416 . . . . 0.0 110.503 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -110.59 73.9 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.786 -0.571 . . . . 0.0 109.612 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.693 ' O ' ' O ' ' A' ' 55' ' ' VAL . 13.9 t -44.89 88.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 0.0 110.158 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.6 tmtt? -84.03 34.66 0.51 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.925 0.869 . . . . 0.0 109.127 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.77 -173.7 3.59 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.652 0.739 . . . . 0.0 111.009 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.562 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.99 179.02 5.41 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.665 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -165.63 144.77 5.24 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 0.0 108.931 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.804 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 67.4 Cg_endo -83.43 113.15 1.98 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.552 2.168 . . . . 0.0 114.445 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.972 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -63.19 142.93 58.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.497 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 55.19 52.83 44.54 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER 173.88 27.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.55 -0.97 . . . . 0.0 108.711 -178.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 18' ' ' THR . . . -111.83 152.98 27.28 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.913 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.19 165.97 6.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.868 -179.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.9 Cg_exo -48.86 34.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.617 1.545 . . . . 0.0 111.627 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.913 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -155.22 54.2 0.96 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.41 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.717 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 17.1 Cg_endo -81.14 167.66 17.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.703 1.602 . . . . 0.0 111.947 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.24 -4.48 3.14 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 121.306 1.337 . . . . 0.0 111.41 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.78 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.7 t -112.92 -71.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.58 -97.97 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.78 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -58.97 -55.13 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 CA-C-N 117.9 0.85 . . . . 0.0 110.354 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.676 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -48.46 -8.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.693 -0.63 . . . . 0.0 110.945 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.698 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -108.61 -48.62 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.643 -1.286 . . . . 0.0 108.8 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.36 98.4 0.02 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.2 tt0 -158.3 -22.64 0.08 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.772 ' CD2' ' N ' ' A' ' 31' ' ' GLY . 1.5 p-80 -81.12 -44.1 18.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.162 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.772 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -166.73 -10.52 0.03 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.29 84.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 112.494 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.638 ' ND2' ' C ' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -155.16 70.95 0.77 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.863 -1.148 . . . . 0.0 108.916 177.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 21.7 mm -44.37 -71.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.224 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.493 ' O ' ' C ' ' A' ' 36' ' ' GLU . 10.1 tpt -41.88 -53.39 3.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.164 . . . . 0.0 109.42 -178.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.3 tp10 -44.88 -49.76 10.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.698 ' CE2' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -51.42 -69.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.973 1.368 . . . . 0.0 109.998 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 42' ' ' ASN . 35.7 t -56.5 -36.06 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.557 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -50.66 -64.08 0.92 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.19 -32.53 64.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.9 t80 -71.3 -76.63 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.392 -1.443 . . . . 0.0 107.116 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.3 m-80 -41.16 -28.14 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.792 -1.192 . . . . 0.0 110.436 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -71.35 -34.52 70.58 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.82 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -90.35 -44.62 9.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.733 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.591 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 6.8 p -59.81 -32.09 70.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.15 -44.93 24.6 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.657 ' ND2' ' O ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -59.33 -21.88 60.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.411 -0.806 . . . . 0.0 108.965 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.658 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.25 -75.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.658 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -178.49 -121.06 0.68 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.035 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.7 OUTLIER -137.76 124.86 21.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -1.129 . . . . 0.0 108.669 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.972 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . 173.86 114.33 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.992 -1.068 . . . . 0.0 110.659 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.804 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -44.97 160.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.495 -1.378 . . . . 0.0 113.014 -178.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 12' ' ' LEU . 6.1 t -153.51 135.38 8.98 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.211 -0.931 . . . . 0.0 110.089 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 69' ' ' THR . 6.3 Cg_endo -66.96 108.87 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.722 1.615 . . . . 0.0 112.565 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -87.47 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.553 -1.342 . . . . 0.0 111.273 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.687 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 11.9 mt-10 -128.65 69.21 1.37 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.656 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.9 mt -70.96 88.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.731 0.777 . . . . 0.0 110.33 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -61.97 94.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 25.5 mt -89.29 94.16 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.714 ' CZ ' ' N ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -84.15 179.13 7.56 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.295 1.045 . . . . 0.0 112.234 -176.133 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 1.096 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.95 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.115 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 63' ' ' ARG . 40.2 p30 -46.73 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 109.319 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 1.096 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 43.91 86.23 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -146.23 124.36 12.16 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.82 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.765 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.95 103.06 13.68 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.172 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 22.2 p -101.03 120.62 40.46 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.078 -1.013 . . . . 0.0 109.0 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.954 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.58 148.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.876 -1.14 . . . . 0.0 111.057 177.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.5 t -169.76 95.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.684 HG21 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -104.5 147.36 27.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.756 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.8 mptt -132.75 124.21 27.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.68 -1.263 . . . . 0.0 110.092 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.756 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.9 p 76.08 149.17 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 CA-C-O 121.232 0.539 . . . . 0.0 109.662 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 73' ' ' PRO . 10.7 Cg_exo -42.07 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.513 2.142 . . . . 0.0 112.722 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.716 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.9 Cg_exo -38.44 172.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.518 1.479 . . . . 0.0 111.951 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.606 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.9 -83.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.763 ' HG ' ' HG3' ' A' ' 79' ' ' ARG . 7.9 t -42.77 -23.37 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 110.11 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.982 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 14.8 p90 -43.84 -38.92 3.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.982 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.17 -19.2 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.952 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.2 mt -56.22 -34.63 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.763 ' HG3' ' HG ' ' A' ' 75' ' ' SER . 13.0 mmt180 -53.08 -49.68 65.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.554 ' CD ' ' C ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -57.81 -63.73 1.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -59.29 -6.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 79' ' ' ARG . . . -84.13 -80.39 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 0.0 111.762 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' C ' ' CG1' ' A' ' 96' ' ' VAL . . . 172.59 -13.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.665 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.763 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.912 -1.346 . . . . 0.0 110.082 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.718 HG12 HD23 ' A' ' 84' ' ' LEU . 2.3 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.279 0.561 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.472 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 104.23 56.77 0.73 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.773 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.25 122.03 24.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.206 -1.173 . . . . 0.0 110.283 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.805 HD12 ' CG1' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -109.55 -165.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.742 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.79 156.42 46.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 0.0 109.125 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.735 ' O ' HG22 ' A' ' 104' ' ' VAL . 15.6 t-105 -48.92 -69.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.877 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.484 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.78 -53.98 21.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.565 -1.334 . . . . 0.0 110.972 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 4.2 mt-30 -47.12 -44.87 21.92 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.328 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.77 -26.03 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.431 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 120' ' ' LEU . 16.0 mt -65.95 -70.5 0.24 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' LEU . 36.0 tt0 -43.7 -42.54 5.42 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.916 -1.115 . . . . 0.0 108.337 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.693 HG12 HD11 ' A' ' 77' ' ' LEU . 41.4 mt -63.26 -31.23 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.05 -1.031 . . . . 0.0 108.329 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.93 -26.33 16.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.77 ' HE3' HD11 ' A' ' 120' ' ' LEU . 8.6 mttp -58.3 -73.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 0.0 108.431 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -48.69 -24.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 108.958 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.564 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -72.83 -16.6 61.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.699 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.48 65.71 76.75 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.768 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.66 -32.88 37.2 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.631 1.554 . . . . 0.0 112.11 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.543 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 2.5 t70 174.98 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.23 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.409 ' H ' ' H ' ' A' ' 114' ' ' ASP . 2.8 mm? -51.36 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.58 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -154.42 -24.97 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.655 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.005 HG22 ' H ' ' A' ' 118' ' ' THR . 24.8 m -65.08 -164.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.005 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.44 -73.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.518 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -61.95 142.13 57.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 110.011 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -61.4 -24.86 66.81 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.237 1.018 . . . . 0.0 109.036 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.17 -38.26 90.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.6 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.567 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.11 -74.35 0.13 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.943 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.94 -44.4 9.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.523 -1.36 . . . . 0.0 109.22 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -48.64 -70.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.765 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.37 -39.66 3.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.693 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.9 ttm -53.0 -78.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.191 -0.943 . . . . 0.0 108.605 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.8 mm -48.1 -64.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.66 0.743 . . . . 0.0 110.082 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.826 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.95 -71.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.85 -42.56 4.97 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 126' ' ' MET . 51.8 m -54.0 -42.21 68.79 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.627 -1.514 . . . . 0.0 107.029 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.74 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -54.34 -48.72 71.08 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.763 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -44.9 -48.16 11.23 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 135' ' ' GLY . 6.1 t -53.58 -69.62 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.536 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 7.0 ttm -44.9 -5.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.579 -0.701 . . . . 0.0 109.956 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 84.02 24.96 46.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.74 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.6 t -107.1 165.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.952 -0.734 . . . . 0.0 109.183 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 136' ' ' VAL . 72.8 tt0 -141.82 164.3 30.56 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.067 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.9 t -82.58 146.22 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.706 HG23 ' HD3' ' A' ' 98' ' ' ARG . 4.3 p . . . . . 0 N--CA 1.487 1.386 0 O-C-N 121.49 -0.757 . . . . 0.0 109.452 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.594 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 60' ' ' TYR . 27.5 m -120.83 -24.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.273 -0.892 . . . . 0.0 110.089 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.704 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -161.01 115.16 2.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.59 -1.319 . . . . 0.0 110.741 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -107.64 74.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.802 ' HB ' HD12 ' A' ' 57' ' ' ILE . 15.1 t -47.84 88.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.663 -1.273 . . . . 0.0 110.538 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.69 36.49 0.55 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.939 0.876 . . . . 0.0 109.158 179.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.886 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -78.04 -173.99 3.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 111.374 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.09 174.54 7.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.711 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -163.87 147.52 8.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.951 -1.093 . . . . 0.0 109.371 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.664 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 96.7 Cg_endo -86.76 128.84 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.389 2.059 . . . . 0.0 113.266 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.079 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -75.26 142.85 43.28 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.05 63.12 5.31 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.664 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 14.0 tttt 174.09 -25.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.65 151.92 32.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 108.368 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.883 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.64 165.9 9.39 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.8 Cg_exo -50.45 37.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.717 1.611 . . . . 0.0 111.638 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.883 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -167.97 55.01 0.28 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 10.9 Cg_endo -79.03 170.83 17.29 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.617 1.545 . . . . 0.0 111.781 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.17 -4.56 1.67 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.115 1.21 . . . . 0.0 110.94 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.886 HG22 ' CD2' ' A' ' 10' ' ' LEU . 1.9 t -108.18 -72.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.482 0.658 . . . . 0.0 110.096 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.62 -98.17 0.06 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.761 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.8 Cg_endo -59.45 -55.38 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.975 0.888 . . . . 0.0 109.988 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.67 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.51 -12.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.19 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.977 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -114.39 -40.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.775 -1.203 . . . . 0.0 108.239 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.8 92.69 0.01 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.564 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -159.06 -25.9 0.07 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 179.178 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.73 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 4.6 p80 -78.75 61.24 2.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.693 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.685 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 83.91 -9.37 63.17 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.35 84.23 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.153 -1.204 . . . . 0.0 112.104 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -157.38 123.72 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 108.731 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.659 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 mm -99.4 -63.47 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.685 -0.634 . . . . 0.0 109.831 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.66 ' O ' ' N ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -41.02 -52.58 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.755 -1.215 . . . . 0.0 109.662 -176.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.2 mm-40 -49.66 -47.25 50.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.647 -1.283 . . . . 0.0 107.831 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.977 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -52.93 -68.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.517 1.151 . . . . 0.0 109.956 178.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.67 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 23.6 t -66.08 -37.71 80.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.081 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.66 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.6 mmmt -46.12 -58.57 3.51 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.32 72.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.318 -0.864 . . . . 0.0 108.939 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' THR . 3.6 t80 -71.34 -77.11 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.67 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 2.0 m-80 -41.33 -32.1 0.28 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.933 -1.104 . . . . 0.0 110.589 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.93 -33.45 73.75 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.668 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . -90.24 -47.97 7.45 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.559 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 41' ' ' PHE . 2.3 p -57.08 -29.2 63.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.47 -46.57 17.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -57.24 -21.25 32.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.406 -0.809 . . . . 0.0 108.842 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.722 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.08 -74.22 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.443 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.722 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 172.97 -156.52 24.9 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 8.1 t70 -93.16 145.34 24.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.02 -1.282 . . . . 0.0 108.967 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.079 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.25 -153.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.745 -1.222 . . . . 0.0 110.905 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.3 mm -146.37 139.42 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 71' ' ' THR . 2.2 t -140.11 135.29 16.18 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.008 -1.058 . . . . 0.0 110.905 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.3 Cg_endo -71.84 105.66 1.85 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.77 1.647 . . . . 0.0 111.056 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.5 m -80.66 135.61 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.711 -1.243 . . . . 0.0 111.702 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.3 mt-10 -129.29 67.49 1.43 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.802 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -68.79 87.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.707 0.765 . . . . 0.0 110.218 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -61.69 94.68 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 64' ' ' SER . 5.6 mt -88.87 134.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.443 -0.786 . . . . 0.0 109.217 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER -122.49 -179.65 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.316 -176.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 1.082 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.82 -85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.224 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' C ' ' A' ' 63' ' ' ARG . 20.9 t0 -46.24 39.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.542 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 1.082 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER 44.03 87.63 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.754 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -143.62 166.37 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.781 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -146.18 103.2 3.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 109.164 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 4.0 p -101.11 120.83 40.79 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.92 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.67 147.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.921 -1.112 . . . . 0.0 110.935 177.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.8 t -168.3 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 122.312 1.053 . . . . 0.0 108.208 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -95.06 146.98 23.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.787 ' NZ ' HG13 ' A' ' 68' ' ' VAL . 2.3 mptt -132.72 127.31 34.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.217 -1.393 . . . . 0.0 110.511 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.768 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.1 p 76.0 149.15 0.12 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-O 121.242 0.544 . . . . 0.0 109.955 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' O ' ' O ' ' A' ' 73' ' ' PRO . 9.2 Cg_exo -42.83 175.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.835 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.75 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -38.66 171.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.639 1.559 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.698 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.33 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.75 ' N ' ' O ' ' A' ' 73' ' ' PRO . 24.8 p -43.02 -22.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.887 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.003 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 15.6 p90 -43.77 -40.54 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.559 -0.713 . . . . 0.0 109.168 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.003 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -134.59 -16.63 2.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.885 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.3 mt -59.28 -33.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.629 ' HG3' HG21 ' A' ' 71' ' ' THR . 16.3 mmt180 -55.78 -42.71 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.9 tmtt? -65.87 -66.06 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.37 -6.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.426 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.24 -80.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.494 -0.754 . . . . 0.0 111.857 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 173.6 35.0 0.04 OUTLIER Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.45 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.509 HD11 HH11 ' A' ' 79' ' ' ARG . 3.2 mt . . . . . 0 N--CA 1.49 1.572 0 O-C-N 120.96 -1.318 . . . . 0.0 109.148 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.302 0.572 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.449 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 67.82 44.78 78.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.792 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.82 115.16 14.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -1.228 . . . . 0.0 110.216 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -108.51 178.2 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.787 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -122.66 161.96 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.057 . . . . 0.0 109.366 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.713 ' O ' HG22 ' A' ' 104' ' ' VAL . 16.0 t-105 -48.57 -70.88 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 111.33 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.539 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 3.8 tp10 -49.31 -51.59 33.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 110.934 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.407 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.2 mt-30 -48.57 -44.6 36.87 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.343 -0.848 . . . . 0.0 110.295 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.57 -25.58 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 117.726 -1.59 . . . . 0.0 107.634 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.749 HD13 HD13 ' A' ' 120' ' ' LEU . 16.1 mt -65.85 -71.56 0.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.539 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 23.8 mm-40 -44.18 -42.37 6.39 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 77' ' ' LEU . 67.0 mt -65.28 -31.49 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 108.999 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.814 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.31 -31.0 13.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.617 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.691 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.1 mtpm? -54.45 -72.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.966 -1.084 . . . . 0.0 108.625 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -51.23 -27.68 9.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' MET . 10.2 tttm -84.62 64.47 8.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.784 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.566 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER 175.99 56.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.843 . . . . 0.0 109.306 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.6 Cg_endo -64.78 -55.06 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.528 1.486 . . . . 0.0 112.231 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 1.7 p-10 -162.56 9.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.164 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.8 mm? -44.97 -62.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -177.75 6.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.04 HG22 ' H ' ' A' ' 118' ' ' THR . 32.0 m -108.88 -164.48 0.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.943 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.04 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 175.97 -44.39 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.3 -0.875 . . . . 0.0 109.708 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.711 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -74.74 143.88 43.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.472 -0.767 . . . . 0.0 110.359 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.749 HD13 HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -65.29 -36.78 85.14 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.385 1.088 . . . . 0.0 108.514 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -61.94 -33.92 75.15 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.932 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.39 -75.4 0.14 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.456 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.92 -40.12 6.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.477 -1.389 . . . . 0.0 109.093 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -52.89 -69.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.661 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.35 -38.62 2.77 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.0 ttm -53.28 -78.04 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.814 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.6 mm -48.76 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.768 0.794 . . . . 0.0 109.832 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.95 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -40.24 3.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.7 m -57.57 -50.25 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.566 -1.549 . . . . 0.0 107.532 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.654 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.39 -49.05 25.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.79 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.14 -54.6 8.34 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.663 ' O ' ' N ' ' A' ' 135' ' ' GLY . 6.9 t -44.88 -68.69 0.18 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.682 ' HG2' HG23 ' A' ' 136' ' ' VAL . 5.5 ttp -47.23 -4.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.637 -0.664 . . . . 0.0 109.271 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.71 -27.61 7.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.682 HG23 ' HG2' ' A' ' 134' ' ' MET . 43.0 t -48.6 165.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.919 -0.754 . . . . 0.0 109.183 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.565 ' N ' HG12 ' A' ' 136' ' ' VAL . 63.2 mm-40 -142.38 162.01 36.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.756 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.95 161.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 139' ' ' VAL . 4.1 p . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.789 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.937 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.7 m -117.17 -24.41 3.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.157 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.16 107.04 4.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.689 -1.257 . . . . 0.0 110.351 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -96.31 73.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.748 ' HB ' HD12 ' A' ' 57' ' ' ILE . 31.2 t -46.47 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.8 -1.188 . . . . 0.0 110.461 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.9 OUTLIER -82.93 34.75 0.46 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.844 0.831 . . . . 0.0 108.999 179.111 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.983 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.11 -174.46 3.65 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.804 0.811 . . . . 0.0 111.147 -178.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -119.69 172.15 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.774 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -168.42 160.06 8.82 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.787 -1.196 . . . . 0.0 110.232 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.774 ' HD2' HD23 ' A' ' 12' ' ' LEU . 15.1 Cg_endo -67.91 109.91 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.249 1.966 . . . . 0.0 111.635 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.804 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -69.01 41.03 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.89 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 177.08 -16.52 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.3 -1.905 . . . . 0.0 111.831 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -135.41 53.92 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.427 -1.631 . . . . 0.0 110.502 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.716 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -73.13 157.9 36.35 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -159.85 162.96 23.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.617 -1.302 . . . . 0.0 110.726 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.0 Cg_endo -56.02 36.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.973 1.782 . . . . 0.0 111.993 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -175.93 58.57 0.18 Allowed Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.34 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.1 Cg_endo -80.68 169.5 16.7 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.568 1.512 . . . . 0.0 111.394 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.88 -4.66 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 121.007 1.138 . . . . 0.0 110.965 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.983 HG22 HD22 ' A' ' 10' ' ' LEU . 2.1 t -104.94 -71.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.6 0.714 . . . . 0.0 109.964 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.69 -98.12 0.05 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.62 -55.38 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 CA-C-N 117.926 0.863 . . . . 0.0 109.867 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.645 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -43.85 -11.41 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.15 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.87 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -116.02 -39.15 3.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.822 -1.174 . . . . 0.0 108.427 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.33 94.1 0.01 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.524 ' CD ' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -161.52 -23.28 0.05 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.677 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -81.14 64.93 6.08 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 80.44 -5.51 63.82 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.29 80.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 111.828 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.54 ' O ' ' NE2' ' A' ' 30' ' ' HIS . 42.9 m-80 -155.95 125.01 6.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.879 -1.138 . . . . 0.0 108.657 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.5 mm -101.16 -62.9 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.686 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.87 -49.77 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.819 -1.176 . . . . 0.0 109.861 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -52.37 -50.54 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.854 -1.154 . . . . 0.0 108.181 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.87 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -48.85 -61.15 2.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.606 1.194 . . . . 0.0 109.076 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.716 HG13 ' CB ' ' A' ' 17' ' ' ALA . 98.6 t -70.52 -29.15 37.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.848 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.686 ' N ' ' O ' ' A' ' 35' ' ' MET . 40.3 tptt -54.44 -55.38 29.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.58 75.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.378 -0.826 . . . . 0.0 109.532 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.3 t80 -68.97 -76.36 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 23.6 m-20 -41.79 -37.19 1.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.455 1.121 . . . . 0.0 110.804 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -63.29 -35.02 78.97 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.355 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.05 -61.54 1.66 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.545 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.3 p -44.8 -30.08 0.9 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.36 -43.21 19.36 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 44' ' ' ALA . 16.3 t-20 -55.3 -24.04 26.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.647 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.09 -85.25 0.54 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.851 -1.156 . . . . 0.0 109.934 179.483 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -161.83 -150.43 5.95 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.121 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.2 123.09 49.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.721 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.804 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -155.39 -152.87 0.41 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 13' ' ' PRO . 5.8 mm -147.19 143.89 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 14' ' ' ALA . 5.6 t -146.94 137.46 12.46 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 110.299 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.9 Cg_endo -73.03 87.24 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.842 1.694 . . . . 0.0 110.776 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.828 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.5 m -58.46 137.42 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.827 1.298 . . . . 0.0 112.231 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 32.6 mt-10 -128.09 63.61 1.4 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.748 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -63.38 88.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.66 0.743 . . . . 0.0 110.174 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.485 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.57 97.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 57' ' ' ILE . 1.9 mt -100.66 146.11 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.17 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.789 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 9.6 m-85 -115.52 141.17 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.937 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.56 -30.37 5.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.153 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 7.2 t70 -52.51 1.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.842 ' H ' ' C ' ' A' ' 61' ' ' ALA . 8.8 tmm_? 71.68 69.8 0.16 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.06 0.933 . . . . 0.0 109.642 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -148.59 125.04 10.97 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.594 ' CD1' ' ND1' ' A' ' 30' ' ' HIS . 17.4 p90 -101.04 103.86 14.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.954 -1.091 . . . . 0.0 110.187 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 58' ' ' THR . 11.2 p -99.43 124.82 44.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 108.854 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.566 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -107.97 171.35 7.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.596 -1.315 . . . . 0.0 109.368 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.994 HG12 ' O ' ' A' ' 68' ' ' VAL . 90.3 t -163.17 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 112.644 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.519 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.0 t -154.02 118.54 4.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 115.945 -2.302 . . . . 0.0 110.754 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.812 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.92 121.43 42.3 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.76 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.6 p 76.86 151.06 0.13 Allowed Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 71' ' ' THR . 12.6 Cg_exo -40.21 175.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.551 2.167 . . . . 0.0 113.038 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.6 Cg_exo -40.51 169.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.6 1.534 . . . . 0.0 112.004 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.934 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.93 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.787 ' N ' ' O ' ' A' ' 73' ' ' PRO . 8.6 t -43.34 -23.62 0.07 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 110.147 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.07 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 20.5 p90 -43.6 -42.09 4.95 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.0 109.41 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.07 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.27 -14.58 2.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.934 HD12 ' HB1' ' A' ' 74' ' ' ALA . 3.1 mt -61.75 -31.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.768 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 2.1 mmp_? -54.82 -44.27 73.71 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HZ3' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -66.03 -65.59 0.66 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.445 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -57.22 -4.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.634 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.55 -79.72 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 112.156 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.417 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 163.64 47.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.682 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 84' ' ' LEU . 5.4 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.003 -1.292 . . . . 0.0 109.195 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 97' ' ' GLY . 72.2 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.302 0.572 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 69.48 60.36 5.12 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.634 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.3 mtt180 -134.7 113.54 11.78 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -1.21 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.702 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.21 179.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.727 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -124.44 155.43 38.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.024 -1.048 . . . . 0.0 109.198 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.715 ' O ' HG22 ' A' ' 104' ' ' VAL . 12.0 t-105 -44.97 -70.25 0.11 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 111.244 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.511 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.32 -52.98 24.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.69 -1.257 . . . . 0.0 111.047 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.3 mt-30 -47.76 -44.6 28.31 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.272 -0.892 . . . . 0.0 110.429 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.9 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.5 -25.33 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 117.681 -1.608 . . . . 0.0 107.585 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 120' ' ' LEU . 16.8 mt -66.16 -70.86 0.22 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' LEU . 78.2 tt0 -43.85 -43.66 6.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.911 -1.118 . . . . 0.0 108.34 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 77' ' ' LEU . 46.9 mt -61.83 -31.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.812 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.19 -27.42 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.783 ' HE3' HD11 ' A' ' 120' ' ' LEU . 13.9 mttp -58.44 -73.44 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.763 -1.21 . . . . 0.0 108.304 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.604 ' N ' ' CD ' ' A' ' 110' ' ' GLN . 1.5 mp0 -44.93 -26.43 0.42 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.041 -1.037 . . . . 0.0 108.794 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 109' ' ' LYS . 13.4 tttt -73.19 -16.96 61.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.68 65.9 76.88 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.039 -1.038 . . . . 0.0 109.746 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.68 -34.76 30.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.704 1.602 . . . . 0.0 112.069 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER 175.0 15.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 109.163 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.403 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.3 mm? -55.49 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 0.0 109.553 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -150.66 -24.99 0.23 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.053 HG22 ' H ' ' A' ' 118' ' ' THR . 23.5 m -62.97 -164.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.053 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.34 -74.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.267 -0.895 . . . . 0.0 109.933 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.524 ' H ' HG23 ' A' ' 118' ' ' THR . 1.9 m-20 -61.78 140.44 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.183 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -62.36 -22.34 66.03 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.204 1.002 . . . . 0.0 108.899 179.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.56 -35.39 80.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.414 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.41 -75.53 0.13 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.899 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.47 -34.15 1.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.491 -1.381 . . . . 0.0 109.27 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -58.11 -69.2 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.031 -1.043 . . . . 0.0 108.509 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.59 -44.79 6.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.703 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.0 mtt -50.29 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.101 -0.999 . . . . 0.0 108.743 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.812 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.7 mm -48.09 -66.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.416 -0.802 . . . . 0.0 110.053 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.9 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.39 -71.37 0.11 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.94 -40.72 4.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.8 m -55.36 -47.8 75.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.584 . . . . 0.0 107.582 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.567 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -50.43 -47.92 56.53 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.782 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.11 -51.99 12.92 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.668 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.0 t -45.24 -67.88 0.25 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.768 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 9.4 ttm -48.53 -2.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.18 -27.21 7.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.672 HG23 ' SD ' ' A' ' 134' ' ' MET . 30.9 t -48.84 165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.927 -0.749 . . . . 0.0 109.326 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' N ' HG12 ' A' ' 136' ' ' VAL . 40.3 mm-40 -142.27 162.37 35.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 109.767 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.27 165.02 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.905 HG13 ' O ' ' A' ' 139' ' ' VAL . 5.1 p . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.77 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.983 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.1 m -119.51 -24.58 3.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.77 107.73 4.51 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.422 -1.311 . . . . 0.0 110.338 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.86 73.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.755 ' HB ' HD12 ' A' ' 57' ' ' ILE . 32.3 t -48.03 88.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.816 -1.178 . . . . 0.0 110.653 -176.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtp? -82.47 36.06 0.47 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.791 0.805 . . . . 0.0 109.2 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.88 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.8 tp -78.31 -174.08 3.56 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.608 0.718 . . . . 0.0 111.119 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 1.054 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.74 177.88 5.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.597 HD13 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -167.61 155.9 8.59 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 109.945 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 15' ' ' GLY . 12.0 Cg_endo -68.83 104.55 1.18 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.037 1.824 . . . . 0.0 111.508 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.802 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -63.1 37.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.932 -1.105 . . . . 0.0 110.38 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -170.56 -26.51 0.02 OUTLIER Glycine 0 N--CA 1.493 2.467 0 C-N-CA 118.096 -2.002 . . . . 0.0 111.842 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 15' ' ' GLY . 2.9 mttm -138.97 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.474 -1.604 . . . . 0.0 110.572 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.659 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -90.45 160.91 15.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.762 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.8 164.95 9.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.799 -1.188 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.468 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.9 Cg_exo -53.1 32.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.717 1.612 . . . . 0.0 112.026 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.68 54.16 4.56 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.221 -0.925 . . . . 0.0 110.046 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.09 155.01 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.696 1.597 . . . . 0.0 111.778 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.79 -4.69 1.49 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.006 1.137 . . . . 0.0 111.432 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.799 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 5.4 t -113.47 -68.96 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.93 -97.62 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.799 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -56.45 -55.04 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 CA-C-N 117.784 0.792 . . . . 0.0 110.479 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.724 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -55.59 -4.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.598 -0.689 . . . . 0.0 111.076 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -112.11 -54.71 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.645 -1.285 . . . . 0.0 109.152 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.26 -26.5 0.96 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.499 ' C ' ' O ' ' A' ' 28' ' ' GLY . 52.0 mm-40 -42.01 -19.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.513 -1.58 . . . . 0.0 109.252 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.773 ' CD2' ' N ' ' A' ' 31' ' ' GLY . 3.6 p-80 -65.25 -48.86 71.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.788 0.804 . . . . 0.0 108.854 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.773 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -162.22 -8.26 0.04 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 71.38 72.49 0.18 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.926 -0.75 . . . . 0.0 111.47 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.24 63.07 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.499 1.142 . . . . 0.0 108.742 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.4 mm -43.12 -66.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.361 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.7 tpt -41.61 -57.7 2.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.38 -1.45 . . . . 0.0 109.009 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.8 tp10 -44.68 -50.16 10.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.77 -1.206 . . . . 0.0 107.936 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -48.27 -62.98 1.21 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.813 1.292 . . . . 0.0 108.863 178.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 17' ' ' ALA . 61.8 t -67.78 -30.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.271 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 35' ' ' MET . 19.0 tttp -52.75 -59.82 4.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.24 74.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.803 . . . . 0.0 109.512 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.683 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.3 t80 -69.66 -77.23 0.09 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.7 m-20 -41.77 -36.43 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.48 1.133 . . . . 0.0 110.539 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -63.27 -35.1 79.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.586 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -91.25 -57.52 2.76 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.813 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.772 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 16.2 p -48.08 -28.53 2.92 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.21 -47.88 11.08 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -50.46 -23.0 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.216 -0.927 . . . . 0.0 109.127 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.759 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.51 -85.2 0.54 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.759 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.41 -117.93 0.42 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.842 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 3.4 t0 -141.26 129.32 22.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -1.176 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.802 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -164.17 -152.81 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.174 -0.953 . . . . 0.0 110.391 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.585 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.3 mm -146.95 141.77 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.622 HG22 ' C ' ' A' ' 71' ' ' THR . 15.0 t -142.76 137.08 14.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.098 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.3 Cg_endo -74.33 88.14 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.882 1.722 . . . . 0.0 111.077 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.88 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -57.37 137.14 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 122.697 1.237 . . . . 0.0 111.946 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 66.0 tt0 -128.89 67.49 1.41 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.755 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.1 mt -68.7 87.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.698 0.761 . . . . 0.0 110.068 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.71 100.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 57' ' ' ILE . 9.0 mt -103.13 145.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.569 -0.707 . . . . 0.0 110.406 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.77 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 8.0 m-85 -116.17 140.02 49.74 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.983 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.61 -32.13 7.7 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.391 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.9 t70 -50.6 -2.3 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.797 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.9 ttm180 75.31 70.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.035 0.921 . . . . 0.0 109.951 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 36.1 t -148.71 127.5 12.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.672 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -103.3 103.82 13.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.833 -1.167 . . . . 0.0 110.399 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.1 p -99.07 124.63 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -107.6 171.56 7.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.506 -1.371 . . . . 0.0 109.321 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.971 HG12 ' O ' ' A' ' 68' ' ' VAL . 98.7 t -162.56 44.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 112.813 -177.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.483 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.3 t -153.83 120.62 5.61 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.669 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.82 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -118.92 122.01 41.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.807 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.6 p 77.48 151.74 0.13 Allowed Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.138 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.514 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 13.8 Cg_exo -38.85 175.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.375 2.717 . . . . 0.0 114.083 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.89 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -40.68 168.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.077 0 C-N-CA 122.035 1.823 . . . . 0.0 112.308 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.78 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 48.11 -74.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.89 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -42.99 -21.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.683 -0.635 . . . . 0.0 110.755 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.78 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -44.05 -35.51 2.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.728 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.978 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -136.55 -16.24 1.57 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.978 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.2 mt -58.86 -34.13 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.828 HH11 ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.85 -38.58 70.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.3 tmtt? -69.72 -66.93 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.86 -7.39 0.3 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.178 -0.951 . . . . 0.0 109.153 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.48 -78.27 0.31 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.676 -0.64 . . . . 0.0 111.433 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.651 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 166.2 14.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.913 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.784 HD12 ' NH1' ' A' ' 79' ' ' ARG . 2.6 mt . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.401 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.651 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.324 0.583 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 96.02 64.21 0.95 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 82' ' ' ALA . 5.8 mtt180 -134.09 114.82 13.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.09 -1.241 . . . . 0.0 110.304 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.7 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -103.38 179.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.715 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -124.86 154.65 40.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.003 -1.06 . . . . 0.0 109.124 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.682 ' O ' HG22 ' A' ' 104' ' ' VAL . 12.8 t-105 -44.91 -69.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 111.386 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.19 -52.22 37.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.522 -1.361 . . . . 0.0 111.004 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.1 mt-30 -48.77 -44.05 38.41 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.452 -0.78 . . . . 0.0 110.492 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.75 -26.39 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 117.726 -1.589 . . . . 0.0 107.614 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.927 HD13 HD13 ' A' ' 120' ' ' LEU . 13.5 mt -65.01 -71.17 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.498 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 7.4 tm-20 -44.35 -44.67 8.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.615 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 77' ' ' LEU . 63.7 mt -61.99 -31.91 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 108.706 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.837 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.66 -26.84 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.111 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.776 ' N ' ' O ' ' A' ' 105' ' ' LEU . 2.0 tptp -58.97 -73.52 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -48.91 -25.01 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 108.988 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.505 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 3.2 tmtt? -83.15 -7.39 59.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.269 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.724 ' O ' ' SD ' ' A' ' 112' ' ' MET . 2.3 ppp? -130.13 59.72 47.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.865 -1.147 . . . . 0.0 109.967 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.7 Cg_endo -61.29 -54.43 1.77 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.537 1.491 . . . . 0.0 112.305 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER 174.74 -1.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.612 ' O ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -44.88 -28.82 0.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.696 -0.628 . . . . 0.0 109.717 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.482 ' N ' ' HG ' ' A' ' 115' ' ' LEU . 8.7 t30 -177.62 -14.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.96 -1.087 . . . . 0.0 109.653 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.043 HG22 ' H ' ' A' ' 118' ' ' THR . 31.9 m -104.02 -164.51 1.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.043 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.48 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 0.0 109.806 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.735 ' OD2' ' HB2' ' A' ' 122' ' ' ALA . 2.9 p-10 -58.0 143.07 44.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.163 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.927 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -71.92 -30.59 65.5 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.502 1.144 . . . . 0.0 108.387 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -62.91 -35.04 78.74 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.404 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.735 ' HB2' ' OD2' ' A' ' 119' ' ' ASP . . . -70.71 -76.32 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.382 -1.327 . . . . 0.0 107.556 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.89 -43.43 8.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.455 -1.403 . . . . 0.0 109.137 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -48.22 -69.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 0.0 108.64 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 129' ' ' GLY . 13.7 ttt180 -43.44 -39.6 3.35 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 130' ' ' SER . 18.5 ttm -53.95 -79.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.249 -0.907 . . . . 0.0 108.742 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.837 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.4 mm -47.62 -63.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.772 . . . . 0.0 110.054 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.709 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.46 -71.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.11 -42.97 5.47 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.0 m -52.59 -45.09 66.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.537 -1.566 . . . . 0.0 107.542 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.662 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -53.72 -48.03 69.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.607 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 3.3 tmm_? -44.94 -44.75 10.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.4 t -55.41 -69.88 0.12 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.771 ' CG ' HH21 ' A' ' 79' ' ' ARG . 5.9 ttm -44.87 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.523 -0.735 . . . . 0.0 110.073 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.32 25.56 47.27 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.662 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.4 t -106.31 165.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.981 -0.717 . . . . 0.0 109.126 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.536 ' N ' HG12 ' A' ' 136' ' ' VAL . 50.3 mm-40 -140.41 161.89 36.61 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.901 -1.12 . . . . 0.0 110.086 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.84 165.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 139' ' ' VAL . 4.5 p . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.772 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -114.05 -24.35 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.17 108.29 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -95.54 73.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.737 ' HB ' HD12 ' A' ' 57' ' ' ILE . 12.2 t -45.69 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.239 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.65 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -82.78 34.58 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.952 0.882 . . . . 0.0 109.093 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.85 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.6 tp -77.08 -174.46 3.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.783 0.801 . . . . 0.0 111.003 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 1.066 ' O ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -123.52 174.22 7.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.066 HD12 ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -171.17 158.88 5.18 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 110.411 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HA ' HD13 ' A' ' 52' ' ' ILE . 11.1 Cg_endo -66.61 108.69 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.197 1.932 . . . . 0.0 111.993 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.804 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -67.47 40.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.457 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -178.09 -21.0 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.527 -1.797 . . . . 0.0 111.525 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -139.92 74.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.521 -1.576 . . . . 0.0 110.259 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.784 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -92.25 165.29 13.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 108.588 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.763 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.4 163.06 6.1 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.915 -1.116 . . . . 0.0 110.036 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HA ' HG21 ' A' ' 34' ' ' ILE . 5.5 Cg_exo -53.13 32.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.681 1.587 . . . . 0.0 111.841 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.763 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.71 54.07 4.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 110.597 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.3 Cg_endo -85.82 160.83 10.51 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.766 1.644 . . . . 0.0 111.467 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.51 -4.81 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 120.898 1.065 . . . . 0.0 111.047 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 26' ' ' ALA . 21.2 t -115.58 -67.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.482 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 56.51 -97.32 0.05 OUTLIER Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.808 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.0 Cg_exo -54.05 -55.02 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 CA-C-N 117.844 0.822 . . . . 0.0 110.45 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -60.79 -0.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.196 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.685 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.58 -58.77 2.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.717 -1.24 . . . . 0.0 109.59 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 32' ' ' ALA . . . -43.18 -18.07 0.05 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.315 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 28' ' ' GLY . 32.5 mm-40 -42.13 -21.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.255 -1.732 . . . . 0.0 108.502 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.764 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 24.6 p-80 -67.32 59.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.653 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 84.62 -13.03 54.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.15 77.14 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.544 -0.974 . . . . 0.0 111.848 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' H ' ' CE1' ' A' ' 30' ' ' HIS . 1.4 m-80 -150.29 60.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.34 1.067 . . . . 0.0 108.536 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.0 mm -42.86 -65.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.623 ' O ' ' N ' ' A' ' 39' ' ' LYS . 8.2 tpt -41.95 -40.43 2.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 108.746 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -58.0 -51.2 70.66 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.685 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -47.85 -62.43 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.94 1.352 . . . . 0.0 108.951 177.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 17' ' ' ALA . 61.0 t -67.26 -30.55 49.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.596 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -54.11 -59.46 4.62 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.33 74.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.433 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.2 t80 -67.2 -75.03 0.1 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.592 HD22 ' HB3' ' A' ' 17' ' ' ALA . 1.5 m-80 -41.99 -37.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.475 1.131 . . . . 0.0 110.874 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -62.7 -35.53 80.02 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.559 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.678 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . -90.83 -56.11 3.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.878 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.756 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.0 p -50.7 -26.22 5.25 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.59 -48.1 10.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -52.61 -21.22 3.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.975 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.545 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.63 -85.22 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.545 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.56 -136.48 2.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.942 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 2.8 p30 -122.12 122.34 39.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -1.102 . . . . 0.0 109.915 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.804 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.08 -153.17 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.908 . . . . 0.0 110.289 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.8 mm -147.28 142.76 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.547 HG22 ' C ' ' A' ' 71' ' ' THR . 8.1 t -145.01 137.66 13.59 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 110.261 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.1 Cg_endo -73.56 86.67 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.796 1.664 . . . . 0.0 110.669 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.85 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -56.68 138.38 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-O 122.749 1.261 . . . . 0.0 112.078 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.5 mt-10 -130.52 65.67 1.53 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.737 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.4 mt -65.44 88.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.812 0.815 . . . . 0.0 110.234 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.559 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -65.48 98.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.663 HG12 HG22 ' A' ' 57' ' ' ILE . 1.7 mt -102.94 147.54 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.772 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.9 m-85 -115.82 141.62 47.85 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.802 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.52 -32.72 8.37 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.304 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.27 -1.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.794 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.4 tmm_? 75.21 70.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -148.99 124.94 10.62 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' CG ' ' A' ' 65' ' ' PHE . 20.6 p90 -100.97 103.73 14.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.003 -1.061 . . . . 0.0 110.197 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 58' ' ' THR . 9.2 p -99.25 124.63 44.48 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.583 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -107.71 170.41 8.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.481 -1.387 . . . . 0.0 109.355 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.963 HG12 ' O ' ' A' ' 68' ' ' VAL . 90.1 t -161.82 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 112.716 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.535 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.0 116.95 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 116.039 -2.264 . . . . 0.0 110.324 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.803 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -114.74 120.0 38.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.032 0.92 . . . . 0.0 108.701 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.779 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.94 152.26 0.13 Allowed Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.364 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 71' ' ' THR . 15.3 Cg_exo -38.15 175.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.751 2.301 . . . . 0.0 113.365 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.795 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.3 Cg_exo -42.26 168.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.761 1.641 . . . . 0.0 112.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.902 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.6 -77.0 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 73' ' ' PRO . 41.6 p -43.42 -24.14 0.09 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.522 -0.736 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 14.6 p90 -43.86 -41.4 5.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.59 -18.82 2.75 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.902 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.4 mt -59.87 -32.65 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 84' ' ' LEU . 14.1 mmt180 -54.91 -43.09 72.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.526 ' CD ' ' C ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -68.39 -66.64 0.54 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -56.14 -4.92 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.965 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.04 -79.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.508 -0.745 . . . . 0.0 112.018 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.486 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 159.36 56.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.407 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 79' ' ' ARG . 10.2 mt . . . . . 0 N--CA 1.488 1.475 0 O-C-N 121.053 -1.263 . . . . 0.0 109.503 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 97' ' ' GLY . 19.2 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 50.98 60.92 6.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.6 mtt180 -134.74 113.54 11.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.071 -1.252 . . . . 0.0 110.686 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 -176.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.651 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -128.93 156.32 43.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 109.093 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.712 ' O ' HG22 ' A' ' 104' ' ' VAL . 10.7 t-105 -44.93 -71.46 0.08 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.801 . . . . 0.0 111.176 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.13 -52.52 34.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.636 -1.29 . . . . 0.0 111.103 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.1 mt-30 -47.82 -43.66 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.383 -0.823 . . . . 0.0 110.303 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.56 -24.88 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.575 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.869 HD13 HD13 ' A' ' 120' ' ' LEU . 21.2 mt -66.0 -72.06 0.17 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 107' ' ' ILE . 11.3 tm-20 -44.28 -45.02 8.42 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.959 -1.088 . . . . 0.0 108.612 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.764 ' CD1' HD21 ' A' ' 77' ' ' LEU . 42.1 mt -61.25 -31.67 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.046 . . . . 0.0 108.623 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.847 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -97.45 -23.68 15.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 108.984 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.9 tptp -62.43 -74.52 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.558 ' NE2' ' H ' ' A' ' 110' ' ' GLN . 2.2 mp0 -44.63 -30.15 0.87 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.022 -1.049 . . . . 0.0 108.806 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -61.82 -24.0 66.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.706 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -126.39 73.85 73.37 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 109.698 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.79 -34.4 24.44 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.551 1.501 . . . . 0.0 111.964 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.521 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 3.6 t70 175.09 11.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.036 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 115' ' ' LEU . 2.4 mm? -49.81 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 109.606 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.764 ' ND2' ' N ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -148.76 -25.05 0.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.607 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.057 HG22 ' H ' ' A' ' 118' ' ' THR . 22.9 m -60.19 -164.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.537 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.057 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.58 -72.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.3 -0.875 . . . . 0.0 109.929 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.53 ' H ' HG23 ' A' ' 118' ' ' THR . 4.8 m-20 -65.32 138.28 58.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.439 -0.788 . . . . 0.0 110.159 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.869 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -61.73 -21.53 64.59 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.282 1.039 . . . . 0.0 108.815 179.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.53 -38.49 91.2 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.54 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.88 -75.13 0.11 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.135 -1.426 . . . . 0.0 107.784 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.53 -41.64 6.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.524 -1.36 . . . . 0.0 109.392 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.09 -69.52 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 0.0 108.764 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.2 ttm180 -43.55 -39.94 3.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.701 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.2 ttm -53.31 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 108.579 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.847 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 24.1 mm -47.92 -63.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.438 -0.789 . . . . 0.0 109.954 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.805 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.97 -71.75 0.12 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.01 -41.87 4.84 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.8 m -54.35 -50.73 66.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.523 -1.575 . . . . 0.0 107.685 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.734 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -48.49 -47.49 38.63 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.0 -55.01 7.4 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.5 t -44.71 -68.59 0.19 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.652 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.2 ttp -46.68 -4.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.63 -31.08 5.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.734 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 29.0 t -45.43 165.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.937 -0.743 . . . . 0.0 109.194 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.547 ' N ' HG12 ' A' ' 136' ' ' VAL . 35.9 mp0 -143.85 163.2 34.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.65 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -79.28 155.08 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p . . . . . 0 N--CA 1.487 1.411 0 O-C-N 121.628 -0.67 . . . . 0.0 109.284 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.794 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.6 m -111.66 -24.5 3.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.3 6.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -94.99 73.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.386 -0.821 . . . . 0.0 108.827 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 55' ' ' VAL . 26.1 t -45.92 88.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.045 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.96 34.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.951 0.881 . . . . 0.0 108.901 179.281 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.921 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.53 -174.66 3.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.872 0.844 . . . . 0.0 111.268 -178.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.578 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -116.98 169.49 9.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.569 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -163.08 144.44 7.6 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.159 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HA ' HD13 ' A' ' 52' ' ' ILE . 30.3 Cg_endo -79.02 126.6 7.2 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.505 2.137 . . . . 0.0 114.216 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.079 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.52 141.43 48.51 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 60.55 -61.24 0.01 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.1 ttpm? -60.64 37.77 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.831 -0.805 . . . . 0.0 108.831 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.704 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -119.27 151.83 37.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.9 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.79 165.77 6.89 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 -179.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.5 Cg_exo -49.46 36.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.696 1.598 . . . . 0.0 111.657 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.9 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -163.77 54.87 0.43 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.53 -0.732 . . . . 0.0 109.78 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.2 Cg_endo -77.93 170.16 19.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.485 1.456 . . . . 0.0 111.716 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -60.75 -4.65 3.7 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.209 1.273 . . . . 0.0 111.03 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.921 HG22 ' CD2' ' A' ' 10' ' ' LEU . 2.2 t -106.16 -71.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.594 0.711 . . . . 0.0 110.333 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.31 -98.37 0.05 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 -177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.3 Cg_endo -60.21 -55.4 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 CA-C-N 118.047 0.924 . . . . 0.0 109.926 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.35 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.362 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.89 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -111.87 -42.84 3.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.631 -1.293 . . . . 0.0 108.751 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.66 84.44 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tt0 -149.18 -15.34 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 65' ' ' PHE . 2.0 p80 -84.42 -37.41 21.49 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.649 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -170.91 -2.8 0.03 OUTLIER Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 81.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.606 -0.938 . . . . 0.0 112.19 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -156.8 120.86 4.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.074 . . . . 0.0 108.639 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.6 mm -96.58 -65.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 110.108 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.669 ' O ' ' N ' ' A' ' 39' ' ' LYS . 5.3 tpt -42.09 -56.97 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.715 -1.241 . . . . 0.0 109.558 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' MET . 6.5 mt-10 -46.86 -50.78 18.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.269 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.89 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -48.72 -61.61 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.644 1.212 . . . . 0.0 109.617 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.671 ' CG1' HD22 ' A' ' 42' ' ' ASN . 56.3 t -71.37 -30.28 39.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.979 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 35' ' ' MET . 32.6 tptt -51.54 -63.1 1.24 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.04 69.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 45' ' ' THR . 1.9 t80 -70.32 -76.83 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.671 HD22 ' CG1' ' A' ' 38' ' ' VAL . 1.3 m-80 -41.37 -34.01 0.47 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.578 1.18 . . . . 0.0 110.63 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -67.39 -35.06 78.55 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.05 -43.99 9.58 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.735 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.697 ' CB ' ' H ' ' A' ' 15' ' ' GLY . 18.1 p -61.16 -32.14 71.87 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.36 -44.74 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.23 -23.7 49.69 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.763 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.8 -74.69 0.64 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.763 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 169.83 149.35 6.28 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.124 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.8 t70 -44.82 148.37 0.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.986 -1.303 . . . . 0.0 109.429 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.079 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.87 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.973 -1.079 . . . . 0.0 110.623 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.641 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.7 mm -147.16 141.78 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 71' ' ' THR . 2.8 t -144.96 133.8 11.05 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.801 -1.187 . . . . 0.0 110.888 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 5.7 Cg_endo -69.13 95.7 0.51 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.484 1.456 . . . . 0.0 110.315 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.792 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.9 m -75.84 137.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.928 1.347 . . . . 0.0 112.61 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 14.4 mt-10 -128.61 61.73 1.48 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.723 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.6 mt -61.71 88.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.729 0.776 . . . . 0.0 109.825 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.489 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -64.23 95.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.654 HG13 HG22 ' A' ' 57' ' ' ILE . 12.9 mt -96.96 140.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.648 -0.657 . . . . 0.0 110.162 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.794 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.5 m-85 -111.83 138.93 47.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.843 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.08 -30.35 2.7 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -53.47 3.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.843 ' H ' ' C ' ' A' ' 61' ' ' ALA . 2.6 tmm_? 70.05 69.64 0.22 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.099 0.952 . . . . 0.0 109.436 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 3.2 m -147.86 125.87 12.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.19 104.08 14.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.052 -1.03 . . . . 0.0 110.288 -179.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.433 ' OG1' ' HB ' ' A' ' 58' ' ' THR . 23.4 p -98.78 124.52 43.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.557 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -109.64 173.74 6.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.58 -1.325 . . . . 0.0 109.281 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.974 HG12 ' O ' ' A' ' 68' ' ' VAL . 85.3 t -162.78 44.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 112.666 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.529 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 t -156.55 118.09 3.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 116.092 -2.243 . . . . 0.0 109.475 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.821 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -114.61 125.15 53.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.339 1.066 . . . . 0.0 109.328 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 1.027 HG21 ' CZ ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 75.02 161.56 0.15 Allowed Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.22 -179.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.681 ' HD2' HG22 ' A' ' 71' ' ' THR . 12.4 Cg_exo -41.35 175.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.469 2.112 . . . . 0.0 113.102 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.1 Cg_exo -44.08 169.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.681 1.587 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.863 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.8 -74.49 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.777 ' N ' ' O ' ' A' ' 73' ' ' PRO . 22.8 t -43.76 -20.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 110.055 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 1.093 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 26.8 p90 -43.49 -43.35 5.37 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.093 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.76 -20.42 2.55 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.895 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -55.36 -35.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 1.027 ' CZ ' HG21 ' A' ' 71' ' ' THR . 0.0 OUTLIER -53.39 -57.6 10.04 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.51 ' C ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -52.04 -64.29 0.86 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.016 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.68 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -48.89 -16.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 0.0 108.463 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.864 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -98.78 -74.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.916 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 95.59 95.12 1.74 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.964 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.817 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 7.1 mt . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.159 -1.201 . . . . 0.0 108.938 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.812 ' O ' ' N ' ' A' ' 98' ' ' ARG . 79.2 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.416 0.627 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.864 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . -43.99 72.98 0.0 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.812 ' N ' ' O ' ' A' ' 96' ' ' VAL . 2.6 mtt180 -135.65 109.74 8.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -1.077 . . . . 0.0 109.563 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.828 HD13 HG12 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.01 -175.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.759 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -125.24 165.84 17.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.082 . . . . 0.0 109.666 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.688 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.3 t-105 -51.01 -71.31 0.07 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.646 -0.659 . . . . 0.0 111.277 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.505 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -47.73 -50.31 25.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.766 -1.209 . . . . 0.0 110.859 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -49.86 -44.9 49.99 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.902 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.73 -25.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 117.535 -1.666 . . . . 0.0 107.379 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.954 HD13 HD13 ' A' ' 120' ' ' LEU . 18.8 mt -66.31 -71.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 105' ' ' LEU . 72.7 tt0 -43.74 -43.77 6.21 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.923 -1.111 . . . . 0.0 108.641 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.724 HG12 HD11 ' A' ' 77' ' ' LEU . 55.7 mt -62.79 -30.75 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.049 . . . . 0.0 108.541 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.799 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.88 -26.11 16.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.478 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -61.78 -74.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 0.0 108.396 179.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.453 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 4.6 tt0 -47.16 -20.29 0.17 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.945 . . . . 0.0 109.26 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -80.89 -9.31 59.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.856 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.52 56.43 20.63 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.045 -1.035 . . . . 0.0 109.785 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.9 Cg_endo -59.33 -33.36 97.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.585 1.523 . . . . 0.0 112.406 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.06 19.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.479 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.2 mp -54.12 -85.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.82 -11.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.801 . . . . 0.0 109.154 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 1.037 HG22 ' H ' ' A' ' 118' ' ' THR . 31.5 m -72.24 -164.57 0.15 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 1.037 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.8 -56.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.314 -0.866 . . . . 0.0 109.674 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.444 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -80.43 134.94 36.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.954 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -55.24 -22.5 18.31 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.179 0.99 . . . . 0.0 109.019 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.6 -36.82 84.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.63 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.53 -75.75 0.11 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.481 -1.387 . . . . 0.0 107.977 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.635 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.35 -40.31 5.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.479 -1.388 . . . . 0.0 109.243 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.77 -68.12 0.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.026 -1.046 . . . . 0.0 108.442 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 129' ' ' GLY . 1.8 ttm180 -43.63 -43.59 5.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.713 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.34 -79.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.057 -1.027 . . . . 0.0 108.563 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.799 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.3 mm -48.19 -65.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.21 -71.49 0.11 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.93 -40.53 4.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.713 ' N ' ' O ' ' A' ' 126' ' ' MET . 45.1 m -56.3 -51.05 69.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.467 -1.608 . . . . 0.0 107.707 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.716 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -46.86 -47.74 21.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.8 -54.32 10.08 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.3 t -44.99 -70.24 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.701 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.2 ttp -46.9 -4.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.613 -0.679 . . . . 0.0 109.355 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.71 -30.11 6.36 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.716 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 50.8 t -44.91 164.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.856 -0.791 . . . . 0.0 108.941 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.1 tm-20 -144.04 162.66 35.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 109.686 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.617 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -80.23 145.41 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.962 HG13 ' O ' ' A' ' 139' ' ' VAL . 2.4 p . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.73 110.64 2.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.92 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -139.81 122.39 16.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -0.878 . . . . 0.0 109.607 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.786 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.85 134.84 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 109.458 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -116.5 -24.49 3.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.259 -0.9 . . . . 0.0 109.008 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.33 108.95 6.21 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.41 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -96.93 73.94 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.787 ' HB ' HD12 ' A' ' 57' ' ' ILE . 39.0 t -48.53 87.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 120.756 -1.215 . . . . 0.0 110.276 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.621 ' N ' ' O ' ' A' ' 7' ' ' VAL . 1.6 tmmt? -82.77 36.65 0.5 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.803 0.811 . . . . 0.0 109.18 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.013 HD22 HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.41 -173.94 3.54 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.775 0.798 . . . . 0.0 111.494 -178.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -121.74 173.61 7.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.752 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -161.62 146.96 10.46 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 109.368 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.699 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 91.1 Cg_endo -87.33 126.91 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.343 2.029 . . . . 0.0 113.47 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.099 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.94 143.17 43.84 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.38 58.64 9.54 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.699 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 9.6 tttp 174.31 -1.17 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.807 -0.82 . . . . 0.0 108.831 -177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 18' ' ' THR . . . -83.5 153.93 24.15 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.902 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.68 165.95 4.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.668 -179.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.1 Cg_exo -49.19 34.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.57 1.513 . . . . 0.0 111.581 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.902 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.67 54.46 0.71 Allowed Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.614 -0.679 . . . . 0.0 109.245 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.727 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 13.3 Cg_endo -80.8 169.89 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.694 1.596 . . . . 0.0 111.729 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -59.27 -4.43 2.31 Favored 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 121.009 1.139 . . . . 0.0 111.039 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.013 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -110.68 -70.51 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.562 0.696 . . . . 0.0 110.253 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.01 -98.24 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.12 -55.57 1.53 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 CA-C-N 118.007 0.903 . . . . 0.0 109.951 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.654 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.44 -12.11 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.173 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.006 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.65 -41.64 3.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.778 -1.201 . . . . 0.0 108.28 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.42 92.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.489 ' N ' ' O ' ' A' ' 27' ' ' LEU . 43.1 mt-30 -158.5 -26.87 0.08 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.754 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.7 p80 -78.24 60.35 2.48 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.485 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.68 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 85.03 -9.87 64.91 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 84.96 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 112.163 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -157.83 122.61 4.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.97 -1.081 . . . . 0.0 108.801 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.4 mm -97.36 -63.91 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.609 -0.682 . . . . 0.0 109.732 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.74 -55.59 2.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.693 -1.254 . . . . 0.0 109.537 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.466 ' C ' ' O ' ' A' ' 35' ' ' MET . 12.0 mt-10 -46.25 -45.73 17.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.498 -1.376 . . . . 0.0 107.468 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 1.006 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -54.18 -68.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.244 1.021 . . . . 0.0 109.636 178.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 42' ' ' ASN . 25.9 t -67.03 -38.29 81.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.681 -0.637 . . . . 0.0 110.018 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.1 tptm -45.29 -58.79 3.04 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.98 74.79 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.265 -0.897 . . . . 0.0 109.094 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.673 ' O ' HG23 ' A' ' 45' ' ' THR . 2.3 t80 -71.39 -77.26 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 120.368 -1.457 . . . . 0.0 107.124 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.2 t-20 -41.08 -33.95 0.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.879 -1.138 . . . . 0.0 110.739 -177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.33 -32.33 72.37 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.918 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.39 -48.54 7.06 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 118.979 -1.089 . . . . 0.0 108.652 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.673 HG23 ' O ' ' A' ' 41' ' ' PHE . 1.5 p -58.92 -30.45 67.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.15 -44.78 21.28 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -57.81 -21.96 44.94 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.558 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.85 -72.46 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.558 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.21 -131.31 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.016 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 4.7 p-10 -121.19 148.0 44.84 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.254 -1.145 . . . . 0.0 108.779 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.099 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.94 -153.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.752 -1.218 . . . . 0.0 110.929 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.607 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.6 mm -146.12 138.42 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 71' ' ' THR . 2.4 t -138.76 134.44 17.16 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.116 -0.99 . . . . 0.0 110.791 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -71.86 107.24 2.16 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 121.69 1.594 . . . . 0.0 111.012 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.832 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.1 m -81.1 136.92 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.722 -1.236 . . . . 0.0 111.464 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -130.74 68.04 1.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.787 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.1 mt -68.19 90.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.79 0.805 . . . . 0.0 110.231 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.09 96.64 0.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.644 HG13 HG22 ' A' ' 57' ' ' ILE . 50.2 mt -101.07 145.14 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.515 0.674 . . . . 0.0 110.728 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.786 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.4 m-85 -116.51 139.89 49.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.802 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.42 -32.78 5.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.147 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -50.94 -1.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.79 ' H ' ' C ' ' A' ' 61' ' ' ALA . 11.2 ttm180 75.33 68.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.952 0.882 . . . . 0.0 109.85 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 1.3 t -148.49 147.93 29.66 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.65 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 36.2 p90 -125.29 103.82 8.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.902 -1.124 . . . . 0.0 110.247 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.4 p -101.44 120.75 40.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.033 -1.042 . . . . 0.0 110.052 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.937 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.1 148.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.089 -1.007 . . . . 0.0 110.99 177.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 67' ' ' PHE . 28.9 t -169.18 91.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.187 0.994 . . . . 0.0 108.491 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -97.5 147.05 24.65 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.752 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.8 OUTLIER -132.25 125.15 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.397 -1.44 . . . . 0.0 110.604 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.752 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 14.8 p 76.18 150.64 0.13 Allowed Pre-proline 0 N--CA 1.493 1.68 0 CA-C-O 121.244 0.545 . . . . 0.0 109.975 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.518 ' O ' ' O ' ' A' ' 73' ' ' PRO . 12.6 Cg_exo -40.8 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.653 2.235 . . . . 0.0 112.993 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.756 ' O ' ' N ' ' A' ' 75' ' ' SER . 25.0 Cg_exo -39.89 168.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.543 1.495 . . . . 0.0 111.905 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.917 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.05 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.832 ' HG ' ' HG3' ' A' ' 79' ' ' ARG . 11.2 t -43.05 -21.72 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 110.24 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.079 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 23.6 p90 -43.6 -38.76 3.17 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.079 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.77 -16.38 1.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.917 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.9 mt -58.27 -34.33 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.832 ' HG3' ' HG ' ' A' ' 75' ' ' SER . 0.0 OUTLIER -54.12 -49.74 68.47 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 82' ' ' ALA . 4.5 tmtt? -58.27 -64.81 0.79 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.58 -6.28 0.69 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.205 -0.934 . . . . 0.0 109.842 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.812 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -78.86 -82.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.842 . . . . 0.0 112.216 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 178.88 32.78 0.06 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.957 -1.592 . . . . 0.0 110.464 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.607 HD11 ' CD ' ' A' ' 79' ' ' ARG . 2.8 mt -84.78 110.25 18.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.997 -1.296 . . . . 0.0 109.392 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -156.24 -21.5 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.3 tttm 65.46 -85.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 0.0 109.623 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.6 -170.0 19.83 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.44 -85.03 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -1.164 . . . . 0.0 109.566 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -119.17 96.96 5.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.499 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mtpp -120.29 159.13 48.9 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.381 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.61 -11.32 6.5 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.576 1.517 . . . . 0.0 112.34 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.29 -165.29 21.56 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.803 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 64.58 84.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -1.147 . . . . 0.0 109.493 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 8.1 tt0 -176.21 -179.46 1.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 94' ' ' GLU . 42.5 mtmt -158.67 -172.36 3.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.612 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.6 t -133.35 153.66 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.598 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.812 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 75.86 58.81 3.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.665 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.8 mtt180 -133.71 115.47 14.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.128 -1.219 . . . . 0.0 110.353 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.721 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.43 175.11 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.815 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -120.85 156.58 31.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.983 -1.073 . . . . 0.0 109.055 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.3 t-105 -45.18 -70.37 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 111.229 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.405 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 6.4 tp10 -50.45 -51.71 44.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.575 -1.328 . . . . 0.0 111.242 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.406 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 4.8 mt-30 -48.72 -44.38 38.24 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.5 m -70.88 -25.9 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.822 -1.551 . . . . 0.0 107.663 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.967 HD13 HD13 ' A' ' 120' ' ' LEU . 18.8 mt -65.36 -70.66 0.22 Allowed 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 105' ' ' LEU . 3.1 tp10 -44.1 -45.7 8.27 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.935 -1.103 . . . . 0.0 108.566 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.818 HG12 HD11 ' A' ' 77' ' ' LEU . 35.3 mt -61.26 -31.75 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.111 -0.993 . . . . 0.0 108.698 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.816 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.53 -25.98 16.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.347 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -58.08 -73.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.057 -1.027 . . . . 0.0 108.286 178.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.552 ' N ' ' CD ' ' A' ' 110' ' ' GLN . 2.4 mp0 -44.95 -26.1 0.38 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.078 -1.014 . . . . 0.0 108.794 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' LYS . 40.1 tttm -74.91 -8.29 56.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.803 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.59 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 7.7 ptm -132.87 62.4 61.98 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.056 -1.028 . . . . 0.0 109.861 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 112' ' ' MET . 3.0 Cg_endo -67.21 -35.06 25.87 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.565 1.51 . . . . 0.0 112.123 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.513 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 2.3 t70 174.96 9.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.359 -0.838 . . . . 0.0 109.107 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.2 mm? -47.96 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 0.0 109.575 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -151.81 -21.56 0.19 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.02 HG22 ' H ' ' A' ' 118' ' ' THR . 26.2 m -64.13 -164.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.101 -0.999 . . . . 0.0 109.616 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.02 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.48 -64.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.225 -0.922 . . . . 0.0 109.871 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.505 ' H ' HG23 ' A' ' 118' ' ' THR . 0.9 OUTLIER -74.93 141.27 44.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.38 -0.825 . . . . 0.0 110.084 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.967 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -59.93 -24.56 64.44 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.211 1.005 . . . . 0.0 109.12 179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.5 -34.65 78.71 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.71 -75.18 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 118.201 -1.399 . . . . 0.0 108.045 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.59 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.0 -40.82 6.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.539 -1.351 . . . . 0.0 109.095 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.97 -69.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 108.647 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.658 ' O ' ' N ' ' A' ' 129' ' ' GLY . 23.1 ttt180 -43.35 -35.68 1.61 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.666 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.0 tpp -57.56 -78.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 108.778 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.816 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 26.9 mm -48.49 -56.99 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.473 -0.767 . . . . 0.0 110.0 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -67.39 -70.93 0.22 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -42.48 5.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.666 ' N ' ' O ' ' A' ' 126' ' ' MET . 54.3 p -54.72 -47.66 73.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.575 -1.544 . . . . 0.0 107.499 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -51.12 -48.53 61.73 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.791 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.01 -53.4 10.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.0 t -44.79 -67.2 0.3 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.805 ' SD ' ' NH1' ' A' ' 79' ' ' ARG . 11.6 ttm -49.94 -3.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 89.21 -26.05 9.44 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.677 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.4 t -49.22 165.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.736 -0.861 . . . . 0.0 109.405 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 136' ' ' VAL . 87.8 mt-10 -142.8 162.66 34.88 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.755 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.32 165.1 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 139' ' ' VAL . 6.4 p -129.17 59.91 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 157.74 -113.82 0.58 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.87 61.79 11.23 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.155 -1.203 . . . . 0.0 109.267 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.516 ' O ' ' CD ' ' A' ' 143' ' ' GLU . 2.2 Cg_endo -61.61 155.32 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.808 1.672 . . . . 0.0 112.627 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.516 ' CD ' ' O ' ' A' ' 142' ' ' PRO . 72.2 mm-40 -156.66 91.04 1.2 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.291 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.74 -179.91 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.564 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -159.82 -15.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 147' ' ' ALA . 1.1 p30 -81.6 29.48 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.538 ' O ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.443 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.51 71.61 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 15.5 tttt -168.92 115.23 0.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.549 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.767 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.97 138.34 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 0.0 109.564 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -115.11 -24.45 3.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.34 100.39 3.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.041 -1.037 . . . . 0.0 110.252 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -87.86 74.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.919 HG13 HD12 ' A' ' 10' ' ' LEU . 11.3 t -48.22 87.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.558 -176.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.681 ' HZ3' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -81.83 36.29 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.897 0.856 . . . . 0.0 108.817 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.919 HD12 HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -77.22 -174.46 3.24 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.725 0.774 . . . . 0.0 110.882 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -127.42 177.21 6.89 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.556 ' HB3' ' CE2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -166.66 146.6 4.96 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 109.213 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.485 ' HA ' HD13 ' A' ' 52' ' ' ILE . 65.8 Cg_endo -84.01 130.08 4.8 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.277 1.984 . . . . 0.0 113.587 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.072 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -76.16 142.77 41.48 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.492 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 51.61 55.35 20.57 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 5.5 mttp 174.53 14.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.695 -0.885 . . . . 0.0 109.212 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 18' ' ' THR . . . -96.13 154.74 17.08 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.862 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.86 165.74 4.07 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.093 -1.005 . . . . 0.0 109.487 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HA ' HG21 ' A' ' 34' ' ' ILE . 5.3 Cg_exo -51.05 32.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.457 1.438 . . . . 0.0 111.562 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.862 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -154.56 54.31 1.03 Allowed Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 121.429 -0.795 . . . . 0.0 109.64 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.739 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.84 169.06 12.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.725 1.617 . . . . 0.0 111.735 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.37 -4.56 3.3 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.077 1.185 . . . . 0.0 110.95 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.748 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.0 -72.62 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.688 -0.633 . . . . 0.0 109.796 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.49 -98.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.748 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.3 Cg_exo -59.03 -55.54 1.88 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 CA-C-N 118.096 0.948 . . . . 0.0 110.003 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.652 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -44.7 -6.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.412 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.862 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -111.12 -44.07 3.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.805 -1.184 . . . . 0.0 108.54 179.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.34 88.67 0.01 OUTLIER Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.6 tt0 -150.97 -12.85 0.22 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.538 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 7.8 p-80 -87.73 -36.5 17.32 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -173.1 -1.49 0.03 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.11 83.38 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.532 -0.981 . . . . 0.0 112.058 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 32' ' ' ALA . 31.8 m120 -157.71 120.09 3.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.982 -1.073 . . . . 0.0 108.614 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.565 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.8 mm -97.44 -65.3 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.689 -0.632 . . . . 0.0 109.853 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.492 ' O ' ' C ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -41.42 -56.35 2.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 109.548 -177.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.3 mt-10 -44.69 -48.15 10.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.755 -1.215 . . . . 0.0 107.768 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.862 ' CE2' HD12 ' A' ' 27' ' ' LEU . 1.1 t80 -51.17 -68.17 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.884 1.326 . . . . 0.0 110.034 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 42' ' ' ASN . 33.9 t -59.21 -37.2 67.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.805 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 7.1 ttpt -49.56 -65.7 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.08 -32.79 62.23 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.23 -0.918 . . . . 0.0 109.04 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.0 t80 -73.19 -78.45 0.09 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' N ' ' O ' ' A' ' 38' ' ' VAL . 7.4 m-20 -41.07 -32.76 0.27 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.856 -1.152 . . . . 0.0 110.745 -177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -70.04 -32.77 71.07 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.139 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.09 -47.17 7.99 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.476 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.556 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 8.7 p -59.5 -29.71 68.05 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.94 -45.27 20.79 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.555 ' OD1' ' O ' ' A' ' 43' ' ' ALA . 12.2 m120 -57.8 -22.14 45.69 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.573 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.32 -73.88 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.573 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -179.64 -127.82 1.15 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.05 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 23.1 t70 -123.84 147.26 47.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.216 -1.167 . . . . 0.0 108.817 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.072 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.88 -153.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.799 -1.188 . . . . 0.0 110.99 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.1 mm -146.82 139.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 71' ' ' THR . 2.0 t -138.58 133.74 17.01 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 110.611 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -72.86 97.1 0.88 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 121.8 1.667 . . . . 0.0 111.03 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.81 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -70.95 134.46 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 122.675 1.226 . . . . 0.0 111.652 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 28.3 mt-10 -127.16 70.32 1.3 Allowed 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.725 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -71.43 89.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 121.677 0.751 . . . . 0.0 110.5 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.16 95.46 0.09 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.53 HG13 HG22 ' A' ' 57' ' ' ILE . 95.7 mt -98.05 141.0 16.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.656 -0.653 . . . . 0.0 110.505 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.767 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 4.8 m-85 -115.99 139.82 49.87 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.835 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.81 -30.7 4.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.277 -177.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 6.0 m-20 -53.47 3.05 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.81 ' H ' ' C ' ' A' ' 61' ' ' ALA . 49.8 mtp180 70.34 68.89 0.21 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.968 0.89 . . . . 0.0 109.793 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 9.5 p -148.97 150.98 33.78 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.2 p90 -128.18 103.76 7.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.992 -1.067 . . . . 0.0 110.105 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p -101.38 120.79 40.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.15 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.933 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 169.96 149.2 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.081 -1.012 . . . . 0.0 110.991 177.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.5 t -168.82 98.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.272 1.034 . . . . 0.0 108.35 176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.39 148.2 29.4 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.78 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.2 mptt -133.21 125.09 28.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.523 -1.361 . . . . 0.0 110.124 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.78 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.3 150.34 0.13 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 121.272 0.558 . . . . 0.0 109.876 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' O ' ' O ' ' A' ' 73' ' ' PRO . 8.7 Cg_exo -42.88 175.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.548 2.166 . . . . 0.0 112.803 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.61 176.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.502 1.468 . . . . 0.0 111.788 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 47.87 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.774 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -43.71 -22.4 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.347 -0.846 . . . . 0.0 109.99 179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.981 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 15.6 p90 -43.84 -37.68 2.92 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 0.0 108.961 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.981 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.35 -15.79 1.89 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.919 HD12 ' HB1' ' A' ' 74' ' ' ALA . 3.9 mt -60.13 -31.85 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.707 ' HB3' HD12 ' A' ' 84' ' ' LEU . 2.2 mmp_? -56.08 -44.01 78.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 82' ' ' ALA . 8.2 tmtm? -65.27 -66.76 0.5 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.746 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.5 -5.26 0.51 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.177 -0.952 . . . . 0.0 109.504 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.01 -80.31 0.19 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.547 -0.721 . . . . 0.0 111.582 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.752 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 166.46 53.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.285 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 83' ' ' GLY . 2.0 mt -126.77 104.75 8.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.236 . . . . 0.0 109.358 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 8.3 tp10 174.86 -51.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.455 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 2.9 tmtm? 75.07 143.97 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 86' ' ' LYS . . . -153.34 -156.25 7.52 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.93 -85.09 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -1.139 . . . . 0.0 109.56 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -59.95 106.24 0.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.408 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' H ' ' HG3' ' A' ' 90' ' ' LYS . 13.3 mttp -83.17 149.35 58.5 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.477 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.41 -53.75 3.18 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.449 1.433 . . . . 0.0 112.399 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 148.67 144.69 4.01 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.792 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 63.03 -164.94 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -1.098 . . . . 0.0 109.514 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -127.12 111.66 14.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.478 ' C ' HG23 ' A' ' 96' ' ' VAL . 3.3 mmmm -145.38 166.16 26.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.58 HG12 ' N ' ' A' ' 97' ' ' GLY . 88.5 t -157.55 164.98 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.58 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 57.0 65.97 3.19 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.657 ' O ' ' O ' ' A' ' 82' ' ' ALA . 4.2 ttt180 -134.32 114.59 13.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -1.16 . . . . 0.0 110.007 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.698 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -107.42 -169.23 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 108.976 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.644 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.4 OUTLIER -131.58 159.36 38.45 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 0.0 109.219 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.679 ' O ' HG22 ' A' ' 104' ' ' VAL . 18.2 t-105 -50.9 -68.72 0.15 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.504 -0.747 . . . . 0.0 110.87 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -51.27 -45.91 62.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.69 -1.256 . . . . 0.0 110.369 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.746 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -50.66 -47.65 58.6 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.234 -0.917 . . . . 0.0 109.777 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.836 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.78 -24.06 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.951 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 120' ' ' LEU . 13.1 mt -66.88 -71.32 0.2 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.491 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 6.1 tm-20 -43.66 -43.12 5.66 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.891 -1.131 . . . . 0.0 108.374 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.66 HG12 HD11 ' A' ' 77' ' ' LEU . 49.4 mt -62.96 -31.36 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.021 -1.049 . . . . 0.0 108.358 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.807 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.41 -27.36 16.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 0.0 109.47 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.656 ' HE2' HD11 ' A' ' 120' ' ' LEU . 17.3 mmtt -57.18 -73.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.837 -1.164 . . . . 0.0 108.124 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.444 ' C ' ' O ' ' A' ' 109' ' ' LYS . 78.9 mt-30 -44.89 -25.01 0.26 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.006 -1.058 . . . . 0.0 108.769 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 109' ' ' LYS . 23.5 tptt -76.89 -8.25 57.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.919 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 123' ' ' ALA . 7.5 ptm -132.27 60.87 53.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.038 -1.039 . . . . 0.0 109.839 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.8 Cg_endo -65.88 -40.34 16.97 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.559 1.506 . . . . 0.0 112.148 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 6.9 t70 -178.75 8.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.431 -0.793 . . . . 0.0 109.13 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.0 mm? -46.76 -81.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.806 . . . . 0.0 109.563 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -151.13 -18.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.129 -0.982 . . . . 0.0 109.699 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.019 HG22 ' H ' ' A' ' 118' ' ' THR . 26.4 m -65.88 -164.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.629 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.019 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.96 -62.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.266 -0.897 . . . . 0.0 109.865 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 118' ' ' THR . 0.8 OUTLIER -75.31 140.64 43.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 110.091 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -60.3 -23.8 64.47 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.126 0.965 . . . . 0.0 109.107 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.64 -34.29 77.94 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.52 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.78 -75.83 0.13 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.111 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.623 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -45.09 -31.37 1.35 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.468 -1.395 . . . . 0.0 109.268 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -60.75 -69.76 0.21 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 108.496 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.694 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.2 ttp180 -43.67 -44.1 6.22 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.631 ' O ' ' N ' ' A' ' 130' ' ' SER . 2.8 mtt -49.72 -79.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.1 -1.0 . . . . 0.0 108.742 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.807 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 18.2 mm -47.28 -67.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.678 0.752 . . . . 0.0 110.076 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.836 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -55.23 -69.55 0.13 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.43 -37.29 2.49 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.631 ' N ' ' O ' ' A' ' 126' ' ' MET . 10.5 p -57.08 -54.21 49.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.445 -1.621 . . . . 0.0 107.336 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.743 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -44.98 -50.36 10.67 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.642 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -44.91 -55.73 5.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 177.169 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.667 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.8 t -44.91 -67.2 0.31 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.679 ' SD ' ' OG ' ' A' ' 75' ' ' SER . 6.8 ttp -47.79 -3.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.73 -24.72 11.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.743 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 31.1 t -52.74 165.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.989 -0.712 . . . . 0.0 109.347 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.586 ' N ' HG12 ' A' ' 136' ' ' VAL . 41.7 mt-10 -142.99 163.28 33.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.199 -0.938 . . . . 0.0 109.655 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.8 t -82.44 143.84 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.698 ' N ' ' O ' ' A' ' 99' ' ' ILE . 5.6 p -96.69 -7.81 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.56 -0.713 . . . . 0.0 109.292 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . -116.85 -123.68 3.47 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.95 61.95 11.08 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.354 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.4 Cg_endo -63.29 -169.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.752 1.635 . . . . 0.0 112.601 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.676 ' CG ' ' H ' ' A' ' 144' ' ' VAL . 13.7 tt0 -151.22 -175.84 5.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 109.278 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.676 ' H ' ' CG ' ' A' ' 143' ' ' GLU . 12.8 m -150.79 166.29 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 109.591 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 19.0 tttp 178.46 158.68 0.51 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.396 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -106.18 -84.95 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.589 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' C ' ' OH ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -175.77 55.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.585 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' C ' ' CZ ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -126.07 114.88 18.99 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.2 -0.938 . . . . 0.0 109.919 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.516 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p -65.16 155.89 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 108.723 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.026 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -123.66 -24.9 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.903 -1.123 . . . . 0.0 110.573 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -154.98 111.66 3.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.451 -1.3 . . . . 0.0 110.731 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -103.78 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.767 ' HB ' HD12 ' A' ' 57' ' ' ILE . 17.6 t -49.51 88.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.73 -1.231 . . . . 0.0 110.743 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.7 tmtp? -82.4 38.28 0.54 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.746 0.784 . . . . 0.0 109.358 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.892 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.24 -173.89 3.45 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.843 0.83 . . . . 0.0 111.437 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.691 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.98 174.83 7.33 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.719 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -167.73 159.66 9.83 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.85 -1.156 . . . . 0.0 110.159 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.719 ' HD2' HD23 ' A' ' 12' ' ' LEU . 11.9 Cg_endo -68.95 109.83 2.24 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.034 1.823 . . . . 0.0 111.37 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.823 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -68.68 38.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.857 -1.152 . . . . 0.0 110.411 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.524 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -172.82 -19.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.425 -1.845 . . . . 0.0 111.372 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -144.37 80.39 1.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.642 -1.505 . . . . 0.0 110.408 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.673 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -96.53 166.05 11.87 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.747 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.0 164.4 4.26 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.874 -1.141 . . . . 0.0 110.086 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' HG21 ' A' ' 34' ' ' ILE . 3.5 Cg_exo -54.11 32.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.663 1.575 . . . . 0.0 111.677 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.747 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.0 54.01 5.0 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.061 -1.024 . . . . 0.0 110.231 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 22.8 Cg_endo -84.67 155.11 11.88 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.73 1.62 . . . . 0.0 111.713 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.91 -4.62 0.37 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.032 1.155 . . . . 0.0 111.136 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.828 HG12 ' N ' ' A' ' 27' ' ' LEU . 2.9 t -111.85 -69.88 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 0.0 110.151 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.83 -97.73 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.774 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.8 Cg_exo -57.83 -55.66 2.2 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 CA-C-N 118.017 0.908 . . . . 0.0 110.28 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.628 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -52.72 -11.83 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.628 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.828 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -96.51 -53.69 3.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.71 -1.244 . . . . 0.0 108.386 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.88 92.3 0.01 OUTLIER Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.9 tp60 -147.39 -15.05 0.39 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.557 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 4.9 p-80 -84.13 -37.37 22.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -171.57 -0.92 0.03 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 73.18 84.53 0.12 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.494 -1.003 . . . . 0.0 112.046 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -159.55 120.81 3.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.052 . . . . 0.0 108.806 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.677 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 50.7 mm -94.4 -64.39 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.723 -0.61 . . . . 0.0 109.689 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.57 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -41.0 -54.38 2.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.791 -1.193 . . . . 0.0 109.774 -176.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 35' ' ' MET . 5.5 mt-10 -48.41 -46.78 37.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.593 -1.317 . . . . 0.0 107.708 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.719 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -53.03 -68.91 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.572 1.177 . . . . 0.0 109.244 178.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.673 HG13 ' CB ' ' A' ' 17' ' ' ALA . 38.3 t -63.46 -36.84 77.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.706 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.0 mmmt -49.32 -55.55 12.44 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.87 -33.11 75.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.184 -0.948 . . . . 0.0 109.484 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.612 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.0 OUTLIER -70.13 -77.05 0.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.431 -1.418 . . . . 0.0 107.305 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 7.2 t-20 -41.52 -33.79 0.48 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.74 -33.88 75.75 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.417 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.891 ' HB1' ' NZ ' ' A' ' 70' ' ' LYS . . . -90.72 -53.18 4.52 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 118.934 -1.106 . . . . 0.0 108.714 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.792 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.8 p -53.35 -31.34 44.03 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.43 -44.71 17.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -54.69 -23.27 16.77 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 109.18 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.603 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.78 -85.3 0.53 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.182 -0.949 . . . . 0.0 109.693 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.603 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.82 -141.8 3.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.062 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -118.07 121.15 39.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -1.122 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.823 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.51 -153.04 0.4 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.343 -0.848 . . . . 0.0 110.03 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.583 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.6 mm -146.85 142.2 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 14' ' ' ALA . 3.7 t -145.34 137.61 13.38 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.933 . . . . 0.0 110.238 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -73.52 95.01 0.85 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.872 1.715 . . . . 0.0 111.52 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.892 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -61.44 138.06 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.739 -1.226 . . . . 0.0 111.354 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 26.8 tt0 -130.44 70.14 1.45 Allowed 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.767 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.6 mt -70.68 89.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.389 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.8 100.89 0.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.4 ' HB ' ' O ' ' A' ' 6' ' ' ALA . 21.1 mt -101.76 137.45 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.589 -0.695 . . . . 0.0 110.615 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.554 ' OH ' ' C ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -113.27 137.85 50.88 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 1.026 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -49.03 -30.76 6.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.583 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 13.6 m-20 -53.56 1.32 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 177.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.807 ' H ' ' C ' ' A' ' 61' ' ' ALA . 5.2 mtm180 71.05 69.91 0.18 Allowed 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.028 0.918 . . . . 0.0 109.953 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 4.4 m -151.27 126.11 9.7 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 18.2 p90 -102.53 103.84 14.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.093 -1.005 . . . . 0.0 110.035 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.2 121.31 41.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.1 -1.0 . . . . 0.0 110.227 179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.932 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.38 148.32 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.052 . . . . 0.0 111.274 177.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.932 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.7 t -168.74 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.263 1.03 . . . . 0.0 108.232 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -98.07 132.4 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.891 ' NZ ' ' HB1' ' A' ' 44' ' ' ALA . 24.5 mmtp -115.82 143.19 45.75 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 118.22 -1.392 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.655 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 1.8 p 55.58 159.21 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.956 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.7 Cg_exo -38.18 175.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.887 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 75' ' ' SER . 22.8 Cg_exo -42.2 169.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.575 1.516 . . . . 0.0 112.161 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.984 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 58.73 -73.52 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 73' ' ' PRO . 5.6 p -43.65 -21.65 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 110.219 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.097 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 25.4 p90 -43.38 -42.95 4.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.366 -0.834 . . . . 0.0 109.087 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.097 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.54 -13.9 3.31 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.984 HD12 ' HB1' ' A' ' 74' ' ' ALA . 2.0 mt -61.02 -31.34 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.704 ' NH1' ' CD1' ' A' ' 84' ' ' LEU . 9.6 mmm180 -54.16 -45.81 72.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.2 tmmm? -65.21 -65.75 0.63 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.751 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.51 -5.39 0.34 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.671 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.643 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.81 -79.66 0.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 111.686 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.402 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 153.49 57.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.085 -1.531 . . . . 0.0 110.674 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.704 ' CD1' ' NH1' ' A' ' 79' ' ' ARG . 9.0 mt -102.66 104.8 15.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.143 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -153.35 -11.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 109.717 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.499 ' HZ1' ' HB3' ' A' ' 86' ' ' LYS . 7.0 mtpp 66.32 63.91 0.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 109.653 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 45.04 -160.68 0.12 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.63 -85.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -1.12 . . . . 0.0 109.537 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 90' ' ' LYS . 12.7 t60 -105.78 -67.84 0.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 89' ' ' HIS . 9.6 mtmt -44.91 160.48 0.24 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.895 . . . . 0.0 109.43 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.0 -51.86 8.63 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.58 1.52 . . . . 0.0 112.443 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.13 -96.89 0.11 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.786 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 59.71 39.43 21.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -1.143 . . . . 0.0 109.47 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 36.9 mt-10 -159.44 -167.76 2.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.69 -164.99 1.66 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.863 . . . . 0.0 109.436 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 97' ' ' GLY . 87.4 t -135.66 165.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.661 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.589 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 65.53 65.64 2.8 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.2 mtt180 -132.53 115.31 15.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.269 -1.136 . . . . 0.0 109.93 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.728 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 173.31 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.549 -0.719 . . . . 0.0 109.539 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.72 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -113.99 150.46 33.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.034 -1.042 . . . . 0.0 109.092 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.719 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.0 t-105 -46.3 -67.6 0.27 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.347 -0.846 . . . . 0.0 110.897 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.505 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.68 -49.29 57.65 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.557 -1.34 . . . . 0.0 110.68 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.751 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -48.97 -45.93 42.84 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.884 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.82 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.4 -24.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 117.979 -1.489 . . . . 0.0 107.797 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.795 ' O ' ' N ' ' A' ' 109' ' ' LYS . 19.3 mt -66.22 -71.71 0.18 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 105' ' ' LEU . 86.7 tt0 -43.99 -44.95 7.6 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.892 -1.13 . . . . 0.0 108.472 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.588 HG12 HD11 ' A' ' 77' ' ' LEU . 67.2 mt -61.58 -32.47 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.045 -1.034 . . . . 0.0 108.493 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.819 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.8 -24.71 16.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.169 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.795 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.6 tptp -63.16 -74.55 0.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 109' ' ' LYS . 26.1 mt-30 -44.5 -27.85 0.51 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.984 -1.073 . . . . 0.0 108.772 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 109' ' ' LYS . 33.7 tttp -66.57 -13.66 61.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.578 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 5.5 ptm -131.02 69.25 82.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 109.638 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -68.82 -46.63 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.68 1.587 . . . . 0.0 112.104 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.534 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 40.1 p30 -171.1 6.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 108.952 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.401 ' H ' ' H ' ' A' ' 114' ' ' ASP . 2.7 mm? -45.02 -83.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.424 -0.798 . . . . 0.0 109.577 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.782 HD22 ' N ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -150.89 -12.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.186 -0.946 . . . . 0.0 109.649 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.026 HG22 ' H ' ' A' ' 118' ' ' THR . 31.8 m -77.99 -164.58 0.54 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.067 -1.021 . . . . 0.0 109.675 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.026 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 178.56 -57.2 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.264 -0.898 . . . . 0.0 109.576 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 1.1 p30 -63.27 132.25 51.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.513 -0.742 . . . . 0.0 109.998 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.675 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -67.22 -28.7 68.29 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.488 1.137 . . . . 0.0 108.469 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -64.45 -34.52 78.4 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.637 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -70.52 -76.27 0.1 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.431 -1.308 . . . . 0.0 107.68 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.578 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.58 -42.1 10.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.478 -1.389 . . . . 0.0 109.339 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -50.4 -69.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.098 -1.001 . . . . 0.0 108.806 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.617 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.49 -38.57 2.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.597 ' O ' ' HB3' ' A' ' 130' ' ' SER . 13.4 tpp -53.79 -79.22 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.819 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.9 mm -47.29 -65.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.666 0.746 . . . . 0.0 110.289 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.82 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -57.5 -69.71 0.16 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.38 -37.8 2.62 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.597 ' HB3' ' O ' ' A' ' 126' ' ' MET . 15.9 p -57.18 -53.79 54.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.506 -1.585 . . . . 0.0 107.451 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.779 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -45.0 -50.28 10.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.791 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.65 -55.01 6.88 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.6 t -44.74 -67.29 0.3 Allowed 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.631 ' HG2' HG23 ' A' ' 136' ' ' VAL . 7.1 ttp -47.77 -3.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.62 -13.9 59.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.779 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 35.7 t -69.36 135.22 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.997 -0.707 . . . . 0.0 109.444 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -112.87 167.25 10.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.572 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.647 ' C ' ' H ' ' A' ' 140' ' ' GLY . 1.8 t -81.97 125.95 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 99' ' ' ILE . 11.2 p -51.72 1.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.563 -0.71 . . . . 0.0 109.736 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.69 ' O ' ' HB3' ' A' ' 141' ' ' ALA . . . -159.85 -127.86 0.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . 75.09 63.02 0.27 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.211 -1.17 . . . . 0.0 109.447 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.2 Cg_endo -65.45 -165.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.76 1.64 . . . . 0.0 112.548 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.55 ' CD ' ' N ' ' A' ' 144' ' ' VAL . 8.2 tm-20 -169.99 151.51 4.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.55 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 3.1 m -150.49 -172.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.517 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.614 ' CG ' ' N ' ' A' ' 146' ' ' ASP . 19.0 ttpt -145.19 168.03 21.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.398 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 0.4 OUTLIER -138.41 -84.96 0.28 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 91.74 0.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.504 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -169.07 114.89 0.59 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 0.0 109.591 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.778 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p -46.21 138.09 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 109.487 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.7 m -113.48 -24.53 3.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.214 -0.929 . . . . 0.0 108.52 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.66 112.27 8.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.05 -1.032 . . . . 0.0 110.273 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -100.47 73.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.15 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.78 ' HB ' HD12 ' A' ' 57' ' ' ILE . 13.6 t -50.08 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.444 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.8 tmtp? -82.96 37.87 0.56 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.885 0.85 . . . . 0.0 109.168 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.815 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -77.28 -174.13 3.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.01 0.91 . . . . 0.0 111.395 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.73 174.94 7.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.729 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -164.42 147.06 7.29 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.959 -1.088 . . . . 0.0 109.361 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.65 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 80.0 Cg_endo -86.17 126.17 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.331 2.021 . . . . 0.0 113.213 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.28 143.06 48.87 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.01 61.86 6.5 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.65 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 8.7 tttp 174.08 -25.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.573 -0.957 . . . . 0.0 108.823 -177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 18' ' ' THR . . . -59.05 152.67 19.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.913 -1.117 . . . . 0.0 108.373 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.869 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -167.36 165.8 8.57 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.038 -1.039 . . . . 0.0 110.009 -178.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.8 Cg_exo -50.25 36.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.721 1.614 . . . . 0.0 111.733 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.869 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -158.5 54.47 0.73 Allowed Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.606 -0.684 . . . . 0.0 109.68 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.2 Cg_endo -79.18 169.68 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.66 1.573 . . . . 0.0 111.849 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.59 -4.68 3.58 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.256 1.304 . . . . 0.0 111.29 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 26' ' ' ALA . 5.2 t -113.23 -70.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.623 -0.673 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.07 -97.83 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.783 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.2 Cg_exo -58.72 -55.54 1.99 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 CA-C-N 117.97 0.885 . . . . 0.0 110.384 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.794 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -48.77 -10.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.67 -0.643 . . . . 0.0 110.779 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.843 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -103.24 -48.44 4.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.682 -1.261 . . . . 0.0 107.956 179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.27 86.74 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 27' ' ' LEU . 50.4 mt-30 -146.33 -20.12 0.44 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.673 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 6.9 p80 -79.49 -38.24 34.92 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -170.89 -4.42 0.03 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 84.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.558 -0.966 . . . . 0.0 112.346 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -158.92 120.11 3.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.076 -1.015 . . . . 0.0 108.711 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.726 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 26.4 mm -93.42 -66.01 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.728 -0.608 . . . . 0.0 110.076 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.658 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.8 tpt -41.14 -57.71 1.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.664 -1.273 . . . . 0.0 109.728 -176.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.5 mm-40 -44.95 -47.06 11.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.56 -1.337 . . . . 0.0 107.793 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.843 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -53.05 -68.84 0.14 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 122.466 1.127 . . . . 0.0 109.899 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.655 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 21.9 t -66.38 -37.7 80.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.775 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.658 ' N ' ' O ' ' A' ' 35' ' ' MET . 44.1 tptt -45.67 -61.81 1.55 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.55 69.25 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.305 -0.872 . . . . 0.0 108.85 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.688 ' O ' HG23 ' A' ' 45' ' ' THR . 3.3 t80 -70.91 -77.07 0.09 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.655 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 1.9 m-80 -41.35 -32.23 0.29 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.953 -1.092 . . . . 0.0 110.751 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -69.52 -33.22 72.5 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.93 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.732 ' HB1' ' HZ3' ' A' ' 70' ' ' LYS . . . -90.52 -47.07 7.93 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.612 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 41' ' ' PHE . 2.2 p -58.6 -31.34 67.97 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.2 -46.04 21.47 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -56.97 -22.46 38.36 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.409 -0.807 . . . . 0.0 108.922 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.724 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.63 -73.98 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.406 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.724 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 175.17 -154.66 18.66 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.561 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.8 t0 -96.28 146.49 24.68 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.006 -1.291 . . . . 0.0 108.934 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.078 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 175.01 -153.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.816 -1.178 . . . . 0.0 110.869 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.2 mm -146.09 137.36 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 71' ' ' THR . 2.6 t -137.94 136.15 19.49 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 110.807 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.8 Cg_endo -72.78 104.66 1.78 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.803 1.669 . . . . 0.0 111.07 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.815 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.5 m -78.34 135.98 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 111.362 -178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.5 tt0 -129.07 69.98 1.4 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.78 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -70.24 90.11 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.855 0.836 . . . . 0.0 109.967 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.403 HG22 HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -70.59 95.88 1.14 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 64' ' ' SER . 60.1 mt -100.11 143.58 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.58 -0.7 . . . . 0.0 110.672 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.778 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.6 m-85 -114.46 138.0 51.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.813 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -46.43 -31.45 2.67 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.227 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.29 2.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.776 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 71.87 66.92 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.137 0.97 . . . . 0.0 109.631 -179.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.4 OUTLIER -149.17 125.15 10.63 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.1 p90 -103.75 104.16 14.15 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.124 -0.985 . . . . 0.0 110.139 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.618 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.87 120.92 41.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.035 . . . . 0.0 110.249 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.945 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.7 OUTLIER 170.38 148.51 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.962 -1.086 . . . . 0.0 111.214 177.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.6 t -169.39 98.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.254 1.026 . . . . 0.0 108.639 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.59 149.2 27.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.746 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -133.63 122.98 24.25 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.343 -1.473 . . . . 0.0 110.525 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.8 p 76.02 148.8 0.12 Allowed Pre-proline 0 N--CA 1.492 1.661 0 CA-C-O 121.272 0.558 . . . . 0.0 110.235 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.2 Cg_exo -42.32 175.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.573 2.182 . . . . 0.0 112.803 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.0 Cg_exo -38.87 174.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.498 1.466 . . . . 0.0 111.855 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 53.03 -84.3 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.707 ' N ' ' O ' ' A' ' 73' ' ' PRO . 71.8 p -44.67 -23.15 0.11 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 111.36 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.675 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 14.1 p90 -43.81 -39.59 3.91 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.174 -0.954 . . . . 0.0 109.199 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.854 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.5 pp -135.05 -14.6 2.04 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.012 HD12 ' HB1' ' A' ' 74' ' ' ALA . 6.6 mt -61.15 -31.22 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.753 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 10.8 mmt180 -55.38 -44.78 76.4 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HZ3' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -64.22 -66.89 0.48 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.695 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.51 -4.94 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.083 -1.011 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.21 -80.36 0.2 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 111.725 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 175.76 28.47 0.03 OUTLIER Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.18 -1.486 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.548 HD11 HH11 ' A' ' 79' ' ' ARG . 3.1 mt -90.27 105.05 17.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.973 -1.31 . . . . 0.0 109.135 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 34.1 tt0 -177.06 -20.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 0.0 109.347 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 9.7 tttm 75.04 -64.46 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.479 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.13 179.84 32.68 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -177.74 86.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -1.124 . . . . 0.0 109.453 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -147.23 -84.94 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.473 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' A' ' 92' ' ' GLY . 22.0 mttt -113.76 160.12 33.18 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.12 5.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.569 1.513 . . . . 0.0 112.383 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 90' ' ' LYS . . . -68.18 -53.01 24.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.817 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.8 OUTLIER 67.11 178.9 0.23 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -1.144 . . . . 0.0 109.452 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -146.65 -165.01 2.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 109.555 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -101.52 -164.98 1.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 20.8 t -144.28 152.24 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.556 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.433 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 72.37 50.46 16.11 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.789 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.58 114.46 14.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.133 -1.216 . . . . 0.0 109.966 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.37 -174.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.649 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -127.51 159.8 33.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.4 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.678 ' O ' HG22 ' A' ' 104' ' ' VAL . 19.3 t-105 -50.61 -69.61 0.11 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.5 -0.75 . . . . 0.0 110.84 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.49 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.24 -46.76 55.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.686 -1.259 . . . . 0.0 110.352 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.695 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -49.19 -47.61 45.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.689 -179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.821 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.3 m -72.11 -23.43 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.097 -1.441 . . . . 0.0 107.99 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 120' ' ' LEU . 17.8 mt -68.09 -73.47 0.14 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 79.5 tt0 -44.03 -41.26 5.32 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.969 -1.082 . . . . 0.0 108.436 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.588 HD13 HD11 ' A' ' 77' ' ' LEU . 48.4 mt -64.6 -30.71 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.128 -0.983 . . . . 0.0 108.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.809 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.73 -26.86 15.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.3 mtpm? -58.54 -73.52 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.992 -1.067 . . . . 0.0 108.402 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 109' ' ' LYS . 64.7 mt-30 -45.99 -27.38 0.9 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.038 -1.039 . . . . 0.0 108.911 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 113' ' ' PRO . 12.5 tttt -70.99 -17.68 62.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.772 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.687 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.04 67.22 79.35 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.143 -0.973 . . . . 0.0 109.761 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 111' ' ' LYS . 2.4 Cg_endo -66.91 -33.5 32.95 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 121.574 1.516 . . . . 0.0 112.088 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 8.0 p30 174.96 15.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 109.207 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.25 -77.18 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.552 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -150.51 -25.02 0.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.037 HG22 ' H ' ' A' ' 118' ' ' THR . 23.8 m -65.65 -164.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.973 . . . . 0.0 109.59 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.037 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.42 -74.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 0.0 109.921 -179.144 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -60.98 141.0 57.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.423 -0.798 . . . . 0.0 110.113 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.37 -22.04 64.59 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.24 1.019 . . . . 0.0 108.919 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.76 -37.81 87.35 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.504 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.548 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.22 -75.33 0.11 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.232 -1.387 . . . . 0.0 107.83 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.642 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.43 -42.09 6.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.462 -1.399 . . . . 0.0 109.32 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.683 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -50.29 -68.76 0.14 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.106 -0.996 . . . . 0.0 108.609 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.696 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.71 -41.95 5.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.595 ' O ' ' N ' ' A' ' 130' ' ' SER . 4.9 tpp -52.84 -80.74 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.077 -1.014 . . . . 0.0 109.082 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.809 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.4 mm -46.57 -62.93 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.478 -0.764 . . . . 0.0 110.019 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.821 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.65 -69.6 0.2 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -39.07 3.38 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 126' ' ' MET . 27.5 p -56.48 -52.0 66.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.516 -1.579 . . . . 0.0 107.592 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.646 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -46.94 -49.05 21.23 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.17 -53.98 9.51 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.648 ' C ' ' H ' ' A' ' 135' ' ' GLY . 9.9 t -44.83 -67.17 0.31 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.753 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 10.1 ttm -49.23 -2.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 88.07 -26.27 7.91 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.231 -1.947 . . . . 0.0 108.231 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.646 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.1 t -49.49 165.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.731 -0.864 . . . . 0.0 109.47 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.571 ' N ' HG12 ' A' ' 136' ' ' VAL . 39.2 mp0 -141.99 162.48 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.627 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.4 164.54 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.928 HG13 ' O ' ' A' ' 139' ' ' VAL . 3.7 p -129.72 58.59 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 165.05 -116.62 0.71 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.71 58.83 14.16 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.206 -1.173 . . . . 0.0 109.317 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.1 Cg_endo -64.83 -169.38 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.702 1.602 . . . . 0.0 112.842 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.758 ' O ' HG13 ' A' ' 144' ' ' VAL . 82.9 mt-10 -159.01 177.85 10.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.773 . . . . 0.0 109.191 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 143' ' ' GLU . 4.3 m -163.45 170.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.594 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.415 ' CD ' ' N ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -97.11 -164.97 1.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.48 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 54.4 m-20 -126.35 -85.04 0.62 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.509 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.516 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.509 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.626 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -45.79 139.04 4.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.491 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 9.0 mttt -170.58 115.11 0.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.714 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.748 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.89 136.76 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.542 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.875 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -115.13 -24.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.19 -0.944 . . . . 0.0 108.478 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.75 107.59 5.39 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.258 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -95.59 73.99 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.831 HG13 HD12 ' A' ' 10' ' ' LEU . 18.1 t -46.78 89.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.804 -1.158 . . . . 0.0 110.662 -176.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.604 ' N ' ' O ' ' A' ' 7' ' ' VAL . 6.0 tmtt? -82.62 34.81 0.44 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.792 0.806 . . . . 0.0 108.909 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.845 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -78.36 -174.57 3.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.678 0.751 . . . . 0.0 111.17 -178.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.6 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -122.19 172.83 7.98 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -166.58 156.99 10.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.839 -1.163 . . . . 0.0 110.059 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.612 ' HA ' HD13 ' A' ' 52' ' ' ILE . 11.3 Cg_endo -68.56 111.24 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.979 1.786 . . . . 0.0 111.668 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.816 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -69.85 39.22 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.982 -1.073 . . . . 0.0 110.499 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.464 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -175.0 -20.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.509 -1.805 . . . . 0.0 111.487 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -142.61 88.4 2.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.609 -1.524 . . . . 0.0 110.291 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 18' ' ' THR . . . -105.14 164.53 11.75 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.711 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.16 164.54 4.11 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 109.367 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HA ' HG21 ' A' ' 34' ' ' ILE . 2.7 Cg_endo -55.56 30.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.309 1.339 . . . . 0.0 111.781 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.756 ' N ' ' HD3' ' A' ' 21' ' ' PRO . . . -151.62 54.07 1.27 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.086 -1.009 . . . . 0.0 110.02 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.756 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 19.8 Cg_endo -86.47 168.74 8.52 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.904 1.736 . . . . 0.0 111.614 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.1 -4.63 1.06 Allowed 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 120.935 1.09 . . . . 0.0 110.765 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.732 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.2 t -114.98 -71.25 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 121.477 0.656 . . . . 0.0 109.911 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 54.41 -98.09 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.732 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -59.39 -55.83 1.62 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 CA-C-N 118.11 0.955 . . . . 0.0 109.961 177.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -44.67 -6.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.358 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -111.09 -44.58 3.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.77 -1.206 . . . . 0.0 108.803 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.34 84.32 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 27' ' ' LEU . 66.3 tp60 -149.07 -12.44 0.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.386 -1.067 . . . . 0.0 108.214 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.599 ' ND1' ' C ' ' A' ' 30' ' ' HIS . 0.3 OUTLIER -85.46 -37.13 20.1 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -170.21 2.26 0.03 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 70.75 78.6 0.18 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.84 -0.8 . . . . 0.0 111.969 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -156.54 120.57 4.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.004 -1.06 . . . . 0.0 108.688 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 30.1 mm -98.55 -63.67 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.724 -0.61 . . . . 0.0 109.746 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.47 ' C ' ' O ' ' A' ' 34' ' ' ILE . 4.9 tpt -41.39 -55.31 2.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.733 -1.229 . . . . 0.0 109.653 -177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 35' ' ' MET . 15.8 mt-10 -46.76 -48.3 20.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 0.0 107.741 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.8 OUTLIER -50.67 -68.65 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.945 1.355 . . . . 0.0 109.177 177.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 17' ' ' ALA . 45.6 t -54.17 -34.68 27.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.375 -1.284 . . . . 0.0 110.608 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 1.5 mmmp? -56.55 -65.8 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.76 64.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.71 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -71.31 -76.74 0.1 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.5 m-80 -41.65 -34.54 0.62 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.512 1.148 . . . . 0.0 110.583 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' O ' ' CG ' ' A' ' 47' ' ' ASN . . . -66.45 -35.67 80.87 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.77 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.77 -52.0 5.09 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.683 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.761 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.1 p -54.32 -29.45 47.84 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.52 -47.2 12.44 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.553 ' CG ' ' O ' ' A' ' 43' ' ' ALA . 7.6 m120 -52.38 -23.24 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.318 -0.864 . . . . 0.0 108.983 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.597 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.65 -85.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 109.678 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.597 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.23 -135.77 1.89 Allowed Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.855 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -125.29 125.87 44.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -1.106 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.816 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -159.4 -153.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.612 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.5 mm -147.44 143.85 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.515 HG22 ' C ' ' A' ' 71' ' ' THR . 5.9 t -145.16 136.94 12.93 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 110.39 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.2 Cg_endo -74.12 90.0 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.823 1.682 . . . . 0.0 110.763 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.845 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.9 m -61.98 137.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 122.783 1.278 . . . . 0.0 112.365 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.4 mt-10 -128.81 64.34 1.45 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.766 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.0 mt -64.98 89.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.697 0.76 . . . . 0.0 110.501 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.22 96.89 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.537 HG13 HG22 ' A' ' 57' ' ' ILE . 36.1 mt -99.31 144.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.63 -0.669 . . . . 0.0 110.368 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.748 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 5.0 m-85 -115.81 140.3 49.36 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.875 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.75 -29.61 4.7 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.235 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 55.4 p30 -53.67 4.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.834 ' H ' ' C ' ' A' ' 61' ' ' ALA . 79.1 mtm180 69.05 68.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.985 0.898 . . . . 0.0 109.655 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.7 p -147.76 128.85 14.58 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -105.51 103.96 13.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.978 -1.076 . . . . 0.0 110.422 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 58' ' ' THR . 8.3 p -98.72 124.64 43.69 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -108.71 172.02 7.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.569 -1.332 . . . . 0.0 109.417 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.975 HG12 ' O ' ' A' ' 68' ' ' VAL . 89.8 t -162.83 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 112.622 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.535 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.53 117.28 4.38 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.67 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.813 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.15 120.96 41.51 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.784 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.2 p 76.93 150.53 0.13 Allowed Pre-proline 0 N--CA 1.493 1.708 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.434 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.61 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.7 Cg_exo -38.62 175.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.817 2.345 . . . . 0.0 113.35 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.763 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.2 Cg_exo -40.72 166.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.574 1.516 . . . . 0.0 111.788 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.987 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 55.01 -76.66 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.763 ' N ' ' O ' ' A' ' 73' ' ' PRO . 55.3 p -43.17 -24.29 0.08 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 110.128 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.087 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 20.0 p90 -43.59 -43.16 5.5 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 0.0 109.227 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.087 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.88 -13.86 2.8 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.987 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.5 mt -62.33 -33.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.799 ' CG ' HH11 ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.81 -40.81 73.27 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 82' ' ' ALA . 1.8 tmtp? -68.91 -66.33 0.59 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.76 -4.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.695 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -84.79 -80.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.42 -0.8 . . . . 0.0 111.958 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 152.01 52.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.419 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.049 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.672 HD11 ' CD ' ' A' ' 79' ' ' ARG . 18.3 mt -76.3 104.95 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.844 -1.386 . . . . 0.0 109.045 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 177.06 -24.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.035 -1.041 . . . . 0.0 109.739 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.48 ' H ' HG22 ' A' ' 96' ' ' VAL . 9.1 mttt 64.71 61.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.485 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.78 174.95 29.98 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.11 -85.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -1.124 . . . . 0.0 109.466 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -143.29 -54.71 0.39 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.445 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -98.02 160.11 29.18 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.478 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -57.57 -16.62 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.604 1.536 . . . . 0.0 112.406 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . -103.54 174.45 22.8 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.55 ' O ' ' O ' ' A' ' 92' ' ' GLY . 10.9 mpt_? 57.13 123.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -1.13 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -145.12 176.26 9.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.463 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.7 tttt 176.99 161.52 0.42 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 97' ' ' GLY . 83.5 t -144.58 163.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.315 -0.866 . . . . 0.0 109.598 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.57 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 72.75 63.66 2.8 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.695 ' O ' ' O ' ' A' ' 82' ' ' ALA . 2.4 mtt180 -134.72 112.48 10.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.152 -1.205 . . . . 0.0 110.082 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.798 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -102.79 177.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.646 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.703 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -119.33 151.89 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 108.979 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.693 ' O ' HG22 ' A' ' 104' ' ' VAL . 23.4 t-105 -45.93 -69.96 0.12 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.439 -0.788 . . . . 0.0 110.91 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.492 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 5.8 tp10 -49.23 -50.36 38.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.718 -1.239 . . . . 0.0 111.018 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.41 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 3.6 mt-30 -51.72 -42.09 62.01 Favored 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.509 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.753 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.56 -26.1 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 117.46 -1.696 . . . . 0.0 107.184 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.896 HD13 HD13 ' A' ' 120' ' ' LEU . 21.6 mt -65.97 -71.27 0.2 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 17.5 mm-40 -43.98 -43.15 6.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.921 -1.112 . . . . 0.0 108.534 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.787 HG12 HD11 ' A' ' 77' ' ' LEU . 52.8 mt -63.5 -31.87 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.592 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.804 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.63 -32.43 13.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.88 . . . . 0.0 109.621 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.726 ' HG2' HD21 ' A' ' 120' ' ' LEU . 4.7 mtpt -52.39 -71.48 0.07 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.835 -1.166 . . . . 0.0 108.275 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 109' ' ' LYS . 16.3 tt0 -44.76 -28.74 0.67 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 108.736 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -72.68 -6.95 47.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.9 . . . . 0.0 109.75 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.589 ' SD ' ' HB3' ' A' ' 123' ' ' ALA . 7.3 ptm -134.13 63.97 63.86 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 109.828 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 112' ' ' MET . 4.0 Cg_endo -68.72 -41.13 6.25 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.607 1.538 . . . . 0.0 112.059 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.558 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 66.2 t0 -177.37 6.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.444 -0.785 . . . . 0.0 109.089 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.407 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.0 mm? -46.42 -83.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.0 109.583 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -148.66 -19.3 0.32 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.049 HG22 ' H ' ' A' ' 118' ' ' THR . 26.9 m -65.87 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.587 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.049 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.69 -65.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.517 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -73.01 140.41 47.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.431 -0.793 . . . . 0.0 110.121 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.896 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -59.65 -23.65 63.22 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.376 1.084 . . . . 0.0 108.883 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -64.15 -35.58 81.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.574 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.552 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.35 -75.99 0.12 Allowed 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.272 -1.371 . . . . 0.0 108.072 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.589 ' HB3' ' SD ' ' A' ' 112' ' ' MET . . . -45.01 -35.87 3.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.539 -1.351 . . . . 0.0 109.191 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -55.77 -70.4 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.022 -1.049 . . . . 0.0 108.668 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.665 ' O ' ' N ' ' A' ' 129' ' ' GLY . 20.1 ttp180 -43.51 -39.57 3.44 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.7 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.5 ttp -53.27 -78.71 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.134 -0.979 . . . . 0.0 108.53 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.804 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.1 mm -47.94 -63.94 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.481 -0.762 . . . . 0.0 109.978 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.74 -71.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.87 -41.91 4.72 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 126' ' ' MET . 49.5 m -54.22 -49.35 69.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.583 -1.539 . . . . 0.0 107.578 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.716 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.18 -47.83 45.64 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.636 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.08 -54.69 8.08 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.71 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.6 t -44.87 -68.83 0.16 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.662 ' HG2' HG23 ' A' ' 136' ' ' VAL . 3.4 ttp -46.0 -4.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.71 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.04 -31.77 5.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.716 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 27.1 t -45.28 165.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' N ' HG12 ' A' ' 136' ' ' VAL . 3.5 tp10 -144.33 163.61 33.22 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.391 -0.923 . . . . 0.0 109.332 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 140' ' ' GLY . 1.8 t -79.04 123.93 36.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 99' ' ' ILE . 9.0 p -49.45 3.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.574 -0.704 . . . . 0.0 110.345 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 138' ' ' VAL . . . 156.23 -91.09 0.12 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.056 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . 75.08 59.25 0.26 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.217 -1.167 . . . . 0.0 109.434 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.6 Cg_endo -65.04 -165.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.776 1.651 . . . . 0.0 112.582 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -135.55 -164.92 1.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.487 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.4 m -64.27 -175.52 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 109.487 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -173.68 -14.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.522 ' CG ' ' O ' ' A' ' 146' ' ' ASP . 4.5 p-10 -49.4 103.34 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.92 . . . . 0.0 109.524 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.527 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -146.57 116.61 7.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.406 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.609 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 11.3 tttt -177.72 123.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.922 . . . . 0.0 109.608 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.563 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -44.73 139.54 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 108.914 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.064 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -122.31 -24.85 2.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.057 -1.027 . . . . 0.0 110.12 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -155.42 104.91 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.605 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -97.26 74.27 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.787 ' HB ' HD12 ' A' ' 57' ' ' ILE . 16.5 t -48.82 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 118.536 -1.266 . . . . 0.0 110.503 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.615 ' N ' ' O ' ' A' ' 7' ' ' VAL . 3.3 tmtp? -82.94 37.31 0.53 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.861 0.839 . . . . 0.0 109.217 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.825 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.9 tp -78.09 -174.09 3.47 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.901 0.858 . . . . 0.0 111.235 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.858 HE21 ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.26 176.56 6.35 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.697 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -164.43 146.36 6.99 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 120.847 -1.158 . . . . 0.0 109.299 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 74.1 Cg_endo -84.9 125.78 3.23 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.324 2.016 . . . . 0.0 113.576 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.058 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -74.41 143.77 44.61 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.21 56.08 16.31 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 22.1 tttp 174.35 3.93 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.733 -0.863 . . . . 0.0 109.191 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 18' ' ' THR . . . -86.73 153.32 21.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.892 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.5 165.78 6.15 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.976 -1.078 . . . . 0.0 110.005 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.7 Cg_exo -49.04 33.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.684 1.589 . . . . 0.0 111.868 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.892 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -150.85 54.34 1.41 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.536 -0.728 . . . . 0.0 109.61 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 14.5 Cg_endo -80.23 167.0 20.06 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.72 1.613 . . . . 0.0 111.898 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.61 -4.66 5.95 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.24 1.294 . . . . 0.0 111.341 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.779 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 4.4 t -113.34 -69.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.584 -0.698 . . . . 0.0 110.193 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.41 -97.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_endo -58.71 -55.29 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 CA-C-N 117.892 0.846 . . . . 0.0 110.408 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.774 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -49.56 -9.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.742 -0.599 . . . . 0.0 110.782 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.865 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -106.27 -49.04 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.682 -1.261 . . . . 0.0 108.237 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -50.62 94.13 0.01 OUTLIER Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 27' ' ' LEU . 51.3 tt0 -154.54 -24.41 0.12 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.724 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -77.77 -44.78 26.54 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.891 179.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.724 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -165.98 -11.53 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.14 82.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -1.09 . . . . 0.0 112.397 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.613 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 28.2 p30 -153.01 69.63 0.85 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.83 -1.169 . . . . 0.0 109.14 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.728 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 24.0 mm -44.32 -69.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.702 ' O ' ' N ' ' A' ' 39' ' ' LYS . 7.8 tpt -41.71 -57.38 2.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.582 -1.324 . . . . 0.0 108.869 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.613 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 69.9 tt0 -44.86 -49.7 10.74 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.865 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -49.58 -65.57 0.54 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 122.723 1.249 . . . . 0.0 109.627 178.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 42' ' ' ASN . 23.8 t -67.21 -35.95 75.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.83 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -46.7 -62.2 1.49 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 177.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.62 -33.73 70.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.339 -0.851 . . . . 0.0 108.922 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' THR . 2.8 t80 -71.05 -77.55 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 38' ' ' VAL . 3.4 t-20 -41.33 -36.91 0.89 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.825 -1.172 . . . . 0.0 110.585 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -64.72 -33.83 76.89 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.11 -59.59 2.15 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.451 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 41' ' ' PHE . 1.7 p -44.53 -31.7 1.19 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.75 23.89 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -56.34 -25.17 48.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.436 -0.79 . . . . 0.0 109.405 179.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.55 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -111.5 -73.71 0.67 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.04 -1.037 . . . . 0.0 109.864 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.51 -165.81 34.73 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 118.944 -1.598 . . . . 0.0 111.392 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.5 p30 -87.22 147.15 25.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.056 -1.261 . . . . 0.0 109.082 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.058 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 174.93 -153.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.906 -1.122 . . . . 0.0 110.81 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 13' ' ' PRO . 1.9 mm -146.26 138.18 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 71' ' ' THR . 2.4 t -137.25 135.41 19.53 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.045 -1.034 . . . . 0.0 110.776 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.0 Cg_endo -73.02 102.95 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.685 1.59 . . . . 0.0 111.161 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.825 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.7 m -76.51 136.53 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.658 -1.276 . . . . 0.0 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.1 tt0 -129.88 69.76 1.43 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.787 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -70.31 88.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.721 0.772 . . . . 0.0 110.063 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.43 ' HB ' ' HG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -64.18 95.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 53.9 mt -95.27 131.15 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 121.575 0.703 . . . . 0.0 110.479 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.609 ' CE2' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -108.29 133.09 52.99 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 1.064 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -45.79 -30.89 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.567 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.53 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 27.4 p30 -53.94 2.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.791 ' H ' ' C ' ' A' ' 61' ' ' ALA . 7.5 ttp180 70.83 67.08 0.18 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.2 1.0 . . . . 0.0 110.08 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 p -150.39 124.92 9.63 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 1.4 p90 -102.24 103.86 14.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.041 -1.037 . . . . 0.0 109.89 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.609 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p -101.04 120.98 40.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 110.189 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.954 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.34 148.78 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 0.0 111.179 177.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.0 t -169.98 96.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.08 145.11 30.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.752 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -129.41 123.69 32.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.509 -1.369 . . . . 0.0 110.545 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.752 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.21 150.66 0.13 Allowed Pre-proline 0 N--CA 1.493 1.685 0 CA-C-O 121.175 0.512 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 73' ' ' PRO . 11.4 Cg_exo -41.86 175.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.731 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.1 Cg_exo -38.9 171.07 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.379 1.386 . . . . 0.0 112.035 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.973 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.67 -80.62 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 73' ' ' PRO . 86.6 p -43.61 -23.14 0.06 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 110.019 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.053 ' CE1' HD12 ' A' ' 77' ' ' LEU . 16.9 p90 -44.02 -38.91 3.8 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 0.0 109.051 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.243 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -136.95 -14.29 1.59 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.243 ' N ' HD13 ' A' ' 77' ' ' LEU . 1.7 mt -63.39 -33.25 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.567 ' CD ' HG21 ' A' ' 71' ' ' THR . 14.2 mmt180 -55.1 -42.69 73.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 82' ' ' ALA . 6.2 tmtt? -64.2 -65.99 0.6 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.67 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.29 -5.3 0.47 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.71 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.65 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.93 -80.64 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 111.778 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.663 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 167.98 47.52 0.03 OUTLIER Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.071 -1.538 . . . . 0.0 110.671 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.467 HD11 ' CD ' ' A' ' 79' ' ' ARG . 4.0 mt -97.42 120.27 37.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 0.0 109.132 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 87' ' ' GLY . 57.3 tt0 -160.43 58.44 0.34 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 0.0 109.529 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.563 ' O ' ' O ' ' A' ' 87' ' ' GLY . 41.3 tttm 45.84 -84.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.944 . . . . 0.0 109.456 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 56.73 126.18 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.685 ' O ' ' CD2' ' A' ' 89' ' ' HIS . . . 175.0 127.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -1.128 . . . . 0.0 109.523 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.685 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 44.6 m-70 -171.47 -84.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.559 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.26 153.85 59.61 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.23 -35.96 98.97 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.488 1.459 . . . . 0.0 112.321 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.01 -163.54 32.38 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.825 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.9 OUTLIER 64.23 88.46 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.2 -1.176 . . . . 0.0 109.482 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 23.2 mt-10 -137.54 108.12 6.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.442 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 94' ' ' GLU . 86.1 mttt -158.52 120.85 3.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.422 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 83' ' ' GLY . 95.5 t -157.91 161.21 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.524 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 78.72 56.92 3.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.65 ' O ' ' O ' ' A' ' 82' ' ' ALA . 3.6 ttt180 -130.57 116.65 18.43 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.287 -1.125 . . . . 0.0 109.833 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.682 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -105.6 168.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.527 -0.733 . . . . 0.0 109.647 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.741 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -109.11 151.04 26.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.114 -0.991 . . . . 0.0 108.985 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 104' ' ' VAL . 25.8 t-105 -45.82 -68.17 0.22 Allowed 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.471 -0.768 . . . . 0.0 110.872 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' CD ' ' C ' ' A' ' 102' ' ' GLU . 5.9 tp10 -51.32 -47.2 62.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.528 -1.357 . . . . 0.0 110.892 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.67 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -51.49 -43.58 62.24 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.171 -0.956 . . . . 0.0 110.017 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.776 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.01 -24.8 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 117.89 -1.524 . . . . 0.0 107.617 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.876 HD13 HD13 ' A' ' 120' ' ' LEU . 20.8 mt -66.14 -71.55 0.19 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -44.19 -44.78 8.02 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 120.964 -1.085 . . . . 0.0 108.515 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.773 HG12 HD21 ' A' ' 77' ' ' LEU . 55.8 mt -61.02 -31.4 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 108.689 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.827 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.03 -24.28 16.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 109.416 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.687 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.1 mtpt -59.57 -73.65 0.08 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.0 -1.063 . . . . 0.0 108.158 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.47 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 37.5 mt-30 -51.27 -17.94 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.815 . . . . 0.0 109.292 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.56 -8.14 58.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.52 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -133.37 57.87 29.93 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.024 -1.047 . . . . 0.0 109.748 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.99 -41.91 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.521 1.481 . . . . 0.0 112.283 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 115' ' ' LEU . 24.9 t70 -160.68 8.66 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.6 mp -44.93 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 109.293 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.427 ' H ' ' H ' ' A' ' 117' ' ' THR . 10.5 t30 -165.18 -4.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.332 -0.855 . . . . 0.0 109.237 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.031 HG22 ' H ' ' A' ' 118' ' ' THR . 29.8 m -74.23 -164.66 0.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.584 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.031 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.97 -57.71 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 118' ' ' THR . 0.7 OUTLIER -80.01 135.02 36.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.876 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -54.24 -24.78 19.96 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.183 0.992 . . . . 0.0 109.172 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -64.14 -36.74 85.03 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.535 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.641 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.65 -74.71 0.14 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.499 -1.376 . . . . 0.0 108.039 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.59 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.89 -37.65 4.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.496 -1.378 . . . . 0.0 109.136 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -55.34 -70.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 108.925 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -43.49 -38.8 3.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.698 ' O ' ' N ' ' A' ' 130' ' ' SER . 14.0 ttm -53.77 -78.65 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.827 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.3 mm -48.04 -63.97 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 109.97 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.776 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.39 -71.84 0.12 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.9 -42.7 5.08 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 126' ' ' MET . 58.7 m -54.74 -46.18 74.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.616 -1.52 . . . . 0.0 107.462 177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.738 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -50.43 -47.55 56.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.0 tmt_? -46.83 -52.32 14.54 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -48.62 -70.37 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.52 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 5.6 ttm -44.51 -4.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.15 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.75 22.91 54.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.738 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 29.8 t -109.23 138.53 36.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -115.03 166.67 11.55 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.837 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.645 ' C ' ' H ' ' A' ' 140' ' ' GLY . 1.9 t -82.79 124.82 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' A' ' 100' ' ' THR . 12.2 p -52.57 1.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.428 -0.795 . . . . 0.0 109.72 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.689 ' O ' ' HB3' ' A' ' 141' ' ' ALA . . . -159.27 -126.93 0.88 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . 75.07 66.47 0.25 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.251 -1.147 . . . . 0.0 109.364 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.9 Cg_endo -62.65 -165.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 121.796 1.664 . . . . 0.0 112.48 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -87.28 -164.96 1.17 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.842 . . . . 0.0 109.504 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 145' ' ' LYS . 3.1 m -95.3 -164.97 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.567 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.593 ' CD ' ' O ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -159.42 134.2 7.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.514 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.593 ' O ' ' CD ' ' A' ' 145' ' ' LYS . 48.6 m-20 -75.47 141.65 43.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.502 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.501 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.275 0.56 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.19 109.62 1.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.892 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.597 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 2.6 mtmt -150.27 125.86 10.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.855 . . . . 0.0 109.56 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.783 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.77 133.59 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 109.341 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.737 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.5 m -116.92 -24.49 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.22 -0.925 . . . . 0.0 109.18 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.53 114.18 9.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.118 . . . . 0.0 110.529 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -102.55 73.66 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.78 ' HB ' HD12 ' A' ' 57' ' ' ILE . 7.9 t -48.56 88.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.764 -1.21 . . . . 0.0 110.606 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.9 tmtt? -82.0 36.74 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.792 0.806 . . . . 0.0 109.168 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.3 mp -77.21 -174.0 3.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.59 0.709 . . . . 0.0 110.977 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 1.09 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -127.07 177.76 6.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.62 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -170.27 157.91 5.98 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.943 -1.098 . . . . 0.0 109.839 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.674 ' O ' ' N ' ' A' ' 15' ' ' GLY . 10.4 Cg_endo -66.69 104.92 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.373 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.813 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -60.9 38.65 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.005 -1.059 . . . . 0.0 110.338 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.57 -19.42 0.02 OUTLIER Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.488 -1.815 . . . . 0.0 111.357 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 10.4 tttm -148.39 79.7 1.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.578 -1.542 . . . . 0.0 110.705 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.771 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -94.96 170.16 9.62 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.78 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.74 164.25 4.51 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.768 -1.207 . . . . 0.0 110.494 -179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.4 Cg_exo -51.75 32.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.029 1.819 . . . . 0.0 112.11 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -137.92 53.98 6.91 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.077 -1.015 . . . . 0.0 110.384 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.713 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.7 Cg_endo -85.97 163.13 10.3 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.8 1.667 . . . . 0.0 111.809 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.1 -4.81 4.17 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 121.016 1.144 . . . . 0.0 111.405 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.815 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 22.0 t -118.59 -66.45 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.588 -0.695 . . . . 0.0 109.354 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.53 -97.23 0.05 OUTLIER Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.815 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.2 Cg_exo -54.3 -55.05 3.72 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 CA-C-N 117.876 0.838 . . . . 0.0 110.538 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -64.22 4.7 0.32 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.635 -0.665 . . . . 0.0 111.211 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.752 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -109.62 -64.18 1.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.66 -1.275 . . . . 0.0 109.797 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.58 -16.75 0.07 OUTLIER Glycine 0 N--CA 1.486 2.018 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 28' ' ' GLY . 22.3 tp60 -42.08 -16.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.472 -1.605 . . . . 0.0 109.528 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.71 ' ND1' ' N ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -65.52 -46.29 80.2 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.71 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.67 -5.31 0.04 OUTLIER Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.624 ' C ' ' ND2' ' A' ' 33' ' ' ASN . . . 70.86 76.7 0.19 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.077 -0.661 . . . . 0.0 111.892 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.624 ' ND2' ' C ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -152.06 64.86 0.84 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 122.307 1.051 . . . . 0.0 108.334 177.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.5 mm -43.22 -66.94 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.643 ' O ' ' N ' ' A' ' 39' ' ' LYS . 11.0 tpt -41.56 -42.52 2.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.619 -1.3 . . . . 0.0 108.759 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.21 -49.39 76.16 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.4 OUTLIER -50.91 -67.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 122.66 1.219 . . . . 0.0 109.093 178.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 17' ' ' ALA . 24.8 t -63.36 -36.46 76.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.3 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 35' ' ' MET . 5.5 ttpt -48.99 -60.17 3.0 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -33.33 71.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.354 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.64 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.9 t80 -68.79 -76.5 0.09 Allowed 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.575 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.9 m-80 -41.8 -32.9 0.44 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.399 1.095 . . . . 0.0 110.893 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.73 -34.75 77.46 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.611 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' A' ' 48' ' ' MET . . . -90.82 -51.55 5.31 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.775 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.791 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 22.7 p -54.36 -31.48 54.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.33 -45.3 16.37 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -54.17 -22.99 12.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.394 -0.816 . . . . 0.0 109.145 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.58 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.1 -85.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.58 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.94 -144.17 3.99 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.015 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.17 119.8 37.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.314 -1.11 . . . . 0.0 109.806 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.813 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -155.8 -152.74 0.4 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.855 . . . . 0.0 110.095 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.595 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.6 mm -146.26 141.83 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 14' ' ' ALA . 6.9 t -144.32 137.5 13.98 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.344 -0.847 . . . . 0.0 109.911 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.6 Cg_endo -73.51 91.72 0.87 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.779 1.653 . . . . 0.0 111.482 178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.2 m -57.92 137.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 111.266 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.3 mt-10 -130.19 70.65 1.44 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.78 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.6 mt -70.67 90.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.856 0.836 . . . . 0.0 110.226 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.8 m -69.98 104.94 2.67 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 64' ' ' SER . 21.1 mt -110.33 148.23 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.494 -0.754 . . . . 0.0 110.927 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.783 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.9 m-85 -116.63 140.94 48.84 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.785 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.56 -32.46 5.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.267 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -51.44 -1.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.785 ' H ' ' C ' ' A' ' 61' ' ' ALA . 13.1 mtp180 75.02 70.03 0.09 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.992 0.901 . . . . 0.0 109.752 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -149.44 138.08 20.96 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 42.9 p90 -115.13 103.93 11.36 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.963 -1.086 . . . . 0.0 110.312 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.47 121.07 41.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.089 179.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.911 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER 170.37 148.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.955 -1.09 . . . . 0.0 111.211 177.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.8 t -168.49 79.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -87.16 138.15 31.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.656 ' O ' ' OG1' ' A' ' 71' ' ' THR . 8.1 mttm -122.94 140.15 53.3 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.198 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.679 ' CB ' ' OG ' ' A' ' 75' ' ' SER . 2.2 p 57.73 158.07 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.603 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.565 ' O ' ' O ' ' A' ' 71' ' ' THR . 12.7 Cg_exo -39.5 175.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.309 2.006 . . . . 0.0 112.691 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.715 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.9 Cg_exo -40.02 170.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.69 1.593 . . . . 0.0 112.253 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.897 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 58.07 -73.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.715 ' N ' ' O ' ' A' ' 73' ' ' PRO . 7.5 p -43.98 -25.34 0.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.471 -0.768 . . . . 0.0 109.945 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.055 ' CE1' HD12 ' A' ' 77' ' ' LEU . 17.4 p90 -43.61 -43.21 5.58 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.237 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.85 -13.79 3.2 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.237 ' N ' HD13 ' A' ' 77' ' ' LEU . 1.4 mt -63.31 -29.78 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.76 ' CD ' HD11 ' A' ' 84' ' ' LEU . 3.6 mmt180 -54.07 -48.68 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.7 tmtt? -63.81 -66.14 0.58 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.61 -6.54 0.12 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.623 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.57 -77.9 0.35 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.783 . . . . 0.0 111.949 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 96' ' ' VAL . . . 146.9 62.13 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.038 -1.553 . . . . 0.0 111.189 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.76 HD11 ' CD ' ' A' ' 79' ' ' ARG . 16.8 mt -85.01 104.95 15.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.951 -1.323 . . . . 0.0 108.901 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.669 ' O ' ' N ' ' A' ' 87' ' ' GLY . 20.9 tt0 -155.94 23.17 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.06 -1.025 . . . . 0.0 109.722 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' GLU . 1.0 OUTLIER 45.04 -85.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.669 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 130.95 172.44 13.12 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.5 -84.99 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -1.173 . . . . 0.0 109.525 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -118.92 131.12 56.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.477 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 mtmm -161.08 160.04 24.59 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.386 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -57.33 -15.28 18.45 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.577 1.518 . . . . 0.0 112.41 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.6 178.1 18.0 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.578 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 82.2 mtt180 57.76 82.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.357 -1.084 . . . . 0.0 109.555 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.578 ' OE1' ' O ' ' A' ' 93' ' ' ARG . 5.1 tp10 -178.99 152.5 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' A' ' 94' ' ' GLU . 41.3 mttt -159.9 -165.12 1.43 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.965 . . . . 0.0 109.566 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 97' ' ' GLY . 86.2 t -109.73 165.02 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.299 -0.875 . . . . 0.0 109.577 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.588 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 70.89 67.81 1.79 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.788 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.57 109.82 9.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -1.212 . . . . 0.0 110.403 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.687 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.42 175.59 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.786 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -123.34 158.38 31.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.078 -1.014 . . . . 0.0 108.961 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.687 ' O ' HG22 ' A' ' 104' ' ' VAL . 11.4 t-105 -45.19 -70.86 0.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 111.351 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.511 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -50.72 -50.8 54.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.562 -1.336 . . . . 0.0 111.108 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.0 mt-30 -49.27 -43.66 43.24 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.288 -0.883 . . . . 0.0 110.35 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.884 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.35 -24.79 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 117.616 -1.634 . . . . 0.0 107.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 120' ' ' LEU . 13.5 mt -66.32 -71.45 0.19 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.497 ' CD ' ' OE2' ' A' ' 102' ' ' GLU . 35.1 mt-10 -43.77 -43.72 6.26 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.93 -1.106 . . . . 0.0 108.461 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.683 HG12 HD21 ' A' ' 77' ' ' LEU . 55.2 mt -61.65 -31.5 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 108.396 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.815 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.97 -26.77 15.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 0.0 109.62 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.8 mtpt -59.26 -73.56 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.92 -1.112 . . . . 0.0 108.211 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 3.1 tt0 -49.35 -18.27 0.36 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.253 -0.904 . . . . 0.0 109.321 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.511 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.8 tmtt? -80.82 -10.2 59.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.581 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -132.38 55.46 17.82 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.13 -0.981 . . . . 0.0 109.872 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.9 Cg_endo -60.2 -40.89 55.87 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.567 1.512 . . . . 0.0 112.3 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.529 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -164.91 9.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.54 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.459 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.2 mp -45.0 -85.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 109.356 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -160.24 -10.68 0.05 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.024 HG22 ' H ' ' A' ' 118' ' ' THR . 29.0 m -68.65 -164.63 0.05 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.531 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.024 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.65 -57.55 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 -179.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -80.2 135.22 36.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -54.86 -23.74 19.89 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.16 0.981 . . . . 0.0 109.103 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.11 -35.8 82.26 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.47 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.627 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.63 -74.69 0.15 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.964 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.644 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.63 -39.05 4.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.342 -1.474 . . . . 0.0 109.152 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.5 -69.25 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.087 -1.008 . . . . 0.0 108.728 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.79 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -42.81 5.36 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.705 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.5 ttm -51.29 -79.03 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.115 -0.991 . . . . 0.0 108.454 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.815 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.5 mm -48.37 -66.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.678 0.751 . . . . 0.0 109.934 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.884 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -57.89 -71.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.86 -40.82 4.23 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 126' ' ' MET . 44.0 m -56.26 -51.25 68.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.518 -1.577 . . . . 0.0 107.723 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.14 -47.63 23.57 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.767 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -47.06 -54.26 10.75 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.701 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.1 t -44.77 -68.59 0.18 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.656 ' HG2' HG23 ' A' ' 136' ' ' VAL . 3.8 ttp -46.46 -4.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.701 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.73 -31.49 4.92 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 107.796 -2.122 . . . . 0.0 107.796 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.656 HG23 ' HG2' ' A' ' 134' ' ' MET . 31.3 t -45.09 165.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.937 -0.743 . . . . 0.0 109.173 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.9 tm-20 -142.43 162.26 35.92 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.598 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.587 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -78.08 164.35 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 139' ' ' VAL . 4.1 p -131.64 58.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 161.88 -114.45 0.61 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.523 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.85 60.66 12.64 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.266 -1.138 . . . . 0.0 109.403 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.0 Cg_endo -65.6 -165.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.682 1.588 . . . . 0.0 112.682 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.71 ' O ' HG13 ' A' ' 144' ' ' VAL . 80.5 mt-10 -146.57 -167.85 2.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 0.0 109.351 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 143' ' ' GLU . 9.0 m -162.31 -179.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 109.584 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -123.27 -167.05 1.54 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.431 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 146' ' ' ASP . 6.8 p-10 -176.89 97.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 mtt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 pttt 176.4 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 109.649 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' C ' ' CE2' ' A' ' 60' ' ' TYR . 3.4 mttm 175.01 114.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.89 . . . . 0.0 109.455 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.748 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.91 140.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.122 -0.986 . . . . 0.0 109.12 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.924 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.0 m -121.12 -24.59 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.221 -0.924 . . . . 0.0 110.026 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.19 110.88 4.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.605 -1.309 . . . . 0.0 110.716 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -100.92 73.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.827 ' HB ' HD12 ' A' ' 57' ' ' ILE . 21.5 t -46.36 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 120.888 -1.133 . . . . 0.0 110.49 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.9 tmmm? -83.26 34.99 0.48 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.091 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.78 -174.15 3.81 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.917 0.865 . . . . 0.0 111.596 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -121.55 172.12 8.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.51 160.93 4.11 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.854 -1.154 . . . . 0.0 109.857 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.79 ' HD2' HD23 ' A' ' 12' ' ' LEU . 8.8 Cg_endo -61.53 129.41 27.91 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.042 1.828 . . . . 0.0 111.81 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.83 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -90.62 42.16 1.09 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 111.28 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.621 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 172.43 -12.96 0.04 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.934 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.59 70.96 1.37 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.419 . . . . 0.0 109.557 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.642 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -90.8 165.21 13.77 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.431 -0.793 . . . . 0.0 109.319 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.69 161.73 5.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.667 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -54.04 31.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.509 1.473 . . . . 0.0 111.466 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -144.94 54.3 2.44 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 0.0 110.265 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.3 Cg_endo -83.09 154.87 14.72 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.584 1.523 . . . . 0.0 111.544 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -54.58 -4.46 0.32 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.048 1.165 . . . . 0.0 111.018 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.091 HG22 HD22 ' A' ' 10' ' ' LEU . 2.9 t -103.77 -71.82 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.524 0.678 . . . . 0.0 110.592 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.29 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.741 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -60.11 -55.5 1.57 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 CA-C-N 118.048 0.924 . . . . 0.0 110.188 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.587 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -45.0 -7.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.815 -0.553 . . . . 0.0 110.657 -178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.745 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -108.37 -45.57 3.87 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.686 -1.259 . . . . 0.0 108.798 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.81 88.95 0.01 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 27' ' ' LEU . 2.7 tt0 -149.73 -15.19 0.27 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.617 ' ND1' ' C ' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -89.46 -36.85 15.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -172.36 -1.82 0.03 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.09 82.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.568 -0.96 . . . . 0.0 112.188 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.583 ' OD1' ' O ' ' A' ' 33' ' ' ASN . 26.7 p-10 -156.74 119.22 3.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.867 -1.145 . . . . 0.0 109.08 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.2 mm -93.96 -65.26 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 39' ' ' LYS . 4.4 tpt -42.72 -55.08 3.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.948 -1.095 . . . . 0.0 109.417 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' CB ' ' ND2' ' A' ' 33' ' ' ASN . 4.8 mp0 -51.01 -53.41 33.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.173 -0.954 . . . . 0.0 108.458 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.745 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -46.17 -59.11 3.09 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.936 1.35 . . . . 0.0 108.796 177.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.642 HG13 ' CB ' ' A' ' 17' ' ' ALA . 87.2 t -70.87 -26.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.815 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 35' ' ' MET . 23.1 tptt -56.26 -55.25 35.6 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.05 -34.79 78.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.433 -0.792 . . . . 0.0 109.729 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CD2' HG21 ' A' ' 45' ' ' THR . 0.6 OUTLIER -67.37 -75.73 0.09 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.637 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 8.9 t-20 -41.78 -35.84 0.89 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.26 1.029 . . . . 0.0 110.715 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -62.95 -34.28 77.15 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.396 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.52 -60.33 1.91 Allowed 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.502 1.144 . . . . 0.0 108.76 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.786 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 52.7 p -47.53 -28.06 2.07 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.764 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.637 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.29 -46.71 9.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -49.54 -19.92 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.239 -0.913 . . . . 0.0 108.883 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.645 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.83 -85.29 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.255 -0.903 . . . . 0.0 109.679 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.645 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -166.21 -150.8 6.48 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 118.912 -1.613 . . . . 0.0 110.962 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HA3' ' A' ' 15' ' ' GLY . 21.4 m-20 -106.39 107.81 19.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.565 -0.962 . . . . 0.0 110.037 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.83 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -143.48 -152.87 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.0 109.616 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 13' ' ' PRO . 7.1 mm -146.6 142.88 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 71' ' ' THR . 1.6 t -144.91 139.25 15.04 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.7 Cg_endo -75.75 91.48 1.08 Allowed 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.766 1.644 . . . . 0.0 111.025 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.849 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.9 m -59.56 138.06 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 9.9 mt-10 -131.14 66.55 1.53 Allowed 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.827 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -66.53 92.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 121.665 0.745 . . . . 0.0 110.397 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 100.11 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 64' ' ' SER . 89.4 mt -103.05 142.88 16.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.509 -0.744 . . . . 0.0 110.683 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.748 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 5.6 m-85 -115.91 138.36 51.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.924 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.9 -30.75 4.42 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.437 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 14.1 m-20 -53.23 1.5 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.809 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.7 OUTLIER 71.38 68.07 0.16 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 122.04 0.924 . . . . 0.0 109.893 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -149.47 131.24 15.05 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 6.3 p90 -108.63 104.11 13.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.049 -1.032 . . . . 0.0 110.098 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.612 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -101.5 121.02 41.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.978 -1.076 . . . . 0.0 110.201 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.95 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.21 149.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.953 -1.092 . . . . 0.0 111.283 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.1 t -169.69 84.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 138.7 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.816 ' O ' ' OG1' ' A' ' 71' ' ' THR . 14.8 mtmt -124.37 141.67 51.89 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.071 -1.451 . . . . 0.0 110.766 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.816 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 41.4 p 62.5 155.13 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.818 -0.552 . . . . 0.0 109.874 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' O ' ' OG ' ' A' ' 75' ' ' SER . 7.8 Cg_exo -42.09 175.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.406 2.071 . . . . 0.0 112.737 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 75' ' ' SER . 29.1 Cg_exo -38.43 170.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.494 1.462 . . . . 0.0 112.088 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.49 -73.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.782 ' N ' ' O ' ' A' ' 73' ' ' PRO . 21.3 p -43.42 -19.43 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.557 -0.714 . . . . 0.0 111.08 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.771 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -43.66 -41.14 4.54 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.779 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -133.2 -14.39 2.64 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.867 HD12 ' HB1' ' A' ' 74' ' ' ALA . 2.0 mt -59.19 -33.14 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.61 ' CD ' HG21 ' A' ' 71' ' ' THR . 15.0 mmt180 -54.7 -42.56 71.64 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 82' ' ' ALA . 13.8 tmtt? -66.47 -66.1 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.833 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.83 -4.75 0.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.485 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.642 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.33 -79.7 0.23 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.437 -0.79 . . . . 0.0 111.694 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.602 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 167.08 45.09 0.02 OUTLIER Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.195 -1.479 . . . . 0.0 110.574 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.526 HD11 HH11 ' A' ' 79' ' ' ARG . 4.4 mt -99.47 105.84 17.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.913 -1.346 . . . . 0.0 109.248 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.657 ' O ' ' N ' ' A' ' 87' ' ' GLY . 5.3 tm-20 -178.07 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 109.512 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.631 ' N ' ' CD ' ' A' ' 85' ' ' GLU . 24.0 tptp 46.28 -85.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 0.0 109.483 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 149.41 -115.02 0.7 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.53 -85.01 0.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -1.134 . . . . 0.0 109.571 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -48.04 157.95 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.952 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -95.04 156.51 37.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.95 . . . . 0.0 109.481 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.59 -55.03 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.535 1.49 . . . . 0.0 112.367 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.689 ' O ' ' N ' ' A' ' 94' ' ' GLU . . . 131.29 115.43 1.71 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER 60.75 -57.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -1.116 . . . . 0.0 109.601 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 92' ' ' GLY . 28.5 mt-10 -44.95 161.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.558 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.61 -165.02 1.28 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -0.897 . . . . 0.0 109.429 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t -126.87 165.02 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 109.669 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.94 66.38 1.04 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.802 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.93 114.87 14.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.705 ' O ' HG12 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -103.97 177.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.778 . . . . 0.0 109.356 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.782 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -117.76 153.94 32.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.012 -1.055 . . . . 0.0 109.292 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.672 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.7 t-105 -48.12 -69.36 0.12 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.421 -0.799 . . . . 0.0 110.93 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.501 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -50.2 -46.47 54.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.696 -1.252 . . . . 0.0 110.646 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.833 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -51.65 -45.07 63.22 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.041 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.872 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.3 m -72.24 -24.45 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 117.732 -1.587 . . . . 0.0 107.732 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.913 HD13 HD13 ' A' ' 120' ' ' LEU . 17.2 mt -66.91 -72.11 0.18 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' LEU . 74.4 tt0 -43.93 -43.17 6.33 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 120.932 -1.105 . . . . 0.0 108.572 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.6 mt -62.66 -31.29 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 108.651 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.819 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.39 -26.94 15.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 109.451 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.636 ' N ' ' O ' ' A' ' 105' ' ' LEU . 5.3 mtpt -58.76 -73.36 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 108.346 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' A' ' 109' ' ' LYS . 70.0 mt-30 -46.86 -25.68 0.82 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.131 -0.981 . . . . 0.0 108.815 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' A' ' 113' ' ' PRO . 27.7 tptt -72.8 -18.43 61.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.697 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -128.69 66.53 75.11 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 109.856 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -63.6 -41.25 26.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.501 1.468 . . . . 0.0 112.284 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.535 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 66.1 t0 -176.84 9.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.402 -0.811 . . . . 0.0 109.376 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 1.1 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.87 -85.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.792 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -145.45 -21.97 0.48 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.398 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.054 HG22 ' H ' ' A' ' 118' ' ' THR . 25.5 m -65.84 -164.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.526 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.054 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.6 -72.99 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.134 -0.979 . . . . 0.0 109.945 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.536 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -61.47 140.3 58.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.169 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.913 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.14 -22.15 64.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.255 1.026 . . . . 0.0 108.928 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.39 -38.07 88.87 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.48 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.525 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.42 -75.27 0.11 Allowed 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.116 -1.434 . . . . 0.0 107.907 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.596 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.5 -43.05 7.63 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.405 -1.435 . . . . 0.0 109.402 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.67 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.69 -68.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.056 -1.027 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.793 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.61 -43.02 5.48 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.688 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.9 ttm -51.61 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -0.963 . . . . 0.0 108.74 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.819 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.4 mm -48.41 -64.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.674 0.749 . . . . 0.0 109.973 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.872 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.4 -71.47 0.12 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.91 -39.39 3.67 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 126' ' ' MET . 36.6 m -56.33 -51.21 69.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.592 -1.534 . . . . 0.0 107.699 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.696 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.79 -47.66 30.75 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -46.62 -54.24 9.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.4 t -44.56 -67.82 0.25 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.624 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.9 ttp -46.64 -3.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.53 -24.02 13.77 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.696 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 27.2 t -57.47 135.07 21.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.975 -0.72 . . . . 0.0 109.387 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -112.09 164.74 12.82 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.493 ' CG1' ' HB2' ' A' ' 141' ' ' ALA . 1.8 t -80.35 140.74 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.837 HG13 ' O ' ' A' ' 139' ' ' VAL . 12.2 p -73.86 77.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.641 -0.662 . . . . 0.0 109.622 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.87 -75.9 2.15 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.597 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 58.43 55.07 5.96 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.228 -1.16 . . . . 0.0 109.361 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.597 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 3.8 Cg_endo -65.82 -164.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.654 1.569 . . . . 0.0 112.641 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -126.48 -165.04 1.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.318 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -102.58 -179.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.565 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.908 ' NZ ' ' HB2' ' A' ' 147' ' ' ALA . 30.7 tttp -155.42 170.44 21.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.512 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.58 ' N ' ' CG ' ' A' ' 145' ' ' LYS . 0.3 OUTLIER -111.73 -84.92 0.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 109.542 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.908 ' HB2' ' NZ ' ' A' ' 145' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.289 0.566 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.46 49.81 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.536 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.579 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -154.89 118.59 4.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.678 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.795 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.95 134.6 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -114.79 -24.38 3.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.241 -0.912 . . . . 0.0 108.867 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.79 113.6 9.75 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.328 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -101.61 73.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 109.128 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.783 ' HB ' HD12 ' A' ' 57' ' ' ILE . 6.0 t -49.11 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.804 0 O-C-N 120.646 -1.284 . . . . 0.0 110.472 -176.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.26 36.74 0.48 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.927 0.87 . . . . 0.0 109.017 179.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.835 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.1 mp -76.23 -174.1 2.66 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.874 0.845 . . . . 0.0 111.045 -178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.643 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.94 176.11 7.21 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.674 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -165.81 145.96 5.5 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 120.968 -1.082 . . . . 0.0 109.292 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.669 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 72.1 Cg_endo -84.94 126.71 3.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.232 1.955 . . . . 0.0 113.437 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.61 143.47 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 51.2 54.17 24.53 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.669 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 34.1 tttt 174.48 4.01 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.729 -0.865 . . . . 0.0 109.521 -178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 18' ' ' THR . . . -84.4 156.17 21.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.895 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.95 165.64 4.03 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.915 -1.115 . . . . 0.0 110.26 -178.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HD2' HG22 ' A' ' 18' ' ' THR . 6.9 Cg_exo -47.79 33.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.925 1.75 . . . . 0.0 111.943 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.895 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -142.06 54.2 3.68 Favored Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.858 . . . . 0.0 109.998 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.716 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -83.35 169.01 12.82 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.832 1.688 . . . . 0.0 112.019 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.31 -4.83 8.6 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 121.244 1.296 . . . . 0.0 111.377 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.812 HG13 ' HB3' ' A' ' 26' ' ' ALA . 19.5 t -119.34 -64.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.582 -0.698 . . . . 0.0 109.505 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.29 -97.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.803 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -55.57 -55.24 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 CA-C-N 117.817 0.808 . . . . 0.0 110.642 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.812 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -60.58 1.94 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.663 -0.648 . . . . 0.0 111.213 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.752 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.41 -58.0 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.697 -1.252 . . . . 0.0 109.411 -179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.751 ' O ' ' N ' ' A' ' 32' ' ' ALA . . . -43.12 -17.29 0.04 OUTLIER Glycine 0 N--CA 1.485 1.948 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.531 ' C ' ' O ' ' A' ' 28' ' ' GLY . 13.0 mm100 -42.63 -27.96 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.176 -1.779 . . . . 0.0 107.885 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.768 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 14.2 p-80 -66.33 54.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 89.55 -18.77 44.32 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.751 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 75.19 83.06 0.1 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -1.118 . . . . 0.0 112.09 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.599 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -153.22 67.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.952 -1.092 . . . . 0.0 109.251 177.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 29.5 mm -43.85 -67.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.728 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.0 tpt -41.1 -56.93 2.19 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.473 -1.392 . . . . 0.0 109.218 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.599 ' OE1' ' ND2' ' A' ' 33' ' ' ASN . 18.9 tt0 -44.71 -47.64 10.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.452 -1.405 . . . . 0.0 107.631 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.756 ' HB3' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -51.97 -69.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.583 1.182 . . . . 0.0 109.705 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 42' ' ' ASN . 27.8 t -65.32 -36.26 77.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.484 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 35' ' ' MET . 16.0 tttt -46.08 -62.06 1.49 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.81 -33.76 68.93 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 2.8 t80 -71.45 -78.36 0.08 Allowed 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.567 ' N ' ' O ' ' A' ' 38' ' ' VAL . 4.1 t-20 -41.23 -30.91 0.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.896 -1.127 . . . . 0.0 110.679 -177.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -70.55 -32.86 70.46 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.089 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB1' ' HZ2' ' A' ' 70' ' ' LYS . . . -90.33 -45.88 8.74 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.552 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.584 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 9.4 p -60.24 -31.16 69.93 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.45 -44.85 23.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.75 -22.45 46.94 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.685 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.55 -71.82 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.685 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 178.47 -130.04 1.5 Allowed Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.123 -1.513 . . . . 0.0 111.067 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -122.64 145.81 48.03 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -1.187 . . . . 0.0 108.85 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.078 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.93 -154.15 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.736 -1.228 . . . . 0.0 111.192 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.072 HD12 ' C ' ' A' ' 51' ' ' ALA . 1.9 mp -144.25 135.5 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 71' ' ' THR . 2.7 t -135.36 132.66 20.05 Favored Pre-proline 0 C--N 1.296 -1.75 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.92 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 8.9 Cg_endo -71.9 103.47 1.48 Allowed 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.654 1.57 . . . . 0.0 111.192 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -75.96 136.39 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.652 -1.28 . . . . 0.0 111.493 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.1 mt-10 -129.08 70.39 1.41 Allowed 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.4 mt -70.55 90.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.882 0.848 . . . . 0.0 110.07 -178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.455 ' HB ' ' HG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -70.82 95.9 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.919 HG23 ' O ' ' A' ' 64' ' ' SER . 46.4 mt -101.57 147.67 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.659 -0.651 . . . . 0.0 110.583 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.795 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.0 m-85 -115.62 142.2 47.05 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.81 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.28 -33.15 8.32 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.238 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 62' ' ' ASP . 56.4 p30 -50.8 -1.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.797 ' H ' ' C ' ' A' ' 61' ' ' ALA . 16.2 ttm180 75.25 70.75 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.048 0.928 . . . . 0.0 109.748 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.919 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -149.49 147.04 27.73 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 5.9 p90 -123.32 103.91 8.79 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.974 -1.079 . . . . 0.0 110.188 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.5 p -101.48 120.77 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.051 -1.031 . . . . 0.0 110.002 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.922 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.9 OUTLIER 170.3 147.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.952 -1.092 . . . . 0.0 111.295 177.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.6 t -168.52 97.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 122.301 1.048 . . . . 0.0 108.519 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.01 144.02 33.32 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.733 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -128.14 131.54 48.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.461 -1.399 . . . . 0.0 111.157 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.733 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER 67.75 160.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.727 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.954 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.624 ' O ' ' OG ' ' A' ' 75' ' ' SER . 14.5 Cg_exo -38.9 175.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.686 2.257 . . . . 0.0 113.193 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.732 ' O ' ' N ' ' A' ' 75' ' ' SER . 19.9 Cg_exo -44.27 171.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.566 1.511 . . . . 0.0 112.183 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.642 ' HB1' ' CD1' ' A' ' 78' ' ' ILE . . . 55.2 -76.51 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.88 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 60.2 p -43.02 -19.95 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.446 -0.784 . . . . 0.0 110.367 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.854 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 27.5 p90 -43.47 -34.48 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.854 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.38 -16.73 1.82 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.88 ' HB ' ' HA ' ' A' ' 75' ' ' SER . 6.8 mt -56.71 -31.73 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 75' ' ' SER . 9.1 mmm180 -54.43 -49.0 71.01 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.4 tmtt? -62.59 -65.74 0.64 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.708 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -56.62 -7.92 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 109.668 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.96 -78.11 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 111.519 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.852 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 147.19 68.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.333 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 83' ' ' GLY . 2.7 mt -133.05 104.57 6.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -1.18 . . . . 0.0 109.313 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 174.85 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 109.401 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.1 tptp 62.31 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.86 . . . . 0.0 109.604 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 113.57 -99.18 0.97 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' O ' ' CG ' ' A' ' 89' ' ' HIS . . . -150.62 117.3 5.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -1.142 . . . . 0.0 109.584 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER 174.98 165.12 0.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -0.9 . . . . 0.0 109.438 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -59.51 160.06 15.04 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' A' ' 93' ' ' ARG . 3.6 Cg_exo -58.14 -54.92 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.548 1.499 . . . . 0.0 112.458 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 57.0 -0.56 0.17 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.778 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 55.65 122.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -1.155 . . . . 0.0 109.467 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -147.0 -165.27 2.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.89 . . . . 0.0 109.487 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -119.67 -164.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.53 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.456 HG13 HD22 ' A' ' 84' ' ' LEU . 86.0 t -151.56 146.12 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.888 . . . . 0.0 109.498 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.899 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 72.03 76.45 0.61 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.597 ' O ' ' O ' ' A' ' 82' ' ' ALA . 14.9 ttm180 -135.36 106.23 6.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -1.144 . . . . 0.0 109.798 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.3 -177.49 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 109.884 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.805 ' HA ' HG12 ' A' ' 139' ' ' VAL . 0.5 OUTLIER -120.95 151.68 39.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.261 -0.899 . . . . 0.0 108.94 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.705 ' O ' HG22 ' A' ' 104' ' ' VAL . 31.9 t-105 -48.28 -67.45 0.27 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 110.561 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.563 ' OE2' ' OE1' ' A' ' 106' ' ' GLU . 7.4 tp10 -50.5 -48.29 56.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.682 -1.261 . . . . 0.0 110.728 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.708 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.6 OUTLIER -50.61 -44.01 56.94 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.946 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -72.02 -25.13 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 117.719 -1.593 . . . . 0.0 107.462 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 120' ' ' LEU . 21.9 mt -66.26 -72.59 0.16 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.563 ' OE1' ' OE2' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -44.31 -43.29 7.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.089 -1.007 . . . . 0.0 108.802 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.822 HG12 HD11 ' A' ' 77' ' ' LEU . 60.2 mt -63.51 -31.29 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.054 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.75 -30.62 13.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.292 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.681 ' N ' ' O ' ' A' ' 105' ' ' LEU . 17.4 mtpt -54.73 -72.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 108.646 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 109' ' ' LYS . 6.8 tt0 -45.59 -31.12 1.72 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.16 -0.963 . . . . 0.0 109.032 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.513 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 2.1 tmtt? -63.99 -15.67 59.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.752 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.496 ' O ' ' CG ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -128.63 70.78 80.54 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.939 -1.101 . . . . 0.0 109.71 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.66 -39.29 21.38 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.565 1.51 . . . . 0.0 112.15 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.56 ' O ' ' OD1' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -178.21 10.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.237 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -48.24 -82.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.905 . . . . 0.0 109.582 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -151.37 -22.97 0.2 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.07 HG22 ' H ' ' A' ' 118' ' ' THR . 27.0 m -59.95 -164.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.117 -0.989 . . . . 0.0 109.546 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.07 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -176.0 -70.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.862 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.551 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -65.28 137.5 57.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -59.21 -21.41 59.45 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.277 1.037 . . . . 0.0 108.746 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -65.69 -34.29 77.85 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.589 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.524 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.56 -76.23 0.12 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.464 -1.398 . . . . 0.0 107.935 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.599 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.64 -39.08 4.75 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.439 -1.413 . . . . 0.0 109.236 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.94 -67.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.06 -1.025 . . . . 0.0 108.535 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 129' ' ' GLY . 12.9 ttt180 -43.36 -36.74 2.01 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.623 ' O ' ' N ' ' A' ' 130' ' ' SER . 7.3 ttm -57.24 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.228 -0.92 . . . . 0.0 108.886 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 30.0 mm -48.63 -57.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.473 -0.767 . . . . 0.0 110.199 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.681 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -66.62 -70.28 0.26 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -42.42 5.04 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.732 ' OG ' ' O ' ' A' ' 127' ' ' ILE . 54.7 p -52.86 -50.0 64.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.512 -1.581 . . . . 0.0 107.152 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.752 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.2 -48.62 45.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.559 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -44.77 -51.67 9.17 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.1 t -50.57 -68.81 0.14 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.534 ' SD ' ' HB3' ' A' ' 75' ' ' SER . 5.5 ttp -44.95 -4.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.713 -0.617 . . . . 0.0 110.407 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.4 25.47 47.3 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.899 HG22 ' HA3' ' A' ' 97' ' ' GLY . 28.9 t -107.71 165.52 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.858 -0.79 . . . . 0.0 109.233 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . 5.1 tt0 -139.53 162.64 34.58 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.795 -1.162 . . . . 0.0 109.989 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.65 ' C ' ' H ' ' A' ' 140' ' ' GLY . 1.8 t -79.07 117.73 25.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.805 HG12 ' HA ' ' A' ' 100' ' ' THR . 7.0 p -49.86 -0.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.823 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.65 ' H ' ' C ' ' A' ' 138' ' ' VAL . . . -140.58 -111.42 0.91 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.442 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 45.18 64.1 8.21 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.293 -1.122 . . . . 0.0 109.343 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.5 Cg_endo -61.47 -168.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.784 1.656 . . . . 0.0 112.464 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 144' ' ' VAL . 23.8 tt0 -178.49 104.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -157.94 167.0 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 0.0 109.501 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 146' ' ' ASP . 19.4 tptm -177.14 148.39 0.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.902 . . . . 0.0 109.461 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.471 ' C ' ' OD1' ' A' ' 146' ' ' ASP . 29.1 t0 -166.19 72.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 109.47 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.403 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -161.22 111.68 1.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.511 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 2.8 ttmp? -177.85 125.06 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.582 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -44.7 140.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.918 . . . . 0.0 108.804 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.998 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -122.59 -24.91 2.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.148 -0.97 . . . . 0.0 110.093 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.41 107.38 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.412 -1.315 . . . . 0.0 110.758 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.62 74.31 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.827 ' HB ' HD12 ' A' ' 57' ' ' ILE . 25.1 t -48.73 88.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.956 -1.09 . . . . 0.0 110.876 -176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.7 tmtm? -82.38 37.05 0.49 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.715 0.769 . . . . 0.0 109.315 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.127 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -80.09 -174.07 4.29 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.721 0.772 . . . . 0.0 111.461 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.827 HE21 ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -123.93 174.77 7.35 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.804 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -172.78 161.75 3.84 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.704 -1.247 . . . . 0.0 110.098 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.804 ' HD2' HD23 ' A' ' 12' ' ' LEU . 9.5 Cg_endo -62.2 126.6 18.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 121.904 1.736 . . . . 0.0 111.668 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.82 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -88.1 42.21 1.05 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.035 -1.041 . . . . 0.0 111.332 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.579 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 174.81 -12.12 0.03 OUTLIER Glycine 0 N--CA 1.493 2.434 0 C-N-CA 118.906 -1.616 . . . . 0.0 110.832 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -143.26 73.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.801 -1.411 . . . . 0.0 109.622 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.653 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -93.2 169.66 10.23 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.193 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.764 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -175.31 162.45 2.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.021 -1.049 . . . . 0.0 109.693 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.1 Cg_exo -53.97 31.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.581 1.521 . . . . 0.0 111.33 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.764 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -147.38 54.03 1.8 Allowed Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.102 -0.999 . . . . 0.0 110.083 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.738 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 20.3 Cg_endo -85.06 157.83 11.42 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.746 1.631 . . . . 0.0 111.522 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.466 ' HG2' HE22 ' A' ' 11' ' ' GLN . 3.5 Cg_exo -52.75 -4.52 0.15 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 120.939 1.093 . . . . 0.0 110.846 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.127 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -105.08 -72.08 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 CA-C-O 121.623 0.725 . . . . 0.0 110.296 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.65 -98.33 0.05 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.4 Cg_endo -59.89 -55.39 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 CA-C-N 118.004 0.902 . . . . 0.0 109.959 176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -43.8 -11.98 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.266 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.861 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -113.25 -38.73 4.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.686 -1.259 . . . . 0.0 108.114 179.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.38 96.13 0.01 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 27' ' ' LEU . 41.2 tt0 -162.94 -22.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.688 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 0.6 OUTLIER -83.84 65.55 8.65 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.679 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 80.54 -5.99 62.64 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.37 83.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -1.18 . . . . 0.0 112.021 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 33.2 m120 -159.32 124.85 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.903 -1.123 . . . . 0.0 108.905 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.565 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 20.8 mm -101.22 -62.1 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 0.0 109.858 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.663 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.49 -47.52 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 109.749 -176.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -55.75 -48.74 74.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.825 -1.172 . . . . 0.0 107.845 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.861 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -49.79 -63.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.612 1.196 . . . . 0.0 108.818 178.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.653 HG13 ' CB ' ' A' ' 17' ' ' ALA . 98.0 t -68.55 -30.15 46.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.194 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 35' ' ' MET . 36.0 tptt -54.83 -54.57 40.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.06 76.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.152 -0.967 . . . . 0.0 109.634 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.532 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.0 OUTLIER -67.76 -75.5 0.1 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.231 -1.543 . . . . 0.0 106.896 176.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.645 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.7 m-20 -41.5 -38.26 1.26 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.117 -0.99 . . . . 0.0 110.735 -177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -61.53 -33.71 74.28 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.712 ' HB1' ' NZ ' ' A' ' 70' ' ' LYS . . . -91.13 -57.77 2.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.784 -1.166 . . . . 0.0 108.591 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.802 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 40.0 p -50.75 -26.82 6.07 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.766 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.645 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -87.12 -45.86 10.3 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -52.7 -18.94 2.05 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 0.0 108.886 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.48 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -107.41 -85.31 0.51 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 14' ' ' ALA . . . -168.15 -150.47 6.6 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 118.89 -1.624 . . . . 0.0 110.794 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -105.62 107.43 18.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.492 -1.005 . . . . 0.0 109.976 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.82 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -144.15 -152.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.854 . . . . 0.0 109.611 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 13' ' ' PRO . 7.8 mm -146.04 143.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 14' ' ' ALA . 2.2 t -143.6 137.18 14.24 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.128 -0.983 . . . . 0.0 110.497 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.7 Cg_endo -74.53 91.61 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.841 1.694 . . . . 0.0 110.628 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.881 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -60.09 136.53 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 122.706 1.241 . . . . 0.0 111.662 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 30.4 tt0 -130.6 69.51 1.46 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.827 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.3 mt -71.08 90.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.719 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.73 96.02 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.1 mt -97.15 135.81 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.446 -0.784 . . . . 0.0 110.865 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.594 ' CE2' ' N ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -111.7 136.01 51.52 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.998 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -46.63 -32.94 3.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.742 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 56.0 m-20 -51.3 -2.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.789 ' H ' ' C ' ' A' ' 61' ' ' ALA . 9.7 ttm180 75.11 68.59 0.08 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.072 0.939 . . . . 0.0 109.74 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 10.4 m -149.72 124.97 10.13 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.717 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -102.9 103.98 14.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.157 -0.964 . . . . 0.0 110.009 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.626 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.7 p -100.55 120.51 40.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.969 -1.082 . . . . 0.0 109.911 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.941 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 169.94 150.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.042 -1.036 . . . . 0.0 110.956 177.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 67' ' ' PHE . 30.6 t -169.45 78.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -84.14 148.97 26.48 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.766 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.1 mttm -136.46 134.1 37.3 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 117.532 -1.667 . . . . 0.0 110.906 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.766 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.3 p 75.34 150.75 0.13 Allowed Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.646 ' HD3' ' HB1' ' A' ' 51' ' ' ALA . 7.1 Cg_exo -43.4 175.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.46 2.106 . . . . 0.0 113.149 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.805 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.0 Cg_exo -41.98 177.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.74 1.627 . . . . 0.0 112.007 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 76' ' ' TYR . . . 44.91 -84.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.805 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -43.96 -15.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 109.614 179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.948 ' CE1' HD12 ' A' ' 77' ' ' LEU . 21.1 p90 -44.15 -35.67 2.3 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.218 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -139.71 -14.86 1.06 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.218 ' N ' HD13 ' A' ' 77' ' ' LEU . 2.0 mt -63.1 -33.25 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.578 ' HG3' HG21 ' A' ' 71' ' ' THR . 1.6 mmt180 -55.44 -44.88 76.73 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 82' ' ' ALA . 2.1 tmtp? -61.54 -65.48 0.68 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.487 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -59.61 -6.13 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.008 -1.077 . . . . 0.0 109.475 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.641 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -82.24 -81.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.45 -0.781 . . . . 0.0 111.555 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.17 34.39 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.549 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.574 HD11 ' CD ' ' A' ' 79' ' ' ARG . 3.5 mt -91.38 104.7 17.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.884 -1.363 . . . . 0.0 109.031 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.677 ' OE1' ' N ' ' A' ' 86' ' ' LYS . 4.6 tm-20 174.83 -70.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.677 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 13.1 tptm 59.31 -85.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 109.559 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' ALA . . . 48.88 87.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 87' ' ' GLY . . . 174.99 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -1.179 . . . . 0.0 109.448 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.595 ' CG ' ' H ' ' A' ' 90' ' ' LYS . 11.2 t60 -126.26 -171.49 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.434 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.595 ' H ' ' CG ' ' A' ' 89' ' ' HIS . 5.6 mptp? -60.77 159.59 25.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.415 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.55 -55.04 2.34 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.578 1.519 . . . . 0.0 112.379 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.83 108.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 57.5 -164.97 0.16 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -1.137 . . . . 0.0 109.513 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -111.41 118.45 35.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.477 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.499 ' O ' ' CG2' ' A' ' 96' ' ' VAL . 8.7 mtpp -152.14 82.62 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.186 -0.946 . . . . 0.0 109.527 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 97' ' ' GLY . 94.8 t -158.3 165.04 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.593 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 72.16 60.26 4.23 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 82' ' ' ALA . 1.4 ttt180 -132.03 117.03 17.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -1.182 . . . . 0.0 110.117 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.47 -169.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.457 -0.777 . . . . 0.0 109.033 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.724 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.12 163.26 28.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.097 179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.686 ' O ' HG22 ' A' ' 104' ' ' VAL . 23.8 t-105 -53.45 -69.5 0.12 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 110.643 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 7.4 tp10 -51.03 -45.31 61.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.527 -1.358 . . . . 0.0 110.427 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.487 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -51.3 -45.89 62.35 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.782 -179.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.5 -22.78 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.774 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.75 HD13 HD13 ' A' ' 120' ' ' LEU . 17.7 mt -68.01 -72.49 0.17 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 105' ' ' LEU . 76.3 tt0 -43.83 -43.95 6.55 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.889 -1.132 . . . . 0.0 108.508 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.724 HG12 HD21 ' A' ' 77' ' ' LEU . 62.9 mt -61.77 -31.11 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.162 -0.961 . . . . 0.0 108.46 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.823 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.69 -20.85 17.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.462 -0.774 . . . . 0.0 109.481 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 105' ' ' LEU . 26.0 mttm -62.49 -74.33 0.09 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.852 -1.155 . . . . 0.0 108.167 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.464 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 56.7 mt-30 -50.48 -20.27 1.1 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.385 -0.822 . . . . 0.0 109.375 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.585 ' HD3' HD11 ' A' ' 127' ' ' ILE . 17.7 tttt -69.4 -4.97 20.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -0.917 . . . . 0.0 110.042 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.586 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -135.69 63.09 51.71 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.903 -1.123 . . . . 0.0 109.715 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 112' ' ' MET . 5.1 Cg_endo -71.3 -30.79 15.19 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.572 1.515 . . . . 0.0 111.883 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -166.84 4.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.9 mp -44.84 -85.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -171.96 -5.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.364 -0.835 . . . . 0.0 109.206 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.033 HG22 ' H ' ' A' ' 118' ' ' THR . 29.6 m -75.43 -164.39 0.33 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.033 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.81 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.691 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -94.82 130.56 41.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 110.109 -179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.75 HD13 HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -58.9 -35.02 72.35 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.418 1.104 . . . . 0.0 108.648 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 50.7 mp0 -62.75 -33.5 75.28 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.467 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.456 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -73.3 -74.25 0.18 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.586 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -45.23 -37.45 4.64 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.489 -1.382 . . . . 0.0 109.019 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -56.65 -69.48 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 108.847 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.646 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.6 OUTLIER -43.38 -35.95 1.74 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.669 ' O ' ' CB ' ' A' ' 130' ' ' SER . 6.0 ttm -56.13 -76.64 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.823 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.9 mm -48.82 -63.48 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.751 . . . . 0.0 109.689 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.12 -72.26 0.11 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.49 -41.16 4.02 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.669 ' CB ' ' O ' ' A' ' 126' ' ' MET . 60.2 m -57.91 -47.87 81.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.547 -1.561 . . . . 0.0 107.443 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.538 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.25 -49.72 42.05 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.794 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -45.71 -55.09 6.89 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.669 ' C ' ' H ' ' A' ' 135' ' ' GLY . 8.5 t -44.67 -67.45 0.28 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.499 ' CE ' ' HB2' ' A' ' 75' ' ' SER . 0.6 OUTLIER -47.4 -4.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.669 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 89.55 -31.11 5.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 137' ' ' GLU . 41.3 t -45.02 165.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.909 -0.759 . . . . 0.0 108.972 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.57 ' N ' HG12 ' A' ' 136' ' ' VAL . 81.0 tt0 -142.25 162.73 34.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.633 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.8 t -83.26 137.68 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.677 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.2 p -92.61 -5.95 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.455 -0.778 . . . . 0.0 109.533 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -125.72 -129.56 3.35 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 50.86 70.97 1.69 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.231 -1.158 . . . . 0.0 109.585 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.84 -164.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.668 1.579 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.625 ' O ' HG13 ' A' ' 144' ' ' VAL . 57.1 tt0 -157.47 160.38 38.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.518 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 143' ' ' GLU . 1.9 m -159.63 158.35 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.528 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -139.86 156.08 46.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.912 . . . . 0.0 109.451 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.03 109.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.574 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.459 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.446 ' O ' ' CD ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -159.07 109.83 2.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.618 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.528 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 1.3 tptm 177.52 121.41 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.443 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.753 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.79 137.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.926 . . . . 0.0 109.417 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.6 m -115.67 -24.51 3.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.44 110.18 6.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.344 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.16 73.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 57' ' ' ILE . 35.4 t -48.52 88.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.542 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.6 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -82.93 36.47 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.819 0.819 . . . . 0.0 109.324 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.016 HD22 HG22 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -77.91 -174.12 3.41 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.432 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.669 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -121.35 172.49 7.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.803 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -169.04 161.05 8.0 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.086 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.803 ' HD2' HD23 ' A' ' 12' ' ' LEU . 13.8 Cg_endo -66.95 109.61 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.065 1.844 . . . . 0.0 111.316 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.829 ' HB3' ' C ' ' A' ' 51' ' ' ALA . . . -67.64 41.08 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.081 -1.012 . . . . 0.0 110.856 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.491 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 176.6 -14.15 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.515 -1.802 . . . . 0.0 111.522 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 13' ' ' PRO . 17.0 tttt -138.25 56.83 1.72 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.481 -1.6 . . . . 0.0 110.557 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.711 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -75.32 160.03 30.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.669 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.41 162.37 23.72 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 120.681 -1.262 . . . . 0.0 110.981 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.551 ' HD2' HG22 ' A' ' 18' ' ' THR . 1.2 Cg_endo -57.05 38.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.087 1.858 . . . . 0.0 111.847 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.669 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -173.06 56.77 0.21 Allowed Pre-proline 0 N--CA 1.49 1.558 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.53 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.653 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.8 Cg_endo -79.76 169.02 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 121.467 1.444 . . . . 0.0 111.382 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -52.08 -4.68 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.071 1.181 . . . . 0.0 110.922 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.016 HG22 HD22 ' A' ' 10' ' ' LEU . 2.0 t -106.85 -72.04 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.582 0.706 . . . . 0.0 110.256 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.35 -98.01 0.05 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.743 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.59 -55.65 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 CA-C-N 118.088 0.944 . . . . 0.0 110.055 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.647 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.79 -10.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.83 -0.544 . . . . 0.0 110.243 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.839 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.75 -44.11 3.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.859 -1.151 . . . . 0.0 108.815 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.62 96.38 0.01 OUTLIER Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 27' ' ' LEU . 10.6 tt0 -159.49 -26.68 0.07 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.717 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 5.4 p80 -78.74 64.17 3.67 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.7 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.661 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 81.82 -7.84 61.44 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.26 83.43 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -1.126 . . . . 0.0 112.097 177.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -157.97 123.69 4.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.959 -1.088 . . . . 0.0 108.676 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 19.8 mm -97.55 -63.71 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.593 -0.692 . . . . 0.0 110.049 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.614 ' O ' ' N ' ' A' ' 39' ' ' LYS . 2.0 tpt -41.29 -51.64 3.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.768 -1.208 . . . . 0.0 109.989 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.57 -48.39 57.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.667 -1.271 . . . . 0.0 108.007 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.839 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -51.81 -65.83 0.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.535 1.16 . . . . 0.0 109.353 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.711 HG13 ' CB ' ' A' ' 17' ' ' ALA . 67.8 t -65.49 -30.03 48.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.915 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.4 OUTLIER -55.67 -56.1 24.38 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.14 77.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 109.608 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.607 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.9 t80 -69.49 -76.77 0.09 Allowed 'General case' 0 C--N 1.308 -1.23 0 O-C-N 120.341 -1.474 . . . . 0.0 107.155 177.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 9.8 t-20 -41.66 -32.36 0.37 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.971 -1.081 . . . . 0.0 110.734 -177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -67.84 -34.08 76.02 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HB1' ' HD3' ' A' ' 70' ' ' LYS . . . -90.45 -53.39 4.46 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.603 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.774 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 27.9 p -53.51 -30.38 41.06 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.6 -45.2 16.16 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -54.15 -21.77 9.56 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.154 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.702 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -108.79 -85.0 0.54 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.241 -0.912 . . . . 0.0 109.69 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.702 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -165.91 -149.8 6.05 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.896 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 2.2 t0 -110.15 120.2 41.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -1.142 . . . . 0.0 109.902 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.829 ' C ' ' HB3' ' A' ' 14' ' ' ALA . . . -153.72 -152.6 0.42 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 109.97 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 13' ' ' PRO . 6.0 mm -146.53 142.7 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 14' ' ' ALA . 4.6 t -146.44 138.53 13.59 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 110.302 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.5 Cg_endo -73.93 93.06 0.87 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.75 1.633 . . . . 0.0 111.258 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.866 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.3 m -60.35 137.93 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.722 -1.236 . . . . 0.0 111.689 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 18.7 mt-10 -129.68 68.55 1.43 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.75 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.0 mt -68.93 93.09 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 121.859 0.838 . . . . 0.0 110.585 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.0 99.88 0.91 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 57' ' ' ILE . 47.9 mt -104.46 145.08 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.537 -0.727 . . . . 0.0 110.756 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.753 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.2 m-85 -116.46 140.67 49.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.781 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.61 -33.08 6.21 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.304 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -1.55 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.781 ' H ' ' C ' ' A' ' 61' ' ' ALA . 36.2 mtm180 75.28 69.05 0.08 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.019 0.914 . . . . 0.0 109.727 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -148.73 148.06 29.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.669 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 39.3 p90 -125.23 103.97 8.25 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.277 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.2 p -101.6 120.92 41.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.985 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.9 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.17 146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.074 177.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 67' ' ' PHE . 31.7 t -167.57 79.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-O 122.284 1.04 . . . . 0.0 108.348 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.44 ' H ' HG22 ' A' ' 69' ' ' THR . 0.7 OUTLIER -87.03 136.79 32.79 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.625 ' O ' ' OG1' ' A' ' 71' ' ' THR . 5.1 mtmp? -121.0 140.62 51.66 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.227 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.625 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER 60.38 163.95 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.838 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 71' ' ' THR . 11.7 Cg_exo -41.08 175.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.099 1.866 . . . . 0.0 112.463 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.17 173.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.629 1.553 . . . . 0.0 112.499 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.972 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 56.79 -73.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 108.711 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -45.48 -17.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.716 . . . . 0.0 110.937 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.751 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 1.2 p90 -43.37 -38.63 2.8 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.889 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.579 HD12 ' C ' ' A' ' 77' ' ' LEU . 3.1 pp -133.65 -22.2 1.91 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.972 HD12 ' HB1' ' A' ' 74' ' ' ALA . 6.5 mt -54.95 -30.84 23.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.716 ' CD ' HD11 ' A' ' 84' ' ' LEU . 6.0 mmt180 -52.65 -57.21 10.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 82' ' ' ALA . 5.3 tmtm? -52.06 -64.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.67 -6.53 0.75 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.406 -0.918 . . . . 0.0 109.813 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.801 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -83.34 -80.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 111.837 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.89 48.89 0.01 OUTLIER Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.99 -1.576 . . . . 0.0 110.817 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.716 HD11 ' CD ' ' A' ' 79' ' ' ARG . 6.7 mt -83.95 104.82 14.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.963 -1.316 . . . . 0.0 109.003 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' C ' ' CD ' ' A' ' 86' ' ' LYS . 37.2 tt0 -143.23 -16.37 0.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.706 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 86' ' ' LYS . 7.4 mptt 59.85 40.63 19.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 109.569 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 86' ' ' LYS . . . 44.99 -158.53 0.19 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.97 -84.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -1.152 . . . . 0.0 109.541 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.457 ' O ' ' CG ' ' A' ' 89' ' ' HIS . 14.5 t-160 -146.33 67.27 1.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 109.515 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.14 161.15 40.19 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.363 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.6 -2.64 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.566 1.511 . . . . 0.0 112.464 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.19 -123.26 1.29 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.817 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.9 OUTLIER 67.17 138.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -1.111 . . . . 0.0 109.407 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -122.96 163.09 21.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 0.0 109.507 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.734 ' NZ ' ' NH2' ' A' ' 98' ' ' ARG . 0.9 OUTLIER 174.98 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.393 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.448 HG23 ' C ' ' A' ' 95' ' ' LYS . 48.6 t -154.8 150.46 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -0.954 . . . . 0.0 109.586 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.801 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 70.08 58.0 6.51 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.734 ' NH2' ' NZ ' ' A' ' 95' ' ' LYS . 4.2 tmm_? -131.5 110.08 10.74 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.172 -1.193 . . . . 0.0 110.916 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -109.15 -175.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.738 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -127.33 164.3 22.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.889 -1.132 . . . . 0.0 109.656 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.701 ' O ' HG22 ' A' ' 104' ' ' VAL . 21.1 t-105 -51.46 -71.04 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.579 -0.7 . . . . 0.0 111.152 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 3.9 tp10 -48.79 -51.12 30.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.693 -1.255 . . . . 0.0 110.884 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.41 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.1 mt-30 -49.18 -44.48 42.98 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.34 -0.85 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.885 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.48 -25.09 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.518 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 120' ' ' LEU . 18.2 mt -66.87 -71.8 0.19 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.478 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 46.7 mt-10 -43.81 -43.08 6.0 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 120.922 -1.111 . . . . 0.0 108.465 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' A' ' 77' ' ' LEU . 57.9 mt -62.76 -30.71 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 119.281 -0.968 . . . . 0.0 108.433 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.803 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -95.63 -25.78 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 109.497 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 105' ' ' LEU . 8.4 mtpt -59.28 -73.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.919 -1.113 . . . . 0.0 108.362 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 110' ' ' GLN . 0.3 OUTLIER -45.35 -28.41 0.85 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.092 -1.005 . . . . 0.0 108.922 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.451 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 12.0 tttm -69.09 -19.28 64.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.826 . . . . 0.0 109.863 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.694 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -129.65 68.9 81.13 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.092 -1.005 . . . . 0.0 109.884 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.45 -34.18 27.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.495 1.463 . . . . 0.0 112.072 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.532 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 3.5 t70 175.02 12.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.0 mm? -50.43 -77.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -149.83 -24.97 0.27 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.5 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.058 HG22 ' H ' ' A' ' 118' ' ' THR . 23.6 m -64.57 -164.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 0.0 109.579 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.058 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.61 -74.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.251 -0.905 . . . . 0.0 109.935 -179.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 118' ' ' THR . 1.3 m-20 -61.09 141.09 57.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.95 -22.72 65.87 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.243 1.021 . . . . 0.0 109.011 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.93 -38.41 90.89 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.526 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.47 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -68.92 -74.92 0.12 Allowed 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 118.2 -1.4 . . . . 0.0 107.944 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.576 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.56 -43.08 7.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.46 -1.4 . . . . 0.0 109.28 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.12 -69.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 108.608 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HG3' HH11 ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.58 -41.81 4.76 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.709 ' O ' ' N ' ' A' ' 130' ' ' SER . 12.0 ttm -52.32 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.187 -0.946 . . . . 0.0 108.643 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.803 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 20.5 mm -48.03 -64.76 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.424 -0.798 . . . . 0.0 109.848 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.885 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.23 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.97 -41.75 4.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.709 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.6 m -54.91 -48.6 72.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.536 -1.567 . . . . 0.0 107.699 178.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 136' ' ' VAL . . . -50.01 -47.71 52.92 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.672 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.8 tmt_? -45.68 -53.5 9.25 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.631 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.4 t -44.89 -67.59 0.27 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.649 ' SD ' HG23 ' A' ' 136' ' ' VAL . 10.7 ttm -49.42 -3.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 132' ' ' ARG . . . 89.64 -27.26 8.1 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.649 HG23 ' SD ' ' A' ' 134' ' ' MET . 52.7 t -48.17 165.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.847 -0.796 . . . . 0.0 109.208 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.583 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -142.52 162.62 35.0 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.711 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.2 164.19 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 139' ' ' VAL . 1.3 p -134.19 58.01 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 165.58 -115.73 0.65 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.511 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.7 60.17 12.93 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.237 -1.155 . . . . 0.0 109.173 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.56 ' O ' ' CG ' ' A' ' 143' ' ' GLU . 2.1 Cg_endo -61.26 165.81 12.14 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.838 1.692 . . . . 0.0 112.773 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.56 ' CG ' ' O ' ' A' ' 142' ' ' PRO . 27.1 mt-10 -165.72 98.82 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.33 -0.857 . . . . 0.0 109.233 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.3 m -127.05 -174.41 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.737 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' CG ' ' N ' ' A' ' 146' ' ' ASP . 12.5 ttpt -175.61 159.81 2.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.355 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.684 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 21.5 m-20 -131.47 -85.05 0.5 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.463 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -175.63 96.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.94 . . . . 0.0 109.588 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 4' ' ' VAL . 1.2 mppt? -141.72 115.49 9.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.599 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.758 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p -44.84 133.13 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.078 -1.014 . . . . 0.0 109.187 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.812 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.3 m -117.79 -24.59 3.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.261 -0.9 . . . . 0.0 109.224 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.24 111.22 6.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.385 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -100.37 73.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.779 ' HB ' HD12 ' A' ' 57' ' ' ILE . 6.1 t -49.12 88.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.611 -1.305 . . . . 0.0 110.715 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtt? -82.04 37.24 0.48 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.843 0.83 . . . . 0.0 109.054 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.855 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.4 mp -76.8 -174.2 2.95 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.817 0.818 . . . . 0.0 111.137 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.626 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -125.87 175.34 7.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.025 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.66 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -169.81 158.46 6.67 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.886 -1.134 . . . . 0.0 109.993 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.674 ' O ' ' N ' ' A' ' 15' ' ' GLY . 11.5 Cg_endo -68.01 104.95 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.935 1.757 . . . . 0.0 111.417 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.812 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -60.94 38.72 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.144 -1.023 . . . . 0.0 110.34 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -172.5 -18.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.526 -1.797 . . . . 0.0 111.3 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -148.38 78.99 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.507 -1.584 . . . . 0.0 110.673 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.733 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -94.24 170.25 9.64 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.778 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -172.36 164.52 3.94 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.773 -1.204 . . . . 0.0 110.487 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.4 Cg_exo -51.97 32.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.048 1.832 . . . . 0.0 112.066 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.778 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -138.2 53.93 6.56 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 0.0 110.415 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.717 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 28.5 Cg_endo -86.36 162.39 9.74 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.83 1.687 . . . . 0.0 111.712 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.56 -4.89 2.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 121.079 1.186 . . . . 0.0 111.34 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.813 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 21.5 t -118.71 -66.51 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.601 -0.687 . . . . 0.0 109.444 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 56.44 -97.16 0.05 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.813 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 4.7 Cg_exo -53.96 -55.1 3.76 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 CA-C-N 117.816 0.808 . . . . 0.0 110.585 177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.797 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -64.96 5.5 0.33 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.544 -0.723 . . . . 0.0 111.182 -178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.744 ' N ' HG12 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -109.64 -65.17 1.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.668 -1.27 . . . . 0.0 109.855 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.69 -16.33 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 27' ' ' LEU . 83.5 mt-30 -41.98 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.45 -1.618 . . . . 0.0 109.571 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.68 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -64.67 -45.37 87.0 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.249 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.678 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -163.92 -3.53 0.04 OUTLIER Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 28' ' ' GLY . . . 69.76 76.64 0.21 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 122.187 -0.596 . . . . 0.0 111.756 177.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 34' ' ' ILE . 1.1 m120 -152.41 63.61 0.82 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 122.291 1.043 . . . . 0.0 108.416 177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 37' ' ' PHE . 26.7 mm -43.01 -66.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.651 ' O ' ' CG ' ' A' ' 39' ' ' LYS . 4.3 tpt -41.43 -37.54 1.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.695 -1.253 . . . . 0.0 108.67 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.13 -49.13 75.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.711 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -50.38 -66.37 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.842 1.306 . . . . 0.0 109.252 177.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.733 HG13 ' HB3' ' A' ' 17' ' ' ALA . 24.4 t -64.11 -37.65 80.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.604 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.651 ' CG ' ' O ' ' A' ' 35' ' ' MET . 5.8 mmmt -47.95 -59.93 2.98 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.82 72.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.397 -0.814 . . . . 0.0 109.364 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.576 ' CD2' HG21 ' A' ' 45' ' ' THR . 2.6 t80 -69.6 -77.42 0.08 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 5.0 m-20 -41.6 -34.86 0.64 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.398 1.094 . . . . 0.0 110.872 -177.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -65.82 -34.15 77.49 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.497 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.599 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.29 -53.72 4.33 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.393 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 21.4 p -52.47 -27.54 16.63 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -82.65 -46.06 13.73 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.677 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -54.67 -21.22 10.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.692 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.03 -85.2 0.54 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 0.0 109.622 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.692 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.32 -137.67 2.29 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 118.977 -1.583 . . . . 0.0 110.909 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.512 ' O ' ' CG ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -119.95 118.35 30.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -1.13 . . . . 0.0 109.971 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.812 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -153.74 -153.13 0.45 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.386 -0.821 . . . . 0.0 109.891 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.602 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.8 mm -146.67 141.8 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 14' ' ' ALA . 2.2 t -145.66 138.62 14.07 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 110.05 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.1 Cg_endo -73.93 91.0 0.93 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.85 1.7 . . . . 0.0 111.519 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.855 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.3 m -56.46 137.15 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.751 -1.218 . . . . 0.0 111.229 -178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 50.6 tt0 -129.24 70.81 1.41 Allowed 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.779 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.7 mt -71.33 89.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.831 0.824 . . . . 0.0 110.307 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.39 104.02 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 64' ' ' SER . 41.2 mt -107.64 144.44 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.509 -0.745 . . . . 0.0 110.867 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.758 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 3.5 m-85 -115.03 139.47 49.84 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.812 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -47.51 -32.89 5.7 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.24 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -51.07 -2.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.792 ' H ' ' C ' ' A' ' 61' ' ' ALA . 4.6 mtt180 75.24 70.1 0.09 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.913 0.863 . . . . 0.0 109.843 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 2.5 t -150.7 125.13 9.53 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.631 ' CD2' ' O ' ' A' ' 65' ' ' PHE . 33.2 p90 -102.14 103.87 14.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.143 -0.973 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -100.74 121.05 41.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.12 -0.987 . . . . 0.0 109.985 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.937 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.45 148.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 111.231 177.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.937 HG23 ' O ' ' A' ' 67' ' ' PHE . 28.0 t -169.3 88.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.489 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -94.74 145.07 25.12 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.237 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.8 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -129.53 118.56 22.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.536 -1.353 . . . . 0.0 110.213 179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 1.018 HG21 ' NE ' ' A' ' 79' ' ' ARG . 23.0 p 75.96 150.02 0.13 Allowed Pre-proline 0 N--CA 1.493 1.689 0 CA-C-O 121.231 0.539 . . . . 0.0 110.025 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -40.16 175.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.682 2.255 . . . . 0.0 113.113 -179.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 75' ' ' SER . 26.4 Cg_exo -39.55 171.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.52 1.48 . . . . 0.0 111.913 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.883 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.49 -80.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.778 ' N ' ' O ' ' A' ' 73' ' ' PRO . 17.7 p -43.64 -27.75 0.33 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.405 -0.809 . . . . 0.0 109.669 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.043 ' CE1' HD12 ' A' ' 77' ' ' LEU . 8.0 p90 -43.55 -38.11 2.79 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.182 HD13 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -135.27 -11.39 2.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.182 ' N ' HD13 ' A' ' 77' ' ' LEU . 2.0 mt -66.32 -29.85 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 1.018 ' NE ' HG21 ' A' ' 71' ' ' THR . 7.3 mmm180 -55.73 -40.12 72.06 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.565 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.6 tmtt? -70.78 -67.95 0.47 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.405 ' N ' ' HD3' ' A' ' 80' ' ' LYS . . . -53.82 -4.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.091 -1.006 . . . . 0.0 109.277 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.713 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -88.61 -78.21 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.562 -0.712 . . . . 0.0 112.155 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.22 55.71 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 118.873 -1.632 . . . . 0.0 110.811 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.707 ' CD1' ' CZ ' ' A' ' 79' ' ' ARG . 9.0 mt -97.78 104.63 16.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.05 -1.265 . . . . 0.0 109.097 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 0.4 OUTLIER 174.74 -75.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' NZ ' ' CD ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER 75.05 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.87 -100.06 2.52 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -171.7 136.31 0.93 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -1.155 . . . . 0.0 109.539 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -177.28 -69.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.461 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -68.91 160.55 77.45 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.891 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.451 ' HG2' ' NH2' ' A' ' 93' ' ' ARG . 5.1 Cg_exo -57.45 -18.61 32.37 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.529 1.486 . . . . 0.0 112.418 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 152.38 -173.63 31.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.536 ' O ' ' CD ' ' A' ' 94' ' ' GLU . 16.9 mtm180 60.2 115.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -1.106 . . . . 0.0 109.486 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.536 ' CD ' ' O ' ' A' ' 93' ' ' ARG . 13.4 mm-40 -145.26 -168.2 2.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.608 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' C ' HG23 ' A' ' 96' ' ' VAL . 40.2 mttp -143.35 -174.66 4.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 97' ' ' GLY . 24.6 t -153.08 164.46 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.913 . . . . 0.0 109.606 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.814 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 65.15 73.44 0.59 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.821 ' HG3' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -133.34 105.31 6.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.128 -1.219 . . . . 0.0 110.979 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.669 HD12 ' CG1' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -105.72 -167.36 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.406 -0.808 . . . . 0.0 109.027 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.761 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -137.7 159.61 41.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.06 -1.025 . . . . 0.0 108.88 178.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.685 ' O ' HG22 ' A' ' 104' ' ' VAL . 17.8 t-105 -47.6 -71.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 110.801 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.465 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.6 tp10 -50.77 -49.21 58.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.526 -1.359 . . . . 0.0 110.895 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.603 ' O ' ' CG1' ' A' ' 107' ' ' ILE . 4.2 mt-30 -51.11 -43.7 61.16 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.349 -0.844 . . . . 0.0 110.23 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 100' ' ' THR . 2.4 m -70.9 -25.3 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.723 -1.591 . . . . 0.0 107.521 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 120' ' ' LEU . 18.1 mt -65.7 -71.54 0.19 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -44.41 -42.36 6.89 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.854 -1.154 . . . . 0.0 108.185 178.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.093 ' CD1' HD21 ' A' ' 77' ' ' LEU . 1.8 mm -60.85 -33.28 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.82 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -98.88 -23.14 15.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.439 -0.788 . . . . 0.0 109.335 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.673 ' N ' ' O ' ' A' ' 105' ' ' LEU . 6.6 mttt -57.03 -72.34 0.08 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -48.75 -34.06 11.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.442 -0.786 . . . . 0.0 109.592 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 112' ' ' MET . 1.2 mptp? -80.06 64.43 4.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.977 . . . . 0.0 110.222 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.584 ' HA ' HD11 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 175.02 55.54 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.315 -0.866 . . . . 0.0 109.217 178.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.553 ' HD3' ' H ' ' A' ' 112' ' ' MET . 1.3 Cg_endo -62.38 -55.05 1.05 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.545 1.497 . . . . 0.0 112.346 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 115' ' ' LEU . 1.5 m-20 -163.53 11.46 0.05 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.356 -0.84 . . . . 0.0 109.164 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 1.077 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -44.79 -85.31 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.613 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -155.43 10.68 0.31 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.398 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.0 HG22 ' H ' ' A' ' 118' ' ' THR . 41.6 m -104.34 -164.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.739 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.0 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 179.25 -55.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.199 -0.938 . . . . 0.0 110.007 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.491 ' H ' HG23 ' A' ' 118' ' ' THR . 3.7 m-20 -74.76 142.92 44.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 0.0 110.342 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -58.77 -33.15 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.221 1.01 . . . . 0.0 109.424 179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -60.46 -37.63 81.61 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.045 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -71.06 -72.72 0.2 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.872 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.493 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -46.16 -37.93 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.523 -1.361 . . . . 0.0 109.089 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -56.0 -71.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.042 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.615 ' O ' ' N ' ' A' ' 129' ' ' GLY . 47.6 ttt180 -43.32 -34.83 1.31 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.683 ' O ' ' N ' ' A' ' 130' ' ' SER . 15.1 ttm -56.2 -76.88 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.82 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 17.4 mm -48.37 -63.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.772 . . . . 0.0 109.785 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.57 -71.73 0.12 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.78 -42.66 4.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 126' ' ' MET . 57.9 m -55.49 -50.27 70.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.591 -1.535 . . . . 0.0 107.5 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.819 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.66 -48.72 28.8 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.2 tmt_? -44.82 -54.9 5.87 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.661 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.2 t -46.71 -69.26 0.14 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.606 ' HG2' HG23 ' A' ' 136' ' ' VAL . 7.6 ttp -45.07 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.622 -0.674 . . . . 0.0 110.639 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.06 8.62 75.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.819 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.2 t -88.5 165.31 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.3 tp10 -142.78 163.02 33.95 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.137 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.67 153.42 4.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 99' ' ' ILE . 1.3 p -118.2 -8.31 11.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.252 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -122.17 -115.94 2.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.472 ' N ' ' HB2' ' A' ' 101' ' ' TRP . . . 44.84 62.4 10.36 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.16 -1.2 . . . . 0.0 109.384 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 2.7 Cg_endo -60.73 177.81 0.59 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 121.688 1.592 . . . . 0.0 112.551 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -112.97 144.46 42.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 109.405 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.54 165.18 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.479 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -162.31 -14.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.89 . . . . 0.0 109.531 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -70.81 119.3 14.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.483 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.02 147.48 50.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 109.464 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.741 ' O ' ' CE2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER 174.88 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.491 ' HA ' ' CE1' ' A' ' 60' ' ' TYR . 1.8 p -82.03 156.67 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.24 -0.912 . . . . 0.0 108.911 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.028 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -119.97 -24.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.063 -1.023 . . . . 0.0 109.621 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 59' ' ' ILE . . . -154.32 101.31 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.316 -1.353 . . . . 0.0 110.635 178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -92.36 73.86 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.773 ' HB ' HD12 ' A' ' 57' ' ' ILE . 24.4 t -45.53 88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 118.573 -1.251 . . . . 0.0 110.215 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.657 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -84.29 34.44 0.52 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.923 0.868 . . . . 0.0 109.019 179.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.908 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.52 -174.72 3.96 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.948 0.88 . . . . 0.0 111.381 -178.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.561 ' O ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -117.19 169.41 9.48 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -163.0 144.59 7.75 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 120.544 -1.347 . . . . 0.0 110.16 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.64 ' HA ' HD13 ' A' ' 52' ' ' ILE . 36.5 Cg_endo -80.5 127.91 6.73 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.426 2.084 . . . . 0.0 113.97 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.084 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.83 141.34 47.99 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.713 ' C ' ' H ' ' A' ' 17' ' ' ALA . . . 61.41 -60.42 0.02 OUTLIER Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.13 -1.988 . . . . 0.0 108.13 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 14' ' ' ALA . 11.8 mtpp -60.46 31.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.801 -0.823 . . . . 0.0 108.884 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.713 ' H ' ' C ' ' A' ' 15' ' ' GLY . . . -114.4 151.42 33.14 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.896 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.73 165.93 6.87 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 109.886 -178.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HD2' HG22 ' A' ' 18' ' ' THR . 3.9 Cg_exo -49.38 36.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.723 1.615 . . . . 0.0 111.749 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.896 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -164.34 55.03 0.42 Allowed Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.631 -0.668 . . . . 0.0 109.819 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.679 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.0 Cg_endo -77.36 169.95 20.3 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.529 1.486 . . . . 0.0 111.801 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -61.02 -4.59 3.89 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 121.134 1.223 . . . . 0.0 110.971 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.908 HG22 ' CD2' ' A' ' 10' ' ' LEU . 2.2 t -105.08 -71.54 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.598 0.713 . . . . 0.0 110.374 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.92 -98.41 0.05 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.676 -1.77 . . . . 0.0 108.676 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.734 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.5 Cg_endo -59.98 -55.41 1.65 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.972 0.886 . . . . 0.0 109.97 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.596 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.31 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.471 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.921 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -112.39 -42.49 3.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.608 -1.307 . . . . 0.0 108.703 179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.5 85.92 0.01 OUTLIER Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 27' ' ' LEU . 8.0 mm-40 -150.64 -13.82 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -1.102 . . . . 0.0 108.06 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.613 ' CD2' ' CE1' ' A' ' 65' ' ' PHE . 2.6 p-80 -86.21 -37.21 18.89 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.637 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . -171.87 -1.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.0 80.62 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.6 -0.941 . . . . 0.0 111.971 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -156.7 121.7 4.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.505 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.5 mm -97.9 -64.83 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.646 . . . . 0.0 110.0 -178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.689 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.97 -57.05 2.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.59 -1.319 . . . . 0.0 109.424 -177.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 35' ' ' MET . 3.7 mp0 -46.54 -51.08 16.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.99 -1.069 . . . . 0.0 108.195 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.921 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -48.15 -59.94 3.02 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.46 1.124 . . . . 0.0 109.623 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 42' ' ' ASN . 50.6 t -73.72 -30.27 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.95 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.1 tttp -50.09 -62.01 1.82 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.62 -33.89 73.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.469 -0.769 . . . . 0.0 108.94 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 44' ' ' ALA . 2.1 t80 -70.73 -77.03 0.09 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -41.29 -34.21 0.47 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.42 1.105 . . . . 0.0 110.692 -177.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.1 -34.01 75.58 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.963 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.587 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -90.75 -45.55 8.77 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.695 ' CB ' ' H ' ' A' ' 15' ' ' GLY . 19.0 p -58.67 -29.31 66.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -80.0 -46.5 16.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.587 ' OD1' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -55.96 -23.18 30.58 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.762 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.83 -74.93 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.394 -0.816 . . . . 0.0 109.407 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.762 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 168.31 150.75 6.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.289 -1.434 . . . . 0.0 111.088 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 1.1 m-20 -44.8 148.76 0.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.015 -1.285 . . . . 0.0 109.497 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.084 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 175.8 -154.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.986 -1.071 . . . . 0.0 110.622 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.5 mm -146.98 141.07 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 71' ' ' THR . 2.7 t -144.32 135.59 12.59 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.744 -1.223 . . . . 0.0 110.863 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.622 ' O ' HG21 ' A' ' 69' ' ' THR . 8.4 Cg_endo -70.96 99.82 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.624 1.55 . . . . 0.0 110.465 177.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.763 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.0 m -79.16 137.01 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 122.782 1.277 . . . . 0.0 112.262 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -128.25 61.32 1.46 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.773 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -61.57 86.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.646 0.736 . . . . 0.0 109.735 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.41 ' HB ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -60.59 95.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.562 HG13 HG22 ' A' ' 57' ' ' ILE . 46.2 mt -95.75 136.53 26.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.566 -0.708 . . . . 0.0 110.237 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.741 ' CE2' ' O ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -110.45 138.66 46.55 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 1.028 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.68 -29.43 4.4 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.573 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 19.7 t0 -53.93 3.03 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.853 ' H ' ' C ' ' A' ' 61' ' ' ALA . 50.4 mtp180 69.69 70.11 0.24 Allowed 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 122.045 0.926 . . . . 0.0 109.624 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 18.2 m -148.25 124.9 11.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.7 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -101.5 104.13 15.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 0.0 110.204 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.41 ' OG1' ' HB ' ' A' ' 58' ' ' THR . 21.9 p -98.3 124.58 43.01 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.594 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -109.4 174.02 6.05 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.526 -1.359 . . . . 0.0 109.349 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.004 HG12 ' O ' ' A' ' 68' ' ' VAL . 97.1 t -163.11 44.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.674 -177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.622 HG21 ' O ' ' A' ' 54' ' ' PRO . 1.2 t -155.19 126.79 7.4 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 115.594 -2.442 . . . . 0.0 110.276 175.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.85 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -124.92 128.13 48.15 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.791 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.81 151.59 0.13 Allowed Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.522 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.0 Cg_exo -40.37 175.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.504 2.136 . . . . 0.0 113.063 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.818 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.4 Cg_exo -43.63 170.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.651 1.567 . . . . 0.0 112.125 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.695 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 49.94 -78.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 -178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.818 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -43.55 -20.23 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.741 . . . . 0.0 109.242 179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 11.6 p90 -43.83 -42.22 5.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.65 -0.656 . . . . 0.0 109.322 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.878 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.66 -19.52 2.66 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.878 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.6 mt -59.27 -32.03 47.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.643 ' HB3' HD12 ' A' ' 84' ' ' LEU . 12.7 mmt180 -55.42 -44.12 75.93 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 82' ' ' ALA . 9.5 tmtt? -66.37 -66.4 0.56 Allowed 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.667 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -57.93 -4.84 0.35 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.667 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.16 -80.38 0.19 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 111.987 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.451 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 163.2 53.46 0.02 OUTLIER Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.036 -1.554 . . . . 0.0 110.466 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.643 HD12 ' HB3' ' A' ' 79' ' ' ARG . 5.7 mt -118.56 106.48 12.68 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.039 -1.271 . . . . 0.0 109.558 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 20.8 tt0 -133.47 -4.33 2.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 2.2 tmtp? 75.14 -80.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.261 -0.899 . . . . 0.0 109.528 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.28 -150.98 21.2 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.05 -85.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.207 -1.172 . . . . 0.0 109.537 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -114.48 140.38 48.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -154.18 158.68 32.43 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.408 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.53 -55.01 2.36 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.621 1.548 . . . . 0.0 112.366 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 178.12 -167.31 37.93 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 18.4 mtp180 60.03 147.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 86.8 mt-10 -157.09 156.47 32.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' CG ' ' C ' ' A' ' 94' ' ' GLU . 39.1 mttm -151.77 142.43 22.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.284 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.559 HG12 ' CD2' ' A' ' 84' ' ' LEU . 2.4 t -151.64 164.98 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 109.734 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 50.87 61.2 6.29 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.797 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.87 111.84 10.19 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.997 -1.296 . . . . 0.0 110.327 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -106.25 -177.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.703 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -125.05 159.02 32.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.925 -1.109 . . . . 0.0 109.351 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.668 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.8 t-105 -49.81 -69.54 0.11 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.597 -0.69 . . . . 0.0 111.042 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.639 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 9.5 tp10 -50.2 -44.74 53.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.58 -1.325 . . . . 0.0 110.981 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.667 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.4 OUTLIER -55.31 -43.76 75.17 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.162 -0.961 . . . . 0.0 110.054 -178.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.873 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.23 -24.32 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 117.649 -1.62 . . . . 0.0 107.656 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 120' ' ' LEU . 17.1 mt -66.31 -71.72 0.19 Allowed 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.639 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 20.5 mm-40 -44.08 -44.5 7.55 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.909 -1.119 . . . . 0.0 108.44 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.728 ' CD1' HD21 ' A' ' 77' ' ' LEU . 65.4 mt -60.84 -32.55 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.224 -0.922 . . . . 0.0 108.632 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.815 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.98 -26.79 15.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.838 . . . . 0.0 109.575 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.653 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.5 mttm -58.82 -73.27 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.935 -1.103 . . . . 0.0 108.242 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 109' ' ' LYS . 6.2 tt0 -45.24 -28.46 0.79 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.83 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.431 ' HE3' ' SD ' ' A' ' 126' ' ' MET . 11.6 tttm -69.8 -18.44 63.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 0.0 109.733 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -130.58 68.13 81.15 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.031 -1.043 . . . . 0.0 109.821 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.8 -33.96 25.64 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.533 1.488 . . . . 0.0 112.088 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER 174.97 15.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.467 -0.77 . . . . 0.0 109.087 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 115' ' ' LEU . 3.5 mm? -54.21 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.597 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -150.65 -25.03 0.23 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.066 HG22 ' H ' ' A' ' 118' ' ' THR . 23.5 m -64.94 -164.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.966 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.066 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.45 -74.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.179 -0.951 . . . . 0.0 109.943 -179.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.523 ' H ' HG23 ' A' ' 118' ' ' THR . 1.2 m-20 -60.68 140.96 57.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 110.051 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.92 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -61.88 -22.65 65.73 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.214 1.007 . . . . 0.0 108.952 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -65.12 -38.42 90.6 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.57 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.483 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -68.69 -75.2 0.11 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.231 -1.387 . . . . 0.0 107.921 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.605 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.56 -43.02 7.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.475 -1.39 . . . . 0.0 109.292 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -49.63 -68.71 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 108.571 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.784 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.57 -42.95 5.35 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.682 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.21 -79.07 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.146 -0.971 . . . . 0.0 108.562 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.815 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.9 mm -48.57 -65.54 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.873 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.81 -71.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.72 -39.04 3.36 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.682 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.9 m -57.8 -47.51 82.37 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.467 -1.608 . . . . 0.0 107.564 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.611 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -49.97 -48.47 52.16 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.649 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.2 tmm_? -46.62 -53.71 10.99 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.676 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.1 t -44.83 -68.5 0.19 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 75' ' ' SER . 0.0 OUTLIER -47.27 -3.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 87.91 -23.67 13.2 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.611 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 47.4 t -53.44 165.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.849 -0.795 . . . . 0.0 109.17 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.8 OUTLIER -142.66 162.58 35.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.025 -1.047 . . . . 0.0 109.723 179.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.76 162.25 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.884 HG13 ' O ' ' A' ' 139' ' ' VAL . 4.1 p -128.2 58.33 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.599 -0.688 . . . . 0.0 109.184 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.47 -108.01 0.34 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 101' ' ' TRP . . . 44.87 62.53 10.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.186 -1.185 . . . . 0.0 109.346 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.1 Cg_endo -64.87 -175.89 0.4 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 121.82 1.68 . . . . 0.0 112.564 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.743 ' O ' HG13 ' A' ' 144' ' ' VAL . 4.5 mt-10 -153.19 129.67 10.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 109.373 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.743 HG13 ' O ' ' A' ' 143' ' ' GLU . 4.0 m -162.94 166.75 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.59 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 144' ' ' VAL . 32.8 mtpt -161.45 163.57 30.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.471 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.666 ' OD1' ' N ' ' A' ' 147' ' ' ALA . 2.7 p30 -176.64 -61.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.52 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.666 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mtt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.52 96.04 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.153 -0.967 . . . . 0.0 109.584 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 4.9 tttp -168.08 115.27 0.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.533 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.744 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.86 138.01 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.309 -0.869 . . . . 0.0 109.501 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.8 m -112.82 -24.43 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.19 107.28 5.73 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.168 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.808 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -94.71 73.62 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 108.94 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.73 ' HB ' HD12 ' A' ' 57' ' ' ILE . 31.7 t -45.96 88.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.192 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.54 34.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.89 0.853 . . . . 0.0 109.076 179.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.993 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.23 -174.42 3.69 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.787 0.803 . . . . 0.0 111.31 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -119.78 171.84 8.12 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.781 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -168.3 160.11 9.02 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.689 -1.257 . . . . 0.0 110.288 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.781 ' HD2' HD23 ' A' ' 12' ' ' LEU . 13.4 Cg_endo -67.74 109.19 1.82 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.251 1.967 . . . . 0.0 111.647 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.812 ' HB3' ' C ' ' A' ' 51' ' ' ALA . . . -69.45 40.21 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.963 -1.086 . . . . 0.0 110.733 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.52 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 179.31 -18.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 118.277 -1.915 . . . . 0.0 111.792 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' CE ' ' OD1' ' A' ' 50' ' ' ASP . 2.1 mptt -135.82 60.74 1.67 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.405 -1.644 . . . . 0.0 110.452 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.705 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -79.64 158.74 26.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.724 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -161.92 163.31 19.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.688 -1.258 . . . . 0.0 110.494 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.507 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.0 Cg_endo -55.47 35.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.936 1.758 . . . . 0.0 111.852 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.724 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -171.17 57.18 0.25 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 110.41 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.0 Cg_endo -80.5 168.45 18.09 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.453 1.435 . . . . 0.0 111.432 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 -4.61 0.19 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 121.126 1.218 . . . . 0.0 111.044 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.993 HG22 HD22 ' A' ' 10' ' ' LEU . 1.9 t -105.48 -72.62 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.604 0.716 . . . . 0.0 110.277 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.55 -98.38 0.05 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.725 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.1 Cg_endo -60.49 -55.51 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 CA-C-N 118.047 0.923 . . . . 0.0 109.854 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.37 -8.6 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.39 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.808 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -111.62 -43.21 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.686 -1.259 . . . . 0.0 108.805 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.26 84.7 0.01 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tp-100 -148.9 -8.4 0.36 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.696 ' O ' ' CG ' ' A' ' 63' ' ' ARG . 6.0 p-80 -92.78 -36.55 12.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.639 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -171.55 2.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 71.86 75.95 0.17 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.661 -0.905 . . . . 0.0 112.058 177.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -154.05 121.32 5.74 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 108.797 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 27.7 mm -97.94 -63.8 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.683 -0.636 . . . . 0.0 109.952 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -42.08 -54.22 3.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.787 -1.195 . . . . 0.0 109.79 -176.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -50.08 -51.25 44.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.948 -1.095 . . . . 0.0 108.601 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.808 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -47.19 -58.89 3.58 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.773 1.273 . . . . 0.0 109.566 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.705 HG13 ' CB ' ' A' ' 17' ' ' ALA . 82.0 t -71.78 -30.25 37.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.212 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.583 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.2 mmtt -53.48 -55.04 28.7 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.22 -34.14 76.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.831 . . . . 0.0 109.575 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.631 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.4 t80 -68.32 -76.19 0.09 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 177.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 19.0 m-20 -41.81 -37.5 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.45 1.119 . . . . 0.0 110.764 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -62.73 -34.56 77.44 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.327 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.57 -61.59 1.64 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.888 -1.125 . . . . 0.0 108.654 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 24.6 p -44.85 -29.74 0.85 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.29 -43.39 16.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 44' ' ' ALA . 4.8 t-20 -54.49 -24.39 20.28 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.44 -85.22 0.54 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.892 -1.13 . . . . 0.0 109.956 179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -159.94 -148.98 5.42 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 118.996 -1.573 . . . . 0.0 111.051 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.521 ' OD1' ' CE ' ' A' ' 16' ' ' LYS . 3.5 t70 -113.55 126.02 54.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.338 -1.095 . . . . 0.0 109.687 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.812 ' C ' ' HB3' ' A' ' 14' ' ' ALA . . . -158.92 -152.85 0.34 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.243 -0.911 . . . . 0.0 110.322 -179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 13' ' ' PRO . 5.8 mm -147.0 143.37 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.569 HG23 ' HB2' ' A' ' 14' ' ' ALA . 5.2 t -145.72 137.58 13.17 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.001 . . . . 0.0 110.405 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.2 Cg_endo -73.3 86.06 1.19 Allowed 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.745 1.63 . . . . 0.0 110.601 177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.816 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.7 m -58.01 137.71 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.762 1.267 . . . . 0.0 112.321 -177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 16.3 mt-10 -128.78 63.98 1.45 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.73 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.7 mt -64.36 90.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 121.812 0.815 . . . . 0.0 110.316 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.505 HG22 HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -64.25 98.48 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.55 HG13 HG22 ' A' ' 57' ' ' ILE . 9.8 mt -100.72 142.68 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.561 -0.712 . . . . 0.0 110.375 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.744 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.7 m-85 -114.34 139.93 49.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.838 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -48.61 -30.0 4.9 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.349 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 8.1 t70 -53.53 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.838 ' H ' ' C ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 70.46 69.04 0.2 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 122.122 0.963 . . . . 0.0 109.627 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 m -148.06 125.07 11.34 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.678 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -101.43 104.02 14.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.008 -1.057 . . . . 0.0 110.232 -179.311 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.5 p -99.16 124.67 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.558 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 1.8 p90 -108.52 171.32 7.49 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.569 -1.332 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.985 HG12 ' O ' ' A' ' 68' ' ' VAL . 88.8 t -162.38 44.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.945 . . . . 0.0 112.691 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 69' ' ' THR . 11.2 t -154.93 118.02 4.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 119.048 -2.282 . . . . 0.0 110.398 176.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.818 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.51 120.06 38.26 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.141 0.972 . . . . 0.0 108.599 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.877 HG21 ' CD ' ' A' ' 79' ' ' ARG . 16.2 p 76.99 151.45 0.13 Allowed Pre-proline 0 N--CA 1.493 1.723 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.353 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.5 Cg_exo -39.12 175.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.762 2.308 . . . . 0.0 113.351 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.5 Cg_exo -40.99 167.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.652 1.568 . . . . 0.0 111.915 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.0 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.67 -77.31 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.776 ' N ' ' O ' ' A' ' 73' ' ' PRO . 8.0 t -43.04 -25.05 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.478 -0.764 . . . . 0.0 109.981 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.049 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 17.9 p90 -43.27 -41.72 4.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.485 -0.76 . . . . 0.0 109.111 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.049 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -133.07 -15.48 2.58 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.0 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.6 mt -60.21 -33.21 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.877 ' CD ' HG21 ' A' ' 71' ' ' THR . 1.5 mtm180 -55.46 -43.37 75.42 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -67.15 -66.23 0.58 Allowed 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.795 ' HB1' ' OE1' ' A' ' 103' ' ' GLN . . . -58.36 -4.8 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.115 -0.991 . . . . 0.0 109.684 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -84.42 -79.76 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.422 -0.799 . . . . 0.0 111.554 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.508 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 154.57 56.09 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.179 -1.486 . . . . 0.0 110.408 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.508 HD23 ' C ' ' A' ' 83' ' ' GLY . 10.8 mt -112.4 104.78 12.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.252 . . . . 0.0 109.23 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -178.86 -48.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.259 -0.901 . . . . 0.0 109.355 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.442 ' NZ ' ' HA2' ' A' ' 92' ' ' GLY . 13.4 mmtt 62.75 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.479 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.96 -110.19 0.43 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.94 -84.99 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -1.161 . . . . 0.0 109.484 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -154.38 82.89 1.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.913 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -101.87 160.66 25.81 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.22 -26.32 60.38 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.556 1.504 . . . . 0.0 112.391 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.442 ' HA2' ' NZ ' ' A' ' 86' ' ' LYS . . . 136.49 -115.79 1.34 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? 58.95 58.27 3.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -1.104 . . . . 0.0 109.496 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 175.23 169.26 0.31 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.177 -0.952 . . . . 0.0 109.582 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -120.14 -164.95 1.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.479 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 97' ' ' GLY . 41.1 t -149.55 165.04 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.577 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.541 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 58.45 66.51 2.75 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.787 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -134.16 113.11 11.68 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -1.166 . . . . 0.0 110.008 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.704 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.81 -173.37 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.647 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -127.5 158.04 38.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.052 -1.03 . . . . 0.0 109.401 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.664 ' O ' HG22 ' A' ' 104' ' ' VAL . 22.7 t-105 -49.95 -69.47 0.11 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.498 -0.751 . . . . 0.0 110.753 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 4.4 tp10 -49.78 -45.04 49.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.706 -1.246 . . . . 0.0 110.539 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.795 ' OE1' ' HB1' ' A' ' 81' ' ' ALA . 0.2 OUTLIER -52.71 -46.3 67.28 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.911 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 101' ' ' TRP . 2.4 m -71.46 -24.55 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.996 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.951 HD13 HD13 ' A' ' 120' ' ' LEU . 18.3 mt -65.91 -71.37 0.19 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.587 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 24.9 mm-40 -43.92 -43.31 6.4 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.959 -1.088 . . . . 0.0 108.66 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.76 HG12 HD11 ' A' ' 77' ' ' LEU . 57.6 mt -63.22 -32.3 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.166 -0.959 . . . . 0.0 108.817 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.21 -27.1 16.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.332 -0.855 . . . . 0.0 109.376 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.655 ' N ' ' O ' ' A' ' 105' ' ' LEU . 15.3 mtpt -59.78 -74.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.012 -1.055 . . . . 0.0 108.594 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 109' ' ' LYS . 71.5 mt-30 -45.04 -27.32 0.54 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.159 -0.963 . . . . 0.0 109.229 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -74.59 -10.41 59.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.927 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.649 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.38 64.03 67.54 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.993 -1.067 . . . . 0.0 109.65 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.5 Cg_endo -66.13 -30.67 46.51 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 121.647 1.565 . . . . 0.0 112.084 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.539 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 1.7 t70 175.16 10.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.188 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -48.42 -79.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.506 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -152.19 -21.5 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.621 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.049 HG22 ' H ' ' A' ' 118' ' ' THR . 27.4 m -64.69 -164.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.948 . . . . 0.0 109.585 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.049 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.75 -67.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.221 -0.924 . . . . 0.0 109.807 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.529 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -69.57 138.39 53.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 0.0 109.932 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.951 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -58.29 -22.66 53.68 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.204 1.002 . . . . 0.0 108.85 179.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.16 -35.9 82.55 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.539 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.596 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.48 -75.84 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.212 -1.395 . . . . 0.0 107.985 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.84 -39.29 5.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.47 -1.394 . . . . 0.0 109.253 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -53.27 -70.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.794 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.54 -38.96 3.18 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' SER . 10.4 ttm -54.54 -80.11 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 108.872 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 24.4 mm -46.07 -63.95 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.642 0.734 . . . . 0.0 110.46 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.31 -69.05 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.29 -38.29 2.72 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 126' ' ' MET . 6.0 p -55.31 -53.75 52.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.602 -1.528 . . . . 0.0 107.282 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.81 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -44.84 -50.2 10.43 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 4.4 tmt_? -44.77 -56.6 4.34 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 135' ' ' GLY . 11.2 t -46.04 -69.82 0.12 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.573 ' HG2' HG23 ' A' ' 136' ' ' VAL . 4.9 ttp -44.89 -5.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.648 -0.657 . . . . 0.0 110.255 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.84 20.06 60.3 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.81 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 30.9 t -102.8 165.27 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.911 -0.758 . . . . 0.0 108.969 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.539 ' N ' HG12 ' A' ' 136' ' ' VAL . 82.8 mt-10 -141.31 162.53 35.26 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.07 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.86 160.98 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.891 HG13 ' O ' ' A' ' 139' ' ' VAL . 5.4 p -122.8 60.6 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 159.3 -113.75 0.58 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.481 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.84 63.03 9.5 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.177 . . . . 0.0 109.361 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.1 Cg_endo -63.89 -165.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.785 1.656 . . . . 0.0 112.697 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.612 ' CG ' ' N ' ' A' ' 144' ' ' VAL . 29.2 tt0 -172.45 167.89 5.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.36 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.612 ' N ' ' CG ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -153.93 172.78 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.477 ' CG ' ' N ' ' A' ' 146' ' ' ASP . 51.7 tttp -171.0 161.29 6.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.425 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.477 ' N ' ' CG ' ' A' ' 145' ' ' LYS . 23.9 t70 -174.59 126.6 0.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.49 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -169.33 133.52 1.39 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.544 ' C ' ' CE1' ' A' ' 60' ' ' TYR . 23.7 ttmt -170.9 130.34 0.8 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.644 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.714 ' N ' ' CZ ' ' A' ' 60' ' ' TYR . 1.7 p -44.72 136.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.274 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 59' ' ' ILE . 27.7 m -120.89 -24.71 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.124 -0.985 . . . . 0.0 110.107 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.684 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -156.51 118.6 3.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.434 -1.416 . . . . 0.0 110.503 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.9 p -110.59 73.9 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.786 -0.571 . . . . 0.0 109.612 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.693 ' O ' ' O ' ' A' ' 55' ' ' VAL . 13.9 t -44.89 88.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 0.0 110.158 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.6 tmtt? -84.03 34.66 0.51 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.925 0.869 . . . . 0.0 109.127 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.894 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.5 tp -78.77 -173.7 3.59 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.652 0.739 . . . . 0.0 111.009 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.562 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -125.99 179.02 5.41 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.665 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -165.63 144.77 5.24 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 0.0 108.931 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.804 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 67.4 Cg_endo -83.43 113.15 1.98 Allowed 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.552 2.168 . . . . 0.0 114.445 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.972 ' HB3' ' H ' ' A' ' 51' ' ' ALA . . . -63.19 142.93 58.2 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.497 ' H ' ' CB ' ' A' ' 45' ' ' THR . . . 55.19 52.83 44.54 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER 173.88 27.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.55 -0.97 . . . . 0.0 108.711 -178.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 18' ' ' THR . . . -111.83 152.98 27.28 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.913 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -169.19 165.97 6.36 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.868 -179.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.9 Cg_exo -48.86 34.69 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.617 1.545 . . . . 0.0 111.627 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.913 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -155.22 54.2 0.96 Allowed Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.59 -0.694 . . . . 0.0 109.41 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.717 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 17.1 Cg_endo -81.14 167.66 17.65 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.703 1.602 . . . . 0.0 111.947 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.24 -4.48 3.14 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 121.306 1.337 . . . . 0.0 111.41 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.78 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 2.7 t -112.92 -71.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 110.468 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.58 -97.97 0.06 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.386 -1.886 . . . . 0.0 108.386 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.78 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 3.0 Cg_exo -58.97 -55.13 2.13 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 CA-C-N 117.9 0.85 . . . . 0.0 110.354 177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.676 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -48.46 -8.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.693 -0.63 . . . . 0.0 110.945 -178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.698 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -108.61 -48.62 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.643 -1.286 . . . . 0.0 108.8 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -49.36 98.4 0.02 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 27' ' ' LEU . 44.2 tt0 -158.3 -22.64 0.08 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.772 ' CD2' ' N ' ' A' ' 31' ' ' GLY . 1.5 p-80 -81.12 -44.1 18.43 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.162 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.772 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -166.73 -10.52 0.03 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.29 84.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 112.494 177.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.638 ' ND2' ' C ' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -155.16 70.95 0.77 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.863 -1.148 . . . . 0.0 108.916 177.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 21.7 mm -44.37 -71.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.224 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.493 ' O ' ' C ' ' A' ' 36' ' ' GLU . 10.1 tpt -41.88 -53.39 3.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.164 . . . . 0.0 109.42 -178.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.3 tp10 -44.88 -49.76 10.76 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.698 ' CE2' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -51.42 -69.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.973 1.368 . . . . 0.0 109.998 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 42' ' ' ASN . 35.7 t -56.5 -36.06 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.557 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -50.66 -64.08 0.92 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.19 -32.53 64.46 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 109.251 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.9 t80 -71.3 -76.63 0.1 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.392 -1.443 . . . . 0.0 107.116 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 1.3 m-80 -41.16 -28.14 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.792 -1.192 . . . . 0.0 110.436 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -71.35 -34.52 70.58 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.82 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 41' ' ' PHE . . . -90.35 -44.62 9.55 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.733 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.591 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 6.8 p -59.81 -32.09 70.31 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.15 -44.93 24.6 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.657 ' ND2' ' O ' ' A' ' 47' ' ' ASN . 0.1 OUTLIER -59.33 -21.88 60.43 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.411 -0.806 . . . . 0.0 108.965 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.658 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.25 -75.63 0.61 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.516 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.658 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -178.49 -121.06 0.68 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.035 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 0.7 OUTLIER -137.76 124.86 21.52 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.281 -1.129 . . . . 0.0 108.669 179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.972 ' H ' ' HB3' ' A' ' 14' ' ' ALA . . . 173.86 114.33 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.992 -1.068 . . . . 0.0 110.659 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.804 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -44.97 160.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.495 -1.378 . . . . 0.0 113.014 -178.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.624 ' N ' ' O ' ' A' ' 12' ' ' LEU . 6.1 t -153.51 135.38 8.98 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.211 -0.931 . . . . 0.0 110.089 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 69' ' ' THR . 6.3 Cg_endo -66.96 108.87 1.57 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.722 1.615 . . . . 0.0 112.565 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.2 m -87.47 136.07 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.553 -1.342 . . . . 0.0 111.273 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.687 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 11.9 mt-10 -128.65 69.21 1.37 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.656 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.9 mt -70.96 88.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.731 0.777 . . . . 0.0 110.33 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -61.97 94.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 25.5 mt -89.29 94.16 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.714 ' CZ ' ' N ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -84.15 179.13 7.56 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.295 1.045 . . . . 0.0 112.234 -176.133 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 1.096 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.95 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.115 -178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 63' ' ' ARG . 40.2 p30 -46.73 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 109.319 -178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 1.096 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER 43.91 86.23 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -146.23 124.36 12.16 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.82 179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.765 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -101.95 103.06 13.68 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.172 179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 22.2 p -101.03 120.62 40.46 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.078 -1.013 . . . . 0.0 109.0 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.954 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER 170.58 148.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.876 -1.14 . . . . 0.0 111.057 177.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.954 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.5 t -169.76 95.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.684 HG21 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -104.5 147.36 27.68 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.756 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.8 mptt -132.75 124.21 27.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.68 -1.263 . . . . 0.0 110.092 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.756 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.9 p 76.08 149.17 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 CA-C-O 121.232 0.539 . . . . 0.0 109.662 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' O ' ' O ' ' A' ' 73' ' ' PRO . 10.7 Cg_exo -42.07 175.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.513 2.142 . . . . 0.0 112.722 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.716 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.9 Cg_exo -38.44 172.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.518 1.479 . . . . 0.0 111.951 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.606 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.9 -83.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.763 ' HG ' ' HG3' ' A' ' 79' ' ' ARG . 7.9 t -42.77 -23.37 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.327 -0.858 . . . . 0.0 110.11 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.982 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 14.8 p90 -43.84 -38.92 3.56 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.982 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -135.17 -19.2 1.73 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.141 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.952 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.2 mt -56.22 -34.63 40.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.763 ' HG3' ' HG ' ' A' ' 75' ' ' SER . 13.0 mmt180 -53.08 -49.68 65.91 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.554 ' CD ' ' C ' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -57.81 -63.73 1.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -59.29 -6.55 1.0 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.276 -0.89 . . . . 0.0 109.845 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 79' ' ' ARG . . . -84.13 -80.39 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 0.0 111.762 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' C ' ' CG1' ' A' ' 96' ' ' VAL . . . 172.59 -13.65 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.21 -1.471 . . . . 0.0 110.665 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.763 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -100.66 129.8 46.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.912 -1.346 . . . . 0.0 110.082 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 1.6 tt0 -168.19 77.16 0.14 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.421 -0.799 . . . . 0.0 109.322 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.581 ' CG ' HD21 ' A' ' 47' ' ' ASN . 9.4 tttm 75.03 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.339 -0.851 . . . . 0.0 109.564 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.15 -168.56 15.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.44 -85.05 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -1.124 . . . . 0.0 109.493 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -138.86 145.44 40.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 160.67 42.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 109.422 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.58 -40.76 70.96 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.565 1.51 . . . . 0.0 112.289 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.95 151.96 5.67 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.567 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 43.2 mtt180 62.08 98.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.567 ' OE1' ' O ' ' A' ' 93' ' ' ARG . 2.5 tp10 177.75 150.74 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.416 ' C ' ' CG2' ' A' ' 96' ' ' VAL . 10.2 mttm -123.7 179.52 4.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.718 HG12 HD23 ' A' ' 84' ' ' LEU . 2.3 t -151.76 165.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.472 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 104.23 56.77 0.73 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.773 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.25 122.03 24.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.206 -1.173 . . . . 0.0 110.283 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.805 HD12 ' CG1' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -109.55 -165.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.742 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -131.79 156.42 46.03 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.03 -1.044 . . . . 0.0 109.125 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.735 ' O ' HG22 ' A' ' 104' ' ' VAL . 15.6 t-105 -48.92 -69.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 110.877 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.484 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.78 -53.98 21.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.565 -1.334 . . . . 0.0 110.972 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 4.2 mt-30 -47.12 -44.87 21.92 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.282 -0.886 . . . . 0.0 110.328 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.77 -26.03 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.431 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 120' ' ' LEU . 16.0 mt -65.95 -70.5 0.24 Allowed 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' LEU . 36.0 tt0 -43.7 -42.54 5.42 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 120.916 -1.115 . . . . 0.0 108.337 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.693 HG12 HD11 ' A' ' 77' ' ' LEU . 41.4 mt -63.26 -31.23 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.05 -1.031 . . . . 0.0 108.329 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.825 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.93 -26.33 16.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.77 ' HE3' HD11 ' A' ' 120' ' ' LEU . 8.6 mttp -58.3 -73.15 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.924 -1.11 . . . . 0.0 108.431 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -48.69 -24.29 1.33 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.103 -0.998 . . . . 0.0 108.958 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.564 ' NZ ' ' SD ' ' A' ' 126' ' ' MET . 0.0 OUTLIER -72.83 -16.6 61.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.327 -0.858 . . . . 0.0 109.707 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.699 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.48 65.71 76.75 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.059 -1.026 . . . . 0.0 109.768 179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.66 -32.88 37.2 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 121.631 1.554 . . . . 0.0 112.11 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.543 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 2.5 t70 174.98 13.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.427 -0.796 . . . . 0.0 109.23 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.409 ' H ' ' H ' ' A' ' 114' ' ' ASP . 2.8 mm? -51.36 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.58 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -154.42 -24.97 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.655 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.005 HG22 ' H ' ' A' ' 118' ' ' THR . 24.8 m -65.08 -164.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.005 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -172.44 -73.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.242 -0.911 . . . . 0.0 109.809 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.518 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -61.95 142.13 57.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 110.011 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.963 HD13 HD13 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -61.4 -24.86 66.81 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.237 1.018 . . . . 0.0 109.036 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.17 -38.26 90.47 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.6 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.567 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -69.11 -74.35 0.13 Allowed 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.087 -1.445 . . . . 0.0 107.943 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.94 -44.4 9.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.523 -1.36 . . . . 0.0 109.22 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -48.64 -70.7 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.183 -0.948 . . . . 0.0 108.871 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.765 HH11 ' CG ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -43.37 -39.66 3.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.693 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.9 ttm -53.0 -78.85 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.191 -0.943 . . . . 0.0 108.605 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.825 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.8 mm -48.1 -64.19 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.66 0.743 . . . . 0.0 110.082 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.826 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.95 -71.6 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.85 -42.56 4.97 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 126' ' ' MET . 51.8 m -54.0 -42.21 68.79 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.627 -1.514 . . . . 0.0 107.029 177.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.74 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -54.34 -48.72 71.08 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.763 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -44.9 -48.16 11.23 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 135' ' ' GLY . 6.1 t -53.58 -69.62 0.11 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.536 ' SD ' ' CG2' ' A' ' 136' ' ' VAL . 7.0 ttm -44.9 -5.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.579 -0.701 . . . . 0.0 109.956 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 84.02 24.96 46.72 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.74 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.6 t -107.1 165.45 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.952 -0.734 . . . . 0.0 109.183 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.562 ' N ' HG12 ' A' ' 136' ' ' VAL . 72.8 tt0 -141.82 164.3 30.56 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.067 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' A' ' 137' ' ' GLU . 1.9 t -82.58 146.22 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.706 HG23 ' HD3' ' A' ' 98' ' ' ARG . 4.3 p -101.09 -6.63 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.49 -0.757 . . . . 0.0 109.452 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -122.99 -119.8 2.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.99 63.07 9.56 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.214 -1.168 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.0 OUTLIER -64.53 -165.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 121.767 1.644 . . . . 0.0 112.48 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.572 ' O ' HG13 ' A' ' 144' ' ' VAL . 96.9 mt-10 -153.26 173.18 15.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.325 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -158.29 -179.52 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.124 -0.985 . . . . 0.0 109.599 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 146' ' ' ASP . 0.0 OUTLIER -173.48 125.84 0.4 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.473 ' N ' ' HD3' ' A' ' 145' ' ' LYS . 21.8 t70 -145.23 144.94 31.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.471 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.439 179.916 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.58 124.85 6.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.64 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 3.7 tttp -177.73 126.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.594 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 1.7 p -44.67 133.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 108.995 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' HA ' ' A' ' 60' ' ' TYR . 27.5 m -120.83 -24.56 2.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.273 -0.892 . . . . 0.0 110.089 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.704 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . . . -161.01 115.16 2.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.59 -1.319 . . . . 0.0 110.741 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -107.64 74.01 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.802 ' HB ' HD12 ' A' ' 57' ' ' ILE . 15.1 t -47.84 88.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 120.663 -1.273 . . . . 0.0 110.538 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.69 36.49 0.55 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.939 0.876 . . . . 0.0 109.158 179.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.886 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.5 OUTLIER -78.04 -173.99 3.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.906 0.86 . . . . 0.0 111.374 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.09 174.54 7.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.711 HD13 HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -163.87 147.52 8.15 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.951 -1.093 . . . . 0.0 109.371 179.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.664 ' HB2' ' HB3' ' A' ' 16' ' ' LYS . 96.7 Cg_endo -86.76 128.84 2.92 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.389 2.059 . . . . 0.0 113.266 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.079 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -75.26 142.85 43.28 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.05 63.12 5.31 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 108.174 -1.97 . . . . 0.0 108.174 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.664 ' HB3' ' HB2' ' A' ' 13' ' ' PRO . 14.0 tttt 174.09 -25.02 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.65 151.92 32.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.099 -1.001 . . . . 0.0 108.368 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.883 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.64 165.9 9.39 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 18' ' ' THR . 5.8 Cg_exo -50.45 37.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.717 1.611 . . . . 0.0 111.638 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.883 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -167.97 55.01 0.28 Allowed Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 10.9 Cg_endo -79.03 170.83 17.29 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.617 1.545 . . . . 0.0 111.781 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.17 -4.56 1.67 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 121.115 1.21 . . . . 0.0 110.94 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.886 HG22 ' CD2' ' A' ' 10' ' ' LEU . 1.9 t -108.18 -72.05 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.482 0.658 . . . . 0.0 110.096 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.62 -98.17 0.06 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.761 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.8 Cg_endo -59.45 -55.38 1.84 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 CA-C-N 117.975 0.888 . . . . 0.0 109.988 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.67 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.51 -12.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.19 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.977 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -114.39 -40.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.775 -1.203 . . . . 0.0 108.239 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.8 92.69 0.01 OUTLIER Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.564 ' O ' ' OE1' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -159.06 -25.9 0.07 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 179.178 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.73 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 4.6 p80 -78.75 61.24 2.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.693 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.685 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 83.91 -9.37 63.17 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.35 84.23 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.153 -1.204 . . . . 0.0 112.104 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -157.38 123.72 4.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.98 -1.075 . . . . 0.0 108.731 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.659 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 mm -99.4 -63.47 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.685 -0.634 . . . . 0.0 109.831 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.66 ' O ' ' N ' ' A' ' 39' ' ' LYS . 1.0 OUTLIER -41.02 -52.58 3.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.755 -1.215 . . . . 0.0 109.662 -176.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 35' ' ' MET . 9.2 mm-40 -49.66 -47.25 50.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.647 -1.283 . . . . 0.0 107.831 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.977 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -52.93 -68.19 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.517 1.151 . . . . 0.0 109.956 178.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.67 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 23.6 t -66.08 -37.71 80.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.081 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.66 ' N ' ' O ' ' A' ' 35' ' ' MET . 9.6 mmmt -46.12 -58.57 3.51 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.94 -33.32 72.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.318 -0.864 . . . . 0.0 108.939 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' THR . 3.6 t80 -71.34 -77.11 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.67 ' ND2' ' CG1' ' A' ' 38' ' ' VAL . 2.0 m-80 -41.33 -32.1 0.28 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.933 -1.104 . . . . 0.0 110.589 -177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -68.93 -33.45 73.75 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.781 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.668 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . -90.24 -47.97 7.45 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.559 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 41' ' ' PHE . 2.3 p -57.08 -29.2 63.28 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -79.47 -46.57 17.21 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -57.24 -21.25 32.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.406 -0.809 . . . . 0.0 108.842 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.722 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -111.08 -74.22 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.443 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.722 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 172.97 -156.52 24.9 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 8.1 t70 -93.16 145.34 24.48 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.02 -1.282 . . . . 0.0 108.967 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.079 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.25 -153.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.745 -1.222 . . . . 0.0 110.905 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 13' ' ' PRO . 2.3 mm -146.37 139.42 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 71' ' ' THR . 2.2 t -140.11 135.29 16.18 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.008 -1.058 . . . . 0.0 110.905 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.3 Cg_endo -71.84 105.66 1.85 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.77 1.647 . . . . 0.0 111.056 178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.835 ' N ' ' O ' ' A' ' 10' ' ' LEU . 5.5 m -80.66 135.61 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.711 -1.243 . . . . 0.0 111.702 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.3 mt-10 -129.29 67.49 1.43 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 177.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.802 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.2 mt -68.79 87.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.707 0.765 . . . . 0.0 110.218 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.408 ' HB ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -61.69 94.68 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.322 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 64' ' ' SER . 5.6 mt -88.87 134.98 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.443 -0.786 . . . . 0.0 109.217 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.64 ' CE2' ' N ' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -122.49 -179.65 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 118.667 -1.213 . . . . 0.0 112.316 -176.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 1.082 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -41.82 -85.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.115 -1.402 . . . . 0.0 113.224 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' O ' ' C ' ' A' ' 63' ' ' ARG . 20.9 t0 -46.24 39.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.542 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 1.082 ' N ' ' O ' ' A' ' 61' ' ' ALA . 0.6 OUTLIER 44.03 87.63 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.754 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -143.62 166.37 25.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.781 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -146.18 103.2 3.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.458 -0.776 . . . . 0.0 109.164 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.617 ' O ' ' HB3' ' A' ' 67' ' ' PHE . 4.0 p -101.11 120.83 40.79 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 0.0 109.424 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.92 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.2 OUTLIER 170.67 147.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.921 -1.112 . . . . 0.0 110.935 177.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.92 HG23 ' O ' ' A' ' 67' ' ' PHE . 29.8 t -168.3 87.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 122.312 1.053 . . . . 0.0 108.208 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -95.06 146.98 23.9 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.787 ' NZ ' HG13 ' A' ' 68' ' ' VAL . 2.3 mptt -132.72 127.31 34.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 118.217 -1.393 . . . . 0.0 110.511 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.768 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.1 p 76.0 149.15 0.12 Allowed Pre-proline 0 N--CA 1.491 1.601 0 CA-C-O 121.242 0.544 . . . . 0.0 109.955 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' O ' ' O ' ' A' ' 73' ' ' PRO . 9.2 Cg_exo -42.83 175.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.489 2.126 . . . . 0.0 112.835 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.75 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -38.66 171.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.639 1.559 . . . . 0.0 111.897 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.698 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 51.33 -82.11 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.75 ' N ' ' O ' ' A' ' 73' ' ' PRO . 24.8 p -43.02 -22.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.887 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.003 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 15.6 p90 -43.77 -40.54 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.559 -0.713 . . . . 0.0 109.168 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.003 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -134.59 -16.63 2.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.885 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.3 mt -59.28 -33.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.629 ' HG3' HG21 ' A' ' 71' ' ' THR . 16.3 mmt180 -55.78 -42.71 75.93 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 82' ' ' ALA . 7.9 tmtt? -65.87 -66.06 0.6 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.37 -6.22 0.41 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.426 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.611 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -83.24 -80.55 0.18 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.494 -0.754 . . . . 0.0 111.857 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 173.6 35.0 0.04 OUTLIER Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.45 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.509 HD11 HH11 ' A' ' 79' ' ' ARG . 3.2 mt -92.92 109.42 20.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.96 -1.318 . . . . 0.0 109.148 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -148.69 -59.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.573 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt 67.74 -82.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.52 -170.4 25.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.15 -85.0 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -1.184 . . . . 0.0 109.45 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -116.54 107.29 14.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.403 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -144.39 154.58 57.09 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.399 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.22 -42.07 72.25 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.554 1.503 . . . . 0.0 112.416 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 135.36 -138.37 9.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 64.53 93.45 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -1.157 . . . . 0.0 109.475 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 175.17 172.32 0.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -134.97 -173.07 3.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.48 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 t -152.35 139.45 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.545 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.449 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . 67.82 44.78 78.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.792 HH11 ' CG ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -132.82 115.16 14.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -1.228 . . . . 0.0 110.216 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -108.51 178.2 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.787 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -122.66 161.96 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.009 -1.057 . . . . 0.0 109.366 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.713 ' O ' HG22 ' A' ' 104' ' ' VAL . 16.0 t-105 -48.57 -70.88 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 111.33 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.539 ' OE2' ' CG ' ' A' ' 106' ' ' GLU . 3.8 tp10 -49.31 -51.59 33.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 110.934 -178.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.407 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 6.2 mt-30 -48.57 -44.6 36.87 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.343 -0.848 . . . . 0.0 110.295 -178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.57 -25.58 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 117.726 -1.59 . . . . 0.0 107.634 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.749 HD13 HD13 ' A' ' 120' ' ' LEU . 16.1 mt -65.85 -71.56 0.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.539 ' CG ' ' OE2' ' A' ' 102' ' ' GLU . 23.8 mm-40 -44.18 -42.37 6.39 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.601 HG12 HD11 ' A' ' 77' ' ' LEU . 67.0 mt -65.28 -31.49 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.131 -0.981 . . . . 0.0 108.999 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.814 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.31 -31.0 13.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 109.617 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.691 ' N ' ' O ' ' A' ' 105' ' ' LEU . 7.1 mtpm? -54.45 -72.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.966 -1.084 . . . . 0.0 108.625 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -51.23 -27.68 9.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' MET . 10.2 tttm -84.62 64.47 8.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.918 . . . . 0.0 109.784 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.566 ' N ' ' HD3' ' A' ' 113' ' ' PRO . 0.0 OUTLIER 175.99 56.19 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.843 . . . . 0.0 109.306 179.331 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.6 Cg_endo -64.78 -55.06 0.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 121.528 1.486 . . . . 0.0 112.231 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' A' ' 114' ' ' ASP . 1.7 p-10 -162.56 9.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -0.837 . . . . 0.0 109.164 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 114' ' ' ASP . 2.8 mm? -44.97 -62.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -177.75 6.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.692 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.04 HG22 ' H ' ' A' ' 118' ' ' THR . 32.0 m -108.88 -164.48 0.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.943 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.04 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER 175.97 -44.39 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.3 -0.875 . . . . 0.0 109.708 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.711 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 0.0 OUTLIER -74.74 143.88 43.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.472 -0.767 . . . . 0.0 110.359 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.749 HD13 HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -65.29 -36.78 85.14 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.385 1.088 . . . . 0.0 108.514 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -61.94 -33.92 75.15 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.932 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.456 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -72.39 -75.4 0.14 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.456 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.92 -40.12 6.06 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.477 -1.389 . . . . 0.0 109.093 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -52.89 -69.7 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.183 -0.948 . . . . 0.0 108.782 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.661 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.35 -38.62 2.77 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' SER . 11.0 ttm -53.28 -78.04 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.814 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 23.6 mm -48.76 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.768 0.794 . . . . 0.0 109.832 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.95 -71.89 0.11 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.73 -40.24 3.86 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.679 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.7 m -57.57 -50.25 73.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.566 -1.549 . . . . 0.0 107.532 178.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.654 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -47.39 -49.05 25.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.79 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.14 -54.6 8.34 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 176.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.663 ' O ' ' N ' ' A' ' 135' ' ' GLY . 6.9 t -44.88 -68.69 0.18 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.682 ' HG2' HG23 ' A' ' 136' ' ' VAL . 5.5 ttp -47.23 -4.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.637 -0.664 . . . . 0.0 109.271 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.71 -27.61 7.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.036 -2.026 . . . . 0.0 108.036 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.682 HG23 ' HG2' ' A' ' 134' ' ' MET . 43.0 t -48.6 165.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.919 -0.754 . . . . 0.0 109.183 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.565 ' N ' HG12 ' A' ' 136' ' ' VAL . 63.2 mm-40 -142.38 162.01 36.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.756 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -79.95 161.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 139' ' ' VAL . 4.1 p -128.26 59.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 161.83 -117.13 0.75 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.517 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.86 61.14 12.1 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.226 -1.161 . . . . 0.0 109.305 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.5 Cg_endo -65.18 -165.11 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.836 1.691 . . . . 0.0 112.688 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -146.04 -164.97 2.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 109.354 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.71 173.02 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -177.33 -12.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.155 -0.966 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 147' ' ' ALA . 25.1 t70 -45.08 144.98 1.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 0.0 109.475 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.495 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -116.01 120.11 38.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.399 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' C ' ' CE2' ' A' ' 60' ' ' TYR . 1.9 tttt 175.93 116.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.622 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.789 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.88 140.15 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.102 -0.999 . . . . 0.0 109.152 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.937 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.7 m -117.17 -24.41 3.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.134 -0.979 . . . . 0.0 109.157 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.16 107.04 4.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.689 -1.257 . . . . 0.0 110.351 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -96.31 73.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.748 ' HB ' HD12 ' A' ' 57' ' ' ILE . 31.2 t -46.47 88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.8 -1.188 . . . . 0.0 110.461 -176.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.618 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.9 OUTLIER -82.93 34.75 0.46 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.844 0.831 . . . . 0.0 108.999 179.111 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.983 HD22 HG22 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -78.11 -174.46 3.65 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.804 0.811 . . . . 0.0 111.147 -178.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -119.69 172.15 7.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.774 HD23 ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -168.42 160.06 8.82 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.787 -1.196 . . . . 0.0 110.232 179.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.774 ' HD2' HD23 ' A' ' 12' ' ' LEU . 15.1 Cg_endo -67.91 109.91 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.249 1.966 . . . . 0.0 111.635 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.804 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -69.01 41.03 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.89 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . 177.08 -16.52 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.3 -1.905 . . . . 0.0 111.831 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -135.41 53.92 1.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.427 -1.631 . . . . 0.0 110.502 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.716 ' CB ' HG13 ' A' ' 38' ' ' VAL . . . -73.13 157.9 36.35 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -159.85 162.96 23.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.617 -1.302 . . . . 0.0 110.726 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HD2' HG22 ' A' ' 18' ' ' THR . 2.0 Cg_endo -56.02 36.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.973 1.782 . . . . 0.0 111.993 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -175.93 58.57 0.18 Allowed Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.34 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 12.1 Cg_endo -80.68 169.5 16.7 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.568 1.512 . . . . 0.0 111.394 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.88 -4.66 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 121.007 1.138 . . . . 0.0 110.965 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.983 HG22 HD22 ' A' ' 10' ' ' LEU . 2.1 t -104.94 -71.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.6 0.714 . . . . 0.0 109.964 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.69 -98.12 0.05 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.9 Cg_endo -59.62 -55.38 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 CA-C-N 117.926 0.863 . . . . 0.0 109.867 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.645 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -43.85 -11.41 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.15 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.87 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -116.02 -39.15 3.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.822 -1.174 . . . . 0.0 108.427 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -51.33 94.1 0.01 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.524 ' CD ' ' O ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -161.52 -23.28 0.05 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.677 ' CD2' ' O ' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -81.14 64.93 6.08 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.657 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 80.44 -5.51 63.82 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.29 80.89 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -1.149 . . . . 0.0 111.828 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.54 ' O ' ' NE2' ' A' ' 30' ' ' HIS . 42.9 m-80 -155.95 125.01 6.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.879 -1.138 . . . . 0.0 108.657 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.5 mm -101.16 -62.9 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.63 -0.669 . . . . 0.0 110.033 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.686 ' O ' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -41.87 -49.77 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.819 -1.176 . . . . 0.0 109.861 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -52.37 -50.54 62.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.854 -1.154 . . . . 0.0 108.181 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.87 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -48.85 -61.15 2.2 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.606 1.194 . . . . 0.0 109.076 178.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.716 HG13 ' CB ' ' A' ' 17' ' ' ALA . 98.6 t -70.52 -29.15 37.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.848 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.686 ' N ' ' O ' ' A' ' 35' ' ' MET . 40.3 tptt -54.44 -55.38 29.37 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.58 75.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.378 -0.826 . . . . 0.0 109.532 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.648 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.3 t80 -68.97 -76.36 0.09 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.581 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 23.6 m-20 -41.79 -37.19 1.18 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 122.455 1.121 . . . . 0.0 110.804 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -63.29 -35.02 78.97 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.355 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.514 ' O ' ' HG2' ' A' ' 48' ' ' MET . . . -90.05 -61.54 1.66 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.964 -1.094 . . . . 0.0 108.545 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.78 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 23.3 p -44.8 -30.08 0.9 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -81.36 -43.21 19.36 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 44' ' ' ALA . 16.3 t-20 -55.3 -24.04 26.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.356 -0.84 . . . . 0.0 109.647 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -109.09 -85.25 0.54 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.851 -1.156 . . . . 0.0 109.934 179.483 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' THR . . . -161.83 -150.43 5.95 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.121 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.2 123.09 49.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.721 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.804 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -155.39 -152.87 0.41 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.316 -0.865 . . . . 0.0 110.205 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.568 HD13 ' HA ' ' A' ' 13' ' ' PRO . 5.8 mm -147.19 143.89 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 14' ' ' ALA . 5.6 t -146.94 137.46 12.46 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.181 -0.949 . . . . 0.0 110.299 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.9 Cg_endo -73.03 87.24 1.03 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.842 1.694 . . . . 0.0 110.776 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.828 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.5 m -58.46 137.42 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.827 1.298 . . . . 0.0 112.231 -177.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 32.6 mt-10 -128.09 63.61 1.4 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.748 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.8 mt -63.38 88.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-O 121.66 0.743 . . . . 0.0 110.174 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.485 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.57 97.3 0.14 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.658 HG12 HG22 ' A' ' 57' ' ' ILE . 1.9 mt -100.66 146.11 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.474 -0.766 . . . . 0.0 110.17 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.789 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 9.6 m-85 -115.52 141.17 48.42 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.937 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.56 -30.37 5.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.153 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 7.2 t70 -52.51 1.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.842 ' H ' ' C ' ' A' ' 61' ' ' ALA . 8.8 tmm_? 71.68 69.8 0.16 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.06 0.933 . . . . 0.0 109.642 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -148.59 125.04 10.97 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.594 ' CD1' ' ND1' ' A' ' 30' ' ' HIS . 17.4 p90 -101.04 103.86 14.99 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.954 -1.091 . . . . 0.0 110.187 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 58' ' ' THR . 11.2 p -99.43 124.82 44.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 108.854 178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.566 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -107.97 171.35 7.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.596 -1.315 . . . . 0.0 109.368 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.994 HG12 ' O ' ' A' ' 68' ' ' VAL . 90.3 t -163.17 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.146 -0.971 . . . . 0.0 112.644 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.519 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.0 t -154.02 118.54 4.89 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 115.945 -2.302 . . . . 0.0 110.754 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.812 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -115.92 121.43 42.3 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.76 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.6 p 76.86 151.06 0.13 Allowed Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 71' ' ' THR . 12.6 Cg_exo -40.21 175.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.551 2.167 . . . . 0.0 113.038 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 75' ' ' SER . 24.6 Cg_exo -40.51 169.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.6 1.534 . . . . 0.0 112.004 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.934 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.93 -77.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.787 ' N ' ' O ' ' A' ' 73' ' ' PRO . 8.6 t -43.34 -23.62 0.07 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 110.147 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.07 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 20.5 p90 -43.6 -42.09 4.95 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.0 109.41 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.07 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -132.27 -14.58 2.96 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.934 HD12 ' HB1' ' A' ' 74' ' ' ALA . 3.1 mt -61.75 -31.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.768 ' NH2' ' SD ' ' A' ' 134' ' ' MET . 2.1 mmp_? -54.82 -44.27 73.71 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.499 ' HZ3' ' HB3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -66.03 -65.59 0.66 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.445 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -57.22 -4.31 0.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.207 -0.933 . . . . 0.0 109.657 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.634 ' O ' ' O ' ' A' ' 98' ' ' ARG . . . -85.55 -79.72 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 112.156 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.417 ' C ' HD23 ' A' ' 84' ' ' LEU . . . 163.64 47.76 0.02 OUTLIER Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.11 -1.519 . . . . 0.0 110.682 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 84' ' ' LEU . 5.4 mt -97.44 105.4 17.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.003 -1.292 . . . . 0.0 109.195 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 84' ' ' LEU . 89.4 mt-10 -156.14 -25.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.571 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.2 mttt 64.26 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 109.535 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.0 -175.17 23.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.98 -85.07 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -1.161 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -93.0 118.1 30.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.449 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.7 151.17 65.44 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.436 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.61 -52.93 5.9 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.491 1.461 . . . . 0.0 112.412 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.94 -164.99 32.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 61.84 152.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -1.119 . . . . 0.0 109.527 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 95' ' ' LYS . 1.8 tp10 -171.24 128.78 0.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.468 ' C ' HG23 ' A' ' 96' ' ' VAL . 42.1 mttm -156.65 167.86 29.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 109.321 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.468 HG23 ' C ' ' A' ' 95' ' ' LYS . 72.2 t -156.39 156.57 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 109.653 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 69.48 60.36 5.12 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.634 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.3 mtt180 -134.7 113.54 11.78 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.143 -1.21 . . . . 0.0 110.376 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.702 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.21 179.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.727 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -124.44 155.43 38.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.024 -1.048 . . . . 0.0 109.198 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.715 ' O ' HG22 ' A' ' 104' ' ' VAL . 12.0 t-105 -44.97 -70.25 0.11 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 111.244 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.511 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.1 tp10 -49.32 -52.98 24.35 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.69 -1.257 . . . . 0.0 111.047 -178.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.3 mt-30 -47.76 -44.6 28.31 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.272 -0.892 . . . . 0.0 110.429 -178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.9 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.5 -25.33 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 117.681 -1.608 . . . . 0.0 107.585 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 120' ' ' LEU . 16.8 mt -66.16 -70.86 0.22 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' LEU . 78.2 tt0 -43.85 -43.66 6.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.911 -1.118 . . . . 0.0 108.34 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.7 HG12 HD11 ' A' ' 77' ' ' LEU . 46.9 mt -61.83 -31.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.812 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.19 -27.42 16.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.37 -0.831 . . . . 0.0 109.573 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.783 ' HE3' HD11 ' A' ' 120' ' ' LEU . 13.9 mttp -58.44 -73.44 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.763 -1.21 . . . . 0.0 108.304 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.604 ' N ' ' CD ' ' A' ' 110' ' ' GLN . 1.5 mp0 -44.93 -26.43 0.42 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.041 -1.037 . . . . 0.0 108.794 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 109' ' ' LYS . 13.4 tttt -73.19 -16.96 61.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.683 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.698 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -131.68 65.9 76.88 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.039 -1.038 . . . . 0.0 109.746 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.0 Cg_endo -66.68 -34.76 30.97 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.704 1.602 . . . . 0.0 112.069 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.403 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER 175.0 15.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 109.163 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.403 ' H ' ' H ' ' A' ' 114' ' ' ASP . 3.3 mm? -55.49 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 0.0 109.553 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -150.66 -24.99 0.23 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.529 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.053 HG22 ' H ' ' A' ' 118' ' ' THR . 23.5 m -62.97 -164.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.167 -0.958 . . . . 0.0 109.499 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.053 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.34 -74.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.267 -0.895 . . . . 0.0 109.933 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.524 ' H ' HG23 ' A' ' 118' ' ' THR . 1.9 m-20 -61.78 140.44 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.768 . . . . 0.0 110.183 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -62.36 -22.34 66.03 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.204 1.002 . . . . 0.0 108.899 179.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.56 -35.39 80.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.414 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -72.41 -75.53 0.13 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.899 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.47 -34.15 1.96 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.491 -1.381 . . . . 0.0 109.27 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -58.11 -69.2 0.19 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.031 -1.043 . . . . 0.0 108.509 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 129' ' ' GLY . 0.0 OUTLIER -43.59 -44.79 6.4 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.703 ' O ' ' N ' ' A' ' 130' ' ' SER . 3.0 mtt -50.29 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.101 -0.999 . . . . 0.0 108.743 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.812 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 19.7 mm -48.09 -66.18 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.416 -0.802 . . . . 0.0 110.053 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.9 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.39 -71.37 0.11 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.94 -40.72 4.27 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 126' ' ' MET . 38.8 m -55.36 -47.8 75.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.507 -1.584 . . . . 0.0 107.582 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.567 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -50.43 -47.92 56.53 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 178.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.782 ' CG ' HH11 ' A' ' 132' ' ' ARG . 0.0 OUTLIER -46.11 -51.99 12.92 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.668 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.0 t -45.24 -67.88 0.25 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.768 ' SD ' ' NH2' ' A' ' 79' ' ' ARG . 9.4 ttm -48.53 -2.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 88.18 -27.21 7.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.032 -2.027 . . . . 0.0 108.032 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.672 HG23 ' SD ' ' A' ' 134' ' ' MET . 30.9 t -48.84 165.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.927 -0.749 . . . . 0.0 109.326 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' N ' HG12 ' A' ' 136' ' ' VAL . 40.3 mm-40 -142.27 162.37 35.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 109.767 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -78.27 165.02 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.905 HG13 ' O ' ' A' ' 139' ' ' VAL . 5.1 p -128.74 59.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 158.79 -112.8 0.54 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.85 61.98 10.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.162 -1.199 . . . . 0.0 109.293 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.8 Cg_endo -62.51 -165.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.822 1.681 . . . . 0.0 112.644 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.566 ' O ' HG13 ' A' ' 144' ' ' VAL . 0.3 OUTLIER -161.32 111.27 1.65 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 109.499 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 143' ' ' GLU . 0.7 OUTLIER -158.03 120.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -153.07 133.4 13.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.232 -0.918 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 22.2 m-20 -141.83 -60.63 0.47 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.84 87.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.878 . . . . 0.0 109.439 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' C ' ' CE2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER 176.94 118.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.89 . . . . 0.0 109.544 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.77 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -44.77 142.15 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.164 -0.96 . . . . 0.0 109.101 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.983 HG11 ' HB2' ' A' ' 61' ' ' ALA . 28.1 m -119.51 -24.58 3.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.77 107.73 4.51 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.422 -1.311 . . . . 0.0 110.338 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -98.86 73.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.755 ' HB ' HD12 ' A' ' 57' ' ' ILE . 32.3 t -48.03 88.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.816 -1.178 . . . . 0.0 110.653 -176.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' VAL . 2.7 tmtp? -82.47 36.06 0.47 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.791 0.805 . . . . 0.0 109.2 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.88 ' O ' ' N ' ' A' ' 55' ' ' VAL . 2.8 tp -78.31 -174.08 3.56 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.608 0.718 . . . . 0.0 111.119 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 1.054 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.74 177.88 5.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.597 HD13 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -167.61 155.9 8.59 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.825 -1.172 . . . . 0.0 109.945 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 15' ' ' GLY . 12.0 Cg_endo -68.83 104.55 1.18 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.037 1.824 . . . . 0.0 111.508 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.802 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -63.1 37.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.932 -1.105 . . . . 0.0 110.38 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' PRO . . . -170.56 -26.51 0.02 OUTLIER Glycine 0 N--CA 1.493 2.467 0 C-N-CA 118.096 -2.002 . . . . 0.0 111.842 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 15' ' ' GLY . 2.9 mttm -138.97 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.474 -1.604 . . . . 0.0 110.572 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.659 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -90.45 160.91 15.79 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.762 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -166.8 164.95 9.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.799 -1.188 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.468 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.9 Cg_exo -53.1 32.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.717 1.612 . . . . 0.0 112.026 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.68 54.16 4.56 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.221 -0.925 . . . . 0.0 110.046 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -83.09 155.01 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.696 1.597 . . . . 0.0 111.778 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.79 -4.69 1.49 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.006 1.137 . . . . 0.0 111.432 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.799 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 5.4 t -113.47 -68.96 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.556 -0.715 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.93 -97.62 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.799 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.7 Cg_exo -56.45 -55.04 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 CA-C-N 117.784 0.792 . . . . 0.0 110.479 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.724 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -55.59 -4.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.598 -0.689 . . . . 0.0 111.076 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -112.11 -54.71 2.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.645 -1.285 . . . . 0.0 109.152 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 30' ' ' HIS . . . -44.26 -26.5 0.96 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.499 ' C ' ' O ' ' A' ' 28' ' ' GLY . 52.0 mm-40 -42.01 -19.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.513 -1.58 . . . . 0.0 109.252 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.773 ' CD2' ' N ' ' A' ' 31' ' ' GLY . 3.6 p-80 -65.25 -48.86 71.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.788 0.804 . . . . 0.0 108.854 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.773 ' N ' ' CD2' ' A' ' 30' ' ' HIS . . . -162.22 -8.26 0.04 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 71.38 72.49 0.18 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.926 -0.75 . . . . 0.0 111.47 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.663 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -148.24 63.07 1.1 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.499 1.142 . . . . 0.0 108.742 177.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.4 mm -43.12 -66.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.361 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.679 ' O ' ' N ' ' A' ' 39' ' ' LYS . 10.7 tpt -41.61 -57.7 2.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.38 -1.45 . . . . 0.0 109.009 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 35' ' ' MET . 21.8 tp10 -44.68 -50.16 10.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.77 -1.206 . . . . 0.0 107.936 177.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -48.27 -62.98 1.21 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.813 1.292 . . . . 0.0 108.863 178.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 17' ' ' ALA . 61.8 t -67.78 -30.56 48.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.271 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 35' ' ' MET . 19.0 tttp -52.75 -59.82 4.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.24 74.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.414 -0.803 . . . . 0.0 109.512 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.683 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.3 t80 -69.66 -77.23 0.09 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.568 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 4.7 m-20 -41.77 -36.43 1.01 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.48 1.133 . . . . 0.0 110.539 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 39' ' ' LYS . . . -63.27 -35.1 79.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.586 ' O ' ' OD1' ' A' ' 47' ' ' ASN . . . -91.25 -57.52 2.76 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.813 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.772 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 16.2 p -48.08 -28.53 2.92 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.21 -47.88 11.08 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.687 ' OD1' ' N ' ' A' ' 48' ' ' MET . 1.9 p-10 -50.46 -23.0 2.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.216 -0.927 . . . . 0.0 109.127 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.759 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.51 -85.2 0.54 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.266 -0.896 . . . . 0.0 109.802 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.759 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -164.41 -117.93 0.42 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.842 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 50' ' ' ASP . 3.4 t0 -141.26 129.32 22.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.2 -1.176 . . . . 0.0 109.721 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.802 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -164.17 -152.81 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.174 -0.953 . . . . 0.0 110.391 -179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.585 HD13 ' HA ' ' A' ' 13' ' ' PRO . 3.3 mm -146.95 141.77 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.622 HG22 ' C ' ' A' ' 71' ' ' THR . 15.0 t -142.76 137.08 14.83 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 110.098 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 9.3 Cg_endo -74.33 88.14 1.16 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.882 1.722 . . . . 0.0 111.077 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.88 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -57.37 137.14 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 CA-C-O 122.697 1.237 . . . . 0.0 111.946 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 66.0 tt0 -128.89 67.49 1.41 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.755 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.1 mt -68.7 87.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.698 0.761 . . . . 0.0 110.068 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -63.71 100.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 57' ' ' ILE . 9.0 mt -103.13 145.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.569 -0.707 . . . . 0.0 110.406 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.77 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 8.0 m-85 -116.17 140.02 49.74 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.983 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.61 -32.13 7.7 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.391 -177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 14.9 t70 -50.6 -2.3 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.797 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.9 ttm180 75.31 70.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.035 0.921 . . . . 0.0 109.951 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 36.1 t -148.71 127.5 12.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.672 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -103.3 103.82 13.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.833 -1.167 . . . . 0.0 110.399 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 58' ' ' THR . 7.1 p -99.07 124.63 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -107.6 171.56 7.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.506 -1.371 . . . . 0.0 109.321 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.971 HG12 ' O ' ' A' ' 68' ' ' VAL . 98.7 t -162.56 44.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 112.813 -177.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.483 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.3 t -153.83 120.62 5.61 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 115.815 -2.354 . . . . 0.0 110.669 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.82 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -118.92 122.01 41.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.807 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 16.6 p 77.48 151.74 0.13 Allowed Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.138 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.514 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 13.8 Cg_exo -38.85 175.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 123.375 2.717 . . . . 0.0 114.083 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.89 ' O ' ' N ' ' A' ' 75' ' ' SER . 27.2 Cg_exo -40.68 168.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.077 0 C-N-CA 122.035 1.823 . . . . 0.0 112.308 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.78 ' N ' ' CE2' ' A' ' 76' ' ' TYR . . . 48.11 -74.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.89 ' N ' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -42.99 -21.05 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.683 -0.635 . . . . 0.0 110.755 -179.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.78 ' CE2' ' N ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -44.05 -35.51 2.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.728 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.978 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -136.55 -16.24 1.57 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.978 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.2 mt -58.86 -34.13 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.828 HH11 ' HG2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -55.85 -38.58 70.27 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 82' ' ' ALA . 11.3 tmtt? -69.72 -66.93 0.53 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.86 -7.39 0.3 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.178 -0.951 . . . . 0.0 109.153 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.48 -78.27 0.31 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.676 -0.64 . . . . 0.0 111.433 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.651 ' O ' ' CG1' ' A' ' 96' ' ' VAL . . . 166.2 14.21 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.913 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.784 HD12 ' NH1' ' A' ' 79' ' ' ARG . 2.6 mt -85.07 117.39 24.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.058 -1.26 . . . . 0.0 109.401 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.668 ' O ' ' N ' ' A' ' 87' ' ' GLY . 41.8 tp10 179.67 -84.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.866 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.431 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 24.6 mttt 44.96 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.93 . . . . 0.0 109.551 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 168.44 -98.83 0.14 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.91 -85.02 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -1.169 . . . . 0.0 109.539 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -78.05 175.84 9.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -140.38 150.61 61.65 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.56 -53.44 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 121.514 1.476 . . . . 0.0 112.328 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.42 140.22 3.64 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.795 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 65.11 97.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -1.148 . . . . 0.0 109.503 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.563 ' OE1' ' O ' ' A' ' 93' ' ' ARG . 4.0 tp10 178.78 152.55 0.34 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.558 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.438 ' C ' ' CG2' ' A' ' 96' ' ' VAL . 8.0 tttp -121.17 169.59 10.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.651 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 1.9 t -152.24 165.03 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 136' ' ' VAL . . . 96.02 64.21 0.95 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.543 ' O ' ' O ' ' A' ' 82' ' ' ALA . 5.8 mtt180 -134.09 114.82 13.57 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.09 -1.241 . . . . 0.0 110.304 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.7 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -103.38 179.88 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.715 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.6 OUTLIER -124.86 154.65 40.73 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.003 -1.06 . . . . 0.0 109.124 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.682 ' O ' HG22 ' A' ' 104' ' ' VAL . 12.8 t-105 -44.91 -69.73 0.13 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.49 -0.756 . . . . 0.0 111.386 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.19 -52.22 37.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.522 -1.361 . . . . 0.0 111.004 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.1 mt-30 -48.77 -44.05 38.41 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.452 -0.78 . . . . 0.0 110.492 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.709 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -71.75 -26.39 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 117.726 -1.589 . . . . 0.0 107.614 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.927 HD13 HD13 ' A' ' 120' ' ' LEU . 13.5 mt -65.01 -71.17 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.498 ' CD ' ' C ' ' A' ' 106' ' ' GLU . 7.4 tm-20 -44.35 -44.67 8.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.615 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.632 HG12 HD11 ' A' ' 77' ' ' LEU . 63.7 mt -61.99 -31.91 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 108.706 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.837 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -96.66 -26.84 15.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.828 . . . . 0.0 109.111 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.776 ' N ' ' O ' ' A' ' 105' ' ' LEU . 2.0 tptp -58.97 -73.52 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -48.91 -25.01 1.68 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.873 -1.142 . . . . 0.0 108.988 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.505 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 3.2 tmtt? -83.15 -7.39 59.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.269 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.724 ' O ' ' SD ' ' A' ' 112' ' ' MET . 2.3 ppp? -130.13 59.72 47.17 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.865 -1.147 . . . . 0.0 109.967 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.7 Cg_endo -61.29 -54.43 1.77 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.537 1.491 . . . . 0.0 112.305 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' H ' ' H ' ' A' ' 115' ' ' LEU . 0.9 OUTLIER 174.74 -1.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.612 ' O ' HD12 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -44.88 -28.82 0.7 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.696 -0.628 . . . . 0.0 109.717 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.482 ' N ' ' HG ' ' A' ' 115' ' ' LEU . 8.7 t30 -177.62 -14.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.96 -1.087 . . . . 0.0 109.653 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.043 HG22 ' H ' ' A' ' 118' ' ' THR . 31.9 m -104.02 -164.51 1.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.124 -0.985 . . . . 0.0 109.857 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.043 ' H ' HG22 ' A' ' 117' ' ' THR . 0.1 OUTLIER -179.48 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.231 -0.918 . . . . 0.0 109.806 -178.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.735 ' OD2' ' HB2' ' A' ' 122' ' ' ALA . 2.9 p-10 -58.0 143.07 44.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.44 -0.787 . . . . 0.0 110.163 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.927 HD13 HD13 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -71.92 -30.59 65.5 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.502 1.144 . . . . 0.0 108.387 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -62.91 -35.04 78.74 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.404 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.735 ' HB2' ' OD2' ' A' ' 119' ' ' ASP . . . -70.71 -76.32 0.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.382 -1.327 . . . . 0.0 107.556 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.89 -43.43 8.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.455 -1.403 . . . . 0.0 109.137 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -48.22 -69.74 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.183 -0.948 . . . . 0.0 108.64 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 129' ' ' GLY . 13.7 ttt180 -43.44 -39.6 3.35 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.708 ' O ' ' N ' ' A' ' 130' ' ' SER . 18.5 ttm -53.95 -79.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.249 -0.907 . . . . 0.0 108.742 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.837 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 22.4 mm -47.62 -63.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.772 . . . . 0.0 110.054 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.709 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -60.46 -71.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.11 -42.97 5.47 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.708 ' N ' ' O ' ' A' ' 126' ' ' MET . 52.0 m -52.59 -45.09 66.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.537 -1.566 . . . . 0.0 107.542 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.662 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -53.72 -48.03 69.99 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.607 ' HB3' ' O ' ' A' ' 129' ' ' GLY . 3.3 tmm_? -44.94 -44.75 10.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 135' ' ' GLY . 4.4 t -55.41 -69.88 0.12 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.771 ' CG ' HH21 ' A' ' 79' ' ' ARG . 5.9 ttm -44.87 -4.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.523 -0.735 . . . . 0.0 110.073 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 83.32 25.56 47.27 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.662 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 28.4 t -106.31 165.17 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.981 -0.717 . . . . 0.0 109.126 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' N ' HG12 ' A' ' 136' ' ' VAL . 50.3 mm-40 -140.41 161.89 36.61 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.901 -1.12 . . . . 0.0 110.086 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -77.84 165.07 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 139' ' ' VAL . 4.5 p -129.99 59.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . 160.74 -112.91 0.54 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.523 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.91 60.51 12.86 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.238 -1.154 . . . . 0.0 109.365 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.3 Cg_endo -64.73 -164.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.732 1.622 . . . . 0.0 112.691 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.444 ' O ' HG13 ' A' ' 144' ' ' VAL . 3.0 mm-40 -138.54 -164.93 1.72 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 143' ' ' GLU . 0.6 OUTLIER -154.24 135.39 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 0.0 109.554 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -179.64 116.74 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.449 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 147' ' ' ALA . 22.1 m-20 -138.78 145.01 39.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 9.3 pttm -142.49 115.47 8.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.539 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -165.32 114.96 1.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.28 -0.887 . . . . 0.0 109.707 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.772 ' N ' ' CE2' ' A' ' 60' ' ' TYR . 1.7 p -45.23 138.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 109.278 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.9 m -114.05 -24.35 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.17 108.29 6.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.001 -1.062 . . . . 0.0 110.331 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.81 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -95.54 73.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.737 ' HB ' HD12 ' A' ' 57' ' ' ILE . 12.2 t -45.69 88.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.239 -176.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.65 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -82.78 34.58 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.952 0.882 . . . . 0.0 109.093 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.85 ' O ' ' N ' ' A' ' 55' ' ' VAL . 1.6 tp -77.08 -174.46 3.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.783 0.801 . . . . 0.0 111.003 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 1.066 ' O ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -123.52 174.22 7.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.066 HD12 ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -171.17 158.88 5.18 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 110.411 179.243 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HA ' HD13 ' A' ' 52' ' ' ILE . 11.1 Cg_endo -66.61 108.69 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.197 1.932 . . . . 0.0 111.993 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.804 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . . . -67.47 40.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.055 -1.028 . . . . 0.0 110.622 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.457 ' N ' ' HB ' ' A' ' 45' ' ' THR . . . -178.09 -21.0 0.03 OUTLIER Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.527 -1.797 . . . . 0.0 111.525 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -139.92 74.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.521 -1.576 . . . . 0.0 110.259 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.784 ' HB3' HG13 ' A' ' 38' ' ' VAL . . . -92.25 165.29 13.19 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.194 -0.941 . . . . 0.0 108.588 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.763 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -170.4 163.06 6.1 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.915 -1.116 . . . . 0.0 110.036 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HA ' HG21 ' A' ' 34' ' ' ILE . 5.5 Cg_exo -53.13 32.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.681 1.587 . . . . 0.0 111.841 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.763 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -140.71 54.07 4.45 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.004 -1.06 . . . . 0.0 110.597 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 25.3 Cg_endo -85.82 160.83 10.51 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.766 1.644 . . . . 0.0 111.467 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.51 -4.81 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 120.898 1.065 . . . . 0.0 111.047 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 26' ' ' ALA . 21.2 t -115.58 -67.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.482 ' H ' ' HG2' ' A' ' 21' ' ' PRO . . . 56.51 -97.32 0.05 OUTLIER Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.808 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 5.0 Cg_exo -54.05 -55.02 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 CA-C-N 117.844 0.822 . . . . 0.0 110.45 177.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.837 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -60.79 -0.16 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.196 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.685 ' CD1' ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -113.58 -58.77 2.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.717 -1.24 . . . . 0.0 109.59 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 32' ' ' ALA . . . -43.18 -18.07 0.05 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.315 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.516 ' C ' ' O ' ' A' ' 28' ' ' GLY . 32.5 mm-40 -42.13 -21.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.255 -1.732 . . . . 0.0 108.502 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.764 ' O ' ' CG ' ' A' ' 30' ' ' HIS . 24.6 p-80 -67.32 59.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.653 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 84.62 -13.03 54.54 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.15 77.14 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.544 -0.974 . . . . 0.0 111.848 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' H ' ' CE1' ' A' ' 30' ' ' HIS . 1.4 m-80 -150.29 60.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.34 1.067 . . . . 0.0 108.536 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.0 mm -42.86 -65.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.623 ' O ' ' N ' ' A' ' 39' ' ' LYS . 8.2 tpt -41.95 -40.43 2.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 108.746 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -58.0 -51.2 70.66 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.685 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -47.85 -62.43 1.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.94 1.352 . . . . 0.0 108.951 177.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.784 HG13 ' HB3' ' A' ' 17' ' ' ALA . 61.0 t -67.26 -30.55 49.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.596 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -54.11 -59.46 4.62 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.33 74.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.0 109.433 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' A' ' 45' ' ' THR . 1.2 t80 -67.2 -75.03 0.1 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.592 HD22 ' HB3' ' A' ' 17' ' ' ALA . 1.5 m-80 -41.99 -37.38 1.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.475 1.131 . . . . 0.0 110.874 -177.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . -62.7 -35.53 80.02 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.559 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.678 ' O ' ' ND2' ' A' ' 47' ' ' ASN . . . -90.83 -56.11 3.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.878 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.756 ' HB ' ' C ' ' A' ' 14' ' ' ALA . 18.0 p -50.7 -26.22 5.25 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -83.59 -48.1 10.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -52.61 -21.22 3.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.3 -0.875 . . . . 0.0 108.975 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.545 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -109.63 -85.22 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.545 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . -168.56 -136.48 2.06 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.087 -1.53 . . . . 0.0 110.942 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 50' ' ' ASP . 2.8 p30 -122.12 122.34 39.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.326 -1.102 . . . . 0.0 109.915 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.804 ' CA ' ' HB3' ' A' ' 14' ' ' ALA . . . -156.08 -153.17 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.908 . . . . 0.0 110.289 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.8 mm -147.28 142.76 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.547 HG22 ' C ' ' A' ' 71' ' ' THR . 8.1 t -145.01 137.66 13.59 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 110.261 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 10.1 Cg_endo -73.56 86.67 1.17 Allowed 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.796 1.664 . . . . 0.0 110.669 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.85 ' N ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -56.68 138.38 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-O 122.749 1.261 . . . . 0.0 112.078 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 10.5 mt-10 -130.52 65.67 1.53 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 177.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.737 HD12 ' HB ' ' A' ' 8' ' ' VAL . 4.4 mt -65.44 88.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.812 0.815 . . . . 0.0 110.234 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.559 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -65.48 98.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.663 HG12 HG22 ' A' ' 57' ' ' ILE . 1.7 mt -102.94 147.54 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.524 -0.735 . . . . 0.0 110.449 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.772 ' CE2' ' N ' ' A' ' 4' ' ' VAL . 3.9 m-85 -115.82 141.62 47.85 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.802 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -48.52 -32.72 8.37 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.304 -177.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.27 -1.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.794 ' H ' ' C ' ' A' ' 61' ' ' ALA . 3.4 tmm_? 75.21 70.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.07 0.938 . . . . 0.0 109.64 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -148.99 124.94 10.62 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' CG ' ' A' ' 65' ' ' PHE . 20.6 p90 -100.97 103.73 14.89 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.003 -1.061 . . . . 0.0 110.197 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.458 ' O ' ' N ' ' A' ' 58' ' ' THR . 9.2 p -99.25 124.63 44.48 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.583 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.6 OUTLIER -107.71 170.41 8.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.481 -1.387 . . . . 0.0 109.355 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.963 HG12 ' O ' ' A' ' 68' ' ' VAL . 90.1 t -161.82 44.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 112.716 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.535 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 11.1 t -154.0 116.95 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 116.039 -2.264 . . . . 0.0 110.324 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.803 ' N ' ' CD ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -114.74 120.0 38.58 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.032 0.92 . . . . 0.0 108.701 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.779 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 15.5 p 76.94 152.26 0.13 Allowed Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.364 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.562 ' O ' ' O ' ' A' ' 71' ' ' THR . 15.3 Cg_exo -38.15 175.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.751 2.301 . . . . 0.0 113.365 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.795 ' O ' ' N ' ' A' ' 75' ' ' SER . 23.3 Cg_exo -42.26 168.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.761 1.641 . . . . 0.0 112.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.902 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 52.6 -77.0 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.795 ' N ' ' O ' ' A' ' 73' ' ' PRO . 41.6 p -43.42 -24.14 0.09 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.522 -0.736 . . . . 0.0 109.702 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 77' ' ' LEU . 14.6 p90 -43.86 -41.4 5.08 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -131.59 -18.82 2.75 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.902 HD12 ' HB1' ' A' ' 74' ' ' ALA . 1.4 mt -59.87 -32.65 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 84' ' ' LEU . 14.1 mmt180 -54.91 -43.09 72.96 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.526 ' CD ' ' C ' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -68.39 -66.64 0.54 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 80' ' ' LYS . . . -56.14 -4.92 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.157 -0.965 . . . . 0.0 109.517 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 78' ' ' ILE . . . -87.04 -79.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.508 -0.745 . . . . 0.0 112.018 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.486 ' O ' HD23 ' A' ' 84' ' ' LEU . . . 159.36 56.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.407 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 79' ' ' ARG . 10.2 mt -118.35 104.82 11.11 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.053 -1.263 . . . . 0.0 109.503 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 87' ' ' GLY . 34.9 tt0 179.57 -33.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.404 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.2 mttm 58.13 -85.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 92.16 -135.23 12.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.88 -84.98 0.46 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -1.181 . . . . 0.0 109.508 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -81.31 122.23 27.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -113.18 158.92 36.76 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.415 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.54 -52.25 5.81 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.577 1.518 . . . . 0.0 112.403 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.569 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 155.58 136.94 2.27 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.792 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 53.71 115.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -1.105 . . . . 0.0 109.471 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 95' ' ' LYS . 1.7 tm-20 -165.41 164.56 19.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.473 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.631 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 5.3 tptp -143.91 -164.96 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 97' ' ' GLY . 19.2 t -121.64 163.67 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.47 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 96' ' ' VAL . . . 50.98 60.92 6.58 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.626 ' O ' ' O ' ' A' ' 82' ' ' ALA . 6.6 mtt180 -134.74 113.54 11.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.071 -1.252 . . . . 0.0 110.686 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.692 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -104.29 -176.72 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.651 ' O ' HG13 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -128.93 156.32 43.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.017 -1.052 . . . . 0.0 109.093 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.712 ' O ' HG22 ' A' ' 104' ' ' VAL . 10.7 t-105 -44.93 -71.46 0.08 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.801 . . . . 0.0 111.176 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -50.13 -52.52 34.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.636 -1.29 . . . . 0.0 111.103 -178.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.408 ' HG3' ' OG1' ' A' ' 100' ' ' THR . 5.1 mt-30 -47.82 -43.66 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.383 -0.823 . . . . 0.0 110.303 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -72.56 -24.88 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.575 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.869 HD13 HD13 ' A' ' 120' ' ' LEU . 21.2 mt -66.0 -72.06 0.17 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 107' ' ' ILE . 11.3 tm-20 -44.28 -45.02 8.42 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.959 -1.088 . . . . 0.0 108.612 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.764 ' CD1' HD21 ' A' ' 77' ' ' LEU . 42.1 mt -61.25 -31.67 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.027 -1.046 . . . . 0.0 108.623 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.847 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -97.45 -23.68 15.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.844 . . . . 0.0 108.984 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.788 ' N ' ' O ' ' A' ' 105' ' ' LEU . 1.9 tptp -62.43 -74.52 0.09 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.558 ' NE2' ' H ' ' A' ' 110' ' ' GLN . 2.2 mp0 -44.63 -30.15 0.87 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.022 -1.049 . . . . 0.0 108.806 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -61.82 -24.0 66.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.706 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -126.39 73.85 73.37 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.197 -0.94 . . . . 0.0 109.698 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.79 -34.4 24.44 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.551 1.501 . . . . 0.0 111.964 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.521 ' CG ' ' O ' ' A' ' 114' ' ' ASP . 3.6 t70 175.09 11.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.036 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 115' ' ' LEU . 2.4 mm? -49.81 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 109.606 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.764 ' ND2' ' N ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -148.76 -25.05 0.31 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.607 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.057 HG22 ' H ' ' A' ' 118' ' ' THR . 22.9 m -60.19 -164.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.537 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.057 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -173.58 -72.68 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.3 -0.875 . . . . 0.0 109.929 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.53 ' H ' HG23 ' A' ' 118' ' ' THR . 4.8 m-20 -65.32 138.28 58.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.439 -0.788 . . . . 0.0 110.159 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.869 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -61.73 -21.53 64.59 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.282 1.039 . . . . 0.0 108.815 179.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.53 -38.49 91.2 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.54 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.436 ' O ' ' C ' ' A' ' 123' ' ' ALA . . . -68.88 -75.13 0.11 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.135 -1.426 . . . . 0.0 107.784 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.537 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.53 -41.64 6.61 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.524 -1.36 . . . . 0.0 109.392 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.09 -69.52 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 0.0 108.764 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.2 ttm180 -43.55 -39.94 3.69 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.701 ' O ' ' N ' ' A' ' 130' ' ' SER . 8.2 ttm -53.31 -78.87 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.178 -0.951 . . . . 0.0 108.579 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.847 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 24.1 mm -47.92 -63.96 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.438 -0.789 . . . . 0.0 109.954 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.805 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -59.97 -71.75 0.12 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -43.01 -41.87 4.84 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 126' ' ' MET . 50.8 m -54.35 -50.73 66.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.523 -1.575 . . . . 0.0 107.685 178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.734 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -48.49 -47.49 38.63 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 135' ' ' GLY . 3.9 tmt_? -46.0 -55.01 7.4 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 135' ' ' GLY . 8.5 t -44.71 -68.59 0.19 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.652 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.2 ttp -46.68 -4.29 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 89.63 -31.08 5.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.734 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 29.0 t -45.43 165.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.937 -0.743 . . . . 0.0 109.194 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.547 ' N ' HG12 ' A' ' 136' ' ' VAL . 35.9 mp0 -143.85 163.2 34.05 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.65 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 138' ' ' VAL . 1.9 t -79.28 155.08 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.692 ' N ' ' O ' ' A' ' 99' ' ' ILE . 4.1 p -115.94 -10.01 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.628 -0.67 . . . . 0.0 109.284 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 141' ' ' ALA . . . -115.6 -124.37 3.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.515 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.94 60.35 13.07 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.16 . . . . 0.0 109.371 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.2 Cg_endo -64.41 -165.01 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.78 1.653 . . . . 0.0 112.642 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -136.6 -164.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.842 . . . . 0.0 109.38 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.76 164.21 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.96 . . . . 0.0 109.541 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -178.33 82.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 146' ' ' ASP . 58.5 p-10 -177.37 76.86 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.479 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.57 98.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.589 ' C ' ' CD2' ' A' ' 60' ' ' TYR . 27.8 ttpt -178.54 124.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 109.674 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.794 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.6 p -44.75 126.2 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.535 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.813 HG11 ' HB2' ' A' ' 61' ' ' ALA . 27.6 m -111.66 -24.5 3.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.3 6.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.166 -0.959 . . . . 0.0 110.247 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 7' ' ' VAL . 1.8 p -94.99 73.57 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.386 -0.821 . . . . 0.0 108.827 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 55' ' ' VAL . 26.1 t -45.92 88.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.045 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -83.96 34.32 0.5 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.951 0.881 . . . . 0.0 108.901 179.281 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.921 ' CD2' HG22 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -78.53 -174.66 3.93 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.872 0.844 . . . . 0.0 111.268 -178.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.578 ' NE2' ' N ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -116.98 169.49 9.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.569 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -163.08 144.44 7.6 Favored Pre-proline 0 C--N 1.3 -1.582 0 C-N-CA 118.279 -1.368 . . . . 0.0 110.159 178.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HA ' HD13 ' A' ' 52' ' ' ILE . 30.3 Cg_endo -79.02 126.6 7.2 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.505 2.137 . . . . 0.0 114.216 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.079 ' HB3' ' N ' ' A' ' 51' ' ' ALA . . . -72.52 141.43 48.51 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 17' ' ' ALA . . . 60.55 -61.24 0.01 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.755 ' N ' ' O ' ' A' ' 14' ' ' ALA . 1.1 ttpm? -60.64 37.77 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.831 -0.805 . . . . 0.0 108.831 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.704 ' N ' ' O ' ' A' ' 15' ' ' GLY . . . -119.27 151.83 37.74 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.9 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -168.79 165.77 6.89 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 -179.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.5 Cg_exo -49.46 36.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.696 1.598 . . . . 0.0 111.657 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.9 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -163.77 54.87 0.43 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.53 -0.732 . . . . 0.0 109.78 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 11.2 Cg_endo -77.93 170.16 19.36 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.485 1.456 . . . . 0.0 111.716 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -60.75 -4.65 3.7 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.209 1.273 . . . . 0.0 111.03 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.921 HG22 ' CD2' ' A' ' 10' ' ' LEU . 2.2 t -106.16 -71.62 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.594 0.711 . . . . 0.0 110.333 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.31 -98.37 0.05 OUTLIER Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.751 -1.739 . . . . 0.0 108.751 -177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 2.3 Cg_endo -60.21 -55.4 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 CA-C-N 118.047 0.924 . . . . 0.0 109.926 176.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.602 ' HB3' ' CG1' ' A' ' 23' ' ' VAL . . . -44.35 -9.55 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.362 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.89 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -111.87 -42.84 3.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.631 -1.293 . . . . 0.0 108.751 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.66 84.44 0.01 OUTLIER Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 27' ' ' LEU . 6.3 tt0 -149.18 -15.34 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 65' ' ' PHE . 2.0 p80 -84.42 -37.41 21.49 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.649 ' N ' ' ND1' ' A' ' 30' ' ' HIS . . . -170.91 -2.8 0.03 OUTLIER Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 75.17 81.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.606 -0.938 . . . . 0.0 112.19 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -156.8 120.86 4.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.982 -1.074 . . . . 0.0 108.639 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 22.6 mm -96.58 -65.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.702 -0.624 . . . . 0.0 110.108 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.669 ' O ' ' N ' ' A' ' 39' ' ' LYS . 5.3 tpt -42.09 -56.97 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.715 -1.241 . . . . 0.0 109.558 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 35' ' ' MET . 6.5 mt-10 -46.86 -50.78 18.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.91 -1.119 . . . . 0.0 108.269 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.89 ' CE2' HD12 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -48.72 -61.61 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.644 1.212 . . . . 0.0 109.617 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.671 ' CG1' HD22 ' A' ' 42' ' ' ASN . 56.3 t -71.37 -30.28 39.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.979 -179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 35' ' ' MET . 32.6 tptt -51.54 -63.1 1.24 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.04 69.76 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 45' ' ' THR . 1.9 t80 -70.32 -76.83 0.09 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.671 HD22 ' CG1' ' A' ' 38' ' ' VAL . 1.3 m-80 -41.37 -34.01 0.47 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.578 1.18 . . . . 0.0 110.63 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 39' ' ' LYS . . . -67.39 -35.06 78.55 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' O ' ' SD ' ' A' ' 48' ' ' MET . . . -91.05 -43.99 9.58 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.735 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.697 ' CB ' ' H ' ' A' ' 15' ' ' GLY . 18.1 p -61.16 -32.14 71.87 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 42' ' ' ASN . . . -78.36 -44.74 24.26 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.23 -23.7 49.69 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.763 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -110.8 -74.69 0.64 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.763 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 169.83 149.35 6.28 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.124 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.8 t70 -44.82 148.37 0.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.986 -1.303 . . . . 0.0 109.429 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.079 ' N ' ' HB3' ' A' ' 14' ' ' ALA . . . 176.87 -153.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.973 -1.079 . . . . 0.0 110.623 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.641 HD13 ' HA ' ' A' ' 13' ' ' PRO . 4.7 mm -147.16 141.78 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 71' ' ' THR . 2.8 t -144.96 133.8 11.05 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.801 -1.187 . . . . 0.0 110.888 -178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 5.7 Cg_endo -69.13 95.7 0.51 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.484 1.456 . . . . 0.0 110.315 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.792 ' N ' ' O ' ' A' ' 10' ' ' LEU . 4.9 m -75.84 137.97 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.928 1.347 . . . . 0.0 112.61 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 14.4 mt-10 -128.61 61.73 1.48 Allowed 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.723 HD12 ' HB ' ' A' ' 8' ' ' VAL . 3.6 mt -61.71 88.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-O 121.729 0.776 . . . . 0.0 109.825 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.489 HG22 HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -64.23 95.18 0.12 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.654 HG13 HG22 ' A' ' 57' ' ' ILE . 12.9 mt -96.96 140.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.648 -0.657 . . . . 0.0 110.162 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.794 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.5 m-85 -111.83 138.93 47.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.843 ' C ' ' H ' ' A' ' 63' ' ' ARG . . . -47.08 -30.35 2.7 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.397 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -53.47 3.67 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.843 ' H ' ' C ' ' A' ' 61' ' ' ALA . 2.6 tmm_? 70.05 69.64 0.22 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 122.099 0.952 . . . . 0.0 109.436 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 3.2 m -147.86 125.87 12.07 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.736 ' CD1' ' N ' ' A' ' 65' ' ' PHE . 0.1 OUTLIER -102.19 104.08 14.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.052 -1.03 . . . . 0.0 110.288 -179.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.433 ' OG1' ' HB ' ' A' ' 58' ' ' THR . 23.4 p -98.78 124.52 43.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.557 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -109.64 173.74 6.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.58 -1.325 . . . . 0.0 109.281 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.974 HG12 ' O ' ' A' ' 68' ' ' VAL . 85.3 t -162.78 44.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 112.666 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.529 ' C ' ' HD2' ' A' ' 70' ' ' LYS . 1.2 t -156.55 118.09 3.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 116.092 -2.243 . . . . 0.0 109.475 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.821 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -114.61 125.15 53.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.339 1.066 . . . . 0.0 109.328 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 1.027 HG21 ' CZ ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 75.02 161.56 0.15 Allowed Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.22 -179.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.681 ' HD2' HG22 ' A' ' 71' ' ' THR . 12.4 Cg_exo -41.35 175.13 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.469 2.112 . . . . 0.0 113.102 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 75' ' ' SER . 21.1 Cg_exo -44.08 169.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.681 1.587 . . . . 0.0 112.071 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.863 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . 54.8 -74.49 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.777 ' N ' ' O ' ' A' ' 73' ' ' PRO . 22.8 t -43.76 -20.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.508 -0.745 . . . . 0.0 110.055 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 1.093 ' CZ ' HD22 ' A' ' 77' ' ' LEU . 26.8 p90 -43.49 -43.35 5.37 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.093 HD22 ' CZ ' ' A' ' 76' ' ' TYR . 0.3 OUTLIER -131.76 -20.42 2.55 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.895 ' N ' HD23 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -55.36 -35.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 1.027 ' CZ ' HG21 ' A' ' 71' ' ' THR . 0.0 OUTLIER -53.39 -57.6 10.04 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.51 ' C ' ' N ' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -52.04 -64.29 0.86 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.016 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.68 ' HB1' HG22 ' A' ' 99' ' ' ILE . . . -48.89 -16.46 0.13 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 0.0 108.463 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.864 ' HB1' ' HA2' ' A' ' 97' ' ' GLY . . . -98.78 -74.43 0.59 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.916 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 79' ' ' ARG . . . 95.59 95.12 1.74 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.964 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.817 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 7.1 mt -118.88 105.0 11.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -1.201 . . . . 0.0 108.938 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.69 ' O ' ' N ' ' A' ' 87' ' ' GLY . 73.2 mm-40 -153.2 16.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.104 -0.998 . . . . 0.0 109.819 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 23.5 tttt 45.04 -85.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.155 -0.966 . . . . 0.0 109.386 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.69 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 124.31 121.81 2.62 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' A' ' 89' ' ' HIS . . . -68.21 -62.9 1.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -1.162 . . . . 0.0 109.341 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.579 ' O ' ' O ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -51.92 -164.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.869 . . . . 0.0 109.315 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 89' ' ' HIS . 15.0 mttm -44.85 159.55 0.26 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 0.0 109.314 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.4 -54.99 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 121.557 1.505 . . . . 0.0 112.552 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.04 -39.23 2.97 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.562 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 3.1 mpt_? 58.77 55.41 4.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -1.102 . . . . 0.0 109.622 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.562 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 32.0 mt-10 -164.74 48.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 109.619 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.612 ' O ' HG23 ' A' ' 96' ' ' VAL . 34.2 mttp -163.28 72.6 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.646 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.812 ' O ' ' N ' ' A' ' 98' ' ' ARG . 79.2 t -159.85 166.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 110.439 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.864 ' HA2' ' HB1' ' A' ' 82' ' ' ALA . . . -43.99 72.98 0.0 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.812 ' N ' ' O ' ' A' ' 96' ' ' VAL . 2.6 mtt180 -135.65 109.74 8.28 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -1.077 . . . . 0.0 109.563 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.828 HD13 HG12 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -114.01 -175.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.759 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -125.24 165.84 17.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.082 . . . . 0.0 109.666 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.688 ' O ' HG22 ' A' ' 104' ' ' VAL . 24.3 t-105 -51.01 -71.31 0.07 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.646 -0.659 . . . . 0.0 111.277 -179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.505 ' C ' ' CD ' ' A' ' 102' ' ' GLU . 4.0 tp10 -47.73 -50.31 25.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.766 -1.209 . . . . 0.0 110.859 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -49.86 -44.9 49.99 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.314 -0.866 . . . . 0.0 110.308 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.902 HG21 ' HB2' ' A' ' 128' ' ' ALA . 2.4 m -70.73 -25.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 117.535 -1.666 . . . . 0.0 107.379 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.954 HD13 HD13 ' A' ' 120' ' ' LEU . 18.8 mt -66.31 -71.08 0.21 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 105' ' ' LEU . 72.7 tt0 -43.74 -43.77 6.21 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.923 -1.111 . . . . 0.0 108.641 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.724 HG12 HD11 ' A' ' 77' ' ' LEU . 55.7 mt -62.79 -30.75 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.021 -1.049 . . . . 0.0 108.541 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.799 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . . . -94.88 -26.11 16.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.478 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -61.78 -74.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 0.0 108.396 179.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.453 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 4.6 tt0 -47.16 -20.29 0.17 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.189 -0.945 . . . . 0.0 109.26 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -80.89 -9.31 59.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.856 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -133.52 56.43 20.63 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.045 -1.035 . . . . 0.0 109.785 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 112' ' ' MET . 2.9 Cg_endo -59.33 -33.36 97.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 121.585 1.523 . . . . 0.0 112.406 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.06 19.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.479 ' CD1' ' HD2' ' A' ' 113' ' ' PRO . 4.2 mp -54.12 -85.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.314 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.82 -11.39 0.23 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.419 -0.801 . . . . 0.0 109.154 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.037 HG22 ' H ' ' A' ' 118' ' ' THR . 31.5 m -72.24 -164.57 0.15 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.301 -0.875 . . . . 0.0 109.498 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.037 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -174.8 -56.42 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.314 -0.866 . . . . 0.0 109.674 -179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.444 ' H ' HG23 ' A' ' 118' ' ' THR . 1.1 m-20 -80.43 134.94 36.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.0 109.886 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.954 HD13 HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -55.24 -22.5 18.31 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.179 0.99 . . . . 0.0 109.019 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.6 -36.82 84.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.409 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.63 ' HB3' ' CG2' ' A' ' 117' ' ' THR . . . -70.53 -75.75 0.11 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.481 -1.387 . . . . 0.0 107.977 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.635 ' HB1' ' HB1' ' A' ' 108' ' ' ALA . . . -44.35 -40.31 5.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.479 -1.388 . . . . 0.0 109.243 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 120' ' ' LEU . . . -51.77 -68.12 0.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.026 -1.046 . . . . 0.0 108.442 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.675 ' O ' ' N ' ' A' ' 129' ' ' GLY . 1.8 ttm180 -43.63 -43.59 5.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.713 ' O ' ' N ' ' A' ' 130' ' ' SER . 9.2 ttm -51.34 -79.48 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.057 -1.027 . . . . 0.0 108.563 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.799 ' CG1' ' HB2' ' A' ' 108' ' ' ALA . 21.3 mm -48.19 -65.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.474 -0.767 . . . . 0.0 109.912 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 104' ' ' VAL . . . -58.21 -71.49 0.11 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -42.93 -40.53 4.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.713 ' N ' ' O ' ' A' ' 126' ' ' MET . 45.1 m -56.3 -51.05 69.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.467 -1.608 . . . . 0.0 107.707 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.716 ' HB1' ' CG1' ' A' ' 136' ' ' VAL . . . -46.86 -47.74 21.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.637 ' O ' ' N ' ' A' ' 135' ' ' GLY . 0.1 OUTLIER -46.8 -54.32 10.08 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 135' ' ' GLY . 7.3 t -44.99 -70.24 0.11 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.701 ' HG2' HG23 ' A' ' 136' ' ' VAL . 2.2 ttp -46.9 -4.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.613 -0.679 . . . . 0.0 109.355 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.68 ' N ' ' O ' ' A' ' 133' ' ' SER . . . 90.71 -30.11 6.36 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 -178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.716 ' CG1' ' HB1' ' A' ' 131' ' ' ALA . 50.8 t -44.91 164.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.856 -0.791 . . . . 0.0 108.941 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 138' ' ' VAL . 2.1 tm-20 -144.04 162.66 35.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 109.686 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.617 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 t -80.23 145.41 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.962 HG13 ' O ' ' A' ' 139' ' ' VAL . 2.4 p -110.01 61.99 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.26 -117.76 0.79 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.479 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 44.72 61.4 11.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.148 -1.207 . . . . 0.0 109.269 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.564 ' O ' ' CG ' ' A' ' 143' ' ' GLU . 2.0 Cg_endo -61.74 156.62 47.06 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.724 1.616 . . . . 0.0 112.689 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.564 ' CG ' ' O ' ' A' ' 142' ' ' PRO . 19.5 mt-10 -165.7 87.96 0.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -0.86 . . . . 0.0 109.351 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 143' ' ' GLU . 5.3 m -156.38 146.23 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 175.03 138.56 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.845 . . . . 0.0 109.401 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 147' ' ' ALA . 28.7 m-20 -133.95 134.85 43.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.55 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.515 179.944 . . . . . . . . 1 1 . 1 stop_ save_